15th Congress of the European Society for Organ Transplantation

ETCO EDC Joint Meeting

ESOT EFI BSHI Symposium 22nd BSHI Conference

A Meeting with a Difference

Programme Book

A meeting with a difference ........................................................... 3 ESOT 2011 Committees ................................................................. 4 Abstracts Board of Reviewers ......................................................... 6 ESOT Grants Recipients ................................................................. 8 Scientific and General Information ............................................... 11 Congress Hotels ........................................................................... 25 Networking Events ....................................................................... 26 Schedule of Business Meetings and Activities ............................. 28 Plan of SECC ................................................................................ 29 Programme Overview ................................................................... 30 Speciality Update Symposia ......................................................... 35 ETCO and EDC Joint meeting ..................................................... 48 ETCO Workshops & CETC Certificate .......................................... 50 ESOT EFI BSHI Joint Symposium & 22nd Annual BSHI Conference .......................................................................... 51 22nd Annual BSHI Conference Posters ........................................ 55 ELPAT Activity ............................................................................... 57 ESOT 2011 Live ............................................................................ 60 ESOT 2011 Scientific Programme ................................................ 61 ESOT 2011 Posters ..................................................................... 193 Corporate Symposia Programme ............................................... 243 ESOT & ESOT 2011 Supporters ................................................. 252 ESOT 2011 Hub & Exhibit Floor Plan ....................................... 254 List of Exhibitors ......................................................................... 255 Company Descriptions ............................................................... 256 Authors Index ............................................................................. 271

Where the story begins

Some years ago at a transplant Congress for international delegates, a few members of the British Transplant Society got together. We felt that international medical meetings had begun to feel too big and that innovation was required. Out of this, there came a bid to hold ESOT 2011 (on behalf of the British Transplantation Society), countless meetings and planning with the final result that we are delighted to welcome you to the 15th ESOT Congress in Glasgow. In making our pitch for the Congress 4 years ago, we committed to a meeting focussed on cutting edge clinical and laboratory science. We were also conscious of the need to embrace modern technologies, the need to improve the integration of educational opportunities in the Congress, and the need to stimulate active participation of delegates. We promised, and we hope you will experience, a Meeting with a Difference. Over the last two years, a Local Organising Committee has worked with the Scientific Programme Committee of ESOT to produce something which we hope is truly innovative. We have tried lots of new ideas some of which will work, perhaps others will not, some have made it to the final meeting, some we dropped on the way ... The main developments include more extensive use of technology to provide new presentation formats and interaction with the audience. These are clinical discussion cases, smaller lecture theatres for short oral presentations and a move to the hybrid poster area to enhance the value of these presentations. We think the Congress will stimulate a strong feel for networking and we want you to tell us if we succeed! On a personal note, we are both delighted that you are able to join us here in Glasgow. We hope that you enjoy the City and your visit to Scotland, a country known for tradition and hospitality. We hope that you will enjoy the science and the social aspects of the Congress, and more than anything, we hope that for you all, the Glasgow Congress will be a memorable event.

Alan Jardine

John Forsythe

ESOT Council & Congress Committees

Glasgow 2011 Local Organising Committee
Chairs: Alan Jardine, Glasgow, United Kingdom John Forsythe, Edinburgh, United Kingdom Executives: Peter Friend, Oxford, United Kingdom Keith Rigg, Nottingham, United Kingdom Anthony Warrens, London, United Kingdom Chris Watson, Cambridge, United Kingdom Members: David Adams, Birmingham, United Kingdom Kesh Baboolal, Cardiff, United Kingdom Andrew Bradley, Cambridge, United Kingdom Lisa Burnapp, London, United Kingdom Andrew Bushell, Oxford, United Kingdom John Dark, Newcastle upon Tyne, United Kingdom Tony Dorling, London, United Kingdom Phil Dyer, Edinburgh, United Kingdom Vincent Emery, London, United Kingdom Stuart Forbes, Edinburgh, United Kingdom Andrew George, London, United Kingdom Alex Gimson, Cambridge, United Kingdom Jane Griffiths, London, United Kingdom Rachel Johnson, London, United Kingdom Lorna Marson, Edinburgh, United Kingdom Dermot McKeown, Edinburgh, United Kingdom Adam McLean, London, United Kingdom Paolo Muiesan, Birmingham, United Kingdom James Neuberger, Birmingham, United Kingdom John Wallwork, Cambridge, United Kingdom Steve Wigmore, Edinburgh, United Kingdom

ESOT Council 20102011

President: Rutger Ploeg, Oxford, United Kingdom Past President: Ferdinand Mhlbacher, Vienna, Austria Secretary: John Forsythe, Edinburgh, United Kingdom Treasurer: Hans Schlitt, Regensburg, Germany Executive Officer: Annalisa Ponchia

Councillors
Ignacio Anegon, Nantes, France Carla Baan, Rotterdam, The Netherlands Thierry Berney, Geneva, Switzerland Patrizia Burra, Padua, Italy Andrew Burroughs, London, United Kingdom Josep Campistol Plana, Barcelona, Spain Alan Jardine, Glasgow, United Kingdom Piotr Kalicinsky, Krakow, Poland George Mourad, Montpellier, France Alessandro Nanni Costa, Rome, Italy Bernadette Haase-Kromwijk, Leiden, The Netherlands Stefan Schneeberger, Innsbruck, Austria Annika Tibell, Stockholm, Sweden Dirk van Raemdonck, Leuven, Belgium Willem Weimar, Rotterdam, The Netherlands

ELITA (European Liver and Intestine Transplant Association) Board

Chair: Andrew Burroughs, London, United Kingdom Vice Chair: Bernard De Hemptinne, Ghent, Belgium Secretary: Paolo Muiesan, Birmingham, United Kingdom Treasurer: Michele Colledan, Bergamo, Italy Custodian of the European Liver Transplant Registry (ELTR): Ren Adam, Villejiuf, France

Scientific Programme Committee

Chair: John Forsythe Carla Baan Andrew Burroughs Peter Friend Alan Jardine Dirk van Raemdonck Willem Weimar

Sponsorship Advisory Committee

Members
William Bennet, Gothenburg, Sweden Gabriela Berlakovich, Vienna, Austria Christophe Duvoux, Paris, France Martin Oliverius, Prague, Czech Republic Jacques Pirenne, Leuven, Belgium Johann Pratschke, Innsbruck, Austria

Rutger Ploeg John Forsythe Hans Schlitt Annalisa Ponchia Alan Jardine, Local liaison

EPITA (European Pancreas and Islet Transplant Association) Board

Chair: Thierry Berney, Geneva, Switzerland Secretary: Frantisek Saudek, Prague, Czech Republic

European Donation Committee

Chair: Bernadette Haase-Kromwijk, Leiden The Netherlands

Members
Lisa Burnapp, London, United Kingdom Peter Friend, Oxford, United Kingdom Gnter Kirste, Neu-Isenburg, Germany Diane Moretti, Geneva, Switzerland Alessandro Nanni Costa, Rome, Italy Dirk Ysebaert, Antwerp, Belgium

Members
Mathias Brendel, Dresden, Germany Torbjrn Lundgren, Stockholm, Sweden Johann Pratschke, Innsbruck, Austria Alexander Schaapherder, Leiden, The Netherlands Antonio Secchi, Milan, Italy

Education Committee
Chair: Patrizia Burra, Padua Italy

Thoracic Committee
Chair: Dirk van Raemdonck, Leuven, Belgium ESHLT Representative: Paul Corris, Newcastle, United Kingdom

Members
Andrzej Baranski, Leiden, The Netherlands Phil Dyer, Edinburgh, United Kingdom Christophe Legendre, Paris, France Wojtek Polak, Rotterdam, The Netherlands Robert Porte, Groningen, The Netherlands

Members
Nicolas Banner, London, United Kingdom Annette Boehler, Zurich, Switzerland Michiel Erasmus, Groningen, The Netherlands Gnter Laufer, Vienna, Austria

Ambassadors Committee
Chair: Jan Lerut, Brussels, Belgium

Members
Wolf Bechstein, Frankfurt am Main, Germany Bo-Gran Ericzon, Stockholm, Sweden Josep Griny, Barcelona, Spain Guido Persijn, Leiden, The Netherlands Per Pfeffer, Oslo, Norway Kaija Salmela, Helsinki, Finland Stefan Tullius, Boston, United States

ELPAT Ethical, Legal and Psychosocial Aspects of Organ Transplantation

Chair: Willem Weimar, Rotterdam, The Netherlands Coordinator: Frederike Ambagtsheer, Rotterdam, The Netherlands Secretary: Marian van Noord, Rotterdam, The Netherlands

CTA Working Group Basic Science Committee

Chair: Carla Baan, Rotterdam, The Netherlands Chair: Stefan Schneeberger, Innsbruck, Austria Senior Advisor: Yves Vanrenterghem, Leuven, Belgium

Members
Ignacio Anegon, Nantes, France Manuela Battaglia, Milan, Italy Michel Braun, Brussels, Belgium Andrew Bushell, Oxford, United Kingdom Johann Pratschke, Innsbruck, Austria Thomas Wekerle, Vienna, Austria

Members
Gerald Brandacher, Innsbruck, Austria Peter Butler, London, United kingdom Christoph Hoehnke, Memming, Germany Jerzy Jableki, Trzebnica, Poland Luis Landin, Madrid, Spain Laurent Lantieri, Creteil, France Alain Lemoine, Brussels, Belgium Emmanuel Morelon, Lyon, France

Kidney Committee
Alan Jardine, Glasgow, United Kingdom Josep Campistol Plana, Barcelona, Spain

Centre for Evidence in Transplantation CET

Director: Sir Peter Morris Senior Research Associate: Liset Pengel PA/Research Assistant: Nishanthi Talawila

Abstracts Board of Reviewers

Allocation Andrew Bradley Thomas Breidenbach Neville Jamieson Rachel Johnson Axel Rahmel Chris Rudge Clinical Case John Forsythe Peter Friend Alan Jardine Keith Rigg Anthony Warrens Chris Watson Composite Tissues Jean-Michel Dubernard Darla Granger Nadey Hakim Emmanuel Morelon Palmina Petruzzo Stefan Schneeberger Donation/Retrieval Beatriz Dominguez-Gil Christian Hiesse Gunter Kirste David Mayer Dermot McKeown Alessandro Nanni Costa Eva Pokorna Leo Roels Rafail Rozental Dirk Ysebaert Ethics/Law/Psychosocial/ Public Policy Frederike Ambagtsheer Mike Bos Fabienne Dobbels Hele Everaus Bernadette Haase-Kromwijk James Neuberger Eva Pokorna David Price Keith Rigg Wojciech Rowinski Annika Tibell Jan Van Busschbach Heart Nick Banner Robert Bonser John Dark Stephen Large Petr Nemec Francesco Parisi Gareth Parry Alain Poncelet Mauro Rinaldi Inez Rodrigus Stephan Schueler Steve Tsui Johan Vanhaecke Marian Zembala Andreas Zuckermann Histocompatibility David Briggs Frans Claas Phil Dyer Susan Fuggle Francesca Poli Tony Slavcev Caroline Suberbielle-Boissel Helder Trindade Immunobiology/ Basic Science Ignacio Anegon Carla Baan Michel Braun Maria Cristina Cuturi Marc Dahlke Thomas Fehr James Fildes Andrew George Nick Jones Marian Klinger Katja Kotsch Jaap Kwekkeboom Alain Le Moine Lorna Marson Bjarne Moller Arcangelo Nocera Johann Pratschke Birgit Sawitzki Stefan Tullius Cees Van Kooten Bernard Vanhove Anthony Warrens Thomas Wekerle Infections Fausto Baldanti Vince Emory Rachel Hilton Tomas Reischig Antonio Secchi Islet / Cell transplant Lucio Barile Pierre-Yves Benhamou Thierry Berney Mathias Brendel Andrzej Chmura Eelco De Koning Ralf Huss Olle Korsgren Torbjorn Lundgren Piero Marchetti Michael Ott Francois Pattou Lorenzo Piemonti Frantisek Saudek Annika Tibell Kidney Jacob Akoh Manuel Arias Argiris Asderakis Simon Ball S. Birkeland Richard Borrows Klemens Budde Catherine Byrne Andrzej Chmura Paul Cockwell Magdlena Durlik John Forsythe Ulrich Frei Fabrizio Ginevri Denis Glotz Sian Griffin Josep Grinyo Paul Harden Uwe Heemann Luuk Hilbrands Mads Hornum Alan Jardine Marian Klinger Amanda Knight Philippe Lang Yvon Lebranchu Christophe Legendre Domingos Machado Nizam Mamode Peter Maxwell David Mayer Peter Morris Ferdinand Muhlbacher Chas Newstead Norberto Perico Ferenc Perner Per Pfeffer Rutger Ploeg Kaija Salmela Silvio Sandrini Antonio Secchi Daniel Seron

Raj Thuraisingham Nicholas Torpey Ondrej Viklicky Stefan Vitko Jonas Wadstrom Lars Wennberg Oliver Witzke Martin Zeier Liver and Intestine David Adams Umberto Baccarani Jacques Belghiti Marina Berenguer Patrizia Burra Lucio Caccamo Andrzej Chmura Michele Colledan Bernard De Hemptinne Bo-Goran Ericzon Juan Carlos GarciaValdecasas Salgado S. Hubscher Helena Isoniemi Alfred Konigsrainer Jurgen Klempnauer Marek Krawczyk Jan Lerut Derek Manas Herold Metselaar Darius Mirza Paolo Muiesan Peter Neuhaus Gerd Otto Markus Peck Joao Pena Raj Prasad Marco Senzolo Pavel Trunecka Bart Van Hoek Hans Van Vlierberghe Krzysztof Zieniewicz Lung Annette Boehler Steve Clarke

Paul Corris John Dark Andy Fisher Martin Iversen Walter Klepetko Robert Lischke Jim Lordan Stephan Schueler Redha Souilamas Martin Strueber Willem Van der Bij Dirk Van Raemdonck Geert Verleden Erseyda Yildirim Pancreas Murat Akyol Helmut Arbogast Andrzej Baranski Thierry Berney Ugo Boggi Diego Cantarovich Laureano Fernandez-Cruz Peter Friend Nadey Hakim Torbjorn Lundgren Paolo Rigotti Frantisek Saudek Alexander Schaapherder Gunnar Tyden Richard Viebahn Chris Watson Pediatric transplantation Bruno Gridelli Hannu Jalanko Marc Lilien Kaija Salmela Tomas Seeman Nick Webb (Pre-) Clinical immunosuppression Bernard Charpentier Josep Cruzado Druska Dragun

Magdlena Durlik Henrik Ekberg Inese Folkmane Anders Hartmann J. Homan van der Heide Alan Jardine Dirk Kuypers Iain Macphee Adam McLean Bruno Meiser Bjorn Nashan Rainer Oberbauer Federico Oppenheimer Marcus Saemann Hans Schlitt Jean-Paul Soulillou Giuseppe Tisone Gunnar Tufveson Yves Vanrenterghem Ondrej Viklicky Stefan Vitko Bruno Watschinger Willem Weimar Tissue injury / preservation Constantino Fondevila Peter Friend Thierry Hauet Henri Leuvenink Thomas Minor Rutger Ploeg Peter Schnuelle Dirk Ysebaert Xenotransplantation Gilles Blancho Tony Dorling Pierre Gianello

ESOT Grants will be presented on Wednesday 7 September at 13:05 during the Awards & Grants Ceremony. Congratulations to the following Recipients of the 2010 and 2011 ESOT grants. 2010 ASTS-ESOT Exchange Grant Soumi Fouraschen Rotterdam, The Netherlands AST-ESOT Exchange Grant Hugo P. Sondermeijer New York, United States BRISTOL-MYERS SQUIBB Senior Clinical Research Grant Dirk van Raemdonck Leuven, Belgium BRISTOL-MYERS SQUIBB Senior Clinical Research Grant Sophie Brouard Nantes, France ROCHE Senior Basic Science Grant Carla Baan Rotterdam, The Netherlands ROCHE Senior Basic Science Grant Katja Kotsch Innsbruck, Austria Lorna Marson Edinburgh, United Kingdom ASTELLAS Junior Basic Science Grant Fabienne Haspot Nantes, France ASTELLAS Junior Basic Science Grant Simon Harper Cambridge, United Kingdom ESOT Junior Clinical Research Grant Thomas Vogel Mnster, Germany ESOT Junior Clinical Research Grant Sabastien Heidt Oxford, United Kingdom INSTITUT GEORGE LOPEZ Organ Viability & Preservation Grant Diethard Monbaliu Leuven, Belgium INSTITUT GEORGE LOPEZ Organ Viability & Preservation Grant Sebastien Giraud Poitiers, France KHLER-CHEMIE Preservation Grant Eleonora Boncompagni Pavia, Italy

2011

2010

2011

2010

2011

2010

2011

2010

2011

2010

2011

2010

2010

NOVARTIS Short Stay & Study Grant Fernanda Ortiz Helsinki, Finland Ali Yeginsu Tokat, Turkey Laura Tariciotti Birmingham, United Kingdom Leonid Kirkovsky Minsk, Belarus Volha Chuhunova Minsk, Belarus Martin Hoogduijn Rotterdam, The Netherlands Michelle de Oliveira Zurich, Switzerland Mohammed Zeeshan Akhtar Oxford, United Kingdom NOVARTIS Short Stay & Study Grant Noel Knops Leuven, Belgium Maciej Wojcicki Szczecin, Poland Rafael Valdez-Ortiz Mexico City, Mexico Phillipp Renner Regensburg, Germany NOVARTIS ESOT-STALYC Grant Lilian Curvelo Sao Paolo, Brazil Luis Covarrubias Mexico City, Mexico ESOT Student Travel Grant Paloma Riquelme Regensburg, Germany Gaurav Gulsin Aberdeen, United Kingdom ESOT Basic Science Travel Grant Gang Feng Oxford, United Kingdom Pinar Eren Istanbul, Turkey Anna Wardowska Gdansk, Poland Dan Luscalov Cluj-Napoca, Romania Valentina Pietroni Rome, Italy

2011

2010

2010

2010

Scientific and General Information

11

ACCREDITATIONS
The European Society for Organ Transplantation is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide this CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net The 15th Congress of the European Society for Organ Transplantation is designated for a maximum of (or for up to) 17 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, contact the AMA. Each medical specialist should claim only those hours of credit he/she actually spent in the education activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and a maximum of 6 ECMECs for a full day event. A questionnaire will be e-mailed out immediately after the Congress. This will include questions relevant for the UEMS Accreditation, it can be completed online and automatically delivered to the Organisers. CPD approval has been sought from the Royal College of Physicians. Credits will be reported on the Certificate of Attendance.

ABSTRACTS & PRESENTATION TYPES

The new structure of this meeting features different type of presentations: Full Oral, Clinical Cases, Mini Oral, Rapid Oral and Traditional Posters. These works represent the most recent researches in the transplantation field.

FULL ORAL PRESENTATIONS

Main topic area presented in large auditoria, to acknowledge the high level of contribution. Presented at ORAL SESSION 1 to ORAL SESSION 42. Biotest Award have been assigned to the six best selected abstracts in Clinical and in Basic Science Transplantation presented during the Presidential Session, to take place on Wednesday, 7 September, at 11:00 12:00, in the Clyde Auditorium.

CLINICAL CASES PRESENTATIONS

Clinical research abstract selected through a separate process and presented and discussed with a panel of experts, to maximize interaction amongst presenters and attendees. Presented at CLINICAL CASES SESSION 1 to CLINICAL CASES SESSION 7.

MINI ORAL PRESENTATIONS

Designed for a smaller audience and presented at one of the purpose built mini theatres situated in the Exhibit area, to create an interactive environment. Presented at MINI ORAL SESSION 1 to MINI ORAL SESSION 9. City of Glasgow Mini Oral presentation Awards have been assigned to the ten best selected abstracts and will be acknowledged during the Presidential Session, to take place on Wednesday, 7 September, at 13:00 13:30.

12

HYBRID POSTER AREA

A real transformation of Poster presentation sessions. The hybrid format mingles the Traditional Poster display with e-poster Rapid Oral presentations, organised into scheduled sessions, moderated and open for discussion. Again the location, in the Exhibit Area, facilitates an active participation and wide visibility.

RAPID ORAL PRESENTATIONS

This type of presentation is introduced for the first time at ESOT 2011. Authors will show their poster on a dedicated plasma screen and are allocated for a short oral presentation. A Moderator will conduct the session and the discussion. Outside session times, these presentations will be displayed as part of a continuous loop on the plasma screens. Presented at RAPID ORAL SESSION 1 to RAPID ORAL SESSION 34. City of Glasgow Rapid Oral presentation Awards have been assigned to the ten best selected abstracts and will be acknowledged during the Presidential Session, to take place on Wednesday, 7 September, at 13:00 13:30.

TRADITIONAL POSTERS
The traditional display is designed in the hybrid poster area as a walk-in path, where the different topics/categories are defined by colours, for easy reference. Please support and focus on these scientific presentations and connect with presenters, who will be in attendance during the rapid oral sessions schedules: Sunday, 4 September 19:15 to 20:30 Monday, 5 September 13:00 to 13:50 and 16:00 to 17:00 Tuesday, 6 September 13:00 to 13:50 and 16:00 to 17:00 City of Glasgow Mini Oral presentation Awards have been assigned to the ten best selected abstracts and will be acknowledged during the Presidential Session, to take place on Wednesday, 7 September, at 13:00 13:30. The Organisation is proud to offer free poster printing and mounting service to all presenters, kindly sponsored by (with financial support only and no input into the choice or content of the material presented). Hybrid Poster Area Sunday, 4 September 18:00 to 20:30 & Exhibit Opening Posters will be dismounted from 11:30 on Wednesday, 7 September and will be rolled and available for collection by presenters, if they so wish, from a poster desk on the Concourse from 12:30 to 14:30. Please note that poster tubes will not be provided. Any posters not collected by 14:30 will be disposed of.

PUBLICATION AND ACCESSIBILITY OF ABSTRACTS

All accepted abstracts are published in the ESOT 2011 Glasgow Congress Programme Book and in the Volume 24, Supplement 2, September 2011 of the ESOT Journal, Transplant International. All accepted abstracts are available online on ESOT website www.esot.org, in combination with the On Line personal itinerary planner. All accepted abstracts and presentations of Clinical Cases, Mini Oral, Rapid Oral and Posters are also collected onto a USB key card that will be distributed on site to all Participants, kindly supported by The USB key card may be obtained throughout the Congress from the Astellas booth upon presentation of the collection card provided with the Congress documentation (financial support is given with no input into the choice or content of the material presented).

i-AREA & NETWORKING LOUNGE

The i-Area is a special feature at ESOT 2011 Glasgow Congress: is the place where attendees can freely browse the digitalized scientific content of the meeting, connect with Authors, arrange a meeting with other participants, meet and network, check e-mails. The space is designed for interaction, with twenty workstations and a seating area to meet with authors, speakers and peers. This area is situated within the Exhibit Hall, assisted by our staff to help with technical facilities and digitalized content. The i-Area is kindly supported by (financial support is given with no input into the choice or content of the material presented).

13

CERTIFICATE OF PARTICIPATION
A Certificate of Participation will be e-mailed to all participants after the Congress, to the e-mail address indicated on the registration form.

ESOT VILLAGE
ESOT is pleased to welcome you in this designated area, located in the Congress Hub at Exhibit Booth 7. Here you can receive information on membership, grant & award programme, education activities and meet our staff. Application for membership can be submitted on site, both online and printed forms.

AUDIO-VISUAL GUIDELINES
The ESOT Congress requires all speakers to make single electronic presentations. We recommend that presentations are created with Microsoft PowerPoint 2007 for Windows. The session halls will be equipped with a PC running Microsoft PowerPoint 2007 + Office 2007. This is compatible with most PowerPoint versions. The PC also includes a DVD/CD player. Please note that if your PowerPoint presentation includes video clips these must be NTSC/PAL compatible. For desktop size screen resolutions SVGA 800 x 600 or XGA 1024 X 768 are the best. Do not use a screen resolution of SXGA 1280 x 1024 or above as the size of the individual pixel is very small and your graphics/text will look smaller. Please bring a second back up copy of your presentation with you to the Speaker Preview Room. You may not use your own laptop for your presentation. Please ensure you bring a copy of your PowerPoint presentation on CD or memory stick. Do NOT email your presentation to the Conference Organisers. Each speaker should bring his/her presentation to the Speaker Preview Room located in the Firth Bar at the rear entrance of the Clyde Auditorium. Please follow the directional signage on the concourse, up the escalator and along the corridor linkway to the Clyde Auditorium and Crowne Plaza Hotel. On any of the following formats: CD or DVD USB Flash Memory Stick USB External Hard Drive If using movie clips or other multimedia, please ensure that all the relevant files are put in a folder and copy this folder to a backup media drive. This is necessary for any clips to run properly, without the clips the PowerPoint presentation will not be able to find the relevant files. Remember to bring this disk with you to the meeting.

AT THE MEETING
All presenters are required to check-in at the Speaker Preview Room to preview their files no later than 2 hours prior to the start of the session in which they are to speak. Even if a presenter is unavoidable delayed, he/she is still required to go directly to the Speaker Preview Room. Please do not go straight to the session, without checking in at the Speaker Preview Room.

14

SPEAKER PREVIEW ROOM

The Speaker Preview Room is located in the Firth Bar and will be open during the following hours: Saturday, 3 September 12:00 to 18:00 Sunday, 4 September 07:00 to 18:00 Monday, 5 September 07:00 to 18:00 Tuesday, 6 September 07:00 to 18:00 Wednesday, 7 September 07:00 to 11:00 Speakers in Mini Oral, Rapid Oral and Clinical Cases Sessions are not required to check in at the Speaker Preview Room as their presentations have already been received. In the Speaker Preview Room, staff will be readily available to help speakers upload and finalise their presentation. The computers in the Speaker Preview Room and presentation rooms will be Windows-based PCs with Microsoft PowerPoint 2007 (Office 2007 installed). Presenters should make sure all fonts appear as expected and all sound/video clips are working properly before they leave the Speaker Preview Room. It is required that all presentations be reviewed, edited and saved as the final version at least two hours prior to the start of the session in which the presenter is scheduled to speak. Proper identification is required in order to submit a presentation and also to upload, preview and edit files in the Speaker Preview Room, please check in with the Congress staff on arrival in the room. Media storage devices (USB Memory Sticks, CDs, DVDs, etc) will not be returned if left behind, please ensure that devices are collected before the close of the Congress, after which they will be destroyed. Cameras and video equipment are not permitted in the Speaker Preview Room.

SESSION ROOM SETUP

Each session room is equipped with: Laptops A computer switcher An audiovisual technician A mouse, keyboard and LCD monitor at the lectern Laser pointer Each session room will be staffed with an audiovisual (AV) hostess, who will assist with the start of each presentation. Before the session begins, the AV technician will confirm all presentations are loaded and accounted for. If the AV technician notices a missing presentation then he/she will contact the Speaker Preview Room for verification and notify the moderator if necessary. Once the presentation is launched, the presenter will control it from the podium using a computer mouse and/or keyboard (which can also be used in lieu of a laser pointer).

USE OF ESOT SCIENTIFIC PROGRAMME CONTENT

Please be aware that the information and materials displayed and/or presented at all sessions of this meeting are the property of ESOT 2011 Congress (and/or the presenter) and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced or distributed without the written permission of ESOT (and/or the presenter). Use of the ESOT name and/or logo in any fashion by any commercial entity for any purpose is expressly prohibited without the express written permission of ESOT.

15

Dates
The 15th Congress of the European Society for Organ Transplantation will be held from Sunday, 4 September 2011 to Wednesday, 7 September 2011 at The Scottish Exhibition and Conference Centre (SECC), Glasgow, UK.

Venue
SECC Exhibition Way, Glasgow G3 8YW, Scotland, UK Tel: +44 (0) 141 248 3000 www.secc.co.uk

Getting to and from The Scottish Exhibition Conference Centre By Taxi

A Glasgow Taxis pick-up and drop -off point is located at the East entrance adjacent to the Clyde Auditorium. There are taxi ranks throughout the city. Main pick-up points include Buchanan Bus Station, Queen Street and Central Stations and most large hotels. The average cost of a journey from the city centre is approximately 5.00.

By Train
Glasgow has the largest rail network in the UK outside London. Glasgows Central Station is connected with every city in the UK, whilst Queen Street Station serves central and northern Scotland. Once in Glasgow, the journey to the SECC may be completed by train. Trains run to the SECC from the city centre with a journey time of just three minutes via First ScotRail. Exhibition Centre Station is The SECCs own dedicated railway station allowing easy access from the city centre and the suburbs. Six trains an hour (approximately every 10 minutes) from Central Station (Platform 17 is on the lower level) will arrive at Exhibition Centre Station in a journey time of just three minutes.

17

From the airport

Glasgow is easily reached by three international airports, Glasgow International, Glasgow Prestwick and Edinburgh International. Glasgows International Airport is the closest to the Congress venue and is less than 15 minutes drive by direct motorway link from the city centre. There is also a 747 AirLink bus service from the airport to Glasgow City Centre where you can make your way to the SECC via the train or a taxi. The bus service has a 20 minute frequency.

Accompanying Persons
The Accompanying Person fee includes: Attendance at the Opening Ceremony in the Clyde Auditorium on Sunday, 4 September Attendance at the Welcome Event and Exhibit Opening on Sunday, 4 September Attendance at the ESOT Networking Event on Monday, 5 September Half day Glasgow Sightseeing Tour The sightseeing tour will depart from The SECC bus shelters in front of the Clyde Auditorium at 09:30 sharp on Monday, 5 September. *Please note Accompanying Persons are not permitted access to sessions or the exhibition from Monday, 5 September to Wednesday, 7 September.

Badge
A name badge will be provided on site with your registration documents. For security and regulation purposes, the wearing of the badge is compulsory at all times inside the Congress venue, the exhibition area and at all official events organised within the context of the Congress. If your badge is lost, a new badge will be issued. The administration cost for a new badge is 2.50. The badges are colour coded as follows: Clear Delegates and Accompanying Persons Yellow Press Green Exhibitors Blue Faculty Purple Presenter Red ESOT Councillor

Badge Policy & Security

Participants are requested to wear their badge at all times. For security reasons admittance is strictly restricted to participants (of all kinds) to the meeting. All presenters must be registered to attend the Congress.

Banking and currency exchange

British currency is Pound Sterling (GBP). An ATM machine is located on the Concourse at The SECC adjacent to the box office. Additional cash machines are available in various parts of the venue, however, some of these may levy an additional charge for withdrawals. Branches of all the major UK banks may be found in the centre of Glasgow. Generally, weekday opening hours for banks are 09:15 16:45 hrs, although this does vary. A limited number are open on Saturday mornings. For exchanging foreign currency and traveller cheques the banks usually provide the most competitive rate. However, it is also possible to change money, in airports, larger rail stations, travel agents, some larger hotels (if you are a resident) and in most Post Offices; there is usually a handling fee and commission. The Glasgow Tourist Board located in George Square is open from 09:30 18:00 hrs every day, including Saturday and Sunday for the purposes of exchanging foreign currency and travellers cheques.

18

Several Scottish banks issue their own notes in denominations of 5, 10, 20, 50 & 100 which are legal tender in England and Northern Ireland. Bank of England and Northern Ireland banknotes are legal tender in Scotland.

Business and Information Centre

There is a Business Centre on the concourse, which provides fax and photocopying services. These services are used at the delegates own expense. The Business & Information Centre will be open during the Registration opening hours. Local and tourist information is also available here.

Car Parking
Delegate car parking is available at the SECC at a cost of 6 per car, per visit.

Cloakroom and Left Luggage Facilities

There will be cloakroom and left luggage facilities available at The SECC during the registration opening hours.

Congress Hub and Exhibit Opening Hours

An exhibition of related products, services and technologies is being held concurrently with the Congress. The exhibition will be located within Halls 4 & 5 at the SECC. Opening hours: Sunday, 4 September 18:00 to 20:30 Monday, 5 September 08:00 to 17:00 Tuesday, 6 September 08:00 to 17:00 Wednesday, 7 September 08:00 to 11:30 Full details of the Exhibition are included within the programme.

Congress Secretariat
The onsite secretariat and registration desks are open at the following hours: Opening hours: Sunday, 4 September 07:00 to 21:00 Monday, 5 September 07:00 to 19:30 Tuesday, 6 September 07:00 to 19:30 Wednesday, 7 September 07:00 to 14:30 From 11:30 on Wednesday, 7 September the Registration and Poster Collection desks will be situated on the concourse.

Credit Cards
Commonly accepted credit cards in hotels, restaurants and stores are American Express, Visa, MasterCard and Diners.

Disclaimer
All best endeavours will be made to present the programme as printed. However, ESOT Glasgow 2011 and its agents reserve the right to alter or cancel, without prior notice, any arrangements, timetables, plans or other items relating directly or indirectly to the Congress, for any cause beyond its reasonable control. ESOT Glasgow 2011 and its agents are not liable for any loss or inconvenience caused as a result of such cancellation. Delegates are advised to take out their own travel insurance and to extend their policy to cover personal possessions as the Congress does not cover individuals against cancellation of bookings or theft or damage to belongings. Tours run by third parties may be subject to cancellation should minimum numbers not be achieved.

19

Electricity
The voltage in the United Kingdom is 220-240V.

First Aid
A fully staffed first aid post will be open at all times during the Congress opening hours. The first aid room is situated on the concourse of the SECC.

Insurance Policy
The organisers cannot be responsible for medical, travel or personal claims. Participants are strongly advised to take out an insurance policy covering three areas: health and accident, loss of luggage and cancellation (travel and registration).

Internet Facilities
There are free wireless facilities available throughout The SECC. Delegates can connect to the Internet by selecting the wireless network (SECC) on their laptop or mobile device. There is no log-in or password required to use this service.

Lost and Found

Enquiries regarding items lost or found can be made at the Registration Desks located in the Congress Hub and Exhibit area. To minimise losses, please ensure that Delegate Bags are not left in any of the session halls.

Lunches and Refreshment breaks

Lunches and refreshment breaks are included in the delegate registration fees in the scheduled programme breaks. Presentation of your badge will be required to access the lunch areas. All refreshments will be served in the Congress Hub and Exhibit area, with the exception of Sunday; some Corporate Symposia will have lunch provided.

Mail
There is a mail box located outside the east entrance of the SECC, which is emptied daily. Stamps are sold at the newsagent situated on the concourse. The nearest post office is located at: 1170 Argyll Street Glasgow G3 Tel: +44 (0) 141 248 7611 Mail may be forwarded to delegates at the SECC. Mail should be addressed as follows: c/o ESOT Glasgow 2011 Hall 5 Scottish Exhibition and Conference Centre Glasgow G3 8YW Scotland, UK

Messages and Correspondence

Messages for delegates should be handed in at the Registration Desks in the Congress Hub/Exhibit. Notification of messages will be displayed on the message board situated at the Registration area. Please check the board daily and pick up your messages they may be urgent. Telephone and fax messages may be received for delegates at the Registration Desks. The telephone number is +44 (0) 141 576 3405 The fax number is +44 (0) 141 576 3409

20

Mobile Phone
It should be noted that mobile phones must be switched off when delegates are in session halls.

Press
Press Passes are issued to individuals representing a recognised news organisation, including freelancers who contribute to such organisations. Individuals involved in public relations, marketing, sales, circulation, advertising, or any other non-editorial function are not eligible for press passes. For members of the press who are also exhibiting at the meeting, press credentials may only be worn during official press duties; otherwise exhibitor credentials must be worn. ESOT Glasgow 2011 reserves the right to inspect the credentials of anyone requesting a pass. ESOT Glasgow 2011 does not make public any list of press attendees or their affliations. Individual Press passes are available at the Registration desks on payment of 100 plus VAT and are valid for the duration of the Congress.

Press Access
Credential media have access to all general sessions, the poster area and satellite symposia. ESOT reserves the right to limit access to any session. Press are required to register at the onsite Press desk, in the Registration area, media credentials must be shown in order to receive a Press badge.

Press Materials
Reproduction of materials such as abstract data, posters, presentation slides, etc requires permission from authors and presenters. Photography of sessions and trade show booths, is forbidden at the Congress. ESOT has designated a professional photographer, who may provide Congress photographic material for journalists who request this. This can be arranged by contacting the organisers at the Registration desks on site.

Programme Changes
The organisers cannot assume responsibility for any change in the programme due to unforeseen or external circumstances.

Public Telephones
Public telephones (coin, credit card and cardphone operated) are located at various points on the concourse. Phone cards can be purchased at the newsagent.

Public Transport to the SECC

A limited number of transport tickets are available on a first come, first served basis and may be collected from the booth 26. This will allow travel on buses, trains and underground within the Strathclyde Passenger Transport region.

Registration Desks
The registration desks are located in the Congress Hub and Exhibit area. Attendees may obtain Congress documentation and other information about Glasgow here.

Shops
Most shops in Central Glasgow are open from 09:00 to 17:30 Monday to Wednesday and Friday to Saturday. Most large department stores and boutiques are open until 19:00 on Thursday evening and some stores also open from 11:00 to 16:00 on Sunday.

21

Smoking Policy
Smoking is prohibited in all areas of the SECC.

Useful Links and Numbers

Congress Centre: Glasgow International Airport: Glasgow Prestwick International Airport: Edinburgh Airport: Glasgow Taxis: First ScotRail: General Scotland Travel Information: www.secc.co.uk +44 (0) 141 248 3000 www.glasgowairport.com +44 (0) 844 481 5555 www.gpia.co.uk +44 (0) 1292 511000 www.edinburghairport.com +44 (0) 844 481 8989 www.glasgowtaxis.co.uk +44 (0) 141 429 7070 www.scotrail.co.uk +44 (0) 845 601 5929 www.travelinescotland.com +44 (0) 0871 200 2233

VAT Value Added Tax

Value Added Tax and similar taxes are charged on most goods and services in the United Kingdom. VAT in the United Kingdom is currently 20%. VAT is included in all Congress fees. As a participant in the ESOT Glasgow 2011 Congress you may have the possibility under certain conditions to recover the VAT paid on certain types of expenses incurred. This may apply to both non-European business travellers visiting Europe and to European business travellers to other EU countries. For further information please contact Customs and Excise on departure at the airport.

22

Registration Fees, Costs and Inclusions:

All the prices below include VAT (20%) On site Full Congress delegate prices ESOT/ETCO/BSHI member 600 Non-member 750 ESOT/ETCO/BSHI trainee, co-ordinator, nurse member 330 Trainee, co-ordinator, nurse, non-member 380 Full ESOT Congress delegates: Opening ceremony Welcome Cocktail and Poster Opening ESOT Networking Event Lunches, tea and coffee refreshment breaks as scheduled from Monday, 5 to Wednesday, 7 September All documentation including book of abstracts Subscription to Transplant International for 2 years (Non Members) Entry to all sessions and the exhibition except: Speciality Update Symposia ETCO EDC Joint Meeting VAT at the prevailing rate ETCO-EDC Joint Meeting Standalone ESOT/ETCO member 210 Non-member 260 ETCO-EDC Joint Meeting (booked with main ESOT Congress) ESOT/ETCO member 180 Non-member 220 ETCO-EDC Joint Meeting registration fee includes: Opening ceremony Welcome Cocktail and Poster Opening Access to full day meeting on Sunday, 4 September 2011 Refreshments breaks When purchased at the discounted rate along with a full ESOT Glasgow 2011 registration then attendance at the ESOT Glasgow 2011 Congress is also included

Update Symposia and Workshop Costs

ELITA or EPITA or Intestinal or Thoracic Update Symposia ESOT/ETCO/BSHI member Non-member ESOT/ETCO/BSHI trainee, co-ordinator, nurse member Trainee, co-ordinator, nurse, non-member Composite Tissue or Basic Science Update Symposia ESOT/ETCO/BSHI member Non-member ESOT/ETCO/BSHI trainee, co-ordinator, nurse member Trainee, co-ordinator, nurse, non-member ETCO Workshops ESOT/ETCO member 30 90 30 50 20 50 20 50

60 160

Registration fee
Accompanying Persons

23

Congress Secretariat ESOT Office

Corso del Popolo, 8 3511 Padua, Italy Tel: +39 049 300 5796 Fax: +39 049 210 6306 Email: esot2011@esot.org

Congress Administrative Secretariat

ESOT Glasgow 2011 Congrex UK Ltd 26 28 Hammersmith Grove London W6 7BA United Kingdom Tel: +44 (0) 20 8834 1014 Fax: +44 (0) 20 8834 1151 Email: esot2011@congrex.com Congrex is the official organiser of ESOT 2011 visit www.congrex.com

Membership Information
ESOT Secretary Mr. J.L.R. Forsythe Room S3316 Transplant Unit Royal Infirmary of Edinburgh Little France Crescent Edinburgh EH16 5SA United Kingdom Tel: +44 (0) 131 242 1715 Fax: +44 (0) 131 242 1739 Email: secretariat@esot.org

24

Hotels
Abode Glasgow **** 129 Bath Street, Glasgow Distance to the congress venue: 3 km/20 minutes by bus service 23/train Blythswood Square ***** 11 Blythswood Square, Glasgow, G2 4AD Distance to congress venue: 1.5 km/walking distance Campanile *** 10 Tunnel Street, Glasgow, G3 8HL Distance to congress venue: on premises SECC Carlton George Hotel **** 44-46 West George Street, Glasgow, G2 1DH Distance to congress venue: 3 km/20 minutes by bus service 24/train Citizen M **** 60 Renfrew Street, (corner of Hope Street), Glasgow, G2 3BW Distance to the congress venue: 2.5 km/19 minutes by public transport, bus 23 Mint Hotel Glasgow **** 5 Finnieston Quay, Glasgow, G3 8HN Distance to the congress venue: On the premises of SECC, walking distance Crowne Plaza Glasgow **** Congress Road, Glasgow, G3 8QT Distance to the congress venue: On the premises of SECC, walking distance Du Vin **** 1 Devonshire Gardens, Glasgow, G12 OUX Distance to the congress venue: 4 km/25 minutes by train Etap ** 2a Springfield Quay, Glasgow, G5 8NP Distance to the congress venue: 1.5 kilometres Express by Holiday Inn Theatreland *** 165 West Nile Street Glasgow, G1 2RL Distance to congress venue: 3 km/15-20 minutes by bus service 24 or 216/train Fraser Suites Glasgow **** 1-19 Albion Street Glasgow, G1 1LH Distance to congress venue: 3 km/20 minutes by bus service 24 or 215/train Grand Central Hotel **** 99 Gordon Street, Glasgow, G1 3SF Distance to the congress venue: 2.5 km/15 minutes by bus service 54 or 215 Hilton Glasgow **** 1 William Street, Glasgow G3 8HT Distance to congress venue: 1 km/walking distance Hilton Grosvenor **** 1-9 Grosvenor Terrace Glasgow, G12 0TA Distance to congress venue: 3 km/20 minutes by bus service 11 or 62 Holiday Inn Theatreland **** 161 West Nile Street, Glasgow G1 2RL Distance to congress venue: 3 km/20 minutes by bus service 757/train from Central Station Holiday Inn Express Glasgow City Riverside *** Glasgow Riverside, 122 Stockwell Street, Glasgow Distance to congress venue: 3.2 km/10 minutes by bus service 240 Ibis Glasgow *** 220 West Regent Street, G2 4DQ, Glasgow Distance to congress venue: 2.5 kilometres/15 minutes by public transport (bus service 204 or 9/train from Central Station) Jurys Inn **** 80 Jamaica Street, Glasgow, G1 4QG, Glasgow Distance to congress venue: 2.0 kilometres/15 minutes by public transport (bus service 23 or 24/train from Central Station) Lorne Hotel*** 923 Sauchiehall Street, Glasgow, G3 7TQ Distance to congress venue: 10 minutes walking distance/3 minutes drive Malmaison Hotel **** 278 West George Street, G2 4LL, Glasgow Distance to congress venue: 2.5 kilometres/15 minutes by public transport (bus service 42 or 62) Marriott Glasgow **** 500 Argyle St Glasgow, G3 8RR, Glasgow Distance to congress venue: 2.0 km/walking distance, 15 minutes/15 minutes by bus service 757 or 62 Menzies **** 27 Washington Street Glasgow, G3 8AZ, Glasgow Distance to congress venue: 1.5 km/walking distance, 10-15 minutes/15 minutes by bus service 24 or 204 Millennium **** George Square Glasgow, G2 1DS, Glasgow Distance to congress venue: 3 km/23 minutes by bus service 23 Novotel Glasgow Centre **** 181 Pitt Street Glasgow, G2 4DT Distance to congress venue: 2.5 km/20 minutes by bus service 11, 18 or 62 Park Inn Glasgow City Centre *** 2 Port Dundas Place, Glasgow, G2 3LD Distance to congress venue: 2.5 km/20 minutes by bus 62/train Pond Hotel *** Great Western Road Glasgow, G12 0XP Distance to congress venue: 5.0 km/25 minutes by train Premier Inn Charing Cross *** Distance to congress venue: 1, 2 km/waking distance Premier Inn Argyle Street *** 377 Argyle Street, Glasgow, G2 8LL Distance to congress venue: 1.5 kilometres/20-25 minutes by public transport (bus service 24, 204, 215) Premier Inn City Centre South *** 80 Ballater Street, G5 0TW, Glasgow Distance to congress venue: 3 kilometres/20-25 minutes by public transport (bus service 62, 215)/train Radisson Blu**** Argyle Street Glasgow, G2 8DL Distance to congress venue: 1.5 km/10-15 minutes by bus service 23, 24, and 215 Ramada Glasgow City Hotel *** 201 Ingram Street, Glasgow, G1 1DQ Distance to congress venue: 3 km/10-15 minutes by public transport Swallow *** 517 Paisley Road West, Glasgow, Strathclyde, G51 1RW Distance to congress venue: 3 kilometres/15-20 minutes by public transport (bus service 36, 9, 38) or 5 minutes by car Thistle **** 36 Cambridge St Glasgow, G2 3HN Distance to congress venue: 3 kilometres/15-20 minutes by public transport (bus service 9, 62, 757) University of Strathclyde Sir Graham Hills Building 50 Richmond Street, Glasgow, G1 1XP Distance to congress venue: 3 km/20 minutes by train

25

Welcome Event Hybrid Poster Area & Exhibit Opening

Sunday, 4 September from 19:15 to 20:30 Poster presentation boasts a totally different setting, this event will provide a great networking opportunity with colleagues and friends to start the meeting with a drink. Posters are presented in a combination of electronic display with moderated sessions as well as traditional printed display. This is an excellent forum for the exchange of information and a means to communicate ideas, research and spark discussions on the hot topics that will be taken up again throughout the Congress.

ESOT Networking Event Monday, 5 September from 20:00 to 22:30 The Congress Organisers are pleased to invite you to the ESOT Reception to be held at the University of Glasgow Main Building. One of the citys most famous and beautiful landmarks, the University of Glasgow dates from the middle of the fifteenth century and boasts a stunning mix of neo-gothic architecture and contemporary design. As well as being one of the UKs leading universities with an outstanding international reputation, the University of Glasgow also embraces the cultural history of the city as it houses within its campus the Hunterian Museum & Art Gallery and the Mackintosh House. Join us for a delightful event where you can get together with colleagues and friends and meet new people all within this most unique and special venue.

26
Admittance: Open to all registered ESOT Congress participants and registered Accompanying Persons.

How to get to the University

Address: University of Glasgow University Avenue Glasgow G12 8QQ Scotland Coaches Coach transfers will be provided from the Congress venue to the University. Coaches will leave from the car park near the Clyde Auditorium from 19:30 on Monday 5 September. Coaches will take guests back to the SECC or Glasgow City Centre at the end of the evening. Buses Routes 11, 44 and 44A run through the main campus from the city centre. Other routes serve Dumbarton Road, Great Western Road and Byres Road. A seasonal tourist bus stops at the University. Subway The main station for the University is Hillhead. Kelvinhall and Kelvinbridge are also convenient. Local trains The nearest suburban rail station is Partick, about one mile west of the University. It has an interchange with the subway and with bus services on Dumbarton Road. Taxis Black taxi cabs can be picked up at most times in the University area and the city centre. Road M8 exits for the University are J18 if travelling from the south, Edinburgh and the north and J19 if coming from Glasgow Airport and the west. Other main routes serving the University include Great Western Road (A82, north of campus), Clydeside Expressway (A814, south) and Byres Road (B808, west). Car parking on the University campus and surrounding area is extremely difficult.

27

Sunday 4 September
13.00 15.00 13:00 14:00 13:00 14:30 13:00 18:00 13:00 18:00 16:00 17:00 16:00 18:00 19:00 20:30 Kidney Committee Meeting Thoracic Committee Board Meeting Transplant International Editorial Board ELITA Board Meeting EPITA Board Meeting V Meeting with Presidents of the National Societies EBSOT Board Meeting CTA Board Meeting

ROOM
GALA 2 NESS LEVEN ETIVE FYNE BOISDALE 2 LEVEN ETIVE

Monday 5 September
10:00 10:30 13:00 18:00 13:00 14:00 15:00 15:30 IPT Introductory Program to Transplantation ATTOM Meeting Transplant Library Live by CET IPT Introductory Program to Transplantation

ROOM
MINI THEATRE 2 ETIVE MINI THEATRE 1 MINI THEATRE 2

Tuesday 6 September
10:00 10:30 11:00 12:00 13:00 14:00 13:00 14:30 13:30 14:00 14:00 15:30 15:45 18:00 18:30 19:30 18:30 20:30 IPT Introductory Program to Transplantation TTS ESOT Women in Transplantation Networking Event DRIFT Dutch Registry for Intestinal Failure and Transplantation ELITA Assembly (Members only) IPT Introductory Program to Transplantation Machine Preservation Trial Steering Group Meeting ELITA New Board Meeting ESOT General Assembly (Members only) 3C Investigators Meeting

ROOM
MINI THEATRE 2 SEMINAR SUITE MINI THEATRE 3 BOISDALE 1&2 MINI THEATRE 2 ETIVE ETIVE LOMOND AUDITORIUM BOISDALE 1

Wednesday 7 September
08:00 18:00 European Exam in Transplantation Surgery European Exam in Transplantation Medicine European Honorary Diploma in Transplantation Medicine European Honorary Diploma in Transplantation Surgery

ROOM
SEMINAR SUITE SEMINAR SUITE SEMINAR SUITE SEMINAR SUITE

28

08:00 18:00 08:00 18:00 08:00 18:00

29

30

31

Speciality Update Symposia

35

EUROPEAN LIVER AND INTESTINE TRANSPLANT ASSOCIATION

The European Liver Transplant Association was founded in 1993 as a section of the ESOT with the aim of creating within ESOT a body representing the liver transplant community in Europe and to support the European Liver Transplant Registry (ELTR). In 2005 Intestine Transplantation was incorporated and the Association was named European Liver and Intestine Transplant Association (ELITA). Several successful meetings and PG courses have been conducted by ELITA. In Glasgow, in addition to the programme below, we also plan to have case discussions for audience interaction and a very challenging session.

ELITA (European Liver and Intestine Transplant Association) Board

Chairman: Andrew K. Burroughs, London, United Kingdom Vice Chairman: Bernard De Hemptinne, Ghent, Belgium Secretary: Paolo Muiesan, Birmingham, United Kingdom Treasurer: Michele Colledan, Bergamo, Italy Custodian of the European Liver Transplant Registry (ELTR): Ren Adam, Villejiuf, France

Members
William Bennet, Gothenburg, Sweden Gabriela B.A. Berlakovich, Vienna, Austria Christophe Duvoux, Paris, France Martin Oliverius, Prague, Czech Republic Jacques Pirenne, Leuven, Belgium Johann Pratschke, Innsbruck, Austria

Sunday 4 September
09:00 12:50

SPECIALTY UPDATE SYMPOSIUM ELITA On Liver Transplantation

Higher risk livers to fight organ shortage: Limitations, benefits and room for improvements

Hall 1

09:00

Welcome from the ELITA Chairman: Andrew Burroughs, London, United Kingdom Part 1: Steatosis and elderly donors Chairs: William Bennet, Gothenburg, Sweden; Andrew Burroughs, London, United Kingdom

09:05 09:25 09:45

Steatotic liver grafts: to which extent can they be used? Philipp Dutkowski, Zurich, Switzerland Cold ischemia and ischaemic preconditioning Brian Davidson, London, United Kingdom Liver age and HCV Mario Angelico, Rome, Italy Part 2: DCD and segmental grafts Chairs: Bernard De Hemptinne, Ghent, Belgium; Christophe Duvoux, Paris, France

10:05

Donors after Cardiac Death: future prospects Controlled DCD Paolo Muiesan, Birmingham, United Kingdom Uncontrolled DCD Jos Ramn Nez Pea, Madrid, Spain Coffee break

36

10:25 10:45 11:05

11:05 11:25

Debate on LDLT for HCC: Transplant Criteria? Pros Roberto Troisi, Ghent, Belgium Cons Olivier Boillot, Lyon, France Split livers Are we there with right/left lobe splits? Michele Colledan, Bergamo, Italy The risks of disease transmission Malignancy and viral diseases: moving the threshold for their use? Antoni Rimola, Barcelona, Spain Matching extended criteria in the donor with the recipient The donor & recipient risk indexes: useful for graft recipient match? Gabriela Berlakovich, Vienna, Austria

11:45

12:05

12:25

Sunday 4 September
09:00 12:50

SPECIALTY UPDATE SYMPOSIUM ELITA On Intestinal Transplantation

Intestinal transplantation-current status and what does the future hold?

Etive

09:00

Welcome and introduction Jacques Pirenne, Leuven, Belgium Part 1: The current status of intestinal transplantation Chairs: Michele Colledan, Bergamo, Italy; Anil Vaidya, Oxford, United Kingdom

09:10 09:35 10:00 10:25 10:50 11:10

Timing of referral for intestinal transplantation Paediatric view Girish Gupte, Birmingham, United Kingdom Timing of referral for intestinal transplantation Adult view Stephen Middleton, Cambridge, United Kingdom Surgical Strategies for intestinal transplantation Jean De Ville de Goyet, Rome, Italy Late graft loss preventive strategies and current management Florence Lacaille, Paris, France Coffee break Part 2: Intestinal transplantation the next 10 years Chairs: Silvio Nadalin, Tbingen, Germany; Martin Oliverius, Prague, Czech Republic

11:10

Immunological aspects of intestinal transplantation future strategies Jacques Pirenne, Leuven, Belgium Antibody mediated rejection in intestinal transplantation lessons to be learnt Kareem Abu-Elmagd, Pittsburgh, United States Non-invasive markers of rejection in intestinal transplantation Andreas Pascher, Berlin, Germany Intestinal transplant registry Is there a need for European transplant registry in the future? Gustaf Herlenius, Gothenburg, Sweden

11:35

12:00 12:25

37

Monday 5 September
09:00 10:30

STATE OF THE ART 1 ELITA

Improving Patient Outcomes after Liver Transplantation

Lomond Auditorium

Chairs: Paolo Muiesan, Birmingham, United Kingdom; Ferdinand Mhlbacher, Vienna, Austria 09:00 Immunosuppression in liver transplantation is there evidence and are there prospects for personalised regimens based on operational tolerances? Alberto Sanchez-Fueyo, Barcelona, Spain Minimising renal dysfunction in liver transplantation preventative strategies how, with what and when John Lake, Minneapolis, United States Minimising cardiovascular risk factors in liver transplantation evidence and prospects Andrew Burroughs, London, United Kingdom Quality of Life and Compliance after Liver Transplantation Patrizia Burra, Padua, Italy Q&A

09:20

09:40

10:00 10:20 10:30

Tuesday 6 September
13:00 14:30 ELITA ASSEMBLY (Members ONLY) Boisdale 1 & 2

38

EUROPEAN PANCREAS AND ISLET TRANSPLANT ASSOCIATION

The European Pancreas and Islet Transplant Association was founded in 2007 as a section of ESOT. The aims of EPITA are to provide a forum for the pancreas and islet transplantation community in Europe and to contribute to the development of this field and of alternate forms of beta-cell replacement therapy for the benefit of patients suffering from diabetes throughout Europe. Awards will be assigned to distinguish the two best abstracts presented in the fields of islet transplantation and pancreas transplantation respectively and selected by the EPITA Committee.

EPITA (European Pancreas and Islet Transplant Association) Board

Chairman: Thierry Berney, Geneva, Switzerland Secretary: Frantisek Saudek, Prague, Czech Republic

Members
Mathias D. Brendel, Dresden, Germany Torbjrn Lundgren, Stockholm, Sweden Johann Pratschke, Innsbruck, Austria Alexander F. Schaapherder, Leiden, The Netherlands Antonio Secchi, Milan, Italy

Sunday 4 September
09:00 12:50

SPECIALTY UPDATE SYMPOSIUM EPITA On Pancreas and Islets Transplantation

Boisdale 1

09:00

09:10

09:30

09:50

10:10 10:40 10:40 11:10

11:10 11:35 12:00 12:50

The current state of pancreas and islet transplantation research in Europe: rationale and design of ongoing studies and interim results Welcome and introduction Thierry Berney, Geneva, Switzerland Session 1: Studies on non-specific injury to the graft Chairs: Mathias Brendel, Giessen, Germany; Jean-Paul Squifflet, Liege, Belgium Protection of the pancreatic graft against ischemia-reperfusion injury Helmut Arbogast, Munich, Germany Protection against IBMIR by low molecular weight dextran sulphate therapy Olle Korsgren, Uppsala, Sweden Improvement of islet engraftment by the chemokine antagonist reparixin Lorenzo Piemonti, Milan, Italy Panel discussion Coffee break Session 2: Randomised studies on beta-cell replacement against best medical treatment Chairs: Lorenzo Piemonti, Milan, Italy; Frantisek Saudek, Prague, Czech Republic Pancreas transplant alone: the PANCREA Study Diego Cantarovich, Nantes, France Islet transplantation alone or after kidney: the TRIMECO Study Pierre-Yves Benhamou, Grenoble, France Panel discussion

39

Tuesday 6 September
09:00 10:30

STATE OF THE ART 5 EPITA

The pancreas/islet donor: new developments Chairs: Thierry Berney, Geneva, Switzerland; Johann Pratschke, Innsbruck, Austria

Room Forth

09:00 09:20 09:40 10:00 10:20 10:30

DCD donors in whole pancreas transplantation Peter Friend, Oxford, United Kingdom Expanding the donor pool for whole pancreas transplantation Hans Schlitt, Regensburg, Germany Donor strategies to improve the outcome of islet transplantation Bernhard Hering, Minneapolis, United States Solitary whole pancreas versus islets: is it time for a clinical trial? Franois Pattou, Lille, France Q&A

EPITA AWARDS
Best abstract in the field of Islet transplantation O-170 CELLULAR IMMUNE REACTIVITY AGAINST DONOR-ANTIGEN CORRELATES WITH THE OUTCOME AFTER CLINICAL ISLET TRANSPLANTATION: TOWARD A BETTER POST-TRANSPLANT MONITORING Stphanie Lacotte, Sylvie Ferrari, Sophie Borot, Jean Villard, Sandrine Demuylder-Mischler, Philippe Morel, Gilles Mentha, Thierry Berney and Christian Toso; Geneva, Switzerland Best abstract in the field of Pancreas transplantation O-184 PANCREAS TRANSPLANTATION IN RECIPIENTS AGED [ge] 50 YEARS Anand Sivaprakash Rathnasamy Muthusamy, Anil Vaidya, Sanjay Sinha, Isabel Quiroga, Srikanth Reddy, James Gilbert and Peter J. Friend; Oxford, United Kingdom

40

THORACIC COMMITTEE
The Thoracic Committee of ESOT was founded in 2006 as a separate section within ESOT to support and represent the Heart and Lung Transplant community in Europe. A close collaboration is established with the European Society for Heart and Lung Transplantation (ESHLT). The aim of the Thoracic Committee is to group all people interested in heart and lung transplantation under the umbrella of ESOT, to share common interest and benefit from the organisational and financial support for educational activities. No membership fee other than ESOT membership is required to participate in the activities organised by the Thoracic Committee.

THORACIC Committee
Chairman: Dirk van Raemdonck, Leuven, Belgium ESHLT Representative: Paul Corris, Newcastle, United Kingdom

Members
Nicolas Banner, London, United Kingdom Annette Boehler, Zurich, Switzerland Michiel E. Erasmus, Groningen, The Netherlands Gnter Laufer, Vienna, Austria

Sunday 4 September
09:00 12:50

SPECIALTY UPDATE SYMPOSIUM On Thoracic Transplantation

Boisdale 2

Session 1: Rejection problems in thoracic transplantation: where are we? Chairs: Paul Corris, Newcastle upon Tyne, United Kingdom; Bruno Meiser, Munich, Germany 09:00 09:30 10:00 10:30 11:00 11:30 Bronchiolitis obliterans after lung transplantation Annette Boehler, Zurich, Switzerland Vasculopathy after heart transplantation Nicholas Banner, London, United Kingdom Antibody mediated rejection in lung transplantation Christiane Knoop, Brussels, Belgium Antibody mediated rejection in heart transplantation Marlene L. Rose, London, United Kingdom Coffee break Session 2: Mechanical support in thoracic transplantation: where do we go? Chairs: Gnter Laufer, Vienna, Austria; Ugolino Livi, Udine, Italy 11:30 12:00 12:30 ECMO and lung transplantation Pierre Emmanuel Falcoz, Strasbourg, France VAD and heart transplantation Andreas Zuckermann, Vienna, Austria Mechanical heart & lung support for destination therapy Martin Strber, Hannover, Germany

41

Wednesday 7 September
09:00 10:30

STATE OF THE ART 7

Thoracic transplantation from non-heart beating donors Chairs: Steve Large, Cambridge, United Kingdom; Dirk Van Raemdonck, Leuven, Belgium

Forth

09:00 09:20 09:40 10:00 10:20

NHBD lung transplantation: how far can we go? Michiel Erasmus, Groningen, The Netherlands NHBD heart transplantation: fiction or reality? Steve Large, Cambridge, United Kingdom Machine perfusion for lung transplantation Karen Redmond, London, United Kingdom Machine perfusion for heart transplantation Olivier Van Caenegem, Leuven, Belgium Q&A

42

KIDNEY COMMITTEE
The one organ system not previously represented as a section within ESOT is the kidney. We aim to redress this by establishing a kidney section. The first meeting will be in Glasgow, at this meeting, to elect members and councillors and to agree the remit and goals of the section. Prior to this we will have an inaugural educational update for trainees and more senior clinicians and scientist. We hope you will attend and agree that the programme covers some of the major current topics in kidney transplantation.

KIDNEY Committee Founding Group

Alan Jardine, Glasgow, United Kingdom Josep Campistol Plana, Barcelona, Spain

Sunday 4 September
09:00 12:50

INAUGURAL COURSE and SECTION MEETING On Kidney Transplantation

Rejection problems in thoracic transplantation: where are we? Chairs: Fritz Diekmann, Barcelona, Spain; Nizam Mamode, London, United Kingdom

Gala 2

09 :00 09:30 10:00 11:00 11:30 12:00

The future: omics in transplantation Rainer Oberbauer, Vienna, Austria Top 10 updates in Transplant Infectious Disease Camille Kotton, Boston, United States All you need to know about transplanting sensitized patients Hallvard Holdaas, Oslo, Norway Topics on transplant histopathology for the non-pathologist Daniel Sron, Barcelona, Spain All you need to know about recurrent disease Christophe Legendre, Paris, France Design, endpoints and interpretation of clinical trials in renal transplantation Bengt Fellstrom, Uppsala, Sweden Discussion

12:30 12:50

43

EUROPEAN BASIC SCIENCE IN ORGAN TRANSPLANTATION COMMITTEE

In 2003, the European Basic Science in Organ Transplantation (EBSOT) committee was founded to promote scientific issues and transplantation research within ESOT. For the future of ESOT it is crucial to link clinical activities and basic research. To stimulate collaboration between scientists a network of European Laboratories of Excellence has been established called the Basic Science Network in transplantation. It is important for the Council to adjust its policies and to be advised by a motivated group of scientists on fundamental research topics and developments in solid organ and cell transplantation. EBSOT wants to contribute to the advancement, communication, education and support of basic science activities in Transplantation. Its educational activities are: The Basic Course in Laboratory Skills This course aims to expand the knowledge of laboratory skills within ESOT and to create an environment that stimulates collaboration between scientists. The Basic Science Specialty Update Symposium This Specialty Update Symposium focuses on research tools for transplantation and will be held at the biannual ESOT meeting. The State-of-the-art Symposium at the biannual ESOT meeting containing lectures on transplant immunology. EBSOT and ESOT Council support research in the field of transplantation by awarding a large grant programme. The BSC makes recommendations to the Council for the Travel Grants as well as for the Junior and Senior Basic Science Grants. The biannual Basic Science meeting to promote basic as well as translational research in the field of organ transplantation

BASIC SCIENCE Committee

Chairman: Carla Baan, Rotterdam, The Netherlands

Members
Ignacio Anegon, Nantes, France Manuela Battaglia, Milan, Italy Michel Braun, Brussels, Belgium Andrew Bushell, Oxford, United Kingdom Johann Pratschke, Innsbruck, Austria Thomas Wekerle, Vienna, Austria

Sunday 4 September
12:00 14:30

EBSOT Speciality Update Symposium on Basic Science

4 Seasons in transplantation: New suppressive mechanisms and new therapeutic horizons Chairs: Ignacio Anegon, Nantes, France; Andrew Bushell, Oxford, United Kingdom

Alsh

12:00 12:15 12:45

Introduction The role of macrophages in rejection and tolerance Cees van Kooten, Leiden, The Netherlands Cell reprogramming for organ regeneration and organ transplantation John de Vos, Montpellier, France Mesenchymal stem cell therapy in organ transplantation Martin Hoogduijn, Rotterdam, The Netherlands Epigenetics and Transplantation: Control of regulatory T cells Andrew Wells, Philadelphia, United States Discussion

44

13:15 13:45 14:15 14:30

Monday 5 September
09:00 10:30

STATE OF THE ART 2 EBSOT

Cells that rule rejection and tolerance Chairs: Matthias Edinger, Regensburg, Germany Thomas Wekerle, Vienna, Austria

Forth

09:00

What can zebra fish tell us about key inflammatory events that drive transplant rejection? Maggie Dallman, London, United Kingdom What cells are actually causing rejection? Frans Claas, Leiden, The Netherlands Regulatory T cells Matthias Edinger, Regensburg, Germany Regulatory B cells Claudia Mauri, London, United Kingdom Q&A

09:20 09:40 10:00 10:20 10:30

45

CTA COMPOSITE TISSUE ALLOTRANSPLANTATION WORKING GROUP

The ESOT CTA Working Group was established on November 2009, under the umbrella of ESOT. The goal of this Organisation is to contribute to the advancement of this novel field in Europe and to establish a bi-directional information exchange on the scientific and clinical development of CTA between centres actively involved in CTA and ESOT and to augment the scientific and clinical development of Composite Tissue Allotransplantation (CTA) in Europe. In order to serve as an educational platform for scientists and clinicians for information exchange between ESOT and the Composite Tissue Transplant Community, the ESOT CTA Working Group intends to provide members of ESOT with information and material for centres who are willing to embark and start a CTA programme in Europe, and serve as a communication platform for such CTA centres. The main tool for the communication is a community forum electronically managed, on the ESOT website. Further, the ESOT CTA working group will work with governmental agencies of the European Union as well as national and local legislative bodies to develop guidelines and/or a legislative framework for CTA in the EU. The ESOT CTA Working Group also intends to collaborate with other national and international CTA Societies as well as Scientific Communities in Solid Organ Transplantation and Reconstructive Surgery and will support representation of ESOT members towards this effort. Towards realisation of this goal, the ESOT CTA WG will organise a Symposium on the progress achieved in the field of Composite Tissue Allotransplantation as well as the challenges ahead. Particular emphasis will be put on the relevance of findings in CTA for solid organ transplantation pointing out how and why CTA is relevant not just for those actively entertaining a CTA programme, but for progress in transplantation in general.

CTA Working Group

Chairman: Stefan Schneeberger, Innsbruck, Austria ESHLT Representative: Yves Vanrenterghem, Leuven, Belgium

Members
Gerald Brandacher, Innsbruck, Austria Peter Butler, London, United Kingdom Christoph Hoehnke, Memming, Germany Jerzy Jableki, Trzebnica, Poland Luis Landin, Madrid, Spain Laurent Lantieri, Creteil, France Alain Lemoine, Brussels, Belgium Emmanuel Morelon, Lyon, France

46

Sunday 4 September
09:00 12:50

CTA SPECIALTY UPDATE SYMPOSIUM Working Group on Composite Tissue Allotransplantation

Ness

Progress and Challenges in CTA and how this Impacts on Solid Organ Transplantation Chairs: Jean-Michel Dubernard, Lyon, France; Raimund Margreiter, Innsbruck, Austria 09 :00 The Lyon Experience with Hand and Face Transplantation: achievements and setbacks and plans for the future Emanuel Morelon, Lyon, France Rejection of the Skin? So Very Different from Solid Organ Allograft Rejection? Stefan Schneeberger, Innsbruck, Austria Transplanting Extremities and Extreme Transplantations. Limitations in a new Transplant World Luis Landin, Valencia, Spain How to Achieve Great Results in Hand Transplantation with Limited Resources Jerzy Jableki, Trzebnica, Poland Coffee break The Solid Organ and Composite Tissue Transplant Pioneers Perspective: Whats Next? Jean-Michel Dubernard, Lyon, France Minimising Immunosuppression in CTA Gerald Brandacher, Baltimore, United States CTA in the United Kingdom Why Not. Why Not? Pros: Peter Butler, London, United Kingdom Cons: Sir Peter Morris, Oxford, United Kingdom

09:30

10:00

10:30

11:00 11:30 11:30

11:50 12:10

47

ORGAN DONATION AND TRANSPLANTATION

The European Transplant Coordinators Organisation (ETCO) and the European Donation Committee (EDC) of ESOT will be holding a joint meeting on Organ Donation and Transplantation at the ESOT Glasgow Congress. It will be an excellent opportunity for surgeons, intensivists, transplant coordinators and all health care providers working in the field of donation and transplantation to share experiences and points of view. The scientific programme was designed to cover the hottest topics and we have the pleasure of having some truly outstanding speakers with us. The scientific programme also includes a joint session with the European Society of Intensive Care Medicine, ESICM The Certificate of European Transplant Coordination examinations will be held on 4 and 5 September.

Sunday 4 September
ETCO and EDC JOINT MEETING ON ORGAN DONATION AND TRANSPLANTATION
09:00 Welcome address Bernadette Haase, EDC Chair; Rui Maio, ETCO President ETCO-ESICM Joint Session Chairs: Rui Maio, Lisbon, Portugal; Jean-Daniel Chiche, Paris, France Admitting possible donors into critical care units: practices and challenges Paul Murphy, Leeds, United Kingdom Donation after circulatory death: competing practice or additional value? Astrid Cornelia Hoedemaekers, Nijmegen, The Netherlands WORKSHOP: Between life and death Introduction: Identical goal but different views. End of life treatment in north and south Europe The view in north Europe Peter Desatnik, Helsingborg, Sweden The view in south Europe Iaki Saralegui, Vitoria-Gasteiz, Spain 10:20 Issues between life and death in the critical care unit: presentation of an ethical case from daily practice Janet Radcliffe, Oxford, United Kingdom Panel discussion: Peter Desatnik, Janet Radcliffe, Iaki Saralegui Coffee break Quality and Safety. Vigilance and Surveillance. Chairs: Alessandro Nanni Costa, Rome, Italy; Dirk Ysebaert, Antwerp, Belgium Organ Vigilance and Surveillance in the EU: the requirements, the facts and the way to go Rosario Marazuela, Madrid, Spain A malignant brain tumour Dariusz Patrzalek, Wroclaw, Poland Forth

09:10 09:50

09:10

09:30

09:50 11:30 09.50

10:35 11:30 11:30 11:45 11:45 12:45

48

11:45

12:00

12:15 12:30 12:45 13:45 13:15 13:45

Risk of emerging infectious disease Carl-Ludwig Fischer-Froehlich, Stuttgart, Germany Acute Intoxication Philippe Hantson, Brussels, Belgium Lunch break LUNCH SESSION KEYNOTE LECTURE Chairs: Mirela Busic, Zagreb, Croatia; Peter Friend, Oxford, United Kingdom High Risk Donors: An overview of the current situation and the challenges Darius Mirza, Birmingham, United Kingdom Organ Procurement in deceased donation Chairs: Gnter Kirste, Frankfurt, Germany; Diane Moretti, Geneva, Switzerland Organisation of procurement in Europe: Can we improve quality? Rutger Ploeg, Oxford, United Kingdom Organization of uncontrolled donation after circulatory death in Spain Jos R. Nuez Pea, Madrid, Spain Systematic analysis of the deceased donation process: lessons to learn Chairs: Marie Thuong, Saint-Denis-La Plaine, France; Dagmar Vernet, Bern, Switzerland National registry of deaths with acute cerebral lesions. The problem of donor identification Francesco Procaccio, Verona, Italy Critical success factors in the process of donation after brain death Beatriz Domnguez-Gil, Barcelona, Spain Assessing and improving performance through external audits to donor centres Nuria Masnou Burrall, Barcelona, Spain Building a national quality assurance programme in the deceased donation process in Belgium Isabelle Snpart, Brussels, Belgium Discussion Coffee break Living Donation Chairs: Lisa Burnapp, London, United Kingdom; Bernadette Haase, Leiden, The Netherlands Living donation in Europe: Facts and figures Willem Weimar, Rotterdam, The Netherlands Critical aspects in the evaluation of living donors from a medical, psychological and social perspective Jen McDermott, London, United Kingdom Panel discussion: The role of the coordinator in increasing awareness and knowledge of the medical society concerning living donation. Creating a strategy: An interactive process with coordinators from different European Countries Discussants: Lisa Burnapp, London, United Kingdom Mart Manyalich, Barcelona, Spain Regien Meijer, Groningen, The Netherlands Discussion

13:15

13:45 14:30

13:45 14:05

14:30 15:45

14:30

14:45 15:00

15:15

15:30 15:45 15:45 16:15 16:15 17:45

16:15 16:30

16:45 17:30

49

17.30 17:45

ETCO WORKSHOP PROGRAMME

MONDAY 5 SEPTEMBER WORKSHOP 1 Brain death diagnosis and donor treatment 14:00 18:00 Faculty: JM Dominguez-Roldn, Sevilla, Spain Dr Francisco Procaccio, Verona, Italy 30 available seats WORKSHOP 2 Interactive Research & Communication Workshop for the Transplant Coordinator 12:30 16:30 Faculty: Maria Stadtlet, Los Angeles, USA Tina Coco, Brisbane, Australia 20 available seats WORKSHOP 3 Quality assurance programme of the donation process in Spain 08:00 12:00 Faculty: Gloria de la Rosa, Madrid, Spain Nuria Masnou, Barcelona, Spain Teresa Pont, Barcelona, Spain 20 available seats WORKSHOP 4 Organ Preservation Workshop. Wet Lab 08:00 12:00 Faculty: Organ Recovery Systems 30 available seats Fyne

Leven

Fyne

Leven

Certificate of European Transplant Coordination (CETC) Examinations

SUNDAY 4 SEPTEMBER 09:00 18:00

Katrine

Organised by the Board of Transplant Coordination, Division of Transplantation of the UEMS in collaboration with ETCO.

50

ESOT EFI BSHI JOINT SYMPOSIUM & 22ND ANNUAL BSHI CONFERENCE
Sunday 4 September
09:00 12:50

ESOT EFI BSHI Joint Symposium

Solid phase assays in kidney transplantation: Too much for too little? Moderator: Ilias Doxiadis, Leiden, The Netherlands Discussants: Frans Claas, Leiden, The Netherlands; Denis Glotz, Paris, France

Leven

Interactive discussion on the following topics: Are the antibodies detected by the single HLA antigen microspheres clinically relevant? Is their detection a contraindication for a transplant? What should the laboratories report in the future to their collaborating clinicians?

Sunday 4 September
14:45 17:00

22nd Annual BSHI Conference

BRITISH SOCIETY FOR HISTOCOMPATIBILITY & IMMUNOGENETICS The British Society for Histocompatibility & Immunogenetics (BSHI) was formed in 1989 following widespread expression of support for a formal professional body to represent scientists in the field. The society has a membership of over 450 which includes Healthcare Scientists, Physicians, Surgeons, Researchers and Academics. The objectives of BSHI are to promote and protect health for the public benefit in particular by: developing and maintaining good practice in Histocompatibility and Immunogenetics by ensuring the highest professional standards of competence encouraging the advancement of scientific research and knowledge of its application in all aspects of Histocompatibility and Immunogenetics and disseminating the useful results thereof BSHI holds an annual three-day scientific meeting in the UK/Ireland. This year BSHI is delighted and honored to be able to stage the 22nd annual BSHI Conference simultaneously with the 15th Congress of the European Society for Organ Transplantation. Opening session Boisdale 1

14:45 15:00 15:00 16:00

Welcome address Paul Sinnott, London, United Kingdom, BSHI Chair Chair: Susan Fuggle, Oxford, United Kingdom Terasaki Lecture Marlene L. Rose, London, United Kingdom

51

16:00 17:00

Oral Presentations Session I Young Scientistis Chairs: Ann-Margaret Little, Glasgow, United Kingdom; David Turner, Edinburgh, United Kingdom BSHI O-01 ALLOANTIBODIES STIMULATED BY PREGNANCY, TRANSFUSION OR TRANSPLANTATION SHOW SIGNIFICANT QUANTITATIVE AND QUALITATIVE DIFFERENCES. D Lowe MSc1;2, D Zehnder MD2;3, R Higgins MD3, D Briggs PhD1; 1 NHS Blood and Transplant, Birmingham, United Kingdom; 2 University of Warwick, Coventry, United Kingdom; 3 University Hospital Coventry and Warwickshire, Coventry, United Kingdom BSHI O-02 CLASS I HLA-SPECIFIC ANTIBODY QUANTIFICATION David Lowe MSc1;2, Daniel Zehnder MD, PhD2;3, Rob Higgins MD3, Arend Mulder PhD4, Frans Claas PhD4, Briggs David PhD1; 1 NHS Blood and Transplant, Birmingham, United Kingdom; 2 University of Warwick, Coventry, United Kingdom; 3 University Hospital Coventry and Warwickshire, Coventry, United Kingdom; 4 Leiden University Medical Center, Leiden, The Netherlands BSHI O-03 DIFFERENTIAL EXPRESSON FOLLOWING A HOMOZYGOUS GENE DELETION AND INCREASED SEVERITY OF ACUTE GRAFT V HOST DISEASE Steven Jervis MSc, Paul Collins MSc, David Tate FIBMS, Victoria Bowman BSc, Christopher Adhern BSc, Kay Poulton PhD; Manchester Royal Infirmary, Manchester, GT Manchester, United Kingdom BSHI O-04 SINGLE ANTIGEN BEAD (SAB)(NORMAL AND CLEAN BEADS) MFI THRESHOLD FOR DONOR SPECIFIC ANTIGEN(DSA), COMPARED TO FLOW AND CYTOTOXIC CROSSMATCH RESULT James Jones MSc, Matthew Howse MD, Pam Beales MSc, Chang Wong MB, Abdul Hammad MD, Derek Middleton DSc PhD; Royal Liverpool University Hospital, Liverpool, United Kingdom BSHI O-05 FLOW CYTOMETRY CROSSMATCHING USING PURIFIED LYMPHOCYTES Anna Barker PhD, Nicola Martin MSc, Susanne Mills MSc, Alison Stewart MSc, Susan Martin PhD; Manchester Royal Infirmary, Manchester, United Kingdom Invitrogen Young Scientist Award

16:00

16:10

16:20

16:30

16:40

16:50

Monday 5 September
17:00 19:00 Oral Presentations Session II Leven & Best Selected Abstracts Chairs: Martin Howell, Newcastle Upon Tyne, United Kingdom; Tracey Rees, Cardiff, United Kingdom BSHI O-06 SPECIFIC REMOVAL OF ANTIBODIES TO HLA-DRB1 FROM PATIENT SERAC McMurtrey PhD1, D Lowe MSc2;3, A Duty BSc1, S Cate PhD1, A Mojsilovic BSc1, R Higgins MD4, R VanGundy MSc5, D Zehnder MD3;4, D Briggs PhD2, R Buchli PhD5, W Hildebrand PhD1;

52

17:00

Monday 5 September
1 2

University of Oklahoma, Oklahoma, United States; NHS Blood and Transplant, Birmingham, United Kingdom; 3 University of Warwick, Coventry, United Kingdom; 4 University Hospital Coventry and Warwickshire, Coventry, United Kingdom; 5 Pure Protein LLC, Oklahoma, United States 17:10 BSHI O-07 SPECIFIC REMOVAL OF HLA CLASS I DIRECTED ANTIBODIES FROM HUMAN SERA. David Lowe MSc1;2, Curtis McMurtrey PhD3, Daniel Zehnder MD, PhD2;4, Steve Cate PhD3, Rob Higgins MD4, Rico Buchli PhD5, Dan Mitchell PhD2, Rodney VanGundy MSc5, William Hildebrand PhD3, David Briggs PhD1; 1 NHS Blood and Transplant, Birmingham, United Kingdom; 2 University of Warwick, Coventry, United Kingdom; 3 University of Oklahoma, Oklahoma, United States; 4 University Hospital Coventry and Warwickshire, Coventry, United Kingdom; 5 Pure Protein LLC, Oklahoma, United States BSHI 0-08 VARIATION OF ANTIGEN DENSITY ON HLA SINGLE ANTIGEN BEADS IMPLICATIONS FOR SENSITISED PATIENTS AWAITING KIDNEY TRANSPLANTATION Shahram Hemmatpour MSc, Sarah Todd MSc, Deborah Sage PhD; NHS Blood & Transplant, London, United Kingdom BSHI O-09 HIGH RESOLUTION ANALYSIS OF RENAL ALLOGRAFT REJECTION HLA CLASS II MISMATCH AND ANTIBODIES Paula Mobillo MSc1, Robert Collins PhD2, Olivia Shaw MSc2, Janice Theron MSc2, Emma Lougee MSc2, Martia Hernandez-Fuentes PhD3, Robert Vaughan PhD1; 1 Kings College, London, United Kingdom; 2 GSTS, London, United Kingdom; 3 Guys & St Thomas Hospital, London, United Kingdom BSHI O-10 THE POSITION OF THE NATURAL KILLER CELLS ACTIVATING KIR GENES PROTECT FROM REACTIVATION OF CYTOMEGALOVIRUS INFECTION AFTER KIDNEY TRANSPLANTATION Martin Stern MD1, Karine Hadaya MD2, Gideon Hnger MD3, Pierre-Yves Martin MD2, Christoph Hess MD4, Sylvie Ferrari-Lacraz MD5, Jean Villard MD5; 1 University Hospital Basel, Basel, Switzerland; 2 Geneva University Hospital and Medical School, Geneva, Switzerland; 3 University Hospital Basel, Basel, Switzerland; 4 University Hospital Basel, Basel, Switzerland; 5 Geneva University Hospital , Geneva, Switzerland BSHI O-11 DEFINING SERUM CYTOTOXICITY: A COMPLEX MIX? D Lowe MSc1;2, D Zehnder MD2;3, R Higgins MD3, D Briggs PhD1; 1 NHS Blood and Transplant, Birmingham, United Kingdom; 2 University of Warwick, Coventry, United Kingdom; 3 University Hospital Coventry and Warwickshire, Coventry, United Kingdom

17:20

17:30

17:40

17:50

53

18:00

BSHI O-12 INTERASSAY VARIABILITY OF ANTI-HLA ANTIBODY MEASUREMENT USING LUMINEX SINGLE ANTIGEN BEADS (SAB). Natasha Caulfield MSc, David Keegan MSc, Grainne Harmon MSc, Patricia Mullany PhD, Derek ONeill MSc, FIMLS, Mary Keogan MD, FRCPath; Beaumont Hospital, Beaumont Road, Dublin 9, Ireland BSHI O-13 SURFACE PLASMON RESONANCE (SPR) TO DEFINE THE AFFINITY/AVIDITY OF THE ANTI-ABO RESPONSE D Lowe MSc1;2, H Moyse BSc2, A Bentall MD3, D Mitchell PhD2, R Higgins MD4, S Ball MD3, D Briggs PhD1, D Zehnder MD2;4, N Evans PhD2; 1 NHS Blood and Transplant, Birmingham, United Kingdom; 2 University of Warwick, Coventry, United Kingdom; 3 University Hospital Birmingham, Birmingham, United Kingdom; 4 University Hospital Coventry and Warwickshire, Coventry, United Kingdom BSHI O-14 TRANSPLANTING THE VIRTUALLY UNTRANSPLANTABLE HEART PATIENT A CASE STUDY Vaughan Carter PhD, FRCPath1, W Martin Howell PhD, FRCPath1, Fotini Partheniou PhD1, Asif Hasan FRCS2, Richard Kirk MA, FRCP, FRCPCH2; 1 National Health Service Blood and Transplant, Newcastle upon Tyne, Tyne and Wear, United Kingdom; 2 Freeman Hospital, Newcastle upon Tyne, Tyne and Wear, United Kingdom BSHI O-15 ANTI-C3D FIXATION ASSAY: A TOOL FOR PREDICTING THE RELEVANCE OF LUMINEX DETECTABLE HLA ANTIBODIES IN RENAL TRANSPLANTATION Shahram Hemmatpour MSc, Amy Percival MSc, Deborah Sage PhD; NHS Blood & Transplant, London, United Kingdom BSHI O-16 FREQUENCY OF DPB1 MISMATCHES IN HLA MATCHED SIBLINGS C Jane Matthews PhD, W Martin Howell PhD; NHSBT, Newcastle upon Tyne, United Kingdom BSHI O-17 PILOT EVALUATION OF C1Q SCREEN IN EVALUATION OF PATIENTS FOR RENAL TRANSPLATATION Catherine Taylor BSc, David Keegan MSc, Kahairin Khalib FRCPI, Derek ONeill FAMLS, MSc, Mary Keogan MD, FRCPath; Beaumont Hospital, Dublin, Ireland BSHI O-18 TRANSPLANT NEPHRECTOMY: WHO GETS IT AND DOES IT MAKE A DIFFERENCE? Peter Thomson MD, Colin Geddes MBChB, Marc Clancy MBBS; Western Infirmary, Glasgow, Lanarkshire, United Kingdom

18:10

18:20

18:30

18:40

18:50

19:00

Tuesday 6 September
16:00 17:00

Leven

54
17:00 18:30 18:30 19:30

Chair: Sue Martin, Manchester, United Kingdom Hilliard Festenstein Lecture Cristina Navarrete, London, United Kingdom The 16th International Histocompatibility Workshop Chairs: Derek Middleton, Liverpool, United Kingdom; Steven Marsh, London, United Kingdom BSHI Annual General Meeting & Award Ceremony

BSHI P-01

FLOW CROSSMATCH RESULTS IN COMBINATION WITH 2 DIFFERENT SINGLE ANTIGEN ASSAYS PROVIDE GREATER RESOLUTION IN PREDICTING RENAL GRAFT SURVIVAL David Keegan M.Sc., Joseph Kelly M.Sc., Derek ONeill M.Sc., Mary Keogan M.D.; Beaumont Hospital, Dublin 9, Ireland PROVISION OF HLA SELECTED RED BLOOD CELLS IN RENAL TRANSPLANTATION John Goodwin MSC, Andrea Harmer PhD, Tunnard Valerie FIMLS, Crookes Susan None, Rafferty Wendy None, Kilgallon Helen MSC; NHSBT, Sheffield, United Kingdom MFI VALUES DON'T TRAVEL: RESULTS OF AN INTER-CENTRE STUDY. Amanda Robson BSc. MSc.1, James Jones BSc. MSc.2, Katherine Cullen BSc. MSc.3, David McKenzie BSc. MSc.4, Alison Wortley BSc. MSc.5; 1 Manchester Royal Infirmary, Manchester, United Kingdom; 2 Royal Liverpool University Hospital, Liverpool, United Kingdom; 3 St. James University Hospital, Leeds, United Kingdom; 4 Gartnavel General Hospital, Glasgow, United Kingdom; 5 VHBio Ltd, Gateshead, United Kingdom A RETROSPECTIVE INVESTIGATION OF THE PREVALANCE OF COMMON NULL ALLELES IN A UK POPULATION Ruth McCurtin BSc MSc, Katherine Poole BSc MSc DipRCPath, Neil Marsden BSc MSc, Brendan Clark DPhil FRCPath; Leeds Teaching Hospital NHS Trust, Leeds, West Yorkshire, United Kingdom THE EFFECT OF DONOR AND RECIPIENT CYTOKINE GENES POLYMORPHISM ON THE OCCURRENCE OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION Ameera Gaafar PhD1, Alia Iqneibi BSc1, Sheereen Atia PhD1, Eldali Abdelmoneim PhD1, Hannu Turpeinen PhD2, Khalid AlMishari MD1, Khaled Al Hussein PhD1; 1 King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; 2Finnish Red Cross Blood Service, Helsinki, Finland POSITIVE B CELL FLOW CROSSMATCHES ARE NOT ALWAYS CAUSED BY HLA ANTIBODIES A TEN YEAR RETROSPECTIVE STUDY USING LUMINEX TESTING. Andrea Butterfield BSc, Martin Howell PhD, Jane Matthews PhD, Fotini Partheniou PhD, Vaughan Carter PhD; NHSBT, Newcastle upon Tyne, Tyne and Wear, United Kingdom EXTRACTING DNA FROM SERUM Vivien Hanson PhD, Judith Worthington PhD, Kay Poulton PhD, Susan Martin PhD; Manchester Royal Infirmary, Manchester, United Kingdom DEVELOPMENT OF GROUP SPECIFIC SEQUENCING BASED TYPING FOR EXON 3 OF THE HLA DQB1 GENE TO RESOLVE AMBIGUITIES David Smillie Ph D, Laura Roche B Sc, Kathryn Sills M Sc, Andrea Harmer Ph D; NHS Blood & Transplant, Sheffield, United Kingdom SBT FOR MICA A PRACTICAL APPROACH David Smillie Ph D, Andrea Harmer Ph D; NHSBT Sheffield Centre, Sheffield, United Kingdom

BSHI P-02

BSHI P-03

BSHI P-04

BSHI P-05

BSHI P-06

BSHI P-07

BSHI P-08

BSHI P-09

55

BSHI P-10

ANTIBODY REDUCTION: REMOVING BOTH HLA AND ABO ANTIBODIES IN A LIVING RELATED KIDNEY TRANSPLANT A CASE STUDY Shireen Callender BSc1, Fotini Partheniou PhD1, Keith Giles MSc1, Alison Brand MSc, Vaughan Carter PhD, FRCPath, Martin Howell PhD, FRCPath, David Bruce MSc; NHS, Blood and Transplant, Newcastle upon Tyne, United Kingdom OUTCOME OF KIR PREVALENCE AND INCOMPATIBLITY IN KINDNEY TRANSPLANT RECIPIENTS VERSUS LIVING RELTED DONORS Ameera Gaafar PhD1, Atia Sheereen PhD1, Alia Iqneibi BSc1, Abdelmoneim Eldali PhD1, Hannu Turpeinen PhD2, Khalid Al-Mishari MD1, Khaled AlHussein PhD1; 1 King Faisal Specialist Hospital & Research Centre, Riyadh, Riyadh, Saudi Arabia; 2 Finnish Red Cross Blood Service, Helsinki, Finland ANALYSIS OF THE HLA-A, -B, AND -DRB1 ALLELES IN NORTHWESTERN ROMANIANS Lucia Dican PhD1;2, Luminita Loga MD2, Dan Luscalov MD2, Mihai Lucan MD, PhD1;2; 1 University of Medicine and Pharmacy, Cluj, Romania; 2 Clinical Institute of Urology and Renal Transplantation , Cluj, Romania PARADOXICAL EFFECTS OF BRAIN DEATH AND ASSOCIATED TRAUMA ON RAT MESENTERIC MICROCIRCULATION: AN INTRAVITAL MICROSCOPIC STUDY Rafael Simas BS, Paulina Sannomiya PhD, Jos Cruz PhD, Fernando Zanoni PhD, Laura Menegat BS, Cristiano Correia BS, Luiz Moreira MD, PhD; Institute (InCor), LIM-11 University of So Paulo Medical School., So Paulo, SP, Brazil AVOID OR ADMINISTER MMF IN RENAL TRANSPLANT RECEIPIENT WITH IDIOPATHIC (AUTOIMMUNE) THROMBOCYTOPENIA? Alina Betkowska-Prokop MD, PhD, Wladyslaw Sulowicz Prof, MD, PhD, Ewa Ignacak MD, PhD, Monika Krasnicka MD, PhD; Cracow University Hospital, Cracow, Poland COMPLETE RESPONSE TO RITUXIMAB IN LIVER-TRANSPLANT PATIENT WITH DIFFUSE LARGE CELL LYMPHOMA Marta Gutirrez Moreno MD, Carmen Bernal Bellido PhD, Gonzalo Surez Artacho MD, Luis MIguel Marn Gmez PhD, Jos Mara lamo Martnez PhD, Juan Serrano Daz-Canedo MD, Francisco Javier Padillo Ruiz PhD, Miguel ngel Gmez Bravo MD; Virgen del Roco University Hospital, Sevilla, Spain THE USEFULNESS OF LIFECODES DONOR SPECIFIC ASSAY IN A SOLID ORGAN TRANSPLANTATION SETTING. Julie Purcell BSc, Derek ONeill Msc, Mary Keogan MD, FRCPath; Beaumont Hospital, Dublin, Ireland

BSHI P-11

BSHI P-12

BSHI P-13

BSHI P-14

BSHI P-15

BSHI P-16

56

ETHICAL, LEGAL AND PSYCHOSOCIAL ASPECTS OF ORGAN TRANSPLANTATION

ELPAT is a European platform that brings continuity and progress in European research and dialogue on Ethical, Legal and Psychosocial Aspects of Organ Transplantation. Since February 2008 ELPAT also functions as the official, advisory committee of the European Society for Organ Transplantation (ESOT) on ethical, legal and psychosocial aspects of organ transplantation. It aims to integrate and structure this field of science by bringing together European professionals. These experts range from (bio)ethicists, philosophers, lawyers and psychologists to clinicians, physicians, sociologists, anthropologists, policy makers and criminologists. ELPAT currently consists of over 100 experts from more than 25 European countries.

ELPAT Ethical, Legal and Psychosocial Aspects of Organ Transplantation

Chairman: Willem Weimar, Rotterdam, The Netherlands Coordinator: Frederike Ambagtsheer, Rotterdam, The Netherlands Secretary: Marian van Noord, Rotterdam, The Netherlands

Tuesday 6 September
09:00 10:30

STATE OF THE ART 4 ELPAT

Lomond Auditorium

Diverse Populations Chairs: Gabriel Danovitch, Los Angeles, United States; Willem Weimar, Rotterdam, The Netherlands 09:00 Organ donation and transplantation: realities for minority ethnic groups Gurch Randhawa, Luton, United Kingdom Social factors and the availability of living kidney donation in diverse populations Joke Roodnat, Rotterdam, The Netherlands Increasing the deceased organ donation rate among immigrant populations Teresa Pont-Castellana, Barcelona, Spain Q&A

09:20

09:40

10:00 10:30

57

The following sessions will be streamed live on the ESOT 2011 Congress website, please tell your friends and colleagues who were unable to attend the meeting that they can participate remotely via this technology. The sessions will be available for ESOT Members only after the meeting on the Members avenue of the ESOT website.

Sunday 4 September
18:10 19:15

OPENING ESOT 2011 Congress & PLENARY SESSION 1

Monday 5 September
09:00 10:30

14:00 15:30

16:00 17:00

Joint Session ESOT & AST Challenges in kidney transplantation PLENARY SESSION 2 Making the most of the marginal organ NEW CONTROVERSIES 1 The treatment for chronic antibody mediated rejection is

Tuesday 6 September
09:00 10:30

14:00 15:30

16:00 17:00

STATE OF THE ART 6 Biomarkers of Tolerance/Rejection PLENARY SESSION 3 Transplantation tomorrow NEW CONTROVERSIES 3 The big advances in transplantation have come from

Wednesday 7 September
08:00 09:00

09:00 10:30

60
11:00 13:45

ORAL SESSION 42 Late breaking STATE OF THE ART 8 Optimizing organ quality PRESIDENTIAL SESSION Whats hot Whats new Best presentation Honorary Members and Awards Ceremony

Scientific Programme

61

62

Sunday 4 September
18:10 19:15 LIVE WEB STREAM 18:10 18:30 19:15 Opening & Welcome Address from the ESOT 2011 Chairs

OPENING ESOT 2011 Congress

Clyde Auditorium

PLENARY SESSION 1 Controlling the immune response

Clyde Auditorium

Chairs: John Forsythe, Edinburgh, United Kingdom; Alan Jardine, Glasgow, United Kingdom 18:30 18:50 19:10 The challenge of immune tolerance in transplant patients Lucienne Chatenoud, Paris, France Immunosuppressive agents, how to make a choice Flavio Vincenti, San Francisco, United States A meeting with a difference how you contribute and benefit Keith Rigg, Nottingham, United Kingdom Welcome Event Hybrid Poster Area & Exhibit Opening POSTER VIEWING

19:20 20:30 19:20 20:30

19:20 20:15

MINI ORAL SESSION 1 Kidney I

Mini Theatre 1

Chairs: Bengt Fellstrom, Uppsala, Sweden; Jaap Homan van der Heide, Groningen, The Netherlands 19:20 19:25 MO-001 WITHDRAWN MO-002 POST TRANSPLANT SOLUBLE CD30 SERUM CONCENTRATION DOES NOT AFFECT DECEASED-DONOR KIDNEY GRAFT OUTCOME THREE YEARS AFTER TRANSPLANTATION Janko Kovac, Miha Arnol, Blanka Vidan-Jeras, Andrej F. Bren, and Aljoa Kandus; Ljubljana, Slovenia MO-003 ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS ARE NOT AFFECTED BY END STAGE RENAL DISEASE Marieke van Rhijn, Marlies Reinders, Annelies de Klein, Hannie Douben, Sander Korevaar, Fane Mensah, Frank Dor, Jan IJzermans, Carla Baan, Willem Weimar, and Martin Hoogduijn; Rotterdam, The Netherlands; and Leiden, The Netherlands MO-004 FRACTIONAL EXCRETION OF PROTEIN MAY HAVE SUPERIOR PREDICTIVE VALUE OVER TRADITIONAL MEASURES OF PROTEINURIA IN DETERMINING THOSE AT HIGHER RISK OF TRANSPLANT FAILURE Kathryn K. Stevens, Rajan K. Patel, Patrick B. Mark, Colin C. Geddes, Marc J. Clancy, and Alan G. Jardine; Glasgow, United Kingdom

19:30

19:35

63

Sunday 4 September
19:40 MO-005 STRONG ASSOCIATION OF PHENYLALANINE AND TRYPTOPHAN METABOLITES WITH ACTIVATED CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS Mahmoud Sadeghi, Imad Lahdou, Daniel Volker, Paul Schnitzler, Jeorg C. Schefold, Martin Zeier, Gerhard Fusch, Gerhard Opelz, and Peter Terness; Heidelberg, Germany; Berlin, Germany; and Greifswald, Germany MO-006 SERIAL ANALYSIS OF SERUM NEUTROPHIL GERATINASEASSOCIATED LIPOCALIN PREDICTS ORGAN RECOVERY FROM DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH Mamoru Kusaka, Fumi Iwamatsu, Miho Nakaya, Manabu Ichino, Hitomi Sasaki, Takahiro Maruyama, Ryoichi Shiroki, Hiroki Kurahashi, and Kiyotaka Hoshinaga; Toyoake, Japan; and Matsudo, Japan MO-007 UNRECOGNISED GRADE II T-CELL MEDIATED REJECTION IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS Chrysothemis Brown, Neil Sebire, and Steve Marks; London, United Kingdom MO-008 EARLY BASAL INSULIN THERAPY DECREASES NEWONSET DIABETES AFTER RENAL TRANSPLANTATION BY PROTECTING ENDOGENOUS INSULIN SECRETION Manfred Hecking, Michael Haidinger, Dominik Dller, Johannes Werzowa, Andrea Tura, Jinyao Zhang, Susanne RasoulRockenschaub, Ferdinand Mhlbacher, Walter H. Hrl, Giovanni Pacini, Friedrich K. Port, Marcus D. Semann; Vienna, Austria; Padova, Italy; Ann Arbor, USA; Vienna, Austria MO-009 TRANSITION FROM PAEDIATRIC TO ADULT CARE AFTER RENAL TRANSPLANT: AN ESSENTIAL LINK TO IMPROVE SURVIVAL Abbas Ghazanfar, Denise Roberts, Anne Palmer, Mohan Shenoy, and Hany N. Riad; Manchester, United Kingdom MO-010 MEDICAL WEB BROWSING- RENAL TRANSPLANT PATIENTS VIEWPOINT Faisal Hanif, Janet C. Read, and Marc J. Clancy; Glasgow, United Kingdom; and Preston, United Kingdom

19:45

19:50

19:55

20:00

20:05

19:20 20:15

MINI ORAL SESSION 2 Donation, retrieval and allocation

Chairs: Thomas Breidenbach, Munich ,Germany; Axel Ramel, Leiden, The Netherlands

Mini Theatre 2

19:20

MO-011 THE CHALLENGE OF LIVE KIDNEY DONOR EVALUATION: PERCENTAGE OF EXCLUSIONS Carme Facundo, Maria Jos Martinez, Llus Guirado, Joan Manuel Daz, Cristina Canal, and Alberto Breda; Barcelona, Spain MO-012 HAS THE DONOR TYPE ANY IMPACT IN THE WILLINGNESS TO DONATE? Marta Alberola, Camino Rodrguez-Villar, David Paredes, Angel Ruiz, Sandra Saavedra, Ferran Vizcano, Rebeca Roque, and Blanca Miranda; Barcelona, Spain

19:25

64

Sunday 4 September
19:30 MO-013 LONG TERM PROSPECTIVE ASSESSMENT Of LIVING KIDNEY DONORS: SINGLE CENTER EXPERIANCE Ayman Maher Nagib, Ayman Fathi Refaie, Yasser Abdelmneim Elhendy, Magdy Abass Elfawal, Mohmed Adel Bakr, Ibtihal Mohamed Ibrahim, Ahmed Abdelrahman Shokeir, and Mohamed Ahmed Ghoneim; Mansoura, Egypt; and Zagazig, Egypt MO-014 COMPUTER-AIDED ALTRUISTIC UNBALANCED PAIRED KIDNEY EXCHANGES BASED ON VIRTUAL CROSSMATCHING AND PREDICTED POST-TRANSPLANT CREATININE CLERANCE Daniele Focosi, Guido Scatena, Fabio Vistoli, Fabrizio Scatena, and Ugo Boggi; Pisa, Italy MO-015 PROSPECTIVE EVALUATION OF THE US-AMERICAN DONOR RISK INDEX FOR THE ACCEPTANCE OF LIVER GRAFTS IN GERMANY Christian Mnch, Frank Ulrich, Franziska Henrich, Christoph Sarrazin, Stefan Zeuzem, and Wolff Otto Bechstein; Frankfurt, Germany MO-016 TRENDS IN DECEASED ORGAN DONATION IN THE UK Rachel J. Johnson, Claire Counter, Chris J.E. Watson, J.A. Bradley, Paul Murphy, and Chris J. Rudge; Bristol, United Kingdom; and London, United Kingdom MO-017 THE UK NATIONAL PANCREAS ALLOCATION SCHEME Alex J. Hudson, Susan V. Fuggle, Peter J. Friend, and Chris J.E. Watson; Bristol, United Kingdom MO-018 DONOR-RECIPIENT MATCHING IN LIVER TRANSPLANTATION BASED ON A RULE-SYSTEM BUILT ON A MULTIOBJECTIVE ARTIFICIAL NEURAL NETWORK Javier Briceo, Manuel Cruz, Martn Prieto, Miquel Navasa, Jorge Ortiz, Rafael Orti, Miguel A. Gmez, Alejandra Otero, Santiago Tom, Evaristo Varo, Gerardo Clemente, Rafel Baares, Rafael Brcena, Valentn Cuervas, Guillermo Solrzano, Csar Hervs, and Manuel de la Mata; Crdoba, Spain; and Madrid, Spain MO-019 ORGAN PROCUREMENT AFTER EUTHANASIA PROCEDURE, RESPECTING PATIENTS WILL Dirk K. Ysebaert, Kathleen De Greef, Geert Roeyen, Thiery Chapelle, Walter Van Donink, Gerda Van Beeumen, and Patrick Cras; EdegemAntwerpen, Belgium MO-020 MILD HYPONATREMIA HAS A SUBSTANTIAL INFLUENCE ON CLINICAL OUTCOME OF PATIENTS ON THE WAITING LIST AND AFTER LIVER TRANSPLANTATION Rhiana Garritsen, Herold J. Metselaar, James V. Guarrera, Scot Henry, Emily Ratner, Felix Braun, Dieter C. Broering, Hugo W. Tilanus, and Geert Kazemier; Rotterdam, The Netherlands; New York, USA; and Kiel, Germany

19:35

19:40

19:45

19:50

19:55

20:00

20:05

19:20 20:15

MINI ORAL SESSION 3 Clinical immunosuppression

Chairs: Stefan Vitko, Prague, Czech Republic; Bruno Watschinger, Vienna, Austria

Mini Theatre 3

65

19:20

MO-021 HIGH TACROLIMUS INTRAPATIENT VARIABILITY IS ASSOCIATED WITH ACUTE REJECTION AND GRAFT LOSS Karen S. Stevenson, Julie Glen, Kathryn K. Stevens, Alan Jardine, Colin Geddes, and Marc J. Clancy; Glasgow, United Kingdom

Sunday 4 September
19:25 MO-022 CONVERSION FROM Prograf TO Advagraf IN LIVER TRANSPLANT. OBSERVATIONAL MULTICENTRIC STUDY Cristina Dopazo, Roberto Rodriguez, Laura Llado, David Calatayud, Lluis Castells, Emilio Ramos, Victor Molina, Raquel Garcia, Joan Fabregat, and Ramon Charco; Barcelona, Spain MO-023 IS THE PRIMARY IMMUNOSUPPRESSION DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE? Vittoria Vero, Marco Senzolo, Luisa Pasulo, Francesca Romana Ponziani, Raffaella Vigano, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy MO-024 THE IMPACT OF EVEROLIMUS BASED IMMUNOSUPPRESSION ON HCV RECURRENCE AFTER LIVER TRANSPLANTATION: CASE-CONTROL STUDY Cristina Dopazo, Itxarone Bilbao, Francesc Espin, Lluis Castells, Gonzalo Sapisochin, Isabel Campos, Roberto Rodriguez, Mireia Caralt, Jose Luis Lazaro, and Ramon Charco; Barcelona, Spain MO-025 BETTER RENAL FUNCTION WITH EARLY EVEROLIMUS (EVL) INTRODUCTION AND CALCINEURIN INHIBITOR (CNI) WITHDRAWAL AT THIRD MONTH IN KIDNEY RECIPIENTS AT MONTH 12: RESULTS OF THE ERIC STUDY J.C. Ruiz, A. Snchez Fructuoso, D. Hernndez, J. Snchez Plumed, A. Fernndez, A. Pastor Rodrguez, J. Paul, and A. Alarcn; Santander, Spain; Madrid, Spain; Mlaga, Spain; Valencia, Spain; La Laguna, Spain; Zaragoza, Spain; and Palma de Mallorca, Spain MO-026 CYCLOSPORINE VERY LOW DOSE WITH EVEROLIMUS HIGH DOSE IS ASSOCIATED WITH EXCELLENT OUTCOMES IN RENAL TRANSPLANT PATIENTS Elisabetta Bertoni, Paolo Carta, and Maurizio Salvadori; Florence, Italy MO-027 EVEROLIMUS MONOTHERAPY AS MAINTENANCE IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION Asuncion Ferrer, Pedro Errasti, Francisco Javier Lavilla, Paloma Martin, Diana Izquierdo, and Carmen Calderon; Pamplona, Spain MO-028 THE ROLE OF SURVEILLANCE BIOPSIES IN CLINICAL RENAL TRANSPLANTATION Lorna K. Henderson, Brian J. Nankivell, and Jeremy R. Chapman; Edinburgh, United Kingdom, Sydney, Australia MO-029 THERAPY OF CHRONIC HUMORAL REJECTION AFTER KIDNEY TRANSPLANTATION Barbara Grandtnerova, Katarina Machalekova, and Nadezda Mckova; Martin, Slovakia; and Banska Bystrica, Slovakia MO-030 CONVERSION OF STABLE CYSTIC FIBROSIS (CF) LUNG TRANSPLANT RECIPIENTS FROM A TWICE-DAILY PROGRAFBASED REGIMEN TO A ONCE-DAILY MODIFIED RELEASE TACROLIMUS-BASED REGIMEN: PRELIMINARY RESULTS OF THE FQ-UST-01 TRIAL Arantxa Sancho, Rosala Laporta, Beln Ruiz-Antorn, Teresa Lzaro, and Piedad Ussetti Gil; Madrid, Spain

19:30

19:35

19:40

19:45

19:50

19:55

20:00

20:05

66

Sunday 4 September
19:20 20:30

RAPID ORAL SESSION 1 Kidney I

HYBRID POSTER AREA Digital Display 1

Chairs: Denis Glotz, Paris, France; Ellon McGregor, Glasgow, United Kingdom 19:20 RO-001 MMF AND RITUXIMAB HAD GREAT BENEFICIAL EFFECTS ON IMPROVING ABO INCOMPATIBLE KIDNEY TRANSPLANTATION Yoji Hyodo, Seiichiro Shishido, Takeshi Kawamura, Masaki Muramatsu, Ken Sakai, and Atsushi Aikawa; Tokyo, Japan RO-002 INITIAL RESISTANCE INDEX EVALUATED BY DOPPLER SONOGRAPHY AND THE RISK OF DEATH IN KIDNEY TRANSPLANT RECIPIENTS A PAIRED KIDNEY ANALYSIS Aureliusz Kolonko, Jerzy Chudek, and Andrzej Wiecek; Katowice, Poland RO-003 SHOULD KIDNEY TRANSPLANT RECIPIENTS RECEIVE CHILDREN AFTER TRANSPLANTATION? Marleen van Buren, Jaqueline Rischen-Vos, Joke Roodnat, Mirjam Tielen, Judith Kal, and Willem Weimar; Rotterdam, The Netherlands RO-004 RENAL OUTCOMES AFTER LIVE KIDNEY TRANSPLANTATION FROM ELDERLY DONORS ARE ACCEPTABLE Masahiro Yashi, Takashi Yagisawa, Takaaki Kimura, Akinori Nukui, Takehito Fujiwara, Yasunaru Sakuma, Nobuo Ishikawa, Toshihisa Iwabuchi, and Osamu Muraishi; Tochigi, Japan; and Tokyo, Japan RO-005 INFLAMMATION AND PRO-FIBROSIS IN BIOPSIES FROM DECEASED BRAIN DEAD DONORS AND LIVING KIDNEY DONORS: ASSOCIATIONS WITH POST-TRANSPLANT RENAL FUNCTION Hilde Tent, Henri G.D. Leuvenink, H. Sijbrand Hofker, Jaap J. Homan van der Heide, Marcory C.R.F. van Dijk, Gerjan Navis, Rutger J. Ploeg, and Harry van Goor; Groningen, The Netherlands RO-006 CIRCULATING AST, H-FABP, AND NGAL ARE EARLY AND ACCURATE BIOMARKERS OF GRAFT INJURY AND DYSFUNCTION IN A PRECLINICAL MODEL OF KIDNEY TRANSPLANTATION Ina Jochmans, Evelyne Lerut, Jos van Pelt, Diethard Monbaliu, and Jacques Pirenne; Leuven, Belgium RO-007 OESOPHAGEAL DOPPLER MONITORING OF HAEMODYNAMIC CHANGES DURING LIVE DONOR KIDNEY TRANSPLANTATION Nicoletta Fossati, Mei Nortley, Thomas Watcyn-Jones, Nicos Kessaris, Jiri Fronek, and Mohamed Morsy; London, United Kingdom RO-008 EXPANSION OF THE KIDNEY DONOR POOL BY USING CARDIAC DEATH DONORS WITH PROLONGED TIME TO CARDIORESPIRATORY ARREST Alex W. Reid, Simon Harper, Chris H. Jackson, Dominic M. Summers, Olivia Gjorgjimajkoska, Linda D. Sharples, Andrew Bradley, and Gavin J. Pettigrew; Cambridge, United Kingdom RO-009 COST ANALYSIS OF RENAL REPLACEMENT THERAPY BY TRANSPLANT IN A SYSTEM OF BUNDLED PAYMENT OF DIALYSIS Maria Joao Rocha, Susana Ferreira, La Salete Martins, Antonio Castro Henriques, and Antonio Cabrita; Porto, Portugal

19:24

19:28

19:32

19:36

19:40

19:44

19:48

19:52

67

Sunday 4 September
19:56 RO-010 EXPANDING THE ENVELOPE: OLDER AGE AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY Sotiris Mastoridis, Benjamin OBrien, Atika Sabharwal, David Taube, Nadey Hakim, and Vassilios Papalois; London, United Kingdom RO-011 CHIMERISM OF BLOOD TYPE ANTIGENS ON THE VESSEL ENDOTHELIUM IN PATIENTS WITH ANTIBODY-MEDIATED REJECTION Hideki Ishida, Tatsu Tanabe, Hiroki Shirakawa, Tomokazu Shimizu, Kazuya Omoto, Taiji Nozaki, and Kazunari Tanabe; Tokyo, Japan RO-012 RECURRENCE OF FSGS AMONG ADULT TRANSPLANT RECIPIENTS: A LONGITUDENAL STUDY Ruth Rahamimov, Maya Mor, Sigal Eizner, Alexander Yussim, Evegny Solomonov, Eviatar Nesher, Ezra Shaharabani, Yanosh Winkler, and Eytan Mor; Petach-Tiqwa, Israel RO-013 KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND LIGANDS IN KIDNEY TRANSPLANT Serena Corsini, Gaetano La Manna, Maria L. Cappuccilli, Francesco Gozzetti, Diletta Conte, Laura Patregnani, Veronica Sgarlato, Maria P. Scolari, and Sergio Stefoni; Bologna, Italy RO-014 EXTENDING THE ANATOMICAL BARRIERS TO A RIGHT SIDED LAPAROSCOPIC LIVE DONOR NEPHRECTOMY (LLDN) Jodie H. Frost, Atul Bagul, Umasankar M. Thiagarajan, and Michael L. Nicholson; Leicester, United Kingdom RO-14/A IMPACT OF HEPATITIS B AND HEPATITIS C VIRUSES ON GRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS Wael F. Nassar, Mostafa A. Mostafa, Esam A. Lotfy, Amir El Okely, Malaka A. Fouad, Walid A. Afifi; Cairo, Egypt; October 6, Egypt; Zagazig, Egypt; Cairo, Egypt

20:00

20:04

20:08

20:12

20:16

19:20 20:30

RAPID ORAL SESSION 2 Kidney II

Chairs: Fritz Diekemann, Berlin, Germany; Emmanuel Morelon, Lyon, France

HYBRID POSTER AREA Digital Display 2

19:20

RO-015 LONG TERM FOLLOW-UP OF OVERWEIGHT AND OBESE LIVING KIDNEY DONORS Hilde Tent, Mieneke Rook, H. Sijbrand Hofker, Rutger J. Ploeg, Gerjan Navis, and Jaap J. Homan van der Heide; Groningen, The Netherlands RO-016 NEUROCOGNITIVE OUTCOMES ONE YEAR AFTER KIDNEY TRANSPLANTATION (KTx): A LONGITUDINAL CONTROLLED STUDY Michal Harciarek, Bogdan Biedunkiewicz, Monika LichodziejewskaNiemierko, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland RO-017 ELEVATED TROPONIN I AND NT-proBNP AT TIME OF RENAL TRANSPLANTATION MAY PREDICT AN ACUTE CARDIAC EVENT IN THE EARLY POST-OPERATIVE PHASE John Hausken, Olav Klingenberg, Halvor Rollag, Aksel Foss, and Karsten Midtvedt; Oslo, Norway

19:24

68

19:28

Sunday 4 September
19:32 RO-018 DETECTION OF RENAL SCARS BY TRANSPLANT RENAL ULTRASOUNDS AND DMSA SCANS AFTER URINARY TRACT INFECTIONS IN PEDIATRIC RENAL TRANSPLLANT RECIPIENTS Cheentan Singh, Vikas Shah, Sachit Shah, Rashika Fernando, Peter J. Anderson, Lorenzo Biassoni, and Stephen D. Marks; London, United Kingdom RO-019 SIROLIMUS THERAPY EXACERBATES NEW ONSET DIABETES MELLITUS AFTER RENAL TRANSPLANTATION: A LONG TERM ANALYSIS OF VARIOUS TREATMENT REGIMENS Zsolt Kaposztas, Eva Gyurus, and Barry D. Kahan; Cardiff, United Kingdom; and Houston, USA RO-020 SERUM ERYTHROPOIETIN LEVEL AND MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS Miklos Z. Molnar, Adam G. Tabak, Ahsan Alam, Maria E. Czira, Anna Rudas, Akos Ujszaszi, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy, Adam Remport, and Istvan Mucsi; Budapest, Hungary; Torrance, USA; London, United Kingdom; Montreal, Canada; Los Angeles, USA; Salem, USA; and Charlottesville, USA RO-021 INFLUENCE OF VIRAL REPLICATION AT THE TIME OF RENAL TRANSPLANTATION ON THE LONG-TERM OUTCOME OF PATIENTS WITH POSITIVE SEROLOGY FOR HEPATITIS C VIRUS J.M. Morales, M.A. Gentil Govantes, N. Esforzado, N. Saval, F.M. Gonzlez Roncero, and J.M. Cruzado; Madrid, Spain; Barcelona, Spain; and Sevilla, Spain RO-022 THE ROLE OF NEUTROPENIA, CMV INFECTION AND MMF DOSE REDUCTION IN ACUTE KIDNEY GRAFT REJECTION eljka Veceric-Haler, Jelka Lindic, Damjan Kovac, Janez Tomazic, Aljoa Kandus, Mateja Komar, and Andrej Bren; Ljubljana, Slovenia RO-023 SELECTIVE PROLIFERATION OF HUMAN CD28NULL EFFECTOR MEMORY T-CELLS INDUCED BY PRIMARY RENAL TUBULAR EPITHELAILC CELLS Martijn W.H.J. Demmers, Carla C. Baan, Willem Weimar, and Ajda T. Rowshani; Rotterdam, The Netherlands RO-024 CMV INFECTION MAY BE AN INDEPENDENT RISK AFFECTING LONG-TERM ALLOGRAFT FUNCTION Masaki Muramatsu, Hiroyuki Satoh, Zenichi Matsui, Sachiko Sakai, Seiichiro Shishido, and Atsushi Aikawa; Tokyo, Japan RO-025 VARIATIONS IN DURATION OF MACHINE PERFUSION AND OTHER PARAMETERS MAY AFFECT GRAFT FUNCTION IN NON HEART-BEATING RENAL TRANSPLANTATION Asantha R. Jayaweera, Murali Somasundaram, Joseph Hughes, Mohammad Heetun, Sanjay Sinha, Anil Vaidya, Chris Darby, and Peter Friend; Oxford, United Kingdom RO-026 OBESITY AND VASCULAR ANOMALIES IN RENAL TRANSPLANTATION EFFECTS ON GRAFT OUTCOME? David van Dellen, Jay Nath, Melanie Field, Hari Krishnan, Ahmed Hamsho, Steve J. Mellor, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom

19:36

19:40

19:44

19:48

19:52

19:56

20:00

20:04

69

Sunday 4 September
20:08 RO-027 OPTIMIZATION OF CARDIAC PRELOAD USING OESOPHAGEAL DOPPLER MONITORING (ODM) AND ITS EFFECTS ON EARLY GRAFT FUNCTION FOLLOWING RENAL TRANSPLANTATION Atul Bagul, Sarah L. Bell, Umashankar Thiyagarajan, Sarah A. Hosgood, Harold Pereira, and Prof Michael L. Nicholson; Leicester, United Kingdom RO-028 ALTERED CARDIAC HIGH ENERGY PHOSPHATE METABOLISM IN ESRD PATIENTS BEING ASSESSED FOR RENAL TRANSPLANTATION Rajan K. Patel, Patrick B. Mark, Kathryn K. Stevens, Tracey Steedman, Henry J. Dargie, and Alan G. Jardine; Glasgow, United Kingdom RO-029 COMPENSATORY RENAL HYPERTROPHY FOLLOWING LAPAROSCOPIC LIVE KIDNEY DONATION: NO REDUCTION COMPARED WITH OPEN TECHNIQUES Stella J. Stanford-Wood, Marc Gingell-Littlejohn, Norman Galbraith, Colin Geddes, and Marc J. Clancy; Glasgow, United Kingdom

20:12

20:16

19:20 20:30

RAPID ORAL SESSION 3 Liver I

HYBRID POSTER AREA Digital Display 3

Chairs: Patrizia Burra, Padua, Italy; Robert Porte, Groningen, The Netherlands 19:20 RO-030 CADAVERIC LEFT LIVER REDUCED OR SPLIT LIVER TRANSPLANTATION Roberto Valente, Carlos Bernardos, Montse Juvany, Pablo Beltran, Mohamed Rela, Parthi Srinivasan, Hector Vilca Melendez, Andreas Prachalias, Wayel Jassem, and Nigel Heaton; London, United Kingdom RO-031 SPLIT LIVER TRANSPLANTATION WITH EXTENDED RIGHT GRAFTS. SINGLE CENTER MATCHED-PAIR OUTCOME ANALYSIS Maria C. Dezza, Alessandro Giacomoni, Abdallah O. Slim, Andrea Lauterio, Iacopo Mangoni, Paolo Aseni, Stefano Di Sandro, Plamen Mihaylov, Luca Belli, Alberto Alberti, Andrea De Gasperi, and Luciano G. De Carlis; Milan, Italy RO-032 OUTCOME AFTER LIVER TRANSPLANTATION USING DONATION AFTER CARDIAC DEATH DONORS: A SINGLECENTER EXPERIENCE J. Francois, S. Vandenbussche, B. Desschans, G. Van Helleputte, N. Grossen, D. Claes, J. De Roey, S. Dirix, R. Aerts, F. Nevens, J. Pirenne, and D. Monbaliu; Leuven, Belgium RO-033 EFFEKT OF Cilostazol ON HEPATIC MICROCIRCULATION AND LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN A RAT MODEL Maximilian von Heesen, Stefan Dold, Pascal Jeanmonod, Michael D. Menger, Martin K. Schilling, and Mohammed R. Moussavian; Homburg/Saar, Germany

19:24

19:28

19:32

70

Sunday 4 September
19:36 RO-034 TRENDS OF USAGE IN STEATOTIC LIVER GRAFTS FOR ORTHOTOPIC LIVER TRANSPLANTATION OVER A TEN YEAR PERIOD IN A SINGLE INSTITUTION Jeffrey T. Lordan, B. Gunson, Hynek Mergental, John Isaac, David A. Mayer, Paolo Muiesan, Simon R. Bramhall, Darius F. Mirza, D.A. Neil, and Thamara Perera; Birmingham, United Kingdom RO-035 LIPOCALIN-2, A PROMISING INFLAMMATORY MARKER IN ACUTE ALLOGRAFT REJECTION? Herbert T. Maier, Natalie Vallant, Markus Kofler, Philipp Schumpp, Hubert Schwelberger, Hanno Ulmer, Stefan Schneeberger, Jakob Troppmair, Johann Pratschke, and Felix Aigner; Innsbruck, Austria RO-036 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER RESECTION: WHY DENY THIS CHANCE OF CURE? Stefano Di Sandro, Plamen Mihaylov, Abdallah Slim, Alessandro Giacomoni, Andrea Lauterio, Iacopo Mangoni, Matteo Tripepi, Cinzia Poli, Luca Lamperti, Caterina Cusumano, and Luciano De Carlis; Milan, Italy RO-037 PATIENTS WITH 18F-FDG NON-AVID HCC BEYOND MILAN BURDEN ACHIEVE EXCELLENT RECURRENCE-FREE LONGTERM SURVIVAL AFTER LIVER TRANSPLANTATION Arno Kornberg, Bernadett Kpper, Jens Wilberg, Olaf Habrecht, Peter Bchler, Katharina Thrum, Helmut Friess, and Dietmar Gottschild; Munich, Germany; Bad Berka, Germany; and Jena, Germany RO-038 TACE BEFORE LIVER TRANSPLANTATION: RESPONSE TO BRIDGING PREDICTS HCC RECURRENCE Gerd Otto, Marcus Schuchmann, Maria Hoppe-Lotichius, Thorsten Hansen, Michael Heise, and Michael Pitton; Mainz, Germany RO-039 ASSESSMENT OF ETHYL GLUCURONIDE IN HAIR IMPROVES EVALUATION OF LONG-TERM ALCOHOL ABSTENTION IN LIVER TRANSPLANT CANDIDATES WITH ALCOHOLIC LIVER DISEASE Katharina Staufer, Hilke Andresen, Susanne Kjer, Michael Yegles, Karl-Heinz Schulz, Bjoern Nashan, and Martina Sterneck; Hamburg, Germany; and Luxembourg, Luxembourg RO-040 RECURRENT HEPATITIS C AND BILE DUCT COMPLICATIONS AFTER LIVER TRANSPLANTATION Marco Vivarelli, Daniele Nicolini, Alen Federici, Federico Mocchegiani, Paolo Garelli, Paolo Vincenzi, Giacomo Martorelli, Marco Gentili, Martina Coletta, Gianluca Svegliati-Baroni, and Andrea Risaliti; Ancona, Italy RO-041 CORRELATION OF MAJOR SURGICAL COMPLICATIONS AFTER LIVER TRANSPLANTATION FOR HEPATITIS-B AND -C AND HEPATITIS RE-INFECTION RATE Arzu Oezcelik, Renate Reinhardt, Juergen W. Treckmann, Georgios C. Sotiropoulos, Gernot M. Kaiser, Jochen Vehlken, Fuat H. Saner, Matthias Heuer, and Andreas Paul; Essen, Germany RO-042 ANTITHROMBIN III AS A PART OF THE ANTICOAGULANT PROTOCOL IN THE EARLY POSTOPERATIVE PEDIATRIC LIVER TRANSPLANTATION: A PROSPECTIVE STUDY Jess Quintero, Juan Ortega, Mara Legarda, Javier Bueno, Itxarone Bilbao, and Ramn Charco; Barcelona, Spain

19:40

19:44

19:48

19:52

19:56

20:00

20:04

20:08

71

Sunday 4 September
20:12 RO-043 PREOPERATIVE PORTAL VEIN THROMBOSIS DOES NOT INFLUENCE MORBIDITY AND MORTALITY AFTER LIVER TRANSPLANTATION Fabrizio Di Benedetto, Giuseppe DAmico, Giuseppe Tarantino, Roberto Montalti, Nicola De Ruvo, Nicola Cautero, Gian Piero Guerrini, Roberto Ballarin, Mario Spaggiari, Antonio Mimmo, and Giorgio Enrico Gerunda; Modena, Italy RO-044 ACUTE KIDNEY INJURY (AKI) AFTER OLT USING AKIN CRITERIA Andrea De Gasperi, Raffaella Collini, Andrea Corti, Elena Roselli, Ombretta Amici, Ernestina Mazza, and Manlio Prosperi; Milan, Italy

20:16

19:20 20:30

RAPID ORAL SESSION 4 Liver II

HYBRID POSTER AREA Digital Display 4

Chairs: Stuart Forbes, Edinburgh, United Kingdom; Pavel Trunecka, Prague, Czech Republic 19:20 RO-045 LEVEL OF ACUTE RENAL DYSFUNCTION IN LIVER TRANSPLANTATION: RELATION WITH PRE- AND POST-TRANSPLANT HEPATIC FUNCTION Francesca Tinti, Ilaria Umbro, Michela Mordenti, Stefano Ginanni Corradini, Massimo Rossi, Lai Quirino, Stefano Ianni, Luca Poli, Pasquale B. Berloco, and Anna Paola Mitterhofer; Rome, Italy RO-046 XEROSTOMIA AND BURNING MOUTH SYNDROME ARE COMMON ORAL SIDE EFFECTS IN LIVER TRANSPLANT PATIENTS Jaana S. Helenius-Hietala, Jukka H. Meurman, Hellevi Ruokonen, Lisa Grnroos, and Helena Isoniemi; Helsinki, Finland RO-047 APURINIC APYRIMIDINIC ENDONUCLEASE/REDOX EFFECTOR FACTOR 1 IMMUNOREACTIVITY IN HEPATOCELLULAR CARCINOMA RISK OF RELAPSE AFTER LIVER TRANSPLANTATION Umberto Baccarani, Anna Rossetto, Maria Orsaria, Gian Luigi Adani, Dario Lorenzin, Chiara Comuzzi, Vittorio Bresadola, Dino De Anna, Gianluca Tell, and Claudio Avellini; Udine, Italy RO-048 EFFECT OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) ON THROMBIN GENERATION (TG) IN CIRRHOTIC PATIENTS Kryssia I. Rodriguez, Valeria Rossetto, Claudia Radu, Sabrina Gavasso, Patrizia Burra, Paolo Simioni, and Marco Senzolo; Padua, Italy RO-049 EARLY SWITCHING TO INTRAMUSCULAR ANTI-HBs IMMUNOGLOBULINS (IgantibeTM) AFTER LIVER TRANSPLANTATION: FEASIBILITY, EFFICACY, AND SAFETY Paolo De Simone, Paola Carrai, Stefania Petruccelli, Emanuele Balzano, Juri Ducci, Laura Coletti, and Franco Filipponi; Pisa, Italy RO-050 A SURGICAL MODEL OF ACUTE LIVER FAILURE FOR TESTING A BIOARTIFICIAL LIVER Delawir Kahn, Wendy Spearman, Clare Selden, Tony Figaji, Hiram Arendse, Malcolm Miller, and Humphrey Hodgson; Cape Town, South Africa RO-051 PRE-TRANSPLANT PARAMETERS PREDICT SURVIVAL DURING AND AFTER LIVER TRANSPLANTATION Rhiana Garritsen, Tien Nguyen, Herold J. Metselaar, Hugo W. Tilanus, and Geert Kazemier; Rotterdam, The Netherlands

19:24

19:28

19:32

19:36

19:40

72
19:44

Sunday 4 September
19:48 RO-052 IS PLASMA DISAPPEARANCE RATE OF INDOCYANINE GREEN (PDR ICG) AFTER LIVER TRANSPLANTATION (OLT) ALWAYS A RELIABLE TOOL TO ASSESS EARLY GRAFT FUNCTION AND OUTCOME ? Ernestina Mazza, Andrea De Gasperi, Manlio Prosperi, Carla Grugni, Luca Bettinelli, and Andrea Corti; Milan, Italy RO-053 TECHNICAL ASPECTS OF HEPATIC ARTERY RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION Abdallah Slim, Andrea Lauterio, Alessandro Giacomoni, Iacopo Mangoni, Plamen Mihaylov, Stefano Di Sandro, Matteo Tripepi, Cinzia Poli, Luca Lamperti, Caterina Cusumano, and Luciano De Carlis; Milan, Italy RO-054 USE OF FUNCTIONAL IMAGING IN THE INVESTIGATION OF PATIENTS WITH SUSPECTED SEPSIS FOLLOWING MULTIVISCERAL TRANSPLANTATION Satheesh Iype, K. Balan, Christopher Watson, Raaj Praseedom, and Neville Jamieson; Cambridge, United Kingdom RO-055 PREDICTING SURVIVAL AFTER LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA USING EXPANDED MILAN CRITERIA AFTER 10th YEAR Ilka F.S.F. Boin, Elaine C. Ataide, Raquel S.B. Stucchi, Tiago SevaPereira, Jazon R.S. Almeida, Thiago Mattosinho, Milena Garcia, Maxwell Boga, Fernando R. Araujo, and Anaisa P. Ramos; Campinas, Brazil RO-056 SOMATOSTATIN IMPROVES HEPATIC HEMODYNAMICS, INJURY, AND OUTCOME IN SMALL-FOR-SIZE LIVER TRANSPLANT A.J. Hessheimer, C. Fondevila, B. Escobar, E. Flores, P. Taur, J. Muoz, D. Calatayud, M. Vendrell, J. Fuster, A. Rimola, and J.C. Garca-Valdecasas; Barcelona, Spain RO-057 LIVER AND LIVER PANCREAS TRANSPLANTATION IN THE TWO STAGE TREATMENT OF LIVER METASTASIZED NEUROENDOCRINE TUMORS OF THE PANCREAS: ABOUT THREE CASES Geert Roeyen, Thiery Chapelle, Kathleen De Greef, Peter Michielsen, Sven Francque, Bart Op de Beeck, and Dirk Ysebaert; Edegem-Antwerp, Belgium RO-058 USE OF NHBD IN RECIPIENTS WITH HCV CIRRHOSIS: INFLUENCE OVER PATIENT SURVIVAL Iago Justo, Manuel Abradelo, Oscar Caso, Naim Fakih, Sergio Olivares, Felix Cambra, Alvaro Garca, Jorge Calvo, Alejandro Manrique, Enrique Moreno, and Carlos Jimenez; Madrid, Spain RO-059 COMBINED EN BLOC LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS Vittorio Corno, Domenico Pinelli, Marco Zambelli, Alessandro Aluffi, Michela Guizzetti, Giovanni Rota, Chiara Rocha, Alessandro Lucianetti, Stefano Fagiuoli, Giuseppe Remuzzi, Roberto Trevisan, and Michele Colledan; Bergamo, Italy

19:52

19:56

20:00

20:04

20:08

20:12

20:16

73

Sunday 4 September
19:20 20:30

RAPID ORAL SESSION 5 Donation/Retrieval

HYBRID POSTER AREA Digital Display 5

Chairs: Alan Kirk, Glasgow, United Kingdom; Axel Rahmel, Leiden, The Netherlands 19:20 RO-060 HEPARIN DOES NOT IMPROVE GRAFT FUNCTION IN NON-HEART BEATING LUNG DONATION. AN EXPERIMENTAL STUDY IN PIGS Andreas Wallinder, Stig Steen, Hans Liden, Aziz A. Hussein, Trygve Sjberg, and Gran Dellgren; Gothenburg, Sweden; and Lund, Sweden RO-061 ENHANCING REFERRAL AND DONATION RATES: NORTH WEST EXPERIENCE Gregory P. Bleakley; Liverpool, United Kingdom RO-062 PANCREAS ALLOGRAFT: IMPACT OF THE RETRIEVAL CENTRE ON THE UTILIZATION OF THE ORGAN Anna Rizzello, Anand Muthusamy, Sanjay Sinha, Doruk Elker, Isabel Quiroga, Anil Vaidya, and Peter J. Friend; Oxford, United Kingdom RO-063 LIVE DONATION IN AN ETHNICALLY DIVERSE INNER CITY COMMUNITY Jen McDermott, Harvinder Dulku, Pauline Reece, Olivia Ferres, Honeylet Orr, Peter Choi, Jack Galliford, Marina Locaidou, Vassilios Papalois, David Taube, and Brenda Rice; London, United Kingdom RO-064 LESS LIVING DONOR NEPHRECTOMY: SURGICAL TECHNIQUE AND RESULTS Sebastien Crouzet, Georges-Pascal Haber, Lionel Badet, and Xavier Martin; Lyon, France; and Cleveland, USA RO-065 OPTIMIZATION OF LONG-TERM GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: THE ROLE OF DONOR AGE Quirino Lai, Fabio Melandro, Gabriele Spoletini, Giovanni B. Levi Sandri, Nicola Guglielmo, Stefano G. Corradini, Pasquale B. Berloco, and Massimo Rossi; Rome, Italy RO-066 IN THE CREATION OF DOCTORS AWARENESS OF ORGAN DONATION THE ADEQUACY OF MEDICAL EDUCATION Meltem Akkas, Esin Glkaya, Ferhat Keser, Naime Gl Demirel, Nuray ztrk, and Taha Yusuf Kuzan; Ankara, Turkey RO-067 THE SOCIO-ECONOMIC CHARACTERISTICS OF LIVE KIDNEY DONORS IN A SINGLE UK CENTRE Lolita Chan, Dan Ridgway, Wei Min Ho, Sue Kost, Janet Gill, Afshin Tavakoli, Ravi Pararajasingam, Neil Parrott, Hany Riad, Titus Augustine, and Tunde Campbell; Manchester, United Kingdom RO-068 THE FACTORS INCREASING THE RISK OF ACUTE KIDNEY INJURY IN DECEASED DONORS Agata Pawlik, Jerzy Chudek, Aureliusz Kolonko, Jaroslaw Wilk, Przemyslaw Jalowiecki, and Andrzej Wiecek; Katowice, Poland RO-069 WHAT PROPORTION OF POTENTIAL LIVE KIDNEY DONORS PROCEED TO DONATION? REVIEW OF 643 CASES WORKED UP BETWEEN 1996-2010 Rosie Peters, Nahida Khan, Helen Gregson, Nicos Kessaris, and Jiri Fronek; London, Tooting, United Kingdom

19:24

19:28

19:32

19:36

19:40

19:44

19:48

19:52

19:56

74

Sunday 4 September
20:00 RO-069/A THE EFFECT OF EVOLVING CVA MANAGEMENT UPON TRANSPLANT DONATION IN THE UK Luke R. Devey, Sarah Power, Dermot McKeown, Stephen J. Wigmore, David Harrison, Kathy Rowan; Edinburgh, United Kingdom; London, United Kingdom RO-069/B THE FIRST YEAR OF A NATIONAL ORGAN RETRIEVAL SERVICE IN THE UK Rachel J. Johnson, Cara Murphy, Karen Quinn, James Neuberger, David Mayer; Bristol, United Kingdom RO-069/C NECMO IS BETTER THAN IMMEDIATE COOLING AFTER UNCONTROLLED CARDIO-CIRCULATORY DEATH Benoit Barrou, Frederic Thibault, Karim Ferhi, Emmanuel Van Glabeke, Stphane Bart, Nebjosa Zivanovitch, Armelle Nicolas Robin, Nadia Arzouk, Victor Gueutin, Saida Ourahma, Pascal Leprince, Gilbert Deray, Bruno Riou, Marc Olivier Bitker; Paris, France

20:04

20:08

19:20 20:30

RAPID ORAL SESSION 6 Tissue injury/preservation I

HYBRID POSTER AREA Digital Display 6

Chairs: Philipp Dutkowski, Zurich, Switzerland; Peter Friend, Oxford, United Kingdom 19:20 RO-070 OXYGENATED IN SITU COLD PERFUSION OF DCD KIDNEYS IN PIGS Henri Leuvenink, Christina Krikke, Sijbrand Hofker, Vincent Nieuwenhuijs, Henk ten Cate Hoedemaker, and Rutger J. Ploeg; Groningen, The Netherlands RO-071 QUALITY ASSESSMENT OF HEART BEATING AND NONHEART BEATING LIVER GRAFTS THROUGH microRNAs IN PRESERVATION SOLUTION Renee J. Verhoeven, Jaap Kwekkeboom, Waqar R.R. Farid, Petra E. de Ruiter, Jeroen de Jonge, Herold J. Metselaar, Hugo W. Tilanus, Geert Kazemier, and Luc J.W. van der Laan; Rotterdam, The Netherlands RO-072 PHARMACOLOGIC PRECONDITIONING PROTECTS LIVERS AND LUNGS AGAINST INFLAMMATORY REACTION OF THE SPLIT LIVER PROCEDURE Maximilian von Heesen, Pascal Jeanmonod, Stefan Dold, Otto Kollmar, Michael D. Menger, Martin K. Schilling, and Mohammed R. Moussavian; Homburg/Saar, Germany RO-073 PRESERVATION SOLUTION AND METHOD AFFECT ORGAN TEMPERATURE DURING PROCUREMENT Claire Billault, Ernst Buiter, Benoit Barrou, Rutger J. Ploeg, and Henri Leuvenink; Groningen, The Netherlands; and Paris, France RO-074 A PREOPERATIVE PROTEIN DEFICIENT DIET PROTECTS AGAINST RENAL AND HEPATIC ISCHEMIA AND REPERFUSION INJURY T. C. Saat, T. M. van Ginhoven, Marielle Verweij, J.N.M. IJzermans, J.H.J. Hoeijmakers, and R. W.F. de Bruin; Rotterdam, The Netherlands

19:24

19:28

19:32

19:36

75

Sunday 4 September
19:40 RO-075 PRESERVATION OF NORMAL MORPHOLOGY OF HUMAN LIVERS AFTER 24 HOURS OF HYPOTHERMIC MACHINE PERFUSION. A FIRST-IN-MAN STUDY D. Monbaliu, Q. Liu, L. Libbrecht, R. De Vos, K. Vekemans, O. Detry, J. van Pelt, T. Roskams, and J. Pirenne; Leuven, Belgium; Ghent, Belgium; and Lige, Belgium RO-076 LIVER WASHOUT PRECONDITIONING: A USEFUL TOOL TO PROTECT THE GRAFT AGAINST REPERFUSION INJURY Mohamed Amine Zaouali, Sussagna Padrissa-Alts, Hassen Ben Abdennebi, Agustn Garcia-Gil, Olivier Boillot, and Joan RosellCatafau; Barcelona, Spain; Monastir, Tunisia; Zaragoza, Spain; and Lyon, France RO-077 HYPOTERMIC MACHINE PERFUSION (HMP) VERSUS STATIC COLD STORAGE (CS) IN KIDNEY ALLOGRAFT PRESERVATION. PROSPECTIVE CASE-CONTROL TRIAL Annalisa Amaduzzi, Fausto Catena, Giulia Montori, Matteo Ravaioli, and Antonio Pinna; Bologna, Italy RO-078 GASEOUS HYDROGEN SULFIDE (H2S) IS PROTECTIVE DURING CARDIAC ISCHEMIA/REPERFUSION Pauline M. Snijder, Rudolf A. de Boer, Eelke M. Bos, Joost C. van den Born, Willem-Peter T. Ruifrok, Inge Vreeswijk-Baudoin, Marcory C.F. van Dijk, Henri G.D. Leuvenink, and Harry van Goor; Groningen, The Netherlands RO-079 IDENTIFICATION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS IN PORCINE MODELS Ivo C.J.H. Post, Robert Weenink, Albert C.W.A. van Wijk, and Thomas M. van Gulik; Amsterdam, The Netherlands RO-080 THE EFFECT OF NORMOTHERMIC RECIRCULATION BEFORE COLD PRESERVATION ON POSTTRANSPLANT INJURY OF ISCHEMICALLY DAMAGED DONOR KIDNEYS Cyril Moers, Geert van Rijt, Rutger J. Ploeg, and Henri G.D. Leuvenink; Groningen, The Netherlands RO-081 STRATEGY FOR REDUCING THE DISCARD RATE FOR CADAVERIC KIDNEYS Lauren Brasile, and Bart Stubenitsky; Albany, USA; and Utrecht, The Netherlands RO-082 A NOVEL CELL CULTURE MODEL FOR STUDYING HEPATIC ISCHAEMIA REPERFUSION INJURY Debabrata Roy, Karl Morten, Elizabeth Rapa, Reza Morovat, and Peter Friend; Oxford, United Kingdom RO-083 THE RELATIONSHIP BETWEEN THE PARAMETERS OF HYPOTHERMIC PULSATILE MACHINE PERFUSION (HPMP) OF KIDNEY GRAFTS FROM DONORS AFTER CARDIAC DEATH (DCD) AND POST-TRANSPLANT KIDNEY FUNCTION Shady G. Hosny, Raphael Uwechue, Nicos Kessaris, and Mohamed Morsy; London, United Kingdom RO-084 ECULIZUMAB FOR SALVAGE IN POST-TRANSPLANT THROMBOTIC MICROANGIOPATHY A. Nicholas R. Barnett, Vassilis G. Hadjianastassiou, Olivia J. Shaw, Partha P. Das, Patrick J. ODonnell, Paramit Chowdhury, Anthony Dorling, and Nizam Mamode; London, United Kingdom

19:44

19:48

19:52

19:56

20:00

20:04

20:08

20:12

20:16

76

Sunday 4 September
19:20 20:30

RAPID ORAL SESSION 7 Ethics, legal and psychosocial aspects of transplantation

HYBRID POSTER AREA Digital Display 7

Chairs: Fabienne Dobbels, Leuven, Belgium; Assya Pascalev, Sofia, Bulgaria 19:20 RO-085 ETHICAL DILEMMAS IN RELIGION-BASED ORGAN DONATION Sandu Frunza, Mihaela Frunza, Iulia Grad, Ovidiu Grad, and CatalinVasile Bobb; Cluj, Romania; and Iasi, Romania RO-086 A MODEL FOR ORGAN DONATION IN SWITZERLAND, THE LATIN ORGAN DONATION PROGRAMME (LODP); AN ONGOING SUCCESSFUL REGIONAL INITIATIVE Diane Moretti, Claudia-Paula Heidegger, Philippe Eckert, Roberto Malacrida, Manuel Pascual, and Jean-Pierre Revelly; Lausanne, Switzerland; Geneva, Switzerland RO-087 EUROPEAN LIVING DONOR PSYCHOSOCIAL FOLLOWUP (ELIPSY PROJECT) Ana Menjvar, Ballest Chlo, Levent Yucetin, Leondio Dias, Christophe Legendre, Christian Hiesse, George Kyriakides, Christina Papachristou, Ingela Fehrman-Ekholm, Niclas Kvarnstrm, John Sfteland, David Paredes, Ignacio Revuelta, Fritz Diekmann, Josep Maria Peri, Xavier Torres, Montserrat Martnez, Antoni Rimola, Constantino Fondevila, and Mart Manyalich; Barcelona, Spain; Antalya, Turkey; Porto, Portugal; Paris, France; Nicosia, Cyprus; Berlin, Germany; and Gothenburg, Sweden RO-088 ETHNIC BACKGROUND GOVERNING ATTITUDES TOWARDS INFLUENZA AND SWINE FLU VACCINATION AMONGST RENAL TRANSPLANT PATIENTS David van Dellen, Jay Nath, Marc Williams, Melanie Field, Hari Krishnan, Stephen J. Mellor, Ahmed Hamsho, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom RO-089 PSYCHOSOCIAL CHARACTERISTICS PREDICTIVE OF POST-OPERATIVE MENTAL HEALTH IN LIVING-RELATED LIVER OR KIDNEY DONORS: A SYSTEMATIC LITERATURE REVIEW Johan van Gogh, Nathalie Duerinckx, Emma Massey, Jan Busschbach, Fabinne Dobbels, and Sohal Ismail; Rotterdam, The Netherlands; and Leuven, Belgium RO-090 ROLE OF TRANSPLANT COORDINATORS FOR INTEGRAL DONOR PROTECTION IN LIVING KIDNEY TRANSPLANT David Paredes, Sandra Saavedra, Camino Rodriguez-Villar, Blanca Miranda, Fritz Diekmann, Ignacio Revuelta, Mireia Musquera, Antonio Alcaraz, and Federico Oppenheimer; Barcelona, Spain RO-091 EUROPEAN DONATION DAY: TOWARDS A COMMON EUROPEAN AWARENESS-RAISING COMPAIGN Danica Avsec; Ljubljana, Slovenia RO-092 VALIDATION STUDY OF THE MTSOSD-59 IN THE ITALIAN CONTEXT Chiara Comuzzi, Elisa Borlini, Vittorio Bresadola, Anna Rossetto, Dario Lorenzin, Gian Luigi Adani, Dino De Anna, Umberto Baccarani, and Alvisa Palese; Udine, Italy

19:24

19:28

19:32

19:36

19:40

19:44

19:48

77

Sunday 4 September
19:52 RO-093 THE PHYSICIAN SAID: YOU HAVE HAD A TRANSPLANT, YOU SHOULD BE HAPPIER!; AN ANTHROPOLOGICAL APPROACH TO PATIENTS DISAPPOINTMENT AFTER A RENAL TRANSPLANTATION Aurlie Desseix, Lionel Couzi, Thomas Bachelet, and Pierre Merville; Bordeaux, France RO-094 WITHDRAWN RO-095 SYSTEM FACTORS AS CORRELATES OF MEDICATION ADHERENCE IN TRANSPLANT AND HIV POPULATIONS: A SYSTEMATIC REVIEW Lut Berben, Sandra Engberg, Fabienne Dobbels, Susan Sereika, Martha Hill, and Sabina De Geest; Basel, Switzerland; Pittsburgh, USA; Leuven, Belgium; and Baltimore, USA RO-096 LACK OF MOTIVATION AMONG THE ICU DOCTORS FOR DONATION PROGRAMME Danica Avsec; Ljubljana, Slovenia RO-097 HIGHER REFUSAL RATES BY RELATIVES OF POTENTIAL UNCONTROLLED ORGAN DONORS VERSUS UNCONTROLLED ORGAN DONORS: A SINGLE CENTER STUDY Tineke J. Wind, Pieter E.R. Hoogland, and Ernest L.W. van Heurn; Maastricht, The Netherlands RO-098 EUROCET: THE EUROPEAN NETWORK OF THE COMPETENT AUTHORITIES FOR TISSUES AND CELLS Angelo Ghirardini, Marzia Filippetti, Maura Mareri, Francesca Vespasiano, Paola Di Ciaccio, and Alessandro Nanni Costa; Rome, Italy RO-099 PIERDUB: KEEP IMPROVING TRAINING OF UNIVERSITY STUDENTS ABOUT DONATION AND TRANSPLANTATION Chlo Ballest, David Paredes, and Mart Manyalich; Barcelona, Spain

19:56 20:00

20:04

20:08

20:12

20:16

19:20 20:30

RAPID ORAL SESSION 8 Immunobiology/Basic science I

HYBRID POSTER AREA Digital Display 8

Chairs: James Fildes, Manchester, United Kingdom; Alexander Kroemer, Boston, United States 19:20 RO-100 HYPOXIA INDUCES MATURATION OF DENDRITIC CELLS TRIGGERING THE SPECIFIC PROLIFERATION OF B-LYMPHOCYTE SUBSETS. TARGETING ABC TRANSPORTERS INTERFERES HYPOXIA DC MATURATION Nuria Lloberas, Ines Rama, Ines Llaud, Marcela Franquesa, Linda Cassis, Joan Torras, Gema Cerezo, Josep M. Cruzado, Oriol Bestard, and Josep M. Griny; Barcelona, Spain RO-101 NITRIC OXIDE POST-PERFUSION LEVELS DIFFER IN DCD AND DBD DONOR TRANSPLANTS Argiris Asderakis, Aisha Chaudhry, Mohamed Adel Ilham, Michael Stephens, and Aled Phillips; Cardiff, United Kingdom

19:24

78

Sunday 4 September
19:28 RO-102 INCREASED PROPORTION OF CIRCULATING BASOPHILS IN LUNG TRANSPLANT PATIENTS WITH OBLITERATIVE BRONCHIOLITIS Alastair Gibb, Alexander T. Glover, Harshith P. Bhat, Sukh Krishan, Mo Al-Aloul, Nizar Yonan, and James E. Fildes; Manchester, United Kingdom RO-103 THE SOURCE OF SOLUBLE CD30 DURING THE ALLOIMMUNE RESPONSE Sonia Y. Velasquez, Gerhard Opelz, Luis F. Garca, Cristiam M. Alvarez, and Caner Ssal; Heidelberg, Germany; and Medelln, Colombia RO-104 AN HIF-1a-INDEPENDENT NEOANGIOGENIC PATHWAY REGULATED BY THE UNFOLDED PROTEIN RESPONSE DURING RENAL ISCHEMIA Nicolas Bouvier, Sophie Fougeray, Dany Anglicheau, Christophe Legendre, Eric Thervet, Philippe Beaune, and Nicolas Pallet; Paris, France RO-105 ALTERED CYTOKINES PATTERN IN PATIENTS WITH ISCHEMIC TYPE BILIARY LESIONS FOLLOWING LIVER TRANSPLANTATION Speranta Iacob, Vito Cicinnati, Alexander Dechene, Irinel Popescu, Andreas Paul, Guido Gerken, and Susanne Beckebaum; Essen, Germany; and Bucharest, Romania RO-106 TACROLIMUS AT CLINICALLY RELEVANT CONCENTRATIONS INDUCES A MYOFIBROBLAST-LIKE PHENOTYPE IN HUMAN KIDNEY FIBROBLASTS BY LIGAND-FREE ACTIVATION OF TGF- RECEPTOR Georg Kern, Sabine Mair, Paul Jennings, Susie-Jane Noppert, Herbert Schramek, Michael Rudnicki, Gerhard A. Mueller, Gert Mayer, and Christian Koppelstaetter; Innsbruck, Austria; and Gttingen, Germany RO-107 TERLIPRESSIN IMPROVES LIVER REGENERATION IN A SMALL-FOR-SIZE LIVER REMNANT MOUSE MODEL Ren Fahrner, Andrea de Gottardi, Daniel Candinas, and Guido Beldi; Bern, Switzerland RO-108 HIGH PRODUCTION OF INF-GAMMA DURING THE ALLOIMMUNE RESPONSE IS ASSOCIATED WITH HIGH RELEASE OF SOLUBLE CD30 Sonia Y. Velasquez, Sara Paris, Gerhard Opelz, Cristiam M. Alvarez, and Caner Ssal; Heidelberg, Germany; and Medelln, Colombia RO-109 INTERLAB CROSSVALIDATION OF IFN- ELISPOT ASSAY FOR MEASURING ALLOREACTIVE MEMORY/EFFECTOR T-CELL RESPONSES IN RENAL TRANSPLANT RECIPIENTS Oriol Bestard, Maik Stein, Dave Roelen, Yvonne de Vaal, Marc Lucia, Maria P. Hernandez-Fuentes, Lucienne Chatenoud, Petra Reinke, Volkmar Schoellhorn, Hans-Dieter Volk, and Josep M. Griny; Barcelona, Spain; Berlin, Germany; Leiden, The Netherlands; London, United Kingdom; Paris, France; and Strassberg, Germany RO-110 DONOR SPECIFIC ANTIBODIES AND THEIR IMPACT ON GRAFT FUNCTION, REJECTION EPISODES- A SINGLE CENTRE EXPERIENCE Umasankar Mathuram Thiyagarajan, Atul Bagul, Prarthana Thiyagarajan, and Michael L. Nicholson; Leicester, United Kingdom

19:32

19:36

19:40

19:44

19:48

19:52

19:56

20:00

79

Sunday 4 September
20:04 RO-111 ENDOTHELIAL AND THROMBOCYTE ACTIVATION ARE NOT MEDIATORS IN EARLY ISCHEMIA-REPERFUSION INJURY IN HUMAN KIDNEY TRANSPLANTATION Dorottya K. de Vries, Mark Roest, Meriem Khairoun, Johannes H. Lindeman, Jan Ringers, Ton J. Rabelink, Philip G. de Groot, Marlies E. Reinders, and Alexander F. Schaapherder; Leiden, The Netherlands; and Utrecht, The Netherlands RO-112 DNAM-1 A NEW PLAYER IN RENAL ALLOGRAFT REJECTION Anna K. Kraus, Pietro E. Cippa, Jin Chen, Gnter Bernhardt, Rudolf P. Wthrich, and Thomas Fehr; Zurich, Switzerland; and Hannover, Germany

20:08

80

82

Monday 5 September
08:00 09:00

CLINICAL CASES SESSION 1 Mini Theatre 1 Kidney and composite tissue Surgical
Chairs: Nadey Hakim, London, United Kingdom; Ferdinand Mhlbacher, Vienna, Austria

08:00

CC-001 USE OF ENDOVASCULAR TECHNIQUES TO CONTROL BLEEDING FROM RENAL TRANSPLANT ASSOCIATED SECONDARY HAEMORRHAGE Lasantha N. Seneviratne, Anthony Goode, Ben Lindsey, Bimbi Fernando, Peter Veitch, and David Nicol; London, United Kingdom Case discussion CC-002 SUCCESSFUL AUTOTRANSPLANTATION OF A FUNCTIONING CADAVERIC RENAL TRANSPLANT WITH A MYCOTIC ANEURYSM: A CASE REPORT Jiri Fronek, Mohammad A. Hossain, Raphael Uwechue, Keith Jones, Uday Patel, and Nicos Kessaris; London, United Kingdom Case discussion CC-003 ARM TRANSPLANTATION-TO TRANSPLANT? NOW, LATER OR NEVER Hatem Amer, Brian T. Carlsen, Sheila G. Jowsey, Brooks S. Edwards, and Steven L. Moran; Rochester, USA Case discussion

08:10 08:20

08:30 08:40

08:50 08:00 09:00

CLINICAL CASES SESSION 2 Infection/malignancy

Mini Theatre 2

Chairs: Camille Kotton, Boston, United States; Nicholas Torpey, Cambridge, United Kingdom 08:00 CC-004 SUCCESSFUL TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) USING RITUXIMAB AND CRANIAL RADIOTHERAPY (CR) Valerie Said Conti, Persis J. Amrolia, Mark N. Gaze, Sara Stoneham, Rukshana Shroff, and Stephen D. Marks; London, United Kingdom Case discussion CC-005 CHRONIC LYMPHOCYTIC LEUKEMIA: CONTRAINDICATION FOR TRANSPLANTATION? Daan Dierickx, Ann Janssens, Diethard Monbaliu, Raymond Aerts, Dirk Kuypers, Yves Vanrenterghem, Frederik Nevens, Gregor Verhoef, and Jacques Pirenne; Leuven, Belgium Case discussion CC-006 PROPHYLAXIS WITH LIPOSOMAL AMPHOTERICINE B AFTER LIVER TRANSPLANT AND ITS IMPACT ON IMMUNE SYSTEM AND INFECTIONS AND MORTALITY WITHIN FIRST YEAR Alessandro Perrella, Ciro Esposito, Walter Santaniello, Donatella Pisaniello, and Oreste Cuomo; Naples, Italy Case discussion

08:10 08:20

08:30 08:40

83

08:50

Monday 5 September
08:00 09:00

ORAL SESSION 1 Lomond Auditorium Kidney (double kidney transplants and surgical aspects)
Chairs: Per Pfeffer, Oslo, Norway; Anthony Warrens, London, United Kingdom

08:00

O-001 MAXIMIZING THE SUCCESS OF TRANSPLANTATION WITH KIDNEYS FROM OLDER DONORS: LONG-TERM RESULTS OF A MULTICENTER, PROSPECTIVE STUDY Silvio Sandrini, Paolo Rigotti, and Giuseppe Rossini; Milan, Italy O-002 LONG TERM RESULTS OF A LARGE EXPERIENCE OF DOUBLE KIDNEY TRANSPLANTATION (DKT) PERFORMED AT A SINGLE CENTER Cristina Silvestre, Lucrezia Furian, Nicola Baldan, Burcin Ekser, Francesco Marchini, Barbara Rossi, Luciana Bonfante, Marialuisa Valente, and Paolo Rigotti; Padua, Italy O-003 USE OF INFERIOR EPIGASTRIC ARTERY AS A CONDUIT FOR ACCESSORY VESSELS IN RENAL TRANSPLANTATION David van Dellen, Otilia M. Mitu-Pretorian, Melissa Cunha, Abbas Ghazanfar, Bence Forgacs, Babatunde Campbell, Neil R. Parrott, Ravi Pararajasingam, Titus Augustine, Hany N. Riad, and Afshin Tavakoli; Manchester, United Kingdom O-004 EFFICACY AND SAFETY OF ROUTINE INTRAOPERATIVE INSERTION OF DOUBLE-J STENTS IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW Xianding Wang, Shaoxiang Ma, and Yiping Lu; Chengdu, China O-005 HAND-ASSISTED SCOPIC LIVING DONOR NEPHRECTOMY: A VERY SAFE PROCEDURE Ole yen, Bjrn H. Lien, Trygve Thorsen, Einar M. Aandahl, Morten Skauby, Geir Mjen, Hallvard Holdaas, and Per Pfeffer; Oslo, Norway O-006 OUTCOME OF RENAL TRANSPLANT INTO PATIENTS WITH LOWER URINARY TRACT ABNORMALITY Lasantha Seneviratne, Hala Kandil, Nadia Godigamuwa, Ben Lindsey, Mahamood Al-Akraa, Gareth Jones, Bimbi Fernando, and David Nicol; London, United Kingdom

08:10

08:20

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 2 Liver transplantation (Hepatocellular carcinoma)

Chairs: Edward Geissler, Regensburg, Germany; Peter Neuhaus, Berlin, Germany

Hall 1

08:00

O-007 PRE-LIVER TRANSPLANT BIOPSY IN MULTIFOCAL HCC: A POTENTIAL EXCLUSION CRITERION FOR TRANSPLANTATION? Richard S. Young, Mohammed Aldiwani, Rebecca Jones, and K.R. Prasad; Leeds, United Kingdom O-008 THE IMPACT OF WAITING LIST ALPHA-FETOPROTEIN CHANGES ON THE OUTCOME OF LIVER TRANSPLANT FOR HEPATOCELLULAR CARCINOMA Christian Toso, Shaheed Merani, Pietro Majno, Norman M. Kneteman, Thierry Berney, Philippe Morel, and Gilles Mentha; Geneva, Switzerland; and Edmonton, Canada

84

08:10

Monday 5 September
08:20 O-009 HEPATOCELLULAR CARCINOMA ON CIRRHOSIS: LIVER RESECTION, LIVER TRANSPLANTATION OR BOTH SURGICAL TREATMENTS? Massimo Del Gaudio, Matteo Cescon, Giorgio Ercolani, Matteo Ravaioli, Alessandro Cucchetti, Augusto Lauro, Matteo Zanello, Alessandro Dazzi, Chiara Zanfi, Valentina Bertuzzo, Paolo Di Gioia, Cristina Morelli, and Antonio Daniele Pinna; Bologna, Italy O-010 INCREASED ALPHA-FETOPROTEIN AFTER BRIDGE THERAPIES AS PREDICTOR OF RECURRENCE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH LIVER TRANSPLANTATION Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, and Massimo Rossi; Rome, Italy O-011 BARCELONA CLINIC LIVER CANCER STAGING PREDICTS THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA Alessandro Vitale, Rafael Ramirez Morales, Giacomo Zanus, Patrizia Burra, and Umberto Cillo; Padua, Italy O-012 TEN-YEAR FOLLOW-UP OF A RCT: NEOADJUVANT CHEMOTHERAPY IN LIVER TRANSPLANTATION FOR HCC Jakob Mhlbacher, Susanne Rasoul-Rockenschaub, Herwig Pokorny, Michael Gnant, Bernd Gollackner, Birgit Steiner, Gnter Steger, Rudolf Steininger, and Ferdinand Mhlbacher; Vienna, Austria

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 3 Clinical pancreas transplantation

Chairs: Ugo Boggi, Pisa, Italy; Hans Schlitt, Regensburg, Germany

Boisdale 1

08:00

O-013 RETROPERITONEAL PANCREAS TRANSPLANTATION WITH ENTERIC DRAINAGE INTO THE RECIPIENT DUODENUM Daniela Kniepeiss, Doris Wagner, Silvia Schaffellner, Philipp Stiegler, Florian Iberer, and Karlheinz Tscheliessnigg; Graz, Austria O-014 IMPACT OF PANCREAS DONOR SCORING SYSTEM IN GRAFT COMPLICATIONS AND OUTCOMES: SINGLE CENTER EXPERIENCE Raquel Garcia-Roca, Gabriele Spoletini, Gabriel Diaz del Gobbo, Santiago Sanchez Cabus, David Paredes, and Maria Jose Ricart; Barcelona, Spain O-015 ACCEPT OR REJECT? MAJOR INCONSISTENCIES IN ASSESSING DONOR CHARACTERISTICS FOR ORGAN ACCEPTANCE IN PANCREAS TRANSPLANTATION Karl Philipp Drewitz, Martin Loss, Katja Kovac, and Julika Loss; Regensburg, Germany; Leiden, The Netherlands; and Regensburg, Germany O-016 SINGLE CENTRE EXPERIENCE WITH DCD PANCREAS TRANSPLANTATION Anand Sivaprakash Rathnasamy Muthusamy, Anil Vaidya, Sanjay Sinha, Isabel Quiroga, Srikanth Reddy, James Gilbert, and Peter J. Friend; Oxford, United Kingdom

08:10

08:20

08:30

85

Monday 5 September
08:40 O-017 FUNCTIONAL CAPACITY OF PANCREAS AND KIDNEY GRAFTS FROM EXTREME PEDIATRIC DONORS Ali-Reza Biglarnia, William Bennet, Anders Magnusson, Mats Bengtsson, Ulla Berg, and Gunnar Tufveson; Uppsala, Sweden; Gothenburg, Sweden; and Stockholm, Sweden O-018 ABO-INCOMPATIBLE DECEASED-DONOR PANCREAS AND KIDNEY TRANSPLANTATION USING A NOVEL PROTOCOL INCLUDING ECULIZUMAB AND MONITORING OF COMPLEMENT FUNCTION Ali-Reza Biglarnia, Bo Nilsson, Thomas Nilsson, Bengt von ZurMuehlen, and Gunnar Tufveson; Uppsala, Sweden

08:50

08:00 09:00

ORAL SESSION 4 DGF/IRI

Chairs: Ina Jochmans, Leuven, Belgium; Thomas Minor, Bonn, Germany

Forth

08:00

O-019 THE EFFECTS OF INFLIXIMAB ON ISCHAEMIC-REPERFUION (I/R) INJURY IN A MODEL OF RENAL TRANSPLANTATION Atul Bagul, Sarah A. Hosgood, James Hunter, and Prof Michael L. Nicholson; Leicester, United Kingdom O-020 BORTEZOMIB PROTECTED AGAINST ISCHEMIAREPERFUSION INJURY ASSOCIATED WITH ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT: AN IGL-1 SOLUTION APPROACH Sussagna Padrissa-Alts, Mohamed Amine Zaouali, Eleonora Boncompagni, Emma Folch-Puy, Olivier Boillot, Hassen Ben Abdennebi, Antoni Rimola, and Joan Rosell-Catafau; Barcelona, Spain; Lyon, France; Monastir, Tunisia; and Barcelona, Spain O-021 PROSPECTIVE TRIAL ON ERYTHROPOIETIN IN CLINICAL TRANSPLANTATION Zeynep Aydin, Jeroen Dubbeld, Marko J. Mallat, Jan Ringers, Ton J. Rabelink, and Johan W. de Fijter; Leiden, The Netherlands O-022 MOLECULAR PREDICTORS OF DELAYED GRAFT FUNCTION OF KIDNEY ALLOGRAFT Mariana Urbanova, Irena Brabcova, Peter Balaz, Libor Janousek, Petra Hribova, Eva Honsova, Peter Wohlfahrt, and Ondrej Viklicky; Prague, Czech Republic O-023 TETRAHYDROBIOPTERIN PREVENTS ISCHEMIA REPERFUSION INJURY INDUCED LETHAL GRAFT PANCREATITIS TARGETING THE NEURONAL NITRIC OXIDE SYNTHASE Benno Cardini, Martin Hermann, Katrin Watschinger, Rupert Oberhuber, Peter Obrist, Gerald Brandacher, Johann Pratschke, Ernst R. Werner, and Manuel Maglione; Innsbruck, Austria; and Zams, Austria O-024 REMOTE ISCHAEMIC PRECONDITIONING PROTECTS THE HEPATIC MICROCIRCULATION FROM LIVER ISCHAEMIA REPERFUSION INJURY THROUGH THE NITRIC OXIDE/cyclicGMP PATHWAY Mahmoud Abu-Amara, Shi Yu Yang, Alexander Seifalian, Brian Davidson, and Barry Fuller; London, United Kingdom

08:10

08:20

08:30

08:40

08:50

86

Monday 5 September
08:00 09:00

ORAL SESSION 5 Applied biology I

Chairs: Mathias Edinger, Regensburg, Germany; Martin Hoogduijn, Rotterdam, The Netherlands

Boisdale 2

08:00

O-025 UP-REGULATION OF EXTRACELLULAR SIGNALREGULATED KINASE 1/2 SIGNALLING IN A MHC MISMATCHED MODEL OF CHRONIC RENAL ALLOGRAFT INJURY Imran S. Butt, Kim Suvarna, Badri M. Shrestha, and John L. Haylor; Sheffield, United Kingdom O-026 mTORC1 PATHWAY ACTIVATION IS INSTRUMENTAL IN VASCULAR LESION INDUCED BY ANTIPHOSPHOLIPID ANTIBODIES Guillaume Canaud, Frank Bienaim, Julien Zuber, Laure-Hlne Noel, Marie-Alexandra Alyanakian, Lise Mecarelli, Christophe Legendre, and Fabiola Terzi; Paris, France O-027 FUNCTIONAL TOLERANCE BY DONOR-SPECIFIC BLOOD TRANSFUSION (DSBT) IN RATS IS ACCOMPANIED BY MICROVASCULAR C4D DEPOSITION. Evelyne Lerut, Toshya Soma, Sabien Fevery, Shengqiao Li, An Billiau, Takaaki Koshiba, Marc Waer, and Jacques Pirenne; Leuven, Belgium; and Kyoto, Japan O-028 MONOCLONAL ANTIBODY INHIBITION OF TLR2 PROMOTES GRAFT FUNCTION IN A MURINE MODEL OF RENAL TRANSPLANTATION Conrad A. Farrar, Brian Keogh, William McCormack, Aisling OShaughnessy, Andy Parker, Mary Reilly, and Steven H. Sacks; London, United Kingdom; and Dublin, Ireland O-029 THE ROLE OF ROR T IN T17-MEDIATED ALLOIMMUNITY Muriel Malaise, Manije Sabet-Baktach, Karoline Edtinger, Hans J. Schlitt, Edward K. Geissler, and Alexander Kroemer; Regensburg, Germany O-227 GENETIC VARIANTS OF FOXP3 INFLUENCE GRAFT SURVIVAL IN KIDNEY TRANSPLANT PATIENTS Anja Grohnert, Annemiek M.A. Peeters, Judith A. Kal-van Gestel, Fernando Rivadeneira, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands

08:10

08:20

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 6 Tissue injury/preservation

Chairs: Philipp Dutkowski, Zurich, Switzerland; Henri G.D. Leuvenink, Groningen, The Netherlands

Alsh

08:00

O-030 HEPATIC PRECONDITIONING BY CILOSTAZOL IMPROVE BILE SECRETION AND REDUCE VACUOLIZATION AND APOPTOSIS IN AN ISOLATED RAT LIVER REPERFUSION MODEL Maximilian von Heesen, Pascal Jeanmonod, Stefan Dold, Michael D. Menger, Martin K. Schilling, and Mohammed R. Moussavian; Homburg/Saar, Germany

87

Monday 5 September
08:10 O-031 FROM PERI-OPERATIVE COMPLEMENT ACTIVATION TO ALLOGRAFT PROTECTION AND REGENERATION A PRELIMINARY REPORT Wojciech Blogowski, Barbara Dolegowska, Daria Salata, Marta Budkowska, Leszek Domanski, and Mariusz Z. Ratajczak; Szczecin, Poland O-032 ASSESMENT OF CONTINIOUS VERSUS SHORT TERM OXYGENATED PULSATILE MACHINE PERFUSION IN A PIG AUTOTRANSPLANT MODEL Anja Gallinat, Juergen Treckmann, Patrik Efferz, Gernot Kaiser, Bastian Luer, Andreas Paul, and Thomas Minor; Essen, Germany; and Bonn, Germany O-033 NMR ANALYSIS OF SOLUTION DURING MACHINE PERFUSION: PREDICTING GRAFT OUTCOME? Delphine Bon, Francois Seguin, Nadege Boildieu, Sebastien Giraud, Raphael Thuillier, and Thierry Hauet; Poitiers, France; and Surgeres, France O-034 MULTI-DRUG DONOR PRECONDITIONING OFFERS AN EFFECTIVE PROTECTION AGAINST ISCHEMIA/REPERFUSION INJURY FOR STEATOTIC LIVERS Maximilian von Heesen, Pascal Jeanmonod, Stefan Dold, Otto Kollmar, Michael D. Menger, Martin K. Schilling, and Mohammed R. Moussavian; Homburg/Saar, Germany O-035 PORCINE MODEL OF EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) IN THE UNCONTROLLED DONATION AFTER CARDIAC DEATH (DCD) DONOR; THE EFFECT ON RENAL VIABILITY Christopher Ray, Aditya Kanwar, Mohammed Saleem Noormohamed, Stephen Ray, Susan Stamp, Soroush Sohrabi, Alex P. Navarro, Katrina Wood, Kathryn White, Robert Peaston, Steven White, Jon Smith, Anne Cunningham, Noel Carter, and David Talbot; Sunderland, United Kingdom; and Newcastle upon Tyne, United Kingdom

08:20

08:30

08:40

08:50

09:00 10:30

STATE OF THE ART 1 Improving Patient Outcomes after Liver Transplantation

Chairs: Paolo Muiesan, Birmingham, United Kingdom; Ferdinand Mhlbacher, Vienna, Austria

Lomond

09:00

Immunosuppression in liver transplantation is there evidence and are there prospects for personalised regimens based on operational tolerances? Alberto Sanchez-Fueyo, Barcelona, Spain Minimising renal dysfunction in liver transplantation preventative strategies how, with what and when John Lake, Minneapolis, United States Minimising cardiovascular risk factors in liver transplantation evidence and prospects Andrew Burroughs, London, United Kingdom Quality of Life and Compliance after Liver Transplantation Patrizia Burra, Padua, Italy Q&A

09:20

88

09:40

10:00 10:20 10:30

Monday 5 September
09:00 10:30

STATE OF THE ART 2 Cells that rule rejection and tolerance

Chairs: Matthias Edinger, Regensburg, Germany; Thomas Wekerle, Vienna, Austria

Forth

09:00

What can zebra fish tell us about key inflammatory events that drive transplant rejection? Maggie Dallman, London, United Kingdom What cells are actually causing rejection? Frans Claas, Leiden, The Netherlands Regulatory T cells Matthias Edinger, Regensburg, Germany Regulatory B cells Claudia Mauri, London, United Kingdom Q&A

09:20 09:40 10:00 10:20 10:30 09:00 10:30 LIVE WEB STREAM 09:00 09:20 09:40 10:00 10:20 10:30

Joint Session ESOT & AST Clyde Auditorium Challenges in kidney transplantation
Chairs: Josep Campistol, Barcelona, Spain; Alan Jardine, Glasgow, United Kingdom Making the graft last longer Robert Gaston, Birmigham, United States When to use antibody removal strategies Gunnar Tyden, Stockholm, Sweden How to manage BK nephropathy Rachel Hilton, London, United Kingdom Non HLA antibody rejection Peter Heeger, New York, United States Q&A

11:00 12:50

ORAL SESSION 7 Liver transplantation (technical and live donor)

Chairs: Jan Lerut, Leuven, Belgium; Paolo Muiesan, Birmingham, United Kingdom

Lomond

11:10

O-037 DONOR DOPAMINE DOES NOT AFFECT GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: DATA FROM A RANDOMIZED CONTROLLED TRIAL Urs Benck, Peter Schemmer, Anja Stckle, Simone Hoeger, Benito A. Yard, Bernhard K. Krmer, and Peter Schnuelle; Mannheim, Germany; and Heidelberg, Germany

89

Monday 5 September
11:20 O-038 LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION Nicholas Gilbo, Francesco Tandoi, Renato Romagnoli, Ilaria Giono, Giorgia Rizza, Giorgia Catalano, Maria Cristina Saffioti, Alessandro Ricchiuti, Francesco Lupo, and Mauro Salizzoni; Turin, Italy O-039 ERYTHROPOIETIN ATTENUATES ISCHEMIA-REPERFUSION INJURY FOLLOWING THE PRINGLE MANEUVER: A PROSPECTIVE RANDOMIZED STUDY Hiroyuki Hachiya, Tokihiko Sawada, Masato Kato, and Keiichi Kubota; Tochigi, Japan O-040 STRATEGIC BREAKTHROUGH AND PARADIGM SHIFT IN ADULT ABO-INCOMPATIBLE LIVER TRANSPLANTATION Yuji Soejima, Ken Shirabe, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Toru Ikegamiu, and Yoshihiko Maehara; Fukuoka, Japan O-041 CONTEMPORANEOUS PORTAL AND ARTERIAL REPERFUSION VERSUS PORTAL REPERFUSION FIRST DURING LIVER TRANSPLANTATION: A PROSPECTIVE RANDOMIZED STUDY Anna Rossetto, Gian Luigi Adani, Dario Lorenzin, Maria Laura Pertoldeo, Chiara Comuzzi, Dino De Anna, Vittorio Bresadola, and Umberto Baccarani; Udine, Italy O-042 POLYMORPHISMS OF FRACTALKINE RECEPTOR AND RISK FOR ANASTOMOSIS STENOSIS AFTER LIVER TRANSPLANTATION Speranta Iacob, Susanne Beckebaum, Gang Wu, Alexander Dechene, Irinel Popescu, Andreas Paul, Guido Gerken, and Vito Cicinnati; Essen, Germany; and Bucharest, Romania O-043 HEPATIC ARTERY KINKING DURING LIVER TRANSPLANTATION: SURVEY AND INTRAOPERATIVE FLOW MEASUREMENT Fabrizio Panaro, Hassan Bouyabrine, Jacques Domergue, and Francis Navarro; Montpellier, France O-044 SINGLE CENTER EXPERIENCE OF CONSECUTIVE 500 CASES OF HEPATIC ARTERY ANASTOMOSIS IN LIVING DONOR LIVER TRANSPLANTATION Sanghyun Song, Choon Hyuck David Kwon, Jae-Won Joh, Milljae Shin, Jong Man Kim, Sung Joo Kim, Suk-Koo Lee, Hyung Hwan Moon, Sanghoon Lee, and Tae-seok Kim; Seoul, Korea O-045 IMPACT OF PREVALENT STEATOSIS ON OUR LIVING DONOR LIVER TRANSPLANT PROGRAM: ANALYSIS OF 975 LIVING RELATED LIVER DONORS Naglaa A. Allam, Mohamed Alsofayan, Hatem Khalaf, Hamad Albahili, Yasser Medhat, Bassem Hegab, Hazem Mohamed, Khalil Alawi, Hadir Almanna, Faisal Abaalkhail, Yasser Elsheikh, Moussa Faguih, Mohamed Neimatallah, Mohamed Faramawi, Ayman Abdo, Mohamed Alsebayel, and Waleed Alhamoudi; Shebeen Al-koam, Egypt; Riyadh, Saudi Arabia; and Shebeen Al-koam, Saudi Arabia O-046 MULTICENTER BELGIAN SURVEY ON DONOR MORBIDITY AND MORTALITY IN ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION Roberto I. Troisi, Dirk Vogelaers, Jan Lerut, Olga Ciccarelli, Francine Roggen, Jacques Pirenne, Diethard Monbaliu, Raymond Aerts, Olivier Detry, Arnaud Deroover, Pierre Honor, and Hans Van Vlierberghe; Ghent, Belgium; Brussels, Belgium; Leuven, Belgium; and Liege, Belgium

11:30

11:40

11:50

12:00

12:10

12:20

12:30

12:40

90

Monday 5 September
11:00 12:50

ORAL SESSION 8 Basic science and immunobiology

Chairs: Katja Kotsch, Berlin, Germany; Claudia Mauri, London, United Kingdom

Forth

11:10

O-047 INTERLEUKIN-33 PROLONGS ALLOGRAFT SURVIVAL THROUGH REDUCTION OF ANTIBODY MEDIATED CARDIAC REJECTION Stefan M. Brunner, Gabriela Schiechl, Hans J. Schlitt, and Stefan Fichtner-Feigl; Regensburg, Germany O-048 B CELLS RECIEVE EFFECTIVE HELP FOR GENERATING ALLOANTIBODY THROUGH AQUISITION AND PRESENTATION OF ADDITIONAL GRAFT ANTIGEN Thomas Conlon, Kourosh Saeb-Parsy, Siva Sivaganesh, Reza Motallebzadeh, Chris Callaghan, Eleanor Bolton, Andrew Bradley, and Gavin Pettigrew; Cambridge, United Kingdom O-049 NON-HLA ANTIBODIES DIRECTED AGAINST AT1 AND ETA RECEPTORS INDUCE VASCULAR PROLIFERATION AND COAGULATION VIA ETS-1 AND TF ACTIVATION Rusan Catar, Naether Melanie, Eisenreich Andreas, Ursula Rauch, and Dragun Duska; Berlin, Germany O-050 MODULATING INTRA-GRAFT LYMPHOID TISSUE INFLUENCES EFFECTOR HUMORAL RESPONSES R. Motallebzadeh, S. Rehakova, I. Harper, C. Callaghan, N. Ruddle, J.A. Bradley, and G.J. Pettigrew; Cambridge, United Kingdom; and New Haven, USA O-051 cAMP/CREB DEPENDENT TRANSCRIPTIONAL CONTROL OF TOLERANCE ASSOCIATED GENE-1 IN BONE MARROW DERIVED DENDRITIC CELLS INHIBITS MATURATION AND RENDERS THEM TOLEROGENIC Ivo Panov, Stephan Schlickeiser, Simone Vogel, Julia Schumann, Friederike Berberich-Siebelt, and Birgit Sawitzki; Berlin, Germany; and Wrzburg, Germany O-052 TOLL-LIKE RECEPTOR 4 (TLR4) PARTICIPATES IN THE IMMUNE RESPONSE TO PANCREATIC ISLETS: IMPLICATIONS FOR HUMAN ISLET TRANSPLANTATION Laurianne Giovannoni, Yannick Muller, Stphanie Lacotte, Philippe Morel, Christian Toso, Bruno Daubeuf, Greg Elson, Kathy De Graaf, Marie Kosco-Villebois, Domenico Bosco, and Thierry Berney; Geneva, Switzerland; and Plan-les-Ouates, Switzerland O-053 CXCR2 INHIBITION IMPROVES ISLET TRANSPLANTATION OUTCOME Antonio Citro, Raffaella Melzi, Elisa Cantarelli, Erica Dugnani, Luisa Daffonchio, Marcello Allegretti, and Lorenzo Piemonti; Milan, Italy; and LAquila, Italy O-054 FUNCTIONAL IMPACT OF MICA A5.1 POLYMORPHISM ON GRAFTS ENDOTHELIAL CELL PHENOTYPE, IMMUNOREGULATORY FUNCTIONS AND ALLOANTIBODY RESPONSES Pierre Tonnerre, Nathalie Grard, Mathias Chatelais, Stphanie Allard, Sylvie Cury, Anne Cesbron, and Batrice Charreau; Nantes, France

11:20

11:30

11:40

11:50

12:00

12:10

12:20

91

Monday 5 September
12:30 O-055 INDUCTION OF CIRCULATING ENDOTHELIAL CELLS (CECs) AND CIRCULATING PROGENITOR CELLS (CPCs) AFTER POLYCLONAL ANTITHYMOCYTE GLOBULIN (ATG) THERAPY IN LIVER TRANSPLANTATION Diana Stauch, Cornelia Fabritius, Ali Yayahzadeh, Andreas Pascher, Peter Neuhaus, Johann Pratschke, and Katja Kotsch; Berlin, Germany; and Innsbruck, Austria O-056 mTORC2 SIGNALLING PATHWAY ACTIVATION IS REQUIRED FOR -ESTRADIOL MEDIATED CARDIOPROTECTION Angelika Kusch, Bjrn Hegner, and Duska Dragun; Berlin, Germany

12:40

11:00 12:50

ORAL SESSION 9 Kidney (long-term outcomes I)

Clyde Auditorium

Chairs: Catherine Byrne, Nottingham, United Kingdom; Uwe Heemann, Munich, Germany 11:10 O-057 CLOSURE OF THE ASYMPTOMATIC ARTERIOVENOUS FISTULA CORRECTS LEFT VENTRICULAR HYPERTROPHY IN RENAL TRANSPLANT RECIPIENTS Masayoshi Okumi, Yasuyuki Kojima, Chifumi Kawamura, Mayumi Hinoue, Koji Yazawa, Shiro Takahara, and Norio Nonomura; Osaka, Japan O-058 CIRCULATING ANGIOPOIETIN-2 LEVELS PREDICT MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS: A PROSPECTIVE CASECOHORT STUDY Miklos Z. Molnar, Philipp Kmpers, Jan T. Kielstein, Mario Schiffer, Maria E. Czira, Akos Ujszaszi, Csaba P. Kovesdy, and Istvan Mucsi; Budapest, Hungary; Torrance, USA; Mnster, Germany; Hannover, Germany; Salem, USA; Charlottesville, USA; and Montreal, Canada O-059 PROTEINURIA STRATIFIES RISK TO THE INDIVIDUAL FOLLOWING KIDNEY TRANSPLANTATION: DEVELOPMENT OF A PROGNOSTIC RISK SCORE David Benavente, Shazia Shabir, Clara Addison, Jason Moore, Charles Ferro, Simon Ball, Paul Cockwell, Graham Lipkin, and Richard Borrows; Birmingham, United Kingdom; and Exeter, United Kingdom O-060 DAYTIME SLEEPINESS IS ASSOCIATED WTH TAKING TIMING NON-ADHERENCE IN RENAL TRANSPLANT RECIPIENTS Hanna Burkhalter, Anna Wirz-Justice, Terri Weaver, Jrg Steiger, and Sabina De Geest; Basel, Switzerland; and Chicago, USA O-061 WITHDRAWN O-062 WITHDRAWN O-063 RISK FACTORS FOR NEW ONSET DIABETES POST KIDNEY TRANSPLANT AND ASSOCIATION WITH ALLOGRAFT FAILURE: DATA FROM THE INTERNATIONAL PORT STUDY Ajay Israni, Melissa Skeans, Jon J. Snyder, and Bertram L. Kasiske for PORT Investigators; Minneapolis, USA

11:20

11:30

11:40

11:50 12:00 12:10

92

Monday 5 September
12:20 O-064 RECIPIENT M235T POLYMORPHISM OF THE ANGIOTENSINOGEN GENE PREDICTS LONG-TERM GRAFT SURVIVAL IN KIDNEY TRANSPLANTATION Patrick B. Mark, Jamie P. Traynor, Kevin McLaughlin, Kathryn K. Stevens, Rajan K. Patel, Catherine J. Clark, and Alan G. Jardine; Glasgow, Scotland, United Kingdom; Airdrie, Scotland, United Kingdom; and Calgary, Canada O-065 IS THERE AN ASSOCIATION OF GLUTATHIONE PEROXIDASE (GPX1) GENE POLYMORPHISM WITH POSTTRANSPLANT GLUCOSE METABOLISM DISORDER? Leszek Domanski, Grazyna Dutkiewicz, Karolina Kloda, Andrzej Pawlik, Andrzej Ciechanowicz, Agnieszka Binczak-Kuleta, Jacek Rzanski, Marek Myslak, Krzysztof Safranow, and Kazimierz Ciechanowski; Szczecin, Poland O-066 SURVIVAL PROGNOSIS OF PATIENTS STARTING RENAL REPLACEMENT THERAPY IN THE NETHERLANDS Aline C. Hemke, Martin B.A. Heemskerk, Bernadette J.J.M. HaaseKromwijk, Willem Weimar, and Andries J. Hoitsma; Leiden, The Netherlands; Rotterdam, The Netherlands; and Nijmegen, The Netherlands

12:30

12:40

11:00 12:50

ORAL SESSION 10 Ethics, legal and psychosocial aspects of transplantation

Room Chairs: Emma Massey, Rotterdam, The Netherlands; James M. Neuberger, Birmingham, United Kingdom

Alsh

11:10

O-067 ALTRUISTIC NON-DIRECTED LIVING KIDNEY DONATION IN THE UK Lisa Burnapp, Rachel J. Johnson, and J. Andrew Bradley; Bristol, United Kingdom O-068 ALL IN THE FAMILY: HOW EARLY GROUP-EDUCATION OF FAMILIES AND FRIENDS OF CKD PATIENTS LEADS TO PREEMPTIVE KIDNEY TRANSPLANTATION Anthony C. van Kooij, Ron P. van Bragt, Dianne G.C.A. van DongenSegeren, Marinus A. van den Dorpel, Daenne A.F. Scheuter-van Oers, and Ellen Versluijs-Rovers; Rotterdam, The Netherlands O-069 EULID PROJECT: EUROPEAN LIVING DONATION AND PUBLIC HEALTH Mart Manyalich, Assumpta Ricart, Chlo Ballest, David Paredes, Christian Hiesse, Leonidio Dias, Ingela Fehrman-Eckholm, Andy Maxwell, Rosana Turcu, Pl-Dag Line, Danica Avsec, Dorota Lewandowska, Niclas Kvarnstrm, Carlo De Cillia, Alessandro Nanni Costa, Janusz Walaszezski, Christophe Legendre, Garabet Khasho, George Kyriakides, and Victor Gheorghe Zota; Barcelona, Spain; Paris, France; Porto, Portugal; Gonthenburg, Sweden; Bristol, United Kingdom; Bucharest, Romania; Oslo, Norway; Ljubljana, Slovenia; Warsaw, Poland; Rome, Italy; and Nicosia, Cyprus

11:20

11:30

93

Monday 5 September
11:40 O-070 EULOD: THE EU-FUNDED PROJECT ON LIVING ORGAN DONATION IN EUROPE Frederike Ambagtsheer, Annette Lennerling, Assya Pascalev, Thomas Gutmann, Judit Sndor, Rutger Ploeg, Fabienne Dobbels, and Willem Weimar; Rotterdam, The Netherlands; Gothenburg, Sweden; Sofia, Bulgaria; Mnster, Germany; Budapest, Hungary; Groningen, The Netherlands; and Leuven, Belgium O-071 PROGRESSIVE PREDICTIVE FACTORS OF ADHERENCE TO MEDICATION AFTER RENAL TRANSPLANTATION: A FRENCH OBSERVATIONAL STUDY Lionel Couzi, Bruno Moulin, Elisabeth Cassuto, Marie-Pierre Morin, Benoit Barrou, Stephane Barbier, Eric Alamartine, Emmanuel Morelon, Gilles Sinasse-Raymond, David Misdrahi, and Pierre Merville; Bordeaux, France; Strasbourg, France; Nice, France; Rennes, France; Paris, France; Rouen, France; Saint-Etienne, France; and Lyon, France O-072 WITHDRAWN O-073 A SCHOOL-BASED ORGAN DONATION EDUCATION PROGRAM TO ENCOURAGE ORGAN DONATION REGISTRATION AND TO CHANGE PUBLIC ATTITUDES RELATED TO ORGAN DONATION Astrid Reubsaet, Hans P. van Hooff, and Emile H.M. Schaeken; Maastricht, The Netherlands O-074 IMPACT OF RECIPIENTS SOCIO-ECONOMIC STATUS ON PATIENT AND GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: THE IsMeTT EXPERIENCE Salvatore Gruttadauria, Giuseppe Grosso, Duilio Pagano, Antonio Mistretta, Giovanbattista Vizzini, Davide Cintorino, Marco Spada, Francesco Basile, and Bruno Gridelli; Palermo, Italy; Pittsburgh, USA; and Catania, Italy O-075 SURVEY ABOUT CURRENT PSYCHOSOCIAL ASSESSMENT/ FOLLOW-UP PRACTICES (ELIPSY PROJECT) Chlo Ballest, Ana Menjvar, Levent Yucetin, Leondio Dias, Christian Hiesse, Christina Papachristou, Ingela Fehrman-Ekholm, Niclas Kvarnstrm, George Kyriakides, and Mart Manyalich; Barcelona, Spain; Antalya, Turkey; Porto, Portugal; Paris, France; Berlin, Germany; Gothenburg, Sweden; and Nicosia, Cyprus O-076 ETHICAL AND LEGAL ISSUES IN CONTROLLED DONATION AFTER CARDIAC DEATH: DID WE EVERYTHING WE COULD FOR OUR PATIENTS? Ivn Ortega, and David Rodriguez-Arias; Madrid, Spain; and Bilbao, Spain

11:50

12:00 12:10

12:20

12:30

12:40

11:00 12:50

ORAL SESSION 11 Kidney (live donation, assessment and allocation)

Chairs: Arthur Matas, Minneapolis, United States; Jonas Wadstrom, Uppsala, Sweden

Hall 1

94

Monday 5 September
11:10 O-077 WHO BENEFITS FROM ALTERNATIVE LIVING KIDNEY DONATION PROGRAMS? Joke Roodnat, Jacqueline Wetering, Judith Kal-van Gestel, Marry Klerk, Willij Zuidema, Jan IJzermans, Madelon Agteren, and Willem Weimar; Rotterdam, The Netherlands O-078 A KIDNEY DONOR RISK INDEX FOR THE UK Rachel J. Johnson, Rhiannon Birch, J. Andrew Bradley, and Chris J.E. Watson; Bristol, United Kingdom O-079 COMPARISON OF PREDICTIVE RISK SCORES FOR KIDNEY ALLOGRAFT FUNCTION Peter Balaz, Slavomir Rokosny, Peter Wohlfahrt, Mariana Urbanova, Libor Janousek, and Milos Adamec; Prague, Czech Republic O-080 LIVING DONOR EXCHANGE FOR INCOMPATIBLE COUPLES AND ITS EFFECT ON ALTERNATIVE PROGRAMS Marry Klerk de, Dave L. Roelen, Bernadette J.J.M. Haase-Kromwijk, Frans H.J. Claas, and Willem Weimar; Rotterdam, The Netherlands; and Leiden, The Netherlands O-081 ISOLATED NON-VISIBLE HAEMATURIA IN LIVING KIDNEY DONORS: CAUSES AND OUTCOMES POST-DONATION Mangalakumar Veerasamy, Robin Ramphul, Catherine Horsfield, John Scoble, and Rachel Hilton; London, United Kingdom O-082 BODY COMPOSITION AND NUTRITIONAL STATUS IN 98 PATIENTS AWAITING KIDNEY TRANSPLANTATION: PRELIMINARY RESULTS OF THE CORPOS STUDY Karine Moreau, Aurlie Desseix, Thomas Bachelet, Delphine Morel, Pierre Merville, Lionel Couzi, Christine Germain, Rodolphe Thiebaut, and Philippe Chauveau; Bordeaux, France; and Gradignan, France O-083 EXCESSIVE PREMATURE AGEING OF T LYMPHOCYTES IN END-STAGE RENAL DISEASE: AN IMPORTANT FACTOR TO CONSIDER IN PRE-TRANSPLANT IMMUNOLOGIC RISK ASSESSMENT Nicolle H.R. Litjens, Elly A. De Wit, Anton W. Langerak, Ashley Van der Spek, Willem Weimar, and Michiel G.H. Betjes; Rotterdam, The Netherlands O-084 LONG TERM CARDIOVASCULAR SURVIVAL IN ESRD PATIENTS UNDERGOING SCREENING FOR RENAL TRANSPLANTATION Rajan K. Patel, Patrick B. Mark, Nicola Johnsom, Kathryn K. Stevens, Emily P. McQuarrie, and Alan G. Jardine; Glasgow, United Kingdom O-085 INFLUENCE OF LIVING DONOR TRANSPLANTATION ON THE COMPOSITION OF THE POPULATION THAT REMAINS DEPENDENT ON DECEASED DONOR TRANSPLANTATION Joke I. Roodnat, Mirjam Laging, Jacqueline Wetering, Marcia Kho, Judith Kal-van Gestel, Jan IJzermans, and Willem Weimar; Rotterdam, The Netherlands O-086 WEIGHING UP THE EVIDENCE: DOES THE OBESE KIDNEY DONOR POSE TOO HIGH AN OPERATIVE RISK TO TAKE? Sotiris Mastoridis, Benjamin OBrien, Atika Sabharwal, David Taube, Nadey Hakim, and Vassilios Papalois; London, United Kingdom

11:20

11:30

11:40

11:50

12:00

12:10

12:20

12:30

12:40

95

Monday 5 September
11:00 12:50

ORAL SESSION 12 Living kidney donation

Chairs: Lisa Burnapp, London, United Kingdom; Dirk Ysebaert, Antwerp, Belgium

Boisdale 1 & 2

11:10

O-087 DIFFUSION -WEIGHTED MRI-IMAGING REVEALS LONGITUDINAL FUNCTIONAL CHANGES IN THE REMAINING KIDNEY DURING THE FIRST YEAR AFTER LIVING DONOR NEPHRECTOMY Ute Eisenberger, Tobias Binser, Harriet C. Thoeny, Chris Boesch, Felix J. Frey, and Peter Vermathen; Bern, Switzerland O-088 HAND-ASSISTED RETROPERITONEOSCOPIC VERSUS STANDARD LAPAROSCOPIC DONOR NEPHRECTOMY: SINGLE BLIND, RANDOMISED CONTROLLED TRIAL Leonienke F.C. Dols, Niels F.M. Kok, T.C. Khe Tran, Turkan Terkivatan, Frank C.H. dAncona, Johan F. Langenhuijsen, Frank J.M.F. Dor, Willem Weimar, and Jan N.M. IJzermans; Rotterdam, The Netherlands; and Nijmegen, The Netherlands O-089 RENAL AND CARDIOVASCULAR OUTCOMES FOLLOWING LIVING DONOR NEPHRECTOMY Nilay Patel, Mark Sullivan, Sally Rushton, Alex Hudson, Sanjay Sinha, Phil Mason, and Peter Friend; Oxford, United Kingdom; and Bristol, United Kingdom O-090 A COMPARISON OF OPEN AND MINIMALLY INVASIVE DONOR NEPHRECTOMY USING A STANDARDIZED DONOR MORBIDITY CLASSIFICATION Lolita Chan, Dan Ridgway, Wei Min Ho, Sue Kost, Janet Gill, Neil Parrott, Hany Riad, Afshin Tavakoli, Ravi Pararajasingam, Titus Augustine, and Tunde Campbell; Manchester, United Kingdom O-091 POSTOPERATIVE COMPLICATIONS IN 777 LIVING KIDNEY DONORS IN A SINGLE CENTRE Heinrich Kloke, Frank DAncona, Daan vd Vliet, Philomena Dooper, and Andries Hoitsma; Nijmegen, The Netherlands O-092 HAND-ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMIES AND ANTERIOR EXTRAPERITONEAL DONOR NEPHRECTOMIES: WHO DOES BETTER? David van Dellen, Otilia M. Mitu-Pretorian, Melissa Cunha, Abbas Ghazanfar, Bence Forgacs, Neil R. Parrott, Ravi Pararajasingam, Babatunde Campbell, Afshin Tavakoli, Titus Augustine, and Hany N. Riad; Manchester, United Kingdom O-093 WEIGHT GAIN AFTER KIDNEY DONATION Franka E. Van Reekum, Paul Berger, Raechel Toorop, Pieter F. Vos, and Arjan D. Van Zuilen; Utrecht, The Netherlands O-094 EXPANDED CRITERIA FOR LIVE DONOR NEPHRECTOMY Carme Facundo, Luis Guirado, Juan Manuel Diaz, Antonio Rosales, Oscar Rodriguz Fava, and Alberto Breda; Barcelona, Spain O-095 THE CHANGING DEMOGRAPHIC OF LIVE DONOR RENAL TRANSPLANTATION: A SINGLE UK CENTRES EXPERIENCE Lolita Chan, Dan Ridgway, Wei Min Ho, Sue Kost, Janet Gill, Neil Parrott, Afshin Tavakoli, Ravi Pararajasingam, Hany Riad, Titus Augustine, and Tunde Campbell; Manchester, United Kingdom

11:20

11:30

11:40

11:50

12:00

12:10

12:20

12:30

96

Monday 5 September
12:40 O-096 HAND-ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY DO WE NEED HAND PORTS? David van Dellen, Jay Nath, Melanie Field, Ahmed Hamsho, Nicholas G. Inston, Stephen J. Mellor, and Andrew R. Ready; Birmingham, United Kingdom

13:00 14:00

RAPID ORAL SESSION 9 Kidney III

HYBRID POSTER AREA Digital Display 1

Chairs: Paul Harden, Oxford, United Kingdom; Daniel Seron, Barcelona, Spain 13:00 RO-113 INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS Maria P. Scolari, Paolo Rigotti, Piergiorgio Messa, Ghil Busnach, Donato Donadi, Silvio Sandrino, Francesco P. Schena, Giambenedetto Piredda, Pierfrancesco Veroux, Giuseppe Tisone, Vito Sparacino, Maria C. Maresca, Antonio Famulari, Giuseppe Segoloni, Pierluca Piselli, Diego Serraino, and Franco Citterio; Bologna, Italy; Padua, Italy; Milan, Italy; Varese, Italy; Brescia, Italy; Bari, Italy; Cagliari, Italy; Catania, Italy; Rome, Italy; Palermo, Italy; Treviso, Italy; LAquila, Italy; Turin, Italy; and Aviano, Italy RO-114 BIOMARKERS OF KIDNEY REJECTION IN ORGAN TRANSPLANTATION Irene Rebollo-Mesa, Esperanza Perucha, Pervinder Sagoo, Kenneth Newell, Laurence A. Turka, Robert I. Lechler, Maria P. HernandezFuentes, and PPal Collaborators www.transplant-tolerance.org.uk; London, United Kingdom; Atlanta, USA; Boston, USA; and Seattle, USA RO-115 HYPERTENSIVE KIDNEY DONORS PERFORM WELL AT SHORT TERM POST-DONATION FOLLOW-UP Hilde Tent, Else van den Berg, H. Sijbrand Hofker, Rutger J. Ploeg, Gerjan Navis, and Jaap J. Homan van der Heide; Groningen, The Netherlands RO-116 TRANSPLANT NEPHRECTOMY IN ALLOGRAFT FAILURE: A SINGLE CENTER REVIEW David D. Lee, Randy S. Sung, Kori N. Bradley, and Jeff D. Punch; Ann Arbor, USA RO-117 INCIDENCE, SITE AND RISK FACTOR OF POSTTRANSPLANT MALIGNANCIES ANALYSIS OF 771 RENAL TRANSPLANT RECIPIRNTS FOR 40 YRS IN JAPANESE SINGLE CENTER Masahiko Okamoto, Kaduki Sakai, Shuji Nobori, Masahide Matsuyama, Hidetaka Ushigome, Hideaki Okajima, and Norio Yoshimura; Kyoto, Japan RO-118 METABOLIC STRESS PROMOTES TUBULAR INFLAMMATION BY TRIGGERING THE UNFOLDED PROTEIN RESPONSE Sophie Fougeray, Nicolas Bouvier, Philippe Beaune, Christophe Legendre, Dany Anglicheau, Eric Thervet, and Nicolas Pallet; Paris, France

13:04

13:08

13:12

13:16

13:20

97

Monday 5 September
13:24 RO-119 EVALUATION OF THE IMPACT OF EARLY PROTOCOL BIOPSY ON RENAL FUNCTION AT MONTH 12 IN DE NOVO MARGINAL KIDNEY TRANSPLANT: PRELIMINARY RESULT AT 12 WEEKS G. Blancho, M. Bchler, B. Hurault de Ligny, I. Etienne, M. Jaureguy, P. Merville, M. Delahousse, V. Moal, M. Hazzan, F. Allano, and C. Legendre; Nantes, France; Tours, France; Caen, France; Rouen, France; Amiens, France; Bordeaux, France; Suresnes, France; Marseille, France; Lille, France; Neuilly/Seine, France; and Paris, France RO-120 FACTORS AFFECTING OUTCOMES OF PATIENTS WITH POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) Jolene Witherspoon, Eiddwen Glyn, David Griffith, Nia Evans, Argiris Asderakis, Rafael Chavez, and Zsolt Kaposztas; Cardiff, United Kingdom RO-121 USE OF ELDERLY LIVING KIDNEY DONORS 20 YEARS EXPERIENCE ON THE BALKANS Ninoslav I. Ivanovski, Jelka G. Masin, Perko D. Kolevski, Ljupco G. Lekovski, and Zivko M. Popov; Skopje, Macedonia, The Former Republic of Yugoslavia RO-121/A RENOVASCULAR RESISTANCE OF MACHINE PERFUSED DCD KIDNEYS IS ASSOCIATED WITH PRIMARY NON-FUNCTION Eva E. de Vries, Pieter Hoogland, Bjorn Winkens, Maarten G. Snoeijs, Ernest van Heurn; Maastricht, The Netherlands

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 10 Kidney IV

HYBRID POSTER AREA Digital Display 2

Chairs: Marc Clancy, Glasgow, United Kingdom; Alan Jardine, Glasgow, United Kingdom 13:00 RO-122 GENETIC ASSOCIATION OF FOXP3 GENE POLYMORPHISMS WITH ALLOGRAFT REJECTION IN RENAL TRANSPLANT PATIENTS Xiao-yan Qiu, Zheng Jiao, Ming Zhang, Jian-ping Chen, Xiao-jin Shi, and Ming-kang Zhong; Shanghai, China RO-123 IMPACT OF RENAL TRANSPLANTECTOMY ON SECOND KIDNEY TRANSPLANT SURVIVAL Xavier Tillou, Nicolas Surga, Hakim Mazouz, Fabien Saint, and Jacques Petit; Amiens, France RO-124 QT INTERVAL VARIABILITY ONE YEAR AFTER KIDNEY TRANSPLANTATION IS ASSOCIATED WITH LEFT VENTRICULAR MASS AND FUTURE CARDIOVASCULAR EVENTS Miha Arnol, Vito Starc, Bojan Knap, Manca Oblak, and Aljoa Kandus; Ljubljana, Slovenia RO-125 ARE THERE DIFFERENCES IN ADHERENCE TO IMMUNOSUPPRESSIVE DRUGS BETWEEN LIVING-RELATED AND DECEASED DONOR TRANSPLANT RECIPIENTS? Kris Denhaerynck, Gabriela Schmid-Mohler, Kiss Alexander, Jrg Steiger, Rudolf P. Wthrich, Bock Andreas, and Sabina De Geest; Basel, Switzerland; Zrich, Switzerland; Aarau, Switzerland; and Leuven, Belgium

13:04

13:08

13:12

98

Monday 5 September
13:16 RO-126 INFLUENCE OF DONOR RELATED FACTORS ON OUTCOMES WITH TACROLIMUS-BASED IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION THE OSAKA STUDY (OPTIMIZING IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION WITH Advagraf Frank Lehner, Bernhard Banas, Nassim Kamar, Maciej Glyda, Ondrej Viklicky, and Laetitia Albano; Hannover, Germany; Regensburg, Germany; Toulouse, France; Poznan, Poland; Prague, Czech Republic; and Nice, France RO-127 CD20+ CELL INFILTRATION AND THE OUTCOME OF ACUTE CELLULAR RENAL ALLOGRAFT REJECTION: CORRELATION OF DENSITY WITH TIME-COURSE Jiqiu Wen, Jinsong Chen, Shuming Ji, Dongrui Cheng, Qiquan Sun, and Zhihong Liu; Nanjing, China RO-128 SERUM ANGIOTENSIN CONVERTING ENZYME (ACE)-2 ACTIVITY AS A MARKER OF GRAFT FUNCTION IN KIDNEY TRANSPLANT (KT) PATIENTS Mara Jos Soler, Marta Riera, Marta Crespo, Marisa Mir, Mara Jos Pascual, Eva Mrquez, Josep Maria Puig, and Julio Pascual; Barcelona, Spain RO-129 TRANSPLANTATION WITH KIDNEYS AFFECTED BY SMALL TUMOURS Muhammad A. Khurram, Omar A. Mownah, Christopher Ray, Aliu O. Sanni, David Rix, and David Talbot; Newcastle upon Tyne, United Kingdom; and New York, USA RO-130 ARTERIAL STIFFNESS AND ANKLE BRACHIAL INDEX MONITORING AMONG KIDNEY TRANSPLATED PATIENTS Dvid Kovcs, Lszl Szab, Roland Fedor, Lszl Asztalos, and Lajos Locsey; Debrecen, Hajd-Bihar megye, Hungary RO-131 ANEMIA AFTER KIDNEY TRANSPLANTATION AND ITS RISK FACTORS Behzad Einollahi, Zohreh Rostami, and Mojtaba Teimooro; Tehran, Islamic Republic of Iran

13:20

13:24

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 11 Liver III

HYBRID POSTER AREA Digital Display 3

Chairs: Herold Metseelar, Rotterdam, The Netherlands; Krzysztof Zieniewicz, Warsaw, Poland 13:00 RO-132 THE IMPORTANCE OF TOTAL WARM ISCHEMIA TIME (WIT) FOR THE OUTCOME OF LIVER TRANSPLANTATION (LTx) FROM DONORS AFTER CARDIAC DEATH (DCD) SINGLE CENTER EXPERIENCE Wojciech G. Polak, Jeroen de Jonge, Geert Kazemier, Huugh W. Tilanus, Herold J. Metselaar, Khe T. Tran, Turkan Terkivatan, Frank J. Dor, and Jan N. IJzermans; Rotterdam, The Netherlands RO-133 LIVING DONOR RELATED LIVER TRANSPLANTATION A PREFERABLE TREATMENT OPTION IN PATIENTS WITH PERIHILAR CHOLANGIOCARCINOMA Falk Rauchfuss, Erik Brthel, Astrid Bauschke, and Utz Settmacher; Jena, Germany

13:04

99

Monday 5 September
13:08 RO-134 LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE IMPACT OF NEO-ADJUVANT TREATMENTS ON THE LONG TERM RESULTS Abdallah Slim, Stefano Di Sandro, Andrea Lauterio, Alessandro Giacomoni, Iacopo Mangoni, Plamen Mihaylov, Matteo Tripepi, Cinzia Poli, Luca Lamperti, Caterina Cusumano, and Luciano De Carlis; Milan, Italy RO-135 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN HIV CO-INFECTED PATIENTS: A SINGLE CENTRE EXPERIENCE Giuseppe Tarantino, Fabrizio Di Benedetto, Giuseppe DAmico, Nicola De Ruvo, Nicola Cautero, Roberto Montalti, Gian Piero Guerrini, Roberto Ballarin, Mauro Codeluppi, and Giorgio E. Gerunda; Modena, Italy RO-136 THE IMPACT OF TRANSARTERIAL CHEMOEMBOLISATION AS BRIDGING THERAPY FOR HCC BEFORE LIVER TRANSPLANTATION IN THE ERA OF MELD ALLOCATION Frank Ulrich, Juliane Liese, Teresa Schreckenbach, Elisa Schwarzbeck, Sven Kohler, Stephan Zangos, Christoph M. Sarrazin, Stefan Zeuzem, Thomas Vogl, Wolf O. Bechstein, and Christian Mnch; Frankfurt, Germany RO-137 ROLE OF -FETOPROTEIN AS PREDICTOR OF RECURRENCE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION Quirino Lai, Alfonso W. Avolio, Tommaso M. Manzia, Salvatore Agnes, Giuseppe Tisone, Pasquale B. Berloco, and Massimo Rossi; Rome, Italy RO-138 RECURRENCE-FREE LONG-TERM SURVIVAL AFTER LIVING DONOR LIVER TRANSPLANTATION FOR HCC IS INDEPENDENT FROM CLINICAL TUMOR MACROMORPHOLOGY Arno Kornberg, Bernadett Kpper, Katharina Thrum, Jens Wilberg, Peter Bchler, Olaf Habrecht, Helmut Friess, and Babette Krause; Munich, Germany; Bad Berka, Germany; and Jena, Germany RO-139 APPLICABILITY OF CRITERIA FOR EARLY ALLOGRAFT DYSFUNCTION IN LIVER TRANSPLANTATION ACCORDING TO DONOR TYPE E. Flores, A.J. Hessheimer, D. Saavedra, J. Fuster, J.C. GarcaValdecasas, and C. Fondevila; Barcelona, Spain RO-140 DEVELOPMENT AND VALIDATION OF AN INSTRUMENT EVALUATING THE IMPACT OF ANTI HBV IMMUNOGLOBULIN THERAPY (HBIg) ON QUALITY OF LIFE (HRQOL) IN LIVER TRANSPLANTATED (LT) PATIENTS Patrizia Burra, Lucio Caccamo, Riccardo Volpes, Giorgio Ercolani, Vincenzo Scuderi, Rosa Pacilio, Beatrice Magni, Patrizia Boccagni, Paolo Strignano, Alessandra Cibelli, Eleonora De Martin, Silvia Lazzaro, Fulvio Calise, Antonio D. Pinna, Giorgio Rossi, Giovan G. Di Costanzo, Paola Carrai, Umberto Cillo, Mauro Salizzoni, Monica Franciosi, and Antonio Nicolucci; Padua, Italy; Milan, Italy; Palermo, Italy; Bologna, Italy; Naples, Italy; Pisa, Italy; Turin, Italy; and Chieti, Italy RO-141 PRELIMINARY STUDIES WITH A NEW BIOARTIFICIAL LIVER Wendy Spearman, Clare Selden, Malcolm Miller, Tony Figaji, Hiram Arendse, Humphrey Hodgson, and Delawir Kahn; Cape Town, South Africa

13:12

13:16

13:20

13:24

13:28

13:32

100
13:36

Monday 5 September
13:00 14:00

RAPID ORAL SESSION 12 Liver IV

HYBRID POSTER AREA Digital Display 4

Chairs: Murat Akyol, Edinburgh, United Kingdom; Luca Belli, Milan, Italy 13:00 RO-142 LIVER HANGING MANEUVER WITH EXTRA-GLISSONIAN APPROACH IN RIGHT LOBE DONOR HEPATECTOMY: IS IT SAFE? Acar Tuzuner, Volkan Gen, Kaan Karayalcin, and Sadik Ersoz; Ankara, Turkey RO-143 COMPARATIVE ANALYSIS BETWEEN THE USE OF COMPLETE LIVER GRAFT AND A PARTIAL ONE IN PEDIATRIC PATIENTS Oscar Caso, Naim Fakih, Iago Justo, Jorge Calvo, Alvaro Garcia, Alejandro Manrique, Felix Cambra, Manuel Abradelo, Enrique Moreno, and Carlos Jimenez; Madrid, Spain RO-144 OUTCOMES AND DIAGNOSTIC CHALLENGES POSED BY INCIDENTAL CHOLANGIOCARCINOMA AFTER LIVER TRANSPLANTATION J. M. Ali, L. Bonomo, R. Brais, W. Griffiths, D. Lomas, E. Huguet, R. Praseedom, N. Jamieson, and A. Jah; Cambridge, United Kingdom RO-145 AB0-(IN)COMPATIBLE CADAVERIC DONOR LIVER TRANSPLANTATIONS DOES REALLY CHANGE AN OUTCOMES? Marcin Kotulski, Krzysztof Zieniewicz, Piotr Remiszewski, and Marek Krawczyk; Warsaw, Poland RO-146 THE PRESENCE OF INCREASED PERIPHERAL Th17 LYMPHOCYTES AND SERUM LEVELS OF IL-17 DURING ACUTE REJECTION IN LIVER TRANSPLANT PATIENTS Hua Fan, Qiang He, Dong-Dong Han, Jian-Tao Kou, Li-Xin Li, Jun Ma, and Ping Li; Beijing, China RO-147 INFLUENCE OF REJECTIONS EPISODES ON QUALITY OF LIFE FOLLOWING LIVER TRANSPLANTATION Klaus H. Michel, Heiko Aselmann, Mark D. Jaeger, Birgit Wiese, Thomas Becker, Hauke Lang, Michael Neipp, and Christian P. Kaudel; Mainz, Germany; Kiel, Germany; Hannover, Germany; and Itzehoe, Germany RO-148 RELEVANCE OF PROCALCITONIN IN THE EARLY POSTOPERATIVE PERIOD AFTER LIVER TRANSPLANTATION Falk Rauchfuss, Juliane Neumann, Rigo Voigt, Michael Heise, and Utz Settmacher; Jena, Germany RO-149 THE IMPACT OF LIVER RETRANSPLANTATION ON SURVIVAL AFTER THE USE OF PARTIAL LIVER GRAFTS IN PATIENTS YOUNGER THAN 13 YEARS Oscar Caso, Iago Justo, Fakih Naim, Alejandro Manrique, Felix Cambra, Manuel Abradelo, Jorge Calvo, Sergio Olivares, Enrique Moreno, and Carlos Jimenez; Madrid, Spain RO-150 EARLY USE OF PROLIFERATION SIGNAL INHIBITORS IS AN INDIPENDENT RISK FACTOR OF INCISIONAL HERNIA DEVELOPEMENT AFTER LIVER TRANSPLANTATION Roberto Montalti, Fabrizio Di Benedetto, Antonio Mimmo, Valentina Serra, Nicola Cautero, Nicola De Ruvo, Gian Piero Guerrini, Roberto Ballarin, Mario Spaggiari, Gianluca Rompianesi, Giuseppe DAmico, Giuseppe Tarantino, Rosa Maria Iemmolo, Maria Marino, and Giorgio Enrico Gerunda; Modena, Italy

13:04

13:08

13:12

13:16

13:20

13:24

13:28

13:32

101

Monday 5 September
13:36 RO-151 CONVERSION TO SUBCUTANEOUS ANTI-HEPATITIS B IMMUNOGLOBULINS (ZutectraTM) IN MAINTENANCE LIVER TRANSPLANT PATIENTS: PRELIMINARY RESULTS OF A MULTICENTER, PROSPECTIVE, SINGLE-ARM STUDY Fulvio Calise, Paola Carrai, Paolo Strignano, Giuliana Verga, Alfonso Galeota Lanza, Andrea Lauterio, Lucio Caccamo, Enzo Scuderi, Mauro Salizzoni, Stefano Fagiuoli, Giovan G. Di Costanzo, Luciano De Carlis, Giorgio Rossi, and Franco Filipponi; Naples, Italy; Pisa, Italy; Turin, Italy; Bergamo, Italy; and Milan, Italy

13:00 14:00

RAPID ORAL SESSION 13 Heart: challenges in heart transplantation

HYBRID POSTER AREA Digital Display 5

Chairs: Michel De Pauw, Ghent, Belgium; Stephen Large, Cambridge, United Kigdom 13:00 RO-152 DONATION AFTER CARDIAC DEATH: CAN HEARTS BE SUCCESSFULLY REANIMATED? Muhammad A. Khurram, Omar A. Mownah, Christopher Ray, Aditya Kanwar, Noel M. Carter, Doug Rees, John Brassil, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom RO-153 USING DIALYSIS FOR PROLONGED EX VIVO WARM REPERFUSION OF DCD HEARTS Omar A. Mownah, Muhammad A. Khurram, Christopher Ray, Noel M. Carter, Robert Peaston, Kelly Phillipson, Kevin Gibbs, Ken Gardener, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom RO-154 IMPACT OF DIFFERENT ATG DOSING PROTOCOLS ON LONG-TERM OUTCOME AFTER CARDIAC TRANSPLANTATION Arezu Z. Aliabadi, Martina Groemmer, Daniela Dunkler, Farsad A. Eskandary, Christoph Pelanek, Thomas Haberl, Sigrid Sandner, Daniel Zimpfer, Guenther Laufer, and Andreas O. Zuckermann; Vienna, Austria RO-155 EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS-BASED STUDY Marco Masetti, Luciano Potena, Paola Prestinenzi, Valeria Pece, Gaia Magnani, Francesco Saia, Paolo Romani, Nevio Taglieri, Fabio Coccolo, Marianna Nardozza, Teresa Ionico, Francesco Grigioni, and Angelo Branzi; Bologna, Italy RO-156 FREQUENT OCCURRENCE OF DERMATOLOGIC COMPLICATION AFTER REPLACEMENT OF CALCINEURIN INHIBITOR WITH EVEROLIMUS LATE AFTER HEART TRANSPLANTATION Michael Zakliczynski, Malgorzata Pindycka-Piaszczynska, Dominika Trybunia, and Marian Zembala; Zabrze, Poland RO-157 IMPROVEMENT OR STABILIZATION OF RENAL FUNCTION AFTER LATE INTRODUCTION OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS 12 MONTH FOLLOW-UP Michael Zakliczynski, Dominika Trybunia, Jerzy Nozynski, and Marian Zembala; Zabrze, Poland

13:04

13:08

13:12

13:16

13:20

102

Monday 5 September
13:24 RO-158 PRETRANSPLANT SOLUBLE CD30 (sCD30) FOR THE PREDICTION OF ACUTE CELLULAR REJECTION IN HEART TRANSPLANT RECIPIENTS Olga V. Orlova, Alex V. Bugrov, Alex O. Shevchenko, Eduard N. Kazakov, Arkady J. Kormer, Igor M. Iljinsky, and Olga P. Shevchenko; Moscow, Russian Federation; and Moscow, Russian Federation RO-159 ANTIBODY-SENSITIZATION AGAINST HLA-A AND HLA-DR SPECIFICITIES AFTER IMPLANTATION OF VENTRICULAR ASSIST DEVICE Markus J. Barten, Maja T. Dieterlen, Jens Garbade, Sven Lehmann, Sara Klein, Stefan Dhein, Friedrich W. Mohr, and Hartmuth B. Bittner; Leipzig, Germany RO-160 THE ROLE OF HLA COMPATIBILITY ASSESSMENT IN CURRENT CARE FOLLOWING HEART TRANSPLANTATION Helena Bedanova, Marek Orban, Jiri Ondrasek, and Petr Nemec; Brno, Czech Republic RO-161 CLINICAL RELEVANCE OF PREFORMED COMPLEMENTAND NON-COMPLEMENT-FIXING HLA ALLOREACTIVITY IN CARDIAC TRANSPLANTATION Stephane L. Mahr, Marcus Wahrmann, Farsad Eskandary, Arezu Z. Aliabadi, Andreas O. Zuckermann, and Georg A. Bhmig; Vienna, Austria

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 14 Infections

HYBRID POSTER AREA Digital Display 6

Chairs: Rachel Hilton, London, United Kingdom; Tomas Reischig, Pilsen, Czech Republic 13:00 RO-162 PREVENTING DONOR DERIVED INFECTIONS THROUGH VIROLOGY SCREENING: REDUCING RISK AND INCREASING ORGAN AVAILABILITY Cristina Baleriola, and William D. Rawlinson; Randwick, Australia RO-163 CYTOMEGALOVIRUS INFECTION IS ASSOCIATED WITH EARLY TUBULAR INJURY AND LATE RENAL ALLOGRAFT DYSFUNCTION Lucio R. Requio-Moura, Eduardo J. Tonato, Eliana Nogueira, Erika A. Ferraz, Thiago C. Filliponi, Rogerio Chinen, Ana Cristina C.C. Matos, Marcelino S. Durao, Niels O.S. Camara, and Alvaro PachecoSilva; So Paulo, Brazil RO-164 PREVENTION OF CYTOMEGALOVIRUS (CMV) INFECTION BY VALGANCICLOVIR (VGCV) IN SOLID ORGAN TRANSPLANT RECIPIENTS: THE ORVAL STUDY C. Legendre, R. Guillemain, A. Fourrier-Rglat, L. Nguyen, N. Tagieva, and F. Saliba; Paris, France; Bordeaux, France; Neuilly-surSeine, France; and Villejuif, France RO-165 LEUKOPENIA & NEUTROPENIA IN KIDNEY TRANSPLANT RECIPIENTS EXPOSED TO 200 VS. 100 DAYS OF VALGANCICLOVIR PROPHYLAXIS: A SUBANALYSIS OF THE IMPACT TRIAL I.A. Hauser, Y. Lebranchu, E. Blumberg, A. Jardine A. Humar, and P. Peeters; Frankfurt, Germany; Tours, France; Philadelphia, USA; Glasgow, United Kingdom; Alberta, Canada; and Ghent, Belgium

13:04

13:08

13:12

103

Monday 5 September
13:16 RO-166 A QUANTITATIVE ANALYSIS OF CMV INFECTION IN SOLID-ORGAN TRANSPLANT RECIPIENTS MANAGED EXCLUSIVELY ON PRE-EMPTIVE THERAPY Sowsan F. Atabani, Claire Atkinson, Robert W. Aldridge, Colette Smith, Mark Harber, Douglas Thornbun, Nancy Rolando, Vincent C. Emery, and Paul D. Griffiths; London, United Kingdom RO-167 HUMAN HERPESVIRUS-6 IN DONOR BIOPSIES ASSOCIATED WITH HIGHER INCIDENCE OF CLINICAL CMV DISEASE AND HCV RECURRENCE Ana Carolina Guardia, Ana Maria Sampaio, Arlete Milan, Raquel S.B. Stuchi, Sandra C.B. Costa, and Ilka F.S.F. Boin; Campinas, Brazil RO-168 CLINICAL PHARMACOKINETICS OF VALGANCICLOVIR IN RENAL TRANSPLANT RECIPIENTS WITH OR WITHOUT RENAL IMPAIRMENT Yuki Nakagawa, Kazuhide Saito, and Kota Takahashi; Niigata, Japan RO-169 IDENTIFICATION OF PATIENTS AT HIGH RISK FOR INFECTIONS AFTER LIVER TRANSPLANTATION; DEVELOPMENT AND VALIDATION OF A NEW RISK MODEL Sophie van Olphen, Ingrid de Koning, Laurens de Grim, Geert Kazemier, Bettina Hansen, Robert de Man, Xavier Rogiers, Karin Schurink, and Herold Metselaar; Rotterdam, The Netherlands; and Ghent, Belgium RO-170 TRANSPLANT PATIENTS UPTAKE OF INFLUENZA AND SWINE FLU VACCINATION: ARE THE JABS BEING GIVEN? David van Dellen, Jay Nath, Marc Williams, Melanie Field, Hari Krishnan, Stephen J. Mellor, Ahmed Hamsho, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom RO-171 TUBERCULOSIS PROPHYLAXIS FOLLOWING RENAL TRANSPLANTATION: IS THERE CONSENSUS? David van Dellen, Melanie Field, Andrew Clarke, Matthew Kelleher, Stephen J. Mellor, Ahmed Hamsho, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom

13:20

13:24

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 15 Islet/cell transplantation

HYBRID POSTER AREA Digital Display 7

Chairs: Mathias Brendel, Essen, Germany; Frantisek Saudek, Prague, Czech Republic 13:00 RO-172 ARE YOUNG DONORS SUITABLE FOR ISLET ISOLATION? Ismail Sert, Sophie Borot, Raphael Meier, Yannick Muller, Domenico Bosco, and Thierry Berney; Geneva, Switzerland RO-173 QUANTIFICATION OF ISLET LOSS DURING IMMUNE REJECTION USING IRON-LABELED ISLET CELLS BY 3T MRI IN THE RAT MODEL Sophie Borot, Lindsey Crowe, Frederic Ris, S. Nielles-Vallespin, P. Speier, Solange Masson-Charvier, Philippe Morel, Christian Toso, Domenico Bosco, Jean-Paul Valle, and Thierry Berney; Geneva, Switzerland; and Erlangen, Germany

13:04

104

Monday 5 September
13:08 RO-174 PRE-TREATMENT WITH DONOR TOLEROGENIC DENDRITIC CELLS RESULTS IN ANTIBODY-MEDIATED, ACCELERATED GRAFT LOSS OF RODENT PANCREATIC ISLETS Hanneke de Kort, Cynthia Crul, Annemieke M. van der Wal, Nicole Schlagwein, Annelein M. Stax, Ingeborg M. Bajema, Jan A. Bruijn, Cees van Kooten, and Emile de Heer; Leiden, The Netherlands RO-175 CO-EXPRESSION OF CD40LIG AND IKBA MEDIATED BY ADENOVIRUS PROLONGED ISLET ALLOGRAFT SURVIVAL Xiaohong Wang, Xiaoming Ding, Yang Li, and Wujun Xue; Xian, China RO-176 BLOCKADE OF BOTH B7-H4 AND CTLA-4 CO-SIGNALING PATHWAYS ENHANCES MOUSE ISLET ALLOGRAFT SURVIVAL Xiaojie Wang, Jianqiang Hao, Daniel Mertzger, Alice Mui, Ziliang Ao, Bruce Verchere, Lieping Chen, Dawei Ou, and Garth Warnock; Vancouver, Canada; and Baltimore, USA RO-177 BETA-CELL PROLIFERATION IN TRANSPLANTED ISLETS OVER TIME Geraldine Parnaud, Caroline Rouget, Domenico Bosco, and Thierry Berney; Geneva, Switzerland RO-178 THE EXPERIMENTAL RESEARCH ON IMPROVING THE CURATIVE EFFECT OF AUTOLOGOUS BM-MSCs IN THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION Zhenya Shen, and Jun Deng; Suzhou, Jiangsu, China RO-179 EXPERIMENTAL STUDY ON ENHANCED THERAPEUTIC EFFECT OF COMBINING MESENCHYMAL STEM CELL TRANSPLANTATION WITH ERYTHROPOIETIN IN MYOCARDIAL INFARCTION MODEL Zhenya Shen, Fang Huang, Michun He, and Xiaomei Teng; Suzhou, Jiangsu, China RO-180 MITOGENIC EFFECT OF HUMAN TISSUE FLUID/LYMPH ON KERATINOCYTE PROLIFERATION Anna Domaszewska, Marzanna Zaleska, and Waldemar L. Olszewski; Warsaw, Poland; and Warsaw, Poland RO-181 EVALUATION OF THE CAPACITY OF MESENCHIMAL STEM CELLS MOBILIZED BY Granulocyte colony-stimulating factor (G-CSF) IN HEPATIC REGENERATION IN PATIENTS SUBMITTED TO HEPATECTOMY Ilka F.S.F. Boin, Angela C.M. Luzo, Adriana S.S. Duarte, Elaine C. Ataide, Ricardo Holtz, and Nelson Caserta; Campinas, Brazil

13:12

13:16

13:20

13:24

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 16 Clinical immunosupression I

HYBRID POSTER AREA Digital Display 8

Chairs: Teun van Gelder, Rotterdam, The Netherlands; Stefan Vitko, Prague, Czech Republic 13:00 RO-182 HIGH GRAFT PROTECTION AND LOW RATES OF INFECTIONS AND MALIGNANCIES BY INTRA-OPERATIVE HIGHDOSE ATG INDUCTION IN KIDNEY GRAFT RECIPIENTS Juergen Kaden, Gottfried May, Andreas Vlp, and Claus Wesslau; Berlin, Germany; and Frankfurt, Germany

105

Monday 5 September
13:04 RO-183 IMMUNOSUPPRESSIVE REGIMEN BASED ON THYMOGLOBLULINE AND EARLY CONVERSION TO SIROLIMUS FOR TRANSPLANT RECIPIENTS WITH MARGINAL DONORS Tain V. Sandes-Freitas, Cludia R. Felipe, Carolina A. Rodrigues, Marina P. Cristelli, Hlio Tedesco-Silva, and Jos O. Medina Pestana; So Paulo, Brazil RO-184 RABBIT ANTI-THYMOCYTE GLOBULIN (rATG)-BASED IMMUNOSUPPRESSION INDUCTION IN KIDNEY TRANSPLANTATION William C. Goggins, Angie Qualey, Tim Taber, John Powelson, Jeanne Chen, Chris Robertson, and Richard S. Mangus; Indianapolis, USA RO-185 RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 2 YEAR FOLLOW-UP DATA OF THE APOLLO TRIAL Claudia Sommerer, Thomas Rath, Klemens Budde, Hermann Haller, Wolfgang Arns, Stefan Scheidl, Eva-Maria Vogel, Oliver Witzke, and Petra Reinke; Zeus Study Group, Germany; and Nuremberg, Germany RO-186 EVEROLIMUS BASED/CNI FREE REGIMEN IN DE-NOVO RENAL TRANSPLANT RECIPIENTS Francesca Fior, Francesco Nacchia, Rostand M. Ngoufet, Carlo Rugiu, Claudio Ghimenton, Cristina Andreotti, and Luigi Boschiero; Verona, Italy; and Trento, Trento, Italy RO-187 CONVERSION TO EVEROLIMUS: EARLY VS LATE? A CASECONTROL STUDY AM Fernandez-Rodriguez, J. Amezquita, C. Galeano, R. Marcen, V. Burguera, H. Sosa, and C. Quereda; Madrid, Spain RO-188 IMPROVED KIDNEY GRAFT FUNCTION AFTER CONVERSION FROM TWICE DAILY TACROLIMUS TO THE ONCE DAILY PROLONGED-RELEASE FORMULA Aureliusz Kolonko, Jerzy Chudek, and Andrzej Wiecek; Katowice, Poland RO-189 TACROLIMUS ONCE DAILY (Advagraf) VERSUS TWICE DAILY (Prograf) IN LIVER TRANSPLANTED PATIENTS: AN OBSERVATIONAL SINGLE-CENTRE STUDY Wanda Utech, Orlandina Di Maro, Salvatore Guardascione, Alfonso Galeota Lanza, Francesco Paolo Picciotto, and Giovan Giuseppe Di Costanzo; Naples, Italy RO-190 THREE-YEAR RESULTS OF CONVERSION FROM CYCLOSPORINE TO TACROLIMUS IN RENAL ALLOGRAFT RECIPIENTS WITH CHRONIC ALLOGRAFT NEPHROPATHY Shu-Ming Ji, Ji-Qiu Wen, Qi-quan Sun, Jin-Song Chen, and Zhi-hong Liu; Nanjing, China RO-191 CLINICAL AND HISTOLOGICAL STUDY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN SOLID ORGAN TRANSPLANT M. Dolores Redondo-Pachn, Laura Quintana, Katia Toledo, M. Luisa Agera, and Pedro Aljama; Cordoba, Spain POSTER VIEWING

13:08

13:12

13:16

13:20

13:24

13:28

13:32

13:36

106
13:00 14:00

Monday 5 September
14:00 15:30 LIVE WEB STREAM 14:00 14:20 14:40 15:00 15:20 15:30 16:00 17:00 LIVE WEB STREAM

PLENARY SESSION 2 Clyde Auditorium Making the most of the marginal organ
Chairs: Peter Friend, Oxford, United Kingdom; Rutger Ploeg, Oxford, United Kingdom The marginal organ information and consent James Neuberger, Birmingham, United Kingdom The science of marginal organs Jacques Pirenne, Leuven, Belgium Using the marginal lung Stig Steen, Lund, Sweden Using the marginal liver Nigel Heaton, London, United Kingdom Q&A

NEW CONTROVERSIES 1 Clyde Auditorium The treatment for chronic antibody mediated rejection is
Chairs: Josep Grinyo, Barcelona, Spain; Anthony Warrens, London, United Kingdom ...probably futile, at present David Taube, London, United Kingdom ...probably of benefit to our patients, even now Christophe Legendre, Paris, France

16:40 17:00 16:00 17:00

Q&A

NEW CONTROVERSIES 2 The solution to the organ shortage is

Chairs: Beatriz Dominguez-Gil, Barcelona, Spain; Willem Weimar, Rotterdam, The Netherlands

Lomond

16:00 16:20 16:40 17:00

Living donation Arthur Matas, Minneapolis, United States Marginal organs Bjrn Nashan, Hamburg, Germany Q&A

16:00 18:00

ORAL SESSION 13 Liver/intestine miscellaneous

Chairs: Bo-Goran Ericzon, Stockholm, Sweden; Paolo Muiesan, Birmingham, United Kingdom

Forth

107

16:00

O-097 CHRONOTROPIC INCOMPETENCE ON DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH END-STAGE LIVER DISEASE Ashish Singhal, Andreas Karachristos, Benjamin Sanchez, and AshokKumar Jain; Philadelphia, USA

Monday 5 September
16:10 O-098 INCIDENTAL PORTOPULMONARY HYPERTENSION DISCOVERED AT THE START OF LIVER TRANSPLANTATION, TO GO AHEAD OR TO LET GO Filip Gryspeerdt, Marion Dupont, Wim Laleman, Raymond Aerts, Dieter Mesotten, Geert Meyfroidt, Marleen Verhaegen, Arne Neyrinck, Frederik Nevens, Jacques Pirenne, and Diethard Monbaliu; Leuven, Belgium O-099 LIVER INMUNOPROTECTIVE EFFECT ON THE KIDNEY ALLOGRAFT IN SIMULTANEOUS LIVER AND KIDNEY TRANSPLANTATION Nuria N. Esforzado, Ana Yurena A.Y. Snchez, Jos Vicente J.V. Torregosa, Nuria N. Serra, Rafael R. Pascualin, Jaume J. Martorell, Federico F. Oppenheimer, and Josep Maria J.M. Campistol; Barcelona, Spain O-100 EVOLUTION OF KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION FOR ADULT POLYCYSTIC LIVER DISEASE AND INDICATIONS FOR COMBINED LIVER AND KIDNEY TRANSPLANTATION Tom Darius, Alexander Patris, Ziad Hassoun, Diethard Monbaliu, Tania Roskams, Olga Ciccarelli, Yves Pirson, Yves Vanrenterghem, Frederik Nevens, Jacques Pirenne, and Jan Lerut; Brussels, Belgium; and Leuven, Belgium O-101 LIVER TRANSPLANTATION (LTx) FOR TRANSTHYRETIN SYSTEMIC AMYLOIDOSIS DISORDERS: ANALYSIS FROM THE FAMILIAL AMYLOIDOTIC POLYNEUROPATHY WORLD TRANSPLANT REGISTER (FAPWTR) 6Bo-Gran Ericzon on Behalf of the Reporting Members of the FAPWTR; Stockholm, Sweden O-102 INDOCYANINE GREEN CLEARENCE AS A TOOL TO PREDICT THE NEED OF LIVER TRANSPLANTATION IN PAEDIATRIC ACUTE LIVER FAILURE Jesus Quintero, Juan Ortega, Mara Legarda, Javier Bueno, Itxarone Bilbao, and Ramn Charco; Barcelona, Spain O-103 CLINICAL RELEVANCE OF HLA-ANTIBODIES AFTER INTESTINAL TRANSPLANTATION Undine A. Gerlach, Constanze Schoenemann, Nils Lachmann, Peter Neuhaus, and Andreas Pascher; Berlin, Germany O-104 VIABILITY OF THE HUMAN SMALL BOWEL GRAFT IN THE SCOPE OF INTESTINAL TRANSPLANTATION (ITX) Anne Margot C. Roskott, Henri G.D. Leuvenink, Gerard Dijkstra, Rutger J. Ploeg, Harry van Goor, and Vincent B. Nieuwenhuijs; Groningen, The Netherlands O-105 COMPREHENSIVE SURGICAL INTESTINAL RESCUE PROGRAM IN ADULT PATIENTS: BOLOGNA EXPERIENCE Chiara Zanfi, Augusto Lauro, Paolo Di Gioia, Sara Pellegrini, and Antonio D. Pinna; Bologna, Italy O-106 YKL-40-GENE POLYMORPHISM IN THE DEVELOPMENT OF ACUTE CELLULAR REJECTION AFTER TRANSPLANTATION FOR HCV-INDUCED LIVER DISEASE Dennis Eurich, Ulf P. Neumann, Sabine Boas-Knoop, Ruth Neuhaus, Christian Trautwein, Hermann Wasmuth, Peter Neuhaus, and Marcus Bahra; Berlin, Germany; and Aachen, Germany

16:20

16:30

16:40

16:50

17:00

17:10

17:20

17:30

108

Monday 5 September
17:40 O-107 ABCG5/8 AND ABCB1 POLYMORPHISMS AS RISK FACTORS FOR ADVANCED FIBROSIS FOLLOWING LIVER TRANSPLANTATION Speranta Iacob, Vito Cicinnati, Gang Wu, Alexander Dechene, Irinel Popescu, Andreas Paul, Guido Gerken, and Susanne Beckebaum; Essen, Germany; and Bucharest, Romania O-108 A SCORE PREDICTING OUTCOME OF LIVER ALLOGRAFT RETRANSPLANTATION FOR HEPATITIS C Axel Andres, Eric Gerstel, Sonal Asthana, Shaheed Merani, Philippe Morel, Thierry Berney, Pietro E. Majno, Gilles Mentha, and Christian Toso; Geneva, Switzerland; and Edmonton, Canada

17:50

16:00 18:00

ORAL SESSION 14 Antigen presentation and T cells

Chairs: Michel Braun, Brussels, Belgium; Birgit Sawitzki, Berlin, Germany

Gala 2

16:00

O-109 CD8 T CELLS RECEIVE HELP FROM INDIRECT-PATHWAY CD4 T CELLS BY PROCESSING ALLOANTIGEN ACQUIRED FROM MHC I AND OTHER ALLOANTIGENS ON GRAFT CELLS K. Saeb-Parsy, T.M. Conlon, M. Negus, E.M. Bolton, J.A. Bradley, and G.J. Pettigrew; Cambridge, United Kingdom O-110 DIRECT-PATHWAY CD4 T CELLS ARE UNABLE TO PROVIDE HELP FOR CLASS-SWITCHED ALLOANTIBODY RESPONSES Jennifer Cole, Kourosh Saeb-Parsy, Margaret C. Negus, Eleanor M. Bolton, Andrew J. Bradley, Thomas M. Conlon, and Gavin J. Pettigrew; Cambridge, United Kingdom O-111 ANTIGENIC RECOGNITION PROPERTIES OF CD8+ REGULATORY T CELLS IN TRANSPLANTATION Elodie Picarda, Ignacio Anegon, and Carole Guillonneau; Nantes, France O-112 DONOR CD40 IS REQUIRED FOR THE Th17 RESPONSE TO DIRECT ALLOSTIMULATION Anna K. Kraus, Pietro E. Cippa, Jin Chen, Gaspert Ariana, Stephan Segerer, Rupolf P. Wthrich, and Thomas Fehr; Zurich, Switzerland O-113 TEMPORARY INHIBITION OF Trem-1 PROLONGS ALLOGRAFT SURVIVAL Gabriela Schiechl, Hans J. Schlitt, Edward K. Geissler, and Stefan Fichtner-Feigl; Regensburg, Germany O-114 TETRAHYDROBIOPTERIN PRECONDITIONING PROTECTS MURINE AORTIC ALLOGRAFTS FROM CHRONIC VASCULOPATHY Rupert Oberhuber, David Bernhard, Barbara Messner, Benno Cardini, Gregor Riede, Walter Mark, Christina Steger, Gerald Brandacher, Johann Pratschke, Katrin Watschinger, Ernst R. Werner, and Manuel Maglione; Innsbruck, Austria; and Vienna, Austria O-115 CRITICAL DIFFERENCES OF THE IMMUNE RESPONSE WITH INCREASING AGE Xupeng Ge, Anke Jurisch, Xiaodong Yuan, Bernhard Floerchinger, Marc-Olivier Timsit, Ying-Lung Lee, and Stefan G. Tullius; Boston, USA

16:10

16:20

16:30

16:40

16:50

17:00

109

Monday 5 September
17:10 O-116 SYSTEMIC EFFECTS OF LIVER REGENERATION ON BETA CELLS IN DIABETIC RAT: IN VIVO AND IN VITRO STUDIES Francois Moreau, Florence Toti, Sverine Sigrist, William Bietigier, Elodie Seyfritz, Michel Pinget, and Laurence Kessler; Strasbourg, France O-117 REGULATORY T AND Th17 T CELL RESPONSES IN THE CONTROL OF AUTOANTIBODY-MEDIATED ALLOGRAFT VASCULOPATHY Ines G. Harper, Chris Callaghan, Kourosh Saeb Parsy, Reza Mottalebzadeh, J.A. Bradley, and Gavin Pettigrew; Cambridge, United Kingdom O-118 MIGRATION INTO THE INJURED LUNG INDUCES LOSS OF CD200 ON NK CELLS: AIR-LIQUID IN VITRO MODEL Mary Gieschen-Krische, Harshith Bhat, John P. Stone, Lea Gregson, William R. Critchley, Susan J. Howard, William W. Hope, Nizar Yonan, and James E. Fildes; Manchester, United Kingdom O-119 REGULATORY T CELL FUNCTION OF SOTRASTAURIN TREATED KIDNEY TRANSPLANT PATIENTS Annelies E. de Weerd, Rens Kraaijeveld, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands O-120 THE IMMUNOLOGICAL TOLERANCE EFFECTS OF DONOR SPECIFIC REGULATORY T CELLS THROUGH INTERFERONGAMMA INDUCIBLE INDOLEAMINE 2, 3-DIOXYGENASE (IDO) + PLASMACYTOID DENDRITIC CELL Koji Sugimoto, Shinichi Matsumoto, Tetsuya Ikemoto, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, Shinichiro Yamada, and Mitsuo Shimada; Tokushima, Japan; and Dallas, USA

17:20

17:30

17:40

17:50

16:00 18:00

ORAL SESSION 15 Allocation

Boisdale 2

Chairs: Bernadette Haase-Kromwijk, Leiden, The Netherlands; James Neuberger, Birmingham, United Kingdom 16:00 O-121 OUTCOME OF PATIENTS WITH A MELD 25, GIVEN REGIONAL PRIORITY FOR LIVER TRANSPLANTATION Maria M. Modolo, Murat Akyol, Ernest L. Hidalgo, Kirsty Martin, and Gabriel C. Oniscu; Edinburgh, United Kingdom O-122 LIVER TRANSPLANTATION: WHO SHOULD OR SHOULD NOT DIE? A NOVEL SCORE TARGETING JUSTICE AND UTILITY IN THE MELD ERA Philipp Dutkowski, Christian E. Oberkofler, Ksenija Slankamenac, Milo A. Puhan, Erik Schadde, Beat Mllhaupt, Andreas Geier, and Pierre-Alain Clavien; Zrich, Switzerland; and Baltimore, USA

16:10

110

Monday 5 September
16:20 O-123 www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH A. Avolio, S. Agnes, M.C. Lirosi, M. Salizzoni, A. D. Pinna, B. Gridelli, L. De Carlis, M. Colledan, G.E. Gerunda, U. Valente, G. Rossi, G. M. Ettorre, A. Risaliti, V. Mazzaferro, F. Bresadola, M. Rossi, G. Tisone, F. Zamboni, L. Lupo, O. Cuomo, F. Calise, M. Donataccio, N. Nicolotti, A. Vitale, R Romagnoli, F. Lupo, A. Cucchetti, S. Gruttadauria, I. Mangoni, D. Pinelli, R Montalti, M. Gelli, L. Caccamo, G. Vennarecci, D. Nicolini, E. Regalia, U. Baccarani, Q. Lai, T. Manzia, E. Tondolo, M. Rendina, A. Perrella, E. Scuderi, B. Antonelli, C. de Waure, T. De Feo, P. Burra, A. Gasbarrini, U. Cillo, and Donor to Recipient Italian Liver Transplant (D2R-ILTx) Study Group; Rome, Italy; Turin, Italy; Bologna, Italy; Palermo, Italy; Milan, Italy; Bergamo, Italy; Modena, Italy; Genova, Italy; Ancona, Italy; Udine, Italy; Cagliari, Italy; Bari, Italy; Naples, Italy; Verona, Italy; and Padua, Italy O-124 LOW TITRE ABO-INCOMPATIBLE DECEASED DONOR RENAL TRANSPLANTATION IN PAEDIATRIC PATIENTS: A NEW APPROACH TO LONG WAITING LISTS A. Nicholas R. Barnett, Stephen D. Marks, Christopher J.D. Reid, Tim P. Maggs, Vassilis G. Hadjianastassiou, Carol Jennings, Maria Scanes, Robert Vaughan, and Nizam Mamode; London, United Kingdom O-125 DONOR SCORING SYSTEM FOR HEART TRANSPLANTATION AND THE IMPACT ON PATIENT SURVIVAL Jacqueline M. Smits, Michel De Pauw, Erwin de Vries, Axel Rahmel, Bruno Meiser, Guenther Laufer, and Andreas Zuckermann; Leiden, The Netherlands; Ghent, Belgium; Munich, Germany; and Vienna, Austria O-126 REVISED NATIONAL HLA MATCHING CRITERIA IMPROVE ACCESS TO TRANSPLANT FOR PATIENTS FROM ETHNIC MINORITIES Susan V. Fuggle, Rachel J. Johnson, Lisa Mumford, Alex Hudson, and J.Andrew Bradley; Bristol, United Kingdom; and Cambridge, United Kingdom O-127 THE 2006 NATIONAL KIDNEY ALLOCATION SCHEME THE FIRST FOUR YEARS Rachel J. Johnson, Lisa Mumford, Alex Hudson, Susan V. Fuggle, and J.Andrew Bradley; Bristol, United Kingdom O-128 A NEW ALLOCATION MODEL FOR LIVER TRANSPLANTATION COMBINING URGENCY BASED PRIORITIZATION WITH DONOR-RECIPIENT MATCHING: A PROSPECTIVE CONTROLLED STUDY Umberto Cillo, Alessandro Vitale, Daniele Neri, Patrizia Boccagni, Francesco DAmico, Enrico Gringeri, Martina Gambato, Patrizia Burra, Paolo Angeli, and Giacomo Zanus; Padua, Italy O-129 LABORATORY MELD-BASED ALLOCATION OF LIVER GRAFTS: IS THE SICKEST FIRST PRINCIPLE JUSTIFIED? Ina Jochmans, Nicolas Meurisse, Bart Van Geluwe, Bruno Desschans, David Cassiman, Werner Van Steenbergen, Chris Verslype, Geert Meyfroidt, Dieter Mesotten, Wim Laleman, Raymond Aerts, Diethard Monbaliu, Frederik Nevens, and Jacques Pirenne; Leuven, Belgium

16:30

16:40

16:50

17:00

17:10

17:20

111

Monday 5 September
17:30 O-130 ALLOCATION OF MARGINAL KIDNEYS: KARPINSKY SCORE 4 FOR SINGLE (SKT) OR DUAL (DKT) TRANSPLANTATION? Antonio Lavacca, Maria Messina, Caterina Dolla, Ester Gallo, Ana M. Manzione, Manuel Burdese, Andrea Ranghino, and Giuseppe P. Segoloni; Turin, Italy O-131 PAIRED LIVING KIDNEY DONATION IN THE UK Rachel J. Johnson, Joanne Allen, Susan V. Fuggle, Lisa Burnapp, and J.Andrew Bradley; Bristol, United Kingdom O-132 HIGH MELD SCORES ARE NOT ALWAYS ASSOCIATED WITH POOR OUTCOME AFTER LIVER TRANSPLANTATION: SINGLE CENTRE EXPERIENCE WITH 51 PATIENTS WITH LAB-MELD > 30 Silvio Nadalin, Paolo Girotti, Jun Li, Ingmar Koenigsrainer, Ruth Ladurner, Alexandra Heininger, Beate Harder, and Alfred Koenigsrainer; Tbingen, Germany

17:40

17:50

16:00 18:00

ORAL SESSION 16 Kidney (ABO and antibody incompatible transplants and immunosuppression)
Chairs: Simon Ball, Birmingham, United Kingdom; Gunnar Tyden, Stockholm, Sweden

Hall 1

16:00

O-133 THE CLINICAL STUDY OF IMMUNOSUPPRESSION PROTOCOL IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION Yuki Nakagawa, Kazuhide Saito, and Kota Takahashi; Niigata, Japan O-134 SUCCESSFUL OUTCOMES AFTER MINIMISING ANTIBODY MODULATION IN BLOOD GROUP INCOMPATIBLE KIDNEY TRANSPLANTATION Nizam Mamode, Vassilis Hadjianastassiou, Anthony Dorling, Shivakumar Kenchayikoppad, and Nicholas Barnett; London, United Kingdom O-135 THE INCIDENCE OF ACUTE ANTIBODY MEDIATED KIDNEY TRANSPLANT REJECTION UNDER MODERN IMMUNOSUPPRESSION: COMPARISON OF TACROLIMUS MONOTHERAPY WITH TACROLIMUS /MMF STEROID-FREE MAINTENANCE REGIMES Michelle Willicombe, David H. Taube, Jack Galliford, Paul Brookes, and Adam G. McLean; London, United Kingdom O-136 WITHDRAWN O-137 A MULTICENTRIC PROTOCOL USING Glycosorb IMMUNADSORPTION FOR AB0-INCOMPATIBLE KIDNEY TRANSPLANTATION: THE SWISS EXPERIENCE Marc Schiesser, Daniel Steinemann, Isabelle Binet, Ute Eisenberger, Karine Hadaya, Thomas Fehr, and Michael Dickenmann; Zurich, Switzerland; St. Gallen, Switzerland; Bern, Switzerland; Geneva, Switzerland; and Basel, Switzerland O-138 SUCCESSFUL PREVENTION OF CHRONIC AMR IN DSAPOSITIVE KIDNEY TRANSPLANTATION BY RITUXIMAB-BASED PRECONDITIONING Toshihito Hirai, Tastu Tanabe, Naoki Kohei, Kazuya Omoto, Hideki Ishida, and Kazunari Tanabe; Tokyo, Japan

16:10

16:20

16:30 16:40

16:50

112

Monday 5 September
17:00 O-139 PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION Michela Seveso, Paolo Rigotti, Francesco P. Schena, Sergio Stefoni, Silvio Sandrini, Maurizio Salvadori, Piero Stratta, Franco Citterio, Giuseppe P. Segoloni, Elena Ruffoni, Lucrezia Furian, Giuseppe Grandaliano, Maria P. Scolari, Elisabetta Bertoni, Antonio Gargiulo, Luigi Biancone, and Emanuele Cozzi; PadUa, Italy; Bari, Italy; Bologna, Italy; Brescia, Italy; Florence, Italy; Novara, Italy; Rome, Italy; and Turin, Italy O-140 ACUTE REJECTION IN RENAL TRANSPLANTATION RECIPIENTS TREATED WITH TACROLIMUS PROLONGED RELEASEAND IMMEDIATE RELEASE-BASED THERAPY THE OSAKA STUDY (OPTIMIZING IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION WITH Advagraf Bernhard Banas, Nassim Kamar, Frank Lehner, Laetitia Albano, Maciej Glyda, and Ondrej Viklicky; Regensburg, Germany; Toulouse, France; Hannover, Germany; Nice, France; Poznan, Poland; and Prague, Czech Republic O-141 EFFICACY AND SAFETY OF TACROLIMUS PROLONGED RELEASE AND IMMEDIATE RELEASE IN DE NOVO RENAL TRANSPLANTATION THE OSAKA STUDY (OPTIMIZING IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION WITH Advagraf Nassim Kamar, Frank Lehner, Bernhard Banas, Ondrej Viklicky, Laetitia Albano, and Maciej Glyda; Toulouse, France; Hannover, Germany; Regensburg, Germany; Prague, Czech Republic; Nice, France; and Poznan, Poland O-142 EFFICACY AND SAFETY OF 24 MONTHS IMMUNOSUPPRESSION WITH CONCENTRATION-CONTROLLED EVEROLIMUS AND REDUCED CYCLOPSORINE IN DE NOVO RENAL TRANSPLANT RECIPIENTS M. Yaqoob, H. Riad, J. Pattison, C. Cornu-Artis, Z. Wang, and H. Tedesco Silva; London, United Kingdom; Manchester, United Kingdom; Basel, Switzerland; East Hanover, United Kingdom; and Sao Paulo, Brazil O-143 EVEROLIMUS (EVE) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNI) IMMUNOSUPPRESSION TREATMENT Manuel Rengel, Soraya Abad, Almudena Vega, rsula Verdalles, and Eduardo Verde; Madrid, Spain O-144 A ONE YEAR PROSPECTIVE, RANDOMISED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDY OF INTRAVENOUS IBANDRONATE ON BONE LOSS FOLLOWING RENAL TRANSPLANTATION Knut T. Smerud, Szilveszter Dolgos, Inge C. Olsen, Anders sberg, Solbjrg Sagedal, Anna V. Reister, Karsten Midtvedt, Per Pfeffer, Jens Bollerslev, and Anders Hartmann; Oslo, Norway

17:10

17:20

17:30

17:40

17:50

113

Monday 5 September
16:00 18:00

ORAL SESSION 17 Infection in transplantation

Chairs: Vincent Emery, London, United Kingdom; Rachel Hilton, London, United Kingdom

Alsh

16:00

O-145 IMPROVED LONG-TERM RENAL ALLOGRAFT SURVIVAL IN PREEMPTIVE VALGANCICLOVIR THERAPY COMPARED TO VALACYCLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS: RESULTS OF RANDOMIZED CONTROLLED TRIAL Tomas Reischig, Petra Hribova, Pavel Jindra, Ondrej Hes, Mirko Bouda, Vladislav Treska, and Ondrej Viklicky; Pilsen, Czech Republic; and Prague, Czech Republic O-146 CMV VALGANCICLOVIR PROPHYLAXIS VS. PREEMPTIVE THERAPY FOLLOWING KIDNEY TRANSPLANTATION: 2-YEARDATA FROM THE VIPP-TRIAL Oliver Witzke for the VIPP Study Group; Essen, Germany O-147 CYTOMEGALOVIRUS AND BK VIRUS INFECTIONS ARE LESS FREQUENT WITH EVEROLIMUS VERSUS MYCOPHENOLATE IMMUNOSUPPRESSION: 24-MONTH UPDATE FROM THE 2309 STUDY IN DE NOVO RENAL TRANSPLANT RECIPIENTS M. Yaqoob, J. Pattison, H. Riad, C. Cornu-Artis, Z. Wang, and F. Shihab; London, United Kingdom; Manchester, United Kingdom; Basel, Switzerland; East Hanover, USA; and Salt Lake City, USA O-148 EFFECT OF EVEROLIMUS AND DONOR/RECIPIENT SEROLOGY ON CYTOMEGALOVIRUS INFECTION IN HEART TRANSPLANT RECIPIENTS: A SUBANALYSIS OF THE RANOMIZED TRIAL A2310 L. Potena, C. Pellegrini, F. Musumeci, J. Parameshwar, G. Dong, P. Lopez, and A. Poncelet; Bologna, Italy; Pavia, Italy; Rome, Italy; Papworth Everard, Cambridge, United Kingdom; East Hanover, USA; Basel, Switzerland; and Brussels, Belgium O-149 PRIMARY CMV INFECTIONS AND HHV-6 REACTIVATIONS IN LIVER TRANSPLANT RECIPIENTS RECEIVING VALGANCICLOVIR PROPHYLAXIS Irmeli Lautenschlager, Raisa Loginov, Teemu Karlsson, and Krister Hckerstedt; Helsinki, Finland O-150 CMV SPECIFIC IMMUNE RECONSTITUTION IN HTx PATIENTS TREATED WITH PRE-EMPTIVE STRATEGY: LIGHTS AND SHADOWS Marta Fiscon, Dino Sgarabotto, Antonio Gambino, DAgostino Chiara, Gino Gerosa, Carlo Mengoli, Alda Saldan, Simona Cofano, Riccardo Cusinato, Luisa Barzon, Giorgio Pal, and Davide Abate; Padua, Italy O-151 A NOVEL CELL EFFECTOR IN THE ANTIBODY MEDIATED MICROCIRCULATION LESIONS Thomas Bachelet, Lionel Couzi, Vincent Pitard, Xavier Sicard, JeanLuc Taupin, Sebastien Lepreux, Pierre Merville, and Julie DechanetMerville; Bordeaux, France O-152 RENAL PATIENTS SHOWED A POOR RESPONSE TO THE 2009 PANDEMIC NEW INFLUENZA A H1N1 VIRUS VACCINE Marta Crespo, Silvia Collado, Marisa Mir, Sara Hurtado, Higini Cao, Francesc Barbosa, Consol Serra, Carlota Hidalgo, Anna Faura, Juan Garca de Lomas, Milagro Montero, Juan P. Horcajada, Josep M. Puig, and Julio Pascual; Barcelona, Spain; and Valencia, Spain

16:10

16:20

16:30

16:40

16:50

17:00

114

17:10

Monday 5 September
17:20 O-153 SAFETY AND EFFICACY OF AN INACTIVATED, UNADJUVANTED VACCINE AGAINST THE NOVEL INFLUENZA A VARIANT (H1N1v) IN RENAL TRANSPLANT RECIPIENTS (INSERM C09-32, TRANSFLUVAC STUDY) Benoit Barrou, Claire Pouteil Noble, Vincent Meiffredy, Frederic Thibault, Sameh Daoud, Remi Cahen, David Bottigioli, Ccile Dollinger, Nicole Lecorre, Isabelle Charreau, Jean Pierre Aboulker, Brigitte Autran, and Emmanuel Morelon; Paris, France; Lyon, France; and Villejuif, France O-154 MONITORING OF PERIPHERAL BLOOD NATURAL KILLER CELLS TO IDENTIFY HEART TRANSPLANT RECIPIENTS AT RISK OF INFECTION Elizabeth Sarmiento, Nadia Del Pozo, Antonio Gallego, Juan Fernandez-Yaez, Jesus Palomo, Adolfo Villa, Joaquin Navarro, Katja Kotsch, and Javier Carbone; Madrid, Spain; and Innsbruck, Austria O-155 EARLY URETERIC STENT REMOVAL REDUCES URINARY TRACT INFECTION IN KIDNEY TRANSPLANT RECIPIENTS, A RANDOMIZED CONTROLLED TRIAL (EUREKA) Watanyu Parapiboon, Atiporn Ingsathit, Phimchanok Junchotikul, Keeratipon Wiengpon, Wit Viseshsindh, Charoen Leenanupunth, Chanika Sritara, Sopon Jirasiritham, and Vasant Sumethkul; Bangkok, Thailand O-156 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): CHARACTERISTICS AND OUTCOME IN A BELGIAN UNIVERSITY HOSPITAL Daan Dierickx, Thomas Tousseyn, Jacques Pirenne, Diethard Monbaliu, Dirk Van Raemdonck, Dirk Kuypers, Yves Vanrenterghem, Johan Van Cleemput, Johan Vanhaecke, Geert Verleden, Lieven Dupont, Frederik Nevens, Rita Lombaerts, and Gregor Verhoef; Leuven, Belgium

17:30

17:40

17:50

16:00 18:00

ORAL SESSION 18 Kidney (DCD/ECD)

Chairs: Gavin Pettigrew, Cambridge, United Kingdom; Maarten Snoeijs, Maastrich, The Netherlands

Boisdale 1

16:00

O-157 BELGIAN EXPERIENCE OF DCD KIDNEY TRANSPLANTATION Tom Darius, Ina Jochmans, Hieu Ledinh, Diethard Monbaliu, Dirk Kuypers, Michel Mourad, Luc De Pauw, Jan Lerut, Olivier Detry, Michel Meurisse, Laurent Weekers, Patrick Peeters, Caren Randon, Marc Vandervennet, Jean-Louis Bosmans, Geert Roeyen, Dirk Ysebaert, Daniel Abramovicz, Dimitri Mikhlaski, Jacques Sennesael, Martin Wissing, Axel Rahmel, Jean-Paul Squifflet, and Jacques Pirenne; Brussels, Belgium; Leuven, Belgium; Lige, Belgium; Ghent, Belgium; Antwerp, Belgium; and Leiden, The Netherlands O-158 DCD KIDNEY TRANSPLANTATION: LONG-TERM RESULTS OF UNCONTROLLED VERSUS CONTROLLED DONORS E.R.P. Hoogland, M.G.J. Snoeijs, and L.W.E. van Heurn; Maastricht, The Netherlands

16:10

115

Monday 5 September
16:20 O-159 KIDNEY GRAFT QUALITY AFTER DONATION FROM UNCONTROLLED DECEASED DONORS AFTER CARDIAC ARREST William Hanf, Ricardo Codas, Vannary Meas Yedid, Aouemeur Hadj Aissa, Brigitte Mc Gregor, Cecile Chauvet, Gisele Perrat, Julien Berthiller, Fanny Buron, Palmina Petruzzo, Lionel Badet, and Emmanuel Morelon; Lyon, France; and Paris, France O-160 DONOR KIDNEY DISEASE AND TRANSPLANT OUTCOMES FOR KIDNEYS DONATED AFTER CARDIAC DEATH Mark J. Salji, Moira Finlay, Meryl Griffiths, Sathia Thiru, Andrew Bradley, and Gavin J. Pettigrew; Cambridge, United Kingdom O-161 PRETRANSPLANT EX VIVO REPAIR OF DENUDED TUBULE EPITHELIUM IN AN UNCONTROLLED PORCINE DCD KIDNEY MODEL Lauren Brasile, Philip Glowacki, David Humes, Angela Westover, Deborah Buffington, and Bart M. Stubenitsky; Albany, USA; Utrecht, The Netherlands; and Ann Arbor, USA O-162 RENAL TRANSPLANTATION USING DCD DONORS: DOES CIT MATTER? Bimbi S. Fernando; London, United Kingdom O-163 KIDNEYS FROM DONORS AFTER CARDIAC DEATH (DCD) PROVIDE SIMILAR ALLOGRAFT FUNCTION AT 1 YEAR COMPARED TO KIDNEYS FROM DONORS AFTER BRAINSTEM DEATH (DBD) P. Nagaraja, G. Roberts, M. Stephens, D. Archampong, S. Horvath, J. Fialova, S. Griffin, R. Chavez, A. Asderakis, and Z. Kaposztas; Cardiff, United Kingdom O-164 EXTRACORPORAL NORMOTHERMIC ABDOMINAL PERFUSION IN SITU FOR RESUSCITATION KIDNEY IN UNCONTROLLED DONORS WITH ONE HOUR WARM ISCHEMIC TIME Oleg Reznik, Andrey Scvortcov, Konstantin Senchik, Alexander Lopota, Alexander Reznik, Yan Moysyuk, Sergey Bagnenko, and Sergey Gautier; Saint-Petersbutg, Russian Federation; SaintPetersburg, Russian Federation; and Moscow, Russian Federation O-165 RESULTS OF UNCONTROLLED DCD MAASTRICHT CLASS II KIDNEY TRANSPLANT (KT) WITH PULSATILE PERFUSION (PP) MACHINE PRESERVATION David Paredes, Angel Ruiz, Camino Rodriguez-Villar, Marta Alberola, Lluis Peri, Blanca Miranda, Antonio Alcaraz, and Federico Oppenheimer; Barcelona, Spain O-166 IMPACT OF THE COMPLEMENTARY EVALUATION OF ECD AND DCD KIDNEYS COMBINING KIDNEY BIOPSY AND PULSATILE PERFUSION (PP) MACHINE David Paredes, Angel Ruiz, Camino Rodriguez-Villar, Marta Alberola, Lluis Peri, Blanca Miranda, Antonio Alcaraz, and Federico Oppenheimer; Barcelona, Spain O-167 KIDNEY INJURIES DURING ORGAN PROCUREMENT IN DONATION AFTER CARDIAC DEATH DONORS Fabio Ausania, Steven A. White, Phil Pocock, and Derek M. Manas; Newcastle upon Tyne, United Kingdom; and Bristol, United Kingdom

16:30

16:40

16:50

17:00

17:10

17:20

17:30

17:40

116

Monday 5 September
17:50 O-168 DELAYED GRAFT FUNCTION LONGER THAN ONE WEEK IS THE CRITICAL RISK FACTOR FOR LONG TERM GRAFT SURVIVAL OF KIDNEY TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH Mamoru Kusaka, Yusuke Kubota, Akihiro Kawai, Naohiko Fukami, Takahiro Maruyama, Hitomi Sasaki, Kunihiro Hayakawa, Ryoichi Shiroki, and Kiyotaka Hoshinaga; Toyoake, Japan

16:00 17:00

MINI ORAL SESSION 4 Immunobiology /Basic science

Mini Theatre 1

Chairs: Michiel Betjes, Rotterdam, The Netherlands; Marc Dahlke, Regensburg, Germany 16:00 MO-031 NUTRACEUTICALS AMELIORATE KIDNEY ISCHEMIA/ REPERFUSION INJURY IN RATS VIA HO-1 INDUCTION Philipp Gehwolf, Florian M. Struller, Arthur Kostron, Michael Wolzt, F.H. Bach, L.E. Otterbein, B. Wegiel, Johann Pratschke, and Robert Ollinger; Innsbruck, Austria; Vienna, Austria; and Boston, USA MO-032 AUTOPHAGY PROTECTS HUMAN HEPATOCYTES FROM CELL DEATH DURING HYPOXIA AND HYPOXIA-REOXYGENATION (H-R) Ricky H. Bhogal, David H. Adams, and Simon C. Afford; Birmingham, United Kingdom MO-033 RENAL ALLOGRAFT FUNCTION AT SIX MONTHS POST TRANSPLANT IS ASSOCIATED WITH DONOR CHROMOSOMAL TELOMERE LENGTH Marc Gingell-Littlejohn, Dagmara McGuinness, Liane M. McGlynn, David Kingsmore, Marc J. Clancy, Christian Koppelstaetter, and Paul G. Shiels; Glasgow, United Kingdom; and Innsbruck, Austria MO-034 CD4+CD25+Foxp3+IFN-g+ INDUCED HUMAN Treg ARE A HETEROGENOUS CELL POPULATION SUPPRESSING ALLORESPONSES SPECIFICALLY AS WELL AS UNSPECIFICALLY Volker Daniel, Mahmoud Sadeghi, Haihao Wang, and Gerhard Opelz; Heidelberg, Germany; and Wuhan, China MO-035 IL-17 PRODUCING CELLS HOME TO THE GRAFT EARLY AFTER HEART TRANSPLANTATION Nicole M. van Besouw, Annemiek M.A. Peeters, Marjolein Dieterich, Kadir Caliskan, Lex P.W.M. Maat, Aggie H.M.M. Balk, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands MO-036 BELATACEPT DOES NOT ACTIVATE INDOLEAMINE 2,3DIOXYGENASE (IDO) IN DE NOVO LIVER TRANSPLANT RECIPIENTS Sinda Bigenzahn, Johann Pratschke, Alfred Koenigsrainer, Thomas Becker, Dietmar Fuchs, Gerald Brandacher, Rainer Oberbauer, Ferdinand Mhlbacher, and Thomas Wekerle; Vienna, Austria; Berlin, Germany; Tbingen, Germany; Innsbruck, Germany; and Innsbruck, Austria MO-037 NO PRIVILEGED ROLE FOR VASCULAR ENDOTHELIAL CELLS DURING CYTOMEGALOVIRUS DISSEMINATION Joachim Andrassy, Torsten Sacher, Markus Guba, Karl-Walter Jauch, and Ullrich Koszinowski; Munich, Germany

16:05

16:10

16:15

16:20

16:25

16:30

117

Monday 5 September
16:35 MO-038 ARTEMISIAE CAPILLARIS HERBA INDUCED PROLONGED SURVIVAL OF FULLY CARDIAC ALLOGRAFTS AND GENERATED REGULATORY CELLS Xiangyuan Jin, Masateru Uchiyama, Qi Zhang, and Masanori Niimi; Tokyo, Japan; and Harbin, China MO-039 CLINICAL RELEVANCE OF DEFINING EQUIVALENCES BETWEEN HUMAN AND MOUSE IMMUNOREGULATORY CELLS James A. Hutchinson, Paloma Riquelme, Stefan Tomiuk, Hans J. Schlitt, and Edward K. Geissler; Regensburg, Germany; and Bergisch Gladbach, Germany MO-039/A EARLY INCREASE IN N(EPSILON)-CARBOXY-METHYLLYSINE AND DECREASE IN sRAGE PLASMA VALUES IN DE NOVO LIVER TRANSPLANTATION Teresa Navarra, Paolo De Simone, Serena Del Turco, Amalia Gastaldelli, Franco Filipponi, Giuseppina Basta; Pisa, Italy

16:40

16:45

16:00 17:00

MINI ORAL SESSION 5 Kidney II

Chairs: Bengt Fellstrom, Uppsala, Sweden; Hallvard Holdaas, Oslo, Norway

Mini Theatre 2

16:00

MO-040 STIMULATION OF THE CHOLINERGIC ANTIINFLAMMATORY PATHWAY IN BRAIN DEAD DONOR RATS IMPROVES LONG-TERM ALLOGRAFT OUTCOME IN RECIPIENTS Simone Hoeger, Jonas Jarczyk, Bernhard Krmer, Peter Schnuelle, and Benito Yard; Mannheim, Germany MO-041 A COMPARISON OF THE PERIPHERAL BLOOD mRNA TRANSCRIPTIONAL PROFILES OF BELATACEPT- AND CYCLOSPORINE-TREATED RENAL TRANSPLANT PATIENTS Bishu J. Ganguly, E.J. Kulbokas, Daniel Brickman, Jun Xing, Gabriella Alexe, Robert Latek, Katy Simonsen, Gregory Di Russo, and Robert Townsend; Princeton, USA; and Baar, Switzerland MO-042 EPITHELIAL TO MESENCHYMAL TRANSITION IN TRANSPLANTED KIDNEY, RELATION TO ALLOGRAFT FUNCTION AND MORPHOLOGY Marek Myslak, Elzbieta Urasinska, Leszek Domanski, Jacek Rzanski, Krzysztof Pabisiak, and Kqazimierz Ciechanowski; Szczecin, Poland MO-043 A PRE-CLINICAL EVALUATION OF RENAL TRANSPLANT FROM DECEASED AFTER CARDIAC ARREST DONORS Graldine Allain, Sebastien Giraud, William Hebrard, Christophe Jayle, Raphael Thuillier, Rodolphe Thuret, Thierry Hauet, and Benot Barrou; Poitiers, France; Surgres, France; Montpellier, France; and Paris, France MO-044 DO THE OXIDOREDUCTASES (ENDOTHELIAL NO SYNTHASE, CATALASE, GLUTATHIONE PEROXIDASE, SUPEROXIDE DISMUTASES) GENES POLYMORPHISMS HAVE AN ASSOCIATION WITH DELAYED GRAFT FUNCTION OF KIDNEY ALLOGRAFTS Leszek Domanski, Grazyna Dutkiewicz, Karolina Kloda, Andrzej Pawlik, Andrzej Ciechanowicz, Agnieszka Binczak-Kuleta, Jacek Rzanski, Marek Myslak, Krzysztof Safranow, and Kazimierz Ciechanowski; Szczecin, Poland

16:05

16:10

16:15

16:20

118

Monday 5 September
16:25 MO-045 SAFETY AND EFFICACY OF EVEROLIMUS AND LOW DOSE CYCLOSPORINE IN PEDIATRIC KIDNEY TRANSPLANTATION Mirco Belingheri, Luisa Murer, Fabrizio Ginevri, Luca Dello Strologo, Mariano Ferraresso, Elena Groppali, Giulia Ghirardo, Angelica Parodi, Isabella Guzzo, Lorena Duca, and Luciana Ghio; Milan, Italy; Padua, Italy; Genova, Italy; and Rome, Italy MO-046 REDUCTION IN COLD ISCHAEMIA TIMES OVER A DECADE OF DECEASED DONOR RENAL TRANSPLANTS IN THE UNITED KINGDOM Sussie Shrestha, Rachel Johnson, Philip Dyer, Michael Patrick, Craig Taylor, Christopher Watson, and Lorna Marson; Edinburgh, United Kingdom; Bristol, United Kingdom; and Cambridge, United Kingdom MO-047 HIGH INCIDENCE OF ANTI-CMV DRUG RESISTANCE AMONG D+R- KIDNEY TRANSPLANT RECIPIENTS RECEIVING PREEMPTIVE THERAPY Lionel Couzi, Sebastien Helou, Isabelle Garrigue, Thomas Bachelet, Karine Moreau, Sophie Alain, Marie-Edith Lafon, and Pierre Merville; Bordeaux, France; and Limoges, France MO-048 CARDIOVASCULAR RISK IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING mTOR INHIBITORS Ewa Watorek, Maciej Szymczak, Maria Boratynska, Dariusz Patrzalek, and Marian Klinger; Wroclaw, Poland MO-049 HOMOGENITY OF GENE EXPRESSION PATTERN IN CHRONIC KIDNEY ALLOGRAFT REJECTION Petra Hribova, Irena Brabcova, Eva Honsova, and Ondrej Viklicky; Prague, Czech Republic

16:30

16:35

16:40

16:45

16:00 17:00

MINI ORAL SESSION 6 Liver and intestine

Mini Theatre 3

Chairs: Andrew Burroughs, London, United Kingdom; Derek Manas, Newcastle upon Tyne, United Kingdom 16:00 MO-050 OUTCOME FROM RIGHT LOBE EX SITU SPLIT LIVER TRANSPLANTATION: SINGLE CENTRE EXPERIENCE Roberto Valente, Montse Juvany, Pablo Beltran, Carlos Bernardos, Andreas Prachalias, Parthi Srinivasan, Wayel Jassem, Hector Vilca Melendez, Mohamed Rela, and Nigel Heaton; London, United Kingdom MO-051 EARLY GRAFT FUNCTION IN LIVING DONOR LIVER TRANSPLANTATION IS NOT PREDICTED BY GRAFT SIZE ALONE, BUT IS DETERMINED BY THE CORRELATION BETWEEN GRAFT SIZE, DONOR AGE, AND RECIPIENT STATUS Yuzo Umeda, Takahito Yagi, Hiroshi Sadamori, Hiroaki Matsuda, Susumu Shinoura, Ryuichi Yoshida, Daisuke Satoh, Masashi Utsumi, and Toshiyoshi Fujiwara; Okayama, Japan MO-052 EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT FOR LIVERS FROM DONORS AFTER CIRCULATORY DEATH: A SYSTEMATIC REVIEW AND META-ANALYSIS Iestyn M. Shapey, and Paolo Muiesan; Birmingham, United Kingdom

16:05

16:10

119

Monday 5 September
16:15 MO-053 PATIENT OUTCOMES FOLLOWING PORTAL VENOUS AND HEPATIC ARTERIAL RECONSTRUCTION IN ORTHOTOPIC LIVER TRANSPLANTATION Anya Adair, Sonia J. Wakelin, Sean Martin, and John J. Casey; Edinburgh, United Kingdom MO-054 THE HISTOPATHOLOGIC RISK FACTORS OF PRIMARY GRAFT DYSFUNCTION AFTER HUMAN LIVER TRANSPLANTATION. Huda M. Noujaim, Cristiane M.R. Freitas, Edna F.S. Montero, Vera L. Capellozzi, Regina G. Santos, Leornado T. Motta, Juan R. Branhez, Marcelo P. de Miranda, and Tercio Genzini; So Paulo, Brazil MO-055 HIV POSITIVE PATIENTS IN THE WAITING LIST FOR LIVER TRANSPLANTATION: HIGH MORTALITY AND LOW ACCESS TO TRANSPLANTATION Alejandra Villamil, Liliana Bisignano, Federico Orozco, Juan C. Bandi, Lucas McCormack, Gabriel Gondolesi, Laura Barcan, Eduardo De Santibaes, and Adrian Gadano; Buenos Aires, Argentina MO-056 EFFECTS OF INDUCTION ON HEPATITIS B AND HEPATITIS C VIRUS CO-INFECTED LIVER TRANSPLANTS: AN ANALYSIS OF UNOS DATA Kayo Waki, Yasuhiko Sugawara, Hideo Fujita, Takashi Kadowaki, Norihiro Kokudo, Paul I. Terasaki, and Kayo Waki; Bunkyo-ku, Tokyo, Japan; and Los Angeles, USA MO-057 IMMUNOSUPPRESSIVE STRATEGIES IN LIVER TRANSPLANTATION IN HIV CO-INFECTED PATIENTS: UNIVERSITY OF MODENA EXPERIENCE Fabrizio Di Benedetto, Giuseppe Tarantino, Giuseppe DAmico, Nicola De Ruvo, Nicola Cautero, Roberto Montalti, Gian Piero Guerrini, Robero Ballarin, Mario Spaggiari, Giovanni Guaraldi, and Giorgio E. Gerunda; Modena, Italy MO-058 EFFECT OF PROLONGATION OF ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS ON SURVIVAL AND FIBROSIS PROGRESSION IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION Valentina R. Bertuzzo, Matteo Cescon, Maria Rosa Tam, Maria Cristina Morelli, Paolo Di Gioia, Stefania Lorenzini, Piero Andreone, Massimo Del Gaudio, Alessandro Cucchetti, Matteo Zanello, Alessandro Dazzi, Giorgio Ercolani, Matteo Ravaioli, Antonietta DErrico-Grigioni, and Antonio Daniele Pinna; Bologna, Italy MO-059 LACK OF INFLUENCE OF GRAFT ISCHEMIA ON REJECTION AND SURVIVAL IN INTESTINAL TRANSPLANTATION Ignacio M. Gonzalez-Pinto, Carlos Zumarraga, Francisco Martinez, Panagiotis Tryphnopoulos, Seigo Nishida, David Levi, Eddie Island, Akin Tekin, Genaro Selvaggi, Jang Moon, Philip Ruiz, and Andreas G. Tzakis; Miami, USA; and Oviedo, Spain

16:20

16:25

16:30

16:35

16:40

16:45

16:00 17:00

120

RAPID ORAL SESSION 17 Kidney V

HYBRID POSTER AREA Digital Display 1

Chairs: Karine Hadaya, Geneva, Switzerland; Graham Lipkin, Birmingham, United Kingdom

Monday 5 September
16:00 RO-192 HEALTH RELATED QUALITY OF LIFE AND CLINICAL OUTCOMES IN KIDNEY TRANSPLANTED PATIENTS Miklos Z. Molnar, Marta Molnar-Varga, Lilla Szeifert, Agnes Z. Kovacs, Andras Szentkiralyi, Maria E. Czira, Adam Remport, Istvan Mucsi, and Marta Novak; Budapest, Hungary; Torrance, USA; Mnster, Germany; Montreal, Canada; and Toronto, Canada RO-193 A COMPARISON OF TRANSPLANT OUTCOMES IN PERITONEAL AND HEMODIALYSIS PATIENTS A PAIRED KIDNEY ANALYSIS Alicja Debska-Slizien, Wojciech Wolyniec, Zuzanna Wolyniec, and Boleslaw Rutkowski; Gdansk, Poland RO-194 IMPACT OF INFLAMMATION AT 6 WEEKS ON INFLAMMATION AND FIBROSIS AT ONE YEAR IN KIDNEY GRAFT PROTOCOL BIOPSIES Willy Aaseb, Hallvard Holdaas, Karsten Midtvedt, Christina Drje, Finn P. Reinholt, and Anna V. Reister; Lrenskog, Norway; and Oslo, Norway RO-195 DUAL KIDNEY TRANSPLANTATION FROM UNCONTROLLED DECEASED DONORS AFTER CARDIAC ARREST (uDDCA) William Hanf, Ricardo Codas, Brigitte Mac Gregor, Vannary Meas Yedid, Aouemeur Hadj Aissa, Julien Berthiller, Gisele Perrat, Fanny Buron, Fatiha Mraiagh, Cecile Chauvet, Palmina Petruzzo, Emmanuel Morelon, and Lionel Badet; Lyon, France; and Paris, France RO-196 SWITCH FROM LAPAROSCOPIC TO RETROPERITONOSCOPIC HAND ASSISTED DONOR NEPHRECTOMY Baris Akin, Muammer Kaya, Koray Bas, Murat Dayangac, Turgut Piskin, and Vedat Celik; Istanbul, Turkey; Lefkosa, Turkey; and Malatya, Turkey RO-197 CORTICOSTEROIDS WITHDRAWL IN STABLE MAINTENANCE RENAL TRANSPLANT PATIENTS Manuel Rengel, Almudena Vega, Soraya Abad, rsula Verdalles, and Eduardo Verde; Madrid, Spain RO-198 IS SINGLE STAPLER TECHNIQUE SAFE IN LAPAROSCOPIC DONOR NEPHRECTOMY? Acar Tuzuner, Volkan Gen, Erkinbek Orozakunov, Gokhan Cipe, Oguzhan Ozsay, and Selcuk M. Hazinedaroglu; Ankara, Turkey RO-199 FEASIBILITY TO MAINTAIN TRIPLE BLOCKADE OF RENIN ANGIOTENSIN SYSTEM IN RENAL TRANSPLANT PATIENT WITH SEVERE PROTEINURIA Maria Jose Toribio, Esther Gonzalez, Raquel Santana, Eduardo Gutierrez, Natalia Polanco, Ignacio Bengoa, Amado Andres, and Jose Maria Morales; Madrid, Spain RO-200 THE USE OF RITUXIMAB IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS Helen E. Jones, Sue Patey, and Stephen D. Marks; London, United Kingdom RO-201 BORDERLINE REJECTION IN RENAL ALLOGRAFTS MANAGEMENT AND OUTCOMES FOR KIDNEY TRANSPLANTS IN 2008 Robin Ramphul, Jonathon Olsburgh, Catherine Horsfield, and Rachel Hilton; London, United Kingdom

16:04

16:08

16:12

16:16

16:20

16:24

16:28

16:32

16:36

121

Monday 5 September
16:00 17:00

RAPID ORAL SESSION 18 Kidney VI

HYBRID POSTER AREA Digital Display 2

Chairs: Amanda Knight, Nottingham, United Kingdom; Michael Nicols, Leicester, United Kingdom 16:00 RO-202 EARLY ULTRASOUND SCAN AFTER LIVING DONOR RENAL TRANSPLANTATION ALLOWS IMMEDIATE CORRECTION OF PERFUSION PROBLEMS AND MAINTAINS GRAFT FUNCTION IN ADULT AND PAEDIATRIC POPULATIONS Ben Pullar, Colin Forman, Manish Sinha, Haran Jogeesvaran, Francis Calder, John Taylor, Martin Drage, Nizam Mamode, Geoff Koffman, and Jonathon Olsburgh; London, United Kingdom RO-203 DISLIPIDEMIA IN KIDNEY TRANSPLANT RECIPIENTS: PREVALENCE IN A NATIONAL COHORT AND THE EFFECT ON GRAFT FUNCTION Gregor Mlinsek, Miha Arnol, Andrej Bren, and Aljosa Kandus; Ljubljana, Slovenia RO-204 PROTEINURIA IN KIDNEY TRANSPLANT RECIPIENTS: PREVALENCE IN A NATIONAL COHORT AND STUDY DESIGN OF THE EFFECT OF PARICALCITOL FOR REDUCTION OF PROTEINURIA Miha Arnol, Manca Oblak, Gregor Mlinek, Andrej F. Bren, Jadranka Buturovic-Ponikvar, and Aljoa Kandus; Ljubljana, Slovenia RO-205 CHRONIC RENAL REJECTION: THE POSSIBLE ROLE OF VEGF, TGF -1 AND POST-TRANSPLANT HLA ALLOANTIBODIES Ines Humar, Maja Puc, and Magdalena Svetec; Zagreb, Croatia RO-206 TRANSITION OF ADOLESCENT RENAL TRANSPLANT RECIPIENTS TO ADULT NEPHROLOGY UNITS Katia Toledo, Suzanne Bradley, Suzan Doyle, Rachel Johnson, and Stephen Marks; London, United Kingdom RO-207 REMOTE ISCHEMIC CONDITIONING IN A PORCINE KIDNEY TRANSPLANTATION MODEL [ndash] POSITIVE IMPACT ON GFR AND RENAL BLOOD PERFUSION Peter Sndergaard, Nicoline V. Krogstrup, Niels G. Secher, Kristian Ravlo, Anna K. Keller, Else Tnnesen, Bo M. Bibby, Ulla Mldrup, Ernst . straat, Michael Pedersen, Troels M. Jrgensen, Henri Leuvenink, Rikke Nrregaard, Henrik Birn, Bente Jespersen; Aarhus, Denmark; Groningen, The Netherlands RO-208 SIROLIMUS IN RENAL TRANSPLANT: ANALYSIS OF SAFETY AND EFFICACY IN A CONVERTION GROUP Pedro H.F. Gois, Gabriel G. Rivelli, Jenaine Oliveira, Iara C. de Carvalho, Leila K. Prado, Janaina G. Gonalves, Ana P.C. de Lima, Lilian M. Pereria, and Marilda Mazzali; Campinas, Brazil RO-209 RIGHT-SIDED VERSUS LEFT-SIDED LAPAROSCOPIC DONOR NEPHRECTOMY: EQUIVALENT IN SAFETY AND EFFICACY Eeke Thomee, Shruti Mittal, Sanjay Sinha, Chris Darby, Anil Vaidya, Mark Sullivan, and Peter Friend; Oxford, United Kingdom RO-210 EXPANDED CRITERIA DONORS (ECD) IS IT THE TIME TO CHANGE THE CRITERIA Faisal Hanif, Tanvir Abbass, Enric Murio, and Marc J. Clancy; Glasgow, United Kingdom

16:04

16:08

16:12

16:16

16:20

16:24

16:28

122

16:32

Monday 5 September
16:36 RO-211 EFFECT OF STATINS ON RECURRENCE OF IgA NEPHROPATHY AND GRAFT LOSS Hilde K. Smerud, Nils Meland, Rune Bjrneklett, Anders Hartmann, Torbjrn Leivestad, Tomas Lorant, and Bengt Fellstrm; Uppsala, Sweden; Oslo, Norway; and Bergen, Norway

16:00 17:00

RAPID ORAL SESSION 19 Liver V

HYBRID POSTER AREA Digital Display 3

Chairs: William Bennet, Gothenburgh, Sweden; Martin Oliverius, Prague, Czech Republic 16:00 RO-212 PREOPERATIVE CARDIAC EVALUATION IN LIVER TRANSPLANT (OLT) CANDIDATES: LESS IS ENOUGH! Andrea de Gasperi, Ernestina Mazza, Andrea Corti, Francesca Tardini, and Federica Garrone;Milan, Italy RO-213 LIVER TRANSPLANTATION IN PATIENTS WITH PREVIOUS NON-HODGKIN LYMPHOMA: REPORT OF A SINGLE CENTRE EXPERIENCE Francesco Lupo, Alessandro Ricchiuti, Giorgia Catalano, Ornella Perotto, Giorgia Rizza, Ilaria Giono, Stefano Mirabella, Renato Romagnoli, Corrado Tarella, and Mauro Salizzoni; Turin, Italy RO-214 LIVER TRANSPLANTATION AFTER RADIOEMBOLIZATION FOR HEPATIC METASTASES OF A PANCREATIC NEUROENDOCRINE TUMOR Sonia Radunz, Hideo A. Baba, Jrgen W. Treckmann, Andreas Paul, and Georgios C. Sotiropoulos; Essen, Germany RO-215 REGENERATION OF CAUDATE LOBE IN EXTENDED LEFT LOBE GRAFT INCLUDING CAUDATE LOBE AFTER LIVING DONOR LIVER TRANSPLANTATION Mitsuo Shimada, Satoru Imura, Hiroki Mori, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saitoh, Michihito Asanoma, Shinichiro Yamada, and Tohru Utsunomiya; Tokushima, Japan RO-216 RESULTS OF LONG-TERM FOLLOW-UP INCLUDING PROTOCOL BIOPSY OF THE FIRST 500 LIVER TRANSPLANT RECIPIENTS IN IKEM PRAGUE Pavel Trunecka, Eva Honsov, Milo Adamec, Eva Kieslichov, Julius pick, Jan Peregrin, Vera Lnsk, and Jan Mal; Prague, Czech Republic RO-217 IMPACT OF VASCULAR COMPLICATIONS IN LIVER TRANSPLANTATION: A COHORT STUDY Fabrizio Moisan, Mnica Martnez, Blanca Norero, Marco Arreses, Alejandro Soza, Rosa Mara Prez, Carlos Bentez, Pilar Domnguez, Juan Francisco Guerra, Nicols Jarufe, and Jorge Martnez; Santiago, Chile RO-218 LOW INCIDENCE OF HEPATIC ARTERY THROMBOSIS IN ORTHOTOPIC LIVER TRANSPLANTATION: TECHNICAL TRICKS IN A 16-YEARS EXPERIENCE OF A SINGLE TRANSPLANT CENTRE Vincenzo Scuderi, Antonio Ceriello, Walter Santaniello, Maurizio Defez, Giuseppe Aragiusto, Marina Romano, and Fulvio Calise; Naples, Italy

16:04

16:08

16:12

16:16

16:20

16:24

123

Monday 5 September
16:28 RO-219 LIVER TRANSPLANTATION IN PATIENTS OVER 60 YEARS OLD: 6 YEAR FOLLOW-UP EXPERIENCE Iago Justo, Naim Fakih, Oscar Caso, Sergio Olivares, Jorge Calvo, Manuel Abradelo, Alejandro Manrique, Alvaro Garca-Sesma, Felix Cambra, Enrique Moreno, and Carlos Jimenez; Madrid, Spain RO-220 THE PROGNOSTIC VALUE OF THE MELD SCORE Iago Justo, Oscar Caso, Naim Fakih, Felix Cambra, Sergio Olivares, Alejandro Manrique, Jorge Calvo, Alvaro Garca, Manuel Abradelo, Enrique Moreno and Carlos Jimenez. Surgery C, U. H. 12 de Octubre, Madrid RO-221 FEASIBILITY EVALUATION OF SUBCUTANEOUS ADMINISTRATION OF IMMUNOGLOBULIN FOR POST LIVER TRANSPLANT HBV RECURRENCE PROPHYLAXIS Vincenzo Scuderi, Antonio Ceriello, Giangiacomo Monti, Marina Romano, Carla Migliaccio, and Fulvio Calise; Naples, Italy

16:32

16:36

16:00 17:00

RAPID ORAL SESSION 20 Paediatric transplantation

HYBRID POSTER AREA Digital Display 4

Chairs: Jean de Ville de Goyet, Rome, Italy; Piotr Kalicinski, Warsaw, Poland 16:00 RO-222 THE IMPACT OF LIVER TRANSPLANTATION DURING CHILDHOOD ON THE COURSE OF LIFE AND TRANSITION INTO ADULTHOOD Y.K. Sze, W. de Vries, J.B.F. Hulscher, E. Sieders, R. Scheenstra, P.G.J.M. Peeters, R.J. Porte, and Jehm Hoekstra-Weebers; Groningen, The Netherlands RO-223 METABOLIC AND CARDIOVASCULAR RISKS AFTER PEDIATRIC LIVER TRANSPLANTATION Carlos E. Gonzalez Cambaceres, Yanina Camicer, Maria B. Araujo, Oscar Imventarza, and Maria Mazza; Buenos Aires, Argentina RO-224 CHRONIC ALLOGRAFT NEPHROPATHY AND PERITUBULAR CAPILLARY C4d DEPOSITION IN PROTOCOL RENAL ALLOGRAFT BIOPSIES Giulia Ghirardo, Manuela Della Vella, Elisa Benetti, Enrico Vidal, Sonia Centi, and Luisa Murer; Padua, Italy RO-225 INVOLVEMENT OF NUCLEAR RECEPTOR SXR SNPs IN CYCLOSPORINE PHARMACOKINETICS VARIABILITY DURING THE FIRST YEAR POST KIDNEY TRANSPLANTATION Mirco Belingheri, Mariano Ferraresso, Elena Groppali, Stefano Turolo, Silvia Amedea Tirelli, Paolo Grillo, Alberto Edefonti, and Luciana Ghio; Milan, Italy RO-226 CLINICAL AND HISTOLOGIC EFFICACY OF INTERLEUKIN 2 RECEPTOR ANTAGONISTS IN PAEDIATRIC KIDNEY TRANSPLANTATION Giulia Ghirardo, Manuela Della Vella, Elisa Benetti, Enrico Vidal, and Luisa Murer; Padua, Italy RO-227 INTERVENTIONS FOR PRE-EXISTING BLADDER DYSFUNCTION IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS; WHEN IS BEST? Naji Al-Khudairi, Paul Riley, Divyesh Y. Desai, Christopher Reid, and Nizam Mamode; London, United Kingdom

16:04

16:08

16:12

16:16

124

16:20

Monday 5 September
16:24 RO-228 RISK OF SEVERE BACTERIAL INFECTIONS AFTER ANTICD20 TREATMENT IN PAEDIATRIC PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME AND KIDNEY TRANSPLANT RECIPIENTS Davide Meneghesso, Petra Reinstadler, Giulia Ghirardo, Elisa Benetti, Enrico Vidal, Dino Sgarabotto, and Luisa Murer; Padua, Italy RO-229 LUNG TRANSPLANTATION IN CHILDREN: A SINGLE CENTER EXPERIENCE Vittorio Corno, MariaClara Dezza, Alessandro Lucianetti, Domenico Pinelli, Paola Stroppa, Michela Bravi, Marco Zambelli, Alesandro Aluffi, Michela Guizzetti, Daniela Codazzi, and Michele Colledan; Bergamo, Italy RO-230 PHARMACOKINETICS FOR ONCE DAILY TACROLIMUS FORMULATION IN CHILDREN WITH DE NOVO KIDNEY TRANSLANTATION Ching-Yuang Lin; Taichung, Taiwan RO-231 RENAL FUNCTION IN CHILDREN AND TEENS WITH LIVER TRANSPLANT. ONE SINGLE CENTER REPORT Carlos E. Gonzalez Cambaceres, Alexia Diaz Moreno, Susana Lopez, Maria C. Fernandez, Oscar Imventarza, and Jorge Sasbon; Buenos Aires, Argentina

16:28

16:32

16:36

16:00 17:00

RAPID ORAL SESSION 21 Lung

HYBRID POSTER AREA Digital Display 5

Chairs: Michiel Erasmus, Groningen, The Netherlands; Pierre-Emmanuel Falcoz, Strasbourg, France 16:00 RO-232 IMPACT OF SUPER URGENCES ON THE ACCESS OF THE O LUNG RECIPIENTS IN FRANCE Christelle Cantrelle, Emilie Savoye, Richard Dorent, Marie Thuong, Alain Atinault, and Jean Franois Mornex; Saint Denis La Plaine, France and Bron cedex, France RO-233 EMOTIONAL EXPERIENCE IN PATIENTS AWAITING LUNG TRANSPLANTATION: A QUALITATIVE ANALYSIS Aurelia Bruegger, John David Aubert, and Chantal Piot-Ziegler; Lausanne, Switzerland RO-234 LUNGS FROM SMOKING DONORS CAN BE SAFELY USED FOR TRANSPLANTATION Noman Khasati, Emma Jackson, Joanne Hassan, and Nizar Yonan; Manchester, United Kingdom RO-235 SINGLE LUNG TRANSPLANTATION AS THE FIRST CHOICE IN EMPHYSEMA Jos M. M. Borro, Maria Delgado, Marina Paradela, Mercedes de la Torre, Teresa Rey, and Pablo Rama; La Corua, Spain RO-236 COMBINED SEQUENTIAL BILATERAL SINGLE LUNG-LIVER TRANSPLANTATION WITH EVEROLIMUS AND LOW DOSE STEROIDS: A LONG TERM FOLLOW-UP Vittorio Corno, Piercarlo Parigi, Alessandro Lucianetti, Domenico Pinelli, Stefano Fagiuoli, Daniela Codazzi, and Michele Colledan; Bergamo, Italy

16:04

16:08

16:12

16:16

125

Monday 5 September
16:20 RO-237 INTERVENTIONAL TREATMENT OF BRONCHIAL ANASTOMOTIC STENOSIS AFTER LUNG TRANSPLANTATION Hauke Winter, Jan Fertmann, Fritz Spelsberg, Gerhard Preissler, Martin Eichhorn, Michael Dolch, Claus Neurohr, Lorenz Frey, Peter berfuhr, Bruno Meiser, and Rudolf Hatz; Munich, Germany RO-238 THE CROSSED WIRING TECHNIQUE, ESPECIALLY THE PARASTERNAL TECHNIQUE, IS ASSOCIATED WITH LESS STERNAL DEHISCENCE AFTER BILATERAL LUNG TRANSPLANTATION T.D. Koster, F.Z. Ramjankhan, E.A. van de Graaf, H.D. Luijk, JC Grutters, R.C.A. Meijer, D.A. van Kessel, and J.M. Kwakkel-van Erp; Utrecht, The Netherlands; and Nieuwegein, The Netherlands RO-239 LUNG CANCER COMPLICATING LUNG TRANSPLANTATION: INCIDENCE AND OUTCOME THE VIENNA EXPERIENCE Mir Alireza Hoda, Victoria Augustin, Peter Jaksch, Bahil Ghanim, Mai-Britt Ernst, Clemens Aigner, Gyoergi Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria RO-240 INCIDENCE OF SOLID DE-NOVO MALIGNOMA AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) AFTER LUNG TRANSPLANTATION EXPERIENCE IN VIENNA Victoria Augustin, Mir Alireza Hoda, Peter Jaksch, Bahil Ghanim, Mai-Britt Ernst, Clemens Aigner, Gyoergi Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria RO-241 CYSTIC FIBROSIS, LUNG TRANSPLANTATION AND CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE Helmy N. Haja Mydin, Andrew Macnair, Paul A. Corris, Andrew J. Fisher, Frances K. Gould, Gerard Meachery, and James L. Lordan; Newcastle upon Tyne, United Kingdom

16:24

16:28

16:32

16:36

16:00 17:00

RAPID ORAL SESSION 22 Tissue injury/preservation II

HYBRID POSTER AREA Digital Display 6

Chairs: Uwe Hoff, Berlin, Germany; Chris Watson, Cambridge, United Kingdom 16:00 RO-242 THE ANTIOXIDANT DOGMA IN HUMAN ISCHEMIAREPERFUSION INJURY: NO EVIDENCE FOR FREE RADICAL MEDIATED DAMAGE Dorottya K. de Vries, Kirsten A. Kortekaas, Dimitrios Tsikas, Robert J. Klautz, Alexander F. Schaapherder, and Johannes H. Lindeman; Leiden, The Netherlands; and Hannover, Germany RO-243 CHANGES IN BIOMECHANICAL FUNCTIONALITY AND STRENGTH FOLLOWING CRYOPRESERVATION OF HUMAN ILIAC VESSELS Stephen Kin Yong Chang, Wah Wah Hlaing, Rui Qi Yu, Chee Kong Chui, Liangjing Yang, Lilia Kuleshova, and Chuen Neng Lee; Singapore RO-244 WARM HTK DONOR PRE-TREATMENT REDUCES ISCHEMIA REPERFUSION INJURY AND MATRIX METALLOPROTEINASE TISSUE ACTIVITY IN AN ORTHOTOPIC RAT LIVER TRANSPLANT MODEL Wenzel N. Schoning, Veeravorn Ariyakhagorn, Anja Schirrmeier, Gero Puhl, and Peter Neuhaus; Berlin, Germany

16:04

16:08

126

Monday 5 September
16:12 RO-245 PREVENTION OF ISCHEMIA REPERFUSION INJURY FOLLOWING KIDNEY TRANSPLANTATION: A PILOT STUDY USING A PIG AUTOTRANSPLANTATION MODEL Manuel Maglione, Benno Cardini, Matthias Biebl, Markus Kofler, Katrin Watschinger, Rupert Oberhuber, Katrin Kienzl, Peter Obrist, Gerald Brandacher, Ernst R. Werner, Raimund Margreiter, and Johann Pratschke; Innsbruck, Austria; and Zams, Austria RO-246 COMPARISON OF REPERFUSION BIOPSIES FROM LIVERS PRESERVED WITH THE HISTIDINE-TRYPTOPHANE-KETOGLUTARATE VERSUS THE UNIVERSITY OF WISCONSIN SOLUTION IN LIVER TRANSPLANTATION Fabrizio Moisan, Mnica Martnez, Mauricio Gabrielli, Marcela Vidal, Pilar Domnguez, Marcos Arrese, Carlos Bentez, Rosa Mara Prez, Juan Franciso Guerra, Nicols Jarufe, and Jorge Martnez; Santiago, Chile RO-247 PROTECTION FROM I/R DAMAGE WITH ANTI-T LYMPHOCYTES ANTIBODIES (THYMOGLOBULIN) DURING LIVER TRANSPLANT (LT) Erika Codarin, Umberto Baccarani, Anna Rossetto, Claudio Avellini, Gian Luigi Adani, Dario Lorenzin, Vittorio Bresadola, Dino De Anna, Franco Quadrifoglio, and Gianluca Tell; Udine, Italy RO-248 PROLONGED RAT KIDNEY PRESERVATION WITH ETKYOTO SOLUTION: COMPARISON WITH HISTIDINE-TRYPTOPHAN-KETOGLUTARATE AND UNIVERSITY OF WISCONSIN SOLUTIONS Xiangdong Zhao, Takuji Fujinaga, Ying Li, Tatsuaki Tsuruyama, Toru Bando, Hiromi Wada, and Hiroshi Date; Kyoto, Japan RO-249 ORGAN VIABILITY ASSESSMENT IN THE PRESERVATION PERIOD UTILISING RAPID SAMPLING MICRODIALYSIS Samir Damji, Karim Hamaoui, Yao-min Chang, Martyn Boutelle, Samer Deeba, George Hanna, David Taube, Ara Darzi, and Vasillios Papalois; London, United Kingdom RO-250 THE OUTCOME OF USING MACROSTEATOTIC GRAFTS IN HUMAN LIVER TRANSPLANTATION AND MECHANISMS OF ISCHEMIA/REPERFUSION INJURY Huda M. Noujaim, Cristiane M.R. Freitas, Edna F.S. Montero, Vera L. Capellozzi, Regina G. Santos, Juan R. Branhez, Leonardo T. Motta, Marcelo P. de Miranda, and Tercio Genzini; So Paulo, Brazil RO-251 MECHANISMS OF COLD ISCHEMIA/WARM REPERFUSION INJURY AFTER HUMAN LIVER TRANSPLANTATION Huda M. Noujaim, Cristiane M.R. Freitas, Regina G. Santos, Juan R. Branhez, Leonardo T. Motta, Marcelo P. de Miranda, and Tercio Genzini; So Paulo, Brazil

16:16

16:20

16:24

16:28

16:32

16:36

16:00 17:00

RAPID ORAL SESSION 23 Clinical immunosuppression II

HYBRID POSTER AREA Digital Display 7

Chairs: Valentin Sojar, Ljubljana, Slovenia; Gunnar Tufveson, Uppsala, Sweden 16:00 RO-252 IMP-DEHYDROGENASE IN ERYTHROCYTES A MAKER OF LONG TERM MPA EXPOSURE? Petra Glander, Pia Hambach, Lutz Liefeldt, Hans H. Neumayer, and Klemens Budde; Berlin, Germany

127

Monday 5 September
16:04 RO-253 INDUCTION THERAPY WITH BASILIXIMAB AND DELAYED INTRODUCTION OF TACROLIMUS IS ASSOCIATED WITH A REDUCED REQUIREMENT FOR POST-OPERATIVE RENAL REPLACEMENT THERAPY IN HIGH-RISK PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION (OLT) A. Adair, R. Hamid, A. Bathgate, and J.J. Powell; Edinburgh, United Kingdom RO-254 ONCE DAILY PROLONGED RELEASED (ADVAGRAF) VERSUS TWICE DAILY TACROLIMUS (PROGRAF) AS PRIMARY IMMUNOSUPPRESSION IN LIVER TRANSPLANTATION Umberto Baccarani, Laura DAmbrosi, Anna Rossetto, Chiara Comuzzi, Dario Lorenzin, Davide Bitetto, Maria Laura Pertoldeo, Gian Luigi Adani, Vittorio Bresadola, and Dino De Anna; Udine, Italy RO-255 THE ROLE OF m-TOR INHIBITORS IN NEUROLOGICAL COMPLICATIONS (NC) DEVELOPMENT AFTER LIVER TRANSPLANTATION (LT) Gianluca Rompianesi, Roberto Montalti, Gian Piero Guerrini, Fabrizio Di Benedetto, Nicola De Ruvo, Nicola Cautero, Valentina Serra, Nazareno Smerieri, Roberto Ballarin, Rosa Maria Iemmolo, Lesley De Pietri, and Giorgio E. Gerunda; Modena, Italy RO-256 SUPERIOR MEDICATION ADHERENCE TO TACROLIMUS MODIFIED RELEASE ONCE-DAILY(QD) COMPARED TO TACROLIMUS TWICE-DAILY(BID) IN STABLE RENAL TRANSPLANT PATIENTS Dirk R.J. Kuypers, Catherine A. Bonvoisin, Patrick Peeters, Jacques J. Sennesael, Mireille N. Kianda, Bernard Vrijens, Paulus Kristanto, Fabienne Dobbels, Yves Vanrenterghem, and Nada Kanaan; Leuven, Belgium; Liege, Belgium; Ghent, Belgium; Brussels, Belgium; and Vis, Belgium RO-257 STEROID WITHDRAWAL IN RENAL TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CYCLOSPORINE BASED IMMUNOSUPPRESSIVE REGIMEN TO TACROLIMUS MONOTHERAPY; A PROSPECTIVE MULTICENTER TRIAL Lars Bckman; Uppsala, Sweden RO-258 MINIMAL DOSE OF CALCINEURIN INHIBITOR COMBINED WITH EVEROLIMUS IS AN EFFECTIVE IMMUNOSUPPRESSIVE REGIMEN FOR KIDNEY TRANSPLANTATION RECIPIENT and Ping Chin Lai; Taoyuan, Taiwan RO-259 PROGRESSION OF RENAL DISEASE IN RENAL TRANSPLANT RECIPIENTS Roberto Marcen, Jose M. Morales, Domingo Del Castillo, Miguel Gonzalez Molina, Francisco Valdes, Daniel Seron, Luis Pallardo, Federico Oppenheimer, Ildefonso Lampreabe, Salvador Gilvernet, F. Javier Gainza, Fernando Escuin, Luis Capdevila, Jose M. Campistol, Mercedes Cabello, Jesus Bustamante, Manuel Arias, Amado Andres, and Fernando Anaya; Madrid, Spain RO-260 HIGHER SELF-REPORTED NON-ADHERENCE WITH COMEDICATION COMPARED TO IMMUNOSUPPRESSIVE DRUGS IN HEART, LIVER AND LUNG TRANSPLANT PATIENTS Leentje De Bleser, Fabienne Dobbels, Lut Berben, Johan Vanhaecke, Geert Verleden, Frederik Nevens, and Sabina De Geest; Leuven, Belgium; and Basel, Switzerland

16:08

16:12

16:16

16:20

16:24

16:28

16:32

128

Monday 5 September
16:36 RO-261 RENAL TRANSPLANTATION IN DONOR SPECIFIC ANTIBODY POSITIVE RECIPIENTS: SINGLE CENTER EXPERIENCE Kenan Keven, Sule Sengul, Huseyin Tutkak, Funda Yalin, Trker Duman, and Acar Tuzuner; Ankara, Turkey

16:00 17:00

RAPID ORAL SESSION 24 Liver VI

HYBRID POSTER AREA Digital Display 8

Chairs: Gabriela Berlakovich, Vienna, Austria; Michele Colledan, Bergamo, Italy 16:00 RO-261/A ABO-INCOMPATIBLE ADULT LIVING DONOR LIVER TRANSPLANTATION WITH NEW PROTOCOL: NO SPLENECTOMY, NO LOCAL INFUSION THERAPY AND USUAL IMMUNOSUPPRESSION UNDER RITUXIMAB PROPHYLAXIS Gi-Won Song, Sung-Gyu Lee, Chun-Su Park, Hyo-Jun Lee, JungMan Namgung, Won-Young Chae, Hee-Sung Park; Seoul, Korea RO-261/B DELTA STUDY: DUTCH EVALUATION IN LIVER TRANSPLANTATION TO ASSESS THE EFFICACY OF CYCLOSPORIN A MICROEMULSION WITH C2 MONITORING VERSUS TACROLIMUS WITH TROUGH MONITORING IN DE NOVO TRANSPLANT RECIPIENTS Akin Inderson, Aad van den Berg, Herold Metselaar, Jan Ringers, Robert J. Porte, Geert Kazemier, Bart van Hoek; Leiden, The Netherlands; Groningen, The Netherlands; Rotterdam, The Netherlands; Leiden, The Netherlands; Groningen, The Netherlands; Rotterdam, The Netherlands RO-261/C POSTINTERVENTIONAL TUMOR NECROSIS PREDICTS RECURRENCE-FREE LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH HCC Arno Kornberg, Ulrike Witt, Alexander Novotny, Olaf Habrecht, Babett Krause, Peter Bchler, Helmut Friess; Munich, Germany; Jena, Germany RO-261/D THE CHANGING MANAGEMENT AND OUTCOMES OF PATIENTS WITH ACUTE HEPATIC FAILURE BEING ASSESSED FOR LIVER TRANSPLANTATION OVER TWO DECADES Karlijn Koers, Pamela Dilworth, Simone Strasser, Nicholas Shackel, Michael Crawford, Geoffrey McCaughan, Deborah Verran; Camperdown, Australia; Maastricht, The Netherlands RO-261/E RESULTS OF LIVER TRANSPLANTATION IN A LARGE COHORT OF MORE THAN 100 HIV INFECTED PATIENTS A MONOCENTRIC EXPERIENCE Jean-Charles Duclos-Vallee, Maria Grazia Tateo, Elina Teicher, AnneMarie Roque-Afonso, Mylene Sebagh, Teresa Maria Antonini, Audrey Coilly, Rodolphe Sobesky, Eric Vibert, Chady Salloum, Rene Adam, Daniel Azoulay, Denis Castaing, Daniel Vittecoq, Didier Samuel; Villejuif, France RO-261/F A NOVEL MICROSURGICAL MODEL OF HETEROTOPIC SMALL BOWEL TRANSPLANTATION IN MICE Qi Mao, Cheng-Hung Lin, Zuhaib Ibrahim, Eric Wimmers, Lehao Wu, Stefan Schneeberger, W.P. Andrew Lee, Gerald Brandacher; Baltimore, USA; Taipei, Taiwan

16:04

16:08

16:12

16:16

16:20

129

Monday 5 September
16:24 RO-261/G REDUCTION OF HEPATIC ARTERIAL PERFUSION BY INHIBITION OF NITRIC OXIDE PRODUCTION IMPAIRS THE RECOVERY FROM FOCAL HEPATIC VENOUS OUTFLOW OBSTRUCTION IN LIVER RESECTED RATS Hai Huang, Meihong Deng, Hao Jin, Anding Liu, Uta Dahmen, Olaf Dirsch; Essen, Germany; Berlin, Germany RO-261/H TREATMENT OF SMALL HEPATOCELLULAR CARCINOMAS (HCC), LIVER (LT) TRANSPLANTATION, LIVER RESECTION (LR) AND RADIOFREQUENCY ABLATION (RFA) Laura Tariciotti, Andrea Monaco, John Isaac, David Mayer, Paolo Muiesan, Simon Bramhall, Thamara Perera, Robert Sutcliffe, Darius Mirza; Birmingham, United Kingdom RO-261/I THE ASSESSMENT OF GFR AFTER ORTHOTOPIC LIVER TRANSPLANTATION USING CYSTATIN C AND CREATININE-BASED EQUATIONS Doris Wagner, Daniela Kniepeiss, Philipp Stiegler, Sabine Zitta, Andrea Bradatsch, Andreas Meinitzer, Florian Iberer, Alexander R. Rosenkranz; Graz, Austria

16:28

16:30

130

132

Tuesday 6 September
08:00 09:00

CLINICAL CASES SESSION 3 Liver Surgical

Mini Theatre 1

Chairs: Patrizia Burra, Padua, Italy; Derek Manas, Newscastle upon Tyne, United Kingdom 08:00 CC-007 UNFLUSHED DONOR BILE DUCTS... TO TRANSPLANT OR TO DISCARD? Nicolas Meurisse, Johan Fierens, Raymond Aerts, Jacques Pirenne, and Diethard Monbaliu; Leuven, Belgium Case discussion CC-008 LATE GRAFT DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION: DIAGNOSTIC DILEMMA Narendra Battula, Arjun Takhar, Dhiraj Tripathi, Hynek Mergental, Paolo Muiesan, John Isaac, Darius Mirza, David Mayer, Simon Bramhall, and Thamara Perera; Birmingham, United Kingdom Case discussion CC-009 PERSISTANTLY ABNORMAL LIVER FUNCTION IN A YOUNG PATIENT AFTER LIVER TRANSPLANTATION: A COMPLEX CASE Arjun S. Takhar, Narendra Battula, Desley Neil, Hynek Mergental, Darius Mirza, M.T. Perera, and Simon R. Bramhall; Birmingham, West Midlands, United Kingdom Case discussion

08:10 08:20

08:30 08:40

08:50 08:00 09:00

CLINICAL CASES SESSION 4 Kidney Medical

Chairs: Robert Langer, Budapest, Hungary; Chris Watson, Cambridge, United Kingdom

Mini Theatre 2

08:00

CC-010 SICKLE CELL TRAIT IN LIVING KIDNEY DONORS Raj Thuraisingham, Magdi Yaqoob, and Carmelo Puliatti; London, United Kingdom Case discussion CC-011 CRESCENTS IN TRANSPLANT BIOPSY: WHAT COULD BE THE CAUSE? CLINICAL CASE Marek Myslak, and Elzbieta Urasinska; Szczecin, Poland Case discussion CC-012 CALCIFIC UREMIC ARTERIOLOPATHY Xoana Barros, Vicen Torregrosa, Maria Jose Ricart, Miquel Blasco, and Federico Oppenheimer; Barcelona, Spain Case discussion

08:10 08:20

08:30 08:40

08:50 08:00 09:00

ORAL SESSION 19 Islet/cell Transplantation

Clyde Auditorium

133

Chairs: Bernhard Hering, Minneapolis, United States; Lorenzo Piemonti, Milan, Italy

Tuesday 6 September
08:00 O-169 BOTH ALLOANTIBODIES AND AUTOANTIBODIES ARE A SIGNIFICANT BARRIER TO PRESERVATION OF ISLET CELL FUNCTION AFTER TRANSPLANTATION Lorenzo Piemonti, Matthew J. Everly, Paola Maffi, Rita Nano, Raffaella Melzi, Alessia Mercalli, Francesca Poli, Massimo Cardillo, Mario Scalamogna, Antonio I. Secchi, and Paul Terasaki; Milan, Italy; Los Angeles, USA; and Milan, Italy O-170 CELLULAR IMMUNE REACTIVITY AGAINST DONORANTIGEN CORRELATES WITH THE OUTCOME AFTER CLINICAL ISLET TRANSPLANTATION: TOWARD A BETTER POST-TRANSPLANT MONITORING Stphanie Lacotte, Sylvie Ferrari, Sophie Borot, Jean Villard, Sandrine Demuylder-Mischler, Philippe Morel, Gilles Mentha, Thierry Berney, and Christian Toso; Geneva, Switzerland O-171 IMPACT OF THE NUMBER OF INFUSIONS ON TWO-YEAR METABOLIC RESULTS OF ISLET-AFTER-KIDNEY TRANSPLANTATION IN THE GRAGIL NETWORK Sophie Borot, Nadja Niclauss, Anne Wojtusciszyn, Coralie Brault, Yannick Muller, Laurianne Giovannoni, Graldine Parnaud, Raphael Meier, Laurence Kessler, Charles Thivolet, Alfred Penfornis, Emmanuel Morelon, Lionel Badet, Franois Bayle, Luc Frimat, Christian Toso, Philippe Morel, Domenico Bosco, Cyrille Colin, Pierre Yves Benhamou, and Thierry Berney; Geneva, Switzerland; Lyon, France; Montpeller, France; Strasbourg, France; Grenoble, France; Besanon, France; and Nancy, France O-172 CONTINUING IMPROVEMENT OF ISLET TRANSPLANTATION EFFICACY OUTCOMES FROM THE COLLABORATIVE ISLET TRANSPLANT REGISTRY 1999-2010 Thierry Berney, Franca B. Barton, Michael Rickels, Alejandro Rodolfo, and Pattou Francois; Geneva, Switzerland; Rockville, MD, USA; Philadelphia, PA, USA; Miami, FL, USA; and Lille, France O-173 MORPHOLOGIC ANALYSIS OF HUMAN ISLETS TRANSPLANTED INTO THE LIVER AFTER 14 YEARS INSULIN INDEPENDENCE Yannick D. Muller, Domenico Bosco, Philippe Morel, Johannes A. Lobrinus, Graldine Parnaud, Laurianne Giovannoni, Raphael Meier, Sophie Borot, Nadja Niclauss, Christian Toso, and Thierry Berney; Geneva, Switzerland O-174 AUTOLOGOUS PANCREATIC ISLET TRANSPLANTATION (IAT) AS ENDOCRINE TISSUE RESCUE IN PATIENTS UNDERGOING COMPLETION PANCREATECTOMY BECAUSE OF SURGICAL COMPLICATION AFTER WHIPPLE RESECTION Giampaolo Balzano, Rita Nano, Paola Maffi, Raffaella Melzi, Alessia Mercalli, Cristina Ridolfi, Federica Merlini, Paola Magistretti, Antonio Secchi, Valerio Di Carlo, and Lorenzo Piemonti; Milan, Italy

08:10

08:20

08:30

08:40

08:50

08:00 09:00

134

ORAL SESSION 20 Hall 1 Improving preservation in transplant organs

Chairs: Jacques Pirenne, Leuven, Belgium; Jean-Paul Squifflet, Liege, Belgium

Tuesday 6 September
08:00 O-175 CYSTATHIONINE -LYASE IS AN ENDOGENOUS MODULATOR OF OXIDATIVE STRESS Eelke M. Bos, Guangdong Yang, Henri G.D. Leuvenink, Harry van Goor, and Rui Wang; Groningen, The Netherlands; and Thunder Bay, Canada O-176 HEMO2LIFE, A DEDICATED OXYGEN CARRIER, OPTIMIZES STATIC KIDNEY PRESERVATION Raphael Thuillier, Delphine Dutheil, Vanessa Mallet, Trieu Minh Tri Ngo, Geraldine Allain, Morgane Rousselot, Magali Denizot, Jean Michel Goujon, Frank Zal, and Thierry Hauet; Poitiers, France; Morlaix, Finland; and Surgeres, France O-177 IMPROVED SHORT AND LONG TERM FUNCTION OF DCD KIDNEYS WITH OXYGENATED MACHINE PERFUSION Raphael Thuillier, Geraldine Allain, Benoit Barrou, Henri Leuvenink, and Thierry Hauet; Poitiers, France; Surgeres, France; Paris, France; and Groningen, The Netherlands O-178 REVERSE SIGNALING THROUGH CD137 LIGAND IN TUBULAR EPITHELIAL CELLS IS CRITICAL FOR RENAL ISCHEMIAREPERFUSION INJURY Hong R. Cho, Hye J. Kim, Jong S. Lee, Hee J. Cha, Robert S. Mittler, Hyun C. Chung, and Byungsuk Kwon; Ulsan, Korea; and Atlanta, USA O-179 A THERAPY TO MAKE BORDERLINE GRAFTS SUITABLE: CURCUMIN SUPPLEMENTATION OPTIMISES FUNCTION RECOVERY AND OUTCOME Raphael Thuillier, Trieu Min Trih Ngo, Sebastien Giraud, Hubert Lathelize, Etienne Marchand, Jaakko Parkkinen, and Thierry Hauet; Poitiers, France; Surgeres, France; and Helsinki, Finland O-180 EXPERIMENTAL ACUTE KIDNEY INJURY CAN BE MODIFIED BY SEX-SPECIFIC PHARMACOLOGIC TARGETING OF CYPDEPENDENT EICOSANOIDS Uwe Hoff, Lyubov Chaykovska, Ivo Lukitsch, Mechthild Ladwig, Wolfgang Schneider, Camille Falck, Erdmann Seeliger, Bert Flemming, Dominik N. Mueller, Friedrich C. Luft, Wolf-Hagen Schunck, and Duska Dragun; Berlin, Germany; and Dallas, TX, Germany

08:10

08:20

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 21 Pancreas

Chairs: Helmut Arbogast, Munich, Germany; Thierry Berney, Geneva, Switzerland

Boisdale 1 & 2

08:00

O-181 APLICATION OF THE CLAVIEN-DINDO CLASSIFICATION OF SURGICAL COMPLICATIONS AFTER PANCREAS TRANSPLANTATION: SINGLE CENTER EXPERIENCE Raquel Garcia-Roca, Gabriele Spoletini, Julia Samame, Gabriel Diaz del Gobbo, and M. Jose Ricart; Barcelona, Spain O-182 TREATMENT OPTIONS FOR PANCREAS ALLOGRAFT THROMBOSIS: 10 YEAR EXPERIENCE Raquel Garcia-Roca, Gabriel Diaz del Gobbo, Julia Samame, Gabriele Spoletini, Emiliano Astudillo, Marta Barrufet, M. Isabel Real, M. Angeles Garcia Criado, Rosa Gilabert, and M. Jose Ricart; Barcelona, Spain

08:10

135

Tuesday 6 September
08:20 O-183 PRE-TRANSPLANT THROMBOELASTOGRAPHY AND THROMBOPHILIA SCREENING DO NOT PREDICT THROMBOSIS FOLLOWING PANCREAS TRANSPLANTATION Petra M. Goldsmith, Stephanie Smith, Andrew J. Butler, and Christopher J.E. Watson; Cambridge, United Kingdom O-184 PANCREAS TRANSPLANTATION IN RECIPIENTS AGED 50 YEARS Anand Sivaprakash Rathnasamy Muthusamy, Anil Vaidya, Sanjay Sinha, Isabel Quiroga, Srikanth Reddy, James Gilbert, and Peter J. Friend; Oxford, United Kingdom O-185 ANALYSIS OF RENAL FUNCTION AFTER SOLITARY PANCREAS TRANSPLANTATION: IS CNIs THE ONLY CULPRIT? Nikolaos A. Chatzizacharias, Anil Vaidya, Sanjay Sinha, Edward Sharples, Richard Smith, Gareth Jones, and Peter J. Friend; Oxford, United Kingdom; Bristol, United Kingdom; and London, United Kingdom O-186 ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION Anand Sivaprakash Rathnasamy Muthusamy, Anil Vaidya, Sanjay Sinha, Isabel Quiroga, Srikanth Reddy, James Gilbert, and Peter J. Friend; Oxford, United Kingdom

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 22 Liver transplantation (Longer term outcome)

Lomond

Chairs: Lucio Caccamo, Milan, Italy; Mark Hudson, Newcastle Upon Tyne, United Kingdom 08:00 O-187 THE JOINT IMPACT OF DONOR AND RECIPIENT CHARACTERISTICS ON THE OUTCOME OF LIVER TRANSPLANTATION IN GERMANY Carl-Ludwig Fischer-Frhlich, Marcus Kutschmann, Irene Schmidtmann, Gnter Kriste, and Nils Frhauf; Frankfurt, Germany; Dsseldorf, Germany; Mainz, Germany; and Hannover, Germany O-188 TRENDS IN LIVER RETRANSPLANTATION IN EUROPE: EVALUATION OF THE LAST 28 YEARS Vanessa M. Banz, Vibha Varma, Vincent Karam, Bridget Gunson, Neville Jamieson, Nigel Heaton, Antonio Pinna, Steve Pollard, Styrbjorn Friman, Robert Porte, Jacques Belghiti, Rene Adam, and Darius Mirza; Birmingham, Switzerland; Bern, Switzerland; Villejuif, Switzerland; Cambridge, United Kingdom; London, United Kingdom; Bologna, Italy; Leeds, United Kingdom; Gothenburg, Sweden; Groningen, The Netherlands; and Paris, France O-189 SECOND AND SUBSEQUENT LIVER RETRANSPLANTS IN EUROPE: ARE WE JUSTIFIED TO CONTINUE? Vanessa M. Banz, Vibha Varma, Vincent Karam, Bridget Gunson, Neville Jamieson, Nigel Heaton, Antonio Pinna, Steve Pollard, Styrbjorn Friman, Robert Porte, Jacques Belghiti, Rene Adam, and Darius Mirza; Birmingham, Switzerland; Bern, Switzerland; Villejuif Cedex,9, Switzerland; Cambridge, United Kingdom; London, United Kingdom; Bologna, Italy; Leeds, United Kingdom; Gothenburg, Sweden; Groningen, Netherlands; and Paris, France

08:10

08:20

136

Tuesday 6 September
08:30 O-190 LONG-TERM SURVIVAL AFTER HEPATIC ARTERY THROMBOSIS Fabrizio Panaro, Benoit Gallix, Jean Pierre Carabalona, Jacques Domergue, and Francis Navarro; Montpellier, France O-191 LONG TERM FOLLOW-UP (1520 YEARS) AFTER LIVER TRANSPLANTATION IN ITALY: AN OBSERVATIONAL MULTICENTER STUDY Umberto Cillo, Alessandro Vitale, Giorgio Rossi, Massimo Rossi, Luciano De Carlis, Giuseppe Tisone, Enrico Regalia, Umberto Baccarani, Oreste Cuomo, Fulvio Calise, Rafael Ramirez Morales, and Giacomo Zanus; Padua, Italy; Milan, Italy; Rome, Italy; Udine, Italy; and Naples, Italy O-192 A RECORD OF DE NOVO NON-SKIN AND MELANOMA MALIGNANCIES POST LIVER TRANSPLANTATION IN AUSTRALIA AND NEW ZEALAND Marie Mulhearn, Pamela Dilworth, Glenda Balderson, Geoffrey McCaughan, and Deborah Verran; Sydney, Australia; and Brisbane, Australia

08:40

08:50

08:00 09:00

ORAL SESSION 23 Kidney (comorbidity)

Chairs: Klemens Budde, Berlin, Germany; Yvon Lebranchu, Tours, France

Forth

08:00

O-193 RECIPIENT AND DONOR BODY MASS INDEX CORRELATE WITH INITIAL KIDNEY GRAFT FUNCTION Annemarie Weienbacher, Matthias Biebl, Maximilian Jara, Claudia Bsmller, Johann Pratschke, and Robert llinger; Innsbruck, Tyrol, Austria O-194 TRANSPLANTATION WITH KIDNEYS REMOVED ELECTIVELY FOR RENAL CELL CARCINOMAS Muhammad A. Khurram, David Rix, David Talbot, and Naeem Soomro; Newcastle upon Tyne, United Kingdom O-195 ANEMIA AS A RISK FACTOR FOR GRAFT LOSS AND MORTALITY IN KIDNEY TRANSPLANT Alberto Rodriguez-Benot, Maria Lopez-Andreu, Miguel A. PerezValdivia, Auxiliadora Mazuecos, Miguel A. Gentil, Mercedes Cabello, Antonio Osuna, and Manuel Alonso; Cordoba, Spain; and , Spain O-196 UNDIAGNOSED GLUCOSE METABOLISM DISORDERS IN GERMAN HEMODIALYSIS PATIENTS Faruk Tokmak, Miriam Banas, Florian Pallmann, Michael Nguyen Quang, Mikail Baran, Tobias Bergler, Stephan Reinhold, Ute Hoffmann, Martin Hausberg, Alexander Lammert, Bernhard Banas, Bernd Krger, and Bernhard K. Krmer; Bochum, Germany; Regensburg, Germany; Karlsruhe, Germany; and Mannheim, Germany O-197 THE EFFECT OF RITONAVIR ON PHARMACOKINETICS OF TACROLIMUS IN PRETRANSPLANT KIDNEY FAILURE PATIENTS WITH HIV Heleen A. Crommelin, Arjan D. van Zuilen, Tania Mudrikova, Marcel P.H. Van de Broek, and Erik M. van Maarseveen; Utrecht, The Netherlands

08:10

08:20

08:30

08:40

137

Tuesday 6 September
08:50 O-198 THE DEVELOPMENT OF BK VIREMIA AFTER RENAL TRANSPLANTATION IS ASSOCIATED WITH A REDUCED CD8 CELL IL-2 RESPONSE Fabrice C. Renner, Hartmut Dietrich, Nuray Bulut, Demet Celik, Natascha D. Gaertner, Stefan Karoui, Julia Mark, Christoph Raatz, Winfried Padberg, and Rolf Weimer; Giessen, Germany

08:00 09:00

ORAL SESSION 24 mTor inhibition

Chairs: Bernard Charpentier, Paris, France; Bjorn Nashan, Hamburg, Germany

Alsh

08:00

O-199 IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: 3 YEAR FOLLOW-UP OF THE ZEUS TRIAL Frank Lehner, Klemens Budde, Wolfgang Arns, Claudia Sommerer, Petra Reinke, Ute Eisenberger, Eva-Maria Vogel, Stefan Scheidl, and Oliver Witzke; Germany; and Nuremberg, Germany O-200 RENAL FUNCTION IN RENAL TRANSPLANT RECIPIENTS AFTER 24 MONTHS OF IMMUNOSUPPRESSION WITH CONCENTRATION-CONTROLLED EVEROLIMUS PLUS REDUCED CYCLOSPORINE EXPOSURE: UPDATE FROM THE A2309 STUDY M. Carmellini, J. Pattison, H. Riad, M. Yaqoob, M. Vergara, S. Witte, and D. Cibrik; Siena, Italy; London, United Kingdom; Manchester, United Kingdom; East Hanover, USA; Basel, Switzerland; and Tuvalu, USA O-201 EFFICACY AND SAFETY OF EARLY CYCLOSPORINE (CsA) CONVERSION TO SIROLIMUS (SRL) WITH MYCOPHENOLATE MOFETIL(MMF): 5-YEAR RESULTS OF THE POST-CONCEPT STUDY Y. Lebranchu, G. Touchard, M. Bchler, E. Thervet, I. Etienne, P.-F. Westeel, B. Hurault de Ligny, B. Moulin, J.-P. Rerolle, S. Girardot Seguin, and O. Toupance; Tours, France; Poitiers, France; Paris, France; Rouen, France; Amiens, France; Caen, France; Strasbourg, France; Limoges, France; Neuilly/Seine, France; and Reims, France O-202 EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION WITH EVEROLIMUS AFTER LIVER TRANSPLANTATION Gian Luca Grazi, Matteo Cescon, Paolo Di Gioia, Matteo Ravaioli, Elisa Ponte, Federico Sacchetti, Gaetano Vetrone, Giorgio Ercolani, Maria Cristina Morelli, and Antonio Daniele Pinna; Rome, Italy; and Bologna, Italy O-203 INCIDENCE OF INTERSTITIAL LUNG DISEASE WITH EVEROLIMUS IN TWO LARGE, RANDOMIZED, MULTICENTER STUDIES IN DE NOVO HEART OR KIDNEY TRANSPLANT RECIPIENTS P. Lopez, N. Shand, M. Tufa, D. Cibrik, and H. Lehmkuhl; Basel, Switzerland; East Hanover, USA; Ann Arbor, USA; and Berlin, Germany

08:10

08:20

08:30

08:40

138

Tuesday 6 September
08:50 O-204 ADVERSE EVENTS ASSOCIATED WITH mTOR INHIBITION: RESULTS FROM THE A2310 STUDY COMPARING EVEROLIMUS AND MMF IN DE NOVO HEART TRANSPLANT RECIPIENTS A. Poncelet, F. Musumeci, U. Fuchs, M. F. Mattei, G. Dong, P. Lopez, and S. Hirt; Brussels, Belgium; Rome, Italy; Bad Oeynhausen, Germany; Nancy, France; East Hanover, USA; Basel, Switzerland; and Regensburg, Germany

09:00 10:30

STATE OF THE ART 4 ELPAT Diverse Populations

Chairs: Gabriel Danovitch, Los Angeles, United States; Willem Weimar, Rotterdam, The Netherlands

Lomond

09:00

Organ donation and transplantation: realities for minority ethnic groups Gurch Randhawa, Luton, United Kingdom Social factors and the availability of living kidney donation in diverse populations Joke Roodnat, Rotterdam, The Netherlands Increasing the deceased organ donation rate among immigrant populations Teresa Pont-Castellana, Barcelona, Spain Q&A

09:20

09:40

10:00 10:30 09:00 10:30

STATE OF THE ART 5 Forth The pancreas/islet donor: new developments

Chairs: Thierry Berney, Geneva, Switzerland; Johann Pratschke, Innsbruck, Austria

09:00 09:20 09:40

DCD donors in whole pancreas transplantation Peter Friend, Oxford, United Kingdom Expanding the donor pool for whole pancreas transplantation Hans Schlitt, Regensburg, Germany Donor strategies to improve the outcome of islet transplantation Bernhard Hering, Minneapolis, United States Solitary whole pancreas versus islets: is it time for a clinical trial? Franois Pattou, Lille, France Q&A

10:00 10:20 10:30 09:00 10:30 LIVE WEB STREAM 09:00

STATE OF THE ART 6 Clyde Auditorium Biomarkers of Tolerance/Rejection

Chairs: Lorna Marson, Edinburgh, United Kingdom; Kathryn Wood, Oxford, United Kingdom Omics, heat-maps and gene expression profiles: What they are and what they mean Minnie Sarwal, United States

139

Tuesday 6 September
09:20 09:40 10:00 10:20 10:30 In vitro assays as biomarkers for rejection and engraftment Maria Hernandez Fuentes, London, United Kingdom Biomarkers: How to model in vivo cellular responses Alberto Sanchez-Fueyo, Barcelona, Spain An overview of biomarkers: What have we learned and does it help? Robert Lechler, London, United Kingdom Q&A

11:00 12:50

ORAL SESSION 25 Experimental immunosuppression

Chairs: Adam Mclean, London, United Kingdom; Bernard Vanhove, Nantes, France

Forth

11:10

O-205 PHOSPHOSPECIFIC FLOW CYTOMETRY TO MONITOR P38 MAP KINASE ACTIVITY IN T LYMPHOCYTES OF RENAL TRANSPLANT PATIENTS Ramin Vafadari, Marcia M. Kho, Marieke Wabbijn, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands O-206 IN VIVO IMMUNOSUPPRESSIVE EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN ON INNATE AND ADAPTIVE IMMUNE CELLS INVOLVED IN ALLOGRAFT REJECTION Angela S.W. Tjon, Thanyalak Tha-In, Martin van Hagen, Luc J.W. van der Laan, Zwier M.A. Groothuismink, Herold J. Metselaar, and Jaap Kwekkeboom; Rotterdam, The Netherlands O-207 PHARMACOLOGICAL APOPTOSIS MODULATION IN ACTIVATED T CELLS PREVENTS ALLOGRAFT REJECTION Pietro E. Cipp, Anna K. Kraus, Annick Guimezanes, Stephan Segerer, Maja T. Lindenmeyer, Rudolf P. Wthrich, and Thomas Fehr; Zrich, Switzerland; and Marseille, France O-208 A NOVEL COMPOUND, DTCM-GLUTARIMIDE MARKEDLY PROLONGS MURINE CARDIAC ALLOGRAFT SURVIVAL IN COMBINATION WITH DONOR SPECIFIC TRANSFUSION Yusuke Tsunetoshi, Kenichiro Yamashita, Susumu Shibasaki, Ryoichi Goto, Kenji Wakayama, Masaaki Zaitsu, Rumi Igarashi, Michitaka Ozaki, Kazuo Umezawa, and Satoru Todo; Sapporo, Japan; and Yokohama, Japan O-209 RAPAMYCIN INHIBITS INNATE AND ADAPTIVE FUNCTIONS OF PLASMACYTOID DENDRITIC CELLS Patrick P.C. Boor, Herold J. Metselaar, Shanta Mancham, Luc J.W. van der Laan, and Jaap Kwekkeboom; Rotterdam, The Netherlands O-210 WITHDRAWN O-211 DANAZOL INDUCED PROLONGED SURVIVAL OF FULLY ALLOGENEIC CARDIAC GRAFTS AND GENERATED REGULATORY CD4+ CELLS Masateru Uchiyama, Xiangyuan Jin, Qi Zhang, Atsushi Amano, and Masanori Niimi; Tokyo, Japan; and Harbin, China

11:20

11:30

11:40

11:50

12:00 12:10

140

Tuesday 6 September
12:20 O-211/A HISTONE DEACETYLASE-6 (HDAC6) PLAYS A CRITICAL ROLE IN DENDRITIC CELL MATURATION AND REVEALS A NEW MECHANISM FOR HDAC-TARGETED IMMUNOSUPPRESSION Hannah Winter, Jonathan Ellis, Hugo De La Pena, Sarah Penny, David Miller, Andrew Ready, Stephen Shuttleworth, Mark Cobbold, Nicholas Inston; Birmingham, United Kingdom; Chilworth, United Kingdom

11:00 12:50

ORAL SESSION 26 Kidney (long-term outcomes II)

Chairs: Domingos Machado, Lisbon, Portugal; Kaija Salmela, Helsinki, Finland

Lomond

11:10

O-212 DE NOVO KIDNEY GRAFT TUMORS: RESULTS FROM A MULTICENTRIC RETROSPECTIVE NATIONAL STUDY Xavier Tillou, Francois Kleinclauss, and Jacques Petit; Amiens, France; and Besancon, France O-213 THE CRITICAL ROLE OF RENAL FUNCTION, PROTEINURIA AND CARDIOVASCULAR DISEASE ON THE RESULTS AFTER RENAL TRANSPLANTATION.A PROSPECTIVE MULTICENTRE STUDY AT FIVE YEARS ACCORDING RECIPIENT AGE Jose M. Morales, Roberto Marcen, Domingo Del Castillo, Miguel Gonzalez Molina, Fernando Anaya, Amado Andrs, Manuel Arias, Jesus Bustamante, Mercedes Cabello, Jose M. Campistol, L. Capdevila, Fernando Escuin, F. Javier Gainza, Salvador Gilvernet, Ildefonso Lampreabe, Federico Oppenheimer, Luis Pallardo, Daniel Seron, and Francisco Valdes; Madrid, Spain; and , Spain O-214 POSTTRANSPLANT sCD30 AS A PREDICTOR OF KIDNEY GRAFT OUTCOME Caner Ssal, Bernd Dhler, Mahmoud Sadeghi, Kaija T. Salmela, Rolf Weimer, Martin Zeier, and Gerhard Opelz; Heidelberg, Germany; Helsinki, Finland; and Giessen, Germany O-215 PROSTAGLANDIN E2 RECEPTOR IDENTIFIES PATIENTS AT RISK OF KIDNEY ALLOGRAFT FUNCTION DETERIORATION Mariana Urbanova, Irena Brabcova, Eva Girmanova, and Ondrej Viklicky; Prague, Czech Republic O-216 SUB-CLINICAL ACUTE REJECTION (SAR) IN PROTOCOL BIOPSIES PERFORMED 3 MONTHS AFTER RENAL TRANSPLANTATION Paul Miller, Arunan Sujenthiran, Rose Scott, Mysore Phanish, Peter Andrews, Joyce Popoola, and Iain Macphee; London, United Kingdom; and Carshalton, United Kingdom O-217 ARE RENAL ALLOGRAFT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) DIFFERENT FROM EXTRA-GRAFT PTLD? Jrme Olagne, Sophie Caillard, and Bruno Moulin; Strasbourg, France O-218 INCREASE OF T CELL SUBSETS EXPRESSING MARKERS OF ACTIVATION AND CYTOXICITY IN PATIENTS WITH POSTTRANSPLANT MALIGNANCY Maria L. Cappuccilli, Giorgia Comai, Gaetano La Manna, Paola Todeschini, Maria L. Angelini, Giorgio Feliciangeli, Vania Cuna, Maria P. Scolari, and Sergio Stefoni; Bologna, Italy

11:20

11:30

11:40

11:50

12:00

12:10

141

Tuesday 6 September
12:20 O-219 COST-EFFECTIVENESS MODEL TO EVALUATE 200-DAYS VS 100-DAYS TREATMENT WITH VALGANCICLOVIR PROPHYLAXIS TO REDUCE CYTOMEGALOVIRUS DISEASE IN HIGH-RISK (D+/R-) KIDNEY TRANSPLANT RECIPIENT IN SPAIN Luis Guirado-Perich, Julian Torre-Cisneros, Constantino FernndezRivera, Itziar Oyagez, and Cristina Varela; Barcelona, Spain; Cordoba, Spain; A Corua, Spain; and Madrid, Spain O-220 POOR OUTCOME OF SECOND KIDNEY TRANSPLANTATION: A DELAYED EVENT Katy Trbern-Launay, Yohann Foucher, Magali Giral, Christophe Legendre, Michle Kessler, Nassim Kamar, Valrie Garrigue, Emmanuel Morelon, and Jacques Dantal; Nantes, France; Paris, France; Nancy, France; Toulouse, France; Montpellier, France; and Lyon, France O-221 ARTERIAL AND ARTERIOLAR LESIONS ASSOCIATED WITH CHRONIC TRANSPLANT GLOMERULOPATHY Agnieszka Perkowska-Ptasinska, Michal Ciszek, Arkadiusz Urbanowicz, Artur Kwiatkowski, Zbigniew Galazka, and Magdalena Durlik; Warsaw, Poland

12:30

12:40

11:00 12:50

ORAL SESSION 27 Applied biology II

Boisdale 1 & 2

Chairs: David H. Adams, Birmingham, United Kingdom; Bart van Hoek, Leiden, The Netherlands 11:10 O-222 THE ROLE OF HEPATIC HEMATOPOIETIC PROGENITOR CELLS IN INTRAGRAFT LEUKOCYTE CHIMERISM AFTER LIVER TRANSPLANTATION Viviana Moroso, Qiuwei Pan, Farbod Famili, Hugo W. Tilanus, Harry L.A. Janssen, Herold J. Metselaar, Luc J.W. van der Laan, and Jaap Kwekkeboom; Rotterdam, The Netherlands O-223 PRIMARY HUMAN HEPATOCYTES FROM METABOLIC DISORDERED CHILDREN RECREATE HIGHLY DIFFERENTIATED LIVER TISSUE-LIKE SPHEROIDS ON ALGINATE SCAFFOLDS Jeanette Bierwolf, Marc Luetgehetmann, Steffen Deichmann, Johannes Erbes, VolzTassilo Tassilo, Maura Dandri, Smadar Cohen, Bjrn Nashan, and Joerg-Matthias Pollok; Hamburg, Germany; and Beer-Sheva, Israel O-224 MESENCHYMAL STEM CELLS REDUCE HEPATIC ISCHEMIA REPERFUSION INJURY Elke Eggenhofer, Alexander Kroemer, Edward Geissler, Hans J. Schlitt, and Marc H. Dahlke; Regensburg, Germany O-225 TRANSFORMING GROWTH FACTOR-1 POLYMORPHISM AND KIDNEY FUNCTION AFTER LIVER TRANSPLANTATION Dennis Eurich, Marcus Bahra, Neumann P. Ulf, Sabine Boas-Knoop, Ruth Neuhaus, Peter Neuhaus, and Volker Schmitz; Berlin, Germany; and Aachen, Germany O-226 TERMINALLY DIFFERENTIATED SUPPRESSOR CD8 T CELLS REDUCE THE RISK FOR ACUTE KIDNEY ALLOGRAFT REJECTION Michiel G.H. Betjes, Elly A. De Wit, Willem Weimar, and Nicolle H.R. Litjens; Rotterdam, The Netherlands

11:20

11:30

11:40

142

11:50

Tuesday 6 September
12:10 O-228 DIET-INDUCED INCREASE IN PLASMA OXIDISED LDL PROMOTES EARLY FIBROSIS IN A RENAL PORCINE AUTOTRANSPLANTATION MODEL Frederic Favreau, Nicolas Chatauret, Sebastien Giraud, Sandrine Joffrion, Ludivine Rossard, Jerome Cau, Lilach O. Lerman, and Thierry Hauet; Poitiers, France; Surgeres, France; and Rochester, USA O-229 INSULIN-PRODUCING CELLS DERIVED FROM ADULT HUMAN BONE MARROW MESENCHYMAL STEM CELLS CONTROL STREPTOZOTOCIN-INDUCED DIABETES IN NUDE MICE Mahmoud M. Gabr, Mahmoud M. Zakaria, Ayman F. Refaie, Amani M. Ismail, Mona A. Abou-El-Mahasen, Sylvia A. Ashamallah, Sherry M. Khater, Sawsan M. El-Halawani, Rana Y. Ibrahim, Gan Shu Uin, Malgorzata Kloc, Anne Clark, Roy Y. Calne, and Mohamed A. Ghoneim; Mansoura, Egypt; Singapore, Singapore; Houston, USA; Oxford, United Kingdom; and Cambridge, United Kingdom

12:20

11:00 12:50

ORAL SESSION 28 Heart: factors affecting transplant outcome

Chairs: Bruno Meiser, Munich, Germany; Andreas Zuckermann, Vienna, Austria

Alsh

11:10

O-230 GENDER MATTERS GENDER-SPECIFIC OUTCOME ANALYSIS OF 67,000 HEARTS FROM THE ISHLT REGISTRY Ingo Kaczmarek, Sandra Eifert, Bruno Reichart, and Bruno Meiser; Munich, Germany O-231 HIGH INCIDENCE OF NON-HLA ANTIBODIES IN HEART TRANSPLANTED RECIPIENTS WITH CARDIAC ALLOGRAFT VASCULOPATHY Markus J. Barten, Duska Dragun, Maja T. Dieterlen, Robert Riede, Sven Lehmann, Sara Klein, Stefan Dhein, Friedrich W. Mohr, and Hartmuth B. Bittner; Leipzig, Germany; and Berlin, Germany O-232 ALLOANTIGEN-PULSED HOST IMMATURE DENDRITIC CELLSINDUCE CD4+CD25+Treg IN RAT CARDIAC ALLOTRANSPLANTATION Zhenya Shen, Xiaomei Teng, and Xiaowei She; Suzhou, China O-233 BOTH DOPAMINE AND ITS DERIVATIVE N-OCTANOYLDOPAMINE PROTECT CARDIOMYOCYTES AGAINST COLD PRESERVATION INJURY Benito A. Yard, Christiane Vettel, Urs Benck, Peter Schnlle, and Simone Hger; Mannheim, Germany O-234 SUCCESFULL TWELVE HOURS OF CARDIAC PRESERVATION WITH Custodiol-N, A NOVEL ORGAN PROTECTION SOLUTION IN AN ORTHOTOPIC HEART TRANSPLANTATION MODEL Gabor Szabo, Tamas Radovits, Gabor Veres, Bastian Schmack, Alexander Weymann, Matthias Karck, Ferenc Horkay, Bela Merkeli, and Istvan Hartyanszky; Heidelberg, Germany; and Budapest, Hungary

11:20

11:30

11:40

11:50

143

Tuesday 6 September
12:00 O-235 DE NOVO EVEROLIMUS- VERSUS MMF-BASED IMMUNOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS: EFFECT ON PROTEINURIA A. Andreassen, M. Rinaldi, G. Gerosa, C. Bara, G. Dong, P. Lopez, and J. Segovia; Oslo, Norway; Torino, Italy; Padua, Italy; Hannover, Germany; East Hanover, Germany; Basel, Switzerland; and Madrid, Spain O-236 DIFFERENTIAL PATTERNS OF RENAL FUNCTION WITH THE COMBINATION OF EVEROLIMUS PLUS REDUCED DOSE CYCLOSPORINE VERSUS MMF WITH STANDARD DOSE CYCLOSPORINE: INSIGHTS FROM THE A2310 STUDY J. Segovia, L. Potena, A. Zuckermann, H. Jiang, P. Lopez, and S.-S. Wang; Madrid, Spain; Bologna, Italy; Vienna, Austria; East Hanover, USA; Basel, Switzerland; and Taipei, Taiwan O-237 FACTORS AFFECTING SURVIVAL OF DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH THYMOGLOBULIN INDUCTION A. Zuckermann, C. Pellegrini, J.M. Arizon, R. Favoloro, H. Jiang, C. Cornu-Artis, P. Lopez, and S.-S. Wang; Vienna, Austria; Pavia, Italy; Cordoba, Spain; Buenos Aires, Argentina; East Hanover, USA; Basel, Switzerland; and Taipei, Taiwan O-238 EVEROLIMUS-RELATED INCREASE IN LIPID VALUES DOES NOT AFFECT THE ANTIPROLIFERATIVE EFFECT ON THE ARTERIAL INTIMA IN HEART TRANSPLANT RECIPIENTS H. Lehmkuhl, E. Epailly, U. Fuchs, P. Boissonnat, G. Dong, P. Lopez, and I. Wilson; Berlin, Germany; Strasbourg, France; Bad Oeynhausen, Germany; Lyon, France; East Hanover, USA; Basel, Switzerland; and Birmingham, United Kingdom O-239 DE NOVO CALCINEURININHIBITOR-FREE IMMUNOSUPPRESSION WITH SIROLIMUS AND MYCOPHENOLATE MOFETIL AFTER HEART TRANSPLANTATION 5-YEAR RE-SULTS Ingo Kaczmarek, Stefan Buchholz, Bruno Reichart, and Bruno Meiser; Munich, Germany

12:10

12:20

12:30

12:40

11:00 12:50

ORAL SESSION 29 Emerging immunosuppression

Chairs: Magdlena Durlik, Warsav, Poland; Josep M. Grinyo, Barcelona, Spain

Clyde Auditorium

11:10

O-240 THREE-YEAR OUTCOMES FROM BENEFIT: A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS Flavio Vincenti, Christian P. Larsen, Josephina Alberu, Valter D. Garcia, Lionel Rostaing, Kim Rice, Mark Schnitzler, Jun Xing, Mamta Agarwal, and Bernard Charpentier; San Francisco, USA; Atlanta, USA; Mxico Mexico; Porto Alegre, Brazil; Toulouse, France; Dallas, USA; St Louis, USA; Princeton, USA; and Kremlin Bictre, France

144

Tuesday 6 September
11:20 O-241 BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL Jose O. Medina Pestana, Josep M. Grinyo, Yves Vanrenterghem, Thomas Becker, Sander Florman, Philippe Lang, Maria del C. Rial, Mark A. Schnitzler, Tao Duan, Alan Block, and Antoine Durrbach; Sao Paolo, Brazil; Barcelona, Spain; Leuven, Belgium; Hannover, Germany; New York, USA; Crteil, France; Buenos Aires, Argentina; St Louis, USA; Hopewell, USA; Princeton, USA; and Le Kremlin Bicetre, France O-242 3-YEAR SAFETY PROFILE OF BELATACEPT IN KIDNEY TRANSPLANT RECIPIENTS FROM THE BENEFIT AND BENEFIT-EXT STUDIES Bernard Charpentier, Josep Grinyo, Jose O. Medina Pestana, Yves Vanrenterghem, Flavio Vincenti, Yuping Dong, Dolca Thomas, and Christian P. Larsen; Kremlin Bictre, France; Barcelona, Spain; Sao Paulo, Brazil; Leuven, Belgium; San Francisco, USA; Hopewell, USA; Princeton, USA; and Atlanta, USA O-243 OUTCOMES AT 3 YEARS IN KIDNEY TRANSPLANT RECIPIENTS WITH PRE-TRANSPLANT DIABETES FROM TWO PHASE 3 BELATACEPT STUDIES Lionel Rostaing, Rafael Reyes-Acevedo, Hans-Hellmut Neumayer, Stefan Vitko, Jun Xing, Dolca Thomas, and Flavio Vincenti; Toulouse, France; Aguascalientes, Mexico; Berlin, Germany; Prague, Czech Republic; Hopewell, USA; Princeton, USA; and San Francisco, USA O-244 EVALUATION OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT PATIENTS TREATED WITH BELATACEPT- OR CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN BENEFIT AND BENEFIT-EXT Christian P. Larsen, Robert Bray, Howard Gebel, Bishu Ganguly, Ej Kulbokas, Daniel Brickman, Tao Duan, and Robert Townsend; Atlanta, USA; and Princeton, USA O-245 RENAL FUNCTION AT 2 YEARS IN KIDNEY TRANSPLANT RECIPIENTS SWITCHED FROM CYCLCOSPORINE OR TACROLIMUS TO BELATACEPT: RESULTS FROM THE LONG-TERM EXTENSION OF A PHASE II STUDY Josep Grinyo, Georgy Nainan, Maria del Carmen Rial, Steven Steinberg, Flavio Vincenti, Yuping Dong, Dolca Thomas, and Nassim Kamar; Barcelona, Spain; Cochin, India; Buenos Aires, Argentina; San Diego, USA; San Francisco, USA; Hopewell, USA; Princeton, USA; and Toulouse, France O-246 EFFICACY AND SAFETY OF ALEFACEPT IN COMBINATION WITH TACROLIMUS, MYCOPHENOLATE MOFETIL AND STEROIDS IN DE NOVO KIDNEY TRANSPLANTATION B. Charpentier, L. Rostaing, M. Mourad, M. Glyda, P. Rigotti, F. Falk, J. Houbiers, R. First, and J. Holman; Bicetre, France; Toulouse, France; Brussels, Belgium; Poznan, Poland; Padua, Italy; Leiderdorp, The Netherlands; and Deerfield, USA O-247 A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF ALEFACEPT (ALEF) IN DE NOVO KIDNEY TRANSPALNT RECIPIENTS D. Cibrik, S. Steinberg, P. West, H. Yang, J. Bromberg, J. Erdman, R. First, and J. Holman; Ann Arbor, USA; San Diego, USA; Chicago, USA; Harrisburg, USA; Baltimore, USA; and Deerfield, USA

11:30

11:40

11:50

12:00

12:10

12:20

145

Tuesday 6 September
12:30 O-248 A PHASE 1 SINGLE ASCENDING DOSE STUDY OF ASKP1240 (ANTI-CD40 MAB) IN HEALTHY SUBJECTS Ronald Goldwater, James Keirns, Paul Blahunka, Roy First, and John Holman; Baltimore, USA; and Deerfield, USA

11:00 12:50

ORAL SESSION 30 Immune regulation and innate immunity

Chairs: Carla Baan, Rotterdam, The Netherlands; Ondrej Viklicky, Prague, Czech Republic

Hall 1

11:10

O-249 MOUSE MACROPHAGES DRIVEN TO A NOVEL STATE OF ACTIVATION PROLONG ALLOGRAFT SURVIVAL IN NONIMMUNOSUPPRESSED RECIPIENTS Paloma Riquelme, Stefan Tomiuk, Hans J. Schlitt, Edward K. Geissler, and James A. Hutchinson; Regensburg, Germany; and Bergisch Gladbach, Germany O-250 THE KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR (KIR) GENOTYPE CORRELATES WITH ACUTE KIDNEY FAILURE IN THE EARLY POST- LIVER TRANSPLANTATION PERIOD Kristina Kunert, Diana Stauch, Ali Yayahzadeh, Wladimir Faber, Sascha Weiss, Johann Pratschke, and Katja Kotsch; Innsbruck, Austria; and Berlin, Germany O-251 QUANTIFICATION OF DEMETHYLATED FOXP3 DNA DEMONSTRATES A LOWER PROPORTION OF NATURAL REGULATORY T CELLS 1 YEAR AFTER KIDNEY TRANSPLANTATION Karin Boer, Annemiek M.A. Peeters, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands O-252 IMMUNOSUPPRESSIVE ROLE OF FIBRINOGEN-LIKEPROTEIN 2 (FGL2) IN CD8+ REGULATORY T CELLS-MEDIATED LONG-TERM GRAFT SURVIVAL Sverine Bzie, Sverine Mnoret, Laurent Tesson, Claire Usal, Mathieu Angin, Brigitte Le Mauff, Xian-Liang Li, Ignacio Anegon, and Lise Caron; Nantes, France; and Caen, France O-253 ABROGATION OF GALECTIN-3 PROTECTS AGAINST CHRONIC RENAL ALLOGRAFT INJURY Lorna Marson, Zexu Dang, Alison MacKinnon, and Tariq Sethi; Edinburgh, United Kingdom O-254 OVER-EXPRESSION OF HSP-27 IN DONOR HEARTS ALLOWS ENHANCED CARDIAC ALLOGRAFT SURVIVAL Borggia Seemampillai, Ann McCormack, Renee Germack, and Marlene Rose; Harefield, United Kingdom O-255 EX-VIVO LUNG PERFUSION REMOVES DONOR DERIVED NON-CLASSICAL MONOCYTES THAT RAPIDLY DIFFERENTIATE INTO INFLAMMATORY DENDRITIC CELLS? James E. Fildes, John P. Stone, Christopher M. Puchalka, Alexander T. Glover, Hannah Sevenoaks, Moa Karlsson-Nellbring, Leigh Gregson, Susan J. Howard, Trygve Sjberg, William W. Hope, Stig Steen, and Nizar Yonan; Manchester, United Kingdom; and Lund, Sweden

11:20

11:30

11:40

11:50

12:00

12:10

146

Tuesday 6 September
12:20 O-256 IL-2-INDEPENDENT INDUCTION OF NOVEL CD4+CD25+ CD127-FOXP3+ T-CELLS BY MESENCHYMAL STEM CELLS AND NATURAL REGULATORY T-CELLS Anja Grohnert, Martin J. Hoogduijn, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands O-257 WITHDRAWN O-258 ORGAN GRAFTS TOLERIZED THROUGH THIRD-PARTY BONE MARROW-DERIVED ADHERENT STEM CELLS CAN BE RETRANSPLANTED WITH NO IMMUNOSUPPRESSION Marc H. Dahlke, Elke Eggenhofer, Felix C. Popp, Philipp Renner, and Hans J. Schlitt; Regensburg, Germany

12:30 12:40

13:00 14:00

RAPID ORAL SESSION 25 Kidney VII

HYBRID POSTER AREA Digital Display 1

Chairs: Isabelle Binet, Saint -Gallen, Switzerland; Henri G.D. Leuvenink, Groningen, The Netherlands 13:00 RO-262 POST KIDNEY TRANSPLANT RE-HOSPITALIZATONS IN THE FIRST YEAR POST TRANSPLANT-A PRACTICE MONITORING AND IMPROVEMENT PROJECT Hatem Amer, Patricia Geerdes, Terry Fettes, Randy C. Walker, Mikel Prieto, and Fernando G. Cosio; Rochester, USA RO-263 IMPLANTATION OF THE RENAL ALLOGRAFT ARTERY ON AN ILIAC VASCULAR GRAFT: EARLY COMPLICATIONS AND LONGTERM RESULTS Damiano Patrono, Luc De Pauw, Martine De Meyer, Fabio Fusaro, and Michel Mourad; Brussels, Belgium RO-264 EXTENSIVE CORONAR CALCIFICATION IN YOUNG SLE RENAL TRANSPLANTED PATIENTS Gudrun E. Norby, Anne Gunther, Geir Mjoen, Rune Andersen, Szilveszter Dolgos, Anders Hartmann, and Hallvard Holdaas; Oslo, Norway RO-265 PRESERVATION SOLUTIONS FOR STATIC COLD STORAGE OF KIDNEY ALLOGRAFTS: A SYSTEMATIC REVIEW AND METAANALYSIS John M. OCallaghan, Simon R. Knight, Robert D. Morgan, and Peter J. Morris; London, United Kingdom; and Oxford, United Kingdom RO-266 RENAL TRANSPLANTATION IN PATIENTS WITH AA AMYLOIDOSIS NEPHROPATHY: RESULTS FROM A FRENCH MULTICENTER STUDY Tomek Koffman, Philippe Grimbert, Julien Zuber, Valerie Guarrigue, Christiane Mousson, Luc Frimat, Nassim Kamar, Gregoire Couvrat, Gabriel Choukroun, Lionel Couzi, Christophe Mariat, Matthias Buchler, Claire Pouteil Noble, Frank Bridoux, Nicolas Bouvier, Patrick Le Pogamp, Laetitia Albano, Julie Peltier, Philippe Lang, and Vincent Audard; Creteil, France; Paris, France; Montpellier, France; Dijon, France; Nancy, France; Toulouse, France; Nantes, France; Amiens, France; Bordeaux, France; Saint Etienne, France; Tours, France; Lyon, France; Poitiers, France; Caen, France; Rennes, France; and Nice, France

13:04

13:08

13:12

13:16

147

Tuesday 6 September
13:20 RO-267 A RELATIVE SURVIVAL MODEL TO ASSESS THE SPECIFIC MORTALITY RELATED TO RENAL TRANSPLANTATION Ahmed Akl, Magali Giral, Vanessa Rousseau, Michle Kessler, Marc Ladrire, Christophe Legendre, Henri Kreis, Lionel Rostaing, Nassim Kamar, Georges Mourad, Valrie Garrigue, Jean Pierre Daures, Jean Paul Soulillou, and Yohann Foucher; Nantes, France; Montpellier, France; Nancy, France; Paris, France; and Toulouse, France RO-268 FIRST WEEK TACROLIMUS LEVEL BUT NOT DELAYED GRAFT FUNCTION PREDICTS 1-YEAR ALLOGRAFT FUNCTION IN RECIPIENTS OF KIDNEYS FROM DONORS AFTER CARDIAC DEATH (DCD) G. Roberts, P. Nagaraja, M. Stephens, D. Archampong, S. Horvath, J. Fialova, S. Griffin, R. Chavez, A. Asderakis, and Z. Kaposztas; Cardiff, United Kingdom RO-269 TRANSPLANT URETERIC STENT TRIAL (TrUST): EARLY VERSUS STANDARD REMOVAL. A RANDOMISED CONTROLLED TRIAL PILOT DATA Pareeta Patel, Manish Sinha, Nizam Mamode, Geoff Koffman, and Jonathon Olsburgh; London, United Kingdom RO-270 EFFECTIVENESS OF RENAL TRANSPLANT ASSESSMENT CLINICS- GLASGOW EXPERIENCE Faisal Hanif, and Marc J. Clancy; Glasgow, United Kingdom PRE-

13:24

13:28

13:32

13:36

RO-271 TRANSPLANT KIDNEYS STIFFNESS MEASUREMENT BY ELASTOGRAPHY: A PILOT STUDY Lionel Couzi, Severine Poulain, Sebastien Lepreux, Yann Lebras, Pierre Merville, Karine Moreau, Jean-Luc Genisson, and Nicolas Grenier; Bordeaux, France

13:00 14:00

RAPID ORAL SESSION 26 Kidney VIII

HYBRID POSTER AREA Digital Display 2

Chairs: Marian Klinger, Warsaw, Poland; Raj Thurasingam, London, United Kingdom 13:00 RO-272 LIVING DONOR KIDNEY TRANSPLANTATION IN A SINGLE CENTER: 45 YEARS EXPERIENCE Fabio Fusaro, Anne Benoit, Martine De Meyer, Luc De Pauw, Damiano Patrono, Eric Goffin, Nada Kanaan, Yves Pirson, Catherine Legrand, and Michel Mourad; Brussels, Belgium RO-273 RENAL DYSFUNCTION IN SPANISH KIDNEY RECIPIENTS UNDER MAINTENANCE J.M. Campistol, A. Gutirrez, J. Crespo, N. Saval, and J.M. Griny; Barcelona, Spain; Zaragoza, Spain; and Valencia, Spain RO-274 MAINTENANCE IMMUNOSUPPRESSION AND LONGTERM RESULTS OF RENAL TRANSPLANTATION: THE DIVAT DATABASE M. Giral, V. Garrigue, N. Kamar, M. Ladrire, E. Morellon, S. Rouanet, N. Tagieva, and C. Legendre; Nantes, France; Montpellier, France; Toulouse, France; Vandoeuvre les Nancy, France; Lyon, France; Neuilly sur Seine, France; and Paris, France

13:04

13:08

148

Tuesday 6 September
13:12 RO-275 ACTIVATED TUBULAR EPITHELIAL CELLS PRODUCE CHEMOKINES THAT ATTRACT TH1, BUT NOT TH17 CELLS Martijn W.H.J. Demmers, Carla C. Baan, Willem Weimar, and Ajda T. Rowshani; Rotterdam, The Netherlands RO-276 EARLY SURGICAL COMPLICATIONS AFTER 348 SINGLE KIDNEY TRANSPLANTATIONS (KT) FROM HEART-BEATING DECEASED DONORS Gian Luigi Adani, Anna Rossetto, Dario Lorenzin, Vittorio Bresadola, and Umberto Baccarani; Udine, Italy RO-277 ASSOCIATION BETWEEN EARLY CHANGES IN CHRONIC KIDNEY DISEASE STAGE FOLLOWING KIDNEY TRANSPLANTATION AND GRAFT SURVIVAL William Irish, Schiffon Wong, Debora Bowers, Digisha Trivedi, and Tony Hebden; Cincinnati, USA; and Plainsboro, USA RO-278 VITAMIN B6 AND IMMUNITY IN ELDERLY KIDNEY TRANSPLANT RECIPIENTS Magdalena Jankowska, Marcin Marszall, Alicja Debska-Slizien, Juan J. Carrero, Bengt Lindholm, Wojciech Czarnowski, Boleslaw Rutkowski, and Piotr Trzonkowski; Gdansk, Poland; and Stockholm, Sweden RO-279 PERIODIC LIMB MOVEMENT IN SLEEP IN WAITLISTED DIALYZED AND KIDNEY TRANSPLANTED PATIENTS Miklos Z. Molnar, Anett Lindner, Katalin Fornadi, Alpar S. Lazar, Maria E. Czira, Rezso Zoller, Andras Szentkiralyi, Zoltan Kiss, Eva Toronyi, Istvan Mucsi, and Marta Novak; Budapest, Hungary; Torrance, USA; Muenster, Germany; Montreal, Canada; and Toronto, Canada RO-280 LIVE DONOR KIDNEY TRANSPLANTATION IN THE LIMITED RESOURCE SETTING; PREDICTORS OF ALLOGRAFT SURVIVAL Nalaka Gunawansa, Niroshan Seneviratne, Rezni Cassim, Anuja Abeydheera, and Mandika Wijeyaratne; Colombo, New Zealand RO-281 RATES OF DELAYED GRAFT FUNCTION IN KIDNEY ALLOGRAFTS IS SIGNIFICANTLY ASSOCIATED WITH A FALL IN TARGET ARTERIAL BLOOD PRESSURE Marc Gingell-Littlejohn, Hoey Koh, and Marc J. Clancy; Glasgow, United Kingdom

13:16

13:20

13:24

13:28

13:32

13:36

13:00 14:00

RAPID ORAL SESSION 27 HYBRID POSTER AREA Digital Display 3 Immunobiology/Basic Science II
Chairs: Alexander Kroemer, Boston, United States; Jaap Kwekkeboom, Rotterdam, The Netherlands

13:00

RO-282 SOLUBLE INTERLEUKIN-2 RECEPTOR INHIBITS CD4+ T CELL ACTIVATION AND MAY REPRESENT A NOVEL THERAPEUTIC AGENT FOR TRANSPLANTATION William R. Critchley, Rebecca E. Rowe, Louise D. Archer, Nizar Yonan, and James E. Fildes; Manchester, United Kingdom RO-283 INTERSTITIAL C4d, ANTI-HUMAN LEUKOCYTE ANTIBODIES(Anti-HLA) AND DONOR SPECIFIC ANTIBODIES(DSA) IN LIVER TRANSPLANTATION(LT): ROLE OF EARLY AND LATE GRAFT DYSFUNCTION M.T.P.R Perera, M.A Silva, D.A Neil, D.C. Briggs, N. Murphy, and D.F. Mirza; Edgbaston, Birmingham, United Kingdom

13:04

149

Tuesday 6 September
13:08 RO-284 INTRAGRAFT Foxp3+Tregs IN PROTOCOL BIOPSIES IS A PROTECTIVE BIOMARKER FOR KIDNEY ALLOGRAFT OUTCOME Oriol Bestard, Leticia Cuetti, Rafael Valdez, Joseph M. Cruzado, Sven Olek, Marc Lucia, Joan Torras, Montse Gom, Marcela Franquesa, and Joseph M. Griny; Barcelona, Spain; Barcelona, Spain; Montevideo, Uruguay; Brussels, Belgium; Mexico, Mexico; and Berlin, Germany RO-285 CD26 INHIBITION RECRUITES REGENERATIVE STEM CELLS VIA SDF-1 CXCR4 AXIS AND IMPROVES ISCHEMIAREPERFUSION INJURY IN THE MOUSE MODEL OF LUNG TRANSPLANTATION Wolfgang Jungraithmayr, Ingrid De Meester, Lesley Baerts, Luc Hrter, Veerle Matheussen, Stephan Korom, and Walter Weder; Zurich, Switzerland; and Antwerp, Belgium RO-286 DIRECT CYTIKINE MEASUREMENT IN URINE AND PLASMA IN A RAT MODEL OF CHRONIC KIDNEY REJECTION Gerhard Hunold, Wenzel N. Schoning, Ashley Frazer-Abel, Gero Puhl, Peter Neuhaus, and Uwe Christians; Berlin, Germany; and Denver, USA RO-287 HISTONE DEACETYLASE INHIBITION REVEALS A POTENT IMMUNOSUPPRESSANT EFFECT IN AN IN VITRO MODEL OF TRANSPLANTATION Jonathan D. Ellis, Nicholas G. Inston, Andrew R. Ready, Eric J. Jenkinson, Mark T. Drayson, Stephen Shuttleworth, and Mark Cobbold; Birmingham, United Kingdom; and Southampton, United Kingdom RO-288 CHARACTERIZATION OF CD4+ NKG2D+ T LYMPHOCYTES IN KIDNEY TRANSPLANT PATIENTS. IMPLICATIONS IN THE OUTCOME OF THE TRANSPLANTATION Beatriz Surez, Susana Garca, Alba Fernndez, Ernesto Gmez, Francisco Ortega, and Carlos Lpez; Oviedo, Spain RO-289 EFFECTS OF ANTIBODY TO HUMAN LEUKOCYTE ANTIGEN (HLA) ON VON WILLEBRAND FACTOR (VWF) SECRETION FROM ENDOTHELIAL CELLS Athinoula Meli, Tom Carter, Ann McCormack, Matthew J. Hannah, and Marlene L. Rose; London, United Kingdom RO-290 INTESTINAL BIOLOGICAL SCAFFOLDS FOR TRANSPLANTATION Murali Somasundaram, Anna Nowocin, Paul Sibbons, Simon Gabe, Peter Friend, and Tahera Ansari; London, United Kingdom; and Oxford, United Kingdom RO-291 MELATONIN INDUCES T CELL PROLIFERATION AND IL10 PRODUCTION IN VITRO Corrie F. Watkins, Ross M. Thomson, William R. Critchley, Mary A. Geischen-Krische, Nizar Yonan, Brian G. Keevil, and James E. Fildes; Manchester, United Kingdom

13:12

13:16

13:20

13:24

13:28

13:32

13:36

150

13:00 14:00

RAPID ORAL SESSION 28 Composite tissues and xenotransplantation

HYBRID POSTER AREA Digital Display 4

Chairs: Palmina Petruzzo, Catania, Italy; Stefan Tullius, Boston, United States

Tuesday 6 September
13:00 RO-292 SIMULTANEOUS BONE MARROW TRANSPLANTATION PREVENTS TRACHEAL ALLOGRAFT OBLITERATION IN RATS Andra-Elena I. Petrascu, Dragos Zamfirescu, and Ioan Lascar; Bucharest, Romania RO-293 VASCULARIZED BONE MARROW TRANSPLANTATION AS AN ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW TRANSPLANTATION Andra-Elena Petrascu, Dragos Zamfirescu, and Ioan Lascar; Bucharest, Romania RO-294 ESTABLISHING A CLINICAL HAND TRANSPLANT PROGRAM Hatem Amer, Nadine Rynerson, Lynette Fix, Ellen Casey, Mary K. Schwab, Bridget F. Avikanen, Charles B. Rosen, Brooks S. Edwards, Keith A. Bengtson, Mike A. Morrey, Sheila G. Jowsey, Thomas R. Schwab, Brian T. Carlsen, Stephen L. Moran, and Stephanie Stewart; Rochester, USA RO-295 ANTI-CLASS II HUMANIZED ANTIBODY, IMMU-114 ATTENUATES HUMAN TO BOVINE XENOGENEIC IMMUNE RESPONSE Tokihiko Sawada, KyungHwa Park, Toru Murakami, Yasuo Ishii, Mineko Yasuo, Manami Urakawa, Yoshito Aoyagi, Shohei Fuchinoe, and Keiichi Kubota; Tochigi, Japan; Tokyo, Japan; and Hokkaido, Japan RO-296 PROLONGED CARDIAC XENOGRAFT SURVIVAL BY ELIMINATING NATURAL KILLER CELLS WITH MONOCLONAL ANTIBODY Zhenya Shen, Xiaomei Teng, and Wei Gao; Suzhou, China RO-296/A BIOLOGICS AND DONOR BONE MARROW CELLS FOR TARGETED IMMUNOMODULATION IN COMPOSITE TISSUE ALLOTRANSPLANTATION [ndash] A LARGE ANIMAL TRANSLATIONAL TRIAL Eric G. Wimmers, Galen S. Wachtman, Stefan Schneeberger, Vijay S. Gorantla, Cheng-Hung Lin, Rishi Jindal, Jignesh V. Unadkat, Xin Xiao Zheng, Gerald Brandacher, W.P. Andrew Lee; Baltimore, USA; Pittsburgh, USA RO-296/B CD4-CD8- DOUBLE NEGATIVE REGULATORY T CELL BASED THERAPY INDUCES DONOR-SPECIFIC TOLERANCE IN A MURINE COMPOSITE TISSUE ALLOTRANSPLANTATION MODEL Cheng-Hung Lin, Timothy W. Ng, Dong Zhang, Wensheng Zhang, Benson Pulikkottil, Gerald Brandacher, W.P. Andrew Lee, Xin Xiao Zheng; Pittsburgh, USA; Baltimore, USA; Taipei, Taiwan RO-296/C NO LONG TERM TRANSMISSION OF PERV IN FIFTY FIVE PATIENTS RECEIVING PORCINE SKIN XENOGRAFTS Linda Scobie, Claire Crossan, Madga Matouskova, Ralph Hector, Emanuele Cozzi, Maria-Chiara Tallachini, Jean-Paul Soulillou, Juan Ribes, Yasu Takeuchi, Jiri Hejnar, Josef Blaha, Pavel Vesely; Glasgow, United Kingdom; Prague, Czech Republic; Padua, Italy; Piacenza, Italy; Nantes, France; London, United Kingdom

13:04

13:08

13:12

13:16

13:20

13:24

13:28

151

Tuesday 6 September
13:00 14:00

RAPID ORAL SESSION 29 Donation/Retrieval II

HYBRID POSTER AREA Digital Display 5

Chairs: Alessandro Nanni Costa, Rome, Italy; Leo Roels, Linden, Belgium 13:00 RO-297 DECEASED ORGAN DONATION AND TRANSPLANTATION ACTIVITY IN SAUDI ARABIA: 2000-2004 VS. 2005-2009 Faissal A.M. Shaheen, Besher A. Al-Attar, Mohd. Ziad Souqiyyeh, Rogelio Q. Mendez, Jr., and Abdulla A. Al-Sayyari; Riyadh, Saudi Arabia RO-298 A ONE YEAR RETROSPECTIVE AUDIT OF REFERRALS COMPARED TO PROCEEDING DONORS AFTER CIRCULATORY DEATH (DCD) Charmaine H. Buss, Sara L. Bagshaw, and Ben R. Cole; Birmingham, United Kingdom RO-299 FEASIBILITY OF LIVE KIDNEY TRANSPLANTATION FROM MORBIDLY OBESE DONORS Jeremy S. Crane, Benjamin OBrien, Sotiris Mastoridis, Nadey S. Hakim, and Vassilios E. Papalois; London, United Kingdom RO-300 REGIONAL PARTNERSHIP FOR TRANSPLANTATION. THE WAY TO INCREASE DONATION RATE FROM DECEASED DONORS Wojciech Rowinski, Jaroslaw Czerwinski, Anna Jakubowska-Winecka, Romuald Bohatyrewicz, Tomasz Kubik, Robert Becler, Pawel Nyckowski, Krzysztof Zieniewicz, and Jaroslaw Czerwinski; Olsztyn, Poland; Warsaw, Poland; and Szczecin, Poland RO-301 STANDARDIZATION OF ORGAN PROCUREMENT AND ELEARNING AS A TOOL TO IMPROVE QUALITY OF EDUCATION IN DONOR SURGERY: FIRST RESULTS OF A NEW CERTIFICATION SYSTEM IN THE NETHERLANDS Jeanne A. De Graauw, Andrzej G. Baranski, Sijbrand S. Hofker, Oscar P. Gobe, Rutger J. Ploeg, Jan Ringers, and Bernadette J. HaaseKromwijk; Leiden, The Netherlands; and Groningen, The Netherlands RO-302 CURRICULUM THORACIC TRANSPLANTATION (CTTx): TRAINING ON HEART AND LUNG EXPLANTATION AND IMPLANTATION Markus J. Barten, Klaus Pschel, Friedrich W. Mohr, Hartmuth B. Bittner, and Thomas Karbe; Leipzig, Germany; and Hamburg, Germany RO-303 A COMPUTER ASSISTED LEARNING PACKAGE ON ORGAN DONATION: A TOOL FOR WIDESPREAD EDUCATION OF PROFESSIONALS Eleanor R. Kissin, Dale C. Gardiner, Charmaine H. Buss, and Megan R. Smith; Nottingham, United Kingdom; and Nottingham, United Kingdom RO-304 TPM: AN EFFECTIVE MODEL IN TRAINING DONATION PROFESSIONALS Ricard Valero, Gloria Pez, and Mart Manyalich; Barcelona, Spain RO-305 ACUTE KIDNEY INJURY (AKI) BEFORE ORGAN PROCUREMENT IS ASSOCIATED WITH THE WORSE LONG-TERM KIDNEY GRAFT OUTCOME Agata Pawlik, Jerzy Chudek, Aureliusz Kolonko, Jaroslaw Wilk, Przemyslaw Jalowiecki, and Andrzej Wiecek; Katowice, Poland

13:04

13:08

13:12

13:16

13:20

13:24

13:28

152

13:32

Tuesday 6 September
13:36 RO-306 EDUCATION FOR HEALTH IN SCHOOLS, INTRODUCING TRANSPLANTATION THE OPORTO MODEL Helena Alves, Rui Pinto Reis, and Joo Mota; Porto, Portugal

13:00 14:00

RAPID ORAL SESSION 30 Allocation Retrieval II

HYBRID POSTER AREA Digital Display 6

Chairs: Andrew Bradley, Cambridge, United Kingdom; Rachel Johnson, London, United Kingdom 13:00 RO-307 DONOR RISK FACTORS AND CORRELATION WITH MELD SCORE IN LIVER TRANSPLANT RECIPIENTS Massimo Del Gaudio, Giorgio Ercolani, Matteo Cescon, Augusto Lauro, Matteo Ravaioli, Alessandro Cucchetti, Matteo Zanello, Alessandro Dazzi, Chiara Zanfi, Cristina Morelli, and Antonio Daniele Pinna; Bologna, Italy RO-308 GRAFT-RELATED TRANSPLANT BENEFIT BASED ON MELD SCORE OF THE RECIPIENT IN LIVER TRANSPLANTATION Umberto Cillo, Alessandro Vitale, Francesco DAmico, Pasquale Bonsignore, Patrizia Burra, Paolo Angeli, and Giacomo Zanus; Padua, Italy RO-309 PRIORITIZATION TOOLS TO PREDICT SHORT AND LONG TERM MORTALITY FOLLOWING LIVER TRANSPLANTATION Martina Gambato, Anna Chiara Frigo, Tullia De Feo, Marco Senzolo, Francesco P. Russo, Giacomo Germani, Eleonora De Martin, Elena Nadal, Francesco DAmico, Umberto Cillo, and Patrizia Burra; Padua, Italy; and Milan, Italy RO-310 WHAT ARE THE PATIENTS VIEWS ON THE CURRENT KIDNEY ALLOCATION SYSTEM IN UK? Talya Kobrin, Zoe Melrose, Natasha Reed, Iain MacPhee, Helen Gregson, Jiri Fronek, Bimbi Fernando, and Nicos Kessaris; London, United Kingdom RO-311 VALIDATION OF CURRENT INTERNATIONAL LEGISLATION ON ORGAN ALLOCATION WITH ACTUAL PRACTICE IN PERSONS WITH DISABILITY Maruska C. Nizzi, Federica Ravera, Decenzio Bonucchi, Elisabetta Genovese, Giampiero Griffo, Giacomo Guaraldi, and Giovanni Guaraldi; Modena, Italy; and Milan, Italy RO-312 ACCESS TO RENAL TRANSPLANTATION AT NOTTINGHAM UNIVERSITY HOSPITALS Linda Bisset, Linda Evans, Charlotte Bebb, and Catherine Byrne; Nottingham, United Kingdom

13:04

13:08

13:12

13:16

13:20

153

Tuesday 6 September
14:00 15:30 LIVE WEB STREAM 14:00 14:20 14:40 15:00

PLENARY SESSION 3 Transplantation tomorrow

Clyde Auditorium

Chairs: Jean-Micheal Dubernard, Lyon, France; Robert Gaston, Birmingham, United States Composite Tissue Transplantation Stefan Schneeberger, Innsbruck, Austria Tissue Engineering - beyond the trachea Doris Taylor, Minneapolis, United States Minimising the immune response what is the current science? Carla Baan, Rotterdam, The Netherlands Xenotransplantation still the future? Emanuele Cozzi, Padua, Italy

16:00 17:00 LIVE WEB STREAM

NEW CONTROVERSIES 3 Clyde Auditorium The big advances in transplantation have come from
Chairs: Bjrn Nashan, Hamburg, Germany; Keith Rigg, Nottingham, United Kingdom

16:00 16:20

The randomized controlled trial Henrik Ekberg, Malmo, Sweden Unrandomized innovation Peter Neuhaus, Berlin, Germany

16:00 17:00

NEW CONTROVERSIES 4 Organ allocation should be based on

Chairs: Jan Lerut, Leuven, Belgium; Chris Watson, Cambridge, United Kingdom

Lomond

16:00 16:20

Fairness/equity Assya Pascalev, Sofia, Bulgaria Transplant benefit Alexander Gimson, Cambridge, United Kingdom

16:00 17:00

ORAL SESSION 31 Ethics, legal and psychosical aspects of transplantation

Forth

Chairs: Frederike Ambagtsheer, Rotterdam, The Netherlands; Gurch Randhawa, Luton, United Kingdom

154

16:00

O-259 HOME-BASED GROUP EDUCATION: THE SOLUTION FOR BREAKING BARRIERS IN COMMUNICATION AND KNOWLEDGE AMONG NON-EUROPEAN KIDNEY PATIENTS? A.E. Luchtenburg, S.Y. Ismail, J.J. van Busschbach, C. Boonstra, W.C. Zuidema, J.I. Roodnat, J. van de Wetering, W. Weimar, and E.K. Massey; Rotterdam, The Netherlands; and Halsteren, The Netherlands

Tuesday 6 September
16:10 O-260 INFORMED CONSENT AND EXTENDED CRITERIA DONORS (ECD) FOR LIVER TRANSPLANTATION Paolo Bruzzone; Rome, Italy O-261 TO GIFT OR NOT TO GIFT? EXPLORING VIEWS ON DECEASED ORGAN DONATION FROM DIFFERENT CONGREGATIONS ACROSS THE UK Kulwinder Kaur-Bola, and Gurch Randhawa; Luton, United Kingdom O-262 GIVING THE GIFT OF LIFE THROUGH DECEASED ORGAN DONATION, EXPLORING THE VIEWS OF LOCAL FAITH LEADERS FROM ACROSS THE UK Kulwinder Kaur-Bola, and Gurch Randhawa; Luton, United Kingdom O-263 REPORTING QUALITY OF RANDOMISED CONTROLLED TRIALS IN SOLID ORGAN TRANSPLANTATION Liang Q. Liu, Liset H.M. Pengel, and Peter J. Morris; London, United Kingdom O-264 ELPATS NEW CLASSIFICATION FOR LIVING ORGAN DONATION Frank J.M.F. Dor, Emma K. Massey, Mihaela Frunza, Rachel Johnson, Annette Lennerling, Charlotte Loven, Nizam Mamode, Assya Pascalev, Sigrid Sterckx, Kristof Van Assche, Willij C. Zuidema, and Willem Weimar; Rotterdam, The Netherlands; Cluj, Romania; Bristol, United Kingdom; Gothenburg, Sweden; London, United Kingdom; Sofia, Bulgaria; Brussels, Belgium; Ghent, Belgium; and Washington, USA

16:20

16:30

16:40

16:50

16:00 17:00

ORAL SESSION 32 Hand and face transplantation

Chairs: Gerald Brandacher, Pittsburgh, United States; Raimund Margreiter, Innsbruck, Austria

Gala 2

16:00

O-265 THE BONE COMPONENT OF CTA GIVES RISE TO DONOR HSC WHICH MIGRATE TO RECIPIENT THYMUS AND DIFFERENTIATE TOWARDS A MATURE T CELL PHENOTYPE Robert Sucher, Cheng-Hung Lin, Dong Zhang, Wensheng Zhang, Vijay Gorantla, W.P. Andrew Lee, Johann Pratschke, Fadi Lakkis, Stefan Schneeberger, Gerald Brandacher, and Xin Xiao Zheng; Innsbruck, Austria; Baltimore, USA; and Pittsburgh, USA O-266 OUTCOME 5 YEARS AFTER THE FIRST HUMAN PARTIAL FACE TRANSPLANTATION Palmina Petruzzo, Sylvie Testelin, Emmanuel Morelon, Jean Kanitakis, Benoit Lengele, Cristophe Malcus, Jean Michel Dubernard, Bernard Devauchelle, and Lionel Badet; Lyon, France; Amiens, France; and Brussels, Belgium O-267 THE INNSBRUCK HAND TRANSPLANT PROGRAM: UPDATE AT 11 YEARS AFTER THE FIRST TRANSPLANT Annemarie Weissenbacher, Gerhard Pierer, Markus Gabl, Marina Ninkovic, Theresa Hautz, Bettina Zelger, Wolfgang Lscher, Martin Kumnig, Michael Rieger, Hildegunde Piza-Katzer, Raimund Margreiter, Johann Pratschke, Gerald Brandacher, and Stefan Schneeberger; Innsbruck, Austria

16:10

16:20

155

Tuesday 6 September
16:30 O-268 FACE TRANSPLANTATION WITH COMBINED HEMATOPOIETIC STEM CELL INFUSION AND VASCULARIZED BONE MARROW: FIRST YEAR OF FOLLOW-UP Emmanuel Morelon, Sylvie Testelin, Palmina Petruzzo, Lionel Badet, Mauricette Michallet, Valrie Dubois, Olivier Hequet, Maria Brunet, Jean Kanitakis, Jean-Michel Dubernard, Benoit Lengele, and Bernard Devauchelle; Lyon, France; Amiens, France; and Brussels, Belgium O-269 EXPRESSION OF PERIPHERAL NODE ADDRESSIN INDICATIVE OF TERTIARY LYMPHOID ORGANS IN SKIN AFTER HAND TRANSPLANTATION Theresa Hautz, Bettina Zelger, Isam Nasr, Gerald Brandacher, Luis Landin, Annemarie Weissenbacher, Pedro Cavadas, Raimund Margreiter, Andrew W.P. Lee, Johann Pratschke, Fadi G. Lakkis, and Stefan Schneeberger; Innsbruck, Austria; Pittsburgh, USA; Baltimore, USA; and Valencia, Spain O-270 EFFECT OF COLD ISCHEMIA AND PRESERVATION SOLUTIONS HTK AND UW ON COMPOSITE TISSUE ALLOGRAFTS Theresa Hautz, Tilman Hickethier, Johanna Grahammer, Christoph Krapf, Michael Kimelman, Martin Hermann, Bettina Zelger, Robert Sucher, Gerald Brandacher, Andrew W.P. Lee, Raimund Margreiter, Johann Pratschke, and Stefan Schneeberger; Innsbruck, Austria; and Baltimore, USA O-271 RESULTS OF THE FIRST PROSPECTIVE PILOT STUDY ON BILATERAL HAND ALLOTRANSPLANTATION Palmina Petruzzo, Lionel Badet, Jean Kanitakis, Vincent Guigal, Christophe Rizzo, Maria Brunet, Helen Parmentier, Emmanuel Morelon, Jean Michel Dubernard, and Aram Gazarian; Lyon, France

16:40

16:50

17:00

16:00 17:00

ORAL SESSION 33 Lung: vaccins and alternative donors

Chairs: Martin Carby, Harefield, United Kingdom; Karen Redmond, London, United Kingdom

Boisdale 1

16:00

O-272 THE IMPACT OF VACCINATION ON THE BREADTH AND STRENGTH OF ALLOSENSITIZATION IN LUNG TRANSPLANT CANDIDATES Garnett Smith, Jacqueline Chu, Lara Danziger-Isakov, Robin Avery, David van Duin, Emilio Poggio, Lynne Klingman, Marie Budev, Titte Srinivas, William Baldwin III, Kenneth McCurry, and Medhat Askar; Cleveland, USA; and Cleveland, USA O-273 CADAVERIC LOBAR LUNG TRANSPLANT: A VALID OPTION FOR SMALL-SIZED CF PATIENTS Alessia Stanzi, Joyce Tiek, Shana Wauters, Herbert Decaluw, Willy Coosemans, Paul De Leyn, Philippe Nafteux, Lieven J. Dupont, Geert M. Verleden, and Dirk E. Van Raemdonck; Leuven, Belgium O-274 IMPROVED CLINICAL OUTCOME OF PATIENTS TRANSPLANTED WITH RECONDITIONED DONOR LUNGS VIA EVLP COMPARED TO STANDARD LUNG TRANSPLANTATION James E. Fildes, Siobhan C. Regan, Mo Al-Aloul, Ali Machaal, Trygve Sjberg, Stig Steen, and Nizar Yonan; Manchester, United Kingdom; and Lund, Sweden

16:10

16:20

156

Tuesday 6 September
16:30 O-275 COMPLIANCE DURING IN SITU LUNG PERFUSION (ISLP) IS A PREDICTOR FOR LUNG INJURY IN NHBD CATEGORY I II Caroline Van De Wauwer, Anita J. Munneke, Gerwin E. Engels, Gerhard Rakhorst, and Michiel E. Erasmus; Groningen, The Netherlands O-276 PROPHYLACTIC SURFACTANT INHALATION AMELIORATES ISCHEMIA-REPERFUSION INJURY IN RAT LUNGS FROM DONATION AFTER CARDIAC DEATH DONORS Akihiro Ohsumi, Fengshi Chen, Daisuke Nakajima, Tetsu Yamada, Jin Sakamoto, Takuji Fujinaga, Tsuyoshi Shoji, Hiroaki Sakai, Toru Bando, and Hiroshi Date; Kyoto, Japan O-277 beta2-ADRENORECEPTOR AGONIST INHALATION AMELIORATES ISCHEMIA REPERFUSION INJURY FOLLOWING LUNG TRANSPLANTATION FROM NON-HEART-BEATING DONORS IN A CANINE MODEL Jin Sakamoto, Fengshi Chen, Daisuke Nakajima, Tetsu Yamada, Akihiro Ohsumi, Xiangdong Zhao, Takuji Fujinaga, Tsuyoshi Shoji, Hiroaki Sakai, Toru Bando, and Hiroshi Date; Kyoto, Japan

16:40

16:50

16:00 17:00

ORAL SESSION 34 Deceased donation

Chairs: Murat Akyol, Edinburgh, United Kingdom; Gnter Kirste, Frankfurt, Germany

Alsh

16:00

O-278 THE LOST OPPORTUNITY IN END-OF-LIFE CARE? DONATION INFORMATION. A MULTI-CENTRIC STUDY Teresa Pont, Joan Gener, Eva Olivier, Mara Bodi, Mariona Badia, Jaume Mestre, Xavier Esquirol, Emma Muoz, Nria Masnou, Roser Deulofeu, and Salvador Quintana; Barcelona, Spain; Badalona, Barcelona, Spain; Barcelona, Spain; Tarragona, Tarragona, Spain; Sabadell, Barcelona, Spain; Granollers, Barcelona, Spain; Lleida, Spain; and Terrassa, Barcelona, Spain O-279 REASONS FOR NOT FORMALLY DIAGNOSING POTENTIAL DONORS BRAIN DEAD: DONOR ACTION MEDICAL RECORD REVIEW DATA FROM 7 COUNTRIES Leo Roels, Jacqueline Smits, and Bernard Cohen; Linden, Belgium; and Leiden, The Netherlands O-280 AGE AS A DETERMINANT OF POTENTIAL DONOR CONVERSION RATES: DONOR ACTION DATABASE FINDINGS Leo Roels, Rita Lombaerts, Jacqueline Smits, and Bernard Cohen; Linden, Belgium; Leuven, Belgium; and Leiden, The Netherlands O-281 A DUTCH MULTI-CENTER STUDY ON THE DECISIONMAKING PROCESS OF FAMILIES REQUESTED FOR DONATION Nichon E. Jansen, Hendrik A. van Leiden, Bernadette J.J.M. HaaseKromwijk, Nardo J.M. van der Meer, Edwin Vorstius Kruijff, Netty van der Lely, Hans van Zon, Arend-Jan Meinders, Machteld Mosselman, and Andries J. Hoitsma; Leiden, The Netherlands; Breda, The Netherlands; Tilburg, The Netherlands; Nieuwegein, The Netherlands; and Nijmegen,The Netherlands O-282 ACTIVATION OF HEMOSTASIS IN BRAIN-DEAD ORGAN DONORS Ton Lisman, Henri G.D. Leuvenink, Robert J. Porte, and Rutger J. Ploeg; Groningen, The Netherlands

16:10

16:20

16:30

157

16:40

Tuesday 6 September
16:50 O-283 THE MASTERPLAN FOR ORGAN DONATION IN THE NETHERLANDS: INTENSIVISTS IN THE LEAD Danielle M. Nijkamp, Rik T. Gerritsen, Jan Niesing, Marije Smit, and Rutger J. Ploeg; Groningen, The Netherlands; and Leeuwarden,The Netherlands

16:00 17:00

ORAL SESSION 35 Immune monitoring /pharmacokinetics

Chairs: Dirk Kuypers, Leuven, Belgium; Iain MacPhee, London, United Kingdom

Boisdale 2

16:00

O-284 IMMUNE-MONITORING OF MEMORY/EFFECTOR T-CELL ALLORESPONSE FOR SELECTION OF CNI-FREE IMMUNOSUPPRESSION IN RENAL TRANPLANTATION Oriol Bestard, Josep M. Cruzado, Marc Lucia, Birgit Sawitzki, Joan Torras, Hans-Dieter Volk, Petra Reinke, Edoardo Melilli, and Josep M. Griny; Barcelona, Spain; and Berlin, Germany O-285 THE CD4+CD25+FoxP3+ AND CD4+CD25low/-FoxP3+ CELLS ARE ASSOCIATED WITH LOW INCIDENCE OF KIDNEY ALLOGRAFT REJECTION Eva Krystufkova, Alena Sekerkova, Ilja Striz, Irena Brabcova, and Ondrej Viklicky; Prague, Czech Republic O-286 CYP3A5 GENOTYPE IS NOT RELATED TO THE INTRAPATIENT VARIABILITY OF TACROLIMUS CLEARANCE IN RENAL TRANSPLANT RECIPIENTS Natalia M.K. Spierings, Nilufar Pashaee, Rachida Bouamar, Dennis A. Hesselink, Joke I. Roodnat, Ron H.N. van Schaik, Willem Weimar, David W. Holt, Iain A.M. MacPhee, and Teun van Gelder; London, United Kingdom; and Rotterdam, The Netherlands O-287 THE EFFECT OF CYP3A5 POLYMORPHISMS ON LONG TERM TACROLIMUS DISPOSITION IN RENAL RECIPIENTS Nora C. Imperiali, Julian M. Larriba, Silvia R. Groppa, Maria C. Giordani, Gabriel B. Maule, Cesar A. Mombelli, Griselda I. Bratti, Pablo F. Argibay, and Salomon L. Algranati; Buenos Aires, Argentina O-288 COMPARATIVE BIOAVAILABILITY STUDY OF TWO MYCOPHENOLATE MOFETIL FORMULATIONS IN STABLE KIDNEY TRANSPLANT RECIPIENTS Gere Sunder-Plassmann, Petra Reinke, Thomas Rath, Andrzej Wiecek, Michal Nowicki, Richard Moore, Jens Lutz, Martina Gaggl, and Marek Ferkl; Vienna, Austria; Berlin, Germany; Kaiserslautern, Germany; Katowice, Poland; Ldz, Poland; Cardiff, United Kingdom; Munich, Germany; and Harlow, United Kingdom O-289 12 MONTH FOLLOW UP RESULTS OF AN INITIAL INTENSIFIED DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN DE NOVO RENAL TRANSPLANT RECIPIENTS W. Arns, D. Kuypers, H. Tedesco Silva, K. Budde, A. Shoker, and H. Prestele; Cologne, Germany; Leuven, Belgium; So Paulo, Brazil; Berlin, Germany; Saskatchewan, Canada; and Basel, Switzerland

16:10

16:20

16:30

16:40

16:50

158

Tuesday 6 September
16:00 17:00

ORAL SESSION 36 Liver

Chairs: Christophe Duvoux, Paris, France; Costantino Fondevilla, Barcelona, Spain

Hall 1

16:00

O-290 LIVER TRANSPLANTATION FROM CARDIAC DEATH DONATION: CURRENT EXPERIENCE IN A SINGLE CENTRE Roberto Valente, Pablo Beltran, Shirin Khorsandi, Montse Juvany, Carlos Bernardos, John OGrady, Michael Heneghan, Wayel Jassem, Andreas Prachalias, Mohamed Rela, Parthi Srinivasan, and Nigel Heaton; London, United Kingdom O-291 A 10 MIN NO TOUCH TIME IN NON-HEART BEATING DONATION IS IT ENOUGH? Michael Sereinigg, Michael Zink, Andreas Puntschart, Ursula Mayrhauser, Bettina Leber, Thomas Seifert-Held, Iris WiedersteinGrasser, Sonja Kstenbauer, Karlheinz Tscheliessnigg, and Philipp Stiegler; Graz, Austria O-292 IMPACT OF ACUTE RENAL DISEASE DEFINED BY RIFLE CRITERIA IN LIVING DONOR LIVER TRANSPLANTATION Masashi Utsumi, Yuzo Umeda, Hiroshi Sadamori, Hiroaki Matsuda, Susumu Shinoura, Ryuichi Yoshida, Daisuke Satoh, Takahito Yagi, and Toshiyoshi Fujiwara; Okayama-city, Japan O-293 MONITORING LIVER-GRAFT DRUG METABOLZING CAPACITY USING PERIPHERAL BLOOD SAMPLE. CYP-PHENOTYPE AND GENOTYPE FREQUENCIES OF CYP2C9, CYP2C19, CYP3A4 AND CYP3A5 Laszlo Kobori, Eniko Sarvary, Zsuzsanna Gerlei, Janos Fazakas, Attila Doros, Denes Gorog, Imre Fehervari, Balazs Nemes, Manna Temesvari, Jozsef Paulik, and Katalin Monostory; Budapest, Hungary O-294 BEYOND THE MILAN CRITERIA: WHAT RISKS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA PROGRESSION BEFORE LIVER TRANSPLANTATION? Stefano Di Sandro, Abdallah Slim, Iacopo Mangoni, Alessandro Giacomoni, Andrea Lauterio, Plamen Mihaylov, Matteo Tripepi, Cinzia Poli, Luca Lamperti, Caterina Cusumano, and Luciano De Carlis; Milan, Italy O-295 HISTOLOGICAL EXAMINATION OF THE DONOR LARGE BILE DUCTS ISOLATED AFTER REPERFUSION DURING LIVER TRANSPLANTATION Gerd Otto, David Hollemann, Michael Heise, and Thorsten Hansen; Mainz, Germany

16:10

16:20

16:30

16:40

16:50

16:00 17:00

MINI ORAL SESSION 7 Pancreas

Chairs: Helmut Abrogast, Munich, Germany; Andrzej Baranski, Leiden, The Netherlands

Mini Theatre 1

16:00

MO-060 PANCREAS TRANSPLANTATION: DOES SURGERY RESULT IN HIGHER MORTALITY FOR DIABETICS? David van Dellen, Stephanie Trevelyan, Otilia M. Mitu-Pretorian, Abbas Ghazanfar, Bence Forgacs, Babatunde Campbell, Ravi Pararajasingam, Hany N. Riad, Neil R. Parrott, Judith Worthington, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom

159

Tuesday 6 September
16:05 MO-061 LAPAROSCOPIC ROBOT-ASSISTED PANCREAS TRANSPLANTATION Ugo Boggi, Fabio Vistoli, Stefano Signori, Simone DImporzano, Gabriella Amorese, Giovanni Consani, Fabio Guarracino, Piero Marchetti, Daniele Focosi, and Franco Mosca; Pisa, Italy MO-062 USE OF COMPUTED TOMOGRAPHY (CT) IN PANCREAS TRANSPLANTATION Faye Powell, Chris Callaghan, Simon Harper, Chris Watson, and Gavin Pettigrew; Cambridge, United Kingdom MO-063 PERCUTANEOUS ULTRASOUND-GUIDED BIOPSY OF PANCREAS ALLOGRAFT: IT IS SAFE, ESSENTIAL AND DIAGNOSTIC Michael Stephens, Jolene Witherspoon, Adel Ilham, David Griffiths, and Argiris Asderakis; Cardiff, United Kingdom MO-064 LUMINEX SCREENING FOR DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN PANCREAS TRANSPLANT ALONE Daniele Focosi, Monica De Donno, Margherita Occhipinti, Piero Marchetti, Fabio Vistoli, Ugo Boggi, and Fabrizio Scatena; Pisa, Italy MO-065 PANCREAS TRANSPLANTS AND REJECTION WITHIN ONE TRANSPLANT UNIT Colette Johnston, Victoria Bowman, Hany Riad, and Afshin Tavakoli; Manchester, United Kingdom MO-066 TRANSPLANT PANCREATITIS: TOWARDS DEFINING ALLOGRAFT FAILURE Stephanie Trevelyan, David van Dellen, Afshin Tavakoli, Titus Augustine, Bence Forgacs, Abbas Ghazanfar, Hany N. Riad, Neil R. Parrott, Babatunde Campbell, and Ravi Pararajasingam; Manchester, United Kingdom MO-067 AMYLASE AND LIPASE CONCENTRATION IN THE DRAINAGE FLUID BUT NOT IN THE SERUM INDICATE THE OCCURRENCE OF PANCREAS FISTULA FOLLOWING PANCREAS TRANSPLANTATION Guido Woeste, Christian Moench, Ingeborg Hauser, Ernst Scheuermann, Helmut Geiger, and Wolf O. Bechstein; Frankfurt, Germany MO-068 MYCOTIC ANEURYSMS FOLLOWING PANCREAS TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE Bence Forgacs, Abbas Ghazanfar, Otilia-Maria Mitu-Pretorian, David van Dellen, Gabriele Di Benedetto, Tunde Campbell, Hany Riad, Neil Parrott, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom MO-069 WHY ORGANS ARE TURNED DOWN AN ANALYSIS OF REASONS GIVEN FOR REJECTING OFFERED PANCREATA FROM GERMANY Karl Philipp Drewitz, Katja Kovac, Martin Loss, and Julika Loss; Regensburg, Germany; and Leiden, The Netherlands

16:10

16:15

16:20

16:25

16:30

16:35

16:40

16:45

160

16:00 17:00

MINI ORAL SESSION 8 Tissue injury /preservation

Mini Theatre 2

Chairs: Frank Dor, Rotterdam, The Netherlands; Steven Wigmore, Edinburgh, United Kingdom

Tuesday 6 September
16:00 MO-070 LEVELS OF A CHOLANGIOCYTE-ABUNDANT microRNA IN LIVER GRAFTS PRIOR TO TRANSPLANTATION ARE PREDICTIVE FOR LONG-TERM GRAFT SURVIVAL Waqar R.R. Farid, Jaap Kwekkeboom, Renee J. Verhoeven, Jeroen de Jonge, Petra E. de Ruiter, Herold J. Metselaar, Hugo W. Tilanus, Geert Kazemier, and Luc J.W. van der Laan; Rotterdam, The Netherlands MO-071 HIGH BOX GROUP RELEASE IN FATTY LIVER GRAFTS PRESERVED IN IGL-1 SOLUTION: A ROLE FOR PPARgamma Mohamed Amine Zaouali, Sussagna Padrissa-Alts, Judit GarcaVilloria, Antonia Ribes, Izabel Alfany-Fernndez, Hassen Ben Abdennebi, Emma Folch-Puy, and Joan Rosell-Catafau; Barcelona, Tunisia; Barcelona, Spain; and Monastir, Tunisia MO-072 PREVENTION OF ENDOPLASMIC RETICULUM STRESS BY KIDNEY GRAFT WASHOUT BEFORE TRANSPLANTATION Kaouther Hadj-Ayed, Asma Mahfoudh-Boussaid, Mohamed Amine Zaoual, Mohamed Bjaoui, Joan Rosell-Catafau, and Hassen Ben Abdennebi; Monastir, Tunisia; and Barcelona, Tunisia MO-073 SUCCESSFUL TRANSPLANTATION OF RAT AND PIG AORTIC GRAFTS AFTER LONG TERM PRESERVATION IN DEHYDRATED SODIUM CHLORIDE Magdalena Gewartowska, Michal Maksymowicz, Malgorzata Frontczak-Baniewicz, and Waldemar L. Olszewski; Warsaw, Poland MO-074 CORONIN-1 DEFICIENCY CONTRIBUTES TO CARDIAC PROTECTION FROM COLD I/R INJURY IN MOUSE Jianping Li, Rajesh Jayachandran, Friedrich Raulf, Grazyna Wieczorek, Andreas Katopodis, Marc Bigaud, Barbara NuessleinHildesheim, Christian Bruns, and Jean Pieters; Basel, Switzerland MO-075 A NEW PERSPECTIVE ON ORGAN PRESERVATION: THE PROTECTIVE EFFECTS OF BORON COMPOUNDS ON THE ISCHEMIA/REPERFUSION INJURIES Eyp Kahveci, Cigdem Ozer, Duygu Tozcu Altin, and Sevim Ercan; Ankara, Turkey MO-076 THE BEST PEG FOR ORGAN PRESERVATION? A PRECLINICAL STUDY Sebastien Giraud, Raphael Thuillier, Alexis Puichaud, Alexandre Valagier, Benoit Barrou, Michel Eugene, and Thierry Hauet; Poitiers, France; Surgeres, France; and Paris, France MO-077 ENDOTHELIAL TARGETED ANTICOAGULATION IN KIDNEY ALLOGRAFTS USING A PORCINE MACHINE PERFUSION THROMBOSIS MODEL Karim Hamaoui, Samir Damji, Richard Smith, Terry Cook, Anthony Dorling, and Vassilios Papalois; London, United Kingdom MO-078 EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT FOR KIDNEYS FROM DONORS AFTER CIRCULATORY DEATH DOES TEMPERATURE MATTER? A SYSTEMATIC REVIEW Iestyn M. Shapey, and Paulo Muiesan; Birmingham, United Kingdom MO-079 THE FINAL SHOWDOWN: PRECLINICAL COMPARISON BETWEEN PERFUSION MACHINES ORS Lifeport AND Waters RM3 Ricardo Codas, Raphael Thuillier, Pierre Olivier Delpech, Lionel Badet, Benoit Barrou, and Thierry Hauet; poitiers, France; Surgeres, Finland; Villeurbanne, France; Paris, Lyon, Nantes, France; and Paris, France

16:05

16:10

16:15

16:20

16:25

16:30

16:35

16:40

16:45

161

Tuesday 6 September
16:00 17:00

MINI ORAL SESSION 9 Ethics, legal and psychoscial aspects of transplantation

Chairs: Mike Bos, Den Haag, The Netherlands; Nizam Mamode, London, United Kingdom

Mini Theatre 3

16:00

MO-080 PRIORITY SETTING IN SWEDISH KIDNEY TRANSPLANTATION: ASSESSMENT FOR TRANSPLANT CANDIDACY AND ALLOCATION OF DECEASED DONOR KIDNEYS Faisal Omar, Per Carlsson, Marie Omnell-Persson, and Stellan Welin; Malm, Sweden MO-081 THE SOCIAL ORIGINS OF MORAL PERCEPTIONS AND PUBLIC POLICIES REGARDING THE BUYING, SELLING AND TRAFFICKING OF ORGANS Zvika Orr; Jerusalem, Israel MO-082 WITHDRAWN MO-083 NEW WAYS OF DYING CREATE NEW ETHICAL CHALLENGES FOR THE SPANISH MODEL OF ORGAN DONATION David Rodriguez-Arias; Bilbao, Spain MO-084 INTRODUCTION OF AN EARLY EDUCATIONAL PROGRAMME TO PROMOTE INFORMED DECISION MAKING REGARDING INITIAL RENAL REPLACEMENT THERAPY A.M.C.A. Da Silva, A.C. van Kooij, M.M.A. van den Dorpel, R.W. Nette, P.J.H. Smak Gregoor, W.C. Zuidema, R. Zietse, J.J. Busschbach, W. Weimar, and E.K. Massey; Rotterdam, The Netherlands; Rotterdam, The Netherlands; and Dordrecht, The Netherlands MO-085 LIVING KIDNEY DONATION AMONG ETHNIC MINORITIES: A DUTCH QUALITATIVE STUDY ON ATTITUDES, COMMUNICATION AND KNOWLEDGE OF KIDNEY PATIENTS S.Y. Ismail, A.E. Luchtenburg, L. Claassens, E.K. Massey, J.J. Busschbach, and W. Weimar; Rotterdam, The Netherlands MO-086 WHICH INTERVENTIONS ARE USED BY HEALTH CARE PROFESSIONALS TO ENHANCE MEDICATION ADHERENCE IN TRANSPLANT PATIENTS? A SURVEY OF CURRENT CLINICAL PRACTICE Lut Berben, Fabienne Dobbels, Christiance Kugler, Cindy Russell, and Sabina De Geest; Basel, Switzerland; Leuven, Belgium; Hannover, Germany; and Columbia, USA MO-087 THE LIVING DONOR STUDY CONCEPTS AND FRAMES OF LIVING KIDNEY DONORS Aimee C. Cunningham, Joan Leach, and Jonathan Fawcett; Woolloongabba, Brisbane,Australia; and Brisbane, Australia MO-088 UNSPECIFIED AND SPECIFIED LIVING KIDNEY DONATION TO UNRELATED RECIPIENTS Willij Zuidema, Jacqueline van de Wetering, Frank J.M.F. Dor, Joke I. Roodnat, Emma K. Massey, Jan N.M. IJzermans, and Willem Weimar; Rotterdam, The Netherlands

16:05

16:10 16:15

16:20

16:25

16:30

16:35

16:40

162

Tuesday 6 September
16:45 MO-089 ORGAN TRANSPLANTATION BETWEEN ALTRUISM AND JURIDICAL REGULATION Beatrice Ioan, Cristina Gavriluta, Andrei Holman, Mihaela Frunza, Irina Streba, Adina Karner-Hutuleac, Alexandra Enache, Lacrima Boila; Iasi, Romania; Cluj, Romania; Iasi, Romania; Timisoara, Romania; Tirgu Mures, Romania

16:00 17:00

RAPID ORAL SESSION 31 Kidney IX

HYBRID POSTER AREA Digital Display 1

Chairs: Jaap Homan van der Heide, Groningen The Netherlands; David Taube, London, United Kingdom 16:00 RO-313 NEW CONCEPT TOWARD CYCLOSPORINE BLOOD LEVEL EFFICACY IN KIDNEY TRANSPLANT PATIENT Bezad Einollahi, Zohreh Rostami, and Mojtaba Teimoori; Tehran, Islamic Republic of Iran RO-314 SURGICAL COMPLICATIONS INFLUENCE EARLY AND LATE KIDNEY GRAFT FUNCTION Slavomir Rokosny, Peter Balaz, Peter Wohlfahrt, Mariana Urbanova, Libor Janousek, and Milos Adamec; Prague, Czech Republic RO-315 EX-VIVO RECONSTRUCTION TECHNIQUES OF MULTIPLE RENAL ARTERIES IN LIVING DONOR KIDNEY TRANSPLANTATION Satheesh Iype, Andrew Butler, Christopher J.E. Watson, and Andrew Bradley; Cambridge, United Kingdom RO-316 DECREASE OF BLOOD-TYPE ANTIGENICITY OVER THE LONG-TERM AFTER ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION. CHIMERISM OF BLOOD TYPE ANTIGENS ON THE VESSEL ENDOTHELIUM IN A RECIPIENT WITH GRAFT LOSS Hideki Ishida, Tatsu Tanabe, Tomokazu Shimizu, Hiroki Shirakawa, Toshihito Hirai, Naoki Kouhei, and Kazunari Tanabe; Tokyo, Japan RO-317 PSA MONITORING IN MALE RENAL TRANSPLANT RECIPIENTS Catherine Byrne, Linda Evans, Keith M. Rigg, and Owen J. Cole; Nottingham, United Kingdom RO-318 NGAL AS A MARKER OF RENAL DAMAGE IN KIDNEY TRANSPLANTATION Katia Nisi, Olga Baraldi, Gaetano La Manna, Irene Capelli, Chiara Valentini, Giorgia Comai, Maria L. Cappuccilli, Anna Laura Chiocchini, Maria P. Scolari, and Sergio Stefoni; Bologna, Italy RO-319 DONATION AFTER CARDIAC DEATH (DCD): A SOURCE FOR KIDNEY TRANSPLANTATION Manuel Rengel, Almudena Vega, Soraya Abad, rsula Verdalles, and Eduardo Verde; Madrid, Spain RO-320 SYSTEMATIC REVIEW ON VITAMIN D PREVENTING AND TREATING BONE LOSS IN RENAL TRANSPLANT PATIENTS Yingming Xiao, Xianding Wang, and Yiping Lu; Chengdu, China RO-321 THE RISK OF CMV RECURRENCE AFTER KIDNEY TRANSPLANTATION Ilkka Helanter, Irmeli Lautenschlager, and Petri Koskinen; Helsinki, Finland

16:04

16:08

16:12

16:16

16:20

16:24

16:28

16:32

163

Tuesday 6 September
16:36 RO-322 CLINICAL FEATURES AND OUTCOME OF Klebsiella pneumoniae CARBAPENEMASE(KPC)-PRODUCING K.pneumoniae INFECTION AMONG KIDNEY TRANSPLANT RECIPIENTS Daniela S.M. Lopes, Tain V. Sandes-Freitas, Gislaine Ono, Vinicius P. da Silva, Ana C. Gales, Hlio Tedesco-Silva, and Jos O. Medina Pestana; So Paulo, SP, Brazil

16:00 17:00

RAPID ORAL SESSION 32 HYBRID POSTER AREA Digital Display 3 Clinical immunosuppression III
Chairs: Aksel Foss, Oslo, Norway; Richard Haynes, Oxford, United Kingdom

16:00

RO-323 IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS James A. Hutchinson, Paloma Riquelme, Stefan Tomiuk, Birgit Sawitzki, Hans J. Schlitt, Edward K. Geissler, and Fred Fndrich; Regensburg, Bavaria, Germany; Bergisch Gladbach, Germany; Berlin, Germany; and Kiel, Germany RO-324 A HIGH GLOMERULAR FILTRATION RATE (GFR) AND THE USE OF AN ENTERIC-COATED FORMULATION OF MYCOPHENOLIC ACID PREDICT LESS GASTROINTESTINAL COMPLAINTS IN RENAL TRANSPLANT PATIENTS F. Ortega, A. Snchez-Fructuoso, J.M. Cruzado, J.C. GmezAlamillo, A. Alarcn, Ll. Pallard, J.M. Morales, J. Oliver, and G. Guinea; Oviedo, Spain; Madrid, Spain; Barcelona, Spain; Santander, Spain; Mallorca, Spain; Valencia, Spain; and A Corua, Spain RO-325 INTRAVENOUS MYCOPHENOLATE MOFETIL WITH CALCINEURIN INHIBITOR FOR RENAL PRESERVATION FOLLOWING LIVER TRANSPLANTATION AshokKumar Jain, Ashish Singhal, Serban Constantinescu, Avrum Gillespie, and Andreas Karachristos; Philadelphia, USA RO-326 THYMOGLOBULINE PRE-TREATMENT AND MINIMIZATION OF IMMUNOSUPPRESSION WITH ADVAGRAF IN LIVER TRANSPLANTATION: PRELIMINARY RESULTS OF OUTCOME AFTER 1 YEAR OF A PROSPECTIVE RANDOMIZED TRIAL Nicola De Ruvo, Fabrizio Di Benedetto, Giuseppe Tarantino, Nicola Cautero, Roberto Montalti, Gianpiero Guerrini, Roberto Ballarin, Rosa M. Iemmolo, Mario Spaggiari, and Giorgio E. Gerunda; Modena, Italy RO-327 CONVERSION FROM CNI TO mTOR INHIBITORS IMPROVES RENAL FUNCTION IN KIDNEY ALLOGRAFT RECIPIENTS WITH MALIGNANCIES Ninoslav Ivanovski, Antoine Jacquet, Alexandre Seidowski, Severine Beaudreuil, Raluca Matesan, Erica Nnang Obada, Hedia Hebibi, Bernard Charpantier, Antoine Durrbach, and Helene Francois; Le Kremlin Bictre, France RO-328 PROLIFERATION SIGNAL INHIBITORS (PSI) CAN BE SAFELY USED AB INITIO AFTER DUAL KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS (ED) Lucrezia Furian, Elisa S. Pierobon, Cristina Silvestre, Emanuele Di Fratta, Paola Donato, Margherita Moro, Andrea Soligo, Nicola Baldan, and Paolo Rigotti; Padua, Italy

16:04

16:08

16:12

16:16

164

16:20

Tuesday 6 September
16:24 RO-329 INTERSTITIAL PNEUMONITIS CAUSED BY EVEROLIMUS; A CASE CONTROL STUDY Marije C. Baas, Geertrude H. Struijk, Dirk J. Moes, Ingrid A. van den Berk, Renee E. Jonkers, Johan Willem de Fijter, Jaap J. Homan, Ineke J. ten Berge, and Frederike J. Bemelman; Amsterdam, The Netherlands; Leiden, The Netherlands; and Groningen, The Netherlands RO-330 PHARMACOKINETICS AND PHARMACODYNAMICS OF TACROLIMUS AND ITS METABOLITES IN KIDNEY TRANSPLANTED PATIENTS; THE RELATIONSHIP WITH THE CYP3A4, CYP3A5, MDR1 GENOTYPES Se-Hee Yoon, Mi-Kyung Jin, Owen Kwon, Kyungdeuk Hong, Jang Hee Cho, Ji-Young Choi, Sun-Hee Park, Yong-Lim Kim, and ChanDuck Kim; Daegu, Republic of Korea RO-331 DONOR SUB-TYPE ANALYSIS OF THREE-YEAR OUTCOMES FROM A PHASE III STUDY OF BELATACEPT IN RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS (BENEFIT-EXT TRIAL) Ferdinand Muehlbacher, Thomas Becker, Josep M. Campistol, Deise B.M. Carvalho, Sander Florman, Philippe Lang, Tao Duan, Mamta Agarwal, and Christian P. Larsen; Vienna, Austria; Hannover, Germany; Barcelona, Spain; Rio de Janeiro, Brazil; New York, USA; Creteil, France; Hopewell, USA; Princeton, USA; and Atlanta, USA RO-332 METASTASIS OR DOUBLE DE NOVO? MOLECULAR AND PATHOLOGIC ANALYSIS OF SIMULTANEOUS RENAL CELL CARCINOMAS IN BOTH NATIVE AND TRANSPLANT KIDNEYS Medhat Askar, Edgar Huang, Bashir Sankari, Steve Jones, and ShihChieh Chueh; OH, USA; WV, USA; and Charleston, WV, USA

16:28

16:32

16:36

16:00 17:00

RAPID ORAL SESSION 33 Pancreas

HYBRID POSTER AREA Digital Display 5

Chairs: Torbjorn Lundgren, Stockholm, Sweden; Frantisek Saudek, Prague, Czech Republic 16:00 RO-333 PANCREAS-KIDNEY TRANSPLANTATION ANALYSIS ON 121 CASES FROM ONE CENTRE La Salete Martins, Isabel Fonseca, Antonio C. Henriques, Leondio Dias, Manuela Almeida, Sofia Pedroso, Rui Alemida, Antonio Cabrita, and Manuel Teixeira; Oporto, Portugal RO-334 INDICATIONS AND OUTCOMES OF AN ILEOSTOMY FOLLOWING PANCREAS TRANSPLANTATION Okechukwu O. Okidi, Bence Forgacs, Tunde Campbell, Neil Parrot, Titus Augustine, Afshin Tavakoli, and Ravi Pararajasingam; Manchester, United Kingdom RO-335 ENTERIC DRAINAGE OF PANCREATIC TRANSPLANT PSEUDOCYSTS: MANAGEMENT OPTIONS David Nasralla, Murali Somasundaram, David Mitchell, and Jens Brockmann; Oxford, United Kingdom; and Zurich, Switzerland RO-336 MANAGEMENT OF RUPTURED MYCOTIC PSEUDOANEURYSM FOLLOWING PANCREAS-KIDNEY TRANSPLANTATION Mohammed Z. Akhtar, Edward Sideso, Anil Vaidya, Sanjay Sinha, and Christopher Darby; Oxford, United Kingdom

16:04

16:08

16:12

165

Tuesday 6 September
16:16 RO-337 ASA PHYSICAL STATUS CLASSIFICATION SYSTEM IN PANCREAS TRANSPLANTATION OUTCOMES; DOES IT ACCURATELY PREDICT RISK? Melissa Oliveira-Cunha, David van Dellen, Gabriele Di Benedetto, Otilia Maria Mitu-Pretorian, Hani Zacharia, Abbas Ghazanfar, Bence Forgacs, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom RO-337/A SIROLIMUS/TACROLIMUS VS MMF/TACROLIMUS IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION (SPKTx): A 3 YEAR FOLLOW-UP IN A SINGLE CENTER Frantisek Saudek, Peter Girman, Kvetoslav Lipar, Petr Boucek, Radomira Koznarova, Tereza Havrdova, Milos Adamec; Prague, Czech Republic

16:20

16:00 17:00

RAPID ORAL SESSION 34 HYBRID POSTER AREA Immunobiology /Basic science III Digital Display 7
Chairs: Maria Cristina Cuturi, Nantes, France; Lorna Marson, Edinburgh, United Kingdom

16:00

RO-338 INTRARENAL IFN mRNA EXPRESSION DIFFERENTIATES CLINICAL AND SUBCLINICAL GLOMERULITIS IN RENAL TRANSPLANT RECIPIENTS Philippe Grimbert, David Buob, Philippe Lang, and Marc Hazan; Creteil, France, Metropolitan; and Lille, France RO-339 POST-OPERATIVE EXERCISE INDUCED PROLONGED SURVIVAL OF CARDIAC GRAFTS AND REGULATORY CD4+ CELLS Masateru Uchiyama, Xiangyuan Jin, Qi Zhang, Atsushi Amano, and Masanori Niimi; Tokyo, Japan; and Harbin, China RO-340 OLFACTORY DYSFUNCTION IMPAIRED PROLONGATION EFFECT OF CARDIAC ALLOGRAFT SURVIVAL BY SMELL OF Tokishakuyaku-san IN MICE Xiangyuan Jin, Masateru Uchiyama, Qi Zhang, and Masanori Niimi; Tokyo, Japan; and Harbin, China RO-341 IMPACT OF POLYMORPHISMS OF TLR3 ON ACUTE REJECTION IN LIVER TRANSPLANTATION FOR HEPATITIS C CIRRHOSIS Maria J. Citores, Isolina Baos, Ana Noblejas, Raquel Castejon, Silvia Rosado, and Valentin Cuervas-Mons; Majadahonda, Spain RO-342 SIGNIFICANCE OF CD127 VERSUS FOXP3 TO DEFINE REGULATORY T CELLS IN TOLERANT RECIPIENTS AFTER PEDIATRIC LIVING-DONOR LIVER TRANSPLANTATION Hanaa Nafady-Hego, Ying Li, Hidenori Ohe, Hamed Elgendy, Shimon Sakaguchi, Shinji Uemoto, and Takaaki Koshiba; Kyoto, Japan RO-343 ACTIVATED T CELLS AND CYTOKINES PRODUCTIONS CORRELATES WITH CLINICAL OUTCOMES IN CHRONIC RENAL ALLOGRAFT REJECTION Ines Humar, and Maja Puc; Zagreb, Croatia

16:04

16:08

16:12

16:16

16:20

166

Tuesday 6 September
16:24 RO-344 EX-VIVO LUNG PERFUSION REDUCES GRAFT IMMUNOGENICITY VIA THE REMOVAL OF PASSENGER MONOCY-TES A PORCINE MODEL James E. Fildes, Christopher M. Puchalka, Alexander T. Glover, Hannah J. Sevenoaks, Mohammed Madi, Moa Karlsson-Nellbring, Trygve Sjberg, Nizar Yonan, and Stig Steen; Manchester, United Kingdom; and Lund, Sweden RO-345 FASTING INDUCES RAPID MATURATION AND MOBILIZATION OF T AND B LYMPHOCYTES Shushimita Shushimita, R.W.F. de Bruin, T.M. van Ginhoven, K. van der Weerd, S. van den Engel, J.N.M. IJzermans, and F.J.M.F. Dor; Rotterdam, The Netherlands RO-346 MUSIC EXPOSURE INDUCED PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL AND GENERATED REGULATORY CD4+ CELLS Masateru Uchiyama, Xiangyuan Jin, Qi Zhang, Atsushi Amano, and Masanori Niimi; Tokyo, Japan; and Harbin, China RO-347 WITHDRAWN

16:28

16:32

16:36 16:00 17:00

RAPID ORAL SESSION 35 HYBRID POSTER AREA Digital Display 8 Clinical Immunosuppression IV
Chairs: Chris Dudley, Bristol, United Kingdom; Sanjay Sinha, Oxford, United Kingdom

16:00

RO-348 THE P450 OXIDOREDUCTASE ([italic]POR[/italic])*[italic] 28C[gt]T[/italic] SINGLE NUCLEOTIDE POLYMORPHISM (SNP) IS ASSOCIATED WITH EARLY TACROLIMUS UNDEREXPOSURE AND HIGHER DOSE REQUIREMENTS IN CYP3A5-EXPRESSING RENAL RECIPIENTS Dirk R. Kuypers, Hylke de Jonge, Dieter Lambrechts, Yves Vanrenterghem; Leuven, Belgium RO-349 IMMUNE MONITORING DURING TOL101-ANTI-[alpha] [beta]TCR MONOCLONAL ANTIBODY THERAPY PHASE 2 RENAL TRANSPLANT TRIALS Alexander C. Wiseman, Shamkant Mulgaonkar, Randall S. Sung, Larry B. Melton, Thomas H. Waid, John S. Thompson, Stephen A. Brown, Meghann K. Teague Getts, Terra J. Frederick, Daniel R. Getts, Stuart M. Flechner; Aurora, USA; Livingston, USA; Ann Arbor, USA; Dallas, USA; Lexington, USA; Kalamazoo, USA; Chicago, USA; Cleveland, USA RO-350 CONVERSION FROM TACROLIMUS CAPSULES TWICE DAILY TO TACROLIMUS TABLETS ONCE DAILY IN STABLE KIDNEY TRANSPLANT PATIENTS: EFFICACY RESULTS FROM A PHASE III, OPEN-LABEL, MULTICENTER, PROSPECTIVE, RANDOMIZED STUDY L. Rostaing, K. Ciechanowski, S. Bunnapradist, S. Mulgaonkar; Toulouse, France RO-351 IMMUNOSUPPRESSION MONITORING BY Cylex Immu know TEST AFTER LIVER TRANSPLANTATION: PRELIMINARY RESULTS OF RANDOMIZED PROSPECTIVE TRIAL Matteo Ravaioli, Cristina Morelli, Massimo Del Gaudio, Matteo Zanello, Sonia Berardi, Giorgio Ercolani, Matteo Cescon, Alessandro Cucchetti, Tiziana Lazzarotto, Antonio Daniele Pinna; Bologna, Italy

16:04

16:08

16:12

167

Tuesday 6 September
16:16 RO-352 ECULIZUMAB THERAPY IN REFRACTORY RECURRENCE OF THROMBOTIC MICRO ANGIOPATHY ASSOCIATED TO ANTIPHOSPHOLIPID ANTIBODIES AFTER RENAL TRANSPLANTATION Karine Hadaya, Sylvie Ferrari-Lacraz, David Fumeaux, Franoise Boehlen, Solange Moll, Pierre-Yves Martin, Jean Villard; Geneva, Switzerland RO-353 PRESERVATION OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS WITH CERTICAN-BASED VS CNI-BASED THERAPY: THE PROTECT STUDY Hans J. Schlitt, Frank Lehner, Peter Neuhaus, Jan Schmidt, Thomas Becker, Michael A. Hack, Stephan Ladenburger, Lutz Fischer; Regensburg, Germany; Hannover, Germany; Berlin, Germany; Heidelberg, Germany; Kiel, Germany; Nuernberg, Germany; Hamburg, Germany RO-354 TEN YEARS IMMUNOSUPPRESSION AVOIDANCE IMPROVE THE NATURAL COURSE OF CIRRHOSIS RECURRENCE IN HCV LIVER TRANSPLANT RECIPIENTS Tommaso Maria Manzia, Leonardo Baiocchi, Roberta Angelico, Luca Toti, Annachiara Casella, Gennaro Giustino, Laura Fazzolari, Daniele Sforza, Matteo Manuelli, Giampiero Palmieri, Giuseppe Tisone; Rome, Italy RO-355 IMMUNOGENETICS TO INDIVIDUALIZE INDUCTION IMMUNOSUPPRESSION Vladimir Abramov, Jan Moisiuk; Moscow, Russian Federation RO-356 STEROID FREE IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION: A USEFUL ALTERNATIVE P. N. Gupta, S. Jain, S. Pokhariyal, S. B. Bansal, V. Saxena, R. Sharma, M. Singhal, S. Gulati, R. Ahlawat, V. Kher; Gurgaon, India; New Delhi, India; Noida, India RO-357 INFLAMMATORY CYTOKINES PROFILE AFTER ONCEDAILY TACROLIMUS CONVERSION IN STABLE KIDNEY TRANSPLANT RECIPIENTS Francesca Tinti, Aurela Meule, Alessandra Bachetoni, Mariadomenica DAlessandro, Cristiano Alessandri, Ilaria Umbro, Alessandro Pignatelli, Luca Poli, Pasquale B. Berloco, Anna Paola Mitterhofer; Rome, Italy

16:20

16:24

16:28

16:32

16:36

168

170

Wednesday 7 September
08:00 09:00

CLINICAL CASES SESSION 5 Early post-transplant problems

Chairs: Diego Cantarovich, Nantes, France; Jonas Wadstrom, Uppsala, Sweden

Mini Theatre 1

08:00

CC-013 RENAL TRANSPLANTATION IN A PATIENT WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND HEPARIN INDUCED THROMBOCYTOPENIA Betzalel Podolak, Dorit Blickstein, Ruth Rahamimov, Aida Inbal, and Eytan Mor; Petach-Tiqwa, Israel Case discussion CC-014 SEVERE UNEXPLAINED TMA AFTER ABOi, A CONTRAINDICATION TO RETRANSPLANTATION? Colin J. Forman, Ben Pullar, and Nizam Mamode; London, United Kingdom Case discussion CC-015 WHAT IMMUNOSUPPRESSIVE TREATMENT SHOULD ONE ENVISAGE WHEN TRANSPLANTECTOMY HAS TO BE CARRIED OUT IMMEDIATELY AFTER TRANSPLANTATION? Anne Parissiadis, Nadine Froelich, Vronique Renner, Bruno Moulin, Daniel Hanau, and Sophie Caillard; Strasbourg, France Case discussion

08:10 08:20

08:30 08:40

08:50 08:00 09:00

CLINICAL CASES SESSION 6 Rejection

Chairs: Christophe Legendre, Paris, France; Bjorn Nashan, Hamburg, Germany

Mini Theatre 2

08:00

CC-016 NEPHROTIC PROTEINURIA AS THE MAIN CLINICAL PRESENTATION OF ACUTE REJECTION IN A RENAL TRASPLANTED PATIENT Ana M. Linchenco, Maria C. Vazquez, Jose L. Sgrosso, Maria A. Gini, Sebastian Jaurretche, and Jaime Ferrer; Rosario, Argentina Case discussion CC-017 LATE RENAL ALLOGRAFT DYSFUNCTION-BK-ACUTE REJECTION: A CONUNDRUM Hatem Amer, and Fernando G. Cosio; Rochester, USA Case discussion CC-018 SALVAGE THERAPY FOR REFRACTORY REJECTION AND PERSISTENCE OF DONOR-SPECIFIC ANTIBODIES AFTER INTESTINAL TRANSPLANTATION USING THE PROTEASOME INHIBITOR BORTEZOMIB Undine A. Gerlach, Constanze Schoenemann, Nils Lachmann, Peter Neuhaus, and Andreas Pascher; Berlin, Germany Case discussion

08:10 08:20

08:30 08:40

08:50

171

Wednesday 7 September
08:00 09:00

CLINICAL CASES SESSION 7 Mini Theatre 3 Challenges in Clinical Transplantation

Chairs: Peter Friend, Oxford, United Kingdom; Keith Rigg, Nottingham, United Kingdom

08:00

CC-019 ALTRUISTIC DONATION: DO THE MEDICAL PROFESSIONALS EVER HAVE THE RIGHT TO SAY NO? Fiona McCaig, Sarah Lundie, Sarah Milne, John L. Forsythe, Gabriel C. Oniscu; Edinburgh, United Kingdom Case discussion CC-020 INTERDISCIPLINARY EFFORT TO DIAGNOSE AND TREAT A POSTTRANSPLANT PATIENT WITH SEVERE CEREBRAL LESIONS IN SYNOPSIS WITH THE INTRAINDIVIDUALLY COMPLEX PHARMACOLOGICAL SITUATION Ursula Wolf, Gerrit Klipp, Tobias J. Mller, Ilka Schneider, Katja E. Wartenberg, Hans H. Wolf, Peter Presek; Halle, Germany Case discussion CC-021 STRONGLY DONOR-SPECIFIC ANTIBODIES AND ABSENCE OF ACUTE REJECTION AFTER COMBINED HEART AND LIVER TRANSPLANTATION, CASE REPORT Samir Saheb, Daniel Eyraud, Flor Fernandez, Maryvonnick Carmagnat, Philippe Rouvier, Akhtar Rama, Vincent Breant, Charles Edouard Luyt, Pascal Lebray, Caroline Suberbielle-Boissel, Serge Herson, Pascal Leprince, Shaida Varnous, Jean Christophe Vaillant, Alain Pavie; Paris, France Case discussion

08:10 08:20

08:30 08:40

08:50 08:00 09:00

ORAL SESSION 37 Non-renal DCD/ECD

Chairs: Andrew Butler, Cambridge, United Kingdom; Juan Carlos Valdecasas, Barcelona, Spain

Alsh

08:00

O-296 SEPTUAGENARIAN AND OCTAGENARIAN DONORS PROVIDE EXCELLENT LIVER GRAFTS FOR TRANSPLANTATION Tom Darius, Diethard Monbaliu, Raymond Aerts, Ina Jochmans, Bruno Desschans, Willy Coosemans, Tania Roskams, Werner Van Steenbergen, Chris Verslype, Wim Laleman, Frederik Nevens, and Jacques Pirenne; Leuven, Belgium O-297 APPLICABILITY OF DONATION AFTER CARDIAC DEATH LIVER TRANSPLANT USING MAASTRICHT TYPE 2 DONORS A.J. Hessheimer, C. Fondevila, E. Flores, A. Ruiz, N. Mestres, D. Calatayud, S. Snchez, R. Garca, J. Ferrer, J. Fuster, M. Navasa, A. Rimola, P. Taur, B. Miranda, and J.C. Garca-Valdecasas; Barcelona, Spain

08:10

172

Wednesday 7 September
08:20 O-298 LIVER TRANSPLANTATION FROM DONATION AFTER CARDIOCIRCULATORY DEATH (DCD) DONORS: BELGIAN EXPERIENCE 2003-2009 Arnaud De Roover, Hieu Le Dinh, Olga Cicarelli, Jan Lerut, Peter Michielsen, Dirk Ysebaert, Valerio Lucidi, Vincent Donckier, Hans Vanvlierberghe, Xavier Rogiers, Roberto Troisi, Diethard Monbaliu, Frederik Nevens, Jacques Pirenne, and Olivier Detry; Lige, Belgium; Brussels, Belgium; Antwerp, Belgium; Ghent, Belgium; and Leuven, Belgium O-299 ISCHEMIC CHOLANGIOPATHY IN LIVER TRANSPLANTATION USING DONATION AFTER CARDIAC DEATH DONORS: ANALYSIS OF A MATCHED CONTROL STUDY IN A SINGLE LARGE VOLUME CENTER Michelle L. DeOliveira, Wayel Jassem, Roberto Valente, Shirin E. Khorsandi, Greogorio Santori, Andreas Prachalis, Parthi Srinivasan, Mohamed Rela, and Nigel Heaton; London, United Kingdom; Zurich, Switzerland; and Genoa, Italy O-300 AGGRESSIVE LUNG DONOR MANAGEMENT INCREASES GRAFT PROCUREMENT WITHOUT INCREASING THE RISK OF RENAL GRAFT LOSS AFTER KIDNEY TRANSPLANTATION Eduardo Miambres, Maria Angeles Ballesteros, Emilio Rodrigo, Ana Garca-Miguelez, Javier Llorca, Juan Carlos Ruiz, and Manuel Arias; Santander, Spain O-301 EXTRA CORPOREAL MEMBERANE OXYGENATION(ECMO) VS COLD PRESERVATION(CP) IN PORCINE DONATION AFTER CARDIAC DEATH(DCD) CATEGORY-2 DONOR LIVERS Aditya Kanwar, Christopher Ray, Saleem Noormohammed, Stephen Ray, Mohammed Arslan Khurram, Susan Stamp, Louis Libbrecht, Diethard Monbaliu, Robert Peaston, Patrick Kesteven, Jon Smith, Noel Carter, Anne Cunningham, and David Talbot; Newcastle upon Tyne, United Kingdom; Sunderland, United Kingdom; and Leuven, Belgium

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 38 Clinical immunosuppression

Chairs: Inese Folkmane, Riga, Latvia; Flavio Vincenti, San Francisco, United States

Boisdale 1 & 2

08:00

O-302 MECANO: MYCOPHENOLATE SODIUM VS EVEROLIMUS OR CICLOSPORIN WITH ALLOGRAFT NEPHROPATHY AS OUTCOME STUDY: CLINICAL RESULTS Jaap J. Homan van der Heide, Johan W. de Fijter, Ineke ten Berge, Eltjo F. de Maar, and Frederike J. Bemelman; Groningen, The Netherlands; Leiden, The Netherlands; and Amsterdam, The Netherlands O-303 A HIGHER DECREASE IN TACROLIMUS TROUGH BLOOD LEVELS FOLLOWING TWICE-DAILY TO ONCE-DAILY TACROLIMUS CONVERSION OCCURS IN STEROID FREE RENAL ALLOGRAFT RECIPIENTS Marta Crespo, Marisa Mir, Clara Barrios, Anna Faura, Eloisa Tellez, Mnica Marn, Josep M. Puig, and Julio Pascual; Barcelona, Spain

08:10

173

Wednesday 7 September
08:20 O-304 STEROID FREE DESENSITIZATION IN LIVING DONOR KIDNEY TRANSPLANTATION: A CASE CONTROL STUDY William C. Goggins, Angie Qualey, John Powelson, Tim Taber, Jeanne Chen, Chris Robertson, and Richard S. Mangus; Indianapolis, USA O-305 LOBSTER LIVER OBSERVATIONAL STUDY TO ASSESS THE EFFECT OF MYCOPHENOLATE MOFETIL ON RENAL FUNCTION IN LIVER TRANSPLANT PATIENTS Hans J. Schlitt, Sven Jonas, Tom M. Ganten, Thomas Becker, Christian Moench, Falk Rauchfuss, Aiman Obed, Guiseppe Tisone, Daniele A. Pinna, Giorgio E. Gerunda, and Susanne Beckebaum; Regensburg, Germany; Leipzig, Germany; Heidelberg, Germany; Hannover, Germany; Frankfurt, Germany; Jena, Germany; Goettingen, Germany; Rome, Italy; Bologna, Italy; Modena, Italy; and Essen, Germany O-306 INTERLEUKIN 2 RECEPTOR ANTAGONISTS FOR LIVER TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND METAANALYSIS OF CONTROLLED STUDIES Armin D. Goralczyk, Nicola Hauke, Narin Bari, Thomas Lorf, and Aiman Obed; Goettingen, Germany O-307 LONG-TERM EFFECTS OF ATG INDUCTION THERAPY ON THE HUMORAL IMMUNE RESPONSE Rolf Weimer, Maryam Ettrich, Hartmut Dietrich, Fabrice Renner, Caner Ssal, Sabine Deisz, Winfried Padberg, and Gerhard Opelz; Giessen, Germany; and Heidelberg, Germany

08:30

08:40

08:50

08:00 09:00

ORAL SESSION 39 Histocompatibility

Chairs: Phil Dyer, Edinburgh, United Kingdom; Antonj Slavcec, Prague, Czech Republic

Forth

08:00

O-308 ALLOSENSITIZATION IN SIMULTANEOUS LIVER-KIDNEY TRANSPLANTS: DO LIVERS EVEN PROTECT THEMSELVES? Medhat Askar, John Fung, Titte Srinivas, Stuart Flechner, Bruce Kaplan, Bijan Eghtesad, Charles Miller, Cristiano Quintini, Nizar Zein, and Jesse Schold; OH, USA; and Tucson, USA O-309 IMPACTS OF DONOR-RECIPIENT HLA MATCHING ON OPERATIONAL TOLERANCE FOLLOWING PEDIATRIC LIVINGDONOR LIVER TRANSPLANTATION Hidenori Ohe, Kayo Waki, Mami Yoshitomi, Takeshi Morimoto, Hanaa Nafady Hego, Shimon Sakaguchi, Shinji Uemoto, and Takaaki Koshiba; Kyoto, Japan; Tokyo, Japan; and Osaka, Japan O-310 PRE-TRANSPLANT ENDOTHELIAL CROSSMATCH CORRELATES WITH ACUTE REJECTION EPISODES IN LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS John Friedewald, Shivani Shah, Charles Jie, Jennifer Wehner, Joseph Leventhal, and Anat Tambur; Chicago, USA O-311 THE IMPACT OF A VIRTUAL CROSSMATCHING POLICY ON COLD ISCHAEMIC TIMES AND OUTCOME FOLLOWING DECEASED DONOR TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE Camilla J. Stewart, Sussie Shrestha, David M. Turner, Phil A. Dyer, and Lorna P. Marson; Edinburgh, United Kingdom

08:10

08:20

174

08:30

Wednesday 7 September
08:40 O-312 RESULTS OF COMPLETELY HLA MISMATCHED LIVING DONOR KIDNEYS ARE AS GOOD AS THOSE OF HLA IDENTICAL DECEASED DONOR KIDNEYS Mirjam Laging, Judith A. Kal-van Gestel, Jacqueline van de Wetering, Jan N.M. IJzermans, Willem Weimar, and Joke I. Roodnat; Rotterdam, The Netherlands O-313 HIGH RESOLUTION THREE-DIMENSIONAL MODELLING OF HLA CLASS I STRUCTURE AND SURFACE ELECTROSTATIC POTENTIAL REVEALS THE MOLECULAR BASIS FOR ALLOANTIBODY BINDING EPITOPES Vasilis Kosmoliaptsis, Timothy R. Dafforn, Afzal N. Chaudhry, David J. Halsall, J. Andrew Bradley, and Craig J. Taylor; Cambridge, United Kingdom; and Birmingham, United Kingdom

08:50

08:00 09:00

ORAL SESSION 40 Paediatric transplantation

Chairs: Michele Colledan, Bergamo, Italy; Rainer Ganschow, Hamburg, Germany

Gala

08:00

O-314 FAMILY STRAIN AFTER PEDIATRIC LIVER TRANSPLANTATION Irene Petersen, Tanja Kaller, Nadine Langguth, Rainer Ganschow, Bjrn Nashan, and Karl-Heinz Schulz; Hamburg, Germany O-315 COGNITIVE FUNCTIONING IN CHILDREN WITH BILIARY ATRESIA AFTER LIVER TRANSPLANTATION Tanja Kaller, Nadine Langguth, Rainer Ganschow, Bjrn Nashan, and Karl-Heinz Schulz; Hamburg, Germany O-316 BEHAVIOUR AND SOCIAL FUNCTIONING AFTER PAEDIATRIC LIVER TRANSPLANTATION Tanja Kaller, Nadine Langguth, Rainer Ganschow, Bjrn Nashan, and Karl-Heinz Schulz; Hamburg, Germany O-317 LIVER Re-TRANSPLANTATION (LReT) IN CHILDRENANALYSIS OF EUROPEAN LIVER TRANSPLANT REGISTRY OVER THREE DECADES Vibha Varma, Vanessa M. Banz, Vincent Karam, Bridget Gunson, Reymond Redding, Nigel Heaton, Jurgen L. Klempnaur, Xavier Rogiers, Denis Castaing, Frdric Gauthier, Michelle Colledan, Rene Adam, and Darius F. Mirza; Birmingham, United Kingdom; London, United Kingdom; and Hannover, Germany O-318 OUTCOME OF EARLY AND LATE LIVER RETRANSPLANTATION IN CHILDREN IN COMPARISON TO PRIMARY TRANSPLANTATION Uta Herden, Rainer Ganschow, Enke Grabhorn, Bjoern Nashan, and Lutz Fischer; Hamburg, Germany O-319 CAMPATH FOR INDUCTION OF IMMUNOSUPRESSION IN PEDIATRIC KIDNEY TRANSPLANTATION Michael M. Kaabak, Nadezda N. Babenko, Alan K. Zokoyev, and Alexey A. Maschan; Moscow, Russian Federation

08:10

08:20

08:30

08:40

08:50

175

Wednesday 7 September
09:00 O-319/A THE ASSOCIATION BETWEEN PRETRANSPLANT SOLUBLE CD40 LIGAND PLASMA LEVELS, THE PRESENCE OF ANTIHLA ANTIBODIES AND GRAFT DYSFUNCTION IN PEDIATRIC LIVING DONOR LIVER TRANSPLANT RECIPIENTS Sergey V. Gautier, Olga M. Tsirulnikova, Olga E. Gichkun, Aleksander A. Ammosov, and Olga P. Shevchenko; Moscow, Russian Federation

08:00 09:00

ORAL SESSION 41 Kidney

Chairs: Eva Pokorna, Prague, Czech Republic; Nicholas Torpey, Cambridge, United Kingdom

Lomond

08:00

O-320 POSTTRANSPLANT HLA ANTIBODY OCCURRENCE CORRELATES WITH HUMORAL REJECTION IN PEDIATRIC KIDNEY RECIPIENTS Fabrizio Ginevri, Angelica Parodi, Iris Fontana, Alberto Magnasco, Annalisa Innocente, Angela Sementa, Angela Nocco, Teresa Cavallero, Francesca R, Arcangelo Nocera, Umberto Valente, Patrizia Comoli, Massimo Cardillo, Mario Scalamogna, and Francesca Poli; Genoa, Italy; Milan, Italy; and Pavia, Italy O-321 EFFICACY OF DESENSITIZATION THERAPY IN LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS WITH LOW-LEVEL DONOR-SPECIFIC SENSITIZATION Alexander Yussim, Michael Gurevitch, and Eytan Mor; Petach Tikva, Israel O-322 COMBINED INTRODUCTION OF ANTI-IL2 RECEPTOR ANTIBODIES, MYCOPHENOLIC ACID AND TACROLIMUS: EFFECT ON MALIGNANCIES IN A SINGLE CENTRE RETROSPECTIVE COHORT STUDY OF 929 RENAL TRANSPLANT RECIPIENTS Philippe Braconnier, Vronique Delmarmol, Nilufer Broeders, Mireille Kianda, Annick Massart, Anne Lemy, Lidia Ghisdal, Alain Le Moine, Philippe Madhoun, Judith Racap, Daniel Abramowicz, and Karl M. Wissing; Brussels, Belgium O-323 LYMPHOPROLIFERATIVE DISORDERS IN RENAL TRANSPLANTATION: ANY CHANGE IN TWO DECADES? Antonio Franco, Luis Jimenez, Carlos Sillero, Miguel Trigueros, Dione Gonzalez, and Jesus Olivares; Alicante, Spain O-324 LONG-TERM IMMUNOLOGICAL EFFECTS OF ATG INDUCTION ASSOCIATED WITH AN INCREASED RISK OF INFECTION Rolf Weimer, Fabrice Renner, Maryam Ettrich, Hartmut Dietrich, Sabine Deisz, Volker Daniel, Shirin Kamali-Ernst, Wolfgang Ernst, Winfried Padberg, and Gerhard Opelz; Giessen, Germany; Heidelberg, Germany; Wetzlar, Germany; and Langenselbold, Germany O-325 FUNCTIONAL PARALYSIS OF CD8 MEMORY T CELLS AFTER RABBIT ANTITHYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANT PATIENTS Anne P. Bouvy, Marcia M.L. Kho, Mariska Klepper, Jan N.M. IJzermans, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands

08:10

08:20

08:30

08:40

08:50

176

Wednesday 7 September
08:00 09:00 LIVE WEB STREAM 08:00

ORAL SESSION 42 Late breaking

Clyde Auditorium

Chairs: John Forsythe, Edinburgh, United Kingdom; Alan Jardine, Glasgow, United Kingdom LB-O-001 EVALUATING SAFETY AND EFFICACY OF TOL101 INDUCTION TO PREVENT KIDNEY TRANSPLANT REJECTION, PART A INTERIM ANALYSIS Daniel R. Getts, Alexander C. Wiseman, Shamkant Mulgaonkar, Randall S. Sung, Larry B. Melton, Thomas H. Waid, John S. Thompson, Stephen A. Brown, Meghann T. Getts, Terra J. Frederick, Stuart M. Flechner; Kalamazoo, USA; Chicago, USA; Denver, USA; Livingston, USA; Ann Arbor, USA; Dallas, USA; Lexington, USA; Cleveland, USA LB-O-002 THE VASCULARIZED BONE MARROW COMPONENT OF COMPOSITE TISSUE ALLOGRAFTS (CTA) COMBINED WITH COSTIMULATORY BLOCKADE PROMOTES DONOR-DERIVED HEMATOPOIETIC STEM CELL ENGRAFTMENT, CHIMERISM AND TOLERANCE Zuhaib Ibrahim, Cheng-Hung Lin, Qi Mao, Wensheng Zhang, Timothy W. Ng, Stefan Schneeberger, Xin Xiao Zheng, W.P. Andrew Lee, Gerald Brandacher; Baltimore, USA; Pittsburgh, USA; Taipei, Taiwan LB-O-003 BETTER GRAFT SURVIVAL WITH MACHINE PERFUSION THAN COLD STORAGE AFTER THREE YEARS: FOLLOW-UP ANALYSIS OF THE EUROPEAN MULTICENTRE RCT IN DECEASEDDONOR KIDNEY TRANSPLANTATION Cyril Moers, Ina Jochmans, Jrgen Treckmann, Jacqueline M. Smits, Jaap J. Homan van der Heide, Jean-Paul Squifflet, Ernest van Heurn, Gnter R. Kirsten, Axel Rahmel, Henri G.D. Leuvenink, Andreas Paul, Jacques Pirenne, Rutger J. Ploeg.; Groningen, The Netherlands; Leuven, Belgium; Essen, Germany; Lige, Belgium; Maastricht, The Netherlands; Groningen, The Netherlands; Frankfurt am Main, Germany; Leiden, The Netherlands LB-O-004 IMPROVED RENAL FUNCTION BY OVERNIGHT SWITCH FROM CYCLOSPORINE TO EVEROLIMUS AT WEEK 7 AFTER RENAL TRANSPLANTATION. ONE YEAR RESULTS FROM A RANDOMIZED, CONTROLLED TRIAL Lars Mjrnstedt, Sren S. Srensen, Bengt von Zur Muhlen, Bente Jespersen, Jesper Melchior Hansen, Claus Bistrup, Helena Andersson, Bengt Gutafsson, Liv H. Undset, Hans Fagertun, Dag Solbu, Hallvard Holdaas.; Gothenburg, Sweden; Copenhagen, Denmark; Uppsala, Sweden; Aarhus, Denmark; Herlev, Denmark; Odense, Denmark; Malm, Sweden; Oslo, Norway; Kjeller, Norway; Oslo, Norway LB-O-005 RENAL TRANSPLANTATION AFTER EX-VIVO NORMOTHERMIC PERFUSION: THE FIRST CLINICAL SERIES Michael L. Nicholson, Sarah A. Hosgood, Atul Bagul; Leicester, United Kingdom

08:10

08:20

08:30

08:40

177

Wednesday 7 September
08:50 LB-O-006 REDUCED RATE OF CUTANEOUS SQUAMOUS CELL CARCINOMA IN A RANDOMISED, PROSPECTIVE, MULTI-CENTRE CONTROLLED TRIAL OF CONVERSION TO SIROLIMUS-BASED IMMUNOSUPPRESSION: THE RESCUE TRIAL P.N. Harden, J.M. Hoogendijk-van den Akker, J.N. Bouwes-Bavinck, C.M. Proby, A.J. Hoitsma, R. Wolterbeck, J.W. de Fijter, on Behalf of the RESCUE Study Investigators; Oxford, United Kingdom; Zwolle, the Netherlands; Leiden, the Netherlands; Dundee, United Kingdom; Nijmegen, the Netherlands; Leiden, the Netherlands

09:00 10:30

STATE OF THE ART 7 Thoracic transplantation from non-heart beating donors

Chairs: Steve Large, Cambridge, United Kingdom; Dirk Van Raemdonck, Leuven, Belgium

Forth

09:00 09:20 09:40 10:00 10:20 09:00 10:30 LIVE WEB STREAM 09:00 09:20 09:40 10:00 10:20

NHBD lung transplantation: how far can we go? Michiel Erasmus, Groningen, The Netherlands NHBD heart transplantation: fiction or reality? Steve Large, Cambridge, United Kingdom Machine perfusion for lung transplantation Karen Redmond, London United Kingdom Machine perfusion for heart transplantation Olivier Van Caenegem, Leuven, Belgium Q&A

STATE OF THE ART 8 Optimizing organ quality

Clyde Auditorium

Chairs: Benoit Barrou, Paris, France; Robert Porte, Groningen, The Netherlands Ischaemic preconditioning Pierre Clavien, Zurich, Switzerland Normothermic recirculation Juan Carlos Garca-Valdecasas, Barcelona, Spain Modifying ischemia reperfusion injury Stefan Tullius, Boston, United States Machine liver perfusion Rutger Ploeg, Oxford, United Kingdom Q&A

178

Wednesday 7 September
09:00 10:30

STATE OF THE ART 9 Histocompatibility & Immunogenetics Joint ESOT EFI BSHI Session
Chairs: Ilias Doxiadis, Leiden, The Netherlands; Paul Sinnott, London, United Kingdom

Lomond

09:00 09:20 09:40 10:00 10:20 11:00 13:45 LIVE WEB STREAM

Current techniques for Clinical H&I testing Craig Taylor, Cambridge, United Kingdom H&I testing to support patient care Robert Bray, Atlanta, United States H&I testing and outcome in transplantation CTS data Caner Ssal, Heidelberg, Germany Future developments for H&I support of clinical transplantation Frans Claas, Leiden, The Netherlands Q&A

PRESIDENTIAL SESSION Clyde Auditorium Whats hot Whats new Best presentation Honorary Members and Awards Ceremony
Chairs: Rutger Ploeg, ESOT President; ESOT President elect

11:00 11:15

Presidential address ESOT President elect Honorary Membership Celebration: Kathryn Wood, past-Councilor of ESOT, past-President of TTS, introduces Honorary Member Leslie Brent, United Kingdom Jan Lerut, past-President of ESOT, introduces Honorary Member Gran Klintmalm, Dallas, United States

11:35 11:55

Whats hot, whats new in clinical transplantation? Steve Wigmore, Edinburgh, United Kingdom Whats hot, whats new in basic science? Olivier Thaunat, Lyon, France BIOTEST Award for Best Oral Presentations Biotest Basic Science Award Jason M. Ali O-326 LONGEVITY OF THE DIRECT AND INDIRECT CD4 T CELL ALLOIMMUNE RESPONSE Jason M. Ali, K. Elliott, M. Negus, T. Conlon, E. Bolton, J.A. Bradley, K. Saeb-Parsy, and G.J. Pettigrew; Cambridge, United Kingdom Biotest Clinical Transplantation Award Kerstin Moench O-327 MALIGNANCY IN ORGAN DONORS IN GERMANY 20062009 Kerstin Moench, Carl-Ludwig Fischer-Froehlich, Gnter Kirste, Undine Samuel, and Thomas Breidenbach; Mainz, Germany; Stuttgart, Germany; Frankfurt/Main, Germany; and Munich, Germany

12:15

12:25

179

Wednesday 7 September
12:35 Biotest Clinical Transplantation Award Palmina Petruzzo O-328 INTERNATIONAL REGISTRY ON HAND AND COMPOSITE TISSUE ALLOTRANSPLANTATION Palmina Petruzzo, Marco Lanzetta, Jean Michel Dubernard, Warren Breidenbach, Stefan Schneeberg, Pedro Cavadas, Jerzy Jablecki, Frederic Schuind, Christian Dumontier, Omer Ozkan, Bernard Devauchelle, Laurent Lantieri, Bo Pomahac, Tomas Gomez-Cia, Juan P. Barret, and Maria Siemionow; Lyon, France; Monza, Milan, Italy; Louisville, USA; Innsbruck, Austria; Valencia, Spain; Wroclaw, Poland; Brussels, Belgium; Paris, France; Antalya, Turkey; Amiens, France; Boston, USA; Seville, Spain; Barcelona, Spain; and Clevaland, USA Biotest Clinical Transplantation Award Flavio Vincenti O-329 12-MONTH RESULTS OF TOFACITINIB (CP-690,550)-BASED CNI-FREE IMMUNOSUPPRESSION IN A PHASE 2B STUDY IN DE NOVO KIDNEY TRANSPLANT PATIENTS Flavio Vincenti, Helio Tedesco Silva, Stephan Busque, Philip OConnell, John Friedewald, Diane Cibrik, Klemens Budde, Atsushi Yoshida, Solomon Cohney, Willem Weimar, Yon Su Kim, Nervin Lawendy, Shirley Lan, Elizabeth Kudlacz, Sriram Krishnaswami, and Gary Chan; San Francisco, USA; Sao Paulo, Brazil; Palo Alto, USA; Sydney, Australia; Chicago, USA; Ann Arbor, USA; Berlin, Germany; Detroit, USA; Parkville, Australia; Rotterdam, The Netherlands; Seoul, Korea; and Groton, USA Biotest Basic Science Award Marta Vadori O-330 LONG TERM CLINICAL RECOVERY OF PARKINSONS DISEASE FOLLOWING TRANSPLANTATION OF CTLA4-IG+ PORCINE EMBRYONIC NEURONAL CELLS IN NON HUMAN PRIMATE Romina Aron Badin, Angelo Padoan, Marta Vadori, Massimo Boldrin, Laura Cavicchioli, Giulia Maria DeBenedictis, Fabio Fante, Michela Seveso, Dino Sgarabotto, Caroline Jan, Veronique Daguin, Philippe Naveilhan, Isabelle Neveu, Jean-Paul Soulillou, Pierre Giannello, Bernard Vanhove, Martine Plat, Francoise Botte, Eric Venturi, Luca Denaro, Renzo Manara, Paolo Zampieri, Domenico DAvella, Domenico Rubello, Ermanno Ancona, Philippe Hantraye, and Emanuele Cozzi; Fontenay aux-Roses, France; Padua, Italy; Nantes, France; Nouzilly, France; Rovigo, Italy; and Leuven, Belgium Biotest Basic Science Award Francesca DAddio O-331 CD160Ig FUSION PROTEIN TARGETS A NOVEL COSTIMULATORY PATHWAY AND PROLONGS ALLOGRAFT SURVIVAL Francesca DAddio, Takuya Ueno, Michael Clarkson, Baogong Zhu, Gordon J. Freeman, Mohamed H. Sayegh, Javeed I. Ansari, and Antje Habicht; Boston, USA; Cork, Ireland; and Munich, Germany Awarded by Christopher Hyde, Managing Director Biotest UK, in representation of Biotest

12:45

12:55

13:05

180

Wednesday 7 September
Awards & Grants Ceremony ESOT GLASGOW 2011 YOUNG INVESTIGATOR AWARDS Stefan Brunner O-047 INTERLEUKIN-33 PROLONGS ALLOGRAFT SURVIVAL THROUGH REDUCTION OF ANTIBODY MEDIATED CARDIAC REJECTION Stefan M. Brunner, Gabriela Schiechl, Hans J. Schlitt, and Stefan Fichtner-Feigl; Regensburg, Germany Robert Sucher O-265 THE BONE COMPONENT OF CTA GIVES RISE TO DONOR HSC WHICH MIGRATE TO RECIPIENT THYMUS AND DIFFERENTIATE TOWARDS A MATURE T CELL PHENOTYPE Robert Sucher, Cheng-Hung Lin, Dong Zhang, Wensheng Zhang, Vijay Gorantla, W.P. Andrew Lee, Johann Pratschke, Fadi Lakkis, Stefan Schneeberger, Gerald Brandacher, and Xin Xiao Zheng; Innsbruck, Austria; Baltimore, USA; and Pittsburgh, USA Xavier Tillou O-212 DE NOVO KIDNEY GRAFT TUMORS: RESULTS FROM A MULTICENTRIC RETROSPECTIVE NATIONAL STUDY Xavier Tillou, Francois Kleinclauss, and Jacques Petit; Amiens, France; and Besancon, France Filip Gryspeerdt O-098 INCIDENTAL PORTOPULMONARY HYPERTENSION DISCOVERED AT THE START OF LIVER TRANSPLANTATION, "TO GO AHEAD OR TO LET GO" Filip Gryspeerdt, Marion Dupont, Wim Laleman, Raymond Aerts, Dieter Mesotten, Geert Meyfroidt, Marleen Verhaegen, Arne Neyrinck, Frederik Nevens, Jacques Pirenne, and Diethard Monbaliu; Leuven, Belgium Alessia Stanzi O-273 CADAVERIC LOBAR LUNG TRANSPLANT: A VALID OPTION FOR SMALL-SIZED CF PATIENTS Alessia Stanzi, Joyce Tiek, Shana Wauters, Herbert Decaluw, Willy Coosemans, Paul De Leyn, Philippe Nafteux, Lieven J. Dupont, Geert M. Verleden, and Dirk E. Van Raemdonck; Leuven, Belgium Eelke Bos O-175 CYSTATHIONINE [ ]-LYASE IS AN ENDOGENOUS MODULATOR OF OXIDATIVE STRESS Eelke M. Bos, Guangdong Yang, Henri G.D. Leuvenink, Harry van Goor, and Rui Wang; Groningen, The Netherlands; and Thunder Bay, Canada Paloma Riquelme O-249 MOUSE MACROPHAGES DRIVEN TO A NOVEL STATE OF ACTIVATION PROLONG ALLOGRAFT SURVIVAL IN NON-IMMUNOSUPPRESSED RECIPIENTS Paloma Riquelme, Stefan Tomiuk, Hans J. Schlitt, Edward K. Geissler, and James A. Hutchinson; Regensburg, Germany; and Bergisch Gladbach, Germany

181

Wednesday 7 September
Jennifer Cole O-110 DIRECT-PATHWAY CD4 T CELLS ARE UNABLE TO PROVIDE HELP FOR CLASS-SWITCHED ALLOANTIBODY RESPONSES Jennifer Cole, Kourosh Saeb-Parsy, Margaret C. Negus, Eleanor M. Bolton, Andrew J. Bradley, Thomas M. Conlon, and Gavin J. Pettigrew; Cambridge, United Kingdom Leonienke F.C. Dols O-088 HAND-ASSISTED RETROPERITONEOSCOPIC VERSUS STANDARD LAPAROSCOPIC DONOR NEPHRECTOMY: SINGLE BLIND, RANDOMISED CONTROLLED TRIAL Leonienke F.C. Dols, Niels F.M. Kok, T.C. Khe Tran, Turkan Terkivatan, Frank C.H. dAncona, Johan F. Langenhuijsen, Frank J.M.F. Dor, Willem Weimar, and Jan N.M. IJzermans; Rotterdam, The Netherlands; and Nijmegen, The Netherlands Raphael Thuillier O-176 H HEMO2LIFE, A DEDICATED OXYGEN CARRIER, OPTIMIZES STATIC KIDNEY PRESERVATION Raphael Thuillier, Delphine Dutheil, Vanessa Mallet, Trieu Minh Tri Ngo, Geraldine Allain, Morgane Rousselot, Magali Denizot, Jean Michel Goujon, Frank Zal, and Thierry Hauet; Poitiers, France; Morlaix, Finland; and Surgeres, France Awarded by John Forsythe & Alan Jardine ESOT2011 Chairs City of Glasgow Award Best Mini Oral Barbara Grandtnerova MO-029 THERAPY OF CHRONIC HUMORAL REJECTION AFTER KIDNEY TRANSPLANTATION Barbara Grandtnerova, Katarina Machalekova, and Nadezda Mckova; Martin, Slovakia; and Banska Bystrica, Slovakia Jaap Kwekkeboom MO-070 LEVELS OF A CHOLANGIOCYTE-ABUNDANT microRNA IN LIVER GRAFTS PRIOR TO TRANSPLANTATION ARE PREDICTIVE FOR LONG-TERM GRAFT SURVIVAL Waqar R.R. Farid, Jaap Kwekkeboom, Renee J. Verhoeven, Jeroen de Jonge, Petra E. de Ruiter, Herold J. Metselaar, Hugo W. Tilanus, Geert Kazemier, and Luc J.W. van der Laan; Rotterdam, The Netherlands Ugo Boggi MO-061 LAPAROSCOPIC ROBOT-ASSISTED PANCREAS TRANSPLANTATION Ugo Boggi, Fabio Vistoli, Stefano Signori, Simone DImporzano, Gabriella Amorese, Giovanni Consani, Fabio Guarracino, Piero Marchetti, Daniele Focosi, and Franco Mosca; Pisa, Italy Daniele Focosi MO-064 LUMINEX SCREENING FOR DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN PANCREAS TRANSPLANT ALONE Daniele Focosi, Monica De Donno, Margherita Occhipinti, Piero Marchetti, Fabio Vistoli, Ugo Boggi, and Fabrizio Scatena; Pisa, Italy Faisal Hanif MO-010 MEDICAL WEB BROWSING- RENAL TRANSPLANT PATIENTS VIEWPOINT Faisal Hanif, Janet C. Read, and Marc J. Clancy; Glasgow, United Kingdom; and Preston, United Kingdom

182

Wednesday 7 September
Vittoria Vero MO-023 IS THE PRIMARY IMMUNOSUPPRESSION DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE? Vittoria Vero, Marco Senzolo, Luisa Pasulo, Francesca Romana Ponziani, Raffaella Vigano, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy Faisal Omar MO-080 PRIORITY SETTING IN SWEDISH KIDNEY TRANSPLANTATION: ASSESSMENT FOR TRANSPLANT CANDIDACY AND ALLOCATION OF DECEASED DONOR KIDNEYS Faisal Omar, Per Carlsson, Marie Omnell-Persson, and Stellan Welin; Malm, Sweden Sergey Gautier O-319A THE ASSOCIATION BETWEEN PRETRANSPLANT SOLUBLE CD40 LIGAND PLASMA LEVELS, THE PRESENCE OF ANTI-HLA ANTIBODIES AND GRAFT DYSFUNCTION IN PEDIATRIC LIVING DONOR LIVER TRANSPLANT RECIPIENTS Sergey V. Gautier, Olga M. Tsirulnikova, Olga E. Gichkun, Aleksander A. Ammosov, and Olga P. Shevchenko; Moscow, Russian Federation Abbas Ghazanfar MO-009 TRANSITION FROM PAEDIATRIC TO ADULT CARE AFTER RENAL TRANSPLANT: AN ESSENTIAL LINK TO IMPROVE SURVIVAL Abbas Ghazanfar, Denise Roberts, Anne Palmer, Mohan Shenoy, and Hany N. Riad; Manchester, United Kingdom Philipp Gehwolf MO-031 NUTRACEUTICALS AMELIORATE KIDNEY ISCHEMIA/ REPERFUSION INJURY IN RATS VIA HO-1 INDUCTION Philipp Gehwolf, Florian M. Struller, Arthur Kostron, Michael Wolzt, F.H. Bach, L.E. Otterbein, B. Wegiel, Johann Pratschke, and Robert Ollinger; Innsbruck, Austria; Vienna, Austria; and Boston, USA Awarded by a representative from the City of Glasgow City of Glasgow Award Best Rapid Oral Mir Alireza Hoda RO-239 LUNG CANCER COMPLICATING LUNG TRANSPLANTATION: INCIDENCE AND OUTCOME [ndash] THE VIENNA EXPERIENCE Mir Alireza Hoda, Victoria Augustin, Peter Jaksch, Bahil Ghanim, Mai-Britt Ernst, Clemens Aigner, Gyoergi Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria Victoria Augustin RO-240 INCIDENCE OF SOLID DE-NOVO MALIGNOMA AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) AFTER LUNG TRANSPLANTATION EXPERIENCE IN VIENNA Victoria Augustin, Mir Alireza Hoda, Peter Jaksch, Bahil Ghanim, Mai-Britt Ernst, Clemens Aigner, Gyoergi Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria

183

Wednesday 7 September
Hauke Winter RO-237 INTERVENTIONAL TREATMENT OF BRONCHIAL ANASTOMOTIC STENOSIS AFTER LUNG TRANSPLANTATION Hauke Winter, Jan Fertmann, Fritz Spelsberg, Gerhard Preissler, Martin Eichhorn, Michael Dolch, Claus Neurohr, Lorenz Frey, Peter berfuhr, Bruno Meiser, and Rudolf Hatz; Munich, Germany Arezu Aliabadi RO-154 IMPACT OF DIFFERENT ATG DOSING PROTOCOLS ON LONG-TERM OUTCOME AFTER CARDIAC TRANSPLANTATION Arezu Z. Aliabadi, Martina Groemmer, Daniela Dunkler, Farsad A. Eskandary, Christoph Pelanek, Thomas Haberl, Sigrid Sandner, Daniel Zimpfer, Guenther Laufer, and Andreas O. Zuckermann; Vienna, Austria Christelle Cantrelle RO-232 IMPACT OF [ldquo]SUPER URGENCES[rdquo] ON THE ACCESS OF THE O LUNG RECIPIENTS IN FRANCE Christelle Cantrelle, Emilie Savoye, Richard Dorent, Marie Thuong, Alain Atinault, and Jean Franois Mornex; Saint Denis La Plaine, France and Bron cedex, France Luciano Potena RO-155 EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS-BASED STUDY Marco Masetti, Luciano Potena, Paola Prestinenzi, Valeria Pece, Gaia Magnani, Francesco Saia, Paolo Romani, Nevio Taglieri, Fabio Coccolo, Marianna Nardozza, Teresa Ionico, Francesco Grigioni, and Angelo Branzi; Bologna, Italy Omar Mownah RO-152 DONATION AFTER CARDIAC DEATH: CAN HEARTS BE SUCCESSFULLY REANIMATED? Muhammad A. Khurram, Omar A. Mownah, Christopher Ray, Aditya Kanwar, Noel M. Carter, Doug Rees, John Brassil, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom Cristina Baleriola RO-162 PREVENTING DONOR DERIVED INFECTIONS THROUGH VIROLOGY SCREENING: REDUCING RISK AND INCREASING ORGAN AVAILABILITY Cristina Baleriola, and William D. Rawlinson; Randwick, Australia Lucio Requiao Moura RO-163 CYTOMEGALOVIRUS INFECTION IS ASSOCIATED WITH EARLY TUBULAR INJURY AND LATE RENAL ALLOGRAFT DYSFUNCTION Lucio R. Requio-Moura, Eduardo J. Tonato, Eliana Nogueira, Erika A. Ferraz, Thiago C. Filliponi, Rogerio Chinen, Ana Cristina C.C. Matos, Marcelino S. Durao, Niels O.S. Camara, and Alvaro PachecoSilva; So Paulo, Brazil

184

Wednesday 7 September
Ingeborg A. Hauser RO-165 LEUKOPENIA & NEUTROPENIA IN KIDNEY TRANSPLANT RECIPIENTS EXPOSED TO 200 VS. 100 DAYS OF VALGANCICLOVIR PROPHYLAXIS: A SUBANALYSIS OF THE IMPACT TRIAL I.A. Hauser, Y. Lebranchu, E. Blumberg, A. Jardine A. Humar, and P. Peeters; Frankfurt, Germany; Tours, France; Philadelphia, USA; Glasgow, United Kingdom; Alberta, Canada; and Ghent, Belgium Awarded by Peter Friend, Local Organising Committee City of Glasgow Award Best Poster Sabina De Geest P-053 BARRIERS FOR IMMUNOSUPPRESSIVE MEDICATIONTAKING DIFFER AMONG ADULT KIDNEY, LIVER AND HEART TRANSPLANT RECIPIENTS Kristel Van de loock, Lut Berben, Sandra Engberg, Susan Sereika, Fabienne Dobbels, Johan Vanhaecke, Kris Denhaerynck, Gabriela Schmid-Mohler, Sandra Martin, Juri Ducci, Paulo De Simone, Rudolf Wthrich, and Sabina De Geest; Leuven, Belgium; Basel, Switzerland; Pittsburgh, USA; Zrich, Switzerland; and Pisa, Italy Raymond Fernando P-118 COMPARING LUMINEX-DEFINED HLA ANTIBODIES WITH FLOW CYTOMETRIC CROSSMATCHES IN RENAL TRANSPLANT PATIENTS Raymond Fernando, Joyce Grant, Aliyye Karasu, Graham D. Shirling, Gita Turakhia, Rachel Wilson, and Henry A.F. Stephens; London, United Kingdom Josep Grinyo P-083 IMPROVING OR SUSTAINING RENAL FUNCTION OVER 3 YEARS WITH BELATACEPT OR CYCLOSPORINE A (CsA): INSIGHTS FROM THE BENEFIT STUDY Josep Grinyo, Marwan Abouljoud, Michael Germain, Roberto Manfro, Jos Morales, Christophe Legendre, Chen-Sheng Lin, Mamta Agarwal, and Jos Medina Pestana; Barcelona, Spain; Detroit, MI, USA; Springfield, MA, USA; Rio Grande do Sul, Brazil; Madrid, Spain; Paris, France; Princeton, NJ, USA; and So Paulo, Brazil Antoine Durrbach P-080 RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES Antoine Durrbach, Franco Citterio, Laura Mulloy, Elias David-Neto, Graeme Russ, Sefan Vitko, Rubin Zhang, Jun Xing, Mary Beth Harler, and Josep Grinyo; Kremlin Bictre, France; Rome, Italy; Augusta, GA, USA; Sao Paulo, Brazil; Adelaide, Australia; Praha, Czech Republic; New Orleans, LA, USA; Hopewell, NJ, USA; Princeton, NJ, USA; and Barcelona, Spain

185

Wednesday 7 September
Dirk Kuypers P-087 INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM ACHIEVES EARLY HIGH DRUG EXPOSURE AND LOWER RATES OF ACUTE REJECTION VERSUS STANDARD DOSING IN DE NOVO RENAL TRANSPLANT RECIPIENTS D. Kuypers, H. Tedesco Silva, K. Budde, W. Arns, A. Shoker, and H. Prestele; Leuven, Belgium; So Paulo, Brazil; Berlin, Germany; Cologne, Germany; Saskatchewan, Canada; and Basel, Switzerland Ana Snchez-Fructuoso P-100 EVEROLIMUS AS PRIMARY IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION: EXPERIENCE IN CONVERSION FROM CALCINEURIN INHIBITORS Ana I. Sanchez-Fructuoso, Juan C. Ruiz, Natividad Calvo, Emilio Rodrigo, Isabel Prez-Flores, Carlos Gomez-Alamillo, Manuel Arias, and Alberto Barrientos; Madrid, Spain; and Santander, Spain Nilay Patel P-183 LIVING DONOR RENAL TRANSPLANTATION IN DONORS WITH INCIDENTAL NEPHROLITHIASIS Nilay Patel, Eeke Thomee, Mark Sullivan, John Reynard, Peter Friend, and Sanjay Sinha; Oxford, United Kingdom Sotiris Mastoridis P-271 RENAL VESSEL MULTIPLICITY AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM DONOR OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY Sotiris Mastoridis, Benjamin OBrien, Atika Sabharwal, David Taube, Nadey Hakim, and Vassilios Papalois; London, United Kingdom Yusuke Arakawa P-325 CHANCE OF SALVAGE TRANSPLANTATION AFTER PRIMARY HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A SPECIAL REFERENCE TO UP-TO-7 CRITERIA Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan Sophie Fougeray P-133 INTERFERON GAMMA PROMOTES STARVATION-INDUCED AUTOPHAGY BY ACTIVATING THE GCN2-ATF4 PATHWAY Sophie Fougeray, Christophe Legendre, Dany Anglicheau, Eric Thervet, and Nicolas Pallet; Paris, France Awarded by Keith Rigg, Local Organising Committee EPITA European Pancreas & Islet Transplant Association AWARDS Best abstract in the field of Islet transplantation Stphanie Lacotte O-170 CELLULAR IMMUNE REACTIVITY AGAINST DONORANTIGEN CORRELATES WITH THE OUTCOME AFTER CLINICAL ISLET TRANSPLANTATION: TOWARD A BETTER POSTTRANSPLANT MONITORING Stphanie Lacotte, Sylvie Ferrari, Sophie Borot, Jean Villard, Sandrine Demuylder-Mischler, Philippe Morel, Gilles Mentha, Thierry Berney, and Christian Toso; Geneva, Switzerland

186

Wednesday 7 September
Best abstract in the field of Pancreas transplantation Anand Sivaprakash Rathnasamy Muthusamy O-184 PANCREAS TRANSPLANTATION IN RECIPIENTS AGED [ge] 50 YEARS Anand Sivaprakash Rathnasamy Muthusamy, Anil Vaidya, Sanjay Sinha, Isabel Quiroga, Srikanth Reddy, James Gilbert, and Peter J. Friend; Oxford, United Kingdom Awarded by Thierry Berney, EPITA Chair EUROLIVER Foundation AWARDS Anthony C. Van Kooij O-068 ALL IN THE FAMILY: HOW EARLY GROUP-EDUCATION OF FAMILIES AND FRIENDS OF CKD PATIENTS LEADS TO PREEMPTIVE KIDNEY TRANSPLANTATION Anthony C. van Kooij, Ron P. van Bragt, Dianne G.C.A. van DongenSegeren, Marinus A. van den Dorpel, Daenne A.F. Scheuter-van Oers, and Ellen Versluijs-Rovers; Rotterdam, The Netherlands David Paredes O-165 and O-166 RESULTS OF UNCONTROLLED DCD MAASTRICHT CLASS II KIDNEY TRANSPLANT (KT) WITH PULSATILE PERFUSION (PP) MACHINE PRESERVATION / IMPACT OF THE COMPLEMENTARY EVALUATION OF ECD AND DCD KIDNEYS COMBINING KIDNEY BIOPSY AND PULSATILE PERFUSION (PP) MACHINE David Paredes, Angel Ruiz, Camino Rodriguez-Villar, Marta Alberola, Lluis Peri, Blanca Miranda, Antonio Alcaraz, and Federico Oppenheimer; Barcelona, Spain Awarded by Herman Tob and Jan Lerut in representation of EUROLIVER 2010 ASTS-ESOT Exchange Grant Soumi Fouraschen Rotterdam, The Netherlands Awarded by ASTS in representation of ASTS 2011 AST-ESOT Exchange Grant Hugo P. Sondermeijer New York, United States Awarded by Robert Gaston in representation of AST 2010 BRISTOL-MYERS SQUIBB Senior Clinical Research Grant Dirk van Raemdonck Leuven, Belgium

187

Wednesday 7 September
2011 BRISTOL-MYERS SQUIBB Senior Clinical Research Grant Sophie Brouard Nantes, France Awarded by Florence Steinhauslin, European Medical Lead Nulojix in representation of BRISTOL-MYERS SQUIBB 2010 ROCHE Senior Basic Science Grant Carla Baan Rotterdam, The Netherlands 2011 ROCHE Senior Basic Science Grant Katja Kotsch Innsbruck, Austria Lorna Marson Edinburgh, United Kingdom Awarded by Christoph Georg Gahlemann, MD, International Medical Leader Transplantation in representation of ROCHE 2010 ASTELLAS Junior Basic Science Grant Fabienne Haspot Nantes, France 2011 ASTELLAS Junior Basic Science Grant Simon Harper Cambridge, United Kingdom Awarded by Simon Rowe, Senior Director, European Marketing Transplantation in representation of ASTELLAS 2010 ESOT Junior Clinical Research Grant Thomas Vogel Mnster, Germany 2011 ESOT Junior Clinical Research Grant Sabastien Heidt Oxford, United Kingdom Awarded by ESOT President

188

Wednesday 7 September
2010 INSTITUT GEORGE LOPEZ Organ Viability & Preservation Grant Diethard Monbaliu Leuven, Belgium 2011 INSTITUT GEORGE LOPEZ Organ Viability & Preservation Grant Sebastien Giraud Poitiers, France Awarded by Silvina Ramella Virieux in representation of INSTITUT GEORGE LOPEZ 2010 KHLER-CHEMIE Preservation Grant Eleonora Boncompagni Pavia, Italy Awarded by Dr. Ekkehard Schaffner in representation of KhlerChemie 2010 NOVARTIS Short Stay & Study Grant Fernanda Ortiz Helsinki, Finland Ali Yeginsu Tokat, Turkey Laura Tariciotti Birmingham, United Kingdom Leonid Kirkovsky Minsk, Belarus Volha Chuhunova Minsk, Belarus Martin Hoogduijn Rotterdam, The Netherlands Michelle de Oliveira Zurich, Switzerland Mohammed Zeeshan Akhtar Oxford, United Kingdom

189

Wednesday 7 September
2011 NOVARTIS Short Stay & Study Grant Noel Knops Leuven, Belgium Maciej Wojcicki Szczecin, Poland Rafael Valdez-Ortiz Mexico City, Mexico Phillipp Renner Regensburg, Germany 2010 NOVARTIS ESOT-STALYC Grant Lilian Curvelo Sao Paolo, Brazil Luis Covarrubias Mexico City, Mexico Awarded by Jeffrey Fletcher in representation of Novartis Pharma 2010 ESOT Student Travel Grant Paloma Riquelme Regensburg, Germany Gaurav Gulsin Aberdeen, United Kingdom Awarded by Phil Dyer, ESOT Education Advisor 2010 ESOT Basic Science Travel Grant Gang Feng Oxford, United Kingdom Pinar Eren Istanbul, Turkey Anna Wardowska Gdansk, Poland Dan Luscalov Cluj-Napoca, Romania Valentina Pietroni Rome, Italy Awarded by Ignacio Anegon in representation of EBSOT

190

Posters

193

Poster Session: Clinical Cases Kidney Surgical

P-001 INCARCERATED SMALL BOWEL THROUGH A RENAL PARATRANSPLANT HERNIA AFTER KIDNEY TRANSPLANTATION Eneida Bra, Naim Fakih, Iago Justo, Oscar Caso, Maria Garcia, Sergio Olivares, Alejandro Manrique, Felix Cambra, Jorge Calvo, Enrique Moreno, and Carlos Jimenez; Madrid, Spain RENAL TRANSPLANTATION WITH ARTERIAL INFLOW FROM AN AXILLO-FEMORAL GRAFT Jodie H. Frost, U. Mathuram Thiagarajan, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom MANAGING EARLY SURGICAL COMPLICATIONS BY KIDNEY GRAFT REPERFUSION WITH A COLD STORAGE SOLUTION Libor Janousek, and Michal Kudla; Prague, Czech Republic ULCUS CRURIS DUE TO PSEUDALLESCHERIA BOYDII INFECTION AFTER RENAL TRANSPLANTATION A RARE DIFFERENTIAL DIAGNOSIS IN A COMMON LESION Martin Jazra, Peter Schenker, Claudia Hempel, Andreas Wunsch, Christian Altenhenne, Agnes Anders, and Richard Viebahn; Bochum, Germany; and Herne, Germany FIBROMUSCULAR DYSPLASIA WITH RENAL ARTERY ANEURYSM: DILEMMA OF AUTOTRANSPLANTATION Avneesh Kumar, and Ahmed Halawa; Sheffield, United Kingdom POST-BIOPSY RENAL ALLOGRAFT COMPARTMENT SYNDROME Umasankar Mathuram Thiyagarajan, Ismail Mohamed, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom SURGICAL AND MEDICAL CHALLENGES WITH KIDNEY TRANSPLANTATION IN VACTERL ASSCOCIATION. CASE REPORT Gabor Telkes, Gyorgy Reusz, Attila Szabo, Marina Varga, and Robert Langer; Budapest, Hungary REGULAR ULTRASONOGRAPHY IN AUTOTRANSPLANTED KIDNEY EARLY DIAGNOSIS OF ASYMPTOMATIC OBSTRUCTIVE UROPATHY Hsu-Han Wang, Yang-Jen Chiang, Kuan-Lin Liu, Kuo-Jen Lin, and ShengHsien Chu; Linkou, Taiwan IMMUNOSUPPRANT RELATED NEUROTOXICITY AFTER ABOINCOMPTIBALE KIDNEY TRANSPLANTATION Chi-Chuan Yeh, Ching-Yao Yang, Wei-Chou Wu, and Meng-Kun Tsai; Taipei, Taiwan

P-002

P-003

P-004

P-005

P-006

P-007

P-008

P-009

Poster Session: Clinical Cases Kidney Medical

P-010 THE CHALLENGE OF TREATING POLYOMA VIRUS ASSOCIATED NEPHROPATHY Christina Drje, Anna Varberg Reister, Tommy Aronsen, Erik H. Strm, and Karsten Midtvedt; Oslo, Norway TREATMENT OF HYPERURICEMIA-GOUT ATTACTS AFTER RENAL TRANSPLANTATION WITH CONVERSION TO EVEROLIMUS MONOTHERAPY Pedro Errasti, Francisco Javier Lavilla, and Asuncion Ferrer; Pamplona, Spain SUCCESSFUL TREATMENT OF REFRACTORY BK VIRUS NEPHROPATHY WITH WEANING ALL IMMUNOSUPPRESSION BUT PREDNISONE A CASE REPORT Barbara Grandtnerova, Nadezda Mckov, and Katarina Machalekova; Martin, Slovakia; and Banska Bystrica, Slovakia

P-011

194
P-012

P-013

URETERIC STRICTURE IN RENAL ALLOGRAFT TO REIMPLANT OR NOT? Vincent C.W. Wong, Norella C.T. Kong, G.A. Halim, M. Rozita, C.A. Rizna, and Jasitha Thevarajah; Cheras, Malaysia KIDNEY GRAFT VENOUS ANASTOMOTIC STENOSIS: AN UNUSUAL CAUSE OF REVERSIBLE PRIMARY NON GRAFT FUNCTION Eva Languille, Lela Tricot, Galle Pell, Christian Hiesse, Anne KolkoLabadens, Alain Raynaud, and Michel Delahousse; Suresnes, France; and Paris, France SUCCESSFUL TREATMENT OF PULMONARY MUCORMYCOSIS WITH DESFERASIROX-POSACONAZOLE-AMPHOTERICIN B AFTER KIDNEY TRANSPLANTATION: A CASE REPORT Nuttasith Larpparisuth, Suchai Sritippawan, Angkana Chaiprasert, Nalinee Premasathian, Attapong Vongwivatana, Somkiat Vasuvattakul, Rujipas Sirijatuphat, and Methee Chayakulkeeree; Bangkok, Thailand METASTATIC SARCOMATOID CARCINOMA TO LIVER AND BONE MARROW IN RENAL TRANSPLANT RECIPIENT: DUE TO EXACERVATION OF QUIESCENT RENAL CANCER? Hyun Hee Lee, Jae Hyun Jang, and Yeon Ho Park; Incheon, Republic of Korea EBV LYNPHOPROLIFIRATIVE SYNDROME A CHILD KIDNEY TRANSPLANTATION Sihem Oussalah, Lynda Badaoui, Rabia Chafai, and Atmane Seba; Tizi Ouzou, Algeria VISCERAL LEISHMANIOUSIS IN A CHILD TRANSPLANTED KIDNEY Sihem Oussalah, Lynda Badaoui, Rabia Chafai, and Atmane Seba; Tizi Ouzou, Algeria ANAESTHESIA FOR KIDNEY TRANPLANTATION IN A PATIENT WITH PRADER WILLI SYNDROME Catherine J. Atkinson, Karunakaran Ramaswamy, and Sabeena Sharma; Oxford, United Kingdom HEADACHES ONE YEAR AFTER RENAL TRANSPLANTATION Simon Rau, Lousia von Baumgarten, Antje Habicht, Bruno Meiser, Michael Fischereder, and Ulf Schnermarck; Munich, Germany PRE- TRANSPLANT HbA1c LEVEL IS AN EARLY PREDICTIVE MARKER FOR NEW-ONSET DIABETES MELLITUS IN RENAL TRASPLANT RECIPIENTS Erhan Tatar, Meltem Sezis Demirci, Ozkan Gungor, Fatih Kircelli, Gulay Asci, Mehmet Ozkahya, Ercan OK, Cuneyt Hoscoskun, and Huseyin Tz; Izmir, Turkey LATE ACUTE RENAL DYSFUNCTION: A CHALLENGE DIAGNOSIS Francesca Tinti, Luca Poli, Ilaria Umbro, Paola Cinti, Pasquale B. Berloco, and Anna Paola Mitterhofer; Rome, Italy HOW MANY TIMES CAN PARVOVIRUS B19-RELATED ANEMIA RECURE IN SOLID-ORGAN TRANSPLANT RECIPIENT? Clment Gosset, Denis Viglietti, Corinne Antoine, Fabiane Rocha, Samuel Cavalcante, Denis Glotz, and Evangline Pillebout; Paris, France

P-014

P-015

P-016

P-017

P-018

P-019

P-020

P-021

P-022

P-023

Poster Session: Clinical Cases Pancreas Medical

P-024 RARE CASE OF URETERAL OBSTRUCTION IN A RENAL TRANSPLANT RECIPIENT: Candida albicans FUNGUS BALL Naoko Arichi, Yozo Mitsui, Keita Inoue, Chiaki Kobara, Takeo Hiraoka, Masahiro Sumura, Satoshi Honda, Hiroaki Yasumoto, Hiroaki Shiina, and Mikio Igawa; Izumo, Japan

195

P-025

ACUTE INFLAMMATORY SYNDROME INDUCED BY MYCOPHENOLATE MOFETIL IN A PATIENT FOLLOWING PANCREAS TRANSPLANTATION Jun Li, Paolo Girotti, Nils Heyne, Ingmar Knigsrainer, Ruth Ladurner, Alfred Knigsrainer, and Silvio Nadalin; Tbingen, Germany

Poster Session: Clinical Cases Liver Surgical

P-026 RECONTRUCTION OF THE HEPATIC OUTFLOW OF A AMYLOID HEPATIC ALLOGRAFT (AHA) FROM A PATIENT RECEIVING A COMBINED HEART LIVER TRANSPLANTATION A CASE REPORT Christoph Anthoni, Hartmut H.J. Schmidt, Norbert Senninger, Hans H. Scheld, T.D.T. Tjan, Klaus Hahnenkamp, and Heiner Wolters; Mnster, Germany EARLY OCCURRENCE OF KAPOSIS SARCOMA IN POST TRANSPLANT PATIENT TREATED SUCCESSFULLY WITH EVEROLIMUS Kamran Beydullayev, Rauf Shahbazov, Rena Bilalova, Elnur Faracov, Hasan Isayev, Shahnaz Cafarova, Alovsat Isayev, Shahin Osmanov, Eldar Ahmedov, and Mircelal Kazimi; Baku, Azerbaijan TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPSS) IN A CHILD TRANSPLANTED WITH A LEFT LATERAL SEGMENT FROM A SPLIT LIVER GRAFT Vittorio Corno, MariaClara Dezza, Roberto Nani, Roberto Agazzi, Paola Stroppa, Michela Bravi, and Michele Colledan; Bergamo, Italy TRIPLE LIVER TRANSPLANTATION FOR RECURRENT AUTOIMMUNE HEPATITIS INITIALLY MASQUERADING AS FULMINANT WILSONS DISEASE Alexander Kroemer, Axel Doenecke, Andreas Schnitzbauer, Gabi Kirchner, Stefan Farkas, Martin Loss, Edward K. Geissler, Marcus Scherer, and Hans J. Schlitt; Regensburg, Germany A RARE CAUSE OF ACUTE LIVER FAILURE: ADULT ONSET STILLS DISEASE CASE REPORT AND SYSTEMATIC REVIEW OF THE LITERATURE Juliane Liese, Frank Ulrich, Teresa Schreckenbach, Matthias Wahle, Stefan Zeuzem, Wolf Otto Bechstein, and Christian Moench; Frankfurt, Germany LIVER TRANSPLANTATION IN A PATIENT WITH AN INTRAABDOMINALLY LOCATED LEFT VENTRICULAR ASSIST DEVICE Nicolas Meurisse, Nina Vermeer, Koen Ameloot, Diethard Monbaliu, Mark De Laat, Dirk Vlasselaers, Lars Desmet, David Cassiman, Bart Meyns, and Jacques Pirenne; Leuven, Belgium DIAPHRAGM RUPTURE IN A LIVER TRANSPLANT PATIENT UNDER CHRONIC IMMUNOSUPPRESSIVE THERAPY WITH SIROLIMUS. CLINICAL CASE Anna Rossetto, Umberto Baccarani, Gian Luigi Adani, Vittorio Bresadola, Giovanni Terrosu, Dario Lorenzin, and Dino De Anna; Udine, Italy DOES LATE RECURRENCE AFTER HEPATECTOMY FOR HCC IMPACT ON SURVIVAL AFTER LIVER TRANSPLANTATION FOR HCC RECURRENCE? A CASE REPORT Gonzalo Sapisochin, Cristina Dopazo, Roberto Rodriguez, Francesc Espin, Luis Castells, Mireia Caralt, Jose Luis Lazaro, Itxarone Bilbao, and Ramon Charco; Barcelona, Spain

P-027

P-028

P-029

P-030

P-031

P-032

P-033

196

P-034

IS SORAFENIB A NEW TESSERA IN THE MOSAIC OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA BEFORE LIVER TRANSPLANTATION? Giuseppe Tarantino, Fabrizio Di Benedetto, Giuseppe DAmico, Nicola De Ruvo, Nicola Cautero, Roberto Montalti, Gian Piero Guerrini, Roberto Ballarin, Rosa M. Iemmolo, and Giorgio E. Gerunda; Modena, Italy LIVER TRANSPLANTATION AFTER THREE-WEEK HEPATIC COMA Toomas Vli, Kadri Tamme, Andres Tein, and Silver Sarapuu; Tartu, Estonia

P-035

Poster Session: Clinical Cases Liver Medical

P-036 P-037 WITHDRAWN TRANSIENT IMPROVEMENT OF ACQUIRED HEPATOCEREBRAL DEGENERATION IN A PATIENT WITH HCV CIRRHOSIS AFTER LIVER TRANSPLANTATION: A CASE REPORT AND REVIEW OF LITERATURE Yuanyuan Chen, Mazhar Haque, Andrew Woolfenden, and Eric Yoshida; Vancouver, Canada POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AFTER LIVER TRANSPLANTATION Oscar Caso, Naim Fakih, Iago Justo, Alejandro Manrique, Jorge Calvo, Alvaro Garcia, Felix Cambra, Manuel Abradelo, Enrique Moreno, and Carlos Jimenez; Madrid, Spain ANTIBODY-MEDIATED CHRONIC REJECTION REVERSED BY B-CELL DEPLETING AGENT IN A LIVER RETRANSPLANT RECIPIENT Cheng-Maw Ho, Yao-Ming Wu, Ming-Chih Ho, Rey-Heng Hu, and PoHuang Lee; Taipei, Taiwan HEMOSUCCUS PANCREATICUS (HP) AFTER LIVER TRANSPLANTATION (LT) Anna Mrzljak, Karlo Novacic, Nikola Sobocan, Miroslava Katicic, Dinko kegro, and Branislav Kocman; Zagreb, Croatia

P-038

P-039

P-040

Poster Session: Clinical Cases Cardiothoracic Surgical

P-041 DIMENSION COUNTS: AN UNUSUAL CASE OF BLEEDING AFTER CENTRIFUGAL LVAD IMPLANTATION Gianluca Santise, Sergio Sciacca, Marco A. Turrisi, Vincenzo Stringi, Robert L. Kormos, and Michele Pilato; Palermo, Italy; and Pittsburgh, USA

Poster Session: Islet / Cell transplant

P-042 CYTOPROTECTIVE EFFECT OF HUMAN ADIPOSE TISSUE DERIVED REGENERATIVE CELL ON PORCINE ISLET CELLS Michihito Asanoma, Mitsuo Shimada, Toru Utunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Syuichi Iwahashi, Yu Saito, and Shinichiro Yamada; Tokushima, Japan IMPROVED THE EFFECT OF ISLET TRANSPLANTATION BY ENDOTHELIAL CELLS COATING AND INFUSION SERTOLI CELLS Yang Li, Wujun Xue, Xiaohui Tian, Xiaoming Ding, Xinshun Feng, Puxun Tian, Jun Hou, Xiaoming Pan, Hang Yan, Heli Xiang, Chenguang Ding, and Shengbin Li; Xian, China SEARCHING FOR KERATINOCYTE SPORE-STEM CELLS Waldemar L. Olszewski, Anna Domaszewska-Szostek, Marzanna Zaleska, and Beata Szymanska; Warsaw, Poland

P-043

197

P-044

P-045

GLYCATED ALBUMIN IMPAIRS GLUCOSE-INDUCED INSULIN SECRETION IN RAT PANCREATIC -CELLS Tokihiko Sawada, Takayuki Shiraki, Yoshikazu Miura, KyungHwa Park, Takashi Muto, and Keiichi Kubota; Tochigi, Japan INVASION AND HOMING EFFICIENCY OF INTRAVENOUS INJECTED MARROW MESENCHYMAL CELLS IN INFARCTED MYOCARDIUM RATS MODEL Zhenya Shen, and Yulong Hou; Suzhou, China THE EXPERIMENTAL STUDY OF AUTOLOGOUS MESENCHYMAL STEM CELLS MOBILIZATION INHIBIT VENTRICULAR REMODELING AFTER ACUTE MYOCARDIAL INFARCTION Zhenya Shen, and Peng Deng; Suzhou, China

P-046

P-047

Poster Session: Composite tissues

P-048 VASCULARIZED BONE MARROW TRANSPLANTATION MODEL IN RATS AS AN ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW TRANSPLANTATION PRELIMINARY RESULTS Dragos Zamfirescu, Ioan Lascar, Ion Zegrea, Marius Popescu, Corina Popoviciu, Anca Lupu, Maya Simionescu, and Marco Lanzetta; Bucharest, Romania; Monza, Italy; and Canberra, Australia

Poster Session: Allocation

P-049 OLD AND NEW INSIGHTS IN THE EVALUATION OF MARGINAL KIDNEY DONORS: A MONOCENTRIC EXPERIENCE Maria Messina, Ester Gallo, Antonio Lavacca, Valentina Borretta, Elisabetta Mezza, Michela Tamagnone, and Giuseppe Paolo Segoloni; Turin, Italy KIDNEY TRANSPLANTATION FROM LIVING DONORS IN NORTHERN PORTUGAL Bruno A. Lima, and Helena Alves; Porto, Portugal

P-050

Poster Session: Ethics, Law, Psychosocial, Public Policy

P-051 NUMBER OF RECIPIENTS LIVING WITH A FUNCTIONING GRAFT: ESTIMATION AND REPARTITION IN FRANCE Katell Bernois, Florian Bayer, Christelle Cantrelle, Emilie Savoye, Nadine Ribet Reinart, and Karim Laouabdia; Saint Denis La Plaine, France I HAD NO END OF PEOPLE TELLING ME NOT TO DO IT: SOCIAL AND PSYCHOLOGICAL PROCESSES IN NON-DIRECTED KIDNEY DONATION A GROUNDED THEORY APPROACH Alexis Clarke, and Annie Mitchell; Plymouth, United Kingdom BARRIERS FOR IMMUNOSUPPRESSIVE MEDICATION-TAKING DIFFER AMONG ADULT KIDNEY, LIVER AND HEART TRANSPLANT RECIPIENTS Kristel Van de loock, Lut Berben, Sandra Engberg, Susan Sereika, Fabienne Dobbels, Johan Vanhaecke, Kris Denhaerynck, Gabriela Schmid-Mohler, Sandra Martin, Juri Ducci, Paulo De Simone, Rudolf Wthrich, and Sabina De Geest; Leuven, Belgium; Basel, Switzerland; Pittsburgh, USA; Zrich, Switzerland; and Pisa, Italy EDHEP, EUROPEAN DONOR HOSPITAL EDUCATION PROGRAM: A SWEDISH PERSPECTIVE Peter Desatnik; Lund, Sweden; and Helsingborg, Sweden

P-052

P-053

198
P-054

P-055

AN ETHICAL ANALYSIS OF THE ROMANIAN DEBATES ON PRESUMED CONSENT Mihaela Frunza, Cristina Gavriluta, Beatrice-Gabriela Ioan, and Sandu Frunza; Iasi, Romania; and Cluj, Romania THE EFFORT TO ENLIGHTEN ABOUT LOCAL CITIZEN ORGAN DONATION TRANSPLANTATION TOGETHER WITH TRANSPLANT PATIENT SOCIETY Masae Ikeda, Kazunari Yoshida, Daisuke Ishii, Kenji Yamamoto, Seiichi Tatematsu, Fumino Noguchi, Tadao Endo, Tadasu Sakai, and Shiro Baba; Sagamihara, Japan QUALITY OF LIFE AFTER KIDNEY TRANSPLANTATION (LIVING NONRELATED REGULATED PROGRAM) Rose Marie R. Liquete, Ma. Lourdes C. Garcia, Wenceslao Agnir, and Pedro L. Mejia IV; Quezon City, Philippines THE HIPPOCRATIC OATH IN THE STUDY OF THE MEDICAL ETHICS OF THE LIVING DONOR HEMI-PANCREATECTOMY Constantinos S. Mammas, George Kottis, Nikolaos Arkadopoulos, Georgia Kostopanagiotou, and Vasileios Smyrniotis; Milan, Italy; and Athens, Greece BARRIERS TO LIVING DONATION: A QUALITATIVE STUDY OF RECIPIENT ANXIETIES Sabrina Qureshi, Nizam Mamode, and John Weinman; London, United Kingdom SELF-REGULATORY FACTORS AND MEDICATION ADHERENCE AFTER KIDNEY TRANSPLANTATION: FINDINGS AT 6 WEEKS POST TRANSPLANT Emma K. Massey, Mirjam Tielen, Mirjam Laging, Teun van Gelder, and Willem Weimar; Rotterdam, The Netherlands SOURCES OF ORGAN TRANSPLANTS IN CHINA David Matas; Winnipeg, Canada ASSESSMENT OF ANXIETY AND DEPRESSION IN KIDNEY TRANSPLANT PATIENTS Daniel Merino, Cecilia Buljevich, Paola Siezien, Andrea Cosmai, Ruben Schiavelli, and Roberto Sabbatiello; Buenos Aires, Argentina WHEN MEDIA CAMPAIGNS FAIL MISCONCEPTIONS ABOUT ORGAN DONATION AND TRANSPLANTATION AMONG THE RURAL MALAY COMMUNITY IN MALAYSIA Selvarani P. Kovil Pillai; Sydney, Australia TERMS AND SIGNIFICANCE IN TRANSPLANTATION MEDICINE Paola Parente, Maria Luisa Di Pietro, Antonio G. Spagnolo, and Barbara Corsano; Rome, Italy THE DEFINITION OF QUALITY OF LIFE IN SOLID ORGAN TRANSPLANTATION: A PSYCHOLOGICAL QUALITATIVE MODEL Chantal Piot-Ziegler, John David Aubert, Manuel Pascual, and Iris 8A Team Health Psychology; Lausanne, Switzerland IS THE TRANSLANTATION ETHICS AT THE CROSSROAD? Wojciech A. Rowinski, and Leszek Paczek; Warsaw, Poland EXPLORING THE ROLE AND RELATIONSHIP BETWEEN THE GIFT, DECEASED ORGAN DONATION AND RELIGION: A CASE STUDY OF POLISH IMMIGRANTS Chloe Sharp, Gurch Randhawa, and Kulwinder Kaur-Bola; Luton, United Kingdom

P-056

P-057

P-058

P-059

P-060

P-061 P-062

P-063

P-064

P-065

P-066 P-067

199

P-068

THE MISTAKE OF COMMUNICATION WITH RELATIVES OF HEARTBEATING DONORS: VIDEO MODEL Anik Smudla, Sndor Mihly, Katalin Hegeds, and Jnos Fazakas; Budapest, Hungary ATTITUDE TOWARDS XENOTRANSPLANTATION OF PATIENTS PRIOR AND AFTER HUMAN ORGAN TRANSPLANTATION Philipp Stiegler, Michael Sereinigg, Andreas Puntschart, Vanessa Stadlbauer-Kllner, Steve Mller, Karlheinz Tscheliessnigg, and Wolfgang Freidl; Graz, Austria Skype SAVED THE ELPAT CONGRESS Marian van Noord-Haubrich, Frederike Ambagtsheer, Annalisa Ponchia, Chiara Parisotto, Judith Kal-van Gestel, Willij Zuidema, and Willem Weimar; Rotterdam, The Netherlands; and Padua, Italy TO IMPROVE LOW ORGAN DONATION RATE AMONG ETHNIC MINORITY GROUPS IN UNITED KINGDOM Yanmei Wei; London, United Kingdom

P-069

P-070

P-071

Poster Session: Clinical immunosuppression

P-073 ATG MODE OF ACTION: T-CELL DEPLETION AND FAR BEYOND Dietmar K. Abendroth, Michael Marzinzig, and Juergen KJaden; Ulm, Germany; and Berlin, Germany IMPACT OF MDR1 AND CYP3A5 GENETIC POLYMORPHISMS ON TACROLIMUS DOSAGE REQUERIMENTS AND ACUTE REJECTION IN CAUCASIAN LIVER TRANSPLANT RECIPIENTS Jose M. Alamo, Miguel A. Gomez-Bravo, Merce Brunet, Magdalena Salcedo, Constantino Fondevilla, Francisco Suarez, Jose Castellote, Sebastian Rufian, Jose A. Pons, Itxarone Bilbao, Elisabet Torradem, and Lydia Barrera; Sevilla, Spain; Barcelona, Spain; Madrid, Spain; A. Corua, Spain; Cordoba, Spain; and Murcia, Spain IN-VITRO ASSESSMENT OF T CELL RESPONSE AND CLINICAL STATUS OF TRANSPLANT PATIENTS ON VARIOUS IMMUNOSUPPRESSIVE DRUGS IN KwaZulu-Natal (SOUTH-AFRICA) Alain G. Assounga, and Saleha Omarjee; Durban, South Africa CORRELATION OF EVEROLIMUS EXPOSURE WITH EFFICACY AND SAFETY OUTCOMES IN RENAL TRANSPLANT RECIPIENTS: 24-MONTH UPDATE M. Carmellini, M. Yaqoob, J. Pattison, H. Riad, Z. Wang, C. Cornu-Artis, and H. Tedesco Silva; Siena, Italy; London, United Kingdom; Manchester, United Kingdom; East Hanover, USA; Basel, Switzerland; and Sao Paulo, Brazil THYMOGLOBULINE PRE-TREATMENT AND MINIMIZATION OF IMMUNOSUPPRESSION WITH ADVAGRAF IN LIVER TRANSPLANTATION ALLOWS INCREASE OF Treg AND GUIDANCE OF TOLEROGENESIS. PRELIMINARY RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL Nicola De Ruvo, Giovanni Riva, Fabrizio Di Benedetto, Giuseppe Tarantino, Patrizia Barozzi, Leonardo Potenza, Mario Luppi, and Giorgio E. Gerunda; Modena, Italy PRELIMINARY RESULTS OF GENERIC MYCOPHENOLATE MOFETIL (Myfenax) TREATMENT IN DE NOVO RENAL TRANSPLANT RECIPIENTS Alicja Debska-Slizien, Beata Bzoma, Boleslaw Rutkowski, and Andrzej Chamienia; Gdansk, Poland

P-074

P-075

P-076

P-077

200

P-078

P-079

CONVERSION FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCEDAILY PROLONGED RELEASE TACROLIMUS (Advagraf) IN LIVER TRANSPLANT RECIPIENTS Massimo Del Gaudio, Matteo Cescon, Giorgio Ercolani, Alessandro Cucchetti, Matteo Zanello, Alessandro Dazzi, Augusto Lauro, Matteo Ravaioli, Cristina Morelli, and Antonio Daniele Pinna; Bologna, Italy RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES Antoine Durrbach, Franco Citterio, Laura Mulloy, Elias David-Neto, Graeme Russ, Sefan Vitko, Rubin Zhang, Jun Xing, Mary Beth Harler, and Josep Grinyo; Kremlin Bictre, France; Rome, Italy; Augusta, USA; Sao Paulo, Brazil; Adelaide, Australia; Praha, Czech Republic; New Orleans, USA; Hopewell, USA; Princeton, USA; and Barcelona, Spain CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS RETARD (Advagraf) Uwe Fuchs, Armin Zittermann, Bernd Schulze, Kavous Hakim-Meibodi, Uwe Schulz, and Jan Gummert; Bad Oeynhausen, Germany IMPACT OF CHANGE TO A PRIMARY IMMUNOSUPPRESSION REGIMEN OF BASILIXIMAB, MYCOPHENOLATE, PREDNISOLONE AND LOW-DOSE TACROLIMUS, ON THE 3 YEAR OUTCOME OF KIDNEY TRANSPLANTATION Matthew Casey, Marc Clancy, Ray Wan, Manolis Mazonakis, and Colin C. Geddes; Glasgow, United Kingdom IMPROVING OR SUSTAINING RENAL FUNCTION OVER 3 YEARS WITH BELATACEPT OR CYCLOSPORINE A (CsA): INSIGHTS FROM THE BENEFIT STUDY Josep Grinyo, Marwan Abouljoud, Michael Germain, Roberto Manfro, Jos Morales, Christophe Legendre, Chen-Sheng Lin, Mamta Agarwal, and Jos Medina Pestana; Barcelona, Spain; Detroit, USA; Springfield, USA; Rio Grande do Sul, Brazil; Madrid, Spain; Paris, France; Princeton, USA; and So Paulo, Brazil EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURININHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION Markus Guba, Johann Pratschke, Christian Hugo, Bernhard K. Kraemer, Andreas Pascher, Katharina Pressmar, Oliver Hakenberg, Michael Fischereder, Jens Brockmann, Joachim Andrassy, Manfred Stangl, Banas Bernhard, and Karl-Walter Jauch; Munich, Germany; Innsbruck, Austria; Dresden, Germany; Mannheim, Germany; Berlin, Germany; Erlangen, Germany; Rostock, Germany; Zurich, Switzerland; and Regensburg, Germany SIROLIMUS RESCUE THERAPY AFTER ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS ONE YEAR FOLLOW UP Medhat M.A. Halim, Torki Al-Otaibi, K.V. Johny, Mohamed H. Hamid, Osama Gheith, Hany Adel, Ahmed Musaad, Tarek Said, Prasad Nair, and M.R.N. Nampoory; Kuwait, Kuwait EVALUATING EFFICACY AND SAFETY OF TWO IMMUNOSUPPRESSIVE REGIMENS IN KIDNEY TRANSPLANT PATIENTS THREE YEARS RESULTS Milan Kuman, Vladimir Mejzlik, Pavel Studenik, Jiri Ondrasek, and Petr Nemec; Brno, Czech Republic

P-080

P-081

P-082

P-083

P-084

P-085

P-086

201

P-087

INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM ACHIEVES EARLY HIGH DRUG EXPOSURE AND LOWER RATES OF ACUTE REJECTION VERSUS STANDARD DOSING IN DE NOVO RENAL TRANSPLANT RECIPIENTS D. Kuypers, H. Tedesco Silva, K. Budde, W. Arns, A. Shoker, and H. Prestele; Leuven, Belgium; So Paulo, Brazil; Berlin, Germany; Cologne, Germany; Saskatchewan, Canada; and Basel, Switzerland EXTENDED-RELEASE TACROLIMUS THERAPY IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS: SINGLE-CENTER EXPERIENCE Jose Luis Lambert Rodriguez, Beatriz Diaz-Molina, Maria Jose Bernardo Rodriguez, Maria Martin Fernandez, Juan Carlos Llosa Cortina, and Carlos Morales; Oviedo, Spain BASILIXIMAB INDUCTION CAN TRIGGER SHOCK AND ARDS IN YOUNG RECIPIENTS Annick Massart, Sarah Heenen, Gilbert Bejjani, Hoang D. Anh, Dimitri Mikhalski, Emine Broeders, Daniel De Backer, and Daniel Abramowicz; Brussels, Belgium EVALUATING THE IMPACT OF GASTROINTESTINAL EPISODES ON THE HEALTH-RELATED QUALITY OF LIFE OF SOLID ORGAN TRANSPLANT RECIPIENTS: SENSITIVITY TO CHANGE OF THE SIGIT QoL QUESTIONNAIRE. MYPACIENTE-2 STUDY F. Ortega, J.M. Puig, F.J. Pal-Ramos, M.M. Salcedo, J.A. Bravo, J. De la Cruz, R. Lauzurica, M. Miras, G. Rodrguez-Goyanes, and the Mypaciente-2 Study Group; Oviedo, Spain; Barcelona, Spain; Zaragoza, Spain; Madrid, Spain; Granada, Spain; Malaga, Spain; Badalona, Spain; El Palmar, Murcia, Spain; and Vigo, Spain EXTENDED RELEASE TACROLIMUS VERSUS CONVENTIONAL TACROLIMUS IN DE NOVO ORTHOTOPIC LIVER TRANSPLANTATION Jorge Ortiz de Urbina-Lopez, Jose Ramn Fernandez Ramos, Amaia Matarranz Sanz, Andres Valdivieso Lopez, Francisco Javier Bustamante Schneide, Mikel Gastaca Mateo, Milagros Testillano Tarrero, P. Ruiz ordorica, Alberto Ventoso Castieiro, Javier Gonzalez Uriarte, and MJ Suarez Regueiro; Barakaldo, Spain ORAL STATUS OF RENAL TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORIN A OR TACROLIMUS Otlia Pereira-Lopes, Benedita Sampaio-Maia, Susana Sampaio, Pedro Vieira-Marques, Maria Ferreira, Elsa Lopes, Filipa Silva, Manuel Pestana, and Antnio Felino; Porto, Portugal IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT Alessandro Perrella, Donatella Pisaniello, and Oreste Cuomo; Naples, Italy IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT Alessandro Perrella, Donatella Pisaniello, Walter Santaniello, Luca Campanella, and Oreste Cuomo; Naples, Italy ANTIBODY-BASED IMMUNOSUPPRESSIVE THERAPY AND IMMUNE RESPONSE TO DECEASED DONORS KIDNEY ALLOGRAFT: A SINGLE CENTRE EXPERIENCE Tatjana Rainiene, Rasa Dobrovolskiene, Nina Izvolskaja, Balys Dainys, Arunas Zelvys, Loreta Vareikiene, and Kestutis Strupas; Vilnius, Lithuania

P-088

P-089

P-090

P-091

P-092

P-093

P-094

P-095

202

P-096

MANAGEMENT OF MODERATE TO SEVERE CHRONIC RENAL GRAFT DYSFUNCTION USING mTOR: LONG-TERM RESULTS Suzimar S. Rioja, Joan Oliveira, Marcelo Bernardino, Adriana DAngeles, Srgio R.M. Souza, Albanita V. Oliveira, and Lilimar S. Rioja; Rio de Janeiro, Brazil PHARMACOKINETICS OF EVEROLIMUS WHEN COMBINED WITH TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS L. Rostaing, J. Pascual, U. Machein, and J.M. Kovarik; Toulouse, France; Barcelona, Spain; and Basel, Switzerland DEVELOPMENT OF ANTI-HLA ANTIBODIES AFTER CONVERSION TO AN mTOR INHIBITOR IN STABLE RENAL TRANSPLANT PATIENTS Estrella Quintela, Juan C. Ruiz, Jose M. Pastor, David San Segundo, Emilio Rodrigo, Maria Gago, Marcos Lopez-Hoyos, and Manuel Arias; Santander, Spain USEFULNES AND SAFETY OF mTOR IN LIVER TRASPLANTATION Gloria Sanchez Antolin, Felix Garca-Pajares, Carolina Almohalla, Judith Gil Dominguez, Sara Lorenzo Pelayo, Lorena Sancho, Rafael Ruiz Zorrilla, and Agustin Caro Paton; Valladolid, Spain EVEROLIMUS AS PRIMARY IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION: EXPERIENCE IN CONVERSION FROM CALCINEURIN INHIBITORS Ana I. Sanchez-Fructuoso, Juan C. Ruiz, Natividad Calvo, Emilio Rodrigo, Isabel Prez-Flores, Carlos Gomez-Alamillo, Manuel Arias, and Alberto Barrientos; Madrid, Spain; and Santander, Spain DIFFERENTIAL EFFECTS OF CALCINEURIN INHIBITORS ON ARTERIAL FUNCTION Felix Seibert, Carolin Behrendt, Sven Schmidt, Walter Zidek, Markus van der Giet, and Timm H. Westhoff; Berlin, Germany PREDICTABLE PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), AND EXPOSURE-RESPONSE (E-R) OF BELATACEPT AVOID THE NEED OF THERAPEUTIC DRUG MONITORING (TDM) Jinshan Shen, Zexun Zhou, Robert Townsend, and Sanjeev Kaul; Princeton, USA RATIONALE FOR BELATACEPT LESS-INTENSIVE (LI) REGIMEN IN RENAL TRANSPLANT RECIPIENTS Jinshan Shen, Jeff S. Gelb, Robert M. Townsend, Zexun Zhou, Marc Pfister, Mary Beth Harler, and Sanjeev Kaul; Princeton, USA COMPARISON OF THE SIDE EFFECTS OF DE NOVO MPAs IN FIRST 3 MONTHS AFTER KIDNEY TRANSPLANTATION: SINGLE CENTER EXPERIENCE Hakan Sozen, Utku Yilmaz, Kibriya Fidan, Galip Gur, Ulver Verici, Sukru Sindel, and Aydin Dalgic; Ankara, Turkey EFFECT OF EARLY CONVERSION FROM CALCINEURIN INHIBITORS TO EVEROLIMUS ON RENAL FUNCTION AND MARKERS OF CARDIOVASCULAR DISEASE: DESIGN OF THE ELEVATE STUDY M. van der Giet, J.W. de Fijter, H. Holdaas, C. Legendre, U. Machein, G. Junge, and J.M. Cruzado; Berlin, Germany; Leiden, Netherlands; Oslo, Norway; Paris, France; Basel, Switzerland; and Barcelona, Spain TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION? Nina Weiler, Ina Thrun, Marion Eberlin, Irene Kraemer, and Gerd Otto; Mainz, Germany

P-097

P-098

P-099

P-100

P-101

P-102

P-103

P-104

P-105

P-106

203

P-107

SPECIALIST PHARMACIST ROLE IN HIV-POSITIVE RENAL TRANSPLANTATION Hayley Wells, Lucy Galloway, Martin Drage, and Rachel Hilton; London, United Kingdom IMMUNOSUPPRESSION IN HCV-RNA POSITIVE LIVER TRANSPLANT RECIPIENTS Ekaterina B. Yaroshenko, Maxim N. Kornilov, Igor A. Miloserdov, and Yan G. Moysyuk; Moscow, Russian Federation PHARMACOKINETICS AND CLINICAL OUTCOMES OF DE NOVO RENAL TRANSPLANTATION WITH ONCE-DAILY TACROLIMUS EXTENDED RELEASE(TER) Kazunari Yoshida, Jun Tomizawa, Daisuke Ishii, Masahiro Kobayashi, Yasuo Takeuchi, Haruki Wakai, Fumino Noguchi, Masae Ikea, Kazuo Yago, and Shiro Baba; Sagamihara, Japan

P-108

P-109

Poster Session: Pre-Clinical immunosuppression

P-110 EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE IN THEIR OFFSPRING Natalia Slabiak-Blaz, Marcin Adamczak, Eberhard Ritz, and Andrzej Wiecek; Katowice, Poland; and Heidelberg, Germany BELATACEPT 6-MONTH INTRAVENOUS MONKEYS Helen G. Haggerty; New Brunswick, USA TOXICITY STUDY IN

P-111

P-112

ANTI-CLASS II HUMANIZED ANTIBODY, IMMU-114 SUCCESSFULLY SUPPRESSES ALLOGENEIC IMMUNE RESPONSE KyungHwa Park, Tokihiko Sawada, Toru Murakami, Yasuo Ishii, Mineko Yasuo, Shohei Fuchinoue, and Keiichi Kubota; Tochigi, Japan; and Tokyo, Japan THE REVERSIBLE REDUCTION OF -CELL ADAPTABILITY INDUCED BY mTOR INHIBITION IN AN EXPERIMENTAL RAT MODEL Jordi Rovira, Barbara Vodenik, Beln Nadal, Maria J. Ramrez-Bajo, Elisenda J. Ban-Maneus, Daniel Moya-Rull, Anna Novials, Fritz Diekmann, and Josep M. Campistol; Barcelona, Spain ATG-Fresenius INHIBITS EBV INFECTION OF HUMAN B-CELLS IN VITRO Reinhard Zeidler, Judith Atz, and Isabell Seitz-Merwald; Munich, Germany; and Graefelfing, Germany

P-113

P-114

Poster Session: Histocompatibility

P-115 GENETICS DETERMINES LONG OR SHORT-TERM KIDNEY SURVIVAL. RARE CLASS I HLA ALLELES FOUND BY SEQUENCE BASED TYPING Helena Alves, Sandra Tafulo, Manuel Dias, Filomena Mendes, Maria Peixoto, Susana Oliveira, and Manuela Monteiro; Porto, Portugal PREDICTIONS IN THE FACE OF CLINICAL REALITY: T-CELL EPITOPE CLASSIFICATION OF HLA-DPB1 MISMATCHES DOES NOT PREDICT SEVERE ACUTE GvHD Medhat Askar, Jesse Schold, Jaroslaw Maciejewski, Robert Dean, Hien Duong, Rabi Hanna, Matt Kalaycio, Edward Copelan, Brian Bolwell, and Ronald Sobecks; OH, USA

P-116

204

P-117

DE NOVO BUT NOT PREFORMED DONOR-SPECIFIC ANTI-HUMAN LEUKOCYTE ANTIGEN ANTIBODIES ARE PREDICTIVE OF SURVIVAL AFTER LUNG TRANSPLANTATION Agns Basire, Anas Rousset, Caroline Bouchet, Kassim Papa, Coralie Frassati, Pascal Thomas, Martine Reynaud-Gaubert, and Christophe Picard; Marseille, France COMPARING LUMINEX-DEFINED HLA ANTIBODIES WITH FLOW CYTOMETRIC CROSSMATCHES IN RENAL TRANSPLANT PATIENTS Raymond Fernando, Joyce Grant, Aliyye Karasu, Graham D. Shirling, Gita Turakhia, Rachel Wilson, and Henry A.F. Stephens; London, United Kingdom HLA MATCHING REDUCES THE INCIDENCE OF EARLY RENAL TRANSPLANT FAILURE IN SENSITISED PATIENTS Susan V. Fuggle, Rachel J. Johnson, Lisa Mumford, Alex Hudson, and J.A. Bradley; Bristol, United Kingdom; and Cambridge, United Kingdom ABO INCOMPATIBLE KIDNEY TRANSPLANTATION WITH CAMPATH INDUCTION Michael M. Kaabak, Nadezda N. Babenko, Alan K. Zokoyev, Emin L. Salimov, and Aligeydar A. Ragymov; Moscow, Russian Federation ANALYSIS OF KIR GENE PROFILES IN RENAL TRANSPLANT RECIPIENTS Aliyye Karasu, Graham D. Shirling, Mark Harber, and Henry A.F. Stephens; London, United Kingdom NO EVIDENCE FOR INVOLVEMENT OF DONOR OR RECIPIENT NKCELL ALLOREACTIVITY IN LIVER TRANSPLANTATION OUTCOME Viviana Moroso, Arnold van der Meer, Geert Kazemier, Luc J.W. van der Laan, Herold J. Metselaar, Irma Joosten, and Jaap Kwekkeboom; Rotterdam, The Netherlands; and Nijmegen, The Netherlands POSITIVE LUMINEX IN CADAVERIC RENAL TRANSPLANTATION AND ITS EARLY PREDICTABILITY OF GRAFT FUNCTION, REJECTION EPISODES Umasankar Mathuram Thiyagarajan, Atul Bagul, Terry Horsburgh, and Michael L. Nicholson; Leicester, United Kingdom HLA-DQ AND -DP ALPHA/BETA CHAIN ANTIBODIES IN RENAL TRANSPLANTATION Antonina Piazza, Elvira Poggi, Giuseppina Ozzella, Daniela Caputo, Giuseppe Iaria, Giuseppe Tisone, and Domenico Adorno; Rome, Italy THE ROLE OF HLA IN CYTOTOXIC T-CELL IMMUNOTHERAPY OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE Victoria J. Robertson, Emily Thompson, Paul Dunn, Lorraine Syme, David M. Turner, Marc L. Turner, Gwen M. Wilkie, David Wilson, and Philip A. Dyer; Edinburgh, United Kingdom; Auckland, New Zealand; and Aberdeen, United Kingdom ARE ADDITIONAL ANTIBODIES DETECTED BY LUMINEX SINGLE ANTIGEN TESTING CLINICALLY RELEVANT? Caner Ssal, Khaled Mahmoud, Jrg Ovens, Bernd Dhler, Andrea Ruhenstroth, Sabine Scherer, and Gerhard Opelz; Heidelberg, Germany HLA MATCHING BASED ON BOTH NUMBER AND TYPE OF MISMATCHES CORRELATES BETTER WITH GRAFT OUTCOMES IN DECEASED-DONOR KIDNEY TRANSPLANTATION (DDKT) Francisco Salcido-Ochoa, N. Yusof, C.Y. Phang, H.C. Wong, Y.H. Chan, Y.M. Lu, M. Chan, and T. Kee; Singapore, Singapore

P-118

P-119

P-120

P-121

P-122

P-123

P-124

P-125

P-126

P-127

205

P-128

SOLUBLE CD30 AND HEPATOCYTE GROWTH FACTOR AS PREDICTIVE MARKERS OF ANTIBODY-MEDIATED REJECTION OF THE KIDNEY ALLOGRAFT Yelena Pavlova, Ondrej Viklicky, Janka Slatinska, Marcela Brgelova, Caner Susal, Ilja Striz, and Antonij Slavcev; Prague, Czech Republic; and Heidelberg, Germany ACUTE MEDIATED REJECTION AFTER A KIDNEY TRANSPLANT WITH PREFORMED anti-HLA ANTIBODIES ABOVE THE LEVEL DESCRIBED TO HAVE CLINICAL SIGNIFICANCE: CASE REPORT Sandra Tafulo, Ceclia Mendes, Manuela Monteiro, Manuela Bustorff, Gerardo Oliveira, and Helena Alves; Porto, Portugal

P-129

Poster Session: Immunobiology / Basic science

P-130 ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE T-786C POLYMORPHISM IN RENAL TRANSPLANT RECIPIENTS Negar Azarpira, Saman Nikeghbalian, Mahdokht Aghdai, Bita Geramizadeh, Masumeh Darai, Marjan Rahsaz, Mehrzad Banihashemi, and Zahra Malekpor; Shiraz, Islamic Republic of Iran RAPAMYCIN MAY ALTER THE PERCENTAGE OF THE Treg FOXP3 AND/OR GITR POSITIVE IN ENVIRONMENT OF THE CALCINEURIN INHIBITORS Katarzyna Bocian, Maja Budziszewska, Tomasz Paz, and Grazyna KorczakKowalska; Warsaw, Poland DIFFERENTIATION OF DENDRITIC CELLS IN IMMUNOSUPPRESSIVE AGENTS IN VITRO Maja Machcinska, Katarzyna Bocian, and Grazyna Korczak-Kowalska; Warsaw, Poland INTERFERON GAMMA PROMOTES STARVATION-INDUCED AUTOPHAGY BY ACTIVATING THE GCN2-ATF4 PATHWAY Sophie Fougeray, Christophe Legendre, Dany Anglicheau, Eric Thervet, and Nicolas Pallet; Paris, France IDENTIFICATION OF A NOVEL MICA ALLELE MICA*002:04 BY SEQUENCING BASED TYPING AND CLONE SEQUENCING Yingfeng Huang, Yin Tan, and Xin Ye; Guangzhou, China IL28B GENE POLYMORPHISM FOR PREDICTION OF EARLY VIROLOGICAL RESPONSE IN ROMANIAN PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION Speranta Iacob, Razvan Iacob, Anca Nastase, Daniel Coriu, Liliana Paslaru, Irinel Popescu, and Liana Gheorghe; Bucharest, Romania Tokishakuyaku-san PROLONGED SUrVIVAL OF FULLY ALLOGENEIC CARDIAC GRAFTS AND GENERATED REGULATORY CD4+ CELLS IN MICE Xiangyuan Jin, Masateru Uchiyama, Qi Zhang, and Masanori Niimi; Tokyo, Japan; and Harbin, China HUMAN B CELL DEVELOPMENT AND ANTIBODY PRODUCTION IN HUMANIZED NOD/SCID/IL-2R null (NSG) MICE CONDITIONED BY BUSULFAN Bongkum Choi, Miyoung Kim, Milljae Shin, Sanghyun Song, Hyung Hwan Moon, Sanghoon Lee, Tae-Seok Kim, Ki-Young Lee, and Sung Joo Kim; Seoul, Republic of Korea; and Suwon, Republic of Korea

P-131

P-132

P-133

P-134

P-135

P-136

P-137

206

P-138

COMPARISON OF ERYTHROCYTE MEMBRANE FATTY ACID CONTENTS AND LIPID PROFILES IN RENAL TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS Joon Seok Oh, Sung Min Kim, Yong Hun Sin, Joong Kyung Kim, Young Ki Son, Won Suk Ahn, Seong Eun Kim, and Ki Hyun Kim; Dong-gu, Busan, Korea; and Busan, Korea AN EX VIVO MODEL FOR ASSESSMENT OF ALTERED LUNG FUNCTION DURING LUNG TRANSPLANTATION Sara Klein, Stefan Dhein, Luisa Bauer, Marcel Vollroth, Maja-Theraesa Dieterlen, Friedrich W. Mohr, and Hartmuth B. Bittner; Leipzig, Germany TCR-INDEPENDENT EXPANSION OF FOXp3+CD4+ REGULATORY T CELLS BY CD137 STIMULATION Hong R. Cho, Jong S. Lee, Juyang Kim, Hyun C. Chung, Wonyoung Kim, and Byungsuk Kwon; Ulsan, Korea TRYPTOPHAN CATABOLITES AS PROGNOSTIC BIOMARKERS FOR THE SEVERITY OF CHRONIC LIVER DISEASES IN POTENTIAL TRANSPLANT RECIPIENTS Imad Lahdou, Hani Oweira, Mahmoud Sadeghi, Volker Daniel, Gerhard Fusch, Jeorg C. Schefold, Gregor Jung, Hazem Elhadedy, Jan Schmidt, Mircea Iancu, Gerhard Opelz, and Peter Terness; Heidelberg, Germany; Greifswald, Germany; and Berlin, Germany DONOR PRETREATMENT WITH ANTI-IL-6 DOES NOT REDUCE INFLAMMATORY ACUTE PHASE PROTEINS IN A RAT BRAIN DEATH MODEL Bo Liu, Jeffery Dammen, Petra J. Ottens, Susanne Veldhuis, Rutger J. Ploeg, and Henri G.D. Leuvenink; Groningen, The Netherlands HLA POSITIVITY BY LUMINEX CROSSMATCH AND ITS EARLY EFFECTS IN LIVE DONOR RENAL TRANSPLANTATION Umasankar Mathuram Thiyagarajan, Atul Bagul, Terry Horsburgh, and Michael L. Nicholson; Leicester, United Kingdom OPTIMIZING LIVER DECELLULARIZATION FOR ORGAN ENGINEERING Reiichi Murakami, H. Abraham Chiang, John Roberts, and Sang-Mo Kang; San Francisco, USA RESPONSES TO NON-POLYMORPHIC HLA CLASS 1 DERIVED PEPTIDES ARE MEDIATED BY CD4+ T EFFECTOR MEMORY CELLS Helen J. Smith, Seema Jham, Paul Cockwell, Richard Borrows, and Simon Ball; Birmingham, United Kingdom CONVERSION TO ONCE-DAILY TACROLIMUS IN RENAL TRANSPLANT RECIPIENTS LEADS TO HIGHER P38 MAPK ACTIVITY IN T LYMPHOCYTES Ramin Vafadari, Dennis A. Hesselink, Teun van Gelder, Willem Weimar, and Carla C. Baan; Rotterdam, The Netherlands MANNOSE RECEPTOR DEFICIENCY PROTECTS MICE FROM ISCHEMIC-REPERFUSION INJURY AND NEPHROTOXIC NEPHRITIS Hsu-Han Wang, Alan D. Salama, Sally Hamour, Ruth Pepper, and Mark Little; London, United Kingdom WITHDRAWN

P-139

P-140

P-141

P-142

P-143

P-144

P-145

P-146

P-147

P-148

207

Poster Session: Heart

P-149 PLACENTA GROWTH FACTOR AS A MARKER OF CARDIAC ALLOGRAFT VASCULOPATHY SEVERITY IN HEART TRANSPLANT RECIPIENTS Olga P. Shevchenko, Olga V. Orlova, Boris L. Mironkov, Eduard N. Kazakov, Arkady J. Kormer, and Alex O. Shevchenko; Moscow, Russian Federation PROFILE OF HEART TRANSPLANT RECIPIENT WITH DYSLIPIDEMIA IN THE ERA OF THE UNIVERSAL USE OF STATINS CROSS-SECTIONAL STUDY Michael Zakliczynski, Julia Boguslawska, Edyta Wojniak, and Marian Zembala; Zabrze, Poland DTCM-GLUTARIMIDE SUPPRESSES IFN- AND AMELIORATES CARDIAC ALLOGRAFT ARTERIOSCLEROSIS IN MICE Masaaki Zaitsu, Kenichiro Yamashita, Susumu Shibasaki, Yusuke Tsunetoshi, Masaomi Ogura, Tadashi Yoshida, Kenji Wakayama, Gentaro Hirokata, Rumi Igarashi, Nozomi Kobayashi, Michitaka Ozaki, Kazuo Umezawa, and Satoru Todo; Sapporo, Japan; and Yokohama, Japan IS ATRIAL SYNCHRONY BENEFICIAL IN HEART TRANSPLANTED PATIENTS? Cristina F. Sirbu, Marie F. Mattei, and Jean-Pierre Villemot; Nancy, France HEART TRANSPLANTATION IS FEASIBLE IN PATIENTS WITH IMPAIRED RENAL FUNCTION Oscar Kolsrud, Sven-Erik Ricksten, Villborg Sigurdardottir, Ulf Kjellman, Hans Liden, Sven-Erik Bartfay, Nedim Selimovic, and Gran Dellgren; Gothenburg, Sweden HEART DONATION AND TRANSPLANTATION IN SAUDI ARABIA Faissal A.M. Shaheen, Besher A. Al-Attar, Abdulqayoum Babiker, Johny E. Cillo, and Michael V. Abeleda; Riyadh, Saudi Arabia IMMUNOSUPPRESSIVE THERAPY IN LONG TERM HEART TRANSPLANTS: 5 YEAR SURVEY ON 56 PATIENTS WITH MORE THAN 10 YEAR FOLLOW-UP Cristiano Amarelli, Mariano Cefarelli, Marianna Buonocore, Claudio Marra, Daniela Pinto, Gianpaolo Romano, Luca S. De Santo, and Ciro Maiello; Naples, Italy; and Foggia, Italy NON WORKING BEATING HEART A NOVEL METHOD OF MYOCARDIAL PROTECTION DURING HEART TRANSPLANTATION Jarbas Jakson Dinkhuysen, Carlos Contreras, Reginaldo Cipullo, Marco Aurlio Finger, Joo Rossi, Ricardo Manrique, Hlio Magalhes, and Paulo Chaccur; So Paulo, Brazil EVALUATION OF EFFICACY AND SAFETY OF DE NOVO ADVAGRAF IN CARDIAC TRANSPLANT PATIENTS: EARLY RESULTS OF AN OBSERVATIONAL STUDY Farsad E. Eskandary, Arezu Z. Aliabadi, Stephane Mahr, Martina Grmmer, Daniel Zimpfer, Sigrid E. Sandner, Gnther Laufer, and Andreas O. Zuckermann; Vienna, Austria CLUSTER TRANSPLANTATION FOR SHORT BOWEL SYNDROME DUE TO COMBINED THROMBOSIS OF THE SUPERIOR MESENTERIC ARTERY AND CELIAC TRUNK Oscar Caso, Iago Justo, Naim Fakih, Sergio Olivares, Jorge Calvo, Felix Cambra, Manuel Abradelo, Alejandro Manrique, Alvaro Garcia, Enrique Moreno, and Carlos Jimenez; Madrid, Spain

P-150

P-151

P-152

P-153

P-154

P-155

P-156

P-157

P-158

208

P-159

ROLE OF HCV POSITIVE DONORS IN HEART TRANSPLANTATION Alberto Forni, Giuseppe Faggian, Bartolomeo Chiominto, and Alessandro Mazzucco; Verona, Italy IMMUNOSUPPRESSION AND RENAL FAILURE (RF) IN HEART TRANSPLANTATION: 3 YEARS EXPERIENCE Francesco Marchini, Andrea Bortolami, Giuseppe Toscano, Antonio Gambino, Cosimo Guglielmi, Barbara Rossi, Giuseppe Feltrin, Gino Gerosa, and Agostino Naso; Padua, Italy QT INTERVAL PARAMETERS ALTERNATION IN PATIENTS RECEIVED RENAL TRANSPLANTATION Ali Monfared, Arsalan Salari, Farshad Asadi, Mohammadkazem Lebadi, Masoud Khosravi, and Sepiedeh Besharati; Rasht, Guilan, Islamic Republic of Iran PRESERVATION OF DONATION AFTER CARDIAC DEATH HEARTS USING OXYGENATED, HYPOTHERMIC MACHINE PERFUSION Omar A. Mownah, Muhammad A. Khurram, Christopher Ray, Joaquim Majo, Noel M. Carter, John Brassil, Robert Peaston, Kelly Phillipson, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom AN EX VIVO MODEL FOR REANIMATING PORCINE HEARTS SOURCED FROM DONORS AFTER CARDIAC DEATH Muhammad A. Khurram, Omar A. Mownah, Christopher Ray, Aditya Kanwar, Noel M. Carter, John Brassil, Doug Rees, Susan Stamp, John H. Dark, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom THE EXPERIMENTAL STUDY OF INDUCING IMMUNETOLERANCE BY USING TLR4 MONOCLONAL ANTIBODYS IN TAT CARDIAC ALLOGRAFTS Zhenya Shen, Xiaomei Teng, and Bing Li; Suzhou, China THE METABOLIC SYNDROME ONE YEAR AFTER HEART TRANSPLANTATION DOES NOT AFFECT 10 YEAR SURVIVAL BUT ISCHEMIC HEART DISEASE BEFORE TRANSPLANTATION INCREASES THE RISK OF METABOLIC SYNDROME Henrik Silfverstolpe, Cecilia Jimhagen, Nedim Selimovic, Gran Dellgren, and Vilborg Sigurdardottir; Gothenburg, Sweden THE ROLE OF SERUM ALBUMIN (SA) IN THE PREDICTION OF MALNUTRITION IN PATIENT AT LEAST ONE HEART TRANSPLANTATION (HTX) Doris Wagner, Barbara Telsnig, Daniela Kniepeiss, Estrella Jakoby, Silvia Schaffellner, Astrid Fahrleitner-Pammer, Andr Wasler, Regina Roller, and KarlHeinz Tscheliessnigg; Graz, Austria INDUCED IMMUNE TOLERANCE TO CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION WITH ALLOGENEIC SPLEEN CELLS AND WHOLE-BODY -RADIATION IN THE PIG Yunsheng Yu, Zhenya Sheng, Shiying Zheng, Wenxue Ye, and Weijie Lao; Suzhou, China INCORPORATION OF THE DONOR DNA IN TO THE RECIPIENT LYMPHOID CELLS AFTER ALLOGENEIC TRANSPLANTATION Malgorzata Zagozda, Agnieszka Sarnecka, Olga Buyanovskaya, and Waldemar L. Olszewski; Warsaw, Poland

P-160

P-161

P-162

P-163

P-164

P-165

P-166

P-167

P-168

209

P-169

BOTH HEART FAILURE AND DIABETES INTENSIFY DEPOSITION OF ADVANCED GLYCATION END (AGE) PRODUCTS IN CORONARY VESSELS, BUT LOCALIZATION IS DIFFERENT Jerzy Nozynski, Michael Zakliczynski, Dominika Konecka-Mrowka, and Marian Zembala; Zabrze, Poland

Poster Session: Donation / Retrieval

P-170 IS HCV (+) A CONTRAINDICATION TO BE RECIPIENT OF LIVING DONOR? Iago Justo, Oscar Caso, Naim Fakih, Sergio Olivares, Felix Cambra, Jorge Calvo, Alejandro Manrique, Alvaro Garca, Manuel Abradelo, Carlos Jimenez and Enrique Moreno. Surgery department C, U. H. 12 de Octubre, Madrid HAND ASSISTED RETROPERITONEOSCOPIC LIVE DONOR NEPHRECTOMY 230 CASES SINGLE CENTRE EXPERIENCE Jiri Fronek, Helen Gregson, Elisabeth Cording, Maria Ventura, Christina Ho, Caroline Azmy, and Nicos Kessaris; London, Tooting, United Kingdom; London, Surrey, United Kingdom; and Brighton, United Kingdom DIFFICULTIES OF ORGAN TRANSPLANTATION COORDINATORS DURING PERFORMING THEIR JOB Esin Glkaya, and Fazil Tuncay Aki; Ankara, Turkey TRENDS IN THE QUALITY OF KIDNEYS OFFERED AND TRANSPLANTED IN RECENT YEARS. HOW MARGINAL IS A MARGINAL DONOR? ARE MARGINAL DONORS THE NORM? AND WHAT IMPACT THEY HAVE ON RENAL ALLOGRAFT FUNCTIONS? A SINGLE CENTRE ANALYSIS Abbas Ghazanfar, Maria Mito Pretorian, Aley Bilgarami, David van Dellen, Bence Forgacs, and Afshin Tavakoli; Manchester, United Kingdom ANALYSIS OF CONSENT RATES FOR ORGAN DONATION IN THE UK Jane Griffiths, Cara Murphy, Claire Counter, and Anthony Clarkson; Bristol, United Kingdom PROPOSED MODEL FOR PATIENT RESPONSE OUTCOME MEASURES (PROM) IN LIVE DONOR NEPHRECTOMY BASED ON DONOR RESPONSES Sarah L. Heap, Laura Tincknell, Keith Rigg, Amanda Knight, Alun Williams, and Shantanu Bhattacharjya; Nottingham, United Kingdom THE DUTCH TRAINING COMMUNICATION ABOUT DONATION Nichon E. Jansen, Bernadette J.J.M. Haase-Kromwijk, Anne-Rose Janssens, and Andries J. Hoitsma; Leiden, The Netherlands; and Nijmegen, The Netherlands URINE NGAL AS A BIOMARKER FOR EVALUATION OF DECEASED KIDNEY DONORS Janis Jushinskis, Diana Amerika, Vadims Suhorukovs, Sergejs Trushkovs, Aleksandrs Maltsevs, and Rafails Rozentals; Riga, Latvia CURRENT STATUS OF THE POTENTIAL DECEASED DONOR IN NEUROSURGICAL INTENSIVE CARE UNIT: A MULTI-CENTER EXPERIENCE FROM KOREA and Samuel Lee; Seoul, Republic of Korea

P-171

P-172

P-173

P-174

P-175

P-176

P-177

P-178

210

P-179

A MODEL OF NON TECHNICAL SKILLS IN ICU AND ORGAN DONATION Gaetano Trabucco, Maddalena Marcanti, Marilena Casartelli Liviero, Francesca Allegrini, Sergio Rambaldelli, Rina Mirandola, Giulia Bisoffi, and Francesco Procaccio; Verona, Italy FOR KIDNEY TRANSPLANTS, IS IT POSSIBLE TO OFFER NON HEARTBEATING DONORS LOCATED MORE THAN 30 MINS AWAY? Philippe Michel, and Bruno Gele; Pontoise, France CAUSES OF REJECTION OF POTENTIAL LIVING DONORS FOR LIVINGRELATED LIVER TRANSPLANTATION Mariana Mihaila, Laurentiu Micu, and Mihai Voiculescu; Bucharest, Romania CHANGING RELATIONSHIPS IN KIDNEY DONATION Geir Mjen, Torbjrn Leivestad, Ole yen, Karsten Midtvedt, Gudrun Norby, and Hallvard Holdaas; Oslo, Norway LIVING DONOR RENAL TRANSPLANTATION IN DONORS WITH INCIDENTAL NEPHROLITHIASIS Nilay Patel, Eeke Thomee, Mark Sullivan, John Reynard, Peter Friend, and Sanjay Sinha; Oxford, United Kingdom 5 YEAR FOLLOW-UP OF INTERNATIONAL CLASSIFICATION OF DISEASES (ICD) BRAIN DEATH RELATED DIAGNOSTICS AT INHOSPITAL DISCHARGE, BRAIN DEAD (BD) DETECTED PATIENTS AND BD ORGAN DONORS (OD) Alba Ribalta, Jorge Twose, Marga Sanrom, and Rosa Deulofeu; Barcelona, Spain ESTABLISHING A BRAIN DEATH DONOR MODEL IN PIGS Michael Sereinigg, Andreas Puntschart, Andrea Bradatsch, Vanessa Stadlbauer-Kllner, Thomas Seifert-Held, Iris Wiederstein-Grasser, Karlheinz Tscheliessnigg, and Philipp Stiegler; Graz, Austria ESTABLISHING A NON-HEART-BEATING DONOR (NHBD) MODEL IN PIGS Philipp Stiegler, Michael Sereinigg, Andreas Puntschart, Martin Schweiger, Ursula Mayhauser, Bettina Leber, Sonja Kstenbauer, Thomas Seifert-Held, Iris Wiederstein-Grasser, and Karlheinz Tscheliessnigg; Graz, Austria ORGAN DONATION IN JAPAN: A LONGITUDINAL STUDY OF QUALITY OF LIFE OF LIVING LIVER DONORS Etsuko Soeda, Minoru Tanabe, Ken Hoshino, Shigeyuki Kawachi, Yasushi Fuchimoto, Hideaki Obara, Masahiro Shinoda, Naoki Shimojima, Yasuhide Morikawa, and Yuko Kitagawa; Tokyo, Japan EFFECT OF OXIDATIVE STRESS AND ENDOTOXIN ON HUMAN SERUM ALBUMIN IN BRAIN-DEAD ORGAN DONORS Philipp Stiegler, Michael Sereinigg, Bettina Leber, Ursula Mayrhauser, Sonja Kstenbauer, Stefanie Stanzer, Andreas Puntschart, Barbara Leopold, Karl Oettl, Karlheinz Tscheliessnigg, and Vanessa StadlbauerKllner; Graz, Austria DONOR MANAGEMENT ON LINE: SEVEN YEARS OF REGIONAL EXPERIENCE Gianfranco Teti, Nicola Torlone, Maurizio Valeri, and Domenico Adorno; Roma, Italy

P-180

P-181

P-182

P-183

P-184

P-185

P-186

P-187

P-188

P-189

211

Poster Session: Infections

P-190 CLINICAL UTILITY OF A QUANTITATIVE AND FUNCTIONAL FLOW CYTOMETRY ASSAY FOR CMV-SPECIFIC CD8 T CELL IMMUNITY IN TRANSPLANT PATIENTS Xiangyang Dong, and Roshini S. Abraham; Rochester, USA DE NOVO RENAL ALLOGRAFT FEMALE RECIPIENTS, BUT NOT MALE ONES, SHOW INCREASES IN URINARY TRACT INFECTION (UTI) INCIDENCE AND RELAPSES AFTER URETERAL STENTING Clara Barrios, Marisa Mir, Marta Crespo, Lluis Fumado, Albert Frances, Josep Maria Puig, Juan Pablo Horcajada, Octavio Arango, and Julio Pascual; Barcelona, Spain CLINICAL STUDY OF RENAL TRANSPLANTATION IN PATIENTS WITH HEPATITIS C Xiaoming Ding, Wujun Xue, Puxun Tian, Xiaoming Pan, Hang Yan, Jun Hou, Xinshun Feng, Heli Xiang, Xiaohui Tian, and Yang Li; Xian, China HEPATIC ABSCESS. A STRANGE COMPLICATION OF OLT Iago Justo, Oscar Caso, Naim Fakih, Sergio Olivares, Felix Cambra, Jorge Calvo, Alejandro Manrique, Alvaro Garca, Manuel Abradelo, Carlos Jimenez and Enrique Moreno. Surgery department C, U. H. 12 de Octubre, Madrid INFECTIONS IN KIDNEY TRANSPLANTATION: INCIDENCE, TYPE AND LOCATION. A PROSPECTIVE STUDY F. Fernandez-Rodriguez, J. Fernandez Rodriguez, AM FernandezRodriguez, C. Galeano, R. Marcen, A. Muriel, and C. Quereda; Madrid, Spain INDIRECT EFFECTS OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS Takuzo Fujiwara, Shinichiro Tanaka, and Kosuke Ohta; Okayama, Japan AGE AND SEX AS RISK FACTORS FOR CMV-INFECTIONS AFTER LUNG TRANSPLANTATION Bahil Ghanim, Peter Jaksch, Mir Alireza Hoda, Viktoria Augustin, Patrick Nierlich, Axel Scheed, Clemens Aigner, Gyoergy Lang, Shahrokh Taghavi, and Walter Klepetko; Vienna, Austria RATE OF URETERIC STRICTURE IS INCREASED IN THE PRESENCE OF BK VIRAEMIA WITHOUT NEPHROPATHY Marc Gingell-Littlejohn, Hoey Koh, Emanolis Mazonakis, Colin C. Geddes, and Marc J. Clancy; Glasgow, United Kingdom DONOR URETER CULTURES IN RENAL TRANSPLANTATION Petra M. Goldsmith, Sani Aliyu, Andrew J. Bulter, and Paul Gibbs; Cambridge, United Kingdom URINARY TRACT INFECTIONS IN RENAL TRANSPLANT RECIPIENTS Justyna Golebiewska, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland BKV VIREMIA IN A WELL-MATCHED KIDNEY TRANSPLANT POPULATION Ilkka Helanter, Kaija Salmela, Lauri Kyllnen, Anne RisnenSokolowski, Laura Mannonen, Eeva Auvinen, Petri Koskinen, and Irmeli Lautenschlager; Helsinki, Finland

P-191

P-192

P-193

P-194

P-195

P-196

P-197

P-198

P-199

P-200

212

P-201

LYMPHOPROLIFERATIVE DISORDER OF THE CENTRAL NERVOUS SYSTEM AFTER RENAL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN JAPAN Daisuke Ishii, Kazunari Yoshida, Masae Ikeda, Ryota Maeyama, Kenichi Tabata, Yasuo Takeuchi, Haruki Wakai, Tadao Endo, and Baba Shiro; Sagamihara, Japan IMPACT OF RITUXIMAB INDUCTION THERAPY ON CMV INFECTIOUS DISEASE IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION Yasuo Ishii, Kazuhiro Iwadoh, Toru Murakami, Kotaro Kai, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan INVASIVE MYCOSIS INFECTIONS AMONG KIDNEY TRANSPLANT RECIPIENTS Maria A. Gini, Sebastian P. Jaurretche, Ana M. Linchenco, Pablo G. Candusso, Jos L. Sgrosso, and Maria C. Vazquez; Rosario, Argentina IL-33 INDUCES DEFENSE MECHANISM AGAINST Candida albicans THROUGH RAPID RECRUITMENT AND ENHANCED FUNCTION OF NEUTROPHILS Hong R. Cho, Jong S. Lee, Hong-Nga T. Le, Hyun C. Chung, Juyang Kim, and Byungsuk Kwon; Ulsan, Korea ISONIAZID PREVENTIVE THERAPY FOR POSTRENAL TRANSPLANT TUBERCULOSIS: A SYSTEMATIC REVIEW Xianding Wang, Jing Zhuang, Libo Xie, Mingyuan Li, and Yiping Lu; Chengdu, China EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC TCELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS Elisa S. Pierobon, Lucrezia Furian, Cristina Silvestre, Luciana Bonfante, Barbara Rossi, Francesco Marchini, Marta Fiscon, Alda Saldan, Luisa Barzon, Dino Sgarabotto, Davide Abate, Giorgio Pal, and Paolo Rigotti; Padua, Italy IMPACT OF CONTAMINATED PRESERVATION FLUID ON CADAVERIC KIDNEY ALLOGRAFT TRANSPLANT 5 YEAR EXPERIENCE Lasantha Seneviratne, Esha Abrol, Natasha Reed, Bimbi Fernando, Ben Lindsey, Mark Harber, Peter Veitch, and David Nicol; London, United Kingdom IS ISONIAZID SAFE IN LIVER TRANSPLANT PATIENTS ON THE WAITING LIST? Raquel S.B. Stucchi, Ilka F.S.F. Boin, Rocrigo N. Angerami, Leticia Zanaga, Elisabete Y. Udo, and Elaine C. Ataide; Campinas, Brazil CMV INFECTION AFTER HEART TRANSPLANTATION IN RELATION WITH DIFFERENT IMMUNOSUPRESSION Jevgenija Vymetalova, and Ivan Malek; Prague, Czech Republic A COMPARATIVE STUDY OF GANCICLOVIR VS. ACYCLOVIR FOR CYTOMEGALOVIRUS INFECTION TREATMENT IN RENAL TRANSPLANT RECIPIENTS Wujun Xue, Yang Li, Puxun Tian, Xiaoming Ding, Hang Yan, Xinshun Feng, Xiaoming Pan, Jun Hou, Heli Xiang, Xiaohui Tian, and Shengbin Li; Xian, China HEPATITIS C VIRUS (HCV) GENOTYPE MISMATCH IN RENAL TRANSPLANTATION AND HCV GENOTYPE CONVERSION Kazuaki Yamanaka, Tomoko Kinoshita, Tetuji Soda, Takeshi Ishimura, Toshiaki Hirai, Hidehumi Kishikawa, Masashi Takeda, Kenji Nishimura, Mituo Hoshimoto, Masato Fujisawa, and Yasuji Ichikawa; Nishinomiya, Hyogo, Japan; and Kobe, Hyogo, Japan

P-202

P-203

P-204

P-205

P-206

P-207

P-208

P-209

P-210

P-211

213

Poster Session: Kidney

P-212 PULSATILE PERFUSION PRESERVATION FOR EXPANDED-CRITERIA DONORS KIDNEYS: IMPACT ON DELAYED GRAFT FUNCTION RATE Imad Abboud, Corinne Antoine, Tomas Serrato, Carmen Lefaucheur, Evangline Pillebout, Franois Gaudez, Fabienne Fieux, Martin Flamant, Jrme Verine, Denis Viglietti, Marie-Nolle Peraldi, and Denis Glotz; Paris, France HAS LONG-TERM SURVIVAL OF KIDNEY TRANSPLANT STABILIZED NOWADAYS? PROJECTED HALF MEAN LIFE Mara Luisa Agera, Alberto Rodrguez-Benot, Mara Dolores Navarro, Mara Dolores Redondo, Maria Jos Prez, Katia Toledo, Domingo Castillo, and Pedro Aljama; Crdoba, Spain DOES RETROPERITONOSCOPIC NEPHRECTOMY INCREASE THE RISK FOR LYMPHOCELE FORMATION? Baris Akin, Erhan Sezer, Muammer Kaya, Murat Dayangac, Jale Saridogan, and Veday Celik; Istanbul, Turkey THE EXPERIENCE OF EXPANDED CRITERIA DONORS; KIDNEY TRANSPLANTATION IN SAUDI ARABIA: 2008-2010 Faissal A.M. Shaheen, Besher A. Al-Attar, Mohd. Ziad Souqiyyeh, Johny E. Cillo, and Abdulla A. Al-Sayyari; Riyadh, Saudi Arabia IMPACT OF THE DETERMINATION OF HLA ANTIBODIES IN KIDNEY TRANSPLANT OVER TEN YEARS OF MONITORING Jackie Apaza, Esther Gonzalez, Natalia Polanco, Carlos Cadenillas, Ignacio Bengoa, Ana Hernandez, Amado Andres, and Jose Maria Morales; Madrid, Spain LAPAROSCOPIC RE-INSERTION/EXCHANGES OF PERITONEAL DIALYSIS CATHETERS (PDC) USING THE MODIFIED Y-TEC SYSTEM Atul Bagul, Louisa C. Firmin, Umasankar M. Thiyagarajan, Jodie H. Frost, and Prof Michael L. Nicholson; Leicester, United Kingdom UROLOGICAL COMPLICATIONS AFTER RENAL TRANSPLANTATION Catalin Baston, Mihai Harza, Bogdan Serbanescu, Bogdan Stefan, Marcian Antonio Manu, Vasile Cerempei, Bogdan Haineala, Silviu Guler Margaritis, Claudiu Codoiu, Bogdan Badescu, and Ionel Sinescu; Bucharest, Romania YOURE WELCOME: SUPPORTING YOUNG ADULTS WITH KIDNEY DISEASE Clare A. Beard, Paul Harden, Bev Matthews, and Donal ODonoghue; Newcastle upon Tyne, United Kingdom; Oxford, United Kingdom; and London, United Kingdom CINACALCET IMPROVES ENDOTHELIAL FUNCTION IN RENAL TRANSPLANT RECIPIENTS WITH PERSISTENT HYPERPARATHYROIDISM pela Bortnar, Damjan Kovac, Barbara Erzen, and Aljoa Kandus; Ljubljana, Slovenia KIDNEY TRANSPLANTATION FROM LIVING DONORS OVER 60: DONOR AGE DOES MATTER Susanne Brakemeier, Klemens Budde, Josep M. Campistol, Rafael Cobera, Petra Glander, Lutz Liefeldt, Hans H. Neumayer, Federico Oppenheimer, Ignacio Revuelta, and Fritz Diekmann; Berlin, Germany; and Barcelona, Spain

P-213

P-214

P-215

P-216

P-217

P-218

P-219

P-220

P-221

214

P-222

SAFE CONVERSION OF STABLE KIDNEY TRANSPLANT RECIPENTS FROM TWICE-DAILY TACROLIMUS (Prograf) TO ONCE-DAILY MODIFIED RELEASE TACROLIMUS (Advagraf) Mario Carmellini, Giuliana Ruggieri, and Andrea Collini; Siena, Italy OPEN PROSPECTIVE STUDY TO EVALUATE CARDIOVASCULAR RISK FACTORS AND RENAL FUNCTION IN TWO DOSAGE REGIMENS OF TACROLIMUS (TAC) COMBINED WITH MYCOPHENOLATE MOFETIL AND STEROIDS IN RENAL TRANSPLANT PATIENTS Andrzej Chamienia, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland SINGLE CENTRE EXPERIENCE IN LIVING DONOR KIDNEY TRANSPLANTATION (LDKT) Andrzej Chamienia, Alicja Debska-Slizien, Boleslaw Rutkowski, Grazyna Moszkowska, Dariusz Zadrozny, and Zbigniew Sledzinski; Gdansk, Poland IMPACT OF CYP3A AND ABCB1 POLYMORPHISMS ON TACROLIMUS DOSE-ADJUSTED TROUGH CONCENTRATIONS AMONG RENAL TRANSPLANT RECIPIENTS IN KOREA Jang-Hee Cho, Mi-Kyung Jin, Young-Deuk Yoon, Ja-Yong Park, Eun-Joo Song, Ji-Young Choi, Se-Hee Yoon, Sun-Hee Park, Yong-Lim Kim, and Chan-Duck Kim; Degu, Republic of Korea RENAL TRANSPLANTATION FOLLOWING AORTO-ILIAC RECONSTRUCTION IS A SAFE A STRATEGY Celine Dubuis, Sebastien Deglise, Francois Saucy, Bertrand Saint-Lebes, Jean-Pierre Venetz, Manuel Pascual, and Jean-Marc Corpataux; Lausanne, Switzerland CONVERSION TO EVEROLIMUS: TO BELIEVE OR NOT BELIEVE? Patricia Cotovio, Marta Neves, Ldia Santos, Fernando Macrio, Rui Alves, and Alfredo Mota; Coimbra, Portugal THE INFLUENCE OF OBESITY ON RENAL TRANSPLANT OUTCOMES A PAIRED KIDNEYS ANALYSIS Zuzanna Wolyniec, Alicja Debska-Slizien, and Boleslaw Rutkowski; Gdansk, Poland ESTIMATING MODEL OF GRAFT FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS Viktor K. Denisov, and Ann S. Ksenofontova; Donetsk, Ukraine PREGNANCY IN KIDNEY TRANSPLANT: RESULTS IN 2 NORTH EAST ITALY TRANSPLANTATION CENTRES Pierluigi Di Loreto, Francesca Martino, Claudio Ronco, Pasquale Catapano, and Domenico Montanaro; Vicenza, Italy; and Udine, Italy MANAGEMENT OF LOCALIZED PROSTATE CANCER BY RETROPUBIC RADICAL PROSTATECTOMY IN KIDNEY RECIPIENTS Arnaud Doerfler, Bruno Hurault de Ligny, Sophie Le Toquin-Bernard, Sophie Le Gal, and Henri Bensadoun; Caen, France LEFT VENTRICULAR HYPERTROPHY AFTER KIDNEY TRANSPLANTATION Katarzyna Slubowska, Anna Sadowska, Barbara Lichodziejewska, Katarzyna Kurnicka, Zbigniew Galazka, Andrzej Chmura, and Magdalena Durlik; Warsaw, Poland A YEAR AFTER THE DONOR/RECIPIENT SERVICE SPLIT ONE RECIPIENT TEAMS EXPERIENCE Diane Evans, and Shirley Dowle; Bristol, United Kingdom

P-223

P-224

P-225

P-226

P-227

P-228

P-229

P-230

P-231

P-232

P-233

215

P-234

DONOR SPECIFIC ANTIBODIES (DSA): CAUSES AND CONSEQUENCES AM Fernandez-Rodriguez, F. Diez, G. Galeano, R. Marcen, C. Quereda, J. Burgos, and J.L. Castaer; Madrid, Spain NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION: RISK FACTORS AND CONSEQUENCES Inese Folkmane, Cristoph Folkmanis, Janis Bicans, Rafail Rosentha, and Ajanthan Johendranathan; Riga, Latvia; Scunthorpe, United Kingdom DOUBLE KIDNEY TRANSPLANTATION IN A SINGLE-CENTER Iris Fontana, Massimo Bertocchi, Gregorio Santori, and Umberto Valente; Genoa, Italy ASSESSING OUTCOME OF ARTERIOVENOUS FISTULAE (AVF) IN RENAL HAEMODIALYSIS PATIENTS WITH AN INDWELLING TUNNELLED DIALYSIS CATHETER (TDC) Jodie H. Frost, Atul Bagul, Umasankar M. Thiyagarajan, and Michael L. Nicholson; Leicester, United Kingdom IS INTRAVENOUS IMMUNOGLOBULIN AN EFFECTIVE TREATMENT FOR ACUTE ANTIBODY-MEDIATED REJECTION? Lucy Galloway, Iek Cheng, Anthony Dorling, Rachel Hilton, and Nizam Mamode; London, United Kingdom IMPACT OF DONOR KIDNEY SIZE ON ALLOGRAFT FUNCTIONS IN LIVING DONOR RENAL TRANSPLANTS: DOES SIZE MATTER? Abbas Ghazanfar, Gabriele Di Benedetto, David Vandellen, Maria Mito Pretorian, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom ERECTILE DYSFUNCTION AMONG PATIENTS WITH END STAGE RENAL DISEASE: A COMPARISON STUDY BETWEEN HAEMODIALYSIS, CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AND RENAL TRANSPLANT PATIENTS Bak-Leong Goh, Eng-Khim Ng, Mohd Rozi, Siew Eng Chew, and N. Noraziah; Kajang, Malaysia EARLY BEDSIDE REMOVAL VERSUS LATE CYSTOSCOPIC REMOVAL OF URETERIC STENTS FOLLOWING RENAL TRANSPLANTATION; DOES IT MAKE A DIFFERENCE? Nalaka Gunawansa, Rezni Cassim, Anuja Abeydheera, and Mandika Wijeyaratne; Colombo, Sri Lanka SERUM PARAOXANASE 1 ACTIVITY PREDICTS ARTERIAL STIFFNESS IN RENAL TRANSPLANT PATIENTS Ozkan Gungor, Fatih Kircelli, Meltem Sezis Demirci, Pinar Balci, Ali Riza Sisman, Erhan Tatar, Ender Hur, Gulay Asci, Ercan Ok, and Huseyin Toz; Izmir, Turkey STUDY OF FACTORS AFFECTING GRAFT AND PATIENT SURVIVAL WITHIN FIVE YEARS OF RENAL TRANSPLANTATION Krishan L. Gupta, Pinaki Mukherjee, Mukut Minz, Harbir Kohli, Vivekanand Jha, and Vinay Sakhuja; Chandigarh, India EARLY PROGRESSION OF AMYLOIDOSIS IN A RENAL TRANSPLANT RECIPIENT WITH FAMILIAL MEDITERRANEAN FEVER Medhat M.A. Halim, Torki Al-Otaibi, Osama Gheith, Hany Adel, Ahmed Musaad, Biju Vareed, Deepak S. Pillai, Tarek Said, Prasad Nair, and M.R.N. Nampoory; Kuwait, Kuwait EFICACY AND SIDE EFFECTS OF H1N1 VACCINATION IN RENAL TRANSPLANT AND DIALYSIS PATIENTS R. Allwin, S. Gauer, Roessel, H. Hoefeld, M. Brzoska, S.K. Han, J. Gossmann, V. Belwe, H. Geiger, and I.A. Hauser; Frankfurt, Germany

P-235

P-236

P-237

P-238

P-239

P-240

P-241

P-242

P-243

P-244

216
P-245

P-246

COMPLICATIONS OF KIDNEY TRANSPLANTATION FROM DONORS AFTER CARDIAC DEATH (DCD) Szabolcs Horvath, David Archampong, Pramod Nagaraja, Gareth Roberts, Michael Stephens, Jana Fialova, Sian Griffin, Rafael Chavez, Argiris Asderakis, and Zsolt Kaposztas; Cardiff, United Kingdom UROTENSIN II LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND KIDNEY TRANSPLANTS Mehmet Hursitoglu, Tufan Tukek, Mehmet Ali Cikrikcioglu, Osman Kara, Rumeyza Kazancioglu, Oktay Ozkan, Mustafa Cakirca, Fatih Akdogan, Erdal Gundogan, Sengul Aydin, Ismet Beycan, Meltem Gursu, Serkan Dogan, and Aybala Erek; Istanbul, Turkey EFFECTS OF CONVERSION FROM TACROLIMUS TO TACROLIMUS EXTENDED-RELEASE ON TREATMENT ADHERENCE IN KIDNEY TRANSPLANT PATIENTS Naotsugu Ichimaru, Taigo Kato, Koichi Tsutahara, Yoichi Kakuta, Toyofumi Abe, Masayoshi Okumi, Koji Yazawa, Norio Nonomura, Junya Kaimori, and Shiro Takahara; Osaka, Japan; and Suita, Japan THE PROGNOSTIC IMPACT OF DONOR-SPECIFIC ANTIBODY (DSA) LEVELS TO PREDICT SEVER ACUTE ANTIBODY MEDIATED REJECTION IN LIVING KIDNEY TRANSPLANTATION Rie Imaizumi, Yasuo Ishii, Kazuhiro Iwadoh, Katsuyuki Miki, Shinji Kudoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan THE IMPACT OF HUSBAND-TO-WIFE SPOUSAL RENAL TRANSPLANTATION ON ACUTE REJECTION IN TERMS OF DONOR-SPECIFIC ANTIGEN Katsuyuki Miki, Kazuhiro Iwadoh, Yasuo Ishii, Yusuke Tomita, Rie Imaizumi, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, and Shouhei Fuchinoue; Tokyo, Japan BENEFITIAL EFFECT OF UBIQUINOL, THE REDUCED FORM OF COENZYME Q10, ON CYCLOSPORINE-INDUCED NEPHROTOXICITY Akira Ishikawa, and Yukio Homma; Tokyo, Japan SLOW EARLY GRAFT FUNCTION: A NEGLECTED ENTITY AFTER RENAL TRANSPLANTATION Daniel Nel, John Vogel, Elmi Muller, Zunaid Barday, and Delawir Kahn; Cape Town, South Africa HEPATITIS B REACTIVATION FOLLOWING KIDNEY TRANSPLANTATION: INCIDENCE AND RISK FACTORS Nada Kanaan, Benoit Kabamba, Cline Marchal, Eric Goffin, and Ziad Hassoun; Brussels, Belgium DONOR KIDNEY WEIGHT TO RECIPIENT BODY-WEIGHT RATIO IS AN IMPORTANT RISK FACTOR FOR LONG-TERM OUTCOME OF LIVING DONOR KIDNEY TRANSPLANTATION Ji Il Kim, Jeong-Kye Hwang, and In-Sung Moon; Seoul, Korea KIDNEYS FROM DECEASED DONORS WITH OLIGURIA ARE FEASIBLE FOR KIDNEY TRANSPLANTATION Jong Man Kim, Sanghyun Song, Milljae Shin, Hyung Hwan Moon, Young Nam Moon, Hyun Sun Ji, Jong Hwan Lee, Choon Hyuck D. Kwon, JaeWon Joh, and Sung-Joo Kim; Seoul, Korea

P-247

P-248

P-249

P-250

P-251

P-252

P-253

P-254

P-255

217

P-256

HORMONAL DIFFERENCE IN BETWEEN FEMALE KIDNEY TRANSPLANT RECIPIENTS AND HEALTHY WOMEN WITH ENDOCRINOLOGIC PROBLEMS IN GYNECOLOGY Jong Man Kim, Sanghyun Song, Milljae Shin, Hyung Hwan Moon, Young Nam Noh, Hyun Sun Ji, Choon Hyuck D. Kwon, Jae-Won Joh, and Sung Joo Kim; Seoul, Korea DEEP VEIN THROMBOSIS IMMEDIATELY AFTER KIDNEY TRANSPLANTATION Ji Il Kim, Jeong Kye Hwang, and In Sung Moon; Seoul, Korea SHORT-TERM RESULTS OF ABO-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION: COMPARISON WITH ABO-COMPATIBLE GRAFTS Ji Il Kim, Jeong Kye Hwang, and In Sung Moon; Seoul, Korea CLINICAL RELEVANCE OF POST TRANSPLANT DE NOVO HLA ANTIBODIES AFTER LIVING DONOR KIDNEY TRANSPLANTATION Martina Koch, Thomas Eiermann, Almut Vernauer, Werner Tenschert, Friedrich Thaiss, and Bjoern Nashan; Hamburg, Germany HLA-C MISMATCH AFFECTS SHORT-TERM RENAL TRANSPLANT FUNCTION Hoey C. Koh, Claire Burt, Marc Gingell-Littlejohn, Ann-Margaret Little, and Marc J. Clancy; Glasgow, United Kingdom THE QUALITY OF LIFE IN LIVING DONOR KIDNEY TRANSPLANTATION Myoung Hee Kim, Oh Jung Kwon, and ChongMyung Kang; Seoul, Korea COMPARISON OF SERUM CYSTATIN C AND CREATININE AS A MARKER FOR EARLY DETECTION OF DECREASING GLOMERULAR FILTRATION RATE IN RENAL TRANSPLANTATION PATIENTS Oh Jung Kwon, Hayng Ran Lee, and Jin Young Kwak; Seoul, Korea PREGNANCY IN KIDNEY TRANSPLANT PATIENTS Vrnica Lpez, Dolores Martnez, Carmen Violo, Mercedes Cabello, Eugenia Sola, Cristina Gutirrez, Dolores Burgos, and Domingo Hernndez; Malaga, Spain REDUCTION IN PROTEINURIA AFTER DUAL BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM (ARB II-ALISKIREN) IN KIDNEY TRANSPLANT PATIENTS Vernica Lpez, Cristina Jironda, Mnica Martn, Carmen Cobelo, Eugenia Sola, Mercedes Cabello, Cristina Gutirrez, Dolores Burgos, Miguel Gonzlez-Molina, and Domingo Hernndez; Malaga, Spain JC POLYOMAVIRUS: DOES IT CAUSE NEPHROPATHY IN RENAL TRANSPLANT PATIENTS? Vernica Lpez, Cristina Gutirrez, Eugenia Sola, Dolores Burgos, Mercedes Cabello, Miguel Gonzlez-Molina, and Domingo Hernndez; Mlaga, Spain HISTOLOGICAL FINDINGS IN RENAL TRANSPLANT PATIENTS WITH PROTEINURIA Vernica Lpez, Eugenia Sola, Cristina Jironda, Mirian Len, Isabel Garca, Cristina Gutirrez, Mercedes Cabello, Dolores Burgos, Miguel Gonzlez-Molina, and Domingo Hernndez; Mlaga, Spain RESTROSPECTIVE ANALYSIS OF INDUCTION THERAPY (IT) FOR KIDNEY TRANSPLANTATION IN A SINGLE CENTER POPULATION OVER 17 YEARS Antonio Lavacca, Maria Massina, Caterina Dolla, Ester Gallo, Giuliana Tognarelli, Vincenzo Cantaluppi, Roberta Giraudi, and Giuseppe P. Segoloni; Turin, Italy

P-257

P-258

P-259

P-260

P-261 P-262

P-263

P-264

P-265

P-266

218

P-267

P-268

SEVERE NEUROLOGICAL COMPLICATIONS(SNC) IN KIDNEY TRANSPLANTATION (KT) Sebastian P. Jaurretche, Maria A. Gini, Ana M. Linchenco, Pablo G. Candusso, Jos L. Sgrosso, and Maria C. Vazquez; Rosario, Argentina SERUM HOMOCYSTEINE THIOLACTONASE AND PARAOXONASE ACTIVITY IN RENAL TRANSPLANTED PATIENTS Lajos Locsey, Ildiko Seres, Ferenc Sztanek, Mariann Harangi, Janos Padra, Laszlo Asztalos, and Gyorgy Paragh; Debrecen, Hungary CONVERSION TO EVEROLIMUS IN PATIENTS WITH NEPHROTOXICITY INDUCED BY CALCINEURIN INHIBITORS. ONE YEAR EVOLUTION AS PER BASELINE BIOPSY FINDINGS P.U. Massari, C. Chiurchiu, C. Agost Carreo, P. Novoa, F. Acosta, M. Arriola, H. Trimarchi, F. Lopez, H. Petrone, J. Davalos Michel, C. Balaguer, R. Schiavelli, and F. Cicora; Cordoba, Argentina; Buenos Aires, Argentina; Rosario, Argentina; Santa Fe, Argentina; Resistencia, Argentina; La Plata, Argentina; and Mendoza, Argentina RENAL VESSEL MULTIPLICITY AND ITS IMPACT ON PERIOPERATIVE AND LONG-TERM DONOR OUTCOMES FOLLOWING LIVING-DONOR NEPHRECTOMY Sotiris Mastoridis, Benjamin OBrien, Atika Sabharwal, David Taube, Nadey Hakim, and Vassilios Papalois; London, United Kingdom UROLOGICAL COMPLICATIONS FOLLOWING RENAL TRANSPLANTATION- A SINGLE CENTRE EXPERIENCE Umasankar Mathuram Thiyagarajan, Prarthana Thiyagarajan, Atul Bagul, and Michael L. Nicholson; Leicester, United Kingdom IMBALANCE OF MMPs/TIMPs SYSTEM IN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC ALLOGRAFT INJURY Oktawia Mazanowska, Dorota Kaminska, Magdalena Krajewska, Marcelina Zabinska, Waclaw Kopec, Maria Boratynska, and Marian Klinger; Wroclaw, Poland VARIATION OF THE KIDNEY GRAFT VESSELS DURING LAPAROSCOPIC LIVING DONOR NEPHRECTOMY (LLDN): SURGICAL MANAGEMENT AND IMPACT ON EARLY GRAFT FUNCTION Anh Dung Hoang, Dimitri Mikhalski, Alexis Buggenhout, Patricia Loi, Daniel Abramowicz, Nilufer Broeders, and Vincent Donckier; Brussels, Belgium eGFR AND 1-HOUR BIOPSY ARE BETTER PREDICTORS OF DECEASED KIDNEY TRANSPLANTS WITH USING IN-SITU-COOLING DOUBLEBALLOON CATHETERS SYSTEM Kazuo Mizutani, Ryohei Hattori, Tsuneo Kinukawa, Osamu Kamihira, and Momokazu Gotoh; Nagoya, Japan; and Komaki, Japan DISTRIBUTION OF RENAL HISTOPATHOLOGY FINDINGS IN GUILAN PROVINCE, NORTH OF IRAN DURING 2001 TO 2006 Ali Monfared, Seyed Amin Mosavian Roshanzamir, Saba Hoda, and Sepiedeh Besharati; Rasht, Islamic Republic of Iran LIVING DONOR KIDNEY TRANSPLANTATION IN CROSSMATCHPOSITIVE PATIENTS ENABLED BY PERITRANSPLANT IMMUNOADSORPTION AND ANTI-CD20 THERAPY Christian Morath, Jorg Beimler, Gerhard Opelz, Sabine Scherer, Jan Schmidt, Marie-Luise Gross, Claudia Sommerer, Vedat Schwenger, Martin Zeier, and Caner Susal; Heidelberg, Germany

P-269

P-270

P-271

P-272

P-273

P-274

P-275

P-276

P-277

219

P-278

ATTITUDES AND PRACTICES TOWARDS RENAL TRANSPLANTATION IN SICKLE CELL SYNDROMES AMONGST UK TRANSPLANT CENTRES Jay Nath, James McDaid, Andrew Bentall, Simon Ball, Andrew R. Ready, and Nicholas G. Inston; Birmingham, United Kingdom RESTARTING A LIVING DONOR KIDNEY TRANSPLANT PROGRAM IN KENYA: 24 TRANSPLANTS PERFORMED IN LESS THAN ONE YEAR John Ngigi, Anthony Were, James Munene, Thomas Chokwe, Peter Mungai, Samuel Kanyi, Divinia Nyarera, Ana Palacio, Conchita Monsalve, Nuria Saval, Nathalie Cretin, Antonio Alcaraz, and Federic Oppenheimer; Nairobi, Kenya; Barcelona, Spain; Barcelona, St. Helena; and Basel, Switzerland IMPACT OF LOW SERUM ADIPONECTIN LEVELS ON ARTERIAL STIFFNESS IN NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION Kenji Nishimura, Toshiaki Hirai, Ayako Okuno, Tetsuji Soda, Shigeaki Nakazawa, Sayoko Yonemoto, Kazuaki Yamanaka, Naohiko Fujii, Hidefumi Kishikawa, and Yasuji Ichikawa; Nishinomiya, Japan VALIDATION OF THE SIMPLIFIED MEDICATION ADHERENCE QUESTIONNAIRE (SMAQ) IN RENAL TRANSPLANT PATIENTS ON TACROLIMUS Francisco J. Ortega, Jaime Snchez, Miguel A. Prez, Porfirio Pereira, Miguel A. Muoz, and Dolores Lorenzo; Oviedo, Spain; Valencia, Spain; Las Palmas, Spain; Sevilla, Spain; Toledo, Spain; and A Corua, Spain THE DIFFERENCES IN THE POST-TRANSPLANT LYMPHOCELES IN DEPENDENCY ON THEIR ORIGIN Jaroslav Pacovsky, Radomir Hyspler, Pavel Navratil, Lukas Holub, and Milos Brodak; Hradec Kralove, Czech Republic THE LONG-TERM RESULTS FOLLOWING THE TREATMENT OF THE POST-TRANSPLANT SYMPTOMATIC LYMPHOCELES Jaroslav Pacovsky, Radomir Hyspler, Pavel Navratil, and Milos Brodak; Hradec Kralove, Czech Republic HIGH LYMPHOCYTE COUNTS IN THE EARLY POST-TRANSPLANT COURSE OF KIDNEY ALLOGRAFT RECIPIENTS CARRYING IMPDH II 3757 T>C SNP Joanna Pazik, Monika Oldak, Zbigniew Lewandowski, Grzegorz Bubak, Malgorzata Puzon, Marta Podgrska, Elzbieta Sitarek, Rafal Ploski, Jacek Malejczyk, and Magdalena Durlik; Warsaw, Poland WEIGHT GAIN IN KIDNEY ALLOGRAFT RECIPIENTS CARRYING MDR2 2 4544G>A POLYMORPHISM Joanna Pazik, Monika Oldak, Zbigniew Lewandowski, Elzbieta Sitarek, Malgorzata Puzon, Grzegorz Bubak, Rafal Ploski, Jacek Malejczyk, and Magdalena Durlik; Warsaw, Poland DOES PRE-OPERATIVE SPLIT RENAL FUNCTION TESTING PREDICT RESIDUAL POST-DONATION FUNCTION IN LIVING DONOR TRANSPLANTATION? Robin Polson, Alex P. Navarro, Alun R. Williams, Amanda J. Knight, Keith M. Rigg, and Shantanu Bhattacharjya; Nottingham, United Kingdom CREATININE REDUCTION RATIO ON DAY 2: THE USEFUL MARKER FOR TRANSPLANT OUTCOME IN PATIENTS WITH LIVING DONOR TRANSPLANTATION Irena Rambabova Busljetic, Popov Zivko, Jelka Masin, Galina Severova, Anita Hristova Dimcevska, and Ninoslav Ivanovski; Skopje, Macedonia

P-279

P-280

P-281

P-282

P-283

P-284

P-285

P-286

P-287

220

P-288

LARGE ANIMAL RENAL ALLOTRANSPLANTATION; A PORCINE RECOVERY MODEL TO ASSESS DELAYED GRAFT FUNCTION Christopher Ray, Muhammad Khurram, Omar Mownah, Aditya Kanwar, Susan Stamp, John Brassil, Douglas Rees, Kathryn White, Katrina Wood, Kelly Philipson, Robert Peaston, Aurelie Thomas, Anne Cunningham, Paul Flecknell, Noel Carter, and David Talbot; Sunderland, United Kingdom; and Newcastle upon Tyne, United Kingdom COMPARISON AMONG ACUTE REJECTION MEDITED BY CELLULAR AND ANTIBODY MECHANISMS IN PATIENTS SUBMITTED TO IDENTIFICATION OF C4d AND DSA IN RENAL BIOPSY Lucio R. Requio-Moura, Eduardo J. Tonato, Erika A. Ferraz, Rogerio Chinen, Thiago C. Filliponi, Ana Cristina C.C. Mattos, Marcelino S. Duro, and Alvaro Pacheco-Silva; So Paulo, Brazil CARDIOVASCULAR RISK ASSESSMENT FOR RENAL TRANSPLANTATION. ARE PATIENTS BEING MANAGED APPROPRIATELY IN OUR HOSPITAL? James Rigby, Selva Velu, and Mark Gunning; Stoke-on-Trent, United Kingdom COMPARISON OF THE EFFICACY AND SAFETY OF CALCINEURIN INHIBITOR CONVERSION TO mTOR INHIBITOR AND CNI MINIMIZATION IN KIDNEY TRANSPLANTS WITH CHRONIC ALLOGRAFT NEPHROPATHY Piyarat Rojsanga, Attapong Vongwiwatana, Nalinee Premasathian, and Somkiat Vasuvattakul; Bangkok, Thailand PREDICTIVE REGRESSION MODELS IN A SINGLE-CENTER SERIES OF DOUBLE KIDNEY TRANSPLANTATION Gregorio Santori, Iris Fontana, Massimo Bertocchi, Sergio Barocci, Arcangelo Nocera, and Umberto Valente; Genoa, Italy THYMOGLOBULIN INDUCTION IN LIVING-DONOR RENAL TRANSPLANTATION Peter Schenker, Arzu ztrk, Oliver Vonend, Bernd Krger, Martin Jazra, Bernhard K. Krmer, and Richard Viebahn; Bochum, Germany; Dsseldorf, Germany; and Mannheim, Germany EARLY DIAGNOSIS AND IMPACT OF TRANSPLANT RENAL ARTERY STENOSIS TREATED BY ANGIOPLASTY Lasantha N. Seneviratne, Prabal Mittal, Anthony Goode, Ben Lindsey, Bimbi Fernando, Mark Harber, Peter Veitch, and David Nicol; London, United Kingdom THE EFFECT OF COLD ISCHEMIA TIME ON THE DELAYED GRAFT FUNCTION AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION Ismail Sert, Sait Murat Dogan, Cem Tugmen, Eyp Kebabci, Ragip Kayar, and Cezmi Karaca; Izmir, Turkey ALLOGRAFT OUTCOME OF SPOUSAL AND LIVING UNRELATED RENAL TRANSPLANTATION Taylan O. Sezer, Huseyin Toz, Erhan Tatar, Ceyhun Isayev, Ozgur Firat, Ilhami Solak, and Cuneyt Hoscoskun; Izmir, Turkey SIGNIFICANT ASSOCIATION BETWEEN RESULT OF NOVEL CROSSMATCH TEST AND ANTIBODY-MEDIATED REJECTION AFTER RENAL TRANSPLANTATION Yusuke Shiraishi, Michio Nojima, Tomoko Kinoshita, Mitsuo Hashimoto, Yasuo Ueda, Hidefumi Kishikawa, Masashi Takeda, Masato Fujisawa, Yasuji Ichikawa, and Shingo Yamamoto; Nishinomiya, Japan; and Kobe, Japan

P-289

P-290

P-291

P-292

P-293

P-294

P-295

P-296

P-297

221

P-298

OUTCOMES OF LIVE KIDNEY DONOR WORK-UP: A SINGLE CENTRE EXPERIENCE Caroline Basarab-Horwath, Carole Clayton, Lisa Hamilton, Veronica Lennon, Peter W.G. Brown, and Badri Man Shrestha; Sheffield, United Kingdom ESTIMATED GLOMERULAR FILTRATION RATE AND LONG-TERM OUTCOMES FOLLOWING LIVE KIDNEY DONATION: A SINGLE CENTRE EXPERIENCE Carole Clayton, Lisa Hamilton, Caroline Basarab-Horwath, Veronica Lennon, and Badri Man Shrestha; Sheffield, United Kingdom DOES CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION HAVE BETTER PROGNOSIS THAN CHRONIC T- CELL MEDIATED REJECTION? Janka Slatinska, Eva Honsova, Marcela Burgelova, Eva Slimackova, and Ondrej Viklicky; Prague, Czech Republic PROGNOSTIC ROLE OF PRE-TRANSPLANT DONOR KIDNEY BIOPSIES Vadims Suhorukovs, Janis Jushinskis, and Tatjana Tihomirova; Riga, Latvia INFLUENCE OF POLYMORPHISMS GLUTATHIONE S-TRANSFERASE AND ANTI-GSTT1 ANTIBODY ON ALLOGRAFT OUTCOME IN RENAL TRANSPLANT RECIPIENTS Sebahat Usta, Yasar aliskan, Hakan Grkan, igdem Kekik, Fatma O. Savran, and Aydin Trkmen; Istanbul, Turkey TREATMENT OF VITAMIN D DEFICIENCY AND ITS IMPACT ON ALBUMIN EXCRETION IN KIDNEY TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL Ursula Thiem, Alois Gessl, Georg Heinze, Ute Gssler, Thomas Perkmann, Franz Kainberger, Ferdinand Mhlbacher, Walter H. Hrl, and Kyra Borchhardt; Vienna, Austria RENAL FUNCTION MONITORING AFTER ORTHOTOPIC LIVER TRANSPLANTATION: ONE YEAR FOLLOW-UP Francesca Tinti, Ilaria Umbro, Valerio Giannelli, Manuela Merli, Stefano Ginanni Corradini, Massimo Rossi, Luca Poli, Pasquale B. Berloco, and Anna Paola Mitterhofer; Rome, Italy ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAY IN CADAVER KIDNEY TRANSPLANTATION LEADS TO THE SLOW GRAFT FUNCTION (SGF) Olexander S. Nikonenko, Andriy V. Trailin, and Tamara M. Nikonenko; Zaporizhzhya, Ukraine VENOUS DISPOSITION PROCEDURE (VDP) ON THE SHORT RENAL VEIN REMOVING BY LAPAROSCOPY: A SIMPLE PROCEDURE Sinh Ng Tran, and Thu Thi Ngoc Du; Ho Chi Minh City, Viet Nam THE EFFECT OF ANEMIA ON KIDNEY FUNCTION IN LIVING KIDNEY TRANSPLANTATION Makoto Tsujita, Takehiko Kawaguchi, Takayuki Yamamoto, Takahisa Hiramitsu, Koji Nanmoku, Norihiko Goto, Yoshihiko Watarai, and Kasuharu Uchida; Nagoya, Japan SUCCESSFUL ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION IN PATIENT WITH CONGENIAL AFIBRINOGENEMIA: FIRST CASE REPORT Yasuo Ueda, Michio Nojima, Akihiko Sawada, Yusuke Shiraishi, Yoshihide Higuchi, and Shingo Yamamoto; Nishinomiya, Japan HEMODIALYSIS ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS: COMPLICATIONS AND SURGICAL INTERVENTIONS Barbara Vajdic, Rafael Ponikvar, Aljosa Kandus, and Jadranka ButurovicPonikvar; Ljubljana, Slovenia

P-299

P-300

P-301

P-302

P-303

P-304

P-305

P-306

P-307

P-308

222
P-309

P-310

LIVE KIDNEY TRANSPLANTATION: DO TRAINEES MAKE THE GRADE? David van Dellen, Otilia M. Mitu-Pretorian, Melissa Cunha, Abbas Ghazanfar, Bence Forgacs, Ravi Pararajasingam, Babatunde Campbell, Hany N. Riad, Neil R. Parrott, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom ePTFE SUTURE ANASTOMOSIS: AN EFFECTIVE TOOL IN VASCULAR KIDNEY TRANSPLANTATION? Francesca Villa, Matteo Tozzi, Gabriele Piffaretti, Marco Franchin, Giuseppe Ietto, Fabrizio Rossi, and Giulio Carcano; Varese, Italy LATE SEVERE NON-INFECTIOUS DIARRHEA AFTER RENAL TRANSPLANTATION: HIGH RISK FACTORS, THERAPY AND PROGNOSIS Jiqiu Wen, Jinsong Chen, Shuming Ji, Dongrui Cheng, Qiquan Sun, Xue Li, and Zhihong Liu; Nanjing, China HLA-DR OVEREXPRESS ON THE TUBULAR OF RENAL ALLOGRAFT IN EARLY ACUTE CELLULAR REJECTION AND LATE REJECTION IN RENAL TRANSPLANTATION Jiqiu Wen, Jinsong Chen, Shuming Ji, Dongrui Cheng, Qiquan Sun, and Zhihong Liu; Nanjing, China WHAT HARM DO WE DO TO OUR ELDERLY PATIENTS? THE BRIDGE BETWEEN EVIDENCE BASED MEDICINE AND REAL LIFE IN TRANSPLANT MEDICINE Gerhard H. Wirnsberger, Matthias Koelbl, and Regina E. RollerWirnsberger; Graz, Austria PURE LAPAROSCOPIC LIVE DONOR NEPHRECTOMY RESULTS: A SINGLE INSTITUTION EXPERIENCE Hakan Sozen, Utku Yilmaz, Lutfi Tunc, and Aydin Dalgic; Ankara, Turkey DONOR DNA LEVEL IN BLOOD OF KIDNEY ALLOGRAFT RECIPIENTS CAN IT BE USED AS A DIAGNOSTIC FACTOR FOR REJECTION Malgorzata Zagozda, Andrzej Rydzewski, Marek Durlik, and Waldemar L. Olszewski; Warsaw, Poland IS IT POSSIBLE TO REDUCE THE RISK OF THROMBOSIS OF VEIN IN RIGHT KIDNEY ALLOGRAFT?HOW? Afshar Zomorrodi, Farzad Kakai, and Sahar Zomorrodi; Tabriz, Islamic Republic of Iran IS LEAVING EXPANSION PLACE FOR SUTURE IN ANASTOMOSIS OF VESSEL SAFE AND HELPFUL FOR PREVENTION OF STENOSIS? Afshar Zomorrodi, Aboulfazel Bahloli, Farzad Kakai, and Sahar Zomorrodi; Tabriz, Islamic Republic of Iran REVASCULARIZATION OF TRANSPLANT RENAL ARTERY STENOSIS: DOPPLER ASSESSMENT Ana Zupunski Cede, Vanja Peric, Aljoa Kandus, and Jadranka Buturovic-Ponikvar; Ljubljana, Slovenia

P-311

P-312

P-313

P-314

P-315

P-316

P-317

P-318

P-319

Poster Session: Liver and Intestine

P-320 RESULTS OF LIVER TRANSPLANTATION CRYPTOGENIC CIRRHOSIS: LONG-TERM FOLLOW-UP Jos Mara lamo, Carmen Benal, Luis Miguel Marn, Lydia Barrera, Gonzalo Surez, Juan Serrano, Javier Padillo, and Miguel ngel Gmez; Seville, Spain RESULTS OF LIVER TRANSPLANT WITH DONORS OLDER THAN 70 Jos Mara lamo, Lydia Barrera, Luis Miguel Marn, Carmen Bernal, Gonzalo Surez, Juan Serrano, Francisco Javier Padillo, and Miguel ngel Gmez; Seville, Spain

223

P-321

P-322

A HIGH MELD SCORE RELATES TO LOWER EMPLOYMENT RATES AFTER LIVER TRANSPLANTATION Fredrik berg, Krister Hckerstedt, Risto P. Roine, and Helena Isoniemi; Helsinki, Finland PREVENTION OF SMALL-FOR-SIZE GRAFT SYNDROME IN LIVING DONOR LIVER TRANSPLANTATION BY PORTOCAVAL SHUNT GRAFTING WITH A BIOABSORBABLE SYNTHETIC VESSEL Masayasu Aikawa, Mitsuo Miyazawa, Yosuke Ueno, Katsuya Okada, Yasuko Toshimitsu, Nobuji Ogawa, and Isamu Koyama; Saitama, Japan LIVER DONATION AND TRANSPLANTATION IN SAUDI ARABIA Faissal A.M. Shaheen, Besher A. Al-Attar, Rogelio Q. Mendez, Jr., Zayed Mohd. Ibrahim, and Elsayed A. Gadalla; Riyadh, Saudi Arabia CHANCE OF SALVAGE TRANSPLANTATION AFTER PRIMARY HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A SPECIAL REFERENCE TO UP-TO-7 CRITERIA Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan REVERSIBLE SEVERE IMMUNOLOGICAL AND INFECTIOUS COMPLICATIONS IN INTESTINE TRANSPLANT: A CASE REPORT Claudia Bsmller, Matthias Biebl, Stefan Schneeberger, Robert llinger, Felix Aigner, Sascha Wei, Rupert Oberhuber, Christian Ensinger, and Johann Pratschke; Innsbruck, Austria PATIENTS SURVIVING AT LEAST 10 YEARS POST LIVER TRANSPLANTATION: LONG TERM RESULTS M. Berenguer, A. Rubin, V. Aguilera, C. Sanchez-Montes, M. Garca-Eliz, C. Ortiz, F. Sanjuan, R. Lopez-Andujar, and M. Prieto; Valencia, Spain HEPATOPULMONARY SYNDROME IN CIRRHOTIC PATIENTS CANDIDATES TO A LIVER TRANSPLANTATION Maria-Dolores Espinosa, Flor Nogueras, Carmen Olmedo, Rosa Macas, Karim Muffak-Granero, Ana Comino, Trinidad Villegas, Jose-Antonio Ramirez, Daniel Garrote, Pablo Bueno, and Jose-Antonio Ferron; Granada, Spain LIVER TRANSPLANT BILIARY MISMATCH: BILIARY TRANSPOSITION VS DUCTOPLASTY Ian C. Carmody, Humberto Bohorquez, David Bruce, Ari Cohen, and George E. Loss; New Orleans, USA THE COMBINATION OF BOTH AICAR AND TMZ IN UW SOLUTION IS UNNECESSARY TO INCREASE SURVIVAL OF RECIPIENTS TRANSPLANTED WITH STEATOTIC LIVERS Maria Elias-Mir, Mnica Jimnez-Castro, Aran Casillas-Ramirez, Marta Massip-Salcedo, Antoni Rimola, Juan Rods, and Carmen Peralta; Barcelona, Spain EARLY AND EXTENDED THERAPY OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION Felix Garca-Pajares, Gloria Sanchez Antolin, Carolina Almohalla, Rosa Conde, Carmen Ramos, Rafael Ruiz Zorrilla, Sara Lorenzo Pelayo, Rosario Velicia Llames, and Agustin Caro Paton; Valladolid, Spain USEFULNESS OF C4d DEPOSITS IN DIFFERENTIAL DIAGNOSIS BETWEEN ACUTE LIVER REJECTION AND HEPATITIS C RECURRENCE Beata Gierej, and Barbara Grnicka; Warsaw, Poland WITHDRAWN

P-323

P-324

P-325

P-326

P-327

P-328

P-329

P-330

P-331

224

P-332

P-333

P-334

COMPARISON OF NORMAL SALINE AND LACTATED RINGERS SOLUTION DURING LIVER TRANSPLANTATION Sun-Ji Hyun, Hyo Jin Kim, Young Hee Shin, Justin Sangwook Ko, Mi Sook Gwak, Gaab Soo Kim, and Sung-Joo Kim; Seoul, Republic of Korea INFLUENCE OF CHOLESTASIS AND HEPATOCYTOLISIS ON LIVER STIFFNESS IN RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION Speranta Iacob, Liana Gheorghe, Gabriel Becheanu, Mona Dumbrava, and Irinel Popescu; Bucharest, Romania METABOLIC DERANGEMENTS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION: THE PROBLEM INTO THE PROBLEM Maddalena Iadevaia, Michela Giusto, Valerio Giannelli, Quirino Lai, Massimo Rossi, Stefano Ginanni Corradini, and Manuela Merli; Rome , Italy MICROVASCULAR RECONSTRUCTION OF HEPATIC ARTERY USING A NEW IMAGING DEVICE Takuya Iida, Makoto Mihara, Mitsunaga Narushima, and Isao Koshima; Tokyo, Japan IMPACT OF LEFT LOBE GRAFT ON ADULT LIVING DONOR LIVER TRANSPLANTATION: SMALL-FOR-SIZE GRAFT IS NOT A RISK FACTOR FOR SHORT AND LONG OUTCOME Satoru Imura, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan WHEY PROTEIN ISOLATE, MEIN, CAN REDUCE LIVER DAMAGE EARLY AFTER LIVING DONOR LIVER TRANSPLANTATION Daichi Ishikawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Michihito Asanoma, Hisae Kume, and Hajime Sasaki; Tokushima, Japan; and Tokyo, Japan LATE ACUTE REJECTION MORE THAN 3 MONTHS AFTER LIVING AND DECEASED DONOR LIVER TRANSPLANTATION Naoki Kawagishi, Ikuo Takeda, Shigehito Miyagi, Kazushige Satoh, Yorihiro Akamatsu, Satoshi Sekiguchi, and Susumu Satomi; Sendai, Miyagi, Japan USEFULNESS OF THE PINCH-BURN-CUT (PBC) TECHNIQUE WITH MONOPOLAR FORCEPS DURING TOTAL HEPATECTOMY OF THE RECIPIENTS IN LIVER TRANSPLANTATION Bong-Wan Kim, Hee-Jung Wang, Myung-Wook Kim, Yong-Keun Park, and Weiguang Xu; Suwon, Korea LIVING DONOR LIVER TRANSPLANTATION: IMPACT ON DONORS HEALTH-RELATED QUALITY OF LIFE Lampros Kousoulas, Nikos Emmanouilidis, Juergen Klempnauer, and Frank Lehner; Hannover, Germany PERIOPERATIVE ANTIMICROBIAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS Robert Krl, Jacek Pawlicki, Joanna Badura, Jacek Ziaja, Tomasz Cierniak, and Lech Cierpka; Katowice, Poland INTRAOPERATIVE HEPATIC ARTERY BLOOD FLOW PREDICTS EARLY HEPATIC ARTERY THOMBOSIS AFTER LIVER TRANSPLANTATION Luis M. Marn Gmez, Carmen Bernal Bellido, Jos M. lamo Mrtinez, Francisco M. Porras-Lpez, Gonzalo Surez-Artacho, Juan Serrano DiazCanedo, Javier Padillo Ruiz, and Miguel A. Gmez Bravo; Seville, Spain

P-335

P-336

P-337

P-338

P-339

P-340

P-341

P-342

P-343

P-344

225

P-345

LONGTERM RENAL DYSFUNCTION IN LIVER TRANSPLANT RECIPIENTS Mariana Mihaila, Alina Elena Tirdea, Laurentiu Micu, Irinel Popescu, and Mihai Voiculescu; Bucharest, Romania AMYLOID POLYNEUROPATHY RELAPSED 7 YEARS AFTER DOMINO TRANSPLANTATION WITH THE LIVER OF A 62-YEAR-OLD FAP DONOR Kohei Miura, Yoshinobu Sato, Satoshi Yamamoto, Hiroshi Oya, Yoshiaki Hara, Takashi Kobayashi, Hidenaka Kokai, and Katsuyoshi Hatakeyama; Niigata, Japan PRE-TRANSPLANT PREDICTORS OF HEMODYNAMIC INSTABILITY AND NEED OF VENO-VENOUS BYPASS DURING LIVER TRANSPLANTATION Bogdan Moldovan, Pascal Fauconnet, Eduardo Schiffer, Pietro E. Majno, Thierry Berney, Isabelle Morard, Emiliano Giostra, Philippe Morel, Gilles Mentha, and Christian Toso; Geneva, Switzerland CAVERNO-PORTAL ANASTOMOSIS TO RESTORE PORTAL FOW IN PATIENTS WITH PORTAL VEIN THROMBOSIS AND HEPATOPETAL CAVERNOMA UNDERGOING LIVER TRANSPLANTATION Bogdan Moldovan, Gilles Mentha, Christian Toso, Philippe Morel, Marek Bednarkiewicz, Thierry Berney, Isabelle Morard, Sylvain Terraz, Emiliano Giostra, and Pietro E. Majno; Geneva, Switzerland THE POSSIBILITY OF ADIPOSE-DERIVED REGENERATIVE CELLS FOR AN ALTERNATIVE THERAPY FOR LIVER FAILURE Hiroki Mori, Mitsuo Shimada, Yu Saito, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, Michihito Asanoma, and Shinichiro Yamada; Tokushima, Japan LIVER TRANSPLANTATION FROM DCD DONORS THE ROYAL FREE EXPERIENCE Neal Banga, Prashant Naik, Dinesh Sharma, Charles Imber, Keith Rolles, Massimo Malago, Brian Davidson, and Bimbi Fernando; London, United Kingdom HEMOLYTIC ANEMIA DUE TO PASSENGER LYMPHOCYTE SYNDROME AFTER LIVER TRANSPLANTATION Baltasar Prez-Saborido, Asterio Barrera-Rebollo, David PachecoSnchez, Pilar Pinto-Fuentes, Paloma Rodriguez-Vielba, Jose Carlos Sarmentero, Marta Gonzalo, Ruth Martinez, Mario Rodriguez, Carolina Almohalla, and Alfonso Anta; Valladolid, Spain GRAFT VERSUS HOST DISEASE AFTER LIVER TRANSPLANTATION, A RARE BUT SEVERE INMUNOLOGICAL COMPLICATION Baltasar Prez-Saborido, David Pacheco-Snchez, Asterio BarreraRebollo, Pilar Pinto-Fuentes, Jose Carlos Sarmentero, Paloma RodriguezVielba, Enrique Asensio, Fernando Labarga, Felix Garca-Pajares, Josee Mara Martnez, Elena Prez, and Alfonso Anta; Valladolid, Spain LIVER TRANSPLANTATION AFTER RADIOEMBOLIZATION WITH YTTRIUM-90 MICROSPHERES Sonia Radunz, Georgios C. Sotiropoulos, Jrg Schlaak, Andreas Bockisch, Thomas Lauenstein, Hideo A. Baba, Andreas Paul, and Jrgen W. Treckmann; Essen, Germany BUDD-CHIARI SYNDROME AS A INDICATION FOR LIVER TRANSPLANTATION Piotr Remiszewski, Marcin Kotulski, Krzysztof Dudek, Piotr Kalinowski, Rafal Paluszkiewicz, Krzysztof Zieniewicz, and Marek Krawczyk; Warsaw, Poland

P-346

P-347

P-348

P-349

P-350

P-351

P-352

P-353

226

P-354

P-355

ASSOCIATED FACTORS WITH THE TRANSFUSIONS NEEDS IN LIVER TRANSPLANTATION Gloria Sanchez Antolin, Ignacio de la Fuente Graciani, Felix GarcaPajares, Esther Fernandez, Carolina Almohalla, Judith Gil Dominguez, Angela Ruiz de Temio, Lorena Sancho, Rafael Ruiz Zorrilla, and Agustin Caro Paton; Valladolid, Spain COAGULATION BETWEEN DONOR AND RECIPIENT IN THE EARLY PERIOD AFTER LIVING DONOR LIVER TRANSPLANTATION Yoshinobu Sato, Satoshi Yamamoto, Hiroshi Oya, Yoshiaki Hara, Hidenaka Kokai, Takashi Kobayashi, Kohei Miura, and Katsuyoshi Hatakeyama; Niigata, Japan POST LIVER TRANSPLANT EVEROLIMUS BASED IMMUNOSUPPRESSION THERAPY: A MONO-CENTRIC EXPERIENCE Vincenzo Scuderi, Giangiacomo Monti, Walter Santaniello, Francesco Sicoli, Antonio Giuliani, Carla Migliaccio, and Fulvio Calise; Naples, Italy ASSOCIATION BETWEEN PATENT FORAMEN OVALE ACUTE SUPERIOR MESENTERIC ARTERY OCCLUSION: IMPLICATIONS FOR INTESTINAL TRANSPLANTATION Sushma Shankar, Mohammed Z. Akhtar, Oliver Ormerod, Anil Vaidya, Sanjay Sinha, and Peter Friend; Oxford, United Kingdom EFFECTS OF CALCINEURIN INHIBITOR-BASED IMMUNOSUPPRESSION ON PRE-EXISTING RENAL IMPAIRMENT FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION Matthew P. Thomas, Jeremy J. French, Richard M. Charnley, Bryon C. Jaques, Steve A. White, and Derek M. Manas; Newcastle upon Tyne, United Kingdom WITHDRAWN WITHDRAWN SVR TO ANTIVIRAL TREATMENT FOR POST-OLT RECURRENT HCV HEPATITIS CAN BE IMPROVED BY THE USE OF GROWTH FACTORS Vittoria Vero, Marco Senzolo, Luisa Pasulo, Francesca Romana Ponziani, Raffaella Vigano, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, Antonio Gasbarrini, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECCURRENCE Vittoria Vero, Marco Senzolo, Pasulo Luisa, Francesca Romana Ponziani, Raffaella Vigan, Maria Marino, Maria Francesca Donato, Maria Rendina, Pierluigi Toniutto, Matteo Cescon, Eleonora De Martin, Lucia Miglioresi, Valerio Giannelli, Daniele Di Paolo, and Stefano Fagiuoli; Rome, Italy; Padua, Italy; Bergamo, Italy; Milan, Italy; Modena, Italy; Bari, Italy; Udine, Italy; and Bologna, Italy MULTIVISCERAL TRANSPLANTATION FOR MASSIVE ABDOMINAL TRAUMA Chiara Zanfi, Augusto Lauro, Paolo Di Gioia, Sara Pellegrini, and Antonio D. Pinna; Bologna, Italy

P-356

P-357

P-358

P-359

P-360 P-361 P-362

P-363

P-364

227

Poster Session: Lung

P-365 AN UNUSUAL CASE OF LUNG TRANSPLANTS AND BREAST IMPLANTS Karthikan A. Srikanthan, Helen J. Ramsey, and Martin R. Carby; Harefield, Middlesex, United Kingdom WITHDRAWN

P-366

Poster Session: Pancreas

P-367 BEWARE THE PANCREAS TRANSPLANT RECIPIENT WITH ELEVATED FIBRINOGEN AND HYPOTENSION Thalis Christophides, John Asher, Emily Shrimpton, Duncan Watt, Jeremy French, Bryon Jaques, Derek Manas, Steve White, and David Talbot; Newcastle upon Tyne, United Kingdom TIMING THE IMPLANT: OUTCOMES IN PANCREAS TRANSPLANTATION Gabriele Di Benedetto, David van Dellen, Melissa Oliveira Cunha, Maria O. Mitu-Pretorian, H. Zacaria, Abbas Ghazanfar, Bence Forgacs, Ravi Pararajasingam, Titus Augustine, and Afshin Tavakoli; Manchester, United Kingdom HHV-8 ASSOCIATED LYMPHADENOPATHIC KAPOSIS SARCOMA MIMICKING PTLD AFTER PANCREAS TRANSPLANT Yi-Ming Shyr, and Shin-E. Wang; Taipei, Taiwan

P-368

P-369

Poster Session: Pediatric transplantation

P-370 PEDIATRIC LIVER-KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE Vittorio Corno, Alessandro Lucianetti, Paola Stroppa, Domenico Pinelli, Eliana Gotti, Michela Bravi, Giovanni Rota, Giuseppe Locatelli, Daniela Codazzi, Giuseppe Remuzzi, and Michele Colledan; Bergamo, Italy PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE Iris Fontana, Sergio Barocci, Fabrizio Ginevri, Gregorio Santori, Massimo Bertocchi, Augusto Tagliamacco, Arcangelo Nocera, and Umberto Valente; Genoa, Italy ABDOMINAL COMPARTMENT SYNDROME IN PEDIATRIC KIDNEY TRANSPLANTATION Iris Fontana, Massimo Bertocchi, Monica Centanaro, Gregorio Santori, Francesca R, Teresa Cavallero, Fabrizio Ginevri, and Umberto Valente; Genoa, Italy LIVER RETRANSPLANTATION IN THE LONG TERM IN CHILDREN Esteban Frauca, Loreto Hierro, Carmen Diaz-Fernandez, Angela de la Vega, Carmen Camarena, Gema Muoz-Bartolo, Dolores Lledn, Manuel Lpez-Santamara, and Paloma Jara; Madrid, Spain FIRST EXPERIENCE WITH EVEROLIMUS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS Dirk Nielsen, Andrea Briem-Richter, Marijke Sornsakrin, Lutz Fischer, Bjoern Nashan, and Rainer Ganschow; Hamburg, Germany ULTRASONOGRAPHY OF THE CAROTID WALL THICKNESS IN PEDIATRIC LIVER TRANSPLANT PATIENTS. OUR FINDINGS Carlos E. Gonzalez Cambaceres, Yanina Camicer, Mara B. Araujo, Oscar Imventarza, Silvia Moguillansky, and Mara C. Mazza; Buenos Aires, Argentina

P-371

P-372

P-373

P-374

228

P-375

P-376

QUALITY OF LIFE RELATED TO HEALTH: EXPERIENCE IN PEDIATRIC PATIENTS WITH CHRONIC DISEASES IN A PUBLIC HOSPITAL IN ARGENTINA Carlos E. Gonzalez Cambaceres, Mariana Roizen, Carlos Figueroa, and Oscar Imventarza; Buenos Aires, Argentina LIVING DONOR LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE IN CHILDREN Marek Szymczak, Piotr Kalicinski, Dorota Broniszczak, Joanna Teisseyre, Hor Ismail, and Joanna Pawlowska; Warsaw, Poland ESTABLISHMENT OF A PAEDIATRIC RENAL TRANSPLANT SERVICE IN TUNISIA Mignon I. McCulloch, Anil Vaidya, Soussen Abroug, W. Sahtout, and Achour Abdellatif; London, United Kingdom; Oxford, United Kingdom; and Sousse, Tunisia SURGICAL COMPLICATIONS OF PEDIATRIC KIDNEY TRANSPLANTATION: A SINGLE CENTER EXPERIENCE Yugo Sawada, Hiroki Shirakawa, Hideki Ishida, Tomokazu Shimizu, and Kazunari Tanabe; Tokyo, Japan THE EFFECT OF ANTI CD-25 AB INDUCTION TREATMENT ON GRAFT FUNCTION IN THE ADOLESCENT KIDNEY TRANSPLANTATION FROM LIVE DONORS Sait Murat Dogan, Ismail Sert, Cem Tugmen, Eyp Kebabci, and Cezmi Karaca; izmir, Turkey

P-377

P-378

P-379

P-380

Poster Session: Tissue injury / preservation

P-381 INNATE IMMUNE RESPONSES IN CORONARY ARTERY BYPASSES BY A NEW P38 MAPK-INHIBITOR Dietmar K. Abendroth, Zhiwei Zhao, and Jianjun Ge; Ulm, Germany; and Hefei, China A NOVEL PERFUSION FLUID FOR DCD DONOR KIDNEYS; BETTER AS A FLUSH OR A STORAGE MEDIUM? Christopher Ray, Muhammad Khurram, Omar Mownah, Aditya Kanwar, Susan Stamp, John Brassil, Douglas Rees, Kelly Philipson, Robert Peaston, Kathryn White, Katrina Wood, Aurelie Thomas, Anne Cunningham, Noel Carter, Paul Flecknell, and David Talbot; Newcastle upon Tyne, United Kingdom; and Sunderland, United Kingdom INFLUENCES OF THE DONOR TYPE ON ORGAN ENERGY STATUS: LIVING VERSUS BRAIN DEAD VERSUS NON-HEART BEATING DONOR Philipp Stiegler, Michael Sereinigg, Vanessa Stadlbauer, Andreas Puntschart, Andrea Bradatsch, Pero Curcic, Thomas Seifert-Held, Tatjana Stojakovic, Barbara Leopold, Daniela Blattl, Ursula Mayrhauser, Bettina Leber, Sonja Kstenbauer, Seth Hallstrm, and Karlheinz Tscheliessnigg; Graz, Austria

P-382

P-383

Late Breaking: Clinical Cases

LB-P-001 ORGAN DONATION AFTER THERAPEUTIC NEPHRECTOMY Colin H. Wilson, David A. Rix, Neil S. Sheerin, David Talbot, Derek M. Manas; Newcastle-upon-Tyne, United Kingdom STILAMIN IN THE TREATMENT OF LYMPHATIC FISTULA AFTER LIVINGRELATED RENAL TRANSPLANTATION Libo Xie, Shaofeng He, Zhongli Huang, Tao Lin; Chengdu, China

229

LB-P-002

LB-P-003

THE EFFECTIVENESS OF THE MOVING TO MORPHINE AUGMENTED MAGNETIC RESONANCE CHOLANGIOPANCREATICOGRAPHY FOR IMPROVING THE QUALITY OF IMAGES IN LIVING LIVER DONORS Doo Jin Kim, Gyu-seong Choi, Hyung-chul Kim, Samuel Lee, Joo Seop Kim; Seoul, Korea; Bucheon, Korea IN SITU SPLITTING USING A DONOR WITH AN INTRA-AORTIC BALLOON PUMP Anya Adair, Khalid Sharif, Sara Gozzini, John Isaac, Paolo Muiesan; Birmingham, United Kingdom ALTERNATIVE PORTO-LEFT GASTRIC VEIN ANASTOMOSIS WITH OVARIAN VEIN GRAFT INTERPOSITION IN POST KASAI EXTRAHEPATIC PORTAL VEIN OBSTRUCTION Mureo Kasahara, Seisuke Sakamoto, Akinari Fukuda, Hiroyuki Kanazawa; Tokyo, Japan ADULT RIGHT LOBE LIVE DONOR LIVER TRANSPLANTATION (LDLT) IN PRESENCE OF A RETRO-PORTAL ACCESSORY RIGHT HEPATIC ARTERY (RPARHA) ARISING FROM LEFT HEPATIC ARTERY (LHA) M.T.P.R. Perera, J.R. Isaac, S.R. Bramhall, A.D. Mayer, D.F. Mirza, P. Muiesan; Birmingham, United Kingdom PASSIVE TRANSFER OF PEANUT ALLERGY BY ORGANS TRANSPLANTATION Herv Creusvaux, Marina Roche, Armelle Boulvard, Annick Andre, Claudie Mouton-Faivre, Pascale Dewachter; Saint-Denis la Plaine, France; Nancy, France; Clermont-Ferrand, France

LB-P-004

LB-P-005

LB-P-006

LB-P-007

Late Breaking: Islet / Cell Transplant

LB-P-008 DEVELOPMENT AND IN VITRO EVALUATION OF CLINICALLY APPLICABLE MICRON-SIZED SILICA-BASED IRON OXIDE PARTICLES FOR CELLULAR IMAGING WITH MRI Carolin M. Langer, Nathanael Raschzok, Martina Mogl, Susanne Rohn, Kerstin Nehls, Christian Schmidt, Lars Stelter, Lutz Ldemann, Ulf Teichgrber, Igor M. Sauer; Berlin, Germany ROLES OF TOLL-LIKE RECEPTORS IN ALLOGENEIC ISLET TRANSPLANTATION Myung-Kyu Kim, Han Ro, Ju Ho Hong, Curie Ahn, Jaeseok Yang; Seoul, Republic of Korea MRI ENABLES NON-INVASIVE MONITORING DURING LIVER CELL TRANSPLANTATION TO THE SPLEEN IN A PORCINE MODEL Nathanael Raschzok, Jens Pinkernelle, Nils Billecke, Kerstin Nehls, Martina T. Mogl, Maciej Powerski, Ulf Teichgrber, Igor M. Sauer; Berlin, Germany; Jena, Germany NEOHYBRID LIVER GRAFT [ndash] A NOVEL CONCEPT OF IN VIVO TISSUE-ENGINEERING Martina T. Mogl, Susanne Rohn, Nathanael Raschzok, Birgit Sawitzki, Igor M. Sauer; Berlin, Germany ISLET AFTER KIDNEY TRANSPLANTATION AND POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE Paola Maffi, Rossana Caldara, Marina Scavini, Lorenzo Piemonti, Paola Magistretti, Carlo Socci, Maurilio Ponzoni, Fabio Ciceri, Antonio Secchi; Milan, Italy

LB-P-009

LB-P-010

LB-P-011

LB-P-012

230

LB-P-013

ESTABLISHING THE SNBTS ISLET ISOLATION LABORATORY Lindsay Fraser, Donna L. Mitchell, Alan P. Timpson, Peter F. Henry, Lora McCracken, Tom McQuillan, John Drain, George Galea, Neil McGowan; Edinburgh, United Kingdom

Late Breaking: Allocation

LB-P-014 HLA-A,B,DR ALLELE FREQUENCIES AND MATCHING ALGORITHM IN CADAVERIC KIDNEY TRANSPLANTATION PAIRS Renata Zunec, Zorana Grubic, Nikolina Basic-Jukic, Ljubica Bubic Filipi, Zeljko Kastelan, Josip Pasini, Jasna Stoic-Brezak; Zagreb, Croatia "CALCULATED RISK" DONOR RELATED SOLID ORGAN TRANSPLANTATIONS IN THE EMILIA-ROMAGNA REGION (ERR) (2003-2009): ANALYSIS OF GRAFT SURVIVAL Carlo De Cillia, Nicola Alvaro, Giacomo Caprara, Deborah Malvi, Walter F. Grigioni, Lorenza Ridolfi; Bologna, Italy IMFLUENCE OF THE RATIO OF GRAFT VOLUME TO RECIPIENT BODY SURFACE AREA ON GRAFT FUNCTION AFTER LIVING DONOR KIDNEY TRANSPLANTATION Jong Hoon Lee, Je Hwan Won, Chang-Kwon Oh; Suwon, Republic of Korea

LB-P-015

LB-P-016

Late Breaking: Ethics, Law, Psychosocial, Public Policy

LB-P-017 LEVEL AND SOURCES OF INFORMATION ON ORGAN TRANSPLANTATION IN ROMANIA Beatrice Ioan, Cristina Gavriluta, Andrei Holman, Mihaela Frunza, Irina Streba, Adina Karner-Hutuleac, Roxana Zavoi, Lacrima Boila; Iasi, Romania; Cluj, Romania; Iasi, Romania; Craiova, Romania; Tirgu Mures, Romania EVALUATING AN ORGAN DONATION TEACHING RESOURCE FOR SECONDARY SCHOOLS IN SCOTLAND Neil Healy, Lesley Logan, Pamela Niven, Elizabeth Burchell; Falkirk, United Kingdom; Edinburgh, United Kingdom ADAPTIVE TRIAL DESIGN FOR IMMUNE TARGETING BIOLOGICS [ndash] A CREATIVE AND COOPERATIVE APPROACH TO ADVANCING TRANSPLANT MEDICINE Ellen Cooper, Meghann Teague Getts, Terra J. Frederick, James J. Herrmann, John Puisis, Daniel R. Getts, Stuart M. Flechner; Kalamazoo, USA; Rockville, USA; Chicago, USA; Cleveland, USA DOES VAMS DONOR NEPHRECTOMY SATISFY DONORS IN BODY IMAGES? Man Ki Ju, Hyei Mi Yang, Seung Hwan Lee, Chang Hee Hong, Sun Young Sohn; Seoul, Korea TOOLS OF ENGAGEMENT WITH YOUNG ADULTS IN RENAL: FINDING FROM YOUNG ADULT PROJECT IN SOUTH WEST ENGLAND Joanna M. Woodland, Sally Tutton; Bristol, United Kingdom CERTIFICATION OF ORGAN AND TISSUE PROCUREMENT ORGANISATIONS: THE FRENCH EXPERIENCE Herv Creusvaux, Eric Auger, Nasser Al Hawajri, Anita Guarinos; Saint Denis la Plaine, France

LB-P-018

LB-P-019

LB-P-020

LB-P-021

LB-P-022

231

Late Breaking: Clinical Immunosuppression

LB-P-023 PHARMACOKINETICS OF TACROLIMUS MODIFIED RELEASE QD FOLLOWING LIVING DONOR LIVER TRANSPLANTATION: RESULTS OF PILOT STUDY Gi-Won Song, Sung-Gyu Lee, Jung-Man Namgung, Chun-Soo Park, Hyo-Jun Lee, Won-Young Chae, Hee-Sung Park; Seoul, Korea DETERMINANTS OF SUCCESSFUL USE OF SIROLIMUS IN RENAL TRANSPLANTATION Wilfried Gwinner, Wolfgang Arns, Klemens Budde, Fritz Diekmann, Frank Eitner, Michael Fischereder, Jan Gomann, Nils Heyne, Marcel G. Naik, Christian Morath, Katharina Pressmar, Jan-Steffen Juergensen; Hannover, Germany; Cologne, Germany; Berlin, Germany A THERAPEUTIC EXPLORATORY STUDY TO DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION (CILT): THE INTERIM ANALYSIS Armin D. Goralczyk, Wijdan Abu-Ajaj, Giuliano Ramadori, Thomas Lorf, Aiman Obed; Goettingen, Germany EFFECT OF INTERLEUKIN 2 RECEPTOR ANTIBODY BASILIXIMAB (IL2RA) IN TACROLIMUS (TAC) BASED IMMUNOSUPPRESSION WITH AZATHIOPRINE (AZA)/ MYCOPHENOLATE MOFETIL (MMF) IN LIVING DONOR KIDNEY TRANSPLANT PROGRAMME S. Jain, P. N. Gupta, S. Pokhariyal, S. B. Bansal, V. Saxena, R. Sharma, M. Singhal, S. Gulati, R. Ahlawat, V. Kher; Gurgaon, India; New Delhi, India; Noida, India THE RELATION BETWEEN TESTOSTERONE LEVELS AND GRAFT FUNCTION IN KIDNEY RECIPIENTS UNDER TREATMENT OF m-TOR OR CALCINEURIN INHIBITOR Hulya Colak, Tufan Colak, Yusuf Kurtulmus, Ismail Sert, Cezmi Karaca; Izmir, Turkey

LB-P-024

LB-P-025

LB-P-026

LB-P-027

Late Breaking: Pre-Clinical Immunosuppression

LB-P-028 CYTOKERATIN DEPLETION IN PROXIMAL TUBULES OF NEPHRONS CORRELATES WITH OXIDATIVE STRESS INDICES IN RATS ON IMMUNOSUPPRESSION Karolina Kedzierska, Miroslaw Parafiniuk, Katarzyna Sporniak-Tutak, Joanna Bober, Maria Laszczynska, Kazimierz Ciechanowski; Szczecin, Poland

Late Breaking: Histocompatibility

LB-P-029 DESENSITIZATION RESULTS ARE INFLUENCED BY THE NATURE OF THE HLA Ab BEING TREATED E. Steve Woodle, Alin Girnita, Paul Brailey, Basma Sadaka, Adele RikeShields, Rita R. Alloway, Garth Wall; Cincinnati, USA

Late Breaking: Immunobiology / Basic Science

232

LB-P-030

ELEVATION OF LBP AFTER LIVER ISCHEMIA AND REPERFUSION INJURY IN RATS Haoshu Fang, Anding Liu, Olaf Dirsch, Uta Dahmen; Jena, Germany; Essen, Germany; Jena, Germany

LB-P-031

FK506 INDUCES APOPTOSIS OF HUMAN JURKAT T CELLS THROUGH MITOCHONDRIA AND DEATH RECEPTOR RELATED SIGNALING PATHWAYS Jong Hun Park, Ho Kyun Lee, Sang Young Chung, Soo Jin Na Choi; Gwangju, Korea THE EXPRESSION OF MicroRNA TREATED TACROLIMUS (FK506) IN JURKAT HUMAN T LYMPOCYTES Ho Kyun Lee, Jon Hun Park, Sang Young Chung, Soo Jin Na Choi; Gwangju, Korea PROTECTIVE EFFECT OF NOVEL mTOR INHIBITORS ON HUMAN PRIMARY CELLS UNDER OXIDATIVE STRESS Vladimira Moulisova, Claire Brown, Paul Shiels; Glasgow, United Kingdom; Alderley Park, United Kingdom QUANTITATIVE STRENGTH OF ANTIOXIDANTS IS MORE ESSENTIAL FOR THE TREATMENT OF ISCHEMIA REPERFUSION INJUY OF SOLID ORGAN TRNASPLANTATION Ik Jin Yun; Seoul, Korea MYCOPHENILIC ACID MEDIATED MITOCHONDRIAL MEMBRANE POTENTIAL TRANSITION CHANGE LEAD TO T LYMPHOCYTE APOPTOSIS Sang Young Chung, Soo Jin Na Choi; Gwangju, Korea TRANSCRIPTIONAL ACTIVATION OF NUCLEAR RELATED FACTOR 2 (Nrf 2) BY FK506 IN JURKAT CELLS Sang Young Chung, Soo Jin Na Choi; Gwangju, Korea PROTECTIVE MECHANISM OF HEME OXYGENASE-1 ON MPAINDUCED APOPTOSIS IN HUMAN JURKAT CELLS Sang Young Chung, Ho Kyun Lee, Jong Hun Park, Soo Jin Na Choi; Gwangju, Korea EFFECT OF FK506 ON ENDOPLASMIC RETICULUM (ER)-MEDIATED APOPTOSIS OF JURKAT CELLS Sang Young Chung, Ho Kyun Lee, Jong Hun Park, Soo Jin Na Choi; Gwangju, Korea BIOMARKERS IN URINE AFTER KIDNEY TRANSPLANTATION: NONINVASIVE MONITORING OF ACUTE REJECTION Zuzana Zilinska, Helena Bandzuchova, Daniel Kuba, Martin Chrastina, Jan Breza, Erika Bilcikova; Bratislava, Slovakia HMGB1 TRANSLOCATION AND EXPRESSION IS CAUSED BY WARM ISCHEMIA REPERFUSION INJURY, BUT NOT BY PARTIAL HEPATECTOMY IN RATS Anding Liu, Haoshu Fang, Olaf Dirsch, Wei Dong, Hao Jin, Hai Huang, Uta Dahmen; Jena, Germany; Essen, Germany; Shaoxing, China; Jena, Germany

LB-P-032

LB-P-033

LB-P-034

LB-P-035

LB-P-036

LB-P-037

LB-P-038

LB-P-039

LB-P-040

Late Breaking: Heart

LB-P-041 CLINICAL RELEVANCE OF HLA-DONOR SPECIFIC ANTIBODIES DETECTED BY SINGLE ANTIGEN ASSAY IN CARDIOTHORACIC TRANSPLANTATION Derrick Rowan, Arun Gupta, Daniel McCloskey, Michael Burch, Matthew Fenton, Paul Sinnott; London, United Kingdom

233

LB-P-042

TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY Doris Wagner, Harald Dobnig, KarlHeinz Tscheliessnigg, Gnther Prenner, Andr Wasler, Claudia Piswagner-Slkner, Daniela Kniepeiss, Astrid Fahrleinter; Graz, Austria

Late Breaking: Donation / Retrieval

LB-P-043 PAEDIATRIC PROCUREMENT IN FRANCE: 2001 [ndash] 2010 Franois-Xavier Lamy, Christian Lamotte, Vronique Reiter-Chenel; SaintDenis, France THE RATE OF DISCARD OF KIDNEYS RECOVERED FOR TRANSPLANTATION IN THE UNITED STATES IS NOT JUSTIFIED Francis L. Delmonico; Waltham, USA DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION (ERR): RESULTS Carlo De Cillia, Maria C. Bonanno, Tiziana Campione, Lorenza Ridolfi; Bologna, Italy IMPLEMENTATION OF A TISSUE PROCUREMENT MULTIDISCIPLINARY FUNCTIONAL PLAN IN A UNIVERSITY HOSPITAL IN SPAIN Alberto Sandiumenge, Virginia Callao, Eduardo Gonzalez, Mari Gilavert, Laia Ramiro, Enric Contreras, Maria Bodi; Tarragona, Spain; Tarragona i Terres del Ebre, Spain EMRS [ndash] UNINTENDED CONSEQUENCE SAVINGS Andrew Inglis, Paul Campbell, Deborah Hill; Glasgow, United Kingdom A MULTIDISCIPLINARY PROTOCOL FOR THE MANAGEMENT OF PEDIATRIC POTENTIAL HBD Roberto Peressutti, Adriana Di Silvestre, Annalisa Sostero, Alessandra Berini, Elisa Mattiussi; Udine, Italy AN AUDIT PROCESS FOR THE IMPLEMENTATION OF A PROTOCOL FOR THE MANAGEMENT OF POTENTIAL ORGAN DONORS IN INTENSIVE CARE UNIT Roberto Peressutti, Adriana Di Silvestre, Annalisa Sostero, Alessandra Berini, Elisa Mattiussi; Udine, Italy ENDOUROLOGICAL MANAGEMENT OF UROLITHIASIS IN DONOR KIDNEYS PRIOR TO RENAL TRANSPLANT Muhammad T. Dosani, Johm Moir, Nikhil Vasdev, David Talbot, David Rix; Newcastle upon Tyne, United Kingdom BROSELOW SYSTEM IN THE MANAGEMENT OF PEDIATRIC ORGAN DONOR Roberto Peressutti, Paola De Stefanis, Adriana Di Silvestre, Elisa Mattiussi; Udine, Italy STAFF OPINIONS ON ORGAN DONATION IN A DISTRICT GENERAL HOSPITAL Charlotte K. Gunner, Liz Waite, Jacques Kerr; Melrose, United Kingdom; Edinburgh, United Kingdom; Melrose, United Kingdom

LB-P-044

LB-P-045

LB-P-046

LB-P-047 LB-P-048

LB-P-049

LB-P-050

LB-P-051

LB-P-052

234

Late Breaking: Infections

LB-P-053 NATIONAL EVALUATION OF HEPATITIS B CORE ANTIBODY-POSITIVE DONORS IN FRANCE Franois-Xavier Lamy, Fabienne Pessione, Herv Creusvaux, Marina Roche, Marie Thuong; Saint Denis - la Plaine, France FULLY AUTOMATED GENERATION OF ANTIGEN-SPECIFIC CD4+ AND CD8+ T CELLS FOR ADOPTIVE IMMUNOTHERAPY Melanie Fahrendorff, Nanette von Oppen, Georg Rauser, Mario Assenmacher, Martin Biehl, Stefan Miltenyi; Bergisch-Gladbach, Germany HIGH PREVALENCE OF MULTIRESISTANT GRAM NEGATIVE BACTERIA IN RENAL TRANSPLANT PATIENTS Ieva Ziedina, Elina Dimina, Dace Vensava-Kaknena, Arta Balode, Janis Jushinskis, Rafail Rozental, Uga Dumpis; Riga, Latvia

LB-P-054

LB-P-055

Late Breaking: Kidney

LB-P-056 MicroRNA REGULATION OF CELLULAR BIO-AGE PROVIDES A NOVEL PRE-TRANSPLANT PROGNOSTIC AND PREDICTIVE ASSESSMENT OF POST TRANSPLANT ALLOGRAFT FUNCTION Dagmara McGuinness, Marc Gingell-Littlejohn, Karen Stevenson, David Kingsmore, Marc Clancy, Paul G. Shiels; Glasgow, United Kingdom LIVING DONOR KIDNEY TRANSPLANTATION IN T-CELL FLOW CYTOMETRY CROSS-MATCH POSITIVE PATIENTS AFTER DESENSITIZATION WITHOUT INTRAVENOUS IMMUNOGLOBULIN Jae Berm Park, Young Hoon Kim, Ki Byung Song, Young Soo Chung, Joo Hee Jung, Heung-Bum Oh, Seog-Woon Kwon, Su Kil Park, SongCheol Kim, Duck Jong Han; Seoul, Republic of Korea STUDY OF SERUM ACTIVIN AND FOLLISTATIN IN POST RENAL TRANSPLANT PATIENTS: CORRELATION WITH RENAL HAEMODYNAMICS, GRAFT FUNCTION AND SURVIVAL Hayam A. El Aggan, Sabah A. Mahmoud, Osama H. Shehata; Alexandria, Egypt THE GENETIC VARIANTS OF IL1R1 AND IL1RN ARE ASSOCIATED WITH THE DEVELOPMENT OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION Seok Ju Park, Yeong Hoon Kim, Young Chul Yoon, Sun Woo Kang, Tae Hee Kim; Busan, Korea SLOW GRAFT FUNCTION IN LIVING DONOR KIDNEY TRANSPLANTATION: AN ISSUE TO BE ADDRESSED Joyce Hellegering, Jetze Visser, Heinrich J. Kloke, Frank C.H. d'Ancona, Andries J. Hoitsma, Daan J.A. van der Vliet, Michiel C. Warl; Nijmegen, The Netherlands THE FATE OF RENAL RECIPIENTS WITH PRETRANSPLANT MALIGNIENCIES Luisa Berardinelli, Raiteri Mauro, Carini Monica, Marenghi Cristina, Campise Maria Rosaria, Rossetti Antonello; Milan, Italy THE VALUE OF RENAL VASCULAR RESISTIVE INDEX MEASUREMENT AFTER RENAL TRANSPLANTATION Line Heylen, Kathleen Claes, Christophe Metalidis, Hylke de Jonge, Liesbeth De Wever, Filip Claus, Raymond Oyen, Dirk Kuypers, Maarten Naesens; Leuven, Belgium

LB-P-057

LB-P-058

LB-P-059

LB-P-060

LB-P-061

LB-P-062

235

LB-P-063

EARLY POST-TRANSPLANT MAG3 RENAL SCAN PREDICTS LONGTERM OUTCOME OF RENAL TRANSPLANTS Ui Jun Park, Hyoung Tae Kim, Won Hyun Cho, Eun Ae Kim, Min Young Kim, Eun A. Hwang, Sung Yeup Han, Sung Bae Park, Hyun Chul Kim; Daegu, Korea MAGNETIC RESONANCE (MR) VENOGRAPHY AND MR UROGRAPHY IN KIDNEY DONOR ASSESSMENT - CORRELATION WITH OPERATIVE FINDINGS Emma L. Aitken, Reddi P. Yadaval, Ram Kasthuri, S. Chandramohan, Giles Roditi, Marc Clancy; Glasgow, United Kingdom TRANSPLANTATION OF RIGHT LIVING DONOR KIDNEYS IN OBESE RECIPIENTS CORRELATES WITH A DECREASED GRAFT SURVIVAL Joyce Hellegering, Jetze Visser, Frank C.H. d'Ancona, Hans J.F. Langenhuijsen, Andries J. Hoistma, Daan J.A. van der Vliet, Michiel C. Warl; Nijmegen, The Netherlands COMPARISON OF HEART RATE VARIABILITY BETWEEN PATIENTS ON KIDNEY TRANSPLANTATION AND HEMODIALYSIS Joon Seok Oh, Kill Huh, Jong In Park, Jong Hyun Park, Young Il Choi; Busan, Korea ASSOCIATIONS BETWEEN MMP-2 GENE POLYMORPHISMS AND POST-TRANSPLANTATIONAL DIABETES MELLITUS IN KOREAN RENAL ALLOGRAFT RECIPIENTS Sun Woo Kang, Seok Ju Park, Tae Hee Kim, Yeong-Hoon Kim, KyungHwan Jeong, Joo-Young Moon, Sang-Ho Lee, Tae-Won Lee, Chun-Gyoo Ihm; Busan, Republic of Korea; Seoul, Republic of Korea PROTEINURIA AND RENAL FUNCTION PREDICT OUTCOME AFTER LATE INITIATION OF SIROLIMUS IN RENAL ALLOGRAFT RECIPIENTS K. Budde, M. G. Naik, W. Arns, F. Diekmann, M. Fischereder, J. Gomann, W. Gwinner, N. Heyne, J. S. Jrgensen, C. Morath, K. Pressmar, F. Eitner; Berlin, Germany INTERLEUKIN 2 (IL2) RECEPTOR ANTAGONIST INDUCTION DRAMATICALLY IMPROVES ECD KIDNEY TRANSPLANTATION RESULTS Kristian Heldal, Anders Hartmann, Torbjrn Leivestad, Anna V. Reister, Axel Foss, Karsten Midtvedt; Skien, Norway; Oslo, Norway CHALLENGING THE OLD TRADITIONS IN RENAL TRANSPLANTATION: ENHANCED RECOVERY AFTER RENAL TRANSPLANTATION Ahmed Halawa, Simon Boyes, Fleur Roberts, Rebecca Palmer, Rory McGoldrick; Sheffield, United Kingdom IMPROVING ACCESS TO PRE-EMPTIVE KIDNEY TRANSPLANTATION IN ENGLAND: A NATIONAL QUALITY IMPROVEMENT PROGRAM Bev Matthews, Ben Bray, Donal O'Donoghue; London, United Kingdom THE QUALITY OF REFERENCE COSTS FOR KIDNEY TRANSPLANTATION Ben Bray, Julie Renfrew, Bev Matthews, Donal O'Donoghue; Nationwide, United Kingdom; London, United Kingdom INCIDENCE AND RISK FACTORS IN NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANT AND SIMULTANEOUS PANCREAS KIDNEY TRANSPLANT Prez-Sez Mara Jos, Agera Mara Luisa, Toledo Katia, Redondo Mara Dolores, Navarro Mara Dolores, Rodrguez-Benot Alberto, Aljama Pedro; Crdoba, Spain

LB-P-064

LB-P-065

LB-P-066

LB-P-067

LB-P-068

LB-P-069

LB-P-070

LB-P-071

LB-P-072

LB-P-073

236

LB-P-074

ABO INCOMPATIBLE LIVING DONOR TRANSPLANTATION (ABOI KT): MINIMAL DOSE OF RITUXIMAB AND NOT A ROUTINE BUT AS NEEDED POSTTRANSPLANT PLASMAPHERESIS Jin M. Kong, Joon H. Jeong, Byung C. Kim, Mi Y. Jeon; Busan, Korea THE INFLUENCE OF OBESITY ON RENAL TRANSPLANT OUTCOMES A PAIRED KIDNEYS ANALYSIS Zuzanna Wolyniec, Alicja Debska-Slizien, Boleslaw Rutkowski; Gdansk, Poland ROBOT-ASSISTED LIVE KIDNEY DONATION: THE ROTTERDAM EXPERIENCE S.M. Hagen, L.F.C. Dols, T. Terkivatan, F.J.M.F. Dor, T.C.K. Tran, J.N.M. IJzermans; Rotterdam, The Netherlands BONE DISEASE AND VERTEBRAL FRACTURES AFTER KIDNEY TRANSPLANTATION Valentina Nastasi, Domenica Taruscia, Gloria Manarini, Giovanni Gaffi, Giovanni Maria Frasc; Ancona, Italy THE EFFECTIVENESS OF LOW DOSE DACLIZUMAB COMPARED WITH STANDARD REGIMEN IN PREVENTING FOR ACUTE REJECTION PREVENTION AFTER RENAL TRANSPLANTATION IN KERMAN-IRAN Jalal Azmandian, Seyed Mojtaba Sohrevardi, Zahra Shafiee; Kerman, Islamic Republic of Iran LOWER DOSE OF MYCOPHENOLATE MOFETIL IS ENOUGH FOR RITUXIMAB TREATED RENAL TRANPLANT PATIENTS Chung Hee Baek, Kyung Sun Park, Duck Jong Han, Jae Berm Park, Tae Young Kim, Su-Kil Park; Seoul, Korea THE PORCINE EXPERIMENTAL MODEL OF HETEROTOPIC RENAL AUTO-TRANSPLANTION Alice Faure, Charlotte Maurin, Eric Lechevallier, Christian Coulange; Marseille, France PARVOVIRUS B 19 INDUCED ANEMIA IN RENAL TRANSPLATATION: EXPERIENCE OF ASAN MEDICAL CENTER Ki Byung Song, Duck Jong Han, Song Cheol Kim, Jae Berm Park, Young Hoon Kim, Young Soo Chung; Songpa-ku, Republic of Korea EXPECTED RELATIONSHIP CHANGES INFLUENCE DECISION MAKING AROUND LIVING KIDNEY TRANSPLANTATION Ingrid I.B. de Groot, Karen K. Schipper, Sandra S. Van Dijk, Paul P.J.M. Van der Boog, Andre A.G. Baranski, Perla P.J. Marang-van de Mheen; Leiden, The Netherlands; Amsterdam, The Netherlands; Leiden, The Netherlands EFFECTIVENESS OF PREOPERATIVE HYDROSTATIC DILATATION OF CONTRACTED BLADDER FOR KIDNEY TRANSPLANTATION Jong Po Kim, Jin Min Kong, Joon Heon Jeong; Busan, Korea SUPPORTING YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE [ndash] BASELINE SERVICE DATA Matthew Tomlin, Heather Langham, Emma Coyne, Wendy Hope, Beverley Matthews, Donal ODonoghue, Charlotte Bebb, Catherine Byrne, Cathy Johnson; Nottingham, United Kingdom; Derby, United Kingdom; East Midlands, United Kingdom; London, United Kingdom MOVING OF RIGHT ILIAC VEIN AND SHORT RENAL VEIN IN LIVING DONOR KIDNEY TRANSPLANTATION Thu Thi Ngoc Du, Sinh Ngoc Tran; Ho Chi Minh City, Vietnam

LB-P-075

LB-P-076

LB-P-077

LB-P-078

LB-P-079

LB-P-080

LB-P-081

LB-P-082

LB-P-083

LB-P-084

LB-P-086

237

LB-P-087

MONITORING OF STABLE RENAL ALLOGRAFTS IN EARLY POSTTRANSPLANT PERIOD: CAN THE SERUM CREATININE AND GLOMERULAR FILTRATION RATE MEASUREMENT REPLACE THE SEQUENTIAL PROTOCOL BIOPSY? Karel Krejc, Tom Tich, Hana Cifersk, Pavel Hork, Andrea Smrzov, Miroslav Hrub, Kamil Zamboch, Petr Bachleda, Josef Zadrazil; Olomouc, Czech Republic EXPLORING THE NEEDS OF YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE Heather Langham, Emma Coyne, Matthew Tomlin, Beverley Matthews, Donal ODonoghue, Charlotte Bebb, Cathy Johnson, Wendy Hope, Catherine Byrne; Nottingham, United Kingdom; Derby, United Kingdom; East Midlands, United Kingdom; London, United Kingdom LIVE DONOR KIDNEY TRANSPLANTATION AFTER LARGE ANGIOMYOLIPOMA EXCISION Abboudi H., Chandak P., Kessaris N., Fronek J; London, United Kingdom; Prague, Czech Republic

LB-P-088

LB-P-088a

Late Breaking: Liver and Intestine

LB-P-089 CLINICAL VALUE OF PREOPERATIVE CORONARY RISK ASSESSMENT WITH COMPUTED TOMOGRAPHY CORONARY ARTERIOGRAPHY FOR ADULT LIVING DONOR LIVER TRANSPLANTATION Won-young Chae, Shin Hwang, Gi-Won Song, Gil-Chun Park, Jung-Man Namgoong, Jae-Jung Kim, Gyu-Sam Hwang; Seoul, Korea THE EFFECTIVENESS OF PLASMAPHERESIS AS A LIVER SUPPORT FOR LIVER GRAFT DYSFUNCTION FOLLOWING ADULT LIVING DONOR LIVER TRANSPLANTATION Cheon-Soo Park, Shin Hwang, Hyeong-Woo Park, Seog-Woon Kwon, Sung-Gyu Lee; Seoul, Korea TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) AFTER LIVER TRANSPLANTATION (LT): VASCULAR COMPLICATIONS (VC) CONSTITUTE A GOOD INDICATION Marco Senzolo, Giulia Magini, Andrew Burroughs, Michele Colledan, Giacomo Zanus, Stefano Fagiuoli; Padua, Italy; Bergamo, Italy; London, United Kingdom; Padua, Italy TRANSESOPHAPHAGEAL ECHOCARDIOGRAPHY DURING ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH ESOPHAGEAL VARICES Maximilian Thum, Remy Schwarzer, Rastko Karatosic, Ursula BurgerKlepp, Valentin Fuhrmann, Gabriela Berlakovich, Andreas Bacher, Peter Faybik; Vienna, Austria DE NOVO MALIGNANCY IN LIVER TRANSPLANT RECIPIENTS Hyeong-Woo Park, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Cheon-Soo Park; Seoul, Korea DIFFERENCE OF REGENERATION POWER BETWEEN HEALTHY AND DISEASED LIVER Man Ki Ju, Gi Hong Choi, Joon Sung Park, Dong Sub Yoon; Seoul, Korea

LB-P-090

LB-P-091

LB-P-092

LB-P-093

LB-P-094

238

LB-P-095

CHARACTERIZATION OF HEPATOCYTE-LIKE CELLS FROM HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS ON A NOVEL HEPATOGENIC MEDIA Maryam Ayatollahi, Masoud Soleimani, Bita Geramizadeh, Mona Entezam, Seyed Ali Malek Hosseini, Saman Nikeghbalian, Negar Azarpira, Mahdokht Aghdai, Paria Haddadi, Marjan Rahsaz; Shiraz, Islamic Republic of Iran; Tehran, Islamic Republic of Iran; Shiraz, Islamic Republic of Iran IMPACT OF PHARMACOLOGICAL PRETREATMENT AND ISCHEMIC PRECONDITIONING IN AN ISCHEMIC REPERFUSION INJURY OF THE LIVER Rauf Shahbazov, Hamdi Karakayali, Sinasi Sevmish, Nihan Haberal, Nilufer Bayraktar, Mehmet Haberal; Baku, Azerbaijan; Ankara, Turkey COMBINATION THERAPY WITH IBANDRONATE AND CALCITRIOL IS EFFECTIVE IN PATIENTS FOLLOWING LIVER TRANSPLANTATION (LTX): A THREE YEAR PROSPECTIVE CONTROLLED STUDY Doris Wagner, Hans-Peter Dimai, Karin Amrein, Harald Dobnig, Daniela Kniepeiss, Astrid Fahrleitner; Graz, Austria INTRAOPERATIVE PLACEMENT OF INFERIOR MESENTERIC VEIN CATHETER: A NOVEL APPROACH FOR PREVENTION OF PORTAL VEIN RETHROMBOSIS IN LIVING DONOR LIVER TRANSPLANTATION Saman Nikeghbalian, Kourosh Kazemi, Farzad Kakaei, Behnam Sanei, Ali Shamsaeefar, Ali Bahador, Heshmatollah Salahi, Mohammad Aliakbarian, Amin Bahraini, Seyed Ali Malekhosseini; Shiraz, Islamic Republic of Iran; Tabriz, Islamic Republic of Iran SMALL BOWEL AUTOTRANSPLANTATION FOR LOCALLY ADVANCED CARCINOMA OF THE PANCREAS Saman Nikeghbalian, Kourosh Kazemi, Behnam Sanei, Farzad Kakaei, Ali Shamsaeefar, Heshmatollah Salahi, Ali Bahador, Mohammad Aliakbarian, Naser Tutuni, Alireza Ghaffari, Amin Bahraini, Seyed Ali Malekhosseini; Shiraz, Islamic Republic of Iran; Tabriz, Islamic Republic of Iran LDLT USING A GRAFT FROM A DONOR WITH SITUS INVERSUS TOTALIS Ki-Hun Kim, Deok-Bok Moon, Tae-Yong Ha, Dong-Hwan Jung, Sam-Youl Yoon, Yo-Han Park, Hyung-Woo Park, Hyo-Jun Lee, Sung-Gyu Lee; Seoul, Republic of Korea IS MICROSURGICAL TECHNIQUE USEFUL IN BILIARY RECONSTRUCTION OF LIVING DONOR LIVER TRANSPLANTATION? Young Seok Han, Joo Dong Kim, Dong Lak Choi; Daegu, Republic of Korea CLINICAL CONSEQUENCE OF HEPATIC PARENCHYMAL INFARCT OF NON-VASCULAR ORIGIN FOLLOWING LIVER TRANSPLANTATION Samyoul Yoon, SungGyu Lee; Seoul, Korea CHANGES IN CORE TEMPERATURE DURING GRAFT WARM ISCHEMIA AND REPERFUSION PHASES IN LIVING DONOR LIVER TRANSPLANT Mahammed H. Abdullah, Ibrahim A. Salama, Wassam S. Morad; Shiben ELkom, Egypt RIGHT POSTERIOR PORTAL VEIN STENOSIS DEVELOPED AFTER LIVING DONOR LIVER TRANSPLANTATION USING A MODIFIED RIGHT LOBE GRAFT WITH A TYPE 2 PORTAL VEIN Youngdong Yu, Dongsik Kim, Geonyoung Byun, Sungock Suh; Seoul, Korea

LB-P-096

LB-P-097

LB-P-098

LB-P-099

LB-P-100

LB-P-101

LB-P-102

LB-P-103

LB-P-104

239

LB-P-105

LIVER ABSCESS DEVELOPED AFTER CADAVERIC LIVER TRANSPLANTATION DUE TO LIGATION OF A ACCESSORY RIGHT HEPATIC ARTERY OF THE DONOR GRAFT Youngdong Yu, Dongsik Kim, Geonyoung Byun, Sungok Suh; Seoul, Korea ESOPHAGOGASTRIC VARICES CORRELATE WITH THE DEGREE OF LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS Remy Schwarzer, Maximilian Thum, Rastko Karatosic, Ursula BurgerKlepp, Valentin Fuhrmann, Gabriela Berlakovich, Andreas Bacher, Peter Faybik; Vienna, Austria LIVING DONOR LIVER TRANSPLANTATION FOR TYPE II CITRULLINEMIA IN THE KOREAN PATIENT Minyoung Jung, SungGyu Lee; Seoul, Korea BENEFITS OF EARLY ENTERAL NUTRITION AFTER LIVER TRANSPLANT SURGERY Ik Jin Yun; Seoul, Korea

LB-P-106

LB-P-107

LB-P-108

Late Breaking: Lung

LB-P-109 EARLY CLINICAL EXPERIANCE OF LUNG TRANSPLANTATION AFTER EX-VIVO LUNG PERFUSION Andreas Wallinder, Sven-Erik Ricksten, Gerdt Riise, Christoffer Hansson, Martin Silverborn, Hans Liden, Gran Dellgren; Gothenburg, Sweden

Late Breaking: Pancreas

LB-P-110 SINGLE CENTER EXPERIENCE OF PANCREAS TRANSPLANTATION Jae Berm Park, Young Hoon Kim, Young Soo Chung, Joong-Yeol Park, Song-Cheol Kim, Duck Jong Han; Seoul, Republic of Korea SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN PATIENTS WITH TYPE 2 DIABETIC END-STAGE RENAL DISEASE Young Hoon Kim, Jae Berm Park, Young Soo Chung, Ki Byung Song, Song-Cheol Kim, Duck Jong Han; Seoul, Republic of Korea A NOVEL TECHNIQUE OF COMBINED EN-BLOC PANCREAS KIDNEY TRANSPLANTATION Saman Nikeghbalian, Farzad Kakaei, Ali Shamsaeefar, Behnam Sanei, Mehdi Salehipour, Seyed Ali Malekhosseini, Farzad Kakaei; Shiraz, Islamic Republic of Iran; Tabriz, Islamic Republic of Iran; Isfahan, Islamic Republic of Iran PERIOPERATIVE TRANSFUSION REQUIREMENTS AND GRAFT SURVIVAL IN PATIENTS WITH PANCREAS RETRANSPLANTATION [ndash] A RETROSPECTIVE STUDY Jan M. Fertmann, Karl-Walter Jauch, Johannes N. Hoffmann; Munich, Germany

LB-P-111

LB-P-112

LB-P-113

Late Breaking: Pediatric Transplantation

LB-P-114

240

PEDIATRIC LIVER TRANSPLANTATION USING GRAFTS FROM DONORS AFTER CARDIAC DEATH: A FEASIBLE OPTION WITH EXCELLENT RESULTS Diego Davila, Ruben Ciria, Wayel Jassem, Anil Dhawan, Hector VilcaMelendez, Mohamed Rela, Nigel Heaton; London, United Kingdom

LB-P-115

PEDIATRIC EXPERIENCE FOR THE USE OF SIROLIMUS IN RENAL TRANSPLANTATION PATIENT WITH CALCINEURIN INHIBITOR (CNI) TOXICITY Pak Chiu Tong, Wai Ming Lai, Lap Tak Ma, Kei Chiu Tse, Man Chun Chiu; Hong Kong, China PREDICTORS OF EARLY GRAFT SURVIVAL IN PEDIATRIC LIVER TRANSPLANTATION Ruben Ciria, Diego Davila, Shirin Khorsandi, Anil Dhawan, Hector VilcaMelendez, Mohamed Rela, Nigel Heaton; London, United Kingdom BILIARY COMPLICATIONS IN PEDIATRIC LIVER TRANSPLANTATION: A 18 YEAR SINGLE CENTER EXPERIENCE IN 429 CASES Jairo Rivera, Tom Darius, Fabio Fusaro, Catherine de Magne, Olga Ciccarelli, Jan Lerut, Magda Janssen, Raymond Reding; Brussels, Belgium; Bogota, Colombia NOVEL HISTOLOGICAL SCORING SYSTEM FOR LONG-TERM ALLOGRAFT FIBROSIS AFTER LIVER TRANSPLANTATION IN CHILDREN Carla Venturi, Christine Sempoux, Joan Carles Ferreres Pinas, Jorge Abarca Quinones, Isabelle Leclercq, Jacques Rahier, Raymond Reding; Brussels, Belgium; Barcelona, Spain; Brussels, Belgium PEDIATRIC ORGAN DONORS AND RECIPIENTS: FACTS AND POTENTIALS Gnter Kirste, Thomas Breidenbach; Erlangen, Germany; Frankfurt, Germany; Munich, Germany

LB-P-116

LB-P-117

LB-P-118

LB-P-119

Late Breaking: Tissue injury / preservation

LB-P-120 ONLINE RAPID SAMPLING MICRODIALYSIS (rsMD) FOR VIABILITY ASSESSMENT, COMPARING STATIC COLD STORAGE VERSUS HYPOTHERMIC MACHINE PERFUSION IN MARGINAL ALLOGRAFTS Samir Damji, Karim Hamaoui, Nick Bullock, Martyn Boutelle, Leong Agnes, Michelle Rogers, Sally Gowers, George Hanna, Ara Darzi, Vasilios Papalois; London, United Kingdom HIGH INCIDENCE OF DELAYED RENAL GRAFT FUNCTION AFTER PROLONGED COLD ISCHEMIA ASSOCIATES WITH 4G/4G PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) GENE POLYMORPHISM Vladimir Abramov, Vera Morozova, Jan Moisiuk; Moscow, Russian Federation PRETREATMENT WITH MANGAFODIPIR IMPROVES LIVER GRAFT TOLERANCE TO ISCHEMIA/REPERFUSION INJURY Yann Mouchel, Ismail Ben Mosbah, Anne Crolu, Fabrice Morel, Karim Boudjema, Philippe Compagnon; Rennes, France A CHEMICAL CHAPERONE INHIBITS ENDOPLASMIC RETICULUM STRESS AND PROTECTS STEATOTIC AND NON-STEATOTIC LIVERS IN PARTIAL HEPATECTOMY UNDER ISCHEMIA-REPERFUSION Ismail Ben Mosbah, Cecile Martel, Mohamed Amine Zouali, Catherine Brenner, Joan Rosello Catafau; Barcelona, Spain; Rennes, France; Chtenay Malabry, France

LB-P-121

LB-P-122

LB-P-123

Late Breaking: Xenotransplantation

LB-P-124 PORCINE ENDOGENOUS RETROVIRUS (PERV) INTEGRATION IN THE PIG GENOME Linda Scobie, Rashmi Wali, Chris Bauser, Claire Rogel-Galliard, Jonas Blomberg, Goran Sperber, Yasu Takeuchi; Glasgow, United Kingdom; Konstanz, Germany; Jouy-en-Josas, France; Uppsala, Sweden; London, United Kingdom

241

242

Corporate Symposia Programme

243

Sunday 4 September Astellas Roche Pfizer Novartis 13:00 14:30 13:00 14:30 14:45 16:15 16:30 18:00 Clyde Auditorium Lomond Auditorium Clyde Auditorium Clyde Auditorium

Monday 5 September Astellas Roche Bristol-Myers Squibb 13:00 14:00 13:00 14:00 18:00 19:30 Clyde Auditorium Lomond Auditorium Clyde Auditorium

Tuesday 6 September One Lambda Pfizer Astellas 13:00 14:00 13:00 14:00 17:00 18:30 Lomond Auditorium Clyde Auditorium Clyde Auditorium

244

Sunday 4 September
ASTELLAS SATELLITE Clyde Auditorium SYMPOSIUM Kidney transplantation: impacting long-term outcomes
13:00 14:30 13:00 Day 1: Looking after the patient Co-chairs: Jonas Wadstrm & Robert Gaston One year on how do you really monitor your patient for the long-term? Jonas Wadstrm (Sweden) The importance of nonimmunological factors in late graft dysfunction and failure Gerhard Opelz (Germany) Interview the expert: how do you do it? Facilitator: John Forsythe (UK) HT and lipid control: Alan Jardine (UK) CMV prevention: Camille Kotton (USA) Management of the patient deterioration of kidney allograft function Robert Gaston (USA) Patient management: nonadherence Sabina De Geest (Switzerland) Closing remarks Jonas Wadstrm (Sweden)

13:10

13:25

13:55

14:10 14:25

13:00 14:30

ROCHE SATELLITE Lomond Auditorium SYMPOSIUM Recent Advancements for CMV Treatment Management in Transplant Patients
Moderator: Regis A. Vilchez, M.D., Ph.D. Director Global Medical & Scientific Affairs/Virology Medical Lead Roche Molecular Systems Presentation 1 Quantifying CMV DNA in Transplant Recipients: Clinical Relevance and Status Report Speaker: Regis A. Vilchez, M.D., Ph.D. Director Global Medical & Scientific Affairs/Virology Medical Lead Roche Molecular Systems Presentation 2 New Developments in the Management of CMV in Solid Organ Transplant Patients Speaker: Prof. Dr. Hans Hirsch Inst. fuer medizinische Mikrobiologie der Uni Basel Basel, Switzerland

245

Sunday 4 September
14:45 16:15

PFIZER SATELLITE SYMPOSIUM Clyde Auditorium Renal transplantation applying new techniques and optimising immunosuppression
Chairman: Professor Peter Friend (Oxford, UK) Chairmans introduction Professor Peter Friend (Oxford, UK) Improving outcomes what can we do today, whats on the horizon? Professor Jeremy Chapman (Sydney, Australia) mTORi-based immunosuppression where may it offer benefit? Professor Josep M. Campistol (Barcelona, Spain) Optimising immunosuppression in kidney transplant recipients an interactive case study-led panel discussion Professor Josep M. Campistol (Barcelona, Spain) Professor Jeremy Chapman (Sydney, Australia) Dr Fritz Diekmann (Barcelona, Spain) Chairmans summary Professor Peter Friend (Oxford, UK) Close

14:45 14:50

15:15 15:40

16:10 16:15 16:30 18:00

NOVARTIS SATELLITE Clyde Auditorium SYMPOSIUM Short- and long-term outcomes in renal transplantation: how can we improve these for our patients?
Chairman: Professor Josep Campistol (Spain) Welcome and introduction Professor Josep Campistol (Spain) Achieving the best short-term outcomes for renal transplant patients Professor Bjrn Nashan (Germany) Beyond the short term: renal function post transplantation Professor Stuart Flechner (USA) Beyond the short term: managing cardiovascular disease post transplantation Professor Daniel Brennan (USA) Question and answer session All Summary and close Professor Josep Campistol (Spain)

16:30 16:35

16:55 17:15

17:35 17:55

246

Monday 5 September
ASTELLAS SATELLITE Clyde Auditorium SYMPOSIUM Kidney transplantation: impacting long-term outcomes
13:00 14:00 13:00 Day 2: Looking after the kidney Co-chairs: Jonas Wadstrm & Robert Gaston Introduction and overview Robert Gaston (USA) Phenotypes of late graft failure Philip Halloran (Canada) 13:20 Current management strategies case studies Facilitator: Arthur Matas (USA) Case study 1 Overview of the sensitised patient; treatment decisions (pre transplant) Robert Montgomery (USA) Case study 2 Donor-specific antigen-positive patient; how to treat, when to treat (peri transplant) James Gloor (USA) Case study 3 Antibody-mediated rejection; how to treat, when to treat (post transplant) Denis Glotz (France) 13:45 14:00 Future strategies: targeting the memory cells Petra Reinke (Germany) Closing remarks Robert Gaston (USA)

13:00 14:00

ROCHE SATELLITE Lomond Auditorium SYMPOSIUM Optimising patient care post-transplantation

Chairman: Alan Jardine, Glasgow, UK Opening remarks Immunosuppression How to optimise short and long-term success? Pierre Merville, Bordeaux, France CMV management From consensus to clinical practice Camille Kotton, Boston, USA The IMPACT of extended prophylaxis on CMV disease Ingeborg Hauser, Frankfurt/Main, Germany Questions and answers

13:00 13:05 13:05 13:20

13:20 13:35 13:35 13:50 13:50 14:00

247

Monday 5 September
18:00 19:30

BRISTOL-MYERS SQUIBB Clyde Auditorium SATELLITE SYMPOSIUM The New Generation of Immunosuppression in Kidney Transplantation
Bristol-Myers Squibb is delighted to invite you to their sponsored symposium at the 15th Congress of the European Society for Organ Transplantation. Scientific programme Welcome and introduction Professor Peter Friend (UK) The challenge of improving long-term patient outcomes Professor Klemens Budde (Germany) Expanding horizons: immunosuppression with NULOJIX (belatacept) Professor Gilles Blancho (France) NULOJIX (belatacept) in clinical practice Professor Josep Griny (Spain) Panel discussion and audience questions Moderated by Professor Peter Friend (UK) Organised and Funded by Bristol-Myers Squibb.

248

Tuesday 6 September
13:00 14:00

ONE LAMBDA SATELLITE Lomond Auditorium SYMPOSIUM The role of donor specific anti-HLA antibodies (DSA) in transplantation
Symposium Moderator Dr. Philip Dyer Scottish National Blood Transfusion Service Symposium Presentations The clinical relevance of donor-specific anti-HLA antibodies Dr. Denis Glotz Hospital St. Louis, Paris, France Strategies to reduce donor-specific anti-HLA antibodies Dr. E. Steve Woodle University of Cincinnati, Cincinnati, Ohio

13:00 14:00

PFIZER SATELLITE SYMPOSIUM Clyde Auditorium The role of mTOR in cancer new insights for managing the transplant patient
Chairman: Professor Josep M. Campistol (Barcelona, Spain) Chairmans introduction Professor Josep M. Campistol (Barcelona, Spain) mTOR what does it do? Professor Owen J. Sansom (Glasgow, UK) How should we apply our knowledge of mTOR to transplantation? Professor Edward K. Geissler (Regensburg, Germany) Summary and panel discussion Professor Josep M. Campistol (Barcelona, Spain) Close

13:00 13:05 13:25

13:45 14:00 17:00 18:30

ASTELLAS SATELLITE SYMPOSIUM

Symposium outline

Clyde Auditorium

21st century immunosuppression in renal transplantation: is evolution the solution? This educational symposium will be sponsored by Astellas Pharma Europe Ltd, and aims to highlight the current status of kidney transplantation in Europe, explore the potential roles of different immunosuppressive therapies in the future and build understanding of what is important in real-life clinical practice in order to improve patient and graft survival and deliver consistently better long-term outcomes. The symposium will include presentations on the new evidence on the factors contributing to late graft failure, the pros and cons of different approaches to immunosuppressive therapy, and optimising CNI-based immunosuppression.

249

Tuesday 6 September
ASTELLAS SATELLITE SYMPOSIUM continued Chair: Professor Kathryn Wood, Nuffield Department of Surgical Sciences, University of Oxford, UK Session 1 Nephrotoxicity as the primary driver of failure fact or fiction? Speaker: Dr Philip Halloran, Director, Alberta Transplant Applied Genomics Centre, Canada Topic: Discussion of whether CNI nephrotoxicity is really a major cause of kidney allograft failure or if there is a possibility that CNI minimisation and withdrawal strategies might be partly responsible for the loss of function and structural changes that have often been attributed to CNI toxicity, through inflammation and immunological damage. The presentation will include practical recommendations for transplant physicians for appropriate long-term protection and management of the kidney. Session 2 Immunosuppressive therapies: the pros and cons Speaker: Professor Henrik Ekberg, Professor of Transplant Surgery, Lund University, Sweden Topic: Discussion of the spectrum of activities of the different immunosuppressive options and an evaluation of their pros and cons, as well as discussion of the most significant studies that will help to define where regimens fit and how immunosuppressive agents can best be used synergistically. The presentation will challenge thinking around which endpoints are the real predictors of outcome and include practical recommendations for choosing the most appropriate regimens and combinations. Session 3 Optimising CNI-based immunosuppression Speaker: Dr Frank Lehner, Senior Staff Surgeon, Hannover Medical School, Germany Topic: Discussion of key clinical priorities in CNI-based immunosuppression, the formulation and pharmacokinetic differences between PROGRAF and ADVAGRAF and how these differences apply to the real-world clinical setting. The presentation will also include practical recommendations for transplant physicians for optimising long-term tacrolimus options.

250

Gold Circle

Silver Circle

252

15th ESOT Congress Corporates Supporters

The ESOT Council and the GLASGOW 2011 Organizing Committee would like to thank the following Corporate and Scientific Partners for their participation. Platinum Circle

Astellas

Gold Circle

BMS

Novartis

One Lambda

Pfizer

Silver Circle

Genzyme

Miltenyi Biotec

Organ Recovery Services

Roche

Teva

Friend Circle

Biotest AG

CareFusion

Fresenius-Biotec

IGL Group

Exhibitors

AbSorber AB

CTL Europe

Cellestis

Cylex Inc

Dr. F Kohler Chemie

Gen-Probe

Organ Assist

Oxiplenish BV

Rose Europe

Thompson Surgical

Transplant Connect

Wiley Blackwell

Wisepress

Abbott Molecular Alpha Biotech Ltd Anachem Life Technologies Ltd MC Diagnostics

Promega UK Ltd Quest Biomedical Ltd Savant Limited STEMCELL Technologies VH Bio Ltd

253

254

Company

Stand

Abbott Molecular 28 AbSorber AB 13 Alpha Biotech Ltd 34a American Transplant Congress 59 Anachem 38a Astellas Pharma Europe Ltd 2 Baskent University-Turkey 56 Biotest AG 31 Bristol-Myers Squibb 3 and 10 C.T.L. Europe GmbH 51 CareFusion 12 Cellestis 43 Cylex, Inc. 19 Donor Action Foundation 47 Dr. F. Khler Chemie GmbH 49 European Society for Organ Transplantation (ESOT) 7 European Transplant Coordinators Organization (ETCO) 54a F. Hoffmann-La Roche Ltd 6 Fresenius Biotech GmbH 23 Gen-Probe 53 Genzyme 5 Guys and St Thomas NHS Foundation Trust (the ReMIND trial) 54 IGL GROUP 16 Life Technologies 35 Maastricht University Medical Center 46 MC Diagnostics 30 Miltenyi Biotec GmbH 32 NHS Kidney Care 60 Novartis Pharma AG 4 and 8 One Lambda, Inc 9 Organ Assist 22 Organ Recovery Systems 24 Oxiplenish B.V 18 Pfizer Inc. 1 Promega UK Ltd 36 Quest Biomedical Ltd 38 R.O.S.E. Europe GmbH 61 Roche Organ Transplantation Research Foundation (ROTRF) 57 Savant Limited 27a STEMCELL Technologies 35a Teva Pharmaceuticals Europe BV 26 The British Transplantation Society 48 Therakos 55a The Transplantation Society 42 Thompson Surgical Instruments 45 Transplant Connect 58 Transplant Procurement Management (TPM) 55 VH Bio Ltd 39 Wiley-Blackwell 50 Wisepress Medical Bookshop 11

255

Abbott Molecular Stand 28 Among Abbott Moleculars portfolio of molecular diagnostic products for infectious diseases, oncology, transplantation and human genetics, are Biofortuna SSP Go reagents for low-resolution HLA typing, AlleleSEQR HLA-SBT products for highresolution HLA typing, and AlleleSEQR Chimerism Assay products for post-transplant engraftment monitoring. Contact: Fiona Bell Abbott Laboratories Ltd, Vanwall Road, Maidenhead, Berkshire SL6 4XF, UK Phone: +44 (0) 1628 774623 Email: fiona.bell@abbott.com Website: www.abbottmolecular.com

AbSorber AB Stand 13 AbSorber AB is a biotech company focused on developing products that increase the probability of transplantation success. XM-ONE is a novel CE-marked and FDA cleared transplantation crossmatch test kit available in Europe and US. XM-ONE rapidly detects antibodies specific for endothelial-specific antigens as well as antibodies specific to major transplantation antigens. For more information please visit www.absorber.se or contact Lars qvist at e-mail lars.oqvist@absorber.se Contact: Franzengatan 5, SE-112 51 Stockholm, SWEDEN

Alpha Biotech Ltd Stand 34a DISTRIBUTORS OF: OLERUP- SSP, GEL RED, OLERUP CONEXIO SBT RESOLVER/ASSIGN, ABSORBER- XM-ONECROSSMATCH. GEN-D X- SBT ENGINE & SBT EXCELLERATOR BIOPLASTICS- PCR AND Q-PCR TUBES AND TRAYS LABQUIP- 60/72 TT-TRAYS ART ROBBINS INSTRUMENTS- SYRINGE DISPENSERS, COMPLEMENT CUPS, SERUM TUBES, AUTOSCOPES LYMPHOLYTE& LYMPHOPREP CELL ISOLATION PRODUCTS XIRIL- LABORATORY ROBOTICS FOR PRE/POST PCR Contact: Robert Cordingley 42 Hughenden Gardens, Glasgow G12 9YH, UK Email: sales@alphabiotech.co.uk Website: www.alphabiotech.co.uk

256

American Transplant Congress Stand 59 The American Transplant Congress is the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. The 2012 Congress will be held June 26 in Boston, Massachusetts. The Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacist who are interested in the clinical and research aspects of solid organ and tissue transplantation. Contact: Suite C, 15000 Commerce Parkway, Mount Laurel, NJ 08096, USA Email: pballinger@ahint.com Website: www.atcmeeting.com

Anachem Stand 38a Anachem is the UK and Irelands leading specialist service and supply organisation for laboratory liquid handling and consumables. Our pipette service organisation is the largest, most experienced in the UK and has been UKAS accredited since 1998. We offer service and calibration of all pipette makes and models. Contact: Catherine OBrien Anachem House, 1 & 2 Titan Court, Laporte Way, Luton, Bedfordshire LU4 8EF, UK Phone: +44 (0) 1582 456256 Email: catherine.obrien@mt.com Website: www.anachem.co.uk

Astellas Pharma Europe Ltd Stand 2 Astellas is a major player in the transplantation community. Its products are recognised worldwide in the prevention of organ rejection following kidney, liver, and heart transplantation. Astellas remains focused on investing in its pipeline of potential future immunosuppressant therapies. Through sustained investment, we are continually striving to advance transplant care by developing both new treatment regimens and innovative therapies that target specific pathways. Contact: Lovett House, Lovett Road, Staines, Middlesex TW18 3AZ, UK Fax: +44 (0) 1784 419 527 Website: www.astellas.eu

Baskent University-Turkey Stand 56 Baskent University was founded in 1993, as one of the foundation universities of Turkey. The founder and honarary president, Prof. Dr. Mehmet Haberal, performed the first successful transplantation surgery in Turkey (1975) and is renowned worldwide in the medical community. Baskent University has a broad spectrum of faculties in all branches of science including medicine; dentistry; engineering; administration, social,political financial sciences and law. Contact: Pharm.Feyyaz Artukoglu 11.Sokak 40/9, Bahcelievler 06490, Ankara, TURKEY Tel: +90 (0) 312 213 25 30 Fax: +90 (0) 312 212 49 67 Email: feyyazart2002@yahoo.com

257

Biotest AG Stand 31 Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In the Biotherapeutic segment, Biotest researches into the clinical development of monoclonal antibodies, including in the indications of rheumatoid arthritis and cancer of plasma cells. Contact: Landsteinerstr 5, 63303 Dreieich, Germany Tel: +49 (0) 6103 801 4716 Fax: +49 (0) 6103 801 880 Email:mail@biotest.de Website: www.biotest.com

Bristol-Myers Squibb Stands 3 and 10 Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are committed to pursuing research that may help make a difference for organ transplant patients. Contact: 3, rue Joseph Monier, 92500 Rueil-Malmaison, France Tel: +33 (0) 158 83 60 00 Fax: +33 (0) 158 83 60 01

C.T.L Europe GmbH Stand 51 CTL is the only company that specializes on GLP compliant high throughput ELISPOT analysis for monitoring T cell immunity in clinical trials (CRO). CTL is also the leading manufacturer of ELISPOT analyzers, reagents required for ELISPOT standardization, including reference PBMCs, and Serum-Free-Test-Media. Contact: Hans-Boeckler-Str. 19-20, 53225 Bonn, Germany Tel: +49 (0) 228 85 44 78 0 Fax: +49 (0) 228 85 44 78 22 Email: ctl-europe@immunospot.com Website: www.immunospot.com

CareFusion Stand 12 The CareFusion, Infection Prevention mission is to deliver clinically differentiated evidence-based products and services that support the global effort to reduce HAIs. ChloraPrep is illustrative of this focus. ChloraPrep is currently the only product licensed for cutaneous antisepsis, which allows healthcare professionals to comply with epic2: National Evidence-Based Guidelines for Preventing Healthcare Associated Infections. Contact: Reigate Place, 43 London Road, Reigate, Surrey RH2 9PW, UK Tel: +44 (0) 1737 237 940 Fax: +44 (0) 1737 237950 Email: enquiries@chloraprep.co.uk Website: www.chloraprep.co.uk

258

Cellestis Stand 43 Cellestis are the developers and marketers of QuantiFERON technology products. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune (CMI) responses of T cell lymphocytes using whole blood samples. It forms the basis of our QuantiFERON-CMV assay which represents the only commercially available immune monitoring test specific for CMV. Contact: Level 1, Office Tower 2, Chadstone Centre, 1341 Dandenong Road, Chadstone, Victoria 3148, Australia Tel: +61 (0) 3 8527 3500 Fax: +61 (0) 3 9568 6623 Email: quantiferon@cellestis.com Website: www.cellestis.com

Cylex, Inc. Stand 19 Cylex is a life sciences company which develops and commercializes in vitro diagnostic products that illuminate immunity. Its patented technology provides an innovative platform to assess immune cell function providing insight for individualized patient management. ImmuKnow, the Companys FDA-cleared product, is used to manage and optimize immunosuppression in transplant patients. Contact: 8980-I Old Annapolis Road, Columbia, MD 21045 Tel: +1 (0) 888 33CYLEX (Toll Free) Tel: +1 (0) 410 964 0236 (Main) Fax: +1 (0) 410 443 259 9919 Email: contact@cylex.net Website: www.cylex.net

Donor Action Foundation Stand 47 Donor Action (DA) is an international initiative that brings together expertise on best hospital practices in organ donation. Its comprehensive and flexible DA Program provides guidelines and tools to assist hospitals and Critical Care Units in assessing their donation potential, creating tailor-made total donation protocols and increasing donation rates significantly. Contact: Prinsendreef 10, B-3210 Linden, Belgium Tel: +32 (0) 16 621469 Fax: +32 (0) 16 623443 Email: info@donoraction.org Website: www.donoraction.org

Dr. F. Khler Chemie GmbH Stand 49 Dr. F. Khler Chemie is an independent, family owned business with representations on all five continents. Since 1959, we provide products in the fields of electrolytes, contrast media, antidotes, anaesthetics, as well as organ protective and cardioplegic solutions. We are a committed partner of cardiac and transplant surgery worldwide. Contact: Werner-von-Siemens-Strae 22-28, 64625 Bensheim, Germany Tel: +49 (0) 6251 1083 0 Fax: +49 (0) 6251 1083 176 Email: info@koehler-chemie.de Website: www.koehler-chemie.de

259

European Society for Organ Transplantation (ESOT) Stand 7 The European Society for Organ Transplantation ESOT Focusses on the pursuit of scientific knowledge and best clinical practice in the field of transplantation. ESOT forms the umbrella for all expert groups in solid organ donation and transplantation in Europe and involves the majority of physicians, surgeons, scientists and other transplant professionals as its members. It promotes a strong educational program for those who have made transplantation a cornerstone in their professional career and has established a scientific network. As the main transplant organization in Europe, ESOT offers expertise and independent advice to European bodies seeking help on questions related to transplantation. Every other year ESOT organizes its main meeting in a European city. Contact: ESOT Office, Corso del Popolo 8, 35131 Padoua, Italy Tel: +39 (0) 49 3005796 Fax: +39 (0) 49 2106306 Email: office@esot.org Website: www.esot.org

European Transplant Coordinators Organization, Stand 54a (ETCO) The European Transplant Coordinators Organization, ETCO provides support and services for professionals in the field of organ procurement, donation and transplantation. ETCO has a website www.etco.org, a journal Organs, Tissues and Cells and organizes an annual congress in Europe, next years being in Dubrovnik, Croatia, 5-7 October, 2012. Contact: Jane Lewis, ETCO Executive Officer Tel: +34 (0) 931 787 028 Fax: +34 (0) 931 787 028 Mobile: +34 (0) 667 419 142 Email: secretariat@etco.org janealewis@gmail.com

Fresenius Biotech GmbH Stand 23 Fresenius Biotech develops and markets immunologically active products. These products target to prevent or treat severe diseases with a high priority unmet medical need. ATG-Fresenius is a well established polyclonal antibody preparation (Anti T-Lymphocyte Globulin) for prevention or treatment of organ rejection after transplantation. ATG-Fresenius is successfully marketed in over 60 countries. Contact: Am Haag 6 + 7, D-82166 Grfelfing, Germany Website: www.fresenius-biotech.com

260

Gen-Probe Stand 53 Gen-Probe is a global leader in molecular diagnostics for infectious disease, transplant diagnostics, oncology and blood screening. The LIFECODES product line includes immunodiagnostic and genotyping assays used to determine human leukocyte antigens (HLA) and detect alloantibodies to donor antigens that may cause unwanted immune responses in transplant or transfusion recipients. Contact: Dr. Christine Heylen Director, European Sales & Marketing Tel +32 (0) 3 385 47 91 Email: christine.heylen@gen-probe.com

Genzyme Stand 5 One of the worlds leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Genzymes products are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and immune disease. Genzyme is part of the Sanofi Group. Contact: Gooimeer 10, Naarden 1411 DD, The Netherlands Tel: +31 (0) 35 699 1200 Website: www.genzyme.com

Guys and St Thomas NHS Foundation Trust Stand 54 (the ReMIND trial) ReMIND RituxiMab INDuction in renal transplantation. An investigator-led, multi-centre randomised controlled trial. (ISRCTN 95769119; Clinicaltrials.gov NCT01095172). A single dose of rituximab 2-4 weeks prior to renal transplant to allow minimisation of maintenance immunosuppression and improve long-term graft function. Visit us to discuss benefits of participation in this exciting new trial. Contact: Nizam Mamode, Principal Investigator Guys and St Thomas NHS Foundation Trust, Renal & Urology Department, 6th Floor, Borough Wing, Guys Hospital, Great Maze Pond, London SE1 9RT, UK Tel: +44 (0) 20 7188 1543 Fax: +44 (0) 20 7188 5646 Email: Nizam.Mamode@gstt.nhs.uk Website: public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=9154

261

IGL GROUP (IGL France, Spain, Amrica Latina, Stand 16 Waters Medical Systems) IGL Group offers a range of products in the field of organ recovery, preservation, and transplantation for your transplantation team, as well as a scientific and technological expertise in the areas of perfusion and preservation. We continuously explore new research opportunities with the goal of enhancing organ quality for transplantation. Contact: Parc Tertaire du Bois Dieu, RN6 1 alle des Chevreuils, F-69380 LISSIEU, France Tel: +33 (0) 4 37 64 63 32 Fax: +33 (0) 4 37 64 60 09 Email: welcome@igl-group.com Website: www.igl-group.com

Life Technologies Ltd Stand 35 Life Technologies is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. The company employs approximately 9,000 people, has a presence in 160 countries. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. Contact: Katie Hanretty, 3 Fountain Drive, Inchinnan Business Park, Paisley PA4 9RF, UK Tel: +44 (0) 141 814 6085 Website: lifetechnologies.com

Maastricht University Medical Center Stand: 46 In most countries a vast disparity exists between the demand for donor organs and its supply. Therefore, the Maastricht University Medical Center developed a digital interactive school-based organ donation education program to prepare adolescents to make a well-informed decision about organ donation. Contact: PO Box 5800, 6200 AZ Maastricht, The Netherlands Tel: +31 (0) 433874516 Email: areubsaet@gmail.com Email.schaeken@mumc.nl

MC Diagnostics Stand: 30 HISTO SPOT enables fully automated typing of HLA A, B, C, DRB1, DRB3/4/5, DQB1 and DPB1 loci. Automation of on call typing is possible, with results available within 3 hours. Fast and simple to set up, Histo Spot feeds typing data directly into HISTO MATCH software, providing interpretation within minutes. Contact: Unit 5, Technium OpTIC, Ffordd William Morgan, St Asaph Business Park, St Asaph, Denbighshire LL17 0JD, UK Tel: +44 (0) 1745 535225 Email: enquiries@mcdiagnostics.co.uk Website.www.mcdiagnostics.co.uk

262

Miltenyi Biotec GmbH Stand 32 Miltenyi Biotec, a diversified biotechnology and medical device company, offers the CliniMACS Cell Selection System. Based on MACS Technology, it can be used for clinical-scale magnetic enrichment of cells. Another exemplary clinical application representsTheraSorb Therapeutic Apheresis, which selectively removes pathogenic substances from the blood by immunoadsorption. Log on to www.miltenybiotec.com to learn more. Contact: Friedrich-Ebert-Strae 68, 51429 Bergisch Gladbach, Germany Tel: +49 (0) 2204 8306 0 Fax.: +49 (0) 2204 85197 Email: macs@miltenyibiotec.de Website: www.miltenyibiotec.com

NHS Kidney Care Stand 60 NHS Kidney Care works to enable the kidney community to build a service that is fit for the 21st century, offering a consistent, high standard of care. We produce a range of resources including commissioning guidance, how-to-guides, toolkits and specifications designed to inform local decision making and to support frontline NHS staff to drive up quality and efficiency. Contact: Third Floor, New Croft House, Market Street East, Newcastle NE1 6ND, UK Tel: +44 (0) 207 972 4248 Fax: +44 (0) 191 229 2987 Email: admin@kidneycare.nhs.uk Website: www.kidneycare.nhs.uk

Novartis Pharma AG Stands 4 and 8 Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. Novartis is headquartered in Basel, Switzerland. For more information, please visit www.novartis.com Contact: Postfach, Basel, CH-4002, Switzerland Tel: +41 (0) 61 3241111 Fax: +41 (0) 61 3248001

One Lambda, Inc. Stand 9 One Lambda will share recent advancements in post-transplant antibody detection, discussing the causal relationship of DSA as it pertains to AMR and chronic rejection. Our Luminex xMAP based LABScreen Single Antigen assays will be showcased, as will C1qScreen, a new tool that distinguishes complement binding from noncomplement binding DSA. Contact: 21001 Kittridge Street, Canoga Park, California 91303, USA Tel: +1 (0) 818 702 0042 Fax: +1 (0) 818 702 6904 Email: onelambda@onelambda.com Website: www.onelambda.com

263

Organ Assist Stand 22 Organ Assist develops and produces innovative equipment for oxygenated machineperfusion of various donor organs (Kidney, Liver, Lung). Organ Assist is a knowledge-based company with its origins in the Universal Medical Center of Groningen, and combines research with the actual development and optimisation of best-in-class lifesaving devices in this specialist field. Contact: L. J. Zielstraweg 1, 9713 GX, Groningen, The Netherlands Tel: +31 (0) 50 313 1905 Email: info@organ-assist.nl Website: www.organ-assist.nl

Organ Recovery Systems Stand 24 Organ Recovery Systems is the worlds leading provider of machine perfusion products and services to the transplant community, supporting over 114 transplant programs worldwide. The LifePort Kidney Transporter has been proven to significantly reduce the odds of developing DGF and to improve 1-year graft survival following kidney transplantation, compared with cold static storage. Contact: Website: www.organ-recovery.com

Oxiplenish B.V. Stand 18 The AirdriveTM a CE registered Portable Organ Perfusion System is a single use device to maintain human organs flushed during transport with an oxygenated perfusion fluid at a +/- 8C. The Airdrive is intended to transport kidney and liver donor grafts and has a running time of 24 hours. Contact: CoC number: 4318290, Meibergdreef 9 (H01-221), 1105 AZ Amsterdam, The Netherlands Tel: + 31 (0) 10 524 4436 Fax: +31 (0) 20 566 9615 Email: info@portableorganperfusion.com

Pfizer Inc. Stand 1 Pfizer Inc: Working together for a healthier world At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Please visit us at www.pfizer.com. Contact: 235 East 42nd Street, New York, NY 10017, USA Tel: +1 (0) 212 733 2323 Website: www.pfizer.com/contact/

264

Promega UK Ltd Stand 36 Promega are world leaders in providing innovative solutions and technical support to life science research. Over 2,000 products enable scientists to advance their knowledge in genomics, proteomics and cellular analysis, promoting understanding of the molecular basis of life and potential mechanisms of disease, as well as identifying targets for drug development. Contact: Karen Read Delta House, Southampton Science Park, Southampton SO16 7NS, UK Tel: +44 (0) 23 8071 7304 Email: karen.read@promega.com Website: www.promega.com

Quest Biomedical Ltd Stand 38 We will be showing our range of Gen-Probe Luminex-based HLA typing and HLA antibody screening and identification products, alongside Inno-trains Sequence-based HLA typing, SSP and new HLA FluoGene system. Also on show will be the Fujifilm QuickGene series of systems for isolating DNA and RNA. Contact: Derek Kelly, Business Manager The Exchange, Haslucks Green Road, Shirley, Solihull, West Midlands B90 2EL, UK Tel: +44 (0) 121 744 7674 Email: Derek.Kelly@questbiomedical.com Website: www.questbiomedical.com

R.O.S.E. Europe GmbH Stand 61 ROSE Europe is a specialist manufacturer and supplier of HLA invitro tissue typing diagnostic kits. All of our manufacturing is undertaken in Frankfurt, Germany. We are compliant with and hold ISO 13485:2003 and ISO 9001: 2000 Certificates. Our kits are manufactured to GMP standards and the TUV Rhineland provides independent quality assurance ISO Standard and CE marks the kits. Contact: Industriepark Hoechst G830, D-65926 Frankfurt am Main, Germany Tel: +49 (0) 69 5700 2800 Fax: +49 (0) 69 5700 2801 Email: info@rose-Europe.de Website: www.rose-Europe.de

F. Hoffmann-La Roche Ltd Stand 6 Headquartered in Basel, Switzerland, Roche is a leader in researchfocused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the worlds largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roches transplant treatments are designed to support the long-term survival of transplanted organs. Contact: Grenzacherstrasse 124, 4070 BASEL, Switzerland Tel: +41 (0) 61 688 11 11 Fax: +41 (0) 61 691 93 91 Email: basel.webmaster@roche.com Website: www.roche.com

266

Roche Organ Transplantation Research Stand 57 Foundation (ROTRF) The Roche Organ Transplantation Research Foundation (ROTRF) is an independent, medical research charity that awards research grants for projects in organ transplantation to faculty members at universities, transplant centres and research institutes. We are committed to funding a broad range of transplantation-related research. Our priority is to support clinically oriented projects. Information at www.rotrf.org. Contact: P.B. Box 222, 6045 Meggen, Switzerland Tel: +41 (0) 41 377 53 35 Fax: +41 (0) 41 377 53 34 Email: admin@rotrf.org Website: www.rotrf.org

Savant Limited Stand 27a Savant Limited supports and develops the PULSE and Hematos systems used by NHSBT, NIBTS, loMBTS and Jersey. Please come and have a chat if you are one of our many users or to find out more about what we do. Contact: Glyn Jones, Business Development Manager Dalton Hall Business Centre, Dalton Lane, Burton-in-Kendal, Cumbria LA6 1BL, UK Tel: +44 (0) 1524 784416 Email: glyn.jones@savant.co.uk Website: www.savant.co.uk

STEMCELL Technologies Stand 35a STEMCELL Technologies provides optimized cell separation products and systems for a variety of HLA applications to facilitate high-volume sample processing and clear, reliable test results. Our cell separation platforms, EasySepTM, isolates cells with minimal hands-on time and no cross-contamination. For more information, visit www.stemcell.com. Contact: European Office, Rutherford House, Manchester Science Park, Pencroft Way, Manchester M15 6SZ, UK Tel: +44 (0) 161 660 0320 Email: info.eu@stemcell.com Website: www.stemcell.com

Teva Pharmaceuticals Europe BV Stand 26 Teva is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active ingredients. Teva produces more than 1,450 molecules fulfilling over 2500 prescriptions every minute and employs 40,000 people globally. Contact: Computerweg 10, 3542DR Utrecht, The Netherlands Tel: +31 (0) 30 290 290 Website: www.tevapharm.com

267

The British Transplantation Society Stand 48 The British Transplantation Society, formed in 1972, draws members from all transplantation professionals clinicians, basic scientists, H&I scientists, transplant nurses, coordinators, ethicists and others. We are delighted to be the host society for the 2011 ESOT Congress and wish you a productive and enjoyable time in one of our most exciting cities. Contact: Chester House, 68 Chestergate, Macclesfield, Cheshire SK11 6DY, UK Tel: +44 (0) 1625 664 547 Fax: +44 (0) 1625 664 510 Email: secretariat@bts.org.uk Website: www.bts.org.uk

Therakos Stand 55a Johnson & Johnson Medical Limited, a pioneer in photopheresis therapy for more than 20 years, currently produce 2 different photopheresis systems The THERAKOS CELLEX Photopheresis System and the THERAKOS UVAR XTS Photopheresis System. Extracorporeal Photopheresis is a therapeutic procedure performed outside the body using the Photopheresis System. Contact: Chris Hart Pinewood Campus, Nine Mile Ride, Wokingham, Berkshire RG40 3EW, UK Tel: +44 (0) 1344 871 095 The Transplantation Society Stand 42 TTS, established since 1966, serves as the principal International forum for the advancement of both basic and clinical transplantation science throughout the world. TTS provides the focus for global leadership in transplantation science and clinical practice, scientific communication, education and guidance on the ethical practice. Please visit our booth in the exhibition hall to get information on our next congress to be held in Berlin July 15-19, 2012 and to find out more about TTS and its Sections. Contact: International Headquarters, 1255 University Street, Suite 605, Montreal QC H3B 3V9, Canada Tel: +1 (0) 514 874 1717 Fax: +1 (0) 514 874 1716 Email: info@tts.org Website: www.tts.org

268

Thompson Surgical Instruments Stand 45 Thompson Surgical is the original manufacturer of table-mounted retractors. In use for over thirty years, the Thompson Retractor is the only mechanical retractor to offer one frame for all exposure needs, multi-planed retraction, and unlimited customization. Stop by our booth so you can see our latest innovations that will provide you uncompromised exposure. Contact: 10170 E. Cherry Bend Road, Traverse City, MI 49682, USA Tel: +1 (0) 231 922 0177 Fax: +1 (0) 231.922.0174 Email: ginette.akoka@thompsonsurgical.com Website: www.thompsonsurgical.com

Transplant Connect Stand 58 Transplant Connect is the leading global provider of web-based electronic medical records software for the organ, tissue and eye donation and transplant field. Our iTransplantSM Platform today enables more than 13,000 organ transplants every year and is trusted by more than 2,500 medical professionals across nearly 50 different organizations worldwide. Contact: 2701 Ocean Park Blvd, Suite 222, Santa Monica, CA 90405, USA Tel: +1 (0) 310 392 1400 Fax: +1 (0) 310 450 7193 Email: jpiano@transplantconnect.com Website: www.transplantconnect.com

Transplant Procurement Management (TPM) Stand 55 Transplant Procurement Management (TPM) is an international educational program whose main goal is to increase the quantity, quality and effectiveness of organ and tissues donation for transplantation, by training healthcare professionals in all the steps of the donation process and the strategies to develop successful organ procurement programs. Contact: Parc Cientfic de Barcelona, Baldiri Reixac, 4-8, 08028 Barcelona, Spain Tel: +34 (0) 93 403 7687 Fax: +34 (0) 93 198 6076 Email: infotpm@pcb.ub.cat Website: www.tpm.org

VH Bio Ltd Stand 39 VH Bio Ltd is a leading supply and distribution company for the life sciences industry. We distribute One Lambda products which include MicroSSPTM and Luminex based LABType and LABScreen for HLA Typing and HLA antibody identification respectfully. Please come and visit the stand to find out about new additions to these comprehensive One Lambda ranges. Contact: Andrew Hewitt, Managing Director Unit 11b, Station Approach, Team Valley Trading Estate, Gateshead NE11 0ZF, UK Tel: +44 (0) 191 495 8210 Email: ahewitt@vhbio.com Website: www.vhbio.com

Wiley-Blackwell Stand 50 Wiley-Blackwell, the STMS publishing business of John Wiley & Sons Ltd, proudly publishes Transplant International on behalf of ESOT. Visit the Wiley-Blackwell stand to collect free journal samples and to browse our extensive book collection all with an exclusive 20% conference discount. For more information, visit www.wiley.com/wiley-blackwell. Contact: 9600 Garsington Road, Oxford OX4 2DQ, UK Email: customer@wiley.com Website: www.wiley.com/wiley-blackwell

269

Wisepress Medical Bookshop Stand 11 Wisepress.com, Europes leading conference bookseller, has a complete range of relevant books and journals which can be purchased at the stand or, if you would rather not carry them, posted to you Wisepress will deliver worldwide. We also have a comprehensive medical and scientific online bookshop with great offers. Contact: 25 High Path, Merton Abbey, London SW19 2JL, UK Tel: +44 (0) 20 8715 1812 Fax: +44 (0) 20 8715 1722 Email: bookshop@wisepress.com Website: www.wisepress.com

270

Aandahl, Einar M. O-005 Aaseb, Willy RO-194 Abaalkhail, Faisal O-045 Abad, Soraya O-143, RO-197, RO-319 Abarca Quinones, Jorge LB-P-118 Abate, Davide O-150, P-206 Abbass, Tanvir RO-210 Abboudi, Hamid LB-P-088/A Abboud, Imad P-212 Abdellatif, Achour P-378 Abdo, Ayman O-045 Abdullah, Mahammed H. LB-P-103 Abe, Toyofumi P-248 Abeleda, Michael V. P-154 Abendroth, Dietmar K. P-073, P-381 berg, Fredrik P-322 Abeydheera, Anuja P-241, RO-280 Abou-El-Mahasen, Mona A. O-229 Abouljoud, Marwan P-083 Aboulker, Jean Pierre O-153 Abradelo, Manuel P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Abraham, Roshini S. P-190 Abramov, Vladimir LB-P-121, RO-355 Abramovicz, Daniel O-157 Abramowicz, Daniel O-322, P-089, P-274 Abrol, Esha P-207 Abroug, Soussen P-378 Abu-Ajaj, Wijdan LB-P-025 Abu-Amara, Mahmoud O-024 Acosta, F. P-270 Adair, A. RO-253 Adair, Anya LB-P-004, MO-053 Adam, Rene O-188, O-189, O-317, RO-261E Adamczak, Marcin P-110 Adamec, Milos O-079, RO-216, RO-314, RO-337A Adams, David H. MO-032 Adani, Gian Luigi O-041, P-032, RO-047, RO-092, RO-247, RO-254, RO-276 Addison, Clara O-059 Adel, Hany P-085, P-244 Adorno, Domenico P-124, P-189 Aerts, R. RO-032 Aerts, Raymond CC-005, CC-007, O-046, O-098, O-129, O-296 Afford, Simon C. MO-032 Afifi, Walid A. RO-014A Agarwal, Mamta O-240, P-083, RO-331 Agazzi, Roberto P-028 Aghdai, Mahdokht LB-P-095, P-130 Agnes, Leong LB-P-120 Agnes, S. O-123 Agnes, Salvatore O-010, RO-137 Agnir, Wenceslao P-057 Agost Carreo, C. P-270 Agteren, Madelon O-077 Agera, M. Luisa RO-191 Agera, Mara Luisa P-213 Aguilera, V. P-327 Ahlawat, R. LB-P-026, RO-356 Ahmedov, Eldar P-027 Ahn, Curie LB-P-009 Ahn, Won Suk P-138 Aigner, Clemens P-196, RO-239, RO-240

Aigner, Felix P-326, RO-035 Aikawa, Atsushi RO-001, RO-024 Aikawa, Masayasu P-323 Aitken, Emma L. LB-P-064 Akamatsu, Yorihiro P-340 Akdogan, Fatih P-247 Akhtar, Mohammed Z. P-358, RO-336 Aki, Fazil Tuncay P-172 Akin, Baris P-214, RO-196 Akkas, Meltem RO-066 Akl, Ahmed RO-267 Akyol, Murat O-121 Al Hawajri, Nasser LB-P-022 Alain, Sophie MO-047 Al-Akraa, Mahamood O-006 Al-Aloul, Mo O-274, RO-102 Alam, Ahsan RO-020 Alamartine, Eric O-071 Alamo, Jose M. P-074 lamo, Jos Mara P-320, P-321 lamo Mrtinez, Jos M. P-344 Alarcn, A. MO-025, RO-324 Al-Attar, Besher A. P-154, P-215, P-324, RO-297 Alawi, Khalil O-045 Albahili, Hamad O-045 Albano, Laetitia O-140, O-141, RO-126, RO-266 Alberola, Marta MO-012, O-165, O-166 Alberti, Alberto RO-031 Alberto, Rodrguez-Benot LB-P-073 Alberu, Josephina O-240 Alcaraz, Antonio O-165, O-166, P-279, RO-090 Aldiwani, Mohammed O-007 Aldridge, Robert W. RO-166 Alemida, Rui RO-333 Alessandri, Cristiano RO-357 Alexander, Kiss RO-125 Alexe, Gabriella MO-041 Alfany-Fernndez, Izabel MO-071 Algranati, Salomon L. O-287 Alhamoudi, Waleed O-045 Ali, Jason M. O-326, RO-144 Aliabadi, Arezu Z. P-157, RO-154, RO-161 Aliakbarian, Mohammad LB-P-098, LB-P-099 Aliyu, Sani P-198 Aljama, Pedro P-213, RO-191 Al-Khudairi, Naji RO-227 Allain, Geraldine MO-043, O-176, O-177 Allam, Naglaa A. O-045 Allano, F. RO-119 Allard, Stphanie O-054 Allegretti, Marcello O-053 Allegrini, Francesca P-179 Allen, Joanne O-131 Alloway, Rita R. LB-P-029 Allwin, R. P-245 Almanna, Hadir O-045 Almeida, Jazon R.S. RO-055 Almeida, Manuela RO-333 Almohalla, Carolina P-099, P-331, P-351, P-355 Alonso, Manuel O-195 Al-Otaibi, Torki P-085, P-244 Al-Sayyari, Abdulla A. P-215, RO-297 Alsebayel, Mohamed O-045

271

272

Alsofayan, Mohamed O-045 Altenhenne, Christian P-004 Aluffi, Alesandro RO-229 Aluffi, Alessandro RO-059 Alvarez, Cristiam M. RO-103, RO-108 Alvaro, Nicola LB-P-015 Alves, Helena P-050, P-115, P-129, RO-306 Alves, Rui P-227 Alyanakian, Marie-Alexandra O-026 Amaduzzi, Annalisa RO-077 Amano, Atsushi O-211, RO-339, RO-346 Amarelli, Cristiano P-155 Ambagtsheer, Frederike O-070, P-070 Ameloot, Koen P-031 Amer, Hatem CC-003, CC-017, RO-262, RO-294 Amerika, Diana P-177 Amezquita, J. RO-187 Amici, Ombretta RO-044 Ammosov, Aleksander A. O-319A Amorese, Gabriella MO-061 Amrein, Karin LB-P-097 Amrolia, Persis J. CC-004 Anaya, Fernando O-213, RO-259 Ancona, Ermanno O-330 Anders, Agnes P-004 Andersen, Rune RO-264 Anderson, Peter J. RO-018 Andersson, Helena LB-O-004 Andrassy, Joachim MO-037, P-084 Andre, Annick LB-P-007 Andreas, Bock RO-125 Andreas, Eisenreich O-049 Andreassen, A. O-235 Andreone, Piero MO-058 Andreotti, Cristina RO-186 Andres, Amado O-213, P-216, RO-199, RO-259 Andres, Axel O-108 Andresen, Hilke RO-039 Andrews, Peter O-216 Anegon, Ignacio O-111, O-252 Angeli, Paolo O-128, RO-308 Angelico, Roberta RO-354 Angelini, Maria L. O-218 Angerami, Rocrigo N. P-208 Angin, Mathieu O-252 Anglicheau, Dany P-133, RO-104, RO-118 Anh, Hoang D. P-089 Ansari, Javeed I. O-331 Ansari, Tahera RO-290 Anta, Alfonso P-351, P-352 Anthoni, Christoph P-026 Antoine, Corinne P-023, P-212 Antonelli, B. O-123 Antonello, Rossetti LB-P-061 Antonini, Teresa Maria RO-261E Ao, Ziliang RO-176 Aoyagi, Yoshito RO-295 Apaza, Jackie P-216 Aragiusto, Giuseppe RO-218 Arakawa, Yusuke P-325 Arango, Octavio P-191 Araujo, Fernando R. RO-055 Araujo, Maria B. P-375, RO-223 Archampong, D. O-163, RO-268 Archampong, David P-246 Archer, Louise D. RO-282 Arendse, Hiram RO-050, RO-141 Argibay, Pablo F. O-287 Ariana, Gaspert O-112 Arias, Manuel O-213, O-300, P-098, P-100, RO-259 Arichi, Naoko P-024 Ariyakhagorn, Veeravorn RO-244 Arizon, J.M. O-237

Arkadopoulos, Nikolaos P-058 Arnol, Miha MO-002, RO-124, RO-203, RO-204 Arns, W. LB-P-068, O-289, P-087 Arns, Wolfgang LB-P-024, O-199, RO-185 Aron Badin, Romina O-330 Aronsen, Tommy P-010 Arrese, Marcos RO-246 Arreses, Marco RO-217 Arriola, M. P-270 Arzouk, Nadia RO-069C Asadi, Farshad P-161 Asanoma, Michihito O-120, P-042, P-325, P-338, P-339, P-349, RO-215 sberg, Anders O-144 Asci, Gulay P-021, P-242 Asderakis, A. O-163, RO-268 Asderakis, Argiris MO-063, P-246, RO-101, RO-120 Aselmann, Heiko RO-147 Aseni, Paolo RO-031 Asensio, Enrique P-352 Ashamallah, Sylvia A. O-229 Asher, John P-367 Askar, Medhat O-272, O-308, P-116, RO-332 Assenmacher, Mario LB-P-054 Assounga, Alain G. P-075 Asthana, Sonal O-108 Astudillo, Emiliano O-182 Asztalos, Laszlo P-269, RO-130 Atabani, Sowsan F. RO-166 Ataide, Elaine C. P-208, RO-055, RO-181 Atinault, Alain RO-232 Atkinson, Catherine J. P-019 Atkinson, Claire RO-166 Atz, Judith P-114 Aubert, John David P-065, RO-233 Audard, Vincent RO-266 Auger, Eric LB-P-022 Augustin, Victoria RO-239, RO-240 Augustin, Viktoria P-196 Augustine, Titus MO-060, MO-066, MO-068, O-003, O-090, O-092, O-095, P-239, P-310, P-368, RO-067, RO-334, RO-337 Ausania, Fabio O-167 Autran, Brigitte O-153 Auvinen, Eeva P-200 Avellini, Claudio RO-047, RO-247 Avery, Robin O-272 Avikanen, Bridget F. RO-294 Avolio, A. W. O-123 Avolio, Alfonso W. O-010, RO-137 Avsec, Danica O-069, RO-091, RO-096 Ayatollahi, Maryam LB-P-095 Aydin, Sengul P-247 Aydin, Zeynep O-021 Azarpira, Negar LB-P-095, P-130 Azmandian, Jalal LB-P-078 Azmy, Caroline P-171 Azoulay, Daniel RO-261E Baan, Carla MO-003 Baan, Carla C. MO-035, O-119, O-205, O-227, O-251, O-256, O-325, P-146, RO-023, RO-275 Baas, Marije C. RO-329 Baba, Hideo A. P-353, RO-214 Baba, Shiro P-056, P-109 Babenko, Nadezda N. O-319, P-120 Babiker, Abdulqayoum P-154 Baccarani, U. O-123 Baccarani, Umberto O-041, O-191, P-032, RO-047, RO-092, RO-247, RO-254, RO-276 Bach, F.H. MO-031

Bachelet, Thomas

MO-047, O-082, O-151, RO-093 Bacher, Andreas LB-P-092, LB-P-106 Bachetoni, Alessandra RO-357 Bachleda, Petr LB-P-087 Bckman, Lars RO-257 Badaoui, Lynda P-017, P-018 Badescu, Bogdan P-218 Badet, Lionel MO-079, O-159, O-171, O-266, O-268, O-271, RO-064, RO-195 Badia, Mariona O-278 Badura, Joanna P-343 Baek, Chung Hee LB-P-079 Baerts, Lesley RO-285 Bagnenko, Sergey O-164 Bagshaw, Sara L. RO-298 Bagul, Atul LB-O-005, O-019, P-002, P-006, P-123, P-143, P-217, P-237, P-272, RO-014, RO-027, RO-110 Bahador, Ali LB-P-098, LB-P-099 Bahloli, Aboulfazel P-318 Bahra, Marcus O-106, O-225 Bahraini, Amin LB-P-098, LB-P-099 Baiocchi, Leonardo RO-354 Bajema, Ingeborg M. RO-174 Bakr, Mohmed Adel MO-013 Balaguer, C. P-270 Balan, K. RO-054 Balaz, Peter O-022, O-079, RO-314 Balci, Pinar P-242 Baldan, Nicola O-002, RO-328 Balderson, Glenda O-192 Baldwin III, William O-272 Baleriola, Cristina RO-162 Balk, Aggie H.M.M. MO-035 Ball, Simon O-059, P-145, P-278 Ballarin, Robero MO-057 Ballarin, Roberto P-034, RO-043, RO-135, RO-150, RO-255, RO-326 Ballest, Chlo O-069, O-075, RO-099 Ballesteros, Maria Angeles O-300 Balode, Arta LB-P-055 Balzano, Emanuele RO-049 Balzano, Giampaolo O-174 Baares, Rafel MO-018 Banas, Bernhard O-140, O-141, O-196, RO-126 Banas, Miriam O-196 Bandi, Juan C. MO-055 Bando, Toru O-276, O-277, RO-248 Bandzuchova, Helena LB-P-039 Banga, Neal P-350 Banihashemi, Mehrzad P-130 Ban-Maneus, Elisenda J. P-113 Baos, Isolina RO-341 Bansal, S. B. LB-P-026, RO-356 Banz, Vanessa M. O-188, O-189, O-317 Bara, C. O-235 Baraldi, Olga RO-318 Baran, Mikail O-196 Baranski, Andre A.G. LB-P-082 Baranski, Andrzej G. RO-301 Barbier, Stephane O-071 Barbosa, Francesc O-152 Barcan, Laura MO-055 Brcena, Rafael MO-018 Barday, Zunaid P-252 Bari, Narin O-306 Barnett, A. Nicholas R. O-124, RO-084 Barnett, Nicholas O-134 Barocci, Sergio P-292, P-371 Barozzi, Patrizia P-077 Barrera, Lydia P-074, P-320, P-321 Barrera-Rebollo, Asterio P-351, P-352 Barret, Juan P. O-328 Barrientos, Alberto P-100

Barrios, Clara O-303, P-191 Barros, Xoana CC-012 Barrou, Benoit MO-043, MO-076, MO-079, O-071, O-153, O-177, RO-069C, RO-073 Barrufet, Marta O-182 Bart, Stphane RO-069C Barten, Markus J. O-231, RO-159, RO-302 Bartfay, Sven-Erik P-153 Brthel, Erik RO-133 Barton, Franca B. O-172 Barzon, Luisa O-150, P-206 Bas, Koray RO-196 Basarab-Horwath, Caroline P-298, P-299 Basic-Jukic, Nikolina LB-P-014 Basile, Francesco O-074 Basire, Agns P-117 Basta, Giuseppina MO-039A Baston, Catalin P-218 Bathgate, A. RO-253 Battula, Narendra CC-008, CC-009 Bauer, Luisa P-139 Bauschke, Astrid RO-133 Bauser, Chris LB-P-124 Bayer, Florian P-051 Bayle, Franois O-171 Bayraktar, Nilufer LB-P-096 Beard, Clare A. P-219 Beaudreuil, Severine RO-327 Beaune, Philippe RO-104, RO-118 Bebb, Charlotte LB-P-084, LB-P-088, RO-312 Becheanu, Gabriel P-335 Bechstein, Wolf O. MO-067, RO-136 Bechstein, Wolf Otto P-030 Bechstein, Wolff Otto MO-015 Beckebaum, Susanne O-042, O-107, O-305, RO-105 Becker, Thomas MO-036, O-241, O-305, RO-147, RO-331, RO-353 Becler, Robert RO-300 Bedanova, Helena RO-160 Bednarkiewicz, Marek P-348 Behrendt, Carolin P-101 Beimler, Jorg P-277 Bejjani, Gilbert P-089 Beldi, Guido RO-107 Belghiti, Jacques O-188, O-189 Belingheri, Mirco MO-045, RO-225 Bell, Sarah L. RO-027 Belli, Luca RO-031 Beltran, Pablo MO-050, O-290, RO-030 Belwe, V. P-245 Bemelman, Frederike J. O-302, RO-329 Ben Abdennebi, Hassen MO-071, MO-072, O-020, RO-076 Ben Mosbah, Ismail LB-P-122, LB-P-123 Benal, Carmen P-320 Benavente, David O-059 Benck, Urs O-037, O-233 Benetti, Elisa RO-224, RO-226, RO-228 Bengoa, Ignacio P-216, RO-199 Bengtson, Keith A. RO-294 Bengtsson, Mats O-017 Benhamou, Pierre Yves O-171 Bentez, Carlos RO-217, RO-246 Bennet, William O-017 Benoit, Anne RO-272 Bensadoun, Henri P-231 Bentall, Andrew P-278 Berardi, Sonia RO-351 Berardinelli, Luisa LB-P-061 Berben, Lut MO-086, P-053, RO-095, RO-260 Berberich-Siebelt, Friederike O-051 Berenguer, M. P-327 Berg, Ulla O-017

273

274

Berger, Paul O-093 Bergler, Tobias O-196 Berini, Alessandra LB-P-048, LB-P-049 Berlakovich, Gabriela LB-P-092, LB-P-106 Berloco, Pasquale B. O-010, P-022, P-304, RO-045, RO-065, RO-137, RO-357 Bernal, Carmen P-321 Bernal Bellido, Carmen P-344 Bernardino, Marcelo P-096 Bernardo Rodriguez, Maria Jose P-088 Bernardos, Carlos MO-050, O-290, RO-030 Berney, Thierry O-008, O-052, O-108, O-170, O-171, O-172, O-173, P-347, P-348, RO-172, RO-173, RO-177 Bernhard, Banas P-084 Bernhard, David O-114 Bernhardt, Gnter RO-112 Bernois, Katell P-051 Berthiller, Julien O-159, RO-195 Bertocchi, Massimo P-236, P-292, P-371, P-372 Bertoni, Elisabetta MO-026, O-139 Bertuzzo, Valentina O-009 Bertuzzo, Valentina R. MO-058 Besharati, Sepiedeh P-161, P-276 Bestard, Oriol O-284, RO-100, RO-109, RO-284 Betjes, Michiel G.H. O-083, O-226 Bettinelli, Luca RO-052 Beycan, Ismet P-247 Beydullayev, Kamran P-027 Bzie, Sverine O-252 Bhat, Harshith O-118 Bhat, Harshith P. RO-102 Bhattacharjya, Shantanu P-175, P-286 Bhogal, Ricky H. MO-032 Biancone, Luigi O-139 Biassoni, Lorenzo RO-018 Bibby, Bo M. RO-207 Bicans, Janis P-235 Biebl, Matthias O-193, P-326, RO-245 Biedunkiewicz, Bogdan RO-016 Biehl, Martin LB-P-054 Bienaim, Frank O-026 Bierwolf, Jeanette O-223 Bietigier, William O-116 Bigaud, Marc MO-074 Bigenzahn, Sinda MO-036 Biglarnia, Ali-Reza O-017, O-018 Bilalova, Rena P-027 Bilbao, Itxarone MO-024, O-102, P-033, P-074, RO-042 Bilcikova, Erika LB-P-039 Bilgarami, Aley P-173 Billault, Claire RO-073 Billecke, Nils LB-P-010 Billiau, An O-027 Binczak-Kuleta, Agnieszka MO-044, O-065 Binet, Isabelle O-137 Binser, Tobias O-087 Birch, Rhiannon O-078 Birn, Henrik RO-207 Bisignano, Liliana MO-055 Bisoffi, Giulia P-179 Bisset, Linda RO-312 Bistrup, Claus LB-O-004 Bitetto, Davide RO-254 Bitker, Marc Olivier RO-069C Bittner, Hartmuth B. O-231, P-139, RO-159, RO-302 Bjaoui, Mohamed MO-072 Bjrneklett, Rune RO-211 Blaha, Josef RO-296C Blahunka, Paul O-248 Blancho, G. RO-119 Blasco, Miquel CC-012

Blattl, Daniela P-383 Bleakley, Gregory P. RO-061 Blickstein, Dorit CC-013 Block, Alan O-241 Blogowski, Wojciech O-031 Blomberg, Jonas LB-P-124 Blumberg, E. RO-165 Boas-Knoop, Sabine O-106, O-225 Bobb, Catalin-Vasile RO-085 Bober, Joanna LB-P-028 Boccagni, Patrizia O-128, RO-140 Bocian, Katarzyna P-131, P-132 Bockisch, Andreas P-353 Bodi, Maria LB-P-046, O-278 Boehlen, Franoise RO-352 Boer, Karin O-251 Boesch, Chris O-087 Boga, Maxwell RO-055 Boggi, Ugo MO-014, MO-061, MO-064 Boguslawska, Julia P-150 Bohatyrewicz, Romuald RO-300 Bhmig, Georg A. RO-161 Bohorquez, Humberto P-329 Boila, Lacrima LB-P-017, MO-089 Boildieu, Nadege O-033 Boillot, Olivier O-020, RO-076 Boin, Ilka F.S.F. P-208, RO-055, RO-167, RO-181 Boissonnat, P. O-238 Boldrin, Massimo O-330 Bollerslev, Jens O-144 Bolton, E. O-326 Bolton, E.M. O-109 Bolton, Eleanor O-048 Bolton, Eleanor M. O-110 Bolwell, Brian P-116 Bon, Delphine O-033 Bonanno, Maria C. LB-P-045 Boncompagni, Eleonora O-020 Bonfante, Luciana O-002, P-206 Bonomo, L. RO-144 Bonsignore, Pasquale RO-308 Bonucchi, Decenzio RO-311 Bonvoisin, Catherine A. RO-256 Boonstra, C. O-259 Boor, Patrick P.C. O-209 Boratynska, Maria MO-048, P-273 Borchhardt, Kyra P-303 Borlini, Elisa RO-092 Borot, Sophie O-170, O-171, O-173, RO-172, RO-173 Borretta, Valentina P-049 Borro, Jos M. M. RO-235 Borrows, Richard O-059, P-145 Bortnar, pela P-220 Bortolami, Andrea P-160 Bos, Eelke M. O-175, RO-078 Boschiero, Luigi RO-186 Bosco, Domenico O-052, O-171, O-173, RO-172, RO-173, RO-177 Bosmans, Jean-Louis O-157 Bsmller, Claudia O-193, P-326 Botte, Francoise O-330 Bottigioli, David O-153 Bouamar, Rachida O-286 Boucek, Petr RO-337A Bouchet, Caroline P-117 Bouda, Mirko O-145 Boudjema, Karim LB-P-122 Boulvard, Armelle LB-P-007 Boutelle, Martyn LB-P-120, RO-249 Bouvier, Nicolas RO-104, RO-118, RO-266 Bouvy, Anne P. O-325 Bouwes-Bavinck, J.N. LB-O-006 Bouyabrine, Hassan O-043 Bowers, Debora RO-277

MO-065 LB-P-070 P-001 MO-049, O-022, O-215, O-285 Braconnier, Philippe O-322 Bradatsch, Andrea P-185, P-383, RO-261I Bradley, Andrew O-048, O-160, RO-008, RO-315 Bradley, Andrew J. O-110 Bradley, J. Andrew O-313 Bradley, J.A. MO-016, O-050, O-067, O-078, O-109, O-117, O-126, O-127, O-131, O-326, P-119 Bradley, Kori N. RO-116 Bradley, Suzanne RO-206 Brailey, Paul LB-P-029 Brais, R. RO-144 Brakemeier, Susanne P-221 Bramhall, S.R. LB-P-006 Bramhall, Simon CC-008, RO-261H Bramhall, Simon R. CC-009, RO-034 Brandacher, Gerald LB-O-002, MO-036, O-023, O-114, O-265, O-267, O-269, O-270, RO-245, RO-261F, RO-296A, RO-296B Branhez, Juan R. MO-054, RO-250, RO-251 Branzi, Angelo RO-155 Brasile, Lauren O-161, RO-081, RO-081 Brassil, John P-162, P-163, P-288, P-382, RO-152 Bratti, Griselda I. O-287 Brault, Coralie O-171 Braun, Felix MO-020 Bravi, Michela P-028, P-370, RO-229 Bravo, J.A. P-090 Bray, Ben LB-P-071, LB-P-072 Bray, Robert O-244 Breant, Vincent CC-021 Breda, Alberto MO-011, O-094 Breidenbach, Thomas O-327, LB-P-119 Breidenbach, Warren O-328 Bren, Andrej RO-022, RO-203 Bren, Andrej F. MO-002, RO-204 Brenner, Catherine LB-P-123 Bresadola, F. O-123 Bresadola, Vittorio O-041, P-032, RO-047, RO-092, RO-247, RO-254, RO-276 Breza, Jan LB-P-039 Briceo, Javier MO-018 Brickman, Daniel MO-041, O-244 Bridoux, Frank RO-266 Briem-Richter, Andrea P-374 Briggs, D.C. RO-283 Brockmann, Jens P-084, RO-335 Brodak, Milos P-282, P-283 Broeders, Emine P-089 Broeders, Nilufer O-322, P-274 Broering, Dieter C. MO-020 Bromberg, J. O-247 Broniszczak, Dorota P-377 Brookes, Paul O-135 Brown, Chrysothemis MO-007 Brown, Claire LB-P-033 Brown, Peter W.G. P-298 Brown, Stephen A. LB-O-001, RO-349 Bruce, David P-329 Bruegger, Aurelia RO-233 Bruijn, Jan A. RO-174 Brunet, Maria O-268, O-271 Brunet, Merce P-074 Brunner, Stefan M. O-047 Bruns, Christian MO-074 Bruzzone, Paolo O-260 Brzoska, M. P-245

Bowman, Victoria Boyes, Simon Bra, Eneida Brabcova, Irena

Bubak, Grzegorz P-284, P-285 Bubic Filipi, Ljubica LB-P-014 Buchholz, Stefan O-239 Bchler, M. O-201, RO-119 Buchler, Matthias RO-266 Bchler, Peter RO-037, RO-138, RO-261C Budde, K. LB-P-068, O-289, P-087 Budde, Klemens LB-P-024, O-199, O-329, P-221, RO-185, RO-252 Budev, Marie O-272 Budkowska, Marta O-031 Budziszewska, Maja P-131 Bueno, Javier O-102, RO-042 Bueno, Pablo P-328 Buffington, Deborah O-161 Buggenhout, Alexis P-274 Bugrov, Alex V. RO-158 Buiter, Ernst RO-073 Buljevich, Cecilia P-062 Bullock, Nick LB-P-120 Bulter, Andrew J. P-198 Bulut, Nuray O-198 Bunnapradist, S. RO-350 Buob, David RO-338 Buonocore, Marianna P-155 Burch, Michael LB-P-041 Burchell, Elizabeth LB-P-018 Burdese, Manuel O-130 Burgelova, Marcela P-128, P-300 Burger-Klepp, Ursula LB-P-092, LB-P-106 Burgos, Dolores P-263, P-264, P-265, P-266 Burgos, J. P-234 Burguera, V. RO-187 Burkhalter, Hanna O-060 Burnapp, Lisa O-067, O-131 Buron, Fanny O-159, RO-195 Burra, P. O-123 Burra, Patrizia O-011, O-128, RO-048, RO-140, RO-308, RO-309 Burroughs, Andrew LB-P-091 Burt, Claire P-260 Busnach, Ghil RO-113 Busque, Stephan O-329 Buss, Charmaine H. RO-298, RO-303 Busschbach, J.J. MO-084, MO-085 Busschbach, Jan RO-089 Bustamante, Jesus O-213, RO-259 Bustamante Schneide, Francisco Javier P-091 Bustorff, Manuela P-129 Butler, Andrew RO-315 Butler, Andrew J. O-183 Butt, Imran S. O-025 Buturovic-Ponikvar, Jadranka P-309, P-319, RO-204 Buyanovskaya, Olga P-168 Byrne, Catherine LB-P-084, LB-P-088, RO-312, RO-317 Byun, Geonyoung LB-P-104, LB-P-105 Bzoma, Beata P-078 Cabello, Mercedes O-195, O-213, P-263, P-264, P-265, P-266, RO-259 Cabrita, Antonio RO-009, RO-333 Caccamo, L. O-123 Caccamo, Lucio RO-140, RO-151 Cadenillas, Carlos P-216 Cafarova, Shahnaz P-027 Cahen, Remi O-153 Caillard, Sophie CC-015, O-217 Cakirca, Mustafa P-247 Calatayud, D. O-297, RO-056 Calatayud, David MO-022 Caldara, Rossana LB-P-012 Calder, Francis RO-202 Calderon, Carmen MO-027 Calise, F. O-123

275

Calise, Fulvio

276

O-191, P-357, RO-140, RO-151, RO-218, RO-221 Caliskan, Kadir MO-035 aliskan, Yasar P-302 Callaghan, Chris MO-062, O-048, O-050, O-117 Callao, Virginia LB-P-046 Calne, Roy Y. O-229 Calvo, Jorge P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Calvo, Natividad P-100 Camara, Niels O.S. RO-163 Camarena, Carmen P-373 Cambra, Felix P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Camicer, Yanina P-375, RO-223 Campanella, Luca P-094 Campbell, Babatunde MO-060, MO-066, O-003, O-092, P-310 Campbell, Paul LB-P-047 Campbell, Tunde MO-068, O-090, O-095, RO-067, RO-334 Campione, Tiziana LB-P-045 Campistol, J.M. RO-273 Campistol, Jose M. O-213, RO-259 Campistol, Josep M. P-113, P-221, RO-331 Campistol, Josep Maria J.M. O-099 Campos, Isabel MO-024 Canal, Cristina MO-011 Canaud, Guillaume O-026 Candinas, Daniel RO-107 Candusso, Pablo G. P-203, P-268 Cantaluppi, Vincenzo P-267 Cantarelli, Elisa O-053 Cantrelle, Christelle P-051, RO-232 Cao, Higini O-152 Capdevila, L. O-213 Capdevila, Luis RO-259 Capelli, Irene RO-318 Capellozzi, Vera L. MO-054, RO-250 Cappuccilli, Maria L. O-218, RO-013, RO-318 Caprara, Giacomo LB-P-015 Caputo, Daniela P-124 Carabalona, Jean Pierre O-190 Caralt, Mireia MO-024, P-033 Carbone, Javier O-154 Carby, Martin R. P-365 Carcano, Giulio P-311 Cardillo, Massimo O-169, O-320 Cardini, Benno O-023, O-114, RO-245 Carlsen, Brian T. CC-003, RO-294 Carlsson, Per MO-080 Carmagnat, Maryvonnick CC-021 Carmellini, M. O-200, P-076 Carmellini, Mario P-222 Carmody, Ian C. P-329 Caro Paton, Agustin P-099, P-331, P-355 Caron, Lise O-252 Carrai, Paola RO-049, RO-140, RO-151 Carrero, Juan J. RO-278 Carta, Paolo MO-026 Carter, Noel O-035, O-301, P-288, P-382 Carter, Noel M. P-162, P-163, RO-152, RO-153 Carter, Tom RO-289 Carvalho, Deise B.M. RO-331 Casartelli Liviero, Marilena P-179 Casella, Annachiara RO-354 Caserta, Nelson RO-181 Casey, Ellen RO-294 Casey, John J. MO-053 Casey, Matthew P-082 Casillas-Ramirez, Aran P-330

P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Cassim, Rezni P-241, RO-280 Cassiman, David O-129, P-031 Cassis, Linda RO-100 Cassuto, Elisabeth O-071 Castaing, Denis O-317, RO-261E Castaer, J.L. P-234 Castejon, Raquel RO-341 Castellote, Jose P-074 Castells, Lluis MO-022, MO-024 Castells, Luis P-033 Castillo, Domingo P-213 Catalano, Giorgia O-038, RO-213 Catapano, Pasquale P-230 Catar, Rusan O-049 Catena, Fausto RO-077 Cau, Jerome O-228 Cautero, Nicola MO-057, P-034, RO-043, RO-135, RO-150, RO-255, RO-326 Cavadas, Pedro O-269, O-328 Cavalcante, Samuel P-023 Cavallero, Teresa O-320, P-372 Cavicchioli, Laura O-330 Cefarelli, Mariano P-155 Celik, Demet O-198 Celik, Vedat RO-196 Celik, Veday P-214 Centanaro, Monica P-372 Centi, Sonia RO-224 Cerempei, Vasile P-218 Cerezo, Gema RO-100 Ceriello, Antonio RO-218, RO-221 Cesbron, Anne O-054 Cescon, Matteo MO-023, MO-058, O-009, O-202, P-079, P-362, P-363, RO-307, RO-351 Cha, Hee J. O-178 Chaccur, Paulo P-156 Chae, Won-Young LB-P-023, LB-P-089, RO-261A Chafai, Rabia P-017, P-018 Chaiprasert, Angkana P-015 Chamienia, Andrzej P-078, P-223, P-224 Chan, Gary O-329 Chan, Lolita O-090, O-095, RO-067 Chan, M. P-127 Chan, Y.H. P-127 Chandak, P LB-P-088/A Chandramohan, S. LB-P-064 Chang, Stephen Kin Yong RO-243 Chang, Yao-min RO-249 Chapelle, Thiery MO-019, RO-057 Chapman, Jeremy R. MO-028 Charco, Ramon MO-022, MO-024, O-102, P-033, RO-042 Charnley, Richard M. P-359 Charpantier, Bernard RO-327 Charpentier, B. O-246 Charpentier, Bernard O-240, O-242 Charreau, Batrice O-054 Charreau, Isabelle O-153 Chatauret, Nicolas O-228 Chatelais, Mathias O-054 Chatenoud, Lucienne RO-109 Chatzizacharias, Nikolaos A. O-185 Chaudhry, Afzal N. O-313 Chaudhry, Aisha RO-101 Chauveau, Philippe O-082 Chauvet, Cecile O-159, RO-195 Chavez, R. O-163, RO-268 Chavez, Rafael P-246, RO-120 Chayakulkeeree, Methee P-015 Chaykovska, Lyubov O-180 Chen, Fengshi O-276, O-277

Caso, Oscar

Chen, Jeanne O-304, RO-184 Chen, Jian-ping RO-122 Chen, Jin O-112, RO-112 Chen, Jinsong P-312, P-313, RO-127 Chen, Jin-Song RO-190 Chen, Lieping RO-176 Chen, Yuanyuan P-037 Cheng, Dongrui P-312, P-313, RO-127 Cheng, Iek P-238 Chew, Siew Eng P-240 Chiang, H. Abraham P-144 Chiang, Yang-Jen P-008 Chinen, Rogerio P-289, RO-163 Chiocchini, Anna Laura RO-318 Chiominto, Bartolomeo P-159 Chiu, Man Chun LB-P-115 Chiurchiu, C. P-270 Chlo, Ballest RO-087 Chmura, Andrzej P-232 Cho, Hong R. O-178, P-140, P-204 Cho, Jang Hee RO-330 Cho, Jang-Hee P-225 Cho, Won Hyun LB-P-063 Choi, Bongkum P-137 Choi, Dong Lak LB-P-101 Choi, Gi Hong LB-P-094 Choi, Gyu-seong LB-P-003 Choi, Ji-Young P-225, RO-330 Choi, Peter RO-063 Choi, Soo Jin Na LB-P-031, LB-P-032, LB-P-035, LB-P-036, LB-P-037, LB-P-038 Choi, Young Il LB-P-066 Chokwe, Thomas P-279 Choukroun, Gabriel RO-266 Chowdhury, Paramit RO-084 Chrastina, Martin LB-P-039 Christians, Uwe RO-286 Christophides, Thalis P-367 Chu, Jacqueline O-272 Chu, Sheng-Hsien P-008 Chudek, Jerzy RO-002, RO-068, RO-188, RO-305 Chueh, Shih-Chieh RO-332 Chui, Chee Kong RO-243 Chung, Hyun C. O-178, P-140, P-204 Chung, Sang Young LB-P-031, LB-P-032, LB-P-035, LB-P-036, LB-P-037, LB-P-038 Chung, Young Soo LB-P-057, LB-P-081, LB-P-110, LB-P-111 Cibelli, Alessandra RO-140 Cibrik, D. O-200, O-203, O-247 Cibrik, Diane O-329 Cicarelli, Olga O-298 Ciccarelli, Olga LB-P-117, O-046, O-100 Ciceri, Fabio LB-P-012 Cicinnati, Vito O-042, O-107, RO-105 Cicora, F. P-270 Ciechanowicz, Andrzej MO-044, O-065 Ciechanowski, K. RO-350 Ciechanowski, Kazimierz LB-P-028, MO-044, O-065 Ciechanowski, Kqazimierz MO-042 Cierniak, Tomasz P-343 Cierpka, Lech P-343 Cifersk, Hana LB-P-087 Cikrikcioglu, Mehmet Ali P-247 Cillo, Johny E. P-154, P-215 Cillo, U. O-123 Cillo, Umberto O-011, O-128, O-191, RO-140, RO-308, RO-309 Cinti, Paola P-022 Cintorino, Davide O-074 Cipe, Gokhan RO-198 Cippa, Pietro E. O-112, O-207, RO-112 Cipullo, Reginaldo P-156 Ciria, Ruben LB-P-114, LB-P-116

Ciszek, Michal O-221 Citores, Maria J. RO-341 Citro, Antonio O-053 Citterio, Franco O-139, P-080, RO-113 Claas, Frans H.J. O-080 Claassens, L. MO-085 Claes, D. RO-032 Claes, Kathleen LB-P-062 Clancy, Marc LB-P-056, LB-P-064, P-082 Clancy, Marc J. MO-004, MO-010, MO-021, MO-033, P-197, P-260, RO-029, RO-210, RO-270, RO-281 Clark, Anne O-229 Clark, Catherine J. O-064 Clarke, Alexis P-052 Clarke, Andrew RO-171 Clarkson, Anthony P-174 Clarkson, Michael O-331 Claus, Filip LB-P-062 Clavien, Pierre-Alain O-122 Clayton, Carole P-298, P-299 Clemente, Gerardo MO-018 Cobbold, Mark LB-O-211A, RO-287 Cobelo, Carmen P-264 Cobera, Rafael P-221 Coccolo, Fabio RO-155 Cockwell, Paul O-059, P-145 Codarin, Erika RO-247 Codas, Ricardo MO-079, O-159, RO-195 Codazzi, Daniela P-370, RO-229, RO-236 Codeluppi, Mauro RO-135 Codoiu, Claudiu P-218 Cofano, Simona O-150 Cohen, Ari P-329 Cohen, Bernard O-279, O-280 Cohen, Smadar O-223 Cohney, Solomon O-329 Coilly, Audrey RO-261E Colak, Hulya LB-P-027 Colak, Tufan LB-P-027 Cole, Ben R. RO-298 Cole, Jennifer O-110 Cole, Owen J. RO-317 Coletta, Martina RO-040 Coletti, Laura RO-049 Colin, Cyrille O-171 Collado, Silvia O-152 Colledan, M. O-123 Colledan, Michele LB-P-091, P-028, P-370, RO-059, RO-229, RO-236 Colledan, Michelle O-317 Collini, Andrea P-222 Collini, Raffaella RO-044 Comai, Giorgia O-218, RO-318 Comino, Ana P-328 Comoli, Patrizia O-320 Compagnon, Philippe LB-P-122 Comuzzi, Chiara O-041, RO-047, RO-092, RO-254 Conde, Rosa P-331 Conlon, T. O-326 Conlon, T.M. O-109 Conlon, Thomas O-048 Conlon, Thomas M. O-110 Consani, Giovanni MO-061 Constantinescu, Serban RO-325 Conte, Diletta RO-013 Contreras, Carlos P-156 Contreras, Enric LB-P-046 Cook, Terry MO-077 Cooper, Ellen LB-P-019 Coosemans, Willy O-273, O-296 Copelan, Edward P-116 Cording, Elisabeth P-171 Coriu, Daniel P-135

277

Corno, Vittorio

278

P-028, P-370, RO-059, RO-229, RO-236 Cornu-Artis, C. O-142, O-147, O-237, P-076 Corpataux, Jean-Marc P-226 Corradini, Stefano G. RO-065 Corris, Paul A. RO-241 Corsano, Barbara P-064 Corsini, Serena RO-013 Corti, Andrea RO-044, RO-052, RO-212 Cosio, Fernando G. CC-017, RO-262 Cosmai, Andrea P-062 Costa, Sandra C.B. RO-167 Cotovio, Patricia P-227 Coulange, Christian LB-P-080 Counter, Claire MO-016, P-174 Couvrat, Gregoire RO-266 Couzi, Lionel MO-047, O-071, O-082, O-151, RO-093, RO-266, RO-271 Coyne, Emma LB-P-084, LB-P-088 Cozzi, Emanuele O-139, O-330, RO-296C Crane, Jeremy S. RO-299 Cras, Patrick MO-019 Crawford, Michael RO-261D Crespo, J. RO-273 Crespo, Marta O-152, O-303, P-191, RO-128 Cretin, Nathalie P-279 Creusvaux, Herv LB-P-007, LB-P-022, LB-P-053 Cristelli, Marina P. RO-183 Cristina, Marenghi LB-P-061 Critchley, William R. O-118, RO-282, RO-291 Crolu, Anne LB-P-122 Crommelin, Heleen A. O-197 Crossan, Claire RO-296C Crouzet, Sebastien RO-064 Crowe, Lindsey RO-173 Crul, Cynthia RO-174 Cruz, Manuel MO-018 Cruzado, J.M. P-105, RO-021, RO-324 Cruzado, Josep M. O-284, RO-100 Cruzado, Joseph M. RO-284 Cucchetti, A. O-123 Cucchetti, Alessandro MO-058, O-009, P-079, RO-307, RO-351 Cuervas, Valentn MO-018 Cuervas-Mons, Valentin RO-341 Cuna, Vania O-218 Cuetti, Leticia RO-284 Cunha, Melissa O-003, O-092, P-310 Cunningham, Aimee C. MO-087 Cunningham, Anne O-035, O-301, P-288, P-382 Cuomo, O. O-123 Cuomo, Oreste CC-006, O-191, P-093, P-094 Curcic, Pero P-383 Cury, Sylvie O-054 Cusinato, Riccardo O-150 Cusumano, Caterina O-294, RO-036, RO-053, RO-134 Czarnowski, Wojciech RO-278 Czerwinski, Jaroslaw RO-300, RO-300 Czira, Maria E. O-058, RO-020, RO-192, RO-279 Da Silva, A.M.C.A. MO-084 da Silva, Vinicius P. RO-322 DAddio, Francesca O-331 Daffonchio, Luisa O-053 Dafforn, Timothy R. O-313 DAgostino, Chiara O-150 Daguin, Veronique O-330 Dahlke, Marc H. O-224, O-258 Dahmen, Uta LB-P-030, LB-P-040, RO-261G Dainys, Balys P-095 DAlessandro, Mariadomenica RO-357 Dalgic, Aydin P-104, P-315

RO-254 O-128, RO-308, RO-309 DAmico, Giuseppe MO-057, P-034, RO-043, RO-135, RO-150 Damji, Samir LB-P-120, MO-077, RO-249 Dammen, Jeffery P-142 DAncona, Frank O-091 dAncona, Frank C.H. LB-P-060, LB-P-065, O-088 Dandri, Maura O-223 Dang, Zexu O-253 DAngeles, Adriana P-096 Daniel, Volker MO-034, O-324, P-141 Dantal, Jacques O-220 Danziger-Isakov, Lara O-272 Daoud, Sameh O-153 Darai, Masumeh P-130 Darby, Chris RO-025, RO-209 Darby, Christopher RO-336 Dargie, Henry J. RO-028 Darius, Tom LB-P-117, O-100, O-157, O-296 Dark, John H. P-162, P-163, RO-152, RO-153 Darzi, Ara LB-P-120, RO-249 Das, Partha P. RO-084 Date, Hiroshi O-276, O-277, RO-248 Daubeuf, Bruno O-052 Daures, Jean Pierre RO-267 Davalos Michel, J. P-270 DAvella, Domenico O-330 David-Neto, Elias P-080 Davidson, Brian O-024, P-350 Davila, Diego LB-P-114, LB-P-116 Dayangac, Murat P-214, RO-196 Dazzi, Alessandro MO-058, O-009, P-079, RO-307 De Anna, Dino O-041, P-032, RO-047, RO-092, RO-247, RO-254 De Backer, Daniel P-089 De Bleser, Leentje RO-260 de Boer, Rudolf A. RO-078 de Bruin, R.W.F. RO-345 de Bruin, Ron W.F. RO-074 De Carlis, L. O-123 De Carlis, Luciano O-191, O-294, RO-036, RO-053, RO-134, RO-151 De Carlis, Luciano G. RO-031 de Carvalho, Iara C. RO-208 De Cillia, Carlo LB-P-015, LB-P-045, O-069 De Donno, Monica MO-064 De Feo, T. O-123 De Feo, Tullia RO-309 de Fijter, J.W. LB-O-006, P-105 de Fijter, Johan W. O-021, O-302 de Fijter, Johan Willem RO-329 De Gasperi, Andrea RO-031, RO-044, RO-052 de Gasperi, Andrea RO-212 De Geest, Sabina MO-086, O-060, P-053, RO-095, RO-125, RO-260 de Gottardi, Andrea RO-107 De Graaf, Kathy O-052 De Graauw, Jeanne A. RO-301 De Greef, Kathleen MO-019, RO-057 de Grim, Laurens RO-169 de Groot, Ingrid I.B. LB-P-082 de Groot, Philip G. RO-111 de Heer, Emile RO-174 de Jonge, Hylke LB-P-062, RO-348 de Jonge, Jeroen MO-070, RO-071, RO-132 de Klein, Annelies MO-003 de Klerk, Marry O-080 de Koning, Ingrid RO-169 de Kort, Hanneke RO-174

DAmbrosi, Laura DAmico, Francesco

De la Cruz, J. P-090 de la Fuente Graciani, Ignacio P-355 de la Mata, Manuel MO-018 De La Pena, Hugo LB-O-211A de la Torre, Mercedes RO-235 de la Vega, Angela P-373 De Laat, Mark P-031 De Leyn, Paul O-273 de Lima, Ana P.C. RO-208 de Maar, Eltjo F. O-302 de Magne, Catherine LB-P-117 de Man, Robert RO-169 De Martin, Eleonora MO-023, P-362, P-363, RO-140, RO-309 De Meester, Ingrid RO-285 De Meyer, Martine RO-263, RO-272 de Miranda, Marcelo P. MO-054, RO-250, RO-251 De Pauw, Luc O-157, RO-263, RO-272 De Pauw, Michel O-125 De Pietri, Lesley RO-255 De Roey, J. RO-032 De Roover, Arnaud O-298 de Ruiter, Petra E. MO-070, RO-071 De Ruvo, Nicola MO-057, P-034, P-077, RO-043, RO-135, RO-150, RO-255, RO-326 De Santibaes, Eduardo MO-055 De Santo, Luca S. P-155 De Simone, Paolo MO-039A, RO-049 De Simone, Paulo P-053 De Stefanis, Paola LB-P-051 de Vaal, Yvonne RO-109 De Vos, R. RO-075 de Vries, Dorottya K. RO-111, RO-242 de Vries, Erwin O-125 de Vries, Eva E. RO-121A de Vries, W. RO-222 de Waure, C. O-123 de Weerd, Annelies E. O-119 De Wever, Liesbeth LB-P-062 De Wit, Elly A. O-083, O-226 Dean, Robert P-116 DeBenedictis, Giulia Maria O-330 Debska-Slizien, Alicja LB-P-075, P-078, P-199, P-223, P-224, P-228, RO-016, RO-193, RO-278 Decaluw, Herbert O-273 Dechanet-Merville, Julie O-151 Dechene, Alexander O-042, O-107, RO-105 Deeba, Samer RO-249 Defez, Maurizio RO-218 Deglise, Sebastien P-226 Deichmann, Steffen O-223 Deisz, Sabine O-307, O-324 del C. Rial, Maria O-241 Del Castillo, Domingo O-213, RO-259 Del Gaudio, Massimo MO-058, O-009, P-079, RO-307, RO-351 Del Pozo, Nadia O-154 Del Turco, Serena MO-039A Delahousse, M. RO-119 Delahousse, Michel P-014 Delgado, Maria RO-235 Della Vella, Manuela RO-224, RO-226 Dellgren, Gran LB-P-109, P-153, P-165, RO-060 Dello Strologo, Luca MO-045 Delmarmol, Vronique O-322 Delmonico, Francis L. LB-P-044 Delpech, Pierre Olivier MO-079 Demirci, Meltem Sezis P-242 Demirel, Naime Gl RO-066 Demmers, Martijn W.H.J. RO-023, RO-275 Demuylder-Mischler, Sandrine O-170 Denaro, Luca O-330

Deng, Jun RO-178 Deng, Meihong RO-261G Deng, Peng P-047 Denhaerynck, Kris P-053, RO-125 Denisov, Viktor K. P-229 Denizot, Magali O-176 DeOliveira, Michelle L. O-299 Deray, Gilbert RO-069C Deroover, Arnaud O-046 DErrico-Grigioni, Antonietta MO-058 Desai, Divyesh Y. RO-227 Desatnik, Peter P-054 Desmet, Lars P-031 Desschans, B. RO-032 Desschans, Bruno O-129, O-296 Desseix, Aurlie O-082, RO-093 Detry, O. RO-075 Detry, Olivier O-046, O-157, O-298 Deulofeu, Rosa P-184 Deulofeu, Roser O-278 Devauchelle, Bernard O-266, O-268, O-328 Devey, Luke R. RO-069A Dewachter, Pascale LB-P-007 Dezza, Maria C. RO-031 Dezza, MariaClara P-028, RO-229 Dhawan, Anil LB-P-114, LB-P-116 Dhein, Stefan O-231, P-139, RO-159 Di Benedetto, Fabrizio MO-057, P-034, P-077, RO-043, RO-135, RO-150, RO-255, RO-326 Di Benedetto, Gabriele MO-068, P-239, P-368, RO-337 Di Carlo, Valerio O-174 Di Ciaccio, Paola RO-098 Di Costanzo, Giovan G. RO-140, RO-151 Di Costanzo, Giovan Giuseppe RO-189 Di Fratta, Emanuele RO-328 Di Gioia, Paolo MO-058, O-009, O-105, O-202, P-364 Di Loreto, Pierluigi P-230 Di Maro, Orlandina RO-189 Di Paolo, Daniele MO-023, P-362, P-363 Di Pietro, Maria Luisa P-064 Di Russo, Gregory MO-041 Di Sandro, Stefano O-294, RO-031, RO-036, RO-053, RO-134 Di Silvestre, Adriana LB-P-048, LB-P-049, LB-P-051 Dias, Leondio O-075, RO-087, RO-333 Dias, Leonidio O-069 Dias, Manuel P-115 Daz, Joan Manuel MO-011 Diaz, Juan Manuel O-094 Diaz del Gobbo, Gabriel O-014, O-181, O-182 Diaz Moreno, Alexia RO-231 Diaz-Fernandez, Carmen P-373 Diaz-Molina, Beatriz P-088 Dickenmann, Michael O-137 Diekmann, F. LB-P-068 Diekmann, Fritz LB-P-024, P-113, P-221, RO-087, RO-090 Dierickx, Daan CC-005, O-156 Dieterich, Marjolein MO-035 Dieterlen, Maja T. O-231, RO-159 Dieterlen, Maja-Theraesa P-139 Dietrich, Hartmut O-198, O-307, O-324 Diez, F. P-234 Dijkstra, Gerard O-104 Dilworth, Pamela O-192, RO-261D Dimai, Hans-Peter LB-P-097 Dimina, Elina LB-P-055 DImporzano, Simone MO-061 Ding, Chenguang P-043 Ding, Xiaoming P-043, P-192, P-210, RO-175 Dinkhuysen, Jarbas Jakson P-156

279

280

Dirix, S. RO-032 Dirsch, Olaf LB-P-030, LB-P-040, RO-261G Dobbels, Fabienne MO-086, O-070, P-053, RO-089, RO-095, RO-256, RO-260 Dobnig, Harald LB-P-042, LB-P-097 Dobrovolskiene, Rasa P-095 Doenecke, Axel P-029 Doerfler, Arnaud P-231 Dogan, Sait Murat P-295, P-380 Dogan, Serkan P-247 Dhler, Bernd O-214, P-126 Dolch, Michael RO-237 Dold, Stefan O-030, O-034, RO-033, RO-072 Dolegowska, Barbara O-031 Dolgos, Szilveszter O-144, RO-264 Dolla, Caterina O-130, P-267 Dller, Dominik MO-008 Dollinger, Ccile O-153 Dols, L.F.C. LB-P-076 Dols, Leonienke F.C. O-088 Domanski, Leszek MO-042, MO-044, O-031, O-065 Domaszewska, Anna RO-180 Domaszewska-Szostek, Anna P-044 Domergue, Jacques O-043, O-190 Domnguez, Pilar RO-217, RO-246 Donadi, Donato RO-113 Donataccio, M. O-123 Donato, Maria Francesca MO-023, P-362, P-363 Donato, Paola RO-328 Donckier, Vincent O-298, P-274 Dong, G. O-148, O-204, O-235, O-238 Dong, Wei LB-P-040 Dong, Xiangyang P-190 Dong, Yuping O-242, O-245 Donor to Recipient Italian Liver Transplant (D2R-ILTx) Study Group O-123 Dooper, Philomena O-091 Dopazo, Cristina MO-022, MO-024, P-033 Dor, F.J.M.F. LB-P-076, RO-345 Dor, Frank MO-003 Dor, Frank J. RO-132 Dor, Frank J.M.F. MO-088, O-088, O-264 Dorent, Richard RO-232 Dorje, Christina P-010, RO-194 Dorling, Anthony MO-077, O-134, P-238, RO-084 Doros, Attila O-293 Dosani, Muhammad T. LB-P-050 Douben, Hannie MO-003 Dowle, Shirley P-233 Doyle, Suzan RO-206 Drage, Martin P-107, RO-202 Dragun, Duska O-056, O-180, O-231 Drain, John LB-P-013 Drayson, Mark T. RO-287 Drewitz, Karl Philipp MO-069, O-015 Du, Thu Thi Ngoc LB-P-086, P-306 Duan, Tao O-241, O-244, RO-331 Duarte, Adriana S.S. RO-181 Dubbeld, Jeroen O-021 Dubernard, Jean Michel O-266, O-271, O-328 Dubernard, Jean-Michel O-268 Dubois, Valrie O-268 Dubuis, Celine P-226 Duca, Lorena MO-045 Ducci, Juri P-053, RO-049 Duclos-Vallee, Jean-Charles RO-261E Dudek, Krzysztof P-354 Duerinckx, Nathalie RO-089 Dugnani, Erica O-053 Dulku, Harvinder RO-063 Duman, Trker RO-261

Dumbrava, Mona Dumontier, Christian Dumpis, Uga Dunkler, Daniela Dunn, Paul Duong, Hien Dupont, Lieven Dupont, Lieven J. Dupont, Marion Durao, Marcelino S. Durlik, Magdalena

P-335 O-328 LB-P-055 RO-154 P-125 P-116 O-156 O-273 O-098 P-289, RO-163 O-221, P-232, P-284, P-285 Durlik, Marek P-316 Durrbach, Antoine O-241, P-080, RO-327 Duska, Dragun O-049 Dutheil, Delphine O-176 Dutkiewicz, Grazyna MO-044, O-065 Dutkowski, Philipp O-122 Dyer, Phil A. O-311 Dyer, Philip MO-046 Dyer, Philip A. P-125 Eberlin, Marion P-106 Eckert, Philippe RO-086 Edefonti, Alberto RO-225 Edtinger, Karoline O-029 Edwards, Brooks S. CC-003, RO-294 Efferz, Patrik O-032 Eggenhofer, Elke O-224, O-258 Eghtesad, Bijan O-308 Eichhorn, Martin RO-237 Eiermann, Thomas P-259 Eifert, Sandra O-230 Einollahi, Behzad RO-131 Einollahi, Bezad RO-313 Eisenberger, Ute O-087, O-137, O-199 Eitner, F. LB-P-068 Eitner, Frank LB-P-024 Eizner, Sigal RO-012 Ekser, Burcin O-002 El Aggan, Hayam A. LB-P-058 El Okely, Amir RO-014A Elfawal, Magdy Abass MO-013 Elgendy, Hamed RO-342 Elhadedy, Hazem P-141 El-Halawani, Sawsan M. O-229 Elhendy, Yasser Abdelmneim MO-013 Elias-Mir, Maria P-330 Elker, Doruk RO-062 Elliott, K. O-326 Ellis, Jonathan LB-O-211A Ellis, Jonathan D. RO-287 Elsheikh, Yasser O-045 Elson, Greg O-052 Emery, Vincent C. RO-166 Emmanouilidis, Nikos P-342 Enache, Alexandra MO-089 Endo, Tadao P-056, P-201 Engberg, Sandra P-053, RO-095 Engels, Gerwin E. O-275 Ensinger, Christian P-326 Entezam, Mona LB-P-095 Epailly, E. O-238 Erasmus, Michiel E. O-275 Erbes, Johannes O-223 Ercan, Sevim MO-075 Ercolani, Giorgio MO-058, O-009, O-202, P-079, RO-140, RO-307, RO-351 Erdman, J. O-247 Erek, Aybala P-247 Ericzon, Bo-Gran O-101 Ernst, Mai-Britt RO-239, RO-240 Ernst, Wolfgang O-324 Errasti, Pedro MO-027, P-011 Ersoz, Sadik RO-142 Erzen, Barbara P-220 Escobar, B. RO-056

Escuin, Fernando O-213, RO-259 Esforzado, N. RO-021 Esforzado, Nuria N. O-099 Eskandary, Farsad RO-161 Eskandary, Farsad A. RO-154 Eskandary, Farsad E. P-157 Espin, Francesc MO-024, P-033 Espinosa, Maria-Dolores P-328 Esposito, Ciro CC-006 Esquirol, Xavier O-278 Etienne, I. O-201, RO-119 Ettorre, G. M. O-123 Ettrich, Maryam O-307, O-324 Eugene, Michel MO-076 Eurich, Dennis O-106, O-225 Evans, Diane P-233 Evans, Linda RO-312, RO-317 Evans, Nia RO-120 Everly, Matthew J. O-169 Eyraud, Daniel CC-021 Faber, Wladimir O-250 Fabregat, Joan MO-022 Fabritius, Cornelia O-055 Facundo, Carme MO-011, O-094 Fagertun, Hans LB-O-004 Faggian, Giuseppe P-159 Fagiuoli, Stefano LB-P-091, MO-023, P-362, P-363, RO-059, RO-151, RO-236 Faguih, Moussa O-045 Fahrendorff, Melanie LB-P-054 Fahrleinter, Astrid LB-P-042 Fahrleitner, Astrid LB-P-097 Fahrleitner-Pammer, Astrid P-166 Fahrner, Ren RO-107 Fakih, Naim P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-219, RO-220 Falck, Camille O-180 Falk, F. O-246 Famili, Farbod O-222 Famulari, Antonio RO-113 Fan, Hua RO-146 Fndrich, Fred RO-323 Fang, Haoshu LB-P-030, LB-P-040 Fante, Fabio O-330 FAPWTR O-101 Faracov, Elnur P-027 Faramawi, Mohamed O-045 Farid, Waqar R.R. MO-070, RO-071 Farkas, Stefan P-029 Farrar, Conrad A. O-028 Fauconnet, Pascal P-347 Faura, Anna O-152, O-303 Faure, Alice LB-P-080 Favoloro, R. O-237 Favreau, Frederic O-228 Fawcett, Jonathan MO-087 Faybik, Peter LB-P-092, LB-P-106 Fazakas, Janos O-293, P-068 Fazzolari, Laura RO-354 Federici, Alen RO-040 Fedor, Roland RO-130 Fehervari, Imre O-293 Fehr, Thomas O-112, O-137, O-207, RO-112 Fehrman-Eckholm, Ingela O-069 Fehrman-Ekholm, Ingela O-075, RO-087 Feliciangeli, Giorgio O-218 Felino, Antnio P-092 Felipe, Cludia R. RO-183 Fellstrm, Bengt RO-211 Feltrin, Giuseppe P-160 Feng, Xinshun P-043, P-192, P-210 Fenton, Matthew LB-P-041 Ferhi, Karim RO-069C Ferkl, Marek O-288 Fernndez, A. MO-025 Fernndez, Alba RO-288

Fernandez, Esther P-355 Fernandez, Flor CC-021 Fernandez, Maria C. RO-231 Fernandez Ramos, Jose Ramn P-091 Fernandez Rodriguez, J. P-194 Fernndez-Rivera, Constantino O-219 Fernandez-Rodriguez, AM P-194, P-234, RO-187 Fernandez-Rodriguez, F. P-194 Fernandez-Yaez, Juan O-154 Fernando, Bimbi CC-001, O-006, P-207, P-294, P-350, RO-310 Fernando, Bimbi S. O-162 Fernando, Rashika RO-018 Fernando, Raymond P-118 Ferraresso, Mariano MO-045, RO-225 Ferrari, Sylvie O-170 Ferrari-Lacraz, Sylvie RO-352 Ferraz, Erika A. P-289, RO-163 Ferreira, Maria P-092 Ferreira, Susana RO-009 Ferrer, Asuncion MO-027, P-011 Ferrer, J. O-297 Ferrer, Jaime CC-016 Ferreres Pinas, Joan Carles LB-P-118 Ferres, Olivia RO-063 Ferro, Charles O-059 Ferron, Jose-Antonio P-328 Fertmann, Jan RO-237 Fertmann, Jan M. LB-P-113 Fettes, Terry RO-262 Fevery, Sabien O-027 Fialova, J. O-163, RO-268 Fialova, Jana P-246 Fichtner-Feigl, Stefan O-047, O-113 Fidan, Kibriya P-104 Field, Melanie O-096, RO-026, RO-088, RO-170, RO-171 Fierens, Johan CC-007 Fieux, Fabienne P-212 Figaji, Tony RO-050, RO-141 Figueroa, Carlos P-376 Fildes, James E. O-118, O-255, O-274, RO-102, RO-282, RO-291, RO-344 Filippetti, Marzia RO-098 Filipponi, Franco MO-039A, RO-049, RO-151 Filliponi, Thiago C. P-289, RO-163 Finger, Marco Aurlio P-156 Finlay, Moira O-160 Fior, Francesca RO-186 Firat, Ozgur P-296 Firmin, Louisa C. P-217 First, R. O-246, O-247 First, Roy O-248 Fischer, Lutz O-318, P-374, RO-353 Fischereder, M. LB-P-068 Fischereder, Michael LB-P-024, P-020, P-084 Fischer-Frhlich, Carl-Ludwig O-187, O-327 Fiscon, Marta O-150, P-206 Fisher, Andrew J. RO-241 Fix, Lynette RO-294 Flamant, Martin P-212 Flechner, Stuart O-308 Flechner, Stuart M. LB-O-001, LB-P-019, RO-349 Flecknell, Paul P-288, P-382 Flemming, Bert O-180 Floerchinger, Bernhard O-115 Flores, E. O-297, RO-056, RO-139 Florman, Sander O-241, RO-331 Focosi, Daniele MO-014, MO-061, MO-064 Folch-Puy, Emma MO-071, O-020 Folkmane, Inese P-235 Folkmanis, Cristoph P-235 Fondevila, C. O-297, RO-056, RO-139

281

282

Fondevila, Constantino RO-087 Fondevilla, Constantino P-074 Fonseca, Isabel RO-333 Fontana, Iris O-320, P-236, P-292, P-371, P-372 Forgacs, Bence MO-060, MO-066, MO-068, O-003, O-092, P-173, P-310, P-368, RO-334, RO-337 Forman, Colin RO-202 Forman, Colin J. CC-014 Fornadi, Katalin RO-279 Forni, Alberto P-159 Forsythe, John L. CC-019 Foss, Aksel RO-017 Foss, Axel LB-P-069 Fossati, Nicoletta RO-007 Fouad, Malaka A. RO-014A Foucher, Yohann O-220, RO-267 Fougeray, Sophie P-133, RO-104, RO-118 Fourrier-Rglat, A. RO-164 Frances, Albert P-191 Franchin, Marco P-311 Franciosi, Monica RO-140 Franco, Antonio O-323 Francois, Helene RO-327 Francois, J. RO-032 Francois, Pattou O-172 Francque, Sven RO-057 Franquesa, Marcela RO-100, RO-284 Frasc, Giovanni Maria LB-P-077 Fraser, Lindsay LB-P-013 Frassati, Coralie P-117 Frauca, Esteban P-373 Frazer-Abel, Ashley RO-286 Frederick, Terra J. LB-O-001, LB-P-019, RO-349 Freeman, Gordon J. O-331 Freidl, Wolfgang P-069 Freitas, Cristiane M.R. MO-054, RO-250, RO-251 French, Jeremy P-367 French, Jeremy J. P-359 Frey, Felix J. O-087 Frey, Lorenz RO-237 Friedewald, John O-310, O-329 Friend, Peter O-089, P-183, P-358, RO-025, RO-082, RO-209, RO-290 Friend, Peter J. MO-017, O-016, O-184, O-185, O-186, RO-062 Friess, Helmut RO-037, RO-138, RO-261C Frigo, Anna Chiara RO-309 Friman, Styrbjorn O-188, O-189 Frimat, Luc O-171, RO-266 Froelich, Nadine CC-015 Fronek, Jiri CC-002, P-171, RO-007, RO-069, RO-310, LB-P-088/A Frontczak-Baniewicz, Malgorzata MO-073 Frost, Jodie H. P-002, P-217, P-237, RO-014 Frhauf, Nils O-187 Frunza, Mihaela LB-P-017, MO-089, O-264, P-055, RO-085 Frunza, Sandu P-055, RO-085 Fuchimoto, Yasushi P-187 Fuchinoe, Shohei RO-295 Fuchinoue, Shohei P-112 Fuchinoue, Shouhei P-202, P-249, P-250 Fuchs, Dietmar MO-036 Fuchs, U. O-204, O-238 Fuchs, Uwe P-081 Fuggle, Susan V. MO-017, O-126, O-127, O-131, P-119 Fuhrmann, Valentin LB-P-092, LB-P-106 Fujii, Naohiko P-280 Fujinaga, Takuji O-276, O-277, RO-248 Fujisawa, Masato P-211, P-297 Fujita, Hideo MO-056

Fujiwara, Takehito Fujiwara, Takuzo Fujiwara, Toshiyoshi Fukami, Naohiko Fukuda, Akinari Fuller, Barry Fumado, Lluis Fumeaux, David Fung, John Furian, Lucrezia

RO-004 P-195 MO-051, O-292 O-168 LB-P-005 O-024 P-191 RO-352 O-308 O-002, O-139, P-206, RO-328 Fusaro, Fabio LB-P-117, RO-263, RO-272 Fusch, Gerhard MO-005, P-141 Fuster, J. O-297, RO-056, RO-139 Gabe, Simon RO-290 Gabl, Markus O-267 Gabr, Mahmoud M. O-229 Gabrielli, Mauricio RO-246 Gadalla, Elsayed A. P-324 Gadano, Adrian MO-055 Gaertner, Natascha D. O-198 Gaffi, Giovanni LB-P-077 Gaggl, Martina O-288 Gago, Maria P-098 Gainza, F. Javier O-213, RO-259 Galazka, Zbigniew O-221, P-232 Galbraith, Norman RO-029 Galea, George LB-P-013 Galeano, C. P-194, RO-187 Galeano, G. P-234 Galeota Lanza, Alfonso RO-151, RO-189 Gales, Ana C. RO-322 Gallego, Antonio O-154 Galliford, Jack O-135, RO-063 Gallinat, Anja O-032 Gallix, Benoit O-190 Gallo, Ester O-130, P-049, P-267 Galloway, Lucy P-107, P-238 Gambato, Martina O-128, RO-309 Gambino, Antonio O-150, P-160 Ganguly, Bishu O-244 Ganguly, Bishu J. MO-041 Ganschow, Rainer O-314, O-315, O-316, O-318, P-374 Ganten, Tom M. O-305 Gao, Wei RO-296 Garbade, Jens RO-159 Garcia, Alvaro P-038, P-158, P-170, P-193, RO-058, RO-143, RO-220 Garca, Isabel P-266 Garca, Luis F. RO-103 Garcia, Ma. Lourdes C. P-057 Garcia, Maria P-001 Garcia, Milena RO-055 Garca, R. O-297 Garcia, Raquel MO-022 Garca, Susana RO-288 Garcia, Valter D. O-240 Garcia Criado, M. Angeles O-182 Garca de Lomas, Juan O-152 Garca-Eliz, M. P-327 Garcia-Gil, Agustn RO-076 Garca-Miguelez, Ana O-300 Garca-Pajares, Felix P-099, P-331, P-352, P-355 Garcia-Roca, Raquel O-014, O-181, O-182 Garca-Sesma, Alvaro RO-219 Garca-Valdecasas, J.C. O-297, RO-056, RO-139 Garca-Villoria, Judit MO-071 Gardener, Ken RO-153 Gardiner, Dale C. RO-303 Garelli, Paolo RO-040 Gargiulo, Antonio O-139 Garrigue, Isabelle MO-047 Garrigue, V. RO-274

Garrigue, Valrie O-220, RO-267 Garritsen, Rhiana MO-020, RO-051 Garrone, Federica RO-212 Garrote, Daniel P-328 Gasbarrini, A. O-123 Gasbarrini, Antonio P-362 Gastaca Mateo, Mikel P-091 Gastaldelli, Amalia MO-039A Gaudez, Franois P-212 Gauer, S. P-245 Gauthier, Frdric O-317 Gautier, Sergey O-164 Gautier, Sergey V. O-319A Gavasso, Sabrina RO-048 Gavriluta, Cristina LB-P-017, MO-089, P-055 Gazarian, Aram O-271 Gaze, Mark N. CC-004 Ge, Jianjun P-381 Ge, Xupeng O-115 Gebel, Howard O-244 Geddes, Colin MO-021, RO-029 Geddes, Colin C. MO-004, P-082, P-197 Geerdes, Patricia RO-262 Gehwolf, Philipp MO-031 Geier, Andreas O-122 Geiger, H. P-245 Geiger, Helmut MO-067 Geischen-Krische, Mary A. RO-291 Geissler, Edward O-224 Geissler, Edward K. MO-039, O-029, O-113, O-249, P-029, RO-323 Gelb, Jeff S. P-103 Gele, Bruno P-180 Gelli, M. O-123 Gen, Volkan RO-142, RO-198 Gener, Joan O-278 Genisson, Jean-Luc RO-271 Genovese, Elisabetta RO-311 Gentil, Miguel A. O-195 Gentil Govantes, M.A. RO-021 Gentili, Marco RO-040 Genzini, Tercio MO-054, RO-250, RO-251 Geramizadeh, Bita LB-P-095, P-130 Grard, Nathalie O-054 Gerken, Guido O-042, O-107, RO-105 Gerlach, Undine A. CC-018, O-103 Gerlei, Zsuzsanna O-293 Germack, Renee O-254 Germain, Christine O-082 Germain, Michael P-083 Germani, Giacomo RO-309 Gerosa, G. O-235 Gerosa, Gino O-150, P-160 Gerritsen, Rik T. O-283 Gerstel, Eric O-108 Gerunda, G.E. O-123 Gerunda, Giorgio E. MO-057, O-305, P-034, RO-135, RO-255, P-077, RO-326 Gerunda, Giorgio Enrico RO-043, RO-150 Gessl, Alois P-303 Getts, Daniel R. LB-O-001, LB-P-019, RO-349 Getts, Meghann T. LB-O-001 Gewartowska, Magdalena MO-073 Ghaffari, Alireza LB-P-099 Ghanim, Bahil P-196, RO-239, RO-240 Ghazanfar, Abbas MO-009, MO-060, MO-066, MO-068, O-003, O-092, P-173, P-239, P-310, P-368, RO-337 Gheith, Osama P-085, P-244 Gheorghe, Liana P-135, P-335 Ghimenton, Claudio RO-186 Ghio, Luciana MO-045, RO-225 Ghirardini, Angelo RO-098 Ghirardo, Giulia MO-045, RO-224, RO-226, RO-228

Ghisdal, Lidia O-322 Ghoneim, Mohamed A. O-229 Ghoneim, Mohamed Ahmed MO-013 Giacomoni, Alessandro O-294, RO-031, RO-036, RO-053, RO-134 Giannelli, Valerio MO-023, P-304, P-336, P-362, P-363 Giannello, Pierre O-330 Gibb, Alastair RO-102 Gibbs, Kevin RO-153 Gibbs, Paul P-198 Gichkun, Olga E. O-319A Gierej, Beata P-332 Gieschen-Krische, Mary O-118 Gil Dominguez, Judith P-099, P-355 Gilabert, Rosa O-182 Gilavert, Mari LB-P-046 Gilbert, James O-016, O-184, O-186 Gilbo, Nicholas O-038 Gill, Janet O-090, O-095, RO-067 Gillespie, Avrum RO-325 Gilvernet, Salvador O-213, RO-259 Ginanni Corradini, Stefano P-304, P-336, RO-045 Ginevri, Fabrizio MO-045, O-320, P-371, P-372 Gingell-Littlejohn, Marc LB-P-056, MO-033, P-197, P-260, RO-029, RO-281 Gini, Maria A. CC-016, P-203, P-268 Giono, Ilaria O-038, RO-213 Giordani, Maria C. O-287 Giostra, Emiliano P-347, P-348 Giovannoni, Laurianne O-052, O-171, O-173 Giral, M. RO-274 Giral, Magali O-220, RO-267 Girardot Seguin, S. O-201 Giraud, Sebastien MO-043, MO-076, O-033, O-179, O-228 Giraudi, Roberta P-267 Girman, Peter RO-337A Girmanova, Eva O-215 Girnita, Alin LB-P-029 Girotti, Paolo O-132, P-025 Giuliani, Antonio P-357 Giustino, Gennaro RO-354 Giusto, Michela P-336 Gjorgjimajkoska, Olivia RO-008 Glander, Petra P-221, RO-252 Glen, Julie MO-021 Glotz, Denis P-023, P-212 Glover, Alexander T. O-255, RO-102, RO-344 Glowacki, Philip O-161 Glyda, M. O-246 Glyda, Maciej O-140, O-141, RO-126 Glyn, Eiddwen RO-120 Gnant, Michael O-012 Gobe, Oscar P. RO-301 Godigamuwa, Nadia O-006 Goffin, Eric P-253, RO-272 Goggins, William C. O-304, RO-184 Goh, Bak-Leong P-240 Gois, Pedro H.F. RO-208 Goldsmith, Petra M. O-183, P-198 Goldwater, Ronald O-248 Golebiewska, Justyna P-199 Gollackner, Bernd O-012 Gom, Montse RO-284 Gmez, Ernesto RO-288 Gmez, Miguel A. MO-018 Gmez, Miguel ngel P-320, P-321 Gmez Bravo, Miguel A. P-344 Gomez-Alamillo, Carlos P-100 Gmez-Alamillo, J.C. RO-324 Gomez-Bravo, Miguel A. P-074 Gomez-Cia, Tomas O-328

283

284

Gonalves, Janaina G. RO-208 Gondolesi, Gabriel MO-055 Gonzalez, Dione O-323 Gonzalez, Eduardo LB-P-046 Gonzalez, Esther P-216, RO-199 Gonzalez Cambaceres, Carlos E. P-375, P-376, RO-223, RO-231 Gonzalez Molina, Miguel O-213, RO-259 Gonzlez Roncero, F.M. RO-021 Gonzalez Uriarte, Javier P-091 Gonzlez-Molina, Miguel P-264, P-265, P-266 Gonzalez-Pinto, Ignacio M. MO-059 Gonzalo, Marta P-351 Goode, Anthony CC-001, P-294 Goralczyk, Armin D. LB-P-025, O-306 Gorantla, Vijay O-265 Gorantla, Vijay S. RO-296A Grnicka, Barbara P-332 Gorog, Denes O-293 Gosset, Clment P-023 Gssler, Ute P-303 Gossmann, J. LB-P-068, P-245 Gomann, Jan LB-P-024 Goto, Norihiko P-307 Goto, Ryoichi O-208 Gotoh, Momokazu P-275 Gotti, Eliana P-370 Gottschild, Dietmar RO-037 Goujon, Jean Michel O-176 Gould, Frances K. RO-241 Gowers, Sally LB-P-120 Gozzetti, Francesco RO-013 Gozzini, Sara LB-P-004 Grabhorn, Enke O-318 Grad, Iulia RO-085 Grad, Ovidiu RO-085 Grahammer, Johanna O-270 Grandaliano, Giuseppe O-139 Grandtnerova, Barbara MO-029, P-012 Grant, Joyce P-118 Grazi, Gian Luca O-202 Gregson, Helen P-171, RO-069, RO-310 Gregson, Lea O-118 Gregson, Leigh O-255 Grenier, Nicolas RO-271 Gridelli, B. O-123 Gridelli, Bruno O-074 Griffin, S. O-163, RO-268 Griffin, Sian P-246 Griffith, David RO-120 Griffiths, David MO-063 Griffiths, Jane P-174 Griffiths, Meryl O-160 Griffiths, Paul D. RO-166 Griffiths, W. RO-144 Griffo, Giampiero RO-311 Grigioni, Francesco RO-155 Grigioni, Walter F. LB-P-015 Grillo, Paolo RO-225 Grimbert, Philippe RO-266, RO-338 Gringeri, Enrico O-128 Griny, J.M. RO-273 Grinyo, Josep O-242, O-245, P-080, P-083 Griny, Josep M. O-241, O-284, RO-100, RO-109 Griny, Joseph M. RO-284 Groemmer, Martina RO-154 Grohnert, Anja O-227, O-256 Grmmer, Martina P-157 Grnroos, Lisa RO-046 Groothuismink, Zwier M.A. O-206 Groppa, Silvia R. O-287 Groppali, Elena MO-045, RO-225 Gross, Marie-Luise P-277 Grossen, N. RO-032

Grosso, Giuseppe O-074 Grubic, Zorana LB-P-014 Grugni, Carla RO-052 Gruttadauria, S. O-123 Gruttadauria, Salvatore O-074 Grutters, JC RO-238 Gryspeerdt, Filip O-098 Guaraldi, Giacomo RO-311 Guaraldi, Giovanni MO-057, RO-311 Guardascione, Salvatore RO-189 Guardia, Ana Carolina RO-167 Guarinos, Anita LB-P-022 Guarracino, Fabio MO-061 Guarrera, James V. MO-020 Guarrigue, Valerie RO-266 Guba, Markus MO-037, P-084 Guerra, Juan Francisco RO-217 Guerra, Juan Franciso RO-246 Guerrini, Gian Piero MO-057, P-034, RO-043, RO-135, RO-150, RO-255 Guerrini, Gianpiero RO-326 Gueutin, Victor RO-069C Guglielmi, Cosimo P-160 Guglielmo, Nicola RO-065 Guigal, Vincent O-271 Guillemain, R. RO-164 Guillonneau, Carole O-111 Guimezanes, Annick O-207 Guinea, G. RO-324 Guirado, Llus MO-011 Guirado, Luis O-094 Guirado-Perich, Luis O-219 Guizzetti, Michela RO-059, RO-229 Gulati, S. LB-P-026, RO-356 Guler Margaritis, Silviu P-218 Glkaya, Esin P-172, RO-066 Gummert, Jan P-081 Gunawansa, Nalaka P-241, RO-280 Gundogan, Erdal P-247 Gungor, Ozkan P-021, P-242 Gunner, Charlotte K. LB-P-052 Gunning, Mark P-290 Gunson, B. RO-034 Gunson, Bridget O-188, O-189, O-317 Gunther, Anne RO-264 Gupta, Arun LB-P-041 Gupta, Krishan L. P-243 Gupta, P. N. LB-P-026, RO-356 Gur, Galip P-104 Gurevitch, Michael O-321 Grkan, Hakan P-302 Gursu, Meltem P-247 Gutafsson, Bengt LB-O-004 Gutirrez, A. RO-273 Gutirrez, Cristina P-263, P-264, P-265, P-266 Gutierrez, Eduardo RO-199 Gutmann, Thomas O-070 Guzzo, Isabella MO-045 Gwak, Mi Sook P-334 Gwinner, W. LB-P-068 Gwinner, Wilfried LB-P-024 Gyurus, Eva RO-019 Ha, Tae-Yong LB-P-100 Haase-Kromwijk, Bernadette J. RO-301 Haase-Kromwijk, Bernadette J.J.M. O-066, O-080, O-281, P-176 Haber, Georges-Pascal RO-064 Haberal, Mehmet LB-P-096 Haberal, Nihan LB-P-096 Haberl, Thomas RO-154 Habicht, Antje O-331, P-020 Habrecht, Olaf RO-037, RO-138, RO-261C Hachiya, Hiroyuki O-039 Hack, Michael A. RO-353 Hadaya, Karine O-137, RO-352

Haddadi, Paria LB-P-095 Hadj Aissa, Aouemeur O-159, RO-195 Hadj-Ayed, Kaouther MO-072 Hadjianastassiou, Vassilis O-134 Hadjianastassiou, Vassilis G. O-124, RO-084 Hagen, S.M. LB-P-076 Haggerty, Helen G. P-111 Hahnenkamp, Klaus P-026 Haidinger, Michael MO-008 Haineala, Bogdan P-218 Haja Mydin, Helmy N. RO-241 Hakenberg, Oliver P-084 Hakim, Nadey O-086, P-271, RO-010 Hakim, Nadey S. RO-299 Hakim-Meibodi, Kavous P-081 Halawa, Ahmed LB-P-070, P-005 Halim, G.A. P-013 Halim, Medhat M.A. P-085, P-244 Haller, Hermann RO-185 Hallstrm, Seth P-383 Halsall, David J. O-313 Hamaoui, Karim LB-P-120, MO-077, RO-249 Hambach, Pia RO-252 Hamid, Mohamed H. P-085 Hamid, R. RO-253 Hamilton, Lisa P-298, P-299 Hamour, Sally P-147 Hamsho, Ahmed O-096, RO-026, RO-088, RO-170, RO-171 Han, Dong-Dong RO-146 Han, Duck Jong LB-P-057, LB-P-079, LB-P-081, LB-P-110, LB-P-111 Han, S.K. P-245 Han, Sung Yeup LB-P-063 Han, Young Seok LB-P-101 Hanaoka, Jun O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Hanau, Daniel CC-015 Hanf, William O-159, RO-195 Hanif, Faisal MO-010, RO-210, RO-270 Hanna, George LB-P-120, RO-249 Hanna, Rabi P-116 Hannah, Matthew J. RO-289 Hansen, Bettina RO-169 Hansen, Thorsten O-295, RO-038 Hansson, Christoffer LB-P-109 Hantraye, Philippe O-330 Hao, Jianqiang RO-176 Haque, Mazhar P-037 Hara, Yoshiaki P-346, P-356 Harangi, Mariann P-269 Harber, Mark P-121, P-207, P-294, RO-166 Harciarek, Michal RO-016 Harden, P.N. LB-O-006 Harden, Paul P-219 Harder, Beate O-132 Harler, Mary Beth P-080, P-103 Harper, I. O-050 Harper, Ines G. O-117 Harper, Simon MO-062, RO-008 Harrison, David RO-069A Hrter, Luc RO-285 Hartmann, Anders LB-P-069, O-144, RO-211, RO-264 Hartyanszky, Istvan O-234 Harza, Mihai P-218 Hashimoto, Mitsuo P-297 Hassan, Joanne RO-234 Hassoun, Ziad O-100, P-253 Hatakeyama, Katsuyoshi P-346, P-356 Hattori, Ryohei P-275 Hatz, Rudolf RO-237 Hauet, Thierry MO-043, MO-076, MO-079, O-033, O-176, O-177, O-179, O-228 Hauke, Nicola O-306 Hausberg, Martin O-196

Hauser, I.A. P-245, RO-165 Hauser, Ingeborg MO-067 Hausken, John RO-017 Hautz, Theresa O-267, O-269, O-270 Havrdova, Tereza RO-337A Hayakawa, Kunihiro O-168 Haylor, John L. O-025 Hazan, Marc RO-338 Hazinedaroglu, Selcuk M. RO-198 Hazzan, M. RO-119 He, Michun RO-179 He, Qiang RO-146 He, Shaofeng LB-P-002 Healy, Neil LB-P-018 Heap, Sarah L. P-175 Heaton, Nigel LB-P-114, LB-P-116, MO-050, O-188, O-189, O-290, O-299, O-317, RO-030 Hebden, Tony RO-277 Hebibi, Hedia RO-327 Hebrard, William MO-043 Hecking, Manfred MO-008 Hector, Ralph RO-296C Heemskerk, Martin B.A. O-066 Heenen, Sarah P-089 Heetun, Mohammad RO-025 Hegab, Bassem O-045 Hegeds, Katalin P-068 Hegner, Bjrn O-056 Hego, Hanaa Nafady O-309 Heidegger, Claudia-Paula RO-086 Heininger, Alexandra O-132 Heinze, Georg P-303 Heise, Michael O-295, RO-038, RO-148 Hejnar, Jiri RO-296C Helanter, Ilkka P-200, RO-321 Heldal, Kristian LB-P-069 Helenius-Hietala, Jaana S. RO-046 Hellegering, Joyce LB-P-060, LB-P-065 Helou, Sebastien MO-047 Hemke, Aline C. O-066 Hempel, Claudia P-004 Henderson, Lorna K. MO-028 Heneghan, Michael O-290 Henrich, Franziska MO-015 Henriques, Antonio C. RO-333 Henriques, Antonio Castro RO-009 Henry, Peter F. LB-P-013 Henry, Scot MO-020 Hequet, Olivier O-268 Herden, Uta O-318 Hermann, Martin O-023, O-270 Hernandez, Ana P-216 Hernndez, D. MO-025 Hernndez, Domingo P-263, P-264, P-265, P-266 Hernandez-Fuentes, Maria P. RO-109, RO-114 Herrmann, James J. LB-P-019 Herson, Serge CC-021 Hervs, Csar MO-018 Hes, Ondrej O-145 Hesselink, Dennis A. O-286, P-146 Hessheimer, A.J. O-297, RO-056, RO-139 Heuer, Matthias RO-041 Heylen, Line LB-P-062 Heyne, N. LB-P-068 Heyne, Nils LB-P-024, P-025 Hickethier, Tilman O-270 Hidalgo, Carlota O-152 Hidalgo, Ernest L. O-121 Hierro, Loreto P-373 Hiesse, Christian O-069, O-075, P-014, RO-087 Higuchi, Yoshihide P-308 Hill, Deborah LB-P-047

285

286

Hill, Martha RO-095 Hilton, Rachel O-081, P-107, P-238, RO-201 Hinoue, Mayumi O-057 Hirai, Toshiaki P-211, P-280 Hirai, Toshihito O-138, RO-316 Hiramitsu, Takahisa P-307 Hiraoka, Takeo P-024 Hirokata, Gentaro P-151 Hirt, S. O-204 Hlaing, Wah Wah RO-243 Ho, Cheng-Maw P-039 Ho, Christina P-171 Ho, Ming-Chih P-039 Ho, Wei Min O-090, O-095, RO-067 Hoang, Anh Dung P-274 Hckerstedt, Krister O-149, P-322 Hoda, Mir Alireza P-196, RO-239, RO-240 Hoda, Saba P-276 Hodgson, Humphrey RO-050, RO-141 Hoefeld, H. P-245 Hoeger, Simone MO-040, O-037 Hoeijmakers, J.H.J. RO-074 Hoekstra-Weebers, Jehm RO-222 Hoff, Uwe O-180 Hoffmann, Johannes N. LB-P-113 Hoffmann, Ute O-196 Hofker, H. Sijbrand RO-005, RO-015, RO-115 Hofker, Sijbrand RO-070 Hofker, Sijbrand S. RO-301 Hger, Simone O-233 Hoistma, Andries J. LB-P-065 Hoitsma, A.J. LB-O-006 Hoitsma, Andries O-091 Hoitsma, Andries J. LB-P-060, O-066, O-281, P-176 Holdaas, H. P-105 Holdaas, Hallvard LB-O-004, O-005, P-182, RO-194, RO-264 Hollemann, David O-295 Holman, Andrei LB-P-017, MO-089 Holman, J. O-246, O-247 Holman, John O-248 Holt, David W. O-286 Holtz, Ricardo RO-181 Holub, Lukas P-282 Homan, Jaap J. RO-329 Homan van der Heide, Jaap J. LB-O-003, O-302, RO-005, RO-015, RO-115 Homma, Yukio P-251 Honda, Satoshi P-024 Hong, Chang Hee LB-P-020 Hong, Ju Ho LB-P-009 Hong, Kyungdeuk RO-330 Honor, Pierre O-046 Honsova, Eva MO-049, O-022, P-300, RO-216 Hoogduijn, Martin MO-003 Hoogduijn, Martin J. O-256 Hoogendijk-van den Akker, J.M. LB-O-006 Hoogland, E.R.P. O-158 Hoogland, Pieter RO-121A Hoogland, Pieter E.R. RO-097 Hope, Wendy LB-P-084, LB-P-088 Hope, William W. O-118, O-255 Hoppe-Lotichius, Maria RO-038 Hork, Pavel LB-P-087 Horcajada, Juan P. O-152 Horcajada, Juan Pablo P-191 Horkay, Ferenc O-234 Hrl, Walter H. MO-008, P-303 Horsburgh, Terry P-123, P-143 Horsfield, Catherine O-081, RO-201 Horvath, S. O-163, RO-268 Horvath, Szabolcs P-246 Hoscoskun, Cuneyt P-021, P-296

LB-O-005, O-019, RO-027 Hoshimoto, Mituo P-211 Hoshinaga, Kiyotaka MO-006, O-168 Hoshino, Ken P-187 Hosny, Shady G. RO-083 Hossain, Mohammad A. CC-002 Hou, Jun P-043, P-192, P-210 Hou, Yulong P-046 Houbiers, J. O-246 Howard, Susan J. O-118, O-255 Hribova, Petra MO-049, O-022, O-145 Hristova Dimcevska, Anita P-287 Hrub, Miroslav LB-P-087 Hu, Rey-Heng P-039 Huang, Edgar RO-332 Huang, Fang RO-179 Huang, Hai LB-P-040, RO-261G Huang, Yingfeng P-134 Huang, Zhongli LB-P-002 Hudson, Alex O-089, O-126, O-127, P-119 Hudson, Alex J. MO-017 Hughes, Joseph RO-025 Hugo, Christian P-084 Huguet, E. RO-144 Huh, Kill LB-P-066 Hulscher, J.B.F. RO-222 Humar, A. RO-165 Humar, Ines RO-205, RO-343 Humes, David O-161 Hunold, Gerhard RO-286 Hunter, James O-019 Hur, Ender P-242 Hurault de Ligny, B. O-201, RO-119 Hurault de Ligny, Bruno P-231 Hursitoglu, Mehmet P-247 Hurtado, Sara O-152 Hussein, Aziz A. RO-060 Hutchinson, James A. MO-039, O-249, RO-323 Hwang, Eun A. LB-P-063 Hwang, Gyu-Sam LB-P-089 Hwang, Jeong Kye P-257, P-258 Hwang, Jeong-Kye P-254 Hwang, Shin LB-P-089, LB-P-090, LB-P-093 Hyodo, Yoji RO-001 Hyspler, Radomir P-282, P-283 Hyun, Sun-Ji P-334 Iacob, Razvan P-135 Iacob, Speranta O-042, O-107, P-135, P-335, RO-105 Iadevaia, Maddalena P-336 Iancu, Mircea P-141 Ianni, Stefano RO-045 Iaria, Giuseppe P-124 Iberer, Florian O-013, RO-261I Ibrahim, Ibtihal Mohamed MO-013 Ibrahim, Rana Y. O-229 Ibrahim, Zayed Mohd. P-324 Ibrahim, Zuhaib LB-O-002, RO-261F Ichikawa, Yasuji P-211, P-280, P-297 Ichimaru, Naotsugu P-248 Ichino, Manabu MO-006 Iemmolo, Rosa M. P-034, RO-326 Iemmolo, Rosa Maria RO-150, RO-255 Ietto, Giuseppe P-311 Igarashi, Rumi O-208, P-151 Igawa, Mikio P-024 Ihm, Chun-Gyoo LB-P-067 Iida, Takuya P-337 IJzermans, J.N.M. LB-P-076, RO-074, RO-345 IJzermans, Jan MO-003, O-077, O-085 IJzermans, Jan N. RO-132 IJzermans, Jan N.M. MO-088, O-088, O-312, O-325

Hosgood, Sarah A.

Ikea, Masae P-109 Ikeda, Masae P-056, P-201 Ikegamiu, Toru O-040 Ikemoto, Tetsuya O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Ilham, Adel MO-063 Ilham, Mohamed Adel RO-101 Iljinsky, Igor M. RO-158 Imaizumi, Rie P-249, P-250 Imber, Charles P-350 Imperiali, Nora C. O-287 Imura, Satoru O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Imventarza, Oscar P-375, P-376, RO-223, RO-231 Inbal, Aida CC-013 Inderson, Akin RO-261B Inglis, Andrew LB-P-047 Ingsathit, Atiporn O-155 Innocente, Annalisa O-320 Inoue, Keita P-024 Inston, Nicholas LB-O-211A Inston, Nicholas G. O-096, P-278, RO-026, RO-088, RO-170, RO-171, RO-287 Ioan, Beatrice LB-P-017, MO-089 Ioan, Beatrice-Gabriela P-055 Ionico, Teresa RO-155 Iris 8A Team Health Psychology P-065 Irish, William RO-277 Isaac, J.R. LB-P-006 Isaac, John CC-008, LB-P-004, RO-034, RO-261H Isayev, Alovsat P-027 Isayev, Ceyhun P-296 Isayev, Hasan P-027 Ishida, Hideki O-138, P-379, RO-011, RO-316 Ishii, Daisuke P-056, P-109, P-201 Ishii, Yasuo P-112, P-202, P-249, P-250, RO-295 Ishikawa, Akira P-251 Ishikawa, Daichi P-339 Ishikawa, Nobuo RO-004 Ishimura, Takeshi P-211 Island, Eddie MO-059 Ismail, Amani M. O-229 Ismail, Hor P-377 Ismail, S.Y. MO-085, O-259 Ismail, Sohal RO-089 Isoniemi, Helena P-322, RO-046 Israni, Ajay O-063 Ivanovski, Ninoslav P-287, RO-327 Ivanovski, Ninoslav I. RO-121 Iwabuchi, Toshihisa RO-004 Iwadoh, Kazuhiro P-202, P-249, P-250 Iwahashi, Shuichi O-120, P-325, P-338, P-339, P-349, RO-215 Iwahashi, Syuichi P-042 Iwamatsu, Fumi MO-006 Iype, Satheesh RO-054, RO-315 Izquierdo, Diana MO-027 Izvolskaja, Nina P-095 Jablecki, Jerzy O-328 Jackson, Chris H. RO-008 Jackson, Emma RO-234 Jacquet, Antoine RO-327 Jaeger, Mark D. RO-147 Jah, A. RO-144 Jain, AshokKumar O-097, RO-325 Jain, S. LB-P-026, RO-356 Jakoby, Estrella P-166 Jaksch, Peter P-196, RO-239, RO-240 Jakubowska-Winecka, Anna RO-300 Jalowiecki, Przemyslaw RO-068, RO-305 Jamieson, N. RO-144 Jamieson, Neville O-188, O-189, RO-054

Jan, Caroline O-330 Jang, Jae Hyun P-016 Jankowska, Magdalena RO-278 Janousek, Libor O-022, O-079, P-003, RO-314 Jansen, Nichon E. O-281, P-176 Janssen, Harry L.A. O-222 Janssen, Magda LB-P-117 Janssens, Ann CC-005 Janssens, Anne-Rose P-176 Jaques, Bryon P-367 Jaques, Bryon C. P-359 Jara, Maximilian O-193 Jara, Paloma P-373 Jarczyk, Jonas MO-040 Jardine, A. RO-165 Jardine, Alan MO-021 Jardine, Alan G. MO-004, O-064, O-084, RO-028 Jarufe, Nicols RO-217, RO-246 Jassem, Wayel LB-P-114, MO-050, O-290, O-299, RO-030 Jauch, Karl-Walter LB-P-113, MO-037, P-084 Jaureguy, M. RO-119 Jaurretche, Sebastian CC-016 Jaurretche, Sebastian P. P-203, P-268 Jayachandran, Rajesh MO-074 Jayaweera, Asantha R. RO-025 Jayle, Christophe MO-043 Jazra, Martin P-004, P-293 Jeanmonod, Pascal O-030, O-034, RO-033, RO-072 Jenkinson, Eric J. RO-287 Jennings, Carol O-124 Jennings, Paul RO-106 Jeon, Mi Y. LB-P-074 Jeong, Joon H. LB-P-074 Jeong, Joon Heon LB-P-083 Jeong, Kyung-Hwan LB-P-067 Jespersen, Bente LB-O-004, RO-207 Jha, Vivekanand P-243 Jham, Seema P-145 Ji, Hyun Sun P-255, P-256 Ji, Shuming P-312, P-313, RO-127 Ji, Shu-Ming RO-190 Jiang, H. O-236, O-237 Jiao, Zheng RO-122 Jie, Charles O-310 Jimenez, Carlos P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Jimenez, Luis O-323 Jimnez-Castro, Mnica P-330 Jimhagen, Cecilia P-165 Jin, Hao LB-P-040, RO-261G Jin, Mi-Kyung P-225, RO-330 Jin, Xiangyuan MO-038, O-211, P-136, RO-339, RO-340, RO-346 Jindal, Rishi RO-296A Jindra, Pavel O-145 Jirasiritham, Sopon O-155 Jironda, Cristina P-264, P-266 Jochmans, Ina LB-O-003, O-129, O-157, O-296, RO-006 Joffrion, Sandrine O-228 Jogeesvaran, Haran RO-202 Joh, Jae-Won O-044, P-255, P-256 Johendranathan, Ajanthan P-235 Johnsom, Nicola O-084 Johnson, Cathy LB-P-084, LB-P-088 Johnson, Rachel MO-046, O-264, RO-206 Johnson, Rachel J. MO-016, O-067, O-078, O-126, O-127, O-131, P-119, RO-069B Johnston, Colette MO-065 Johny, K.V. P-085

287

288

Jonas, Sven O-305 Jones, Gareth O-006, O-185 Jones, Helen E. RO-200 Jones, Keith CC-002 Jones, Rebecca O-007 Jones, Steve RO-332 Jonkers, Renee E. RO-329 Joosten, Irma P-122 Jrgensen, Troels M. RO-207 Jowsey, Sheila G. CC-003, RO-294 Ju, Man Ki LB-P-020, LB-P-094 Juergensen, Jan-Steffen LB-P-024 Junchotikul, Phimchanok O-155 Jung, Dong-Hwan LB-P-100 Jung, Gregor P-141 Jung, Joo Hee LB-P-057 Jung, Minyoung LB-P-107 Junge, G. P-105 Jungraithmayr, Wolfgang RO-285 Jrgensen, J. S. LB-P-068 Jurisch, Anke O-115 Jushinskis, Janis LB-P-055, P-177, P-301 Justo, Iago P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Juvany, Montse MO-050, O-290, RO-030 Kaabak, Michael M. O-319, P-120 Kabamba, Benoit P-253 Kaczmarek, Ingo O-230, O-239 Kaden, Juergen RO-182 Kadowaki, Takashi MO-056 Kahan, Barry D. RO-019 Kahn, Delawir P-252, RO-050, RO-141 Kahveci, Eyp MO-075 Kai, Kotaro P-202 Kaimori, Junya P-248 Kainberger, Franz P-303 Kaiser, Gernot O-032 Kaiser, Gernot M. RO-041 Kakaei, Farzad LB-P-098, LB-P-099, LB-P-112, LB-P-112 Kakai, Farzad P-317, P-318 Kakuta, Yoichi P-248 Kal, Judith RO-003 Kalantar-Zadeh, Kamyar RO-020 Kalaycio, Matt P-116 Kalicinski, Piotr P-377 Kalinowski, Piotr P-354 Kaller, Tanja O-314, O-315, O-316 Kal-van Gestel, Judith O-077, O-085, P-070 Kal-van Gestel, Judith A. O-227, O-312 Kamali-Ernst, Shirin O-324 Kamar, N. RO-274 Kamar, Nassim O-140, O-141, O-220, O-245, RO-126, RO-266, RO-267 Kamihira, Osamu P-275 Kaminska, Dorota P-273 Kanaan, Nada P-253, RO-256, RO-272 Kanamoto, Mami P-042, P-325, P-338, P-339, RO-215 Kanazawa, Hiroyuki LB-P-005 Kandil, Hala O-006 Kandus, Aljoa MO-002, P-220, P-309, P-319, RO-022, RO-124, RO-203, RO-204 Kang, ChongMyung P-261 Kang, Sang-Mo P-144 Kang, Sun Woo LB-P-059, LB-P-067 Kanitakis, Jean O-266, O-268, O-271 Kanwar, Aditya O-035, O-301, P-163, P-288, P-382, RO-152 Kanyi, Samuel P-279 Kaplan, Bruce O-308 Kaposztas, Z. O-163, RO-268 Kaposztas, Zsolt P-246, RO-019, RO-120 Kara, Osman P-247 Karaca, Cezmi LB-P-027, P-295, P-380

Karachristos, Andreas O-097, RO-325 Karakayali, Hamdi LB-P-096 Karam, Vincent O-188, O-189, O-317 Karasu, Aliyye P-118, P-121 Karatosic, Rastko LB-P-092, LB-P-106 Karayalcin, Kaan RO-142 Karbe, Thomas RO-302 Karck, Matthias O-234 Karlsson, Teemu O-149 Karlsson-Nellbring, Moa O-255, RO-344 Karner-Hutuleac, Adina LB-P-017, MO-089 Karoui, Stefan O-198 Kasahara, Mureo LB-P-005 Kasiske, Bertram L. O-063 Kastelan, Zeljko LB-P-014 Kasthuri, Ram LB-P-064 Katia, Toledo LB-P-073 Katicic, Miroslava P-040 Kato, Masato O-039 Kato, Taigo P-248 Katopodis, Andreas MO-074 Kaudel, Christian P. RO-147 Kaul, Sanjeev P-102, P-103 Kaur-Bola, Kulwinder O-261, O-262, P-067 Kawachi, Shigeyuki P-187 Kawagishi, Naoki P-340 Kawaguchi, Takehiko P-307 Kawai, Akihiro O-168 Kawamura, Chifumi O-057 Kawamura, Takeshi RO-001 Kaya, Muammer P-214, RO-196 Kayar, Ragip P-295 Kazakov, Eduard N. P-149, RO-158 Kazancioglu, Rumeyza P-247 Kazemi, Kourosh LB-P-098, LB-P-099 Kazemier, Geert MO-020, MO-070, P-122, RO-051, RO-071, RO-132, RO-169, RO-261B Kazimi, Mircelal P-027 Kebabci, Eyp P-295, P-380 Kedzierska, Karolina LB-P-028 Kee, T. P-127 Keevil, Brian G. RO-291 Keirns, James O-248 Kekik, igdem P-302 Kelleher, Matthew RO-171 Keller, Anna K. RO-207 Kenchayikoppad, Shivakumar O-134 Keogh, Brian O-028 Kern, Georg RO-106 Kerr, Jacques LB-P-052 Keser, Ferhat RO-066 Kessaris, Nicos CC-002, P-171, RO-007, RO-069, RO-083, RO-310, LB-P-088/A Kessler, Laurence O-116, O-171 Kessler, Michle O-220, RO-267 Kesteven, Patrick O-301 Keven, Kenan RO-261 Khairoun, Meriem RO-111 Khalaf, Hatem O-045 Khan, Nahida RO-069 Khasati, Noman RO-234 Khasho, Garabet O-069 Khater, Sherry M. O-229 Kher, V. LB-P-026, RO-356 Kho, Marcia O-085 Kho, Marcia M. O-205 Kho, Marcia M.L. O-325 Khorsandi, Shirin LB-P-116, O-290 Khorsandi, Shirin E. O-299 Khosravi, Masoud P-161 Khurram, Mohammed Arslan O-301 Khurram, Muhammad P-288, P-382 Khurram, Muhammad A. O-194, P-162, P-163, RO-129, RO-152, RO-153 Kianda, Mireille O-322

Kianda, Mireille N. Kielstein, Jan T. Kienzl, Katrin Kieslichov, Eva Kim, Bong-Wan Kim, Byung C. Kim, Chan-Duck Kim, Dongsik Kim, Doo Jin Kim, Eun Ae Kim, Gaab Soo Kim, Hye J. Kim, Hyo Jin Kim, Hyoung Tae Kim, Hyun Chul Kim, Hyung-chul Kim, Jae-Jung Kim, Ji Il Kim, Jong Man Kim, Jong Po Kim, Joo Dong Kim, Joo Seop Kim, Joong Kyung Kim, Juyang Kim, Ki Hyun Kim, Ki-Hun Kim, Min Young Kim, Miyoung Kim, Myoung Hee Kim, Myung-Kyu Kim, Myung-Wook Kim, Seong Eun Kim, Song Cheol Kim, Song-Cheol

RO-256 O-058 RO-245 RO-216 P-341 LB-P-074 P-225, RO-330 LB-P-104, LB-P-105 LB-P-003 LB-P-063 P-334 O-178 P-334 LB-P-063 LB-P-063 LB-P-003 LB-P-089 P-254, P-257, P-258 O-044, P-255, P-256 LB-P-083 LB-P-101 LB-P-003 P-138 P-140, P-204 P-138 LB-P-093, LB-P-100 LB-P-063 P-137 P-261 LB-P-009 P-341 P-138 LB-P-081 LB-P-057, LB-P-110, LB-P-111 Kim, Sung Joo O-044, P-137, P-256 Kim, Sung Min P-138 Kim, Sung-Joo P-255, P-334 Kim, Tae Hee LB-P-059, LB-P-067 Kim, Tae Young LB-P-079 Kim, Tae-seok O-044 Kim, Tae-Seok P-137 Kim, Wonyoung P-140 Kim, Yeong Hoon LB-P-059 Kim, Yeong-Hoon LB-P-067 Kim, Yon Su O-329 Kim, Yong-Lim P-225, RO-330 Kim, Young Hoon LB-P-057, LB-P-081, LB-P-110, LB-P-111 Kimelman, Michael O-270 Kimura, Takaaki RO-004 Kingsmore, David LB-P-056, MO-033 Kinoshita, Tomoko P-211, P-297 Kinukawa, Tsuneo P-275 Kircelli, Fatih P-021, P-242 Kirchner, Gabi P-029 Kirste, Gnter O-327, LB-P-119 Kirsten, Gnter R. LB-O-003 Kishikawa, Hidefumi P-280, P-297 Kishikawa, Hidehumi P-211 Kiss, Zoltan RO-279 Kissin, Eleanor R. RO-303 Kitagawa, Yuko P-187 KJaden, Juergen P-073 Kjellman, Ulf P-153 Kjer, Susanne RO-039 Klautz, Robert J. RO-242 Klein, Sara O-231, P-139, RO-159 Kleinclauss, Francois O-212 Klempnauer, Juergen P-342 Klempnaur, Jurgen L. O-317 Klepetko, Walter P-196, RO-239, RO-240 Klepper, Mariska O-325 Klerk, Marry O-077 Klingenberg, Olav RO-017 Klinger, Marian MO-048, P-273

Klingman, Lynne O-272 Klipp, Gerrit CC-020 Kloc, Malgorzata O-229 Kloda, Karolina MO-044, O-065 Kloke, Heinrich O-091 Kloke, Heinrich J. LB-P-060 Knap, Bojan RO-124 Kneteman, Norman M. O-008 Kniepeiss, Daniela LB-P-042, LB-P-097, O-013, P-166, RO-261I Knight, Amanda P-175 Knight, Amanda J. P-286 Knight, Simon R. RO-265 Ko, Justin Sangwook P-334 Kobara, Chiaki P-024 Kobayashi, Masahiro P-109 Kobayashi, Nozomi P-151 Kobayashi, Takashi P-346, P-356 Kobori, Laszlo O-293 Kobrin, Talya RO-310 Koch, Martina P-259 Kocman, Branislav P-040 Koelbl, Matthias P-314 Koenigsrainer, Alfred MO-036, O-132 Koenigsrainer, Ingmar O-132 Koers, Karlijn RO-261D Koffman, Geoff RO-202, RO-269 Koffman, Tomek RO-266 Kofler, Markus RO-035, RO-245 Koh, Hoey P-197, RO-281 Koh, Hoey C. P-260 Kohei, Naoki O-138 Kohler, Sven RO-136 Kohli, Harbir P-243 Kojima, Yasuyuki O-057 Kok, Niels F.M. O-088 Kokai, Hidenaka P-346, P-356 Kokudo, Norihiro MO-056 Kolevski, Perko D. RO-121 Kolko-Labadens, Anne P-014 Kollmar, Otto O-034, RO-072 Kolonko, Aureliusz RO-002, RO-068, RO-188, RO-305 Kolsrud, Oscar P-153 Komar, Mateja RO-022 Konecka-Mrowka, Dominika P-169 Kong, Jin M. LB-P-074 Kong, Jin Min LB-P-083 Kong, Norella C.T. P-013 Knigsrainer, Alfred P-025 Knigsrainer, Ingmar P-025 Kopec, Waclaw P-273 Koppelstaetter, Christian MO-033, RO-106 Korczak-Kowalska, Grazyna P-131, P-132 Korevaar, Sander MO-003 Kormer, Arkady J. P-149, RO-158 Kormos, Robert L. P-041 Kornberg, Arno RO-037, RO-138, RO-261C Kornilov, Maxim N. P-108 Korom, Stephan RO-285 Kortekaas, Kirsten A. RO-242 Kosco-Villebois, Marie O-052 Koshiba, Takaaki O-027, O-309, RO-342 Koshima, Isao P-337 Koskinen, Petri P-200, RO-321 Kosmoliaptsis, Vasilis O-313 Kost, Sue O-090, O-095, RO-067 Kstenbauer, Sonja O-291, P-186, P-188, P-383 Koster, T.D. RO-238 Kostopanagiotou, Georgia P-058 Kostron, Arthur MO-031 Koszinowski, Ullrich MO-037 Kotsch, Katja O-055, O-154, O-250 Kottis, George P-058 Kotulski, Marcin P-354, RO-145

289

290

Kou, Jian-Tao RO-146 Kouhei, Naoki RO-316 Kousoulas, Lampros P-342 Kovac, Damjan P-220, RO-022 Kovac, Janko MO-002 Kovac, Katja MO-069, O-015 Kovacs, Agnes Z. RO-192 Kovcs, Dvid RO-130 Kovarik, J.M. P-097 Kovesdy, Csaba P. O-058, RO-020 Kovil Pillai, Selvarani P. P-063 Koyama, Ichiro P-202, P-249, P-250 Koyama, Isamu P-323 Koznarova, Radomira RO-337A Kraaijeveld, Rens O-119 Kraemer, Bernhard K. P-084 Kraemer, Irene P-106 Krajewska, Magdalena P-273 Krmer, Bernhard MO-040 Krmer, Bernhard K. O-037, O-196, P-293 Krapf, Christoph O-270 Kraus, Anna K. O-112, O-207, RO-112 Krause, Babett RO-261C Krause, Babette RO-138 Krawczyk, Marek P-354, RO-145 Kreis, Henri RO-267 Krejc, Karel LB-P-087 Krikke, Christina RO-070 Krishan, Sukh RO-102 Krishnan, Hari RO-026, RO-088, RO-170 Krishnaswami, Sriram O-329 Kristanto, Paulus RO-256 Kriste, Gnter O-187 Kroemer, Alexander O-029, O-224, P-029 Krogstrup, Nicoline V. RO-207 Krl, Robert P-343 Krger, Bernd O-196, P-293 Krystufkova, Eva O-285 Ksenofontova, Ann S. P-229 Kuba, Daniel LB-P-039 Kubik, Tomasz RO-300 Kubota, Keiichi O-039, P-045, P-112, RO-295 Kubota, Yusuke O-168 Kudla, Michal P-003 Kudlacz, Elizabeth O-329 Kudoh, Shinji P-249 Kugler, Christiance MO-086 Kulbokas, E.J. MO-041 Kulbokas, Ej O-244 Kuleshova, Lilia RO-243 Kuman, Milan P-086 Kumar, Avneesh P-005 Kume, Hisae P-339 Kumnig, Martin O-267 Kmpers, Philipp O-058 Kunert, Kristina O-250 Kpper, Bernadett RO-037, RO-138 Kurahashi, Hiroki MO-006 Kurnicka, Katarzyna P-232 Kurtulmus, Yusuf LB-P-027 Kusaka, Mamoru MO-006, O-168 Kusch, Angelika O-056 Kutschmann, Marcus O-187 Kuypers, D. O-289, P-087 Kuypers, Dirk CC-005, LB-P-062, O-156, O-157 Kuypers, Dirk R. RO-348 Kuypers, Dirk R.J. RO-256 Kuzan, Taha Yusuf RO-066 Kvarnstrm, Niclas O-069, O-075, RO-087 Kwak, Jin Young P-262 Kwakkel-van Erp, J.M. RO-238 Kwekkeboom, Jaap MO-070, O-206, O-209, O-222, P-122, RO-071 Kwiatkowski, Artur O-221

Kwon, Byungsuk O-178, P-140, P-204 Kwon, Choon Hyuck D. P-255, P-256 Kwon, Choon Hyuck David O-044 Kwon, Oh Jung P-261, P-262 Kwon, Owen RO-330 Kwon, Seog-Woon LB-P-057, LB-P-090 Kyllnen, Lauri P-200 Kyriakides, George O-069, O-075, RO-087 La Manna, Gaetano O-218, RO-013, RO-318 Labarga, Fernando P-352 Lachmann, Nils CC-018, O-103 Lacotte, Stphanie O-052, O-170 Ladenburger, Stephan RO-353 Ladrire, M. RO-274 Ladrire, Marc RO-267 Ladurner, Ruth O-132, P-025 Ladwig, Mechthild O-180 Lafon, Marie-Edith MO-047 Laging, Mirjam O-085, O-312, P-060 Lahdou, Imad MO-005, P-141 Lai, Ping Chin RO-258 Lai, Q. O-123 Lai, Quirino O-010, P-336, RO-065, RO-137 Lai, Wai Ming LB-P-115 Lakkis, Fadi O-265 Lakkis, Fadi G. O-269 Laleman, Wim O-098, O-129, O-296 Lambert Rodriguez, Jose Luis P-088 Lambrechts, Dieter RO-348 Lammert, Alexander O-196 Lamotte, Christian LB-P-043 Lamperti, Luca O-294, RO-036, RO-053, RO-134 Lampreabe, Ildefonso O-213, RO-259 Lamy, Franois-Xavier LB-P-043, LB-P-053 Lan, Shirley O-329 Landin, Luis O-269 Lang, Gyoergi RO-239, RO-240 Lang, Gyoergy P-196 Lang, Hauke RO-147 Lang, Philippe O-241, RO-266, RO-331, RO-338 Langenhuijsen, Hans J.F. LB-P-065 Langenhuijsen, Johan F. O-088 Langer, Carolin M. LB-P-008 Langer, Robert P-007 Langerak, Anton W. O-083 Langguth, Nadine O-314, O-315, O-316 Langham, Heather LB-P-084, LB-P-088 Languille, Eva P-014 Lnsk, Vera RO-216 Lantieri, Laurent O-328 Lanzetta, Marco O-328, P-048 Lao, Weijie P-167 Laouabdia, Karim P-051 Laporta, Rosala MO-030 Larpparisuth, Nuttasith P-015 Larriba, Julian M. O-287 Larsen, Christian P. O-240, O-242, O-244, RO-331 Lascar, Ioan P-048, RO-292, RO-293 Laszczynska, Maria LB-P-028 Latek, Robert MO-041 Lathelize, Hubert O-179 Lauenstein, Thomas P-353 Laufer, Guenther O-125, P-157, RO-154 Lauro, Augusto O-009, O-105, P-079, P-364, RO-307 Lautenschlager, Irmeli O-149, P-200, RO-321 Lauterio, Andrea O-294, RO-031, RO-036, RO-053, RO-134, RO-151 Lauzurica, R. P-090 Lavacca, Antonio O-130, P-049, P-267 Lavilla, Francisco Javier MO-027, P-011 Lawendy, Nervin O-329 Lazar, Alpar S. RO-279

Lazaro, Jose Luis MO-024, P-033 Lzaro, Teresa MO-030 Lazzaro, Silvia RO-140 Lazzarotto, Tiziana RO-351 Le, Hong-Nga T. P-204 Le Dinh, Hieu O-298 Le Gal, Sophie P-231 Le Mauff, Brigitte O-252 Le Moine, Alain O-322 Le Pogamp, Patrick RO-266 Le Toquin-Bernard, Sophie P-231 Leach, Joan MO-087 Lebadi, Mohammadkazem P-161 Leber, Bettina O-291, P-186, P-188, P-383 Lebranchu, Y. O-201, RO-165 Lebras, Yann RO-271 Lebray, Pascal CC-021 Lechevallier, Eric LB-P-080 Lechler, Robert I. RO-114 Leclercq, Isabelle LB-P-118 Lecorre, Nicole O-153 Ledinh, Hieu O-157 Lee, Andrew W.P. O-269, O-270 Lee, Chuen Neng RO-243 Lee, David D. RO-116 Lee, Hayng Ran P-262 Lee, Ho Kyun LB-P-031, LB-P-032, LB-P-037, LB-P-038 Lee, Hyo-Jun LB-P-023, LB-P-100, RO-261A Lee, Hyun Hee P-016 Lee, Jong S. O-178, P-140, P-204 Lee, Jong Hoon LB-P-016 Lee, Jong Hwan P-255 Lee, Ki-Young P-137 Lee, Po-Huang P-039 Lee, Samuel LB-P-003, P-178 Lee, Sang-Ho LB-P-067 Lee, Sanghoon O-044, P-137 Lee, Seung Hwan LB-P-020 Lee, Suk-Koo O-044 Lee, SungGyu LB-P-102, LB-P-107 Lee, Sung-Gyu LB-P-023, LB-P-090, LB-P-093, LB-P-100, RO-261A Lee, Tae-Won LB-P-067 Lee, W.P. Andrew LB-O-002, O-265, RO-261F, RO-296A, RO-296B Lee, Ying-Lung O-115 Leenanupunth, Charoen O-155 Lefaucheur, Carmen P-212 Legarda, Mara O-102, RO-042 Legendre, C. P-105, RO-119, RO-164, RO-274 Legendre, Christophe O-026, O-069, O-220, P-083, P-133, RO-087, RO-104, RO-118, RO-267 Legrand, Catherine RO-272 Lehmann, Sven O-231, RO-159 Lehmkuhl, H. O-203, O-238 Lehner, Frank O-140, O-141, O-199, P-342, RO-126, RO-353 Leivestad, Torbjrn LB-P-069, P-182, RO-211 Lekovski, Ljupco G. RO-121 Lemy, Anne O-322 Lengele, Benoit O-266, O-268 Lennerling, Annette O-070, O-264 Lennon, Veronica P-298, P-299 Len, Mirian P-266 Leopold, Barbara P-188, P-383 Lepreux, Sebastien O-151, RO-271 Leprince, Pascal CC-021, RO-069C Lerman, Lilach O. O-228 Lerut, Evelyne O-027, RO-006 Lerut, Jan LB-P-117, O-046, O-100, O-157, O-298 Leuvenink, Henri O-177, RO-070, RO-073, RO-207

Leuvenink, Henri G.D. LB-O-003, O-104, O-175, O-282, P-142, RO-005, RO-078, RO-080 Leventhal, Joseph O-310 Levi, David MO-059 Levi Sandri, Giovanni B. RO-065 Lewandowska, Dorota O-069 Lewandowski, Zbigniew P-284, P-285 Li, Bing P-164 Li, Jianping MO-074 Li, Jun O-132, P-025 Li, Li-Xin RO-146 Li, Mingyuan P-205 Li, Ping RO-146 Li, Shengbin P-043, P-210 Li, Shengqiao O-027 Li, Xian-Liang O-252 Li, Xue P-312 Li, Yang P-043, P-192, P-210, RO-175 Li, Ying RO-248, RO-342 Libbrecht, L. RO-075 Libbrecht, Louis O-301 Lichodziejewska, Barbara P-232 Lichodziejewska-Niemierko, Monika RO-016 Liden, Hans LB-P-109, P-153, RO-060 Liefeldt, Lutz P-221, RO-252 Lien, Bjrn H. O-005 Liese, Juliane P-030, RO-136 Lima, Bruno A. P-050 Lin, Cheng-Hung LB-O-002, O-265, RO-261F, RO-296A, RO-296B Lin, Chen-Sheng P-083 Lin, Ching-Yuang RO-230 Lin, Kuo-Jen P-008 Lin, Tao LB-P-002 Linchenco, Ana M. CC-016, P-203, P-268 Lindeman, Johannes H. RO-111, RO-242 Lindenmeyer, Maja T. O-207 Lindholm, Bengt RO-278 Lindic, Jelka RO-022 Lindner, Anett RO-279 Lindsey, Ben CC-001, O-006, P-207, P-294 Line, Pl-Dag O-069 Lipar, Kvetoslav RO-337A Lipkin, Graham O-059 Liquete, Rose Marie R. P-057 Lirosi, M.C. O-123 Lisman, Ton O-282 Litjens, Nicolle H.R. O-083, O-226 Little, Ann-Margaret P-260 Little, Mark P-147 Liu, Anding LB-P-030, LB-P-040, RO-261G Liu, Bo P-142 Liu, Kuan-Lin P-008 Liu, Liang Q. O-263 Liu, Q. RO-075 Liu, Zhihong P-312, P-313, RO-127 Liu, Zhi-hong RO-190 Llado, Laura MO-022 Llaud, Ines RO-100 Lledn, Dolores P-373 Lloberas, Nuria RO-100 Llorca, Javier O-300 Llosa Cortina, Juan Carlos P-088 Lobrinus, Johannes A. O-173 Locaidou, Marina RO-063 Locatelli, Giuseppe P-370 Locsey, Lajos P-269, RO-130 Logan, Lesley LB-P-018 Loginov, Raisa O-149 Loi, Patricia P-274 Lomas, D. RO-144 Lombaerts, Rita O-156, O-280 Lopes, Daniela S.M. RO-322 Lopes, Elsa P-092 Lpez, Carlos RO-288

291

Lopez, F. Lopez, P.

292

P-270 O-148, O-203, O-204, O-235, O-236, O-237, O-238 Lopez, Susana RO-231 Lpez, Vernica P-263, P-264, P-265, P-266 Lopez-Andreu, Maria O-195 Lopez-Andujar, R. P-327 Lopez-Hoyos, Marcos P-098 Lpez-Santamara, Manuel P-373 Lopota, Alexander O-164 Lorant, Tomas RO-211 Lordan, James L. RO-241 Lordan, Jeffrey T. RO-034 Lorenzin, Dario O-041, P-032, RO-047, RO-092, RO-247, RO-254, RO-276 Lorenzini, Stefania MO-058 Lorenzo, Dolores P-281 Lorenzo Pelayo, Sara P-099, P-331 Lorf, Thomas LB-P-025, O-306 Lscher, Wolfgang O-267 Loss, George E. P-329 Loss, Julika MO-069, O-015 Loss, Martin MO-069, O-015, P-029 Lotfy, Esam A. RO-014A Loven, Charlotte O-264 Lu, Y.M. P-127 Lu, Yiping O-004, P-205, RO-320 Luchtenburg, A.E. MO-085, O-259 Lucia, Marc O-284, RO-109, RO-284 Lucianetti, Alessandro P-370, RO-059, RO-229, RO-236 Lucidi, Valerio O-298 Ldemann, Lutz LB-P-008 Luer, Bastian O-032 Luetgehetmann, Marc O-223 Luft, Friedrich C. O-180 Luijk, H.D. RO-238 Luisa, Pasulo P-363 Lukitsch, Ivo O-180 Lundie, Sarah CC-019 Lupo, F. O-123 Lupo, Francesco O-038, RO-213 Lupo, L. O-123 Luppi, Mario P-077 Lupu, Anca P-048 Lutz, Jens O-288 Luyt, Charles Edouard CC-021 Luzo, Angela C.M. RO-181 Ma, Jun RO-146 Ma, Lap Tak LB-P-115 Ma, Shaoxiang O-004 Maat, Lex P.W.M. MO-035 Mac Gregor, Brigitte RO-195 Macrio, Fernando P-227 Macas, Rosa P-328 Machaal, Ali O-274 Machalekova, Katarina MO-029, P-012 Machcinska, Maja P-132 Machein, U. P-097, P-105 Maciejewski, Jaroslaw P-116 MacKinnon, Alison O-253 Mckov, Nadezda MO-029, P-012 Macnair, Andrew RO-241 Macphee, Iain O-216 MacPhee, Iain RO-310 MacPhee, Iain A.M. O-286 Madhoun, Philippe O-322 Madi, Mohammed RO-344 Maehara, Yoshihiko O-040 Maeyama, Ryota P-201 Maffi, Paola LB-P-012, O-169, O-174 Magalhes, Hlio P-156 Maggs, Tim P. O-124 Magini, Giulia LB-P-091 Magistretti, Paola LB-P-012, O-174 Maglione, Manuel O-023, O-114, RO-245

Magnani, Gaia RO-155 Magnasco, Alberto O-320 Magni, Beatrice RO-140 Magnusson, Anders O-017 Mahfoudh-Boussaid, Asma MO-072 Mahmoud, Khaled P-126 Mahmoud, Sabah A. LB-P-058 Mahr, Stephane P-157 Mahr, Stephane L. RO-161 Maiello, Ciro P-155 Maier, Herbert T. RO-035 Mair, Sabine RO-106 Majno, Pietro O-008 Majno, Pietro E. O-108, P-347, P-348 Majo, Joaquim P-162 Maksymowicz, Michal MO-073 Malacrida, Roberto RO-086 Malago, Massimo P-350 Malaise, Muriel O-029 Malcus, Cristophe O-266 Malejczyk, Jacek P-284, P-285 Malek, Ivan P-209 Malek Hosseini, Seyed Ali LB-P-095 Malekhosseini, Seyed Ali LB-P-098, LB-P-099, LB-P-112 Malekpor, Zahra P-130 Mallat, Marko J. O-021 Mallet, Vanessa O-176 Maltsevs, Aleksandrs P-177 Malvi, Deborah LB-P-015 Mal, Jan RO-216 Mammas, Constantinos S. P-058 Mamode, Nizam CC-014, O-124, O-134, O-264, P-059, P-238, RO-084, RO-202, RO-227, RO-269 Manara, Renzo O-330 Manarini, Gloria LB-P-077 Manas, Derek P-367 Manas, Derek M. LB-P-001, O-167, P-359 Mancham, Shanta O-209 Manfro, Roberto P-083 Mangoni, I. O-123 Mangoni, Iacopo O-294, RO-031, RO-036, RO-053, RO-134 Mangus, Richard S. O-304, RO-184 Mannonen, Laura P-200 Manrique, Alejandro P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Manrique, Ricardo P-156 Manu, Marcian Antonio P-218 Manuelli, Matteo RO-354 Manyalich, Mart O-069, O-075, RO-087, RO-099, RO-304 Manzia, T. O-123 Manzia, Tommaso M. O-010, RO-137 Manzia, Tommaso Maria RO-354 Manzione, Ana M. O-130 Mao, Qi LB-O-002, RO-261F Marang-van de Mheen, Perla P.J. LB-P-082 Marcanti, Maddalena P-179 Marcen, R. P-194, P-234, RO-187 Marcen, Roberto O-213, RO-259 Marchand, Etienne O-179 Marchetti, Piero MO-061, MO-064 Marchini, Francesco O-002, P-160, P-206 Marchal, Cline P-253 Mareri, Maura RO-098 Maresca, Maria C. RO-113 Margreiter, Raimund O-267, O-269, O-270, RO-245 Mara Dolores, Navarro LB-P-073 Mara Dolores, Redondo LB-P-073 Mara Jos, Prez-Sez LB-P-073 Mara Luisa, Agera LB-P-073 Maria Rosaria, Campise LB-P-061

Mariat, Christophe RO-266 Marn, Luis Miguel P-320, P-321 Marn, Mnica O-303 Marn Gmez, Luis M. P-344 Marino, Maria MO-023, P-362, P-363, RO-150 Mark, Julia O-198 Mark, Patrick B. MO-004, O-064, O-084, RO-028 Mark, Walter O-114 Marks, Stephen RO-206 Marks, Stephen D. CC-004, O-124, RO-018, RO-200 Marks, Steve MO-007 Mrquez, Eva RO-128 Marra, Claudio P-155 Marson, Lorna MO-046, O-253 Marson, Lorna P. O-311 Marszall, Marcin RO-278 Martnez, Dolores P-263 Martnez, Jorge RO-217, RO-246 Martnez, Josee Mara P-352 Martnez, Mnica RO-217, RO-246 Martnez, Montserrat RO-087 Martel, Cecile LB-P-123 Martin, Kirsty O-121 Martn, Mnica P-264 Martin, Paloma MO-027 Martin, Pierre-Yves RO-352 Martin, Sandra P-053 Martin, Sean MO-053 Martin, Xavier RO-064 Martin Fernandez, Maria P-088 Martinez, Francisco MO-059 Martinez, Maria Jos MO-011 Martinez, Ruth P-351 Martino, Francesca P-230 Martins, La Salete RO-009, RO-333 Martorell, Jaume J. O-099 Martorelli, Giacomo RO-040 Maruyama, Takahiro MO-006, O-168 Marzinzig, Michael P-073 Maschan, Alexey A. O-319 Masetti, Marco RO-155 Masin, Jelka P-287 Masin, Jelka G. RO-121 Masnou, Nria O-278 Mason, Phil O-089 Massari, P.U. P-270 Massart, Annick O-322, P-089 Massey, E.K. MO-084, MO-085, O-259 Massey, Emma RO-089 Massey, Emma K. MO-088, O-264, P-060 Massina, Maria P-267 Massip-Salcedo, Marta P-330 Masson-Charvier, Solange RO-173 Mastoridis, Sotiris O-086, P-271, RO-010, RO-299 Matarranz Sanz, Amaia P-091 Matas, David P-061 Matesan, Raluca RO-327 Matheussen, Veerle RO-285 Mathuram Thiyagarajan, Umasankar P-006, P-123, P-143, P-272, RO-110 Matos, Ana Cristina C.C. RO-163 Matouskova, Madga RO-296C Matsuda, Hiroaki MO-051, O-292 Matsui, Zenichi RO-024 Matsumoto, Shinichi O-120 Matsuyama, Masahide RO-117 Mattei, M. F. O-204 Mattei, Marie F. P-152 Matthews, Bev LB-P-071, LB-P-072, P-219 Matthews, Beverley LB-P-084, LB-P-088 Mattiussi, Elisa LB-P-048, LB-P-049, LB-P-051

Mattos, Ana Cristina C.C. P-289 Mattosinho, Thiago RO-055 Maule, Gabriel B. O-287 Maurin, Charlotte LB-P-080 Mauro, Raiteri LB-P-061 Maxwell, Andy O-069 May, Gottfried RO-182 Mayer, A.D. LB-P-006 Mayer, David CC-008, RO-069B, RO-261H Mayer, David A. RO-034 Mayer, Gert RO-106 Mayhauser, Ursula P-186 Mayrhauser, Ursula O-291, P-188, P-383 Mazanowska, Oktawia P-273 Mazonakis, Emanolis P-197 Mazonakis, Manolis P-082 Mazouz, Hakim RO-123 Mazuecos, Auxiliadora O-195 Mazza, Ernestina RO-044, RO-052, RO-212 Mazza, Maria RO-223 Mazza, Mara C. P-375 Mazzaferro, V. O-123 Mazzali, Marilda RO-208 Mazzucco, Alessandro P-159 Mc Gregor, Brigitte O-159 McCaig, Fiona CC-019 McCaughan, Geoffrey O-192, RO-261D McCloskey, Daniel LB-P-041 McCormack, Ann O-254, RO-289 McCormack, Lucas MO-055 McCormack, William O-028 McCracken, Lora LB-P-013 McCulloch, Mignon I. P-378 McCurry, Kenneth O-272 McDaid, James P-278 McDermott, Jen RO-063 McGlynn, Liane M. MO-033 McGoldrick, Rory LB-P-070 McGowan, Neil LB-P-013 McGuinness, Dagmara LB-P-056, MO-033 McKeown, Dermot RO-069A McLaughlin, Kevin O-064 McLean, Adam G. O-135 McQuarrie, Emily P. O-084 McQuillan, Tom LB-P-013 Meachery, Gerard RO-241 Meas Yedid, Vannary O-159, RO-195 Mecarelli, Lise O-026 Meule, Aurela RO-357 Medhat, Yasser O-045 Medina Pestana, Jos P-083 Medina Pestana, Jos O. O-241, O-242, RO-183, RO-322 Meier, Raphael O-171, O-173, RO-172 Meiffredy, Vincent O-153 Meijer, R.C.A. RO-238 Meinders, Arend-Jan O-281 Meinitzer, Andreas RO-261I Meiser, Bruno O-125, O-230, O-239, P-020, RO-237 Mejia IV, Pedro L. P-057 Mejzlik, Vladimir P-086 Meland, Nils RO-211 Melandro, Fabio RO-065 Melanie, Naether O-049 Melchior Hansen, Jesper LB-O-004 Meli, Athinoula RO-289 Melilli, Edoardo O-284 Mellor, Stephen J. O-096, RO-088, RO-170, RO-171 Mellor, Steve J. RO-026 Melrose, Zoe RO-310 Melton, Larry B. LB-O-001, RO-349 Melzi, Raffaella O-053, O-169, O-174 Mendes, Ceclia P-129 Mendes, Filomena P-115

293

294

Mendez, Jr., Rogelio Q. P-324, RO-297 Meneghesso, Davide RO-228 Menger, Michael D. O-030, O-034, RO-033, RO-072 Mengoli, Carlo O-150 Menjvar, Ana O-075, RO-087 Mnoret, Sverine O-252 Mensah, Fane MO-003 Mentha, Gilles O-008, O-108, O-170, P-347, P-348 Merani, Shaheed O-008, O-108 Mercalli, Alessia O-169, O-174 Mergental, Hynek CC-008, CC-009, RO-034 Merino, Daniel P-062 Merkeli, Bela O-234 Merli, Manuela P-304, P-336 Merlini, Federica O-174 Mertzger, Daniel RO-176 Merville, P. RO-119 Merville, Pierre MO-047, O-071, O-082, O-151, RO-093, RO-271 Mesotten, Dieter O-098, O-129 Messa, Piergiorgio RO-113 Messina, Maria O-130, P-049 Messner, Barbara O-114 Mestre, Jaume O-278 Mestres, N. O-297 Metalidis, Christophe LB-P-062 Metselaar, Herold RO-169, RO-261B Metselaar, Herold J. MO-020, MO-070, O-206, O-209, O-222, P-122, RO-051, RO-071, RO-132 Meurisse, Michel O-157 Meurisse, Nicolas CC-007, O-129, P-031 Meurman, Jukka H. RO-046 Meyfroidt, Geert O-098, O-129 Meyns, Bart P-031 Mezza, Elisabetta P-049 Michallet, Mauricette O-268 Michel, Klaus H. RO-147 Michel, Philippe P-180 Michielsen, Peter O-298, RO-057 Micu, Laurentiu P-181, P-345 Midtvedt, Karsten LB-P-069, O-144, P-010, P-182, RO-017, RO-194 Migliaccio, Carla P-357, RO-221 Miglioresi, Lucia MO-023, P-362, P-363 Mihaila, Mariana P-181, P-345 Mihly, Sndor P-068 Mihara, Makoto P-337 Mihaylov, Plamen O-294, RO-031, RO-036, RO-053, RO-134 Mikhalski, Dimitri P-089, P-274 Mikhlaski, Dimitri O-157 Miki, Katsuyuki P-249, P-250 Milan, Arlete RO-167 Miller, Charles O-308 Miller, David LB-O-211A Miller, Malcolm RO-050, RO-141 Miller, Paul O-216 Milne, Sarah CC-019 Miloserdov, Igor A. P-108 Miltenyi, Stefan LB-P-054 Mimmo, Antonio RO-043, RO-150 Min Trih Ngo, Trieu O-179 Miambres, Eduardo O-300 Minh Tri Ngo, Trieu O-176 Minor, Thomas O-032 Minz, Mukut P-243 Mir, Marisa O-152, O-303, P-191, RO-128 Mirabella, Stefano RO-213 Miranda, B. O-297 Miranda, Blanca MO-012, O-165, O-166, RO-090 Mirandola, Rina P-179 Miras, M. P-090

P-149 LB-P-006, RO-283 CC-008, CC-009, O-188, O-189, RO-261H Mirza, Darius F. O-317, RO-034 Misdrahi, David O-071 Mistretta, Antonio O-074 Mitchell, Annie P-052 Mitchell, David RO-335 Mitchell, Donna L. LB-P-013 Mito Pretorian, Maria P-173, P-239 Mitsui, Yozo P-024 Mittal, Prabal P-294 Mittal, Shruti RO-209 Mitterhofer, Anna Paola P-022, P-304, RO-045, RO-357 Mittler, Robert S. O-178 Mitu-Pretorian, Maria O. P-368 Mitu-Pretorian, Otilia M. MO-060, O-003, O-092, P-310 Mitu-Pretorian, Otilia Maria RO-337 Mitu-Pretorian, Otilia-Maria MO-068 Miura, Kohei P-346, P-356 Miura, Yoshikazu P-045 Miyagi, Shigehito P-340 Miyazawa, Mitsuo P-323 Mizutani, Kazuo P-275 Mjen, Geir O-005, P-182, RO-264 Mjrnstedt, Lars LB-O-004 Mlinek, Gregor RO-203, RO-204 Moal, V. RO-119 Mocchegiani, Federico RO-040 Modolo, Maria M. O-121 Moench, Christian MO-015, MO-067, O-305, P-030 Moench, Kerstin O-327 Moers, Cyril LB-O-003, RO-080 Moes, Dirk J. RO-329 Mogl, Martina LB-P-008 Mogl, Martina T. LB-P-010, LB-P-011 Moguillansky, Silvia P-375 Mohamed, Hazem O-045 Mohamed, Ismail P-006 Mohr, Friedrich W. O-231, P-139, RO-159, RO-302 Moir, Johm LB-P-050 Moisan, Fabrizio RO-217, RO-246 Moisiuk, Jan LB-P-121, RO-355 Moldovan, Bogdan P-347, P-348 Mldrup, Ulla RO-207 Molina, Victor MO-022 Moll, Solange RO-352 Molnar, Miklos Z. O-058, RO-020, RO-192, RO-279 Molnar-Varga, Marta RO-192 Mombelli, Cesar A. O-287 Monaco, Andrea RO-261H Monbaliu, D. RO-032, RO-075 Monbaliu, Diethard CC-005, CC-007, O-046, O-098, O-100, O-129, O-156, O-157, O-296, O-298, O-301, P-031, RO-006 Mnch, Christian RO-136 Monfared, Ali P-161, P-276 Monica, Carini LB-P-061 Monostory, Katalin O-293 Monsalve, Conchita P-279 Montalti, R O-123 Montalti, Roberto MO-057, P-034, RO-043, RO-135, RO-150, RO-255, RO-326 Montanaro, Domenico P-230 Monteiro, Manuela P-115, P-129 Montero, Edna F.S. MO-054, RO-250 Montero, Milagro O-152 Monti, Giangiacomo P-357, RO-221 Montori, Giulia RO-077 Moon, Deok-Bok LB-P-100

Mironkov, Boris L. Mirza, D.F. Mirza, Darius

O-044, P-137, P-255, P-256 Moon, In Sung P-257, P-258 Moon, In-Sung P-254 Moon, Jang MO-059 Moon, Joo-Young LB-P-067 Moon, Young Nam P-255 Moore, Jason O-059 Moore, Richard O-288 Mor, Eytan CC-013, O-321, RO-012 Mor, Maya RO-012 Morad, Wassam S. LB-P-103 Morales, Carlos P-088 Morales, J.M. RO-021, RO-324 Morales, Jos P-083 Morales, Jose M. O-213, RO-259 Morales, Jose Maria P-216, RO-199 Moran, Stephen L. RO-294 Moran, Steven L. CC-003 Morard, Isabelle P-347, P-348 Morath, C. LB-P-068 Morath, Christian LB-P-024, P-277 Mordenti, Michela RO-045 Moreau, Francois O-116 Moreau, Karine MO-047, O-082, RO-271 Morel, Delphine O-082 Morel, Fabrice LB-P-122 Morel, Philippe O-008, O-052, O-108, O-170, O-171, O-173, P-347, P-348, RO-173 Morelli, Cristina O-009, P-079, RO-307, RO-351 Morelli, Maria Cristina MO-058, O-202 Morellon, E. RO-274 Morelon, Emmanuel O-071, O-153, O-159, O-171, O-220, O-266, O-268, O-271, RO-195 Moreno, Enrique P-001, P-038, P-158, P-170, P-193, RO-058, RO-143, RO-149, RO-219, RO-220 Moretti, Diane RO-086 Morgan, Robert D. RO-265 Mori, Hiroki O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Morikawa, Yasuhide P-187 Morimoto, Takeshi O-309 Morin, Marie-Pierre O-071 Morine, Yuji O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Mornex, Jean Franois RO-232 Moro, Margherita RO-328 Moroso, Viviana O-222, P-122 Morovat, Reza RO-082 Morozova, Vera LB-P-121 Morrey, Mike A. RO-294 Morris, Peter J. O-263, RO-265 Morsy, Mohamed RO-007, RO-083 Morten, Karl RO-082 Mosavian Roshanzamir, Seyed Amin P-276 Mosca, Franco MO-061 Mosselman, Machteld O-281 Mostafa, Mostafa A. RO-014A Moszkowska, Grazyna P-224 Mota, Alfredo P-227 Mota, Joo RO-306 Motallebzadeh, Reza O-048, O-050 Motta, Leonardo T. RO-250, RO-251 Motta, Leornado T. MO-054 Mottalebzadeh, Reza O-117 Mouchel, Yann LB-P-122 Moulin, B. O-201 Moulin, Bruno CC-015, O-071, O-217 Moulisova, Vladimira LB-P-033 Mourad, Georges RO-267 Mourad, M. O-246 Mourad, Michel O-157, RO-263, RO-272

Moon, Hyung Hwan

O-030, O-034, RO-033, RO-072 Mousson, Christiane RO-266 Mouton-Faivre, Claudie LB-P-007 Mownah, Omar P-288, P-382 Mownah, Omar A. P-162, P-163, RO-129, RO-152, RO-153 Moya-Rull, Daniel P-113 Moysyuk, Yan O-164 Moysyuk, Yan G. P-108 Mraiagh, Fatiha RO-195 Mrzljak, Anna P-040 Mucsi, Istvan O-058, RO-020, RO-192, RO-279 Mudrikova, Tania O-197 Muehlbacher, Ferdinand MO-036, O-012, RO-331 Muehlbacher, Jakob O-012 Mueller, Dominik N. O-180 Mueller, Gerhard A. RO-106 Muffak-Granero, Karim P-328 Mhlbacher, Ferdinand MO-008, P-303 Mui, Alice RO-176 Muiesan, P. LB-P-006 Muiesan, Paolo CC-008, LB-P-004, MO-052, RO-034, RO-261H Muiesan, Paulo MO-078 Mukherjee, Pinaki P-243 Mulgaonkar, S. RO-350 Mulgaonkar, Shamkant LB-O-001, RO-349 Mulhearn, Marie O-192 Muller, Elmi P-252 Mller, Steve P-069 Mller, Tobias J. CC-020 Muller, Yannick O-052, O-171, RO-172 Muller, Yannick D. O-173 Mllhaupt, Beat O-122 Mulloy, Laura P-080 Mumford, Lisa O-126, O-127, P-119 Munene, James P-279 Mungai, Peter P-279 Munneke, Anita J. O-275 Muoz, Emma O-278 Muoz, J. RO-056 Muoz, Miguel A. P-281 Muoz-Bartolo, Gema P-373 Muraishi, Osamu RO-004 Murakami, Reiichi P-144 Murakami, Toru P-112, P-202, P-249, P-250, RO-295 Muramatsu, Masaki RO-001, RO-024 Murer, Luisa MO-045, RO-224, RO-226, RO-228 Muriel, A. P-194 Murio, Enric RO-210 Murphy, Cara P-174, RO-069B Murphy, N. RO-283 Murphy, Paul MO-016 Musaad, Ahmed P-085, P-244 Musquera, Mireia RO-090 Musumeci, F. O-148, O-204 Muthusamy, Anand RO-062 Muto, Takashi P-045 Mypaciente-2 Study Group P-090 Myslak, Marek CC-011, MO-042, MO-044, O-065 Nacchia, Francesco RO-186 Nadal, Beln P-113 Nadal, Elena RO-309 Nadalin, Silvio O-132, P-025 Naesens, Maarten LB-P-062 Nafady-Hego, Hanaa RO-342 Nafteux, Philippe O-273 Nagaraja, P. O-163, RO-268 Nagaraja, Pramod P-246 Nagib, Ayman Maher MO-013

Moussavian, Mohammed R.

295

296

Naik, M. G. LB-P-068 Naik, Marcel G. LB-P-024 Naik, Prashant P-350 Naim, Fakih RO-149 Nainan, Georgy O-245 Nair, Prasad P-085, P-244 Nakagawa, Yuki O-133, RO-168 Nakajima, Daisuke O-276, O-277 Nakajima, Ichiro P-202, P-249, P-250 Nakaya, Miho MO-006 Nakazawa, Shigeaki P-280 Namgoong, Jung-Man LB-P-089 Namgung, Jung-Man LB-P-023, RO-261A Nampoory, M.R.N. P-085, P-244 Nani, Roberto P-028 Nankivell, Brian J. MO-028 Nanmoku, Koji P-307 Nanni Costa, Alessandro O-069, RO-098 Nano, Rita O-169, O-174 Nardozza, Marianna RO-155 Narushima, Mitsunaga P-337 Nashan, Bjoern O-223, O-314, O-315, O-316, O-318, P-259, P-374, RO-039 Naso, Agostino P-160 Nasr, Isam O-269 Nasralla, David RO-335 Nassar, Wael F. RO-014A Nastase, Anca P-135 Nastasi, Valentina LB-P-077 Nath, Jay O-096, P-278, RO-026, RO-088, RO-170 Navarra, Teresa MO-039A Navarro, Alex P. O-035, P-286 Navarro, Francis O-043, O-190 Navarro, Joaquin O-154 Navarro, Mara Dolores P-213 Navasa, M. O-297 Navasa, Miquel MO-018 Naveilhan, Philippe O-330 Navis, Gerjan RO-005, RO-015, RO-115 Navratil, Pavel P-282, P-283 Negus, M. O-109, O-326 Negus, Margaret C. O-110 Nehls, Kerstin LB-P-008, LB-P-010 Neil, D.A RO-283 Neil, D.A. RO-034 Neil, Desley CC-009 Neimatallah, Mohamed O-045 Neipp, Michael RO-147 Nel, Daniel P-252 Nemec, Petr P-086, RO-160 Nemes, Balazs O-293 Neri, Daniele O-128 Nesher, Eviatar RO-012 Nette, R.W. MO-084 Neuberger, James RO-069B Neuhaus, Peter CC-018, O-055, O-103, O-106, O-225, RO-244, RO-286, RO-353 Neuhaus, Ruth O-106, O-225 Neumann, Juliane RO-148 Neumann, Ulf P. O-106 Neumayer, Hans H. P-221, RO-252 Neumayer, Hans-Hellmut O-243 Neurohr, Claus RO-237 Nevens, F. RO-032 Nevens, Frederik CC-005, O-098, O-100, O-129, O-156, O-296, O-298, RO-260 Neves, Marta P-227 Neveu, Isabelle O-330 Newell, Kenneth RO-114 Neyrinck, Arne O-098 Ng, Eng-Khim P-240 Ng, Timothy W. LB-O-002, RO-296B Ngigi, John P-279 Ngoufet, Rostand M. RO-186 Nguyen, L. RO-164

Nguyen, Tien RO-051 Nguyen Quang, Michael O-196 Nicholson, Michael L. LB-O-005, P-002, P-006, P-123, P-143, P-237, P-272, RO-014, RO-110 Nicholson, Prof Michael L. O-019, P-217, RO-027 Niclauss, Nadja O-171, O-173 Nicol, David CC-001, O-006, P-207, P-294 Nicolas Robin, Armelle RO-069C Nicolini, D. O-123 Nicolini, Daniele RO-040 Nicolotti, N. O-123 Nicolucci, Antonio RO-140 Nielles-Vallespin, S. RO-173 Nielsen, Dirk P-374 Nierlich, Patrick P-196 Niesing, Jan O-283 Nieuwenhuijs, Vincent RO-070 Nieuwenhuijs, Vincent B. O-104 Niimi, Masanori MO-038, O-211, P-136, RO-339, RO-340, RO-346 Nijkamp, Danielle M. O-283 Nikeghbalian, Saman LB-P-095, LB-P-098, LB-P-099, LB-P-112, P-130 Nikonenko, Olexander S. P-305 Nikonenko, Tamara M. P-305 Nilsson, Bo O-018 Nilsson, Thomas O-018 Ninkovic, Marina O-267 Nishida, Seigo MO-059 Nishimura, Kenji P-211, P-280 Nisi, Katia RO-318 Niven, Pamela LB-P-018 Nizzi, Maruska C. RO-311 Nnang Obada, Erica RO-327 Noblejas, Ana RO-341 Nobori, Shuji RO-117 Nocco, Angela O-320 Nocera, Arcangelo O-320, P-292, P-371 Noel, Laure-Hlne O-026 Noguchi, Fumino P-056, P-109 Nogueira, Eliana RO-163 Nogueras, Flor P-328 Noh, Young Nam P-256 Nojima, Michio P-297, P-308 Nonomura, Norio O-057, P-248 Noormohamed, Mohammed Saleem O-035 Noormohammed, Saleem O-301 Noppert, Susie-Jane RO-106 Noraziah, N. P-240 Norby, Gudrun P-182 Norby, Gudrun E. RO-264 Norero, Blanca RO-217 Nrregaard, Rikke RO-207 Nortley, Mei RO-007 Noujaim, Huda M. MO-054, RO-250, RO-251 Novacic, Karlo P-040 Novak, Marta RO-192, RO-279 Novials, Anna P-113 Novoa, P. P-270 Novotny, Alexander RO-261C Nowicki, Michal O-288 Nowocin, Anna RO-290 Nozaki, Taiji RO-011 Nozynski, Jerzy P-169, RO-157 Nuesslein-Hildesheim, Barbara MO-074 Nukui, Akinori RO-004 Nyarera, Divinia P-279 Nyckowski, Pawel RO-300 Obara, Hideaki P-187 Obed, Aiman LB-P-025, O-305, O-306 Oberbauer, Rainer MO-036 Oberhuber, Rupert O-023, O-114, P-326, RO-245

Oberkofler, Christian E. O-122 Oblak, Manca RO-124, RO-204 OBrien, Benjamin O-086, P-271, RO-010, RO-299 Obrist, Peter O-023, RO-245 OCallaghan, John M. RO-265 Occhipinti, Margherita MO-064 OConnell, Philip O-329 ODonnell, Patrick J. RO-084 ODonoghue, Donal LB-P-071, LB-P-072, LB-P-084, LB-P-088, P-219 Oettl, Karl P-188 Oezcelik, Arzu RO-041 Ogawa, Nobuji P-323 OGrady, John O-290 Ogura, Masaomi P-151 Oh, Chang-Kwon LB-P-016 Oh, Heung-Bum LB-P-057 Oh, Joon Seok LB-P-066, P-138 Ohe, Hidenori O-309, RO-342 Ohsumi, Akihiro O-276, O-277 Ohta, Kosuke P-195 Ok, Ercan P-021, P-242 Okada, Katsuya P-323 Okajima, Hideaki RO-117 Okamoto, Masahiko RO-117 Okidi, Okechukwu O. RO-334 Okumi, Masayoshi O-057, P-248 Okuno, Ayako P-280 Olagne, Jrme O-217 Oldak, Monika P-284, P-285 Olek, Sven RO-284 Olivares, Jesus O-323 Olivares, Sergio P-001, P-158, P-170, P-193, RO-058, RO-149, RO-219, RO-220 Oliveira, Albanita V. P-096 Oliveira, Gerardo P-129 Oliveira, Jenaine RO-208 Oliveira, Joan P-096 Oliveira Cunha, Melissa P-368 Oliveira-Cunha, Melissa RO-337 Oliver, J. RO-324 Olivier, Eva O-278 llinger, Robert MO-031, O-193, P-326 Olmedo, Carmen P-328 Olsburgh, Jonathon RO-201, RO-202, RO-269 Olsen, Inge C. O-144 Olszewski, Waldemar L. MO-073, P-044, P-168, P-316, RO-180 Omar, Faisal MO-080 Omarjee, Saleha P-075 Omnell-Persson, Marie MO-080 Omoto, Kazuya O-138, RO-011 Ondrasek, Jiri P-086, RO-160 Oniscu, Gabriel C. CC-019, O-121 Ono, Gislaine RO-322 Op de Beeck, Bart RO-057 Opelz, Gerhard MO-005, MO-034, O-214, O-307, O-324, P-126, P-141, P-277, RO-103, RO-108 Oppenheimer, Federic CC-012, P-279 Oppenheimer, Federico O-213, P-221, RO-259 Oppenheimer, Federico F. O-099 Oppenheimer, Frederic O-165, O-166, RO-090 Orban, Marek RO-160 Orlova, Olga V. P-149, RO-158 Ormerod, Oliver P-358 Orozakunov, Erkinbek RO-198 Orozco, Federico MO-055 Orr, Honeylet RO-063 Orr, Zvika MO-081 Orsaria, Maria RO-047 Ortega, F. P-090, RO-324

Ortega, Francisco RO-288 Ortega, Francisco J. P-281 Ortega, Ivn O-076 Ortega, Juan O-102, RO-042 Orti, Rafael MO-018 Ortiz, C. P-327 Ortiz, Jorge MO-018 Ortiz de Urbina-Lopez, Jorge P-091 OShaughnessy, Aisling O-028 Osmanov, Shahin P-027 straat, Ernst . RO-207 Osuna, Antonio O-195 Otero, Alejandra MO-018 Ottens, Petra J. P-142 Otterbein, L.E. MO-031 Otto, Gerd O-295, P-106, RO-038 Ou, Dawei RO-176 Ourahma, Saida RO-069C Oussalah, Sihem P-017, P-018 Ovens, Jrg P-126 Oweira, Hani P-141 Oya, Hiroshi P-346, P-356 Oyagez, Itziar O-219 yen, Ole O-005, P-182 Oyen, Raymond LB-P-062 Ozaki, Michitaka O-208, P-151 Ozer, Cigdem MO-075 Ozkahya, Mehmet P-021 Ozkan, Oktay P-247 Ozkan, Omer O-328 Ozsay, Oguzhan RO-198 ztrk, Arzu P-293 ztrk, Nuray RO-066 Ozzella, Giuseppina P-124 Pabisiak, Krzysztof MO-042 Pacheco-Snchez, David P-351, P-352 Pacheco-Silva, Alvaro P-289, RO-163 Pacilio, Rosa RO-140 Pacini, Giovanni MO-008 Pacovsky, Jaroslav P-282, P-283 Paczek, Leszek P-066 Padberg, Winfried O-198, O-307, O-324 Padillo, Francisco Javier P-321 Padillo, Javier P-320 Padillo Ruiz, Javier P-344 Padoan, Angelo O-330 Padra, Janos P-269 Padrissa-Alts, Sussagna MO-071, O-020, RO-076 Pez, Gloria RO-304 Pagano, Duilio O-074 Palacio, Ana P-279 Palese, Alvisa RO-092 Pallard, Ll. RO-324 Pallardo, Luis O-213, RO-259 Pallet, Nicolas P-133, RO-104, RO-118 Pallmann, Florian O-196 Palmer, Anne MO-009 Palmer, Rebecca LB-P-070 Palmieri, Giampiero RO-354 Palomo, Jesus O-154 Pal, Giorgio O-150, P-206 Paluszkiewicz, Rafal P-354 Pan, Qiuwei O-222 Pan, Xiaoming P-043, P-192, P-210 Panaro, Fabrizio O-043, O-190 Panov, Ivo O-051 Papa, Kassim P-117 Papachristou, Christina O-075, RO-087 Papalois, Vasilios LB-P-120 Papalois, Vasillios RO-249 Papalois, Vassilios MO-077, O-086, P-271, RO-010, RO-063 Papalois, Vassilios E. RO-299 Paradela, Marina RO-235 Parafiniuk, Miroslaw LB-P-028

297

298

Paragh, Gyorgy P-269 Parameshwar, J. O-148 Parapiboon, Watanyu O-155 Pararajasingam, Ravi MO-060, MO-066, MO-068, O-003, O-090, O-092, O-095, P-239, P-310, P-368, RO-067, RO-334, RO-337 Paredes, David MO-012, O-014, O-069, O-165, O-166, RO-087, RO-090, RO-099 Parente, Paola P-064 Parigi, Piercarlo RO-236 Paris, Sara RO-108 Parisotto, Chiara P-070 Parissiadis, Anne CC-015 Park, Cheon-Soo LB-P-090, LB-P-093 Park, Chun-Soo LB-P-023 Park, Chun-Su RO-261A Park, Gil-Chun LB-P-089 Park, Hee-Sung LB-P-023, RO-261A Park, Hyeong-Woo LB-P-090, LB-P-093 Park, Hyung-Woo LB-P-100 Park, Jae Berm LB-P-057, LB-P-079, LB-P-081, LB-P-110, LB-P-111 Park, Ja-Yong P-225 Park, Jon Hun LB-P-032 Park, Jong Hun LB-P-031, LB-P-037, LB-P-038 Park, Jong Hyun LB-P-066 Park, Jong In LB-P-066 Park, Joon Sung LB-P-094 Park, Joong-Yeol LB-P-110 Park, Kyung Sun LB-P-079 Park, KyungHwa P-045, P-112, RO-295 Park, Seok Ju LB-P-059, LB-P-067 Park, Su Kil LB-P-057 Park, Su-Kil LB-P-079 Park, Sung Bae LB-P-063 Park, Sun-Hee P-225, RO-330 Park, Ui Jun LB-P-063 Park, Yeon Ho P-016 Park, Yo-Han LB-P-100 Park, Yong-Keun P-341 Parker, Andy O-028 Parkkinen, Jaakko O-179 Parmentier, Helen O-271 Parnaud, Graldine O-171, O-173, RO-177 Parodi, Angelica MO-045, O-320 Parrot, Neil RO-334 Parrott, Neil MO-068, O-090, O-095, RO-067 Parrott, Neil R. MO-060, MO-066, O-003, O-092, P-310 Pascalev, Assya O-070, O-264 Pascher, Andreas CC-018, O-055, O-103, P-084 Pascual, J. P-097 Pascual, Julio O-152, O-303, P-191, RO-128 Pascual, Manuel P-065, P-226, RO-086 Pascual, Mara Jos RO-128 Pascualin, Rafael R. O-099 Pashaee, Nilufar O-286 Pasini, Josip LB-P-014 Paslaru, Liliana P-135 Pastor, Jose M. P-098 Pastor Rodrguez, A. MO-025 Pasulo, Luisa MO-023, P-362 Patel, Nilay O-089, P-183 Patel, Pareeta RO-269 Patel, Rajan K. MO-004, O-064, O-084, RO-028 Patel, Uday CC-002 Patey, Sue RO-200 Patregnani, Laura RO-013 Patrick, Michael MO-046 Patris, Alexander O-100 Patrono, Damiano RO-263, RO-272

Patrzalek, Dariusz MO-048 Pattison, J. O-142, O-147, O-200, P-076 Paul, Andreas LB-O-003, O-032, O-042, O-107, P-353, RO-041, RO-105, RO-214 Paul, J. MO-025 Pal-Ramos, F.J. P-090 Paulik, Jozsef O-293 Pavie, Alain CC-021 Pavlova, Yelena P-128 Pawlicki, Jacek P-343 Pawlik, Agata RO-068, RO-305 Pawlik, Andrzej MO-044, O-065 Pawlowska, Joanna P-377 Paz, Tomasz P-131 Pazik, Joanna P-284, P-285 Peaston, Robert O-035, O-301, P-162, P-288, P-382, RO-153 Pece, Valeria RO-155 Pedersen, Michael RO-207 Pedro, Aljama LB-P-073 Pedroso, Sofia RO-333 Peeters, Annemiek M.A. MO-035, O-227, O-251 Peeters, P. RO-165 Peeters, P.G.J.M. RO-222 Peeters, Patrick O-157, RO-256 Peixoto, Maria P-115 Pelanek, Christoph RO-154 Pell, Galle P-014 Pellegrini, C. O-148, O-237 Pellegrini, Sara O-105, P-364 Peltier, Julie RO-266 Penfornis, Alfred O-171 Pengel, Liset H.M. O-263 Penny, Sarah LB-O-211A Pepper, Ruth P-147 Peraldi, Marie-Nolle P-212 Peralta, Carmen P-330 Peregrin, Jan RO-216 Pereira, Harold RO-027 Pereira, Porfirio P-281 Pereira-Lopes, Otlia P-092 Perera, M.T. CC-009 Perera, M.T.P.R. LB-P-006, RO-283 Perera, Thamara CC-008, RO-034, RO-261H Pereria, Lilian M. RO-208 Peressutti, Roberto LB-P-048, LB-P-049, LB-P-051 Prez, Elena P-352 Prez, Maria Jos P-213 Prez, Miguel A. P-281 Prez, Rosa Mara RO-217, RO-246 Prez-Flores, Isabel P-100 Prez-Saborido, Baltasar P-351, P-352 Perez-Valdivia, Miguel A. O-195 Peri, Josep Maria RO-087 Peri, Lluis O-165, O-166 Perkmann, Thomas P-303 Perkowska-Ptasinska, Agnieszka O-221 Perotto, Ornella RO-213 Perrat, Gisele O-159, RO-195 Perrella, A. O-123 Perrella, Alessandro CC-006, P-093, P-094 Peric, Vanja P-319 Pertoldeo, Maria Laura O-041, RO-254 Perucha, Esperanza RO-114 Pessione, Fabienne LB-P-053 Pestana, Manuel P-092 Peters, Rosie RO-069 Petersen, Irene O-314 Petit, Jacques O-212, RO-123 Petrascu, Andra-Elena RO-293 Petrascu, Andra-Elena I. RO-292 Petrone, H. P-270 Petruccelli, Stefania RO-049

Petruzzo, Palmina

O-159, O-266, O-268, O-271, O-328, RO-195 Pettigrew, G.J. O-050, O-109, O-326 Pettigrew, Gavin MO-062, O-048, O-117 Pettigrew, Gavin J. O-110, O-160, RO-008 Pfeffer, Per O-005, O-144 Pfister, Marc P-103 Phang, C.Y. P-127 Phanish, Mysore O-216 Philipson, Kelly P-288, P-382 Phillips, Aled RO-101 Phillipson, Kelly P-162, RO-153 Piazza, Antonina P-124 Picard, Christophe P-117 Picarda, Elodie O-111 Picciotto, Francesco Paolo RO-189 Piemonti, Lorenzo LB-P-012, O-053, O-169, O-174 Pierer, Gerhard O-267 Pierobon, Elisa S. P-206, RO-328 Pieters, Jean MO-074 Piffaretti, Gabriele P-311 Pignatelli, Alessandro RO-357 Pilato, Michele P-041 Pillai, Deepak S. P-244 Pillebout, Evangline P-023, P-212 Pindycka-Piaszczynska, Malgorzata RO-156 Pinelli, D. O-123 Pinelli, Domenico P-370, RO-059, RO-229, RO-236 Pinget, Michel O-116 Pinkernelle, Jens LB-P-010 Pinna, A.D. O-123 Pinna, Antonio O-188, O-189, RO-077 Pinna, Antonio D. O-105, P-364, RO-140 Pinna, Antonio Daniele MO-058, O-009, O-202, P-079, RO-307, RO-351 Pinna, Daniele A. O-305 Pinto, Daniela P-155 Pinto Reis, Rui RO-306 Pinto-Fuentes, Pilar P-351, P-352 Piot-Ziegler, Chantal P-065, RO-233 Piredda, Giambenedetto RO-113 Pirenne, J. RO-032, RO-075 Pirenne, Jacques CC-005, CC-007, LB-O-003, O-027, O-046, O-098, O-100, O-129, O-156, O-157, O-296, O-298, P-031, RO-006 Pirson, Yves O-100, RO-272 Pisaniello, Donatella CC-006, P-093, P-094 Piselli, Pierluca RO-113 Piskin, Turgut RO-196 Piswagner-Slkner, Claudia LB-P-042 Pitard, Vincent O-151 Pitton, Michael RO-038 Piza-Katzer, Hildegunde O-267 Plat, Martine O-330 Ploeg, Rutger O-070, RO-073 Ploeg, Rutger J. LB-O-003, O-104, O-282, O-283, P-142, RO-005, RO-015, RO-070, RO-080, RO-115, RO-301 Ploski, Rafal P-284, P-285 Pocock, Phil O-167 Podgrska, Marta P-284 Podolak, Betzalel CC-013 Poggi, Elvira P-124 Poggio, Emilio O-272 Pokhariyal, S. LB-P-026, RO-356 Pokorny, Herwig O-012 Polak, Wojciech G. RO-132 Polanco, Natalia P-216, RO-199 Poli, Cinzia O-294, RO-036, RO-053, RO-134 Poli, Francesca O-169, O-320 Poli, Luca P-022, P-304, RO-045, RO-357 Pollard, Steve O-188, O-189

O-223 P-286 O-328 O-148, O-204 P-070 P-309 P-074 O-278 O-202 MO-023, P-362, P-363 Ponzoni, Maurilio LB-P-012 Popescu, Irinel O-042, O-107, P-135, P-335, P-345, RO-105 Popescu, Marius P-048 Popoola, Joyce O-216 Popov, Zivko M. RO-121 Popoviciu, Corina P-048 Popp, Felix C. O-258 Porras-Lpez, Francisco M. P-344 Port, Friedrich K. MO-008 PORT Investigators O-063 Porte, R.J. RO-222 Porte, Robert O-188, O-189 Porte, Robert J. O-282, RO-261B Post, Ivo C.J.H. RO-079 Potena, L. O-148, O-236 Potena, Luciano RO-155 Potenza, Leonardo P-077 Poulain, Severine RO-271 Pouteil Noble, Claire O-153, RO-266 Powell, Faye MO-062 Powell, J.J. RO-253 Powelson, John O-304, RO-184 Power, Sarah RO-069A Powerski, Maciej LB-P-010 PPal Collaborators RO-114 Prachalias, Andreas MO-050, O-290, RO-030 Prachalis, Andreas O-299 Prado, Leila K. RO-208 Prasad, K.R. O-007 Praseedom, R. RO-144 Praseedom, Raaj RO-054 Pratschke, Johann MO-031, MO-036, O-023, O-055, O-114, O-193, O-250, O-265, O-267, O-269, O-270, P-084, P-326, RO-035, RO-245 Preissler, Gerhard RO-237 Premasathian, Nalinee P-015, P-291 Prenner, Gnther LB-P-042 Presek, Peter CC-020 Pressmar, K. LB-P-068 Pressmar, Katharina LB-P-024, P-084 Prestele, H. O-289, P-087 Prestinenzi, Paola RO-155 Prieto, M. P-327 Prieto, Martn MO-018 Prieto, Mikel RO-262 Proby, C.M. LB-O-006 Procaccio, Francesco P-179 Prosperi, Manlio RO-044, RO-052 Puc, Maja RO-205, RO-343 Puchalka, Christopher M. O-255, RO-344 Puhan, Milo A. O-122 Puhl, Gero RO-244, RO-286 Puichaud, Alexis MO-076 Puig, J.M. P-090 Puig, Josep M. O-152, O-303 Puig, Josep Maria P-191, RO-128 Puisis, John LB-P-019 Puliatti, Carmelo CC-010 Pulikkottil, Benson RO-296B Pullar, Ben CC-014, RO-202 Punch, Jeff D. RO-116

Pollok, Joerg-Matthias Polson, Robin Pomahac, Bo Poncelet, A. Ponchia, Annalisa Ponikvar, Rafael Pons, Jose A. Pont, Teresa Ponte, Elisa Ponziani, Francesca Romana

299

Puntschart, Andreas

300

O-291, P-069, P-185, P-186, P-188, P-383 Pschel, Klaus RO-302 Puzon, Malgorzata P-284, P-285 Qiu, Xiao-yan RO-122 Quadrifoglio, Franco RO-247 Qualey, Angie O-304, RO-184 Quereda, C. P-194, P-234, RO-187 Quinn, Karen RO-069B Quintana, Laura RO-191 Quintana, Salvador O-278 Quintela, Estrella P-098 Quintero, Jesus O-102, RO-042 Quintini, Cristiano O-308 Quirino, Lai RO-045 Quiroga, Isabel O-016, O-184, O-186, RO-062 Qureshi, Sabrina P-059 Raatz, Christoph O-198 Rabelink, Ton J. O-021, RO-111 Racap, Judith O-322 Radovits, Tamas O-234 Radu, Claudia RO-048 Radunz, Sonia P-353, RO-214 Ragymov, Aligeydar A. P-120 Rahamimov, Ruth CC-013, RO-012 Rahier, Jacques LB-P-118 Rahmel, Axel LB-O-003, O-125, O-157 Rahsaz, Marjan LB-P-095, P-130 Rainiene, Tatjana P-095 Risnen-Sokolowski, Anne P-200 Rakhorst, Gerhard O-275 Rama, Akhtar CC-021 Rama, Ines RO-100 Rama, Pablo RO-235 Ramadori, Giuliano LB-P-025 Ramaswamy, Karunakaran P-019 Rambabova Busljetic, Irena P-287 Rambaldelli, Sergio P-179 Ramirez, Jose-Antonio P-328 Ramirez Morales, Rafael O-011, O-191 Ramrez-Bajo, Maria J. P-113 Ramiro, Laia LB-P-046 Ramjankhan, F.Z. RO-238 Ramos, Anaisa P. RO-055 Ramos, Carmen P-331 Ramos, Emilio MO-022 Ramphul, Robin O-081, RO-201 Ramsey, Helen J. P-365 Randhawa, Gurch O-261, O-262, P-067 Randon, Caren O-157 Ranghino, Andrea O-130 Rapa, Elizabeth RO-082 Raschzok, Nathanael LB-P-008, LB-P-010, LB-P-011 Rasoul-Rockenschaub, Susanne MO-008, O-012 Ratajczak, Mariusz Z. O-031 Rath, Thomas O-288, RO-185 Rathnasamy Muthusamy, Anand Sivaprakash O-016, O-184, O-186 Ratner, Emily MO-020 Rau, Simon P-020 Rauch, Ursula O-049 Rauchfuss, Falk O-305, RO-133, RO-148 Raulf, Friedrich MO-074 Rauser, Georg LB-P-054 Ravaioli, Matteo MO-058, O-009, O-202, P-079, RO-077, RO-307, RO-351 Ravera, Federica RO-311 Ravlo, Kristian RO-207 Rawlinson, William D. RO-162 Ray, Christopher O-035, O-301, P-162, P-163, P-288, P-382, RO-129, RO-152, RO-153 Ray, Stephen O-035, O-301

Raynaud, Alain P-014 R, Francesca O-320, P-372 Read, Janet C. MO-010 Ready, Andrew LB-O-211A Ready, Andrew R. O-096, P-278, RO-026, RO-088, RO-170, RO-171, RO-287 Real, M. Isabel O-182 Rebollo-Mesa, Irene RO-114 Redding, Reymond O-317 Reddy, Srikanth O-016, O-184, O-186 Reding, Raymond LB-P-117, LB-P-118 Redondo, Mara Dolores P-213 Redondo-Pachn, M. Dolores RO-191 Reece, Pauline RO-063 Reed, Natasha P-207, RO-310 Rees, Doug P-163, RO-152 Rees, Douglas P-288, P-382 Refaie, Ayman F. O-229 Refaie, Ayman Fathi MO-013 Regalia, E. O-123 Regalia, Enrico O-191 Regan, Siobhan C. O-274 Rehakova, Sylvia O-050 Reichart, Bruno O-230, O-239 Reid, Alex W. RO-008 Reid, Christopher RO-227 Reid, Christopher J.D. O-124 Reilly, Mary O-028 Reinders, Marlies MO-003 Reinders, Marlies E. RO-111 Reinhardt, Renate RO-041 Reinhold, Stephan O-196 Reinholt, Finn P. RO-194 Reinke, Petra O-199, O-284, O-288, RO-109, RO-185 Reinstadler, Petra RO-228 Reister, Anna V. LB-P-069, O-144, RO-194 Reischig, Tomas O-145 Reiter-Chenel, Vronique LB-P-043 Rela, Mohamed LB-P-114, LB-P-116, MO-050, O-290, O-299, RO-030 Remiszewski, Piotr P-354, RO-145 Remport, Adam RO-020, RO-192 Remuzzi, Giuseppe P-370, RO-059 Rendina, M. O-123 Rendina, Maria MO-023, P-362, P-363 Renfrew, Julie LB-P-072 Rengel, Manuel O-143, RO-197, RO-319 Renner, Fabrice O-307, O-324 Renner, Fabrice C. O-198 Renner, Philipp O-258 Renner, Vronique CC-015 Requio-Moura, Lucio R. P-289, RO-163 Rerolle, J.-P. O-201 RESCUE Study Investigators LB-O-006 Reubsaet, Astrid O-073 Reusz, Gyorgy P-007 Revelly, Jean-Pierre RO-086 Revuelta, Ignacio P-221, RO-087, RO-090 Rey, Teresa RO-235 Reyes-Acevedo, Rafael O-243 Reynard, John P-183 Reynaud-Gaubert, Martine P-117 Reznik, Alexander O-164 Reznik, Oleg O-164 Riad, H. O-142, O-147, O-200, P-076 Riad, Hany MO-065, MO-068, O-090, O-095, RO-067 Riad, Hany N. MO-009, MO-060, MO-066, O-003, O-092, P-310 Rial, Maria del Carmen O-245 Ribalta, Alba P-184 Ribes, Antonia MO-071 Ribes, Juan RO-296C Ribet Reinart, Nadine P-051 Ricart, Assumpta O-069

Ricart, M. Jose O-014, O-181, O-182 Ricart, Maria Jose CC-012 Ricchiuti, Alessandro O-038, RO-213 Rice, Brenda RO-063 Rice, Kim O-240 Rickels, Michael O-172 Ricksten, Sven-Erik LB-P-109, P-153 Ridgway, Dan O-090, O-095, RO-067 Ridolfi, Cristina O-174 Ridolfi, Lorenza LB-P-015, LB-P-045 Riede, Gregor O-114 Riede, Robert O-231 Rieger, Michael O-267 Riera, Marta RO-128 Rigby, James P-290 Rigg, Keith P-175 Rigg, Keith M. P-286, RO-317 Rigotti, P. O-246 Rigotti, Paolo O-001, O-002, O-139, P-206, RO-113, RO-328 Riise, Gerdt LB-P-109 Rike-Shields, Adele LB-P-029 Riley, Paul RO-227 Rimola, A. O-297, RO-056 Rimola, Antoni O-020, P-330, RO-087 Rinaldi, M. O-235 Ringers, Jan O-021, RO-111, RO-261B, RO-301 Rioja, Lilimar S. P-096 Rioja, Suzimar S. P-096 Riou, Bruno RO-069C Riquelme, Paloma MO-039, O-249, RO-323 Ris, Frederic RO-173 Risaliti, A. O-123 Risaliti, Andrea RO-040 Rischen-Vos, Jaqueline RO-003 Ritz, Eberhard P-110 Riva, Giovanni P-077 Rivadeneira, Fernando O-227 Rivelli, Gabriel G. RO-208 Rivera, Jairo LB-P-117 Rix, David LB-P-050, O-194, RO-129 Rix, David A. LB-P-001 Rizna, C.A. P-013 Rizza, Giorgia O-038, RO-213 Rizzello, Anna RO-062 Rizzo, Christophe O-271 Ro, Han LB-P-009 Roberts, Denise MO-009 Roberts, Fleur LB-P-070 Roberts, G. O-163, RO-268 Roberts, Gareth P-246 Roberts, John P-144 Robertson, Chris O-304, RO-184 Robertson, Victoria J. P-125 Rocha, Chiara RO-059 Rocha, Fabiane P-023 Rocha, Maria Joao RO-009 Roche, Marina LB-P-007, LB-P-053 Rods, Juan P-330 Roditi, Giles LB-P-064 Rodolfo, Alejandro O-172 Rodrigo, Emilio O-300, P-098, P-100 Rodrigues, Carolina A. RO-183 Rodriguez, Kryssia I. RO-048 Rodriguez, Mario P-351 Rodriguez, Roberto MO-022, MO-024, P-033 Rodrguez-Arias, David MO-083, O-076 Rodriguez-Benot, Alberto O-195, P-213 Rodrguez-Goyanes, G. P-090 Rodriguez-Vielba, Paloma P-351, P-352 Rodriguez-Villar, Camino MO-012, O-165, O-166, RO-090 Rodriguz Fava, Oscar O-094 Roelen, Dave RO-109

Roelen, Dave L. O-080 Roels, Leo O-279, O-280 Roessel P-245 Roest, Mark RO-111 Roeyen, Geert MO-019, O-157, RO-057 Rogel-Galliard, Claire LB-P-124 Rogers, Michelle LB-P-120 Roggen, Francine O-046 Rogiers, Xavier O-298, O-317, RO-169 Rohn, Susanne LB-P-008, LB-P-011 Roine, Risto P. P-322 Roizen, Mariana P-376 Rojsanga, Piyarat P-291 Rokosny, Slavomir O-079, RO-314 Rolando, Nancy RO-166 Rollag, Halvor RO-017 Roller, Regina P-166 Roller-Wirnsberger, Regina E. P-314 Rolles, Keith P-350 Romagnoli, R O-123 Romagnoli, Renato O-038, RO-213 Romani, Paolo RO-155 Romano, Gianpaolo P-155 Romano, Marina RO-218, RO-221 Rompianesi, Gianluca RO-150, RO-255 Ronco, Claudio P-230 Roodnat, J.I. O-259 Roodnat, Joke O-077, RO-003 Roodnat, Joke I. MO-088, O-085, O-286, O-312 Rook, Mieneke RO-015 Roque, Rebeca MO-012 Roque-Afonso, Anne-Marie RO-261E Rosado, Silvia RO-341 Rosales, Antonio O-094 Rose, Marlene O-254 Rose, Marlene L. RO-289 Roselli, Elena RO-044 Rosello Catafau, Joan LB-P-123 Rosell-Catafau, Joan MO-071, MO-072, O-020, RO-076 Rosen, Charles B. RO-294 Rosenkranz, Alexander R. RO-261I Rosenthal, Rafail P-235 Roskams, T. RO-075 Roskams, Tania O-100, O-296 Roskott, Anne Margot C. O-104 Rossard, Ludivine O-228 Rossetto, Anna O-041, P-032, RO-047, RO-092, RO-247, RO-254, RO-276 Rossetto, Valeria RO-048 Rossi, Barbara O-002, P-160, P-206 Rossi, Fabrizio P-311 Rossi, G. O-123 Rossi, Giorgio O-191, RO-140, RO-151 Rossi, Joo P-156 Rossi, M. O-123 Rossi, Massimo O-010, O-191, P-304, P-336, RO-045, RO-065, RO-137 Rossini, Giuseppe O-001 Rostaing, L. O-246, P-097, RO-350 Rostaing, Lionel O-240, O-243, RO-267 Rostami, Zohreh RO-131, RO-313 Rota, Giovanni P-370, RO-059 Rouanet, S. RO-274 Rouget, Caroline RO-177 Rousseau, Vanessa RO-267 Rousselot, Morgane O-176 Rousset, Anas P-117 Rouvier, Philippe CC-021 Rovira, Jordi P-113 Rowan, Derrick LB-P-041 Rowan, Kathy RO-069A Rowe, Rebecca E. RO-282 Rowinski, Wojciech RO-300 Rowinski, Wojciech A. P-066

301

302

Rowshani, Ajda T. RO-023, RO-275 Roy, Debabrata RO-082 Rzanski, Jacek MO-042, MO-044, O-065 Rozental, Rafail LB-P-055 Rozentals, Rafails P-177 Rozi, Mohd P-240 Rozita, M. P-013 Rubello, Domenico O-330 Rubin, A. P-327 Rudas, Anna RO-020 Ruddle, N. O-050 Rudge, Chris J. MO-016 Rudnicki, Michael RO-106 Ruffoni, Elena O-139 Rufian, Sebastian P-074 Ruggieri, Giuliana P-222 Rugiu, Carlo RO-186 Ruhenstroth, Andrea P-126 Ruifrok, Willem-Peter T. RO-078 Ruiz, A. O-297 Ruiz, Angel MO-012, O-165, O-166 Ruiz, J.C. MO-025 Ruiz, Juan C. P-098, P-100 Ruiz, Juan Carlos O-300 Ruiz, Philip MO-059 Ruiz de Temio, Angela P-355 Ruiz Ordorica, P. P-091 Ruiz Zorrilla, Rafael P-099, P-331, P-355 Ruiz-Antorn, Beln MO-030 Ruokonen, Hellevi RO-046 Rushton, Sally O-089 Russ, Graeme P-080 Russell, Cindy MO-086 Russo, Francesco P. RO-309 Rutkowski, Boleslaw LB-P-075, P-078, P-199, P-223, P-224, P-228, RO-016, RO-193, RO-278 Rydzewski, Andrzej P-316 Rynerson, Nadine RO-294 Saat, Tanja C. RO-074 Saavedra, D. RO-139 Saavedra, Sandra MO-012, RO-090 Sabbatiello, Roberto P-062 Sabet-Baktach, Manije O-029 Sabharwal, Atika O-086, P-271, RO-010 Sacchetti, Federico O-202 Sacher, Torsten MO-037 Sacks, Steven H. O-028 Sadaka, Basma LB-P-029 Sadamori, Hiroshi MO-051, O-292 Sadeghi, Mahmoud MO-005, MO-034, O-214, P-141 Sadowska, Anna P-232 Saeb Parsy, Kourosh O-117 Saeb-Parsy, K. O-109, O-326 Saeb-Parsy, Kourosh O-048, O-110 Semann, Marcus D. MO-008 Saffioti, Maria Cristina O-038 Safranow, Krzysztof MO-044, O-065 Sagedal, Solbjrg O-144 Sagoo, Pervinder RO-114 Saheb, Samir CC-021 Sahtout, W. P-378 Saia, Francesco RO-155 Said, Tarek P-085, P-244 Said Conti, Valerie CC-004 Saint, Fabien RO-123 Saint-Lebes, Bertrand P-226 Saito, Kazuhide O-133, RO-168 Saito, Yu O-120, P-042, P-325, P-338, P-339, P-349 Saitoh, Yu RO-215 Sakaguchi, Shimon O-309, RO-342 Sakai, Hiroaki O-276, O-277 Sakai, Kaduki RO-117 Sakai, Ken RO-001

Sakai, Sachiko RO-024 Sakai, Tadasu P-056 Sakamoto, Jin O-276, O-277 Sakamoto, Seisuke LB-P-005 Sakhuja, Vinay P-243 Sakuma, Yasunaru RO-004 Salahi, Heshmatollah LB-P-098, LB-P-099 Salama, Alan D. P-147 Salama, Ibrahim A. LB-P-103 Salari, Arsalan P-161 Salata, Daria O-031 Salcedo, M.M. P-090 Salcedo, Magdalena P-074 Salcido-Ochoa, Francisco P-127 Saldan, Alda O-150, P-206 Salehipour, Mehdi LB-P-112 Saliba, F. RO-164 Salimov, Emin L. P-120 Salizzoni, M. O-123 Salizzoni, Mauro O-038, RO-140, RO-151, RO-213 Salji, Mark J. O-160 Salloum, Chady RO-261E Salmela, Kaija P-200 Salmela, Kaija T. O-214 Salvadori, Maurizio MO-026, O-139 Samame, Julia O-181, O-182 Sampaio, Ana Maria RO-167 Sampaio, Susana P-092 Sampaio-Maia, Benedita P-092 Samuel, Didier RO-261E Samuel, Undine O-327 San Segundo, David P-098 Snchez, Ana Yurena A.Y. O-099 Sanchez, Benjamin O-097 Snchez, Jaime P-281 Snchez, S. O-297 Sanchez Antolin, Gloria P-099, P-331, P-355 Sanchez Cabus, Santiago O-014 Snchez Fructuoso, A. MO-025 Sanchez-Fructuoso, Ana I. P-100 Sanchez-Montes, C. P-327 Snchez Plumed, J. MO-025 Snchez-Fructuoso, A. RO-324 Sancho, Arantxa MO-030 Sancho, Lorena P-099, P-355 Sandes-Freitas, Tain V. RO-183, RO-322 Sandiumenge, Alberto LB-P-046 Sandner, Sigrid RO-154 Sandner, Sigrid E. P-157 Sndor, Judit O-070 Sandrini, Silvio O-001, O-139 Sandrino, Silvio RO-113 Sanei, Behnam LB-P-098, LB-P-099, LB-P-112 Saner, Fuat H. RO-041 Sanjuan, F. P-327 Sankari, Bashir RO-332 Sanni, Aliu O. RO-129 Sanrom, Marga P-184 Santana, Raquel RO-199 Santaniello, Walter CC-006, P-094, P-357, RO-218 Santise, Gianluca P-041 Santori, Gregorio P-236, P-292, P-371, P-372 Santori, Greogorio O-299 Santos, Ldia P-227 Santos, Regina G. MO-054, RO-250, RO-251 Sapisochin, Gonzalo MO-024, P-033 Sarapuu, Silver P-035 Saridogan, Jale P-214 Sarmentero, Jose Carlos P-351, P-352 Sarmiento, Elizabeth O-154 Sarnecka, Agnieszka P-168

Sarrazin, Christoph Sarrazin, Christoph M. Sarvary, Eniko Sasaki, Hajime Sasaki, Hitomi Sasbon, Jorge Sato, Yoshinobu Satoh, Daisuke Satoh, Hiroyuki Satoh, Kazushige Satomi, Susumu Saucy, Francois Saudek, Frantisek Sauer, Igor M.

MO-015 RO-136 O-293 P-339 MO-006, O-168 RO-231 P-346, P-356 MO-051, O-292 RO-024 P-340 P-340 P-226 RO-337A LB-P-008, LB-P-010, LB-P-011 Saval, N. RO-021, RO-273 Saval, Nuria P-279 Savoye, Emilie P-051, RO-232 Savran, Fatma O. P-302 Sawada, Akihiko P-308 Sawada, Tokihiko O-039, P-045, P-112, RO-295 Sawada, Yugo P-379 Sawitzki, Birgit LB-P-011, O-051, O-284, RO-323 Saxena, V. LB-P-026, RO-356 Sayegh, Mohamed H. O-331 Scalamogna, Mario O-169, O-320 Scanes, Maria O-124 Scatena, Fabrizio MO-014, MO-064 Scatena, Guido MO-014 Scavini, Marina LB-P-012 Schaapherder, Alexander F. RO-111, RO-242 Schadde, Erik O-122 Schaeken, Emile H.M. O-073 Schaffellner, Silvia O-013, P-166 Scheed, Axel P-196 Scheenstra, R. RO-222 Schefold, Jeorg C. MO-005, P-141 Scheidl, Stefan O-199, RO-185 Scheld, Hans H. P-026 Schemmer, Peter O-037 Schena, Francesco P. O-139, RO-113 Schenker, Peter P-004, P-293 Scherer, Marcus P-029 Scherer, Sabine P-126, P-277 Scheuermann, Ernst MO-067 Scheuter-van Oers, Daenne A.F. O-068 Schiavelli, R. P-270 Schiavelli, Ruben P-062 Schiechl, Gabriela O-047, O-113 Schiesser, Marc O-137 Schiffer, Eduardo P-347 Schiffer, Mario O-058 Schilling, Martin K. O-030, O-034, RO-033, RO-072 Schipper, Karen K. LB-P-082 Schirrmeier, Anja RO-244 Schlaak, Jrg P-353 Schlagwein, Nicole RO-174 Schlickeiser, Stephan O-051 Schlitt, Hans J. MO-039, O-029, O-047, O-113, O-224, O-249, O-258, O-305, P-029, RO-323, RO-353 Schmack, Bastian O-234 Schmid-Mohler, Gabriela P-053, RO-125 Schmidt, Christian LB-P-008 Schmidt, Hartmut H.J. P-026 Schmidt, Jan P-141, P-277, RO-353 Schmidt, Sven P-101 Schmidtmann, Irene O-187 Schmitz, Volker O-225 Schneeberg, Stefan O-328 Schneeberger, Stefan LB-O-002, O-265, O-267, O-269, O-270, P-326, RO-035, RO-261F, RO-296A

Schneider, Ilka CC-020 Schneider, Wolfgang O-180 Schnitzbauer, Andreas P-029 Schnitzler, Mark O-240 Schnitzler, Mark A. O-241 Schnitzler, Paul MO-005 Schnuelle, Peter MO-040, O-037 Schnlle, Peter O-233 Schoellhorn, Volkmar RO-109 Schoenemann, Constanze CC-018, O-103 Schold, Jesse O-308, P-116 Schnermarck, Ulf P-020 Schoning, Wenzel N. RO-244, RO-286 Schramek, Herbert RO-106 Schreckenbach, Teresa P-030, RO-136 Schuchmann, Marcus RO-038 Schuind, Frederic O-328 Schulz, Karl-Heinz O-314, O-315, O-316, RO-039 Schulz, Uwe P-081 Schulze, Bernd P-081 Schumann, Julia O-051 Schumpp, Philipp RO-035 Schunck, Wolf-Hagen O-180 Schurink, Karin RO-169 Schwab, Mary K. RO-294 Schwab, Thomas R. RO-294 Schwarzbeck, Elisa RO-136 Schwarzer, Remy LB-P-092, LB-P-106 Schweiger, Martin P-186 Schwelberger, Hubert RO-035 Schwenger, Vedat P-277 Sciacca, Sergio P-041 Scianna, Giovanni O-074 Scobie, Linda LB-P-124, RO-296C Scoble, John O-081 Scolari, Maria P. O-139, O-218, RO-013, RO-113, RO-318 Scott, Rose O-216 Scuderi, E. O-123 Scuderi, Enzo RO-151 Scuderi, Vincenzo P-357, RO-140, RO-218, RO-221 Scvortcov, Andrey O-164 Seba, Atmane P-017, P-018 Sebagh, Mylene RO-261E Sebire, Neil MO-007 Secchi, Antonio LB-P-012, O-174 Secchi, Antonio I. O-169 Secher, Niels G. RO-207 Seeliger, Erdmann O-180 Seemampillai, Borggia O-254 Segerer, Stephan O-112, O-207 Segoloni, Giuseppe RO-113 Segoloni, Giuseppe P. O-130, O-139, P-267 Segoloni, Giuseppe Paolo P-049 Segovia, J. O-235, O-236 Seguin, Francois O-033 Seibert, Felix P-101 Seidowski, Alexandre RO-327 Seifalian, Alexander O-024 Seifert-Held, Thomas O-291, P-185, P-186, P-383 Seitz-Merwald, Isabell P-114 Sekerkova, Alena O-285 Sekiguchi, Satoshi P-340 Selden, Clare RO-050, RO-141 Selimovic, Nedim P-153, P-165 Selvaggi, Genaro MO-059 Sementa, Angela O-320 Sempoux, Christine LB-P-118 Senchik, Konstantin O-164 Seneviratne, Lasantha O-006, P-207 Seneviratne, Lasantha N. CC-001, P-294 Seneviratne, Niroshan RO-280 Sengul, Sule RO-261

303

304

Sennesael, Jacques O-157 Sennesael, Jacques J. RO-256 Senninger, Norbert P-026 Senzolo, Marco LB-P-091, MO-023, P-362, P-363, RO-048, RO-309 Serbanescu, Bogdan P-218 Sereika, Susan P-053, RO-095 Sereinigg, Michael O-291, P-069, P-185, P-186, P-188, P-383 Seres, Ildiko P-269 Seron, Daniel O-213, RO-259 Serra, Consol O-152 Serra, Nuria N. O-099 Serra, Valentina RO-150, RO-255 Serraino, Diego RO-113 Serrano, Juan P-320, P-321 Serrano Diaz-Canedo, Juan P-344 Serrato, Tomas P-212 Sert, Ismail LB-P-027, P-295, P-380, RO-172 Sethi, Tariq O-253 Settmacher, Utz RO-133, RO-148 Seva-Pereira, Tiago RO-055 Sevenoaks, Hannah O-255 Sevenoaks, Hannah J. RO-344 Severova, Galina P-287 Seveso, Michela O-139, O-330 Sevmish, Sinasi LB-P-096 Seyfritz, Elodie O-116 Sezer, Erhan P-214 Sezer, Taylan O. P-296 Sezis Demirci, Meltem P-021 Sforza, Daniele RO-354 Sgarabotto, Dino O-150, O-330, P-206, RO-228 Sgarlato, Veronica RO-013 Sgrosso, Jos L. CC-016, P-203, P-268 Shabir, Shazia O-059 Shackel, Nicholas RO-261D Shafiee, Zahra LB-P-078 Shah, Sachit RO-018 Shah, Shivani O-310 Shah, Vikas RO-018 Shaharabani, Ezra RO-012 Shahbazov, Rauf LB-P-096, P-027 Shaheen, Faissal A.M. P-154, P-215, P-324, RO-297 Shamsaeefar, Ali LB-P-098, LB-P-099, LB-P-112 Shand, N. O-203 Shankar, Sushma P-358 Shapey, Iestyn M. MO-052, MO-078 Sharif, Khalid LB-P-004 Sharma, Dinesh P-350 Sharma, R. LB-P-026, RO-356 Sharma, Sabeena P-019 Sharp, Chloe P-067 Sharples, Edward O-185 Sharples, Linda D. RO-008 Shaw, Olivia J. RO-084 She, Xiaowei O-232 Sheerin, Neil S. LB-P-001 Shehata, Osama H. LB-P-058 Shen, Jinshan P-102, P-103 Shen, Zhenya O-232, P-046, P-047, P-164, RO-178, RO-179, RO-296 Sheng, Zhenya P-167 Shenoy, Mohan MO-009 Shevchenko, Alex O. P-149, RO-158 Shevchenko, Olga P. O-319A, P-149, RO-158 Shi, Xiao-jin RO-122 Shibasaki, Susumu O-208, P-151 Shiels, Paul LB-P-033 Shiels, Paul G. LB-P-056, MO-033 Shihab, F. O-147 Shiina, Hiroaki P-024

Shimada, Mitsuo O-120, P-042, P-325, P-338, P-339, P-349, RO-215 Shimizu, Tomokazu P-379, RO-011, RO-316 Shimojima, Naoki P-187 Shin, Milljae O-044, P-137, P-255, P-256 Shin, Young Hee P-334 Shinoda, Masahiro P-187 Shinoura, Susumu MO-051, O-292 Shirabe, Ken O-040 Shiraishi, Yusuke P-297, P-308 Shirakawa, Hiroki P-379, RO-011, RO-316 Shiraki, Takayuki P-045 Shirling, Graham D. P-118, P-121 Shiro, Baba P-201 Shiroki, Ryoichi MO-006, O-168 Shishido, Seiichiro RO-001, RO-024 Shoji, Tsuyoshi O-276, O-277 Shokeir, Ahmed Abdelrahman MO-013 Shoker, A. O-289, P-087 Shrestha, Badri M. O-025 Shrestha, Badri Man P-298, P-299 Shrestha, Sussie MO-046, O-311 Shrimpton, Emily P-367 Shroff, Rukshana CC-004 Shushimita, Shushimita RO-345 Shuttleworth, Stephen LB-O-211A, RO-287 Shyr, Yi-Ming P-369 Sibbons, Paul RO-290 Sicard, Xavier O-151 Sicoli, Francesco P-357 Sideso, Edward RO-336 Sieders, E. RO-222 Siemionow, Maria O-328 Siezien, Paola P-062 Signori, Stefano MO-061 Sigrist, Sverine O-116 Sigurdardottir, Vilborg P-165 Sigurdardottir, Villborg P-153 Silfverstolpe, Henrik P-165 Sillero, Carlos O-323 Silva, Filipa P-092 Silva, M.A RO-283 Silverborn, Martin LB-P-109 Silvestre, Cristina O-002, P-206, RO-328 Simionescu, Maya P-048 Simioni, Paolo RO-048 Simonsen, Katy MO-041 Sin, Yong Hun P-138 Sinasse-Raymond, Gilles O-071 Sindel, Sukru P-104 Sinescu, Ionel P-218 Singh, Cheentan RO-018 Singhal, Ashish O-097, RO-325 Singhal, M. LB-P-026, RO-356 Sinha, Manish RO-202, RO-269 Sinha, Sanjay O-016, O-089, O-184, O-185, O-186, P-183, P-358, RO-025, RO-062, RO-209, RO-336 Sinnott, Paul LB-P-041 Sirbu, Cristina F. P-152 Sirijatuphat, Rujipas P-015 Sisman, Ali Riza P-242 Sitarek, Elzbieta P-284, P-285 Sivaganesh, Siva O-048 Sjberg, Trygve O-255, O-274, RO-060, RO-344 Skauby, Morten O-005 Skeans, Melissa O-063 kegro, Dinko P-040 Slabiak-Blaz, Natalia P-110 Slankamenac, Ksenija O-122 Slatinska, Janka P-128, P-300 Slavcev, Antonij P-128 Sledzinski, Zbigniew P-224 Slim, Abdallah O-294, RO-036, RO-053, RO-134

Slim, Abdallah O. RO-031 Slimackova, Eva P-300 Slubowska, Katarzyna P-232 Smak Gregoor, P.J.H. MO-084 Smerieri, Nazareno RO-255 Smerud, Hilde K. RO-211 Smerud, Knut T. O-144 Smit, Marije O-283 Smith, Colette RO-166 Smith, Garnett O-272 Smith, Helen J. P-145 Smith, Jon O-035, O-301 Smith, Megan R. RO-303 Smith, Richard MO-077, O-185 Smith, Stephanie O-183 Smits, Jacqueline O-279, O-280 Smits, Jacqueline M. LB-O-003, O-125 Smrzov, Andrea LB-P-087 Smudla, Anik P-068 Smyrniotis, Vasileios P-058 Snijder, Pauline M. RO-078 Snoeijs, M.G.J. O-158 Snoeijs, Maarten G. RO-121A Snyder, Jon J. O-063 Sobecks, Ronald P-116 Sobesky, Rodolphe RO-261E Sobocan, Nikola P-040 Socci, Carlo LB-P-012 Soda, Tetsuji P-280 Soda, Tetuji P-211 Soeda, Etsuko P-187 Soejima, Yuji O-040 Sfteland, John RO-087 Sohn, Sun Young LB-P-020 Sohrabi, Soroush O-035 Sohrevardi, Seyed Mojtaba LB-P-078 Sola, Eugenia P-263, P-264, P-265, P-266 Solak, Ilhami P-296 Solbu, Dag LB-O-004 Soleimani, Masoud LB-P-095 Soler, Mara Jos RO-128 Soligo, Andrea RO-328 Solomonov, Evegny RO-012 Solrzano, Guillermo MO-018 Soma, Toshya O-027 Somasundaram, Murali RO-025, RO-290, RO-335 Sommerer, Claudia O-199, P-277, RO-185 Son, Young Ki P-138 Sndergaard, Peter RO-207 Song, Eun-Joo P-225 Song, Gi-Won LB-P-023, LB-P-089, RO-261A Song, Ki Byung LB-P-057, LB-P-081, LB-P-111 Song, Sanghyun O-044, P-137, P-255, P-256 Soomro, Naeem O-194 Srensen, Sren S. LB-O-004 Sornsakrin, Marijke P-374 Sosa, H. RO-187 Sostero, Annalisa LB-P-048, LB-P-049 Sotiropoulos, Georgios C. P-353, RO-041, RO-214 Soulillou, Jean Paul RO-267 Soulillou, Jean-Paul O-330, RO-296C Souqiyyeh, Mohd. Ziad P-215, RO-297 Souza, Srgio R.M. P-096 Soza, Alejandro RO-217 Sozen, Hakan P-104, P-315 Spada, Marco O-074 Spaggiari, Mario MO-057, RO-043, RO-150, RO-326 Spagnolo, Antonio G. P-064 Sparacino, Vito RO-113 Spearman, Wendy RO-050, RO-141

Speier, P. RO-173 Spelsberg, Fritz RO-237 Sperber, Goran LB-P-124 pick, Julius RO-216 Spierings, Natalia M.K. O-286 Spoletini, Gabriele O-014, O-181, O-182, RO-065 Sporniak-Tutak, Katarzyna LB-P-028 Squifflet, Jean-Paul LB-O-003, O-157 Srikanthan, Karthikan A. P-365 Srinivas, Titte O-272, O-308 Srinivasan, Parthi MO-050, O-290, O-299, RO-030 Sritara, Chanika O-155 Sritippawan, Suchai P-015 Stadlbauer, Vanessa P-383 Stadlbauer-Kllner, Vanessa P-069, P-185, P-188 Stamp, Susan O-035, O-301, P-162, P-163, P-288, P-382, RO-152, RO-153 Stanford-Wood, Stella J. RO-029 Stangl, Manfred P-084 Stanzer, Stefanie P-188 Stanzi, Alessia O-273 Starc, Vito RO-124 Stauch, Diana O-055, O-250 Staufer, Katharina RO-039 Stax, Annelein M. RO-174 Steedman, Tracey RO-028 Steen, Stig O-255, O-274, RO-060, RO-344 Stefan, Bogdan P-218 Stefoni, Sergio O-139, O-218, RO-013, RO-318 Steger, Christina O-114 Steger, Gnter O-012 Steiger, Jrg O-060, RO-125 Stein, Maik RO-109 Steinberg, S. O-247 Steinberg, Steven O-245 Steinemann, Daniel O-137 Steiner, Birgit O-012 Steininger, Rudolf O-012 Stelter, Lars LB-P-008 Stephens, Henry A.F. P-118, P-121 Stephens, M. O-163, RO-268 Stephens, Michael MO-063, P-246, RO-101 Sterckx, Sigrid O-264 Sterneck, Martina RO-039 Stevens, Kathryn K. MO-004, MO-021, O-064, O-084, RO-028 Stevenson, Karen LB-P-056 Stevenson, Karen S. MO-021 Stewart, Camilla J. O-311 Stewart, Stephanie RO-294 Stiegler, Philipp O-013, O-291, P-069, P-185, P-186, P-188, P-383, RO-261I Stckle, Anja O-037 Stoic-Brezak, Jasna LB-P-014 Stojakovic, Tatjana P-383 Stone, John P. O-118, O-255 Stoneham, Sara CC-004 Strasser, Simone RO-261D Stratta, Piero O-139 Streba, Irina LB-P-017, MO-089 Strignano, Paolo RO-140, RO-151 Stringi, Vincenzo P-041 Striz, Ilja O-285, P-128 Strm, Erik H. P-010 Stroppa, Paola P-028, P-370, RO-229 Struijk, Geertrude H. RO-329 Struller, Florian M. MO-031 Strupas, Kestutis P-095 Stubenitsky, Bart RO-081 Stubenitsky, Bart M. O-161 Stucchi, Raquel S.B. P-208, RO-055

305

306

Stuchi, Raquel S.B. RO-167 Studenik, Pavel P-086 Surez, Beatriz RO-288 Suarez, Francisco P-074 Surez, Gonzalo P-320, P-321 Suarez Regueiro, MJ P-091 Surez-Artacho, Gonzalo P-344 Suberbielle-Boissel, Caroline CC-021 Sucher, Robert O-265, O-270 Sugawara, Yasuhiko MO-056 Sugimoto, Koji O-120 Suh, Sungock LB-P-104 Suh, Sungok LB-P-105 Suhorukovs, Vadims P-177, P-301 Sujenthiran, Arunan O-216 Sullivan, Mark O-089, P-183, RO-209 Sumethkul, Vasant O-155 Summers, Dominic M. RO-008 Sumura, Masahiro P-024 Sun, Qiquan P-312, P-313, RO-127 Sun, Qi-quan RO-190 Sunder-Plassmann, Gere O-288 Sung, Randall S. LB-O-001, RO-349 Sung, Randy S. RO-116 Surga, Nicolas RO-123 Ssal, Caner O-214, O-307, P-126, P-128, P-277, RO-103, RO-108 Sutcliffe, Robert RO-261H Suvarna, Kim O-025 Svegliati-Baroni, Gianluca RO-040 Svetec, Magdalena RO-205 Syme, Lorraine P-125 Szabo, Attila P-007 Szabo, Gabor O-234 Szab, Lszl RO-130 Sze, Y.K. RO-222 Szeifert, Lilla RO-192 Szentkiralyi, Andras RO-192, RO-279 Sztanek, Ferenc P-269 Szymanska, Beata P-044 Szymczak, Maciej MO-048 Szymczak, Marek P-377 Tabak, Adam G. RO-020 Tabata, Kenichi P-201 Taber, Tim O-304, RO-184 Tafulo, Sandra P-115, P-129 Taghavi, Shahrokh P-196, RO-239, RO-240 Tagieva, N. RO-164, RO-274 Tagliamacco, Augusto P-371 Taglieri, Nevio RO-155 Takahara, Shiro O-057, P-248 Takahashi, Kota O-133, RO-168 Takeda, Ikuo P-340 Takeda, Masashi P-211, P-297 Taketomi, Akinobu O-040 Takeuchi, Yasu LB-P-124, RO-296C Takeuchi, Yasuo P-109, P-201 Takhar, Arjun CC-008 Takhar, Arjun S. CC-009 Talbot, David LB-P-001, LB-P-050, O-035, O-194, O-301, O-301, P-162, P-163, P-288, P-367, P-382, RO-129, RO-152, RO-153 Tallachini, Maria-Chiara RO-296C Tamagnone, Michela P-049 Tambur, Anat O-310 Tam, Maria Rosa MO-058 Tamme, Kadri P-035 Tan, Yin P-134 Tanabe, Kazunari O-138, P-379, RO-011, RO-316 Tanabe, Minoru P-187 Tanabe, Tastu O-138 Tanabe, Tatsu RO-011, RO-316 Tanaka, Shinichiro P-195 Tandoi, Francesco O-038

Tarantino, Giuseppe MO-057, P-034, P-077, RO-043, RO-135, RO-150, RO-326 Tardini, Francesca RO-212 Tarella, Corrado RO-213 Tariciotti, Laura RO-261H Taruscia, Domenica LB-P-077 Tassilo, VolzTassilo O-223 Tatar, Erhan P-021, P-242, P-296 Tatematsu, Seiichi P-056 Tateo, Maria Grazia RO-261E Taube, David O-086, P-271, RO-010, RO-063, RO-249 Taube, David H. O-135 Taupin, Jean-Luc O-151 Taur, P. O-297, RO-056 Tavakoli, Afshin MO-060, MO-065, MO-066, MO-068, O-003, O-090, O-092, O-095, P-173, P-239, P-310, P-368, RO-067, RO-334, RO-337 Taylor, Craig MO-046 Taylor, Craig J. O-313 Taylor, John RO-202 Teague Getts, Meghann LB-P-019 Teague Getts, Meghann K. RO-349 Tedesco Silva, H. O-142, O-289, P-076, P-087 Tedesco Silva, Helio O-329 Tedesco-Silva, Hlio RO-183, RO-322 Teicher, Elina RO-261E Teichgrber, Ulf LB-P-008, LB-P-010 Teimoori, Mojtaba RO-313 Teimooro, Mojtaba RO-131 Tein, Andres P-035 Teisseyre, Joanna P-377 Teixeira, Manuel RO-333 Tekin, Akin MO-059 Telkes, Gabor P-007 Tell, Gianluca RO-047, RO-247 Tellez, Eloisa O-303 Telsnig, Barbara P-166 Temesvari, Manna O-293 ten Berge, Ineke O-302 ten Berge, Ineke J. RO-329 ten Cate Hoedemaker, Henk RO-070 Teng, Xiaomei O-232, P-164, RO-179, RO-296 Tenschert, Werner P-259 Tent, Hilde RO-005, RO-015, RO-115 Terasaki, Paul O-169 Terasaki, Paul I. MO-056 Terkivatan, T. LB-P-076 Terkivatan, Turkan O-088, RO-132 Terness, Peter MO-005, P-141 Terraz, Sylvain P-348 Terrosu, Giovanni P-032 Terzi, Fabiola O-026 Tesson, Laurent O-252 Testelin, Sylvie O-266, O-268 Testillano Tarrero, Milagros P-091 Teti, Gianfranco P-189 Tha-In, Thanyalak O-206 Thaiss, Friedrich P-259 Thervet, E. O-201 Thervet, Eric P-133, RO-104, RO-118 Thevarajah, Jasitha P-013 Thiagarajan, U. Mathuram P-002 Thiagarajan, Umasankar M. RO-014 Thibault, Frederic O-153, RO-069C Thiebaut, Rodolphe O-082 Thiem, Ursula P-303 Thiru, Sathia O-160 Thivolet, Charles O-171 Thiyagarajan, Prarthana P-272, RO-110 Thiyagarajan, Umasankar M. P-217, P-237 Thiyagarajan, Umashankar RO-027 Thoeny, Harriet C. O-087

Thomas, Aurelie P-288, P-382 Thomas, Dolca O-242, O-243, O-245 Thomas, Matthew P. P-359 Thomas, Pascal P-117 Thomee, Eeke P-183, RO-209 Thompson, Emily P-125 Thompson, John S. LB-O-001, RO-349 Thomson, Ross M. RO-291 Thornbun, Douglas RO-166 Thorsen, Trygve O-005 Thrum, Katharina RO-037, RO-138 Thrun, Ina P-106 Thuillier, Raphael MO-043, MO-076, MO-079, O-033, O-176, O-177, O-179 Thum, Maximilian LB-P-092, LB-P-106 Thuong, Marie LB-P-053, RO-232 Thuraisingham, Raj CC-010 Thuret, Rodolphe MO-043 Tian, Puxun P-043, P-192, P-210 Tian, Xiaohui P-043, P-192, P-210 Tich, Tom LB-P-087 Tiek, Joyce O-273 Tielen, Mirjam P-060, RO-003 Tihomirova, Tatjana P-301 Tilanus, Hugo W. MO-020, MO-070, O-222, RO-051, RO-071 Tilanus, Huugh W. RO-132 Tillou, Xavier O-212, RO-123 Timpson, Alan P. LB-P-013 Timsit, Marc-Olivier O-115 Tincknell, Laura P-175 Tinti, Francesca P-022, P-304, RO-045, RO-357 Tirdea, Alina Elena P-345 Tirelli, Silvia Amedea RO-225 Tisone, G. O-123 Tisone, Giuseppe O-010, O-191, P-124, RO-113, RO-137, RO-354 Tisone, Guiseppe O-305 Tjan, T.D.T. P-026 Tjon, Angela S.W. O-206 Todeschini, Paola O-218 Todo, Satoru O-208, P-151 Tognarelli, Giuliana P-267 Tokmak, Faruk O-196 Toledo, Katia P-213, RO-191, RO-206 Tomazic, Janez RO-022 Tom, Santiago MO-018 Tomita, Yusuke P-250 Tomiuk, Stefan MO-039, O-249, RO-323 Tomizawa, Jun P-109 Tomlin, Matthew LB-P-084, LB-P-088 Tonato, Eduardo J. P-289, RO-163 Tondolo, E. O-123 Tong, Pak Chiu LB-P-115 Toniutto, Pierluigi MO-023, P-362, P-363 Tonnerre, Pierre O-054 Tnnesen, Else RO-207 Toorop, Raechel O-093 Toribio, Maria Jose RO-199 Torlone, Nicola P-189 Toronyi, Eva RO-279 Torradem, Elisabet P-074 Torras, Joan O-284, RO-100, RO-284 Torre-Cisneros, Julian O-219 Torregosa, Jos Vicente J.V. O-099 Torregrosa, Vicen CC-012 Torres, Xavier RO-087 Toscano, Giuseppe P-160 Toshimitsu, Yasuko P-323 Toso, Christian O-008, O-052, O-108, O-170, O-171, O-173, P-347, P-348, RO-173 Toti, Florence O-116 Toti, Luca RO-354 Touchard, G. O-201

Toupance, O. O-201 Tousseyn, Thomas O-156 Townsend, Robert MO-041, O-244, P-102 Townsend, Robert M. P-103 Toz, Huseyin P-021, P-242, P-296 Tozcu Altin, Duygu MO-075 Tozzi, Matteo P-311 Trabucco, Gaetano P-179 Trailin, Andriy V. P-305 Tran, Khe T. RO-132 Tran, Sinh Ng P-306 Tran, Sinh Ngoc LB-P-086 Tran, T.C. Khe O-088 Tran, T.C.K. LB-P-076 Trautwein, Christian O-106 Traynor, Jamie P. O-064 Trbern-Launay, Katy O-220 Treckmann, Jrgen LB-O-003, O-032 Treckmann, Jrgen W. P-353, RO-041, RO-214 Treska, Vladislav O-145 Trevelyan, Stephanie MO-060, MO-066 Trevisan, Roberto RO-059 Tricot, Lela P-014 Trigueros, Miguel O-323 Trimarchi, H. P-270 Tripathi, Dhiraj CC-008 Tripepi, Matteo O-294, RO-036, RO-053, RO-134 Trivedi, Digisha RO-277 Troisi, Roberto O-298 Troisi, Roberto I. O-046 Troppmair, Jakob RO-035 Trunecka, Pavel RO-216 Trushkovs, Sergejs P-177 Trybunia, Dominika RO-156, RO-157 Tryphnopoulos, Panagiotis MO-059 Trzonkowski, Piotr RO-278 Tsai, Meng-Kun P-009 Tscheliessnigg, Karlheinz LB-P-042, O-013, O-291, P-069, P-166, P-185, P-186, P-188, P-383 Tse, Kei Chiu LB-P-115 Tsikas, Dimitrios RO-242 Tsirulnikova, Olga M. O-319A Tsujita, Makoto P-307 Tsunetoshi, Yusuke O-208, P-151 Tsuruyama, Tatsuaki RO-248 Tsutahara, Koichi P-248 Tufa, M. O-203 Tufveson, Gunnar O-017, O-018 Tugmen, Cem P-295, P-380 Tukek, Tufan P-247 Tullius, Stefan G. O-115 Tunc, Lutfi P-315 Tura, Andrea MO-008 Turakhia, Gita P-118 Turcu, Rosana O-069 Turka, Laurence A. RO-114 Trkmen, Aydin P-302 Turner, David M. O-311, P-125 Turner, Marc L. P-125 Turolo, Stefano RO-225 Turrisi, Marco A. P-041 Tutkak, Huseyin RO-261 Tutton, Sally LB-P-021 Tutuni, Naser LB-P-099 Tuzuner, Acar RO-142, RO-198, RO-261 Twose, Jorge P-184 Tzakis, Andreas G. MO-059 berfuhr, Peter RO-237 Uchida, Kasuharu P-307 Uchiyama, Hideaki O-040 Uchiyama, Masateru MO-038, O-211, P-136, RO-339, RO-340, RO-346 Udo, Elisabete Y. P-208

307

308

Ueda, Yasuo P-297, P-308 Uemoto, Shinji O-309, RO-342 Ueno, Takuya O-331 Ueno, Yosuke P-323 Uin, Gan Shu O-229 Ujszaszi, Akos O-058, RO-020 Ulf, Neumann P. O-225 Ulmer, Hanno RO-035 Ulrich, Frank MO-015, P-030, RO-136 Umbro, Ilaria P-022, P-304, RO-045, RO-357 Umeda, Yuzo MO-051, O-292 Umezawa, Kazuo O-208, P-151 Unadkat, Jignesh V. RO-296A Undset, Liv H. LB-O-004 Urakawa, Manami RO-295 Urasinska, Elzbieta CC-011, MO-042 Urbanova, Mariana O-022, O-079, O-215, RO-314 Urbanowicz, Arkadiusz O-221 Usal, Claire O-252 Ushigome, Hidetaka RO-117 Ussetti Gil, Piedad MO-030 Usta, Sebahat P-302 Utech, Wanda RO-189 Utsumi, Masashi MO-051, O-292 Utsunomiya, Tohru P-338, P-349, RO-215 Utsunomiya, Toru O-120, P-325, P-339 Utunomiya, Toru P-042 Uwechue, Raphael CC-002, RO-083 Vadori, Marta O-330 Vafadari, Ramin O-205, P-146 Vaidya, Anil O-016, O-184, O-185, O-186, P-358, P-378, RO-025, RO-062, RO-209, RO-336 Vaillant, Jean Christophe CC-021 Vajdic, Barbara P-309 Valagier, Alexandre MO-076 Valdes, Francisco O-213, RO-259 Valdez, Rafael RO-284 Valdivieso Lopez, Andres P-091 Valente, Marialuisa O-002 Valente, Roberto MO-050, O-290, O-299, RO-030 Valente, U. O-123 Valente, Umberto O-320, P-236, P-292, P-371, P-372 Valentini, Chiara RO-318 Valeri, Maurizio P-189 Valero, Ricard RO-304 Vli, Toomas P-035 Vallant, Natalie RO-035 Valle, Jean-Paul RO-173 Van Assche, Kristof O-264 Van Beeumen, Gerda MO-019 van Besouw, Nicole M. MO-035 van Bragt, Ron P. O-068 van Buren, Marleen RO-003 van Busschbach, J.J. O-259 Van Cleemput, Johan O-156 Van de Broek, Marcel P.H. O-197 van de Graaf, E.A. RO-238 Van de loock, Kristel P-053 Van De Wauwer, Caroline O-275 van de Wetering, J. O-259 van de Wetering, Jacqueline MO-088, O-312 van Dellen, David MO-060, MO-066, MO-068, O-003, O-092, O-096, P-173, P-310, P-368, RO-026, RO-088, RO-170, RO-171, RO-337 van den Berg, Aad RO-261B van den Berg, Else RO-115 van den Berk, Ingrid A. RO-329 van den Born, Joost C. RO-078 van den Dorpel, M.M.A. MO-084 van den Dorpel, Marinus A. O-068 van den Engel, S. RO-345

Van der Boog, Paul P.J.M. LB-P-082 van der Giet, M. P-105 van der Giet, Markus P-101 van der Laan, Luc J.W. MO-070, O-206, O-209, O-222, P-122, RO-071 van der Lely, Netty O-281 van der Meer, Arnold P-122 van der Meer, Nardo J.M. O-281 Van der Spek, Ashley O-083 van der Vliet, Daan J.A. LB-P-060, LB-P-065 van der Wal, Annemieke M. RO-174 van der Weerd, K. RO-345 van Dijk, Marcory C.F. RO-078 van Dijk, Marcory C.R.F. RO-005 Van Dijk, Sandra S. LB-P-082 van Dongen-Segeren, Dianne G.C.A. O-068 Van Donink, Walter MO-019 van Duin, David O-272 van Gelder, Teun O-286, P-060, P-146 Van Geluwe, Bart O-129 van Ginhoven, T.M. RO-345 van Ginhoven, Tessa M. RO-074 Van Glabeke, Emmanuel RO-069C van Gogh, Johan RO-089 van Goor, Harry O-104, O-175, RO-005, RO-078 van Gulik, Thomas M. RO-079 van Hagen, Martin O-206 Van Helleputte, G. RO-032 van Heurn, Ernest LB-O-003, RO-121A van Heurn, Ernest L.W. RO-097 van Heurn, L.W.E. O-158 van Hoek, Bart RO-261B van Hooff, Hans P. O-073 van Kessel, D.A. RO-238 van Kooij, A.C. MO-084 van Kooij, Anthony C. O-068 van Kooten, Cees RO-174 van Leiden, Hendrik A. O-281 van Maarseveen, Erik M. O-197 van Noord-Haubrich, Marian P-070 van Olphen, Sophie RO-169 van Pelt, J. RO-075 van Pelt, Jos RO-006 Van Raemdonck, Dirk O-156 Van Raemdonck, Dirk E. O-273 Van Reekum, Franka E. O-093 van Rhijn, Marieke MO-003 van Rijt, Geert RO-080 van Schaik, Ron H.N. O-286 Van Steenbergen, Werner O-129, O-296 Van Vlierberghe, Hans O-046 van Wijk, Albert C.W.A. RO-079 van Zon, Hans O-281 Van Zuilen, Arjan D. O-093 van Zuilen, Arjan D. O-197 Vandellen, David P-239 Vandenbussche, S. RO-032 Vandervennet, Marc O-157 Vanhaecke, Johan O-156, P-053, RO-260 Vanhove, Bernard O-330 Vanrenterghem, Yves CC-005, O-100, O-156, O-241, O-242, RO-256, RO-348 Vanvlierberghe, Hans O-298 Varberg Reister, Anna P-010 Vareed, Biju P-244 Vareikiene, Loreta P-095 Varela, Cristina O-219 Varga, Marina P-007 Varma, Vibha O-188, O-189, O-317 Varnous, Shaida CC-021 Varo, Evaristo MO-018 Vasdev, Nikhil LB-P-050 Vasuvattakul, Somkiat P-015, P-291 Vaughan, Robert O-124 Vazquez, Maria C. CC-016, P-203, P-268

vd Vliet, Daan O-091 Veceric-Haler, eljka RO-022 Veerasamy, Mangalakumar O-081 Vega, Almudena O-143, RO-197, RO-319 Vehlken, Jochen RO-041 Veitch, Peter CC-001, P-207, P-294 Vekemans, K. RO-075 Velasquez, Sonia Y. RO-103, RO-108 Veldhuis, Susanne P-142 Velicia Llames, Rosario P-331 Velu, Selva P-290 Vendrell, M. RO-056 Venetz, Jean-Pierre P-226 Vennarecci, G. O-123 Vensava-Kaknena, Dace LB-P-055 Ventoso Castieiro, Alberto P-091 Ventura, Maria P-171 Venturi, Carla LB-P-118 Venturi, Eric O-330 Verchere, Bruce RO-176 Verdalles, rsula O-143, RO-197, RO-319 Verde, Eduardo O-143, RO-197, RO-319 Veres, Gabor O-234 Verga, Giuliana RO-151 Vergara, M. O-200 Verhaegen, Marleen O-098 Verhoef, Gregor CC-005, O-156 Verhoeven, Renee J. MO-070, RO-071 Verici, Ulver P-104 Verine, Jrme P-212 Verleden, Geert O-156, RO-260 Verleden, Geert M. O-273 Vermathen, Peter O-087 Vermeer, Nina P-031 Vernauer, Almut P-259 Vero, Vittoria MO-023, P-362, P-363 Veroux, Pierfrancesco RO-113 Verran, Deborah O-192, RO-261D Versluijs-Rovers, Ellen O-068 Verslype, Chris O-129, O-296 Verweij, Marielle RO-074 Vesely, Pavel RO-296C Vespasiano, Francesca RO-098 Vetrone, Gaetano O-202 Vettel, Christiane O-233 Vibert, Eric RO-261E Vidal, Enrico RO-224, RO-226, RO-228 Vidal, Marcela RO-246 Vidan-Jeras, Blanka MO-002 Viebahn, Richard P-004, P-293 Vieira-Marques, Pedro P-092 Vigan, Raffaella P-363 Vigano, Raffaella MO-023, P-362 Viglietti, Denis P-023, P-212 Viklicky, Ondrej MO-049, O-022, O-140, O-141, O-145, O-215, O-285, P-128, P-300, RO-126 Vilca Melendez, Hector MO-050, RO-030 Vilca-Melendez, Hector LB-P-114, LB-P-116 Villa, Adolfo O-154 Villa, Francesca P-311 Villamil, Alejandra MO-055 Villard, Jean O-170, RO-352 Villegas, Trinidad P-328 Villemot, Jean-Pierre P-152 Vincenti, Flavio O-240, O-242, O-243, O-245, O-329 Vincenzi, Paolo RO-040 Violo, Carmen P-263 VIPP Study Group O-146 Viseshsindh, Wit O-155 Visser, Jetze LB-P-060, LB-P-065 Vistoli, Fabio MO-014, MO-061, MO-064 Vitale, A. O-123 Vitale, Alessandro O-011, O-128, O-191, RO-308

P-080 O-243 RO-261E RO-040 MO-012 O-074 P-031 P-113 O-199, RO-185 P-252 O-051 O-046 RO-136 P-181, P-345 RO-148 O-284, RO-109 MO-005 P-139 RO-182 RO-140 P-020 O-030, O-034, RO-033, RO-072 von Oppen, Nanette LB-P-054 von Zur Muhlen, Bengt LB-O-004 von Zur-Muehlen, Bengt O-018 Vonend, Oliver P-293 Vongwivatana, Attapong P-015 Vongwiwatana, Attapong P-291 Vorstius Kruijff, Edwin O-281 Vos, Pieter F. O-093 Vreeswijk-Baudoin, Inge RO-078 Vrijens, Bernard RO-256 Vymetalova, Jevgenija P-209 Wabbijn, Marieke O-205 Wachtman, Galen S. RO-296A Wada, Hiromi RO-248 Waer, Marc O-027 Wagner, Doris LB-P-042, LB-P-097, O-013, P-166, RO-261I Wahle, Matthias P-030 Wahrmann, Marcus RO-161 Waid, Thomas H. LB-O-001, RO-349 Waite, Liz LB-P-052 Wakai, Haruki P-109, P-201 Wakayama, Kenji O-208, P-151 Wakelin, Sonia J. MO-053 Waki, Kayo MO-056, MO-056, O-309 Walaszezski, Janusz O-069 Wali, Rashmi LB-P-124 Walker, Randy C. RO-262 Wall, Garth LB-P-029 Wallinder, Andreas LB-P-109, RO-060 Wan, Ray P-082 Wang, Haihao MO-034 Wang, Hee-Jung P-341 Wang, Hsu-Han P-008, P-147 Wang, Rui O-175 Wang, S.-S. O-236, O-237 Wang, Shin-E. P-369 Wang, Xianding O-004, P-205, RO-320 Wang, Xiaohong RO-175 Wang, Xiaojie RO-176 Wang, Z. O-142, O-147, P-076 Warl, Michiel C. LB-P-060, LB-P-065 Warnock, Garth RO-176 Wartenberg, Katja E. CC-020 Wasler, Andr LB-P-042, P-166 Wasmuth, Hermann O-106 Watarai, Yoshihiko P-307 Watcyn-Jones, Thomas RO-007 Watkins, Corrie F. RO-291 Watorek, Ewa MO-048 Watschinger, Katrin O-023, O-114, RO-245 Watson, Chris MO-062 Watson, Chris J.E. MO-016, MO-017, O-078

Vitko, Sefan Vitko, Stefan Vittecoq, Daniel Vivarelli, Marco Vizcano, Ferran Vizzini, Giovanbattista Vlasselaers, Dirk Vodenik, Barbara Vogel, Eva-Maria Vogel, John Vogel, Simone Vogelaers, Dirk Vogl, Thomas Voiculescu, Mihai Voigt, Rigo Volk, Hans-Dieter Volker, Daniel Vollroth, Marcel Vlp, Andreas Volpes, Riccardo von Baumgarten, Lousia von Heesen, Maximilian

309

310

Watson, Christopher MO-046, RO-054 Watson, Christopher J.E. O-183, RO-315 Watt, Duncan P-367 Wauters, Shana O-273 Weaver, Terri O-060 Weder, Walter RO-285 Weekers, Laurent O-157 Weenink, Robert RO-079 Wegiel, B. MO-031 Wehner, Jennifer O-310 Wei, Yanmei P-071 Weiler, Nina P-106 Weimar, W. MO-084, MO-085, O-259 Weimar, Willem MO-003, MO-035, MO-088, O-066, O-070, O-077, O-080, O-083, O-085, O-088, O-119, O-205, O-226, O-227, O-251, O-256, O-264, O-286, O-312, O-325, O-329, P-060, P-070, P-146, RO-003, RO-023, RO-275 Weimer, Rolf O-198, O-214, O-307, O-324 Weinman, John P-059 Weiss, Jutta LB-P-119 Weiss, Sascha O-250, P-326 Weissenbacher, Annemarie O-193, O-267, O-269 Wekerle, Thomas MO-036 Welin, Stellan MO-080 Wells, Hayley P-107 Wen, Jiqiu P-312, P-313, RO-127 Wen, Ji-Qiu RO-190 Were, Anthony P-279 Werner, Ernst R. O-023, O-114, RO-245 Werzowa, Johannes MO-008 Wesslau, Claus RO-182 West, P. O-247 Westeel, P.-F. O-201 Westhoff, Timm H. P-101 Westover, Angela O-161 Wetering, Jacqueline O-077, O-085 Weymann, Alexander O-234 White, Kathryn O-035, P-288, P-382 White, Steve P-367 White, Steve A. P-359 White, Steven O-035 White, Steven A. O-167 Wiecek, Andrzej O-288, P-110, RO-002, RO-068, RO-188, RO-305 Wieczorek, Grazyna MO-074 Wiederstein-Grasser, Iris O-291, P-185, P-186 Wiengpon, Keeratipon O-155 Wiese, Birgit RO-147 Wigmore, Stephen J. RO-069A Wijeyaratne, Mandika P-241, RO-280 Wilberg, Jens RO-037, RO-138 Wilk, Jaroslaw RO-068, RO-305 Wilkie, Gwen M. P-125 Williams, Alun P-175 Williams, Alun R. P-286 Williams, Marc RO-088, RO-170 Willicombe, Michelle O-135 Wilson, Colin H. LB-P-001 Wilson, David P-125 Wilson, I. O-238 Wilson, Rachel P-118 Wimmers, Eric RO-261F Wimmers, Eric G. RO-296A Wind, Tineke J. RO-097 Winkens, Bjorn RO-121A Winkler, Yanosh RO-012 Winter, Hannah LB-O-211A Winter, Hauke RO-237 Wirnsberger, Gerhard H. P-314 Wirz-Justice, Anna O-060 Wiseman, Alexander C. LB-O-001, RO-349 Wissing, Karl M. O-322

Wissing, Martin O-157 Witherspoon, Jolene MO-063, RO-120 Witt, Ulrike RO-261C Witte, S. O-200 Witzke, Oliver O-146, O-199, RO-185 Woeste, Guido MO-067 Wohlfahrt, Peter O-022, O-079, RO-314 Wojniak, Edyta P-150 Wojtusciszyn, Anne O-171 Wolf, Hans H. CC-020 Wolf, Ursula CC-020 Wolterbeck, R. LB-O-006 Wolters, Heiner P-026 Wolyniec, Wojciech RO-193 Wolyniec, Zuzanna LB-P-075, P-228, RO-193 Wolzt, Michael MO-031 Won, Je Hwan LB-P-016 Wong, H.C. P-127 Wong, Schiffon RO-277 Wong, Vincent C.W. P-013 Wood, Katrina O-035, P-288, P-382 Woodland, Joanna M. LB-P-021 Woodle, E. Steve LB-P-029 Woolfenden, Andrew P-037 Worthington, Judith MO-060 Wu, Gang O-042, O-107 Wu, Lehao RO-261F Wu, Wei-Chou P-009 Wu, Yao-Ming P-039 Wunsch, Andreas P-004 Wthrich, Rudolf P-053 Wthrich, Rudolf P. O-207, RO-112, RO-125 Wthrich, Rupolf P. O-112 Xiang, Heli P-043, P-192, P-210 Xiao, Yingming RO-320 Xie, Libo LB-P-002, P-205 Xing, Jun MO-041, O-240, O-243, P-080 Xu, Weiguang P-341 Xue, Wujun P-043, P-192, P-210, RO-175 Yadaval, Reddi P. LB-P-064 Yagi, Takahito MO-051, O-292 Yagisawa, Takashi RO-004 Yago, Kazuo P-109 Yalin, Funda RO-261 Yamada, Shinichiro O-120, P-042, P-325, P-338, P-349, RO-215 Yamada, Tetsu O-276, O-277 Yamamoto, Kenji P-056 Yamamoto, Satoshi P-346, P-356 Yamamoto, Shingo P-297, P-308 Yamamoto, Takayuki P-307 Yamanaka, Kazuaki P-211, P-280 Yamashita, Kenichiro O-208, P-151 Yan, Hang P-043, P-192, P-210 Yang, Ching-Yao P-009 Yang, Guangdong O-175 Yang, H. O-247 Yang, Hyei Mi LB-P-020 Yang, Jaeseok LB-P-009 Yang, Liangjing RO-243 Yang, Shi Yu O-024 Yaqoob, M. O-142, O-147, O-200, P-076 Yaqoob, Magdi CC-010 Yard, Benito MO-040 Yard, Benito A. O-037, O-233 Yaroshenko, Ekaterina B. P-108 Yashi, Masahiro RO-004 Yasumoto, Hiroaki P-024 Yasuo, Mineko P-112, RO-295 Yayahzadeh, Ali O-055, O-250 Yazawa, Koji O-057, P-248 Ye, Wenxue P-167 Ye, Xin P-134 Yegles, Michael RO-039 Yeh, Chi-Chuan P-009 Yilmaz, Utku P-104, P-315

Yonan, Nizar O-118, O-255, O-274, RO-102, RO-234, RO-282, RO-291, RO-344 Yonemoto, Sayoko P-280 Yoon, Dong Sub LB-P-094 Yoon, Samyoul LB-P-102 Yoon, Sam-Youl LB-P-100 Yoon, Se-Hee P-225, RO-330 Yoon, Young Chul LB-P-059 Yoon, Young-Deuk P-225 Yoshida, Atsushi O-329 Yoshida, Eric P-037 Yoshida, Kazunari P-056, P-109, P-201 Yoshida, Ryuichi MO-051, O-292 Yoshida, Tadashi P-151 Yoshimura, Norio RO-117 Yoshitomi, Mami O-309 Yoshizumi, Tomoharu O-040 Young, Richard S. O-007 Ysebaert, Dirk O-157, O-298, RO-057 Ysebaert, Dirk K. MO-019 Yu, Rui Qi RO-243 Yu, Youngdong LB-P-104, LB-P-105 Yu, Yunsheng P-167 Yuan, Xiaodong O-115 Yucetin, Levent O-075, RO-087 Yun, Ik Jin LB-P-034, LB-P-108 Yusof, N. P-127 Yussim, Alexander O-321, RO-012 Zabinska, Marcelina P-273 Zacaria, H. P-368 Zacharia, Hani RO-337 Zadrazil, Josef LB-P-087 Zadrozny, Dariusz P-224 Zagozda, Malgorzata P-168, P-316 Zaitsu, Masaaki O-208, P-151 Zakaria, Mahmoud M. O-229 Zakliczynski, Michael P-150, P-169, RO-156, RO-157 Zal, Frank O-176 Zaleska, Marzanna P-044, RO-180 Zambelli, Marco RO-059, RO-229 Zamboch, Kamil LB-P-087 Zamboni, F. O-123 Zamfirescu, Dragos P-048, RO-292, RO-293 Zampieri, Paolo O-330 Zanaga, Leticia P-208 Zanello, Matteo MO-058, O-009, P-079, RO-307, RO-351 Zanfi, Chiara O-009, O-105, P-364, RO-307 Zangos, Stephan RO-136 Zanus, Giacomo LB-P-091, O-011, O-128, O-191, RO-308 Zaouali, Mohamed Amine MO-071, MO-072, O-020, RO-076 Zavoi, Roxana LB-P-017 Zegrea, Ion P-048

P-114 MO-005, O-214, P-277 O-308 O-267, O-269, O-270 P-095 P-150, P-169, RO-156, RO-157 Zeuzem, Stefan MO-015, P-030, RO-136 Zhang, Dong O-265, RO-296B Zhang, Jinyao MO-008 Zhang, Ming RO-122 Zhang, Qi MO-038, O-211, P-136, RO-339, RO-340, RO-346 Zhang, Rubin P-080 Zhang, Wensheng LB-O-002, O-265, RO-296B Zhao, Xiangdong O-277, RO-248 Zhao, Zhiwei P-381 Zheng, Shiying P-167 Zheng, Xin Xiao LB-O-002, O-265, RO-296A, RO-296B Zhong, Ming-kang RO-122 Zhou, Zexun P-102, P-103 Zhu, Baogong O-331 Zhuang, Jing P-205 Ziaja, Jacek P-343 Zidek, Walter P-101 Ziedina, Ieva LB-P-055 Zieniewicz, Krzysztof P-354, RO-145, RO-300 Zietse, R. MO-084 Zilinska, Zuzana LB-P-039 Zimpfer, Daniel P-157, RO-154 Zink, Michael O-291 Zitta, Sabine RO-261I Zittermann, Armin P-081 Zivanovitch, Nebjosa RO-069C Zivko, Popov P-287 Zokoyev, Alan K. O-319, P-120 Zoller, Rezso RO-279 Zomorrodi, Afshar P-317, P-318 Zomorrodi, Sahar P-317, P-318 Zota, Victor Gheorghe O-069 Zouali, Mohamed Amine LB-P-123 Zuber, Julien O-026, RO-266 Zuckermann, A. O-236, O-237 Zuckermann, Andreas O-125 Zuckermann, Andreas O. P-157, RO-154, RO-161 Zuidema, W.C. MO-084, O-259 Zuidema, Willij MO-088, O-077, P-070 Zuidema, Willij C. O-264 Zumarraga, Carlos MO-059 Zunec, Renata LB-P-014 Zupunski Cede, Ana P-319

Zeidler, Reinhard Zeier, Martin Zein, Nizar Zelger, Bettina Zelvys, Arunas Zembala, Marian

311

312

Programme designed and produced by MWGC 01892 677702 www.webberdesign.co.uk